{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "a8e7a1d7066a4b4f987f45eccc9e8614": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_b2f1cc1759aa4a9da35bdb94042aff13",
              "IPY_MODEL_3aaf7f75bdd243beb591b3165a322611",
              "IPY_MODEL_3ea5569b317d49bdb301cc1cba91e69c"
            ],
            "layout": "IPY_MODEL_2e838c7166a64a988f15e7f7c426285b"
          }
        },
        "b2f1cc1759aa4a9da35bdb94042aff13": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e1c32d724c1945e5b7ad314a9c43cf5e",
            "placeholder": "​",
            "style": "IPY_MODEL_a0e057a0b0ce4d119ee79c949475808a",
            "value": "Downloading: 100%"
          }
        },
        "3aaf7f75bdd243beb591b3165a322611": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f8540b1e39924dcb917d9551ef956215",
            "max": 231508,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_1dd5dc9d2bbb45eab30f024ae3a66a36",
            "value": 231508
          }
        },
        "3ea5569b317d49bdb301cc1cba91e69c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_db01d1793f77498dbc93900872090dc8",
            "placeholder": "​",
            "style": "IPY_MODEL_f9a250341cb34bf2bc4a3b8619e40cb3",
            "value": " 232k/232k [00:00&lt;00:00, 3.28MB/s]"
          }
        },
        "2e838c7166a64a988f15e7f7c426285b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e1c32d724c1945e5b7ad314a9c43cf5e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a0e057a0b0ce4d119ee79c949475808a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f8540b1e39924dcb917d9551ef956215": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1dd5dc9d2bbb45eab30f024ae3a66a36": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "db01d1793f77498dbc93900872090dc8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f9a250341cb34bf2bc4a3b8619e40cb3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "221d707cc39440f69c9d81f2c2a1c372": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_b335cdb18d2e43438546932d7a554761",
              "IPY_MODEL_96569e7d1d1d4c3a9bf2b5eb41d161b2",
              "IPY_MODEL_f98fa073d1d747a9a7e12745f535a60c"
            ],
            "layout": "IPY_MODEL_43390a4f7cf840b3ada0917ab7345aa6"
          }
        },
        "b335cdb18d2e43438546932d7a554761": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_a991d231640a4e26979bb2573a4ac991",
            "placeholder": "​",
            "style": "IPY_MODEL_65a62a5dda2d4f5bb3f6cb11811f808f",
            "value": "Downloading: 100%"
          }
        },
        "96569e7d1d1d4c3a9bf2b5eb41d161b2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_468e1019166649e783e8f18ec67297b6",
            "max": 28,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4c31e7bda81548f2a2cfac3e6b989c72",
            "value": 28
          }
        },
        "f98fa073d1d747a9a7e12745f535a60c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_cd6f05bc0f384a81bf5d03b4efa70d45",
            "placeholder": "​",
            "style": "IPY_MODEL_e2e239c656fd4b43b24004b56d7b3535",
            "value": " 28.0/28.0 [00:00&lt;00:00, 779B/s]"
          }
        },
        "43390a4f7cf840b3ada0917ab7345aa6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a991d231640a4e26979bb2573a4ac991": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "65a62a5dda2d4f5bb3f6cb11811f808f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "468e1019166649e783e8f18ec67297b6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4c31e7bda81548f2a2cfac3e6b989c72": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "cd6f05bc0f384a81bf5d03b4efa70d45": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e2e239c656fd4b43b24004b56d7b3535": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "098a64b1364148d1b650e72ae1a30d55": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f9c013b0e6a34817b23c4f367091d48e",
              "IPY_MODEL_253a6cffbc7c46168b43e27fb2db6840",
              "IPY_MODEL_d2f14e36573340b5bee69e99e23e9b80"
            ],
            "layout": "IPY_MODEL_9516bd39c3e54a4db5fc467b824a178a"
          }
        },
        "f9c013b0e6a34817b23c4f367091d48e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_11c780bfab9a4be59180baa1ee3fc433",
            "placeholder": "​",
            "style": "IPY_MODEL_24b53ff5032347c8b10345e7dc642eab",
            "value": "Downloading: 100%"
          }
        },
        "253a6cffbc7c46168b43e27fb2db6840": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ff0521d4fe0440b09d9232eb0d5914c8",
            "max": 570,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_a259597da2604f98a2b865aee74a4e23",
            "value": 570
          }
        },
        "d2f14e36573340b5bee69e99e23e9b80": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_dede65bed46b41568704d65c7c7bbbe4",
            "placeholder": "​",
            "style": "IPY_MODEL_77374a00c0bc4fd583a3f4cb838041d7",
            "value": " 570/570 [00:00&lt;00:00, 10.2kB/s]"
          }
        },
        "9516bd39c3e54a4db5fc467b824a178a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "11c780bfab9a4be59180baa1ee3fc433": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "24b53ff5032347c8b10345e7dc642eab": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ff0521d4fe0440b09d9232eb0d5914c8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a259597da2604f98a2b865aee74a4e23": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "dede65bed46b41568704d65c7c7bbbe4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "77374a00c0bc4fd583a3f4cb838041d7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d1ddd4c416494eeaa30648eb6c94783d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_b1a0f6de49aa4d629d972cd4649538c5",
              "IPY_MODEL_843725fc45da4889b8b119fcb0caad50",
              "IPY_MODEL_8e44c4e3abaf40ac832fa7cbbc85a8f2"
            ],
            "layout": "IPY_MODEL_46481f3be96948b390538d52a1300dff"
          }
        },
        "b1a0f6de49aa4d629d972cd4649538c5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c5012b62253542dda12e4df98bbdcb2e",
            "placeholder": "​",
            "style": "IPY_MODEL_1d51d0df5ae1403f802d79226e460e29",
            "value": "Downloading: 100%"
          }
        },
        "843725fc45da4889b8b119fcb0caad50": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ead04d73417e4c828e6456733ed18b65",
            "max": 440473133,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_9d116e218ca14febb31ba38d2863a56e",
            "value": 440473133
          }
        },
        "8e44c4e3abaf40ac832fa7cbbc85a8f2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_aa6f3119ecb04cbe8a95de93a55460c8",
            "placeholder": "​",
            "style": "IPY_MODEL_8f6241d5cdec4e39a29c7c2d7c8f798b",
            "value": " 440M/440M [00:09&lt;00:00, 47.5MB/s]"
          }
        },
        "46481f3be96948b390538d52a1300dff": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c5012b62253542dda12e4df98bbdcb2e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1d51d0df5ae1403f802d79226e460e29": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ead04d73417e4c828e6456733ed18b65": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9d116e218ca14febb31ba38d2863a56e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "aa6f3119ecb04cbe8a95de93a55460c8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8f6241d5cdec4e39a29c7c2d7c8f798b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "<a href=\"https://nbviewer.org/github/alisonmitchell/Stock-Prediction/blob/main/Sentiment_Analysis/BERT_Long_Text_Classification.ipynb\" \n",
        "   target=\"_parent\">\n",
        "   <img src=\"https://raw.githubusercontent.com/jupyter/design/master/logos/Badges/nbviewer_badge.svg\" \n",
        "      width=\"109\" height=\"20\" alt=\"render in nbviewer\">\n",
        "</a>"
      ],
      "metadata": {
        "id": "Zn-VwSgdnqtL"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "pmu27SbyX2a5"
      },
      "source": [
        "# Sentiment Classification for long text inputs using BERT with a PyTorch interface from the Hugging Face Transformers library\n",
        "\n",
        "## 1. Introduction\n",
        "\n",
        "BERT (Bidirectional Encoder Representations from Transformers) is a transfer learning technique for NLP developed by Google, and is the first deeply bidirectional, unsupervised and contextual language representation, pre-trained using only a plain text corpus. It is used to create models that can be downloaded, modified, fine-tuned and implemented to extract high quality language features from text or for a specific task (e.g. classification, entity recognition, question answering) to produce predictions. \n",
        "\n",
        "Here we will investigate the influence of news article sentiment on next-day AstraZeneca stock price direction by fine-tuning BERT for sentiment analysis, performing the required text preprocessing and formatting, building a Sentiment Classifier with the Hugging Face transformers library, and evaluating the model on test data.\n",
        "\n",
        "For our supervised task of classifying sentiment as positive (1) or negative (0) we will fine-tune a pre-trained BERT model to give outputs for classification using the BertForSequenceClassification class. This adds a single untrained linear layer on top of the pooled output so that, as we add data, the pre-trained BERT model and the additional untrained classification layer is trained on our article sentiment classification task.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "QxhV44JabF4J"
      },
      "source": [
        "## 2. Install/import libraries\n",
        "\n",
        "Firstly, we will install the Hugging Face transformers library to give us a PyTorch interface for working with BERT. This strikes a balance between high-level APIs and TensorFlow code and is the most widely accepted and powerful PyTorch interface for working with BERT. In addition to supporting a variety of different pre-trained transformer models, the library also includes pre-built modifications of those models, or task-specific classes, to simplify the process of modifying BERT for our purposes.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "ARUJ2CWgpKp2",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "bc9760a1-5f1a-4170-9cc3-5b08e66d93ab"
      },
      "source": [
        "!pip install transformers"
      ],
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Looking in indexes: https://pypi.org/simple, https://us-python.pkg.dev/colab-wheels/public/simple/\n",
            "Collecting transformers\n",
            "  Downloading transformers-4.24.0-py3-none-any.whl (5.5 MB)\n",
            "\u001b[K     |████████████████████████████████| 5.5 MB 17.0 MB/s \n",
            "\u001b[?25hRequirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.7/dist-packages (from transformers) (21.3)\n",
            "Requirement already satisfied: importlib-metadata in /usr/local/lib/python3.7/dist-packages (from transformers) (4.13.0)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.7/dist-packages (from transformers) (3.8.0)\n",
            "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.7/dist-packages (from transformers) (4.64.1)\n",
            "Collecting tokenizers!=0.11.3,<0.14,>=0.11.1\n",
            "  Downloading tokenizers-0.13.1-cp37-cp37m-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (7.6 MB)\n",
            "\u001b[K     |████████████████████████████████| 7.6 MB 49.9 MB/s \n",
            "\u001b[?25hCollecting huggingface-hub<1.0,>=0.10.0\n",
            "  Downloading huggingface_hub-0.10.1-py3-none-any.whl (163 kB)\n",
            "\u001b[K     |████████████████████████████████| 163 kB 56.5 MB/s \n",
            "\u001b[?25hRequirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.7/dist-packages (from transformers) (6.0)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.7/dist-packages (from transformers) (2022.6.2)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.7/dist-packages (from transformers) (2.23.0)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.7/dist-packages (from transformers) (1.21.6)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.7/dist-packages (from huggingface-hub<1.0,>=0.10.0->transformers) (4.1.1)\n",
            "Requirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /usr/local/lib/python3.7/dist-packages (from packaging>=20.0->transformers) (3.0.9)\n",
            "Requirement already satisfied: zipp>=0.5 in /usr/local/lib/python3.7/dist-packages (from importlib-metadata->transformers) (3.10.0)\n",
            "Requirement already satisfied: idna<3,>=2.5 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (2.10)\n",
            "Requirement already satisfied: chardet<4,>=3.0.2 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (3.0.4)\n",
            "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (1.24.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (2022.9.24)\n",
            "Installing collected packages: tokenizers, huggingface-hub, transformers\n",
            "Successfully installed huggingface-hub-0.10.1 tokenizers-0.13.1 transformers-4.24.0\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "9eZI2pHvpNLQ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "534bb474-2f1e-4bab-9eba-25d87140c835"
      },
      "source": [
        "# Libraries\n",
        "import torch\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "import nltk\n",
        "import time\n",
        "import datetime\n",
        "import random\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "# Tokenize to add stopwords\n",
        "from nltk import word_tokenize\n",
        "nltk.download('punkt')\n",
        "nltk.download('stopwords')\n",
        "nltk.download('wordnet')\n",
        "from nltk.corpus import stopwords\n",
        "\n",
        "# Data loading utility\n",
        "from torch.utils.data import Dataset, TensorDataset, DataLoader, RandomSampler, SequentialSampler, random_split\n",
        "\n",
        "# Models\n",
        "from torch import nn\n",
        "from transformers import BertModel, BertTokenizer, BertForSequenceClassification, AdamW, get_linear_schedule_with_warmup\n",
        "from transformers import logging\n",
        "logging.set_verbosity_error()\n",
        "\n",
        "# Training\n",
        "from torch import optim\n",
        "\n",
        "# Evaluation\n",
        "from sklearn.metrics import accuracy_score, matthews_corrcoef\n",
        "\n",
        "%matplotlib inline\n",
        "\n",
        "# specify GPU device\n",
        "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")"
      ],
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt.zip.\n",
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Unzipping corpora/stopwords.zip.\n",
            "[nltk_data] Downloading package wordnet to /root/nltk_data...\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6Ylon7DbbRSJ"
      },
      "source": [
        "## 3. Import data\n",
        "\n",
        "Read article sentiment and historical stock price data into a DataFrame. "
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "uT3P5rwuptGq",
        "outputId": "0cd97663-e298-4b16-cbe3-1552f666d16d"
      },
      "source": [
        "article_sentiments = pd.read_csv('/azn_prices_labels_news_updated.csv') \n",
        "article_sentiments"
      ],
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "           Date  Adj Close Next  Label     Open          High           Low  \\\n",
              "0    2020-01-10     7070.484375      1   7690.0   7717.000000   7608.000000   \n",
              "1    2020-02-10     7105.605957      0   7659.0   7710.000000   7610.000000   \n",
              "2    2020-03-12     5955.197266      1   6692.0   6778.000000   6314.000000   \n",
              "3    2020-05-11     8350.098633      1   8549.0   8719.000000   8522.000000   \n",
              "4    2020-06-10     7803.232422      0   8237.0   8444.219727   8170.000000   \n",
              "..          ...             ...    ...      ...           ...           ...   \n",
              "141  2022-09-27    10076.000000      1   9897.0   9995.000000   9795.586914   \n",
              "142  2022-10-24     9753.000000      0   9594.0   9823.000000   9594.000000   \n",
              "143  2022-10-26     9951.000000      0   9800.0  10038.000000   9789.675781   \n",
              "144  2022-10-27    10124.000000      1  10042.0  10100.000000   9899.000000   \n",
              "145  2022-11-02    10682.000000      1  10452.0  10560.000000  10424.000000   \n",
              "\n",
              "       Close     Adj Close   Volume  Unnamed: 0  ...  \\\n",
              "0     7645.0   7065.863770  1020795         331  ...   \n",
              "1     7710.0   7125.938965  1136979         324  ...   \n",
              "2     6314.0   5953.311523  4529777         248  ...   \n",
              "3     8707.0   8209.611328  1908220         283  ...   \n",
              "4     8404.0   7923.920410  2515293         310  ...   \n",
              "..       ...           ...      ...         ...  ...   \n",
              "141   9923.0   9923.000000  2973886          11  ...   \n",
              "142   9782.0   9782.000000   987863         285  ...   \n",
              "143  10034.0  10034.000000  3656171           1  ...   \n",
              "144   9951.0   9951.000000  1891142           2  ...   \n",
              "145  10520.0  10520.000000  1219515          77  ...   \n",
              "\n",
              "                                             body_text  \\\n",
              "0    Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "1    2/2 Â© Reuters. FILE PHOTO: Small toy figures ...   \n",
              "2    Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "3    Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...   \n",
              "4    Â© Reuters. FILE PHOTO: A sign is pictured out...   \n",
              "..                                                 ...   \n",
              "141  Â© Reuters AstraZeneca gets its third regulato...   \n",
              "142  2/2 Â© Reuters. FILE PHOTO: A test tube labell...   \n",
              "143  AstraZeneca Touts Positive Data From Two Exper...   \n",
              "144  AstraZeneca's Ultomiris Showed Zero Relapses I...   \n",
              "145  Â© Reuters.\\n \\n BATS +0.79% Add to/Remove fro...   \n",
              "\n",
              "                                                   url    neg    neu    pos  \\\n",
              "0    https://uk.investing.com//news/stock-market-ne...  0.073  0.900  0.027   \n",
              "1    https://uk.investing.com//news/stock-market-ne...  0.058  0.872  0.070   \n",
              "2    https://uk.investing.com//news/stock-market-ne...  0.055  0.900  0.045   \n",
              "3    https://uk.investing.com//news/stock-market-ne...  0.028  0.895  0.077   \n",
              "4    https://uk.investing.com//news/coronavirus/eu-...  0.000  0.965  0.035   \n",
              "..                                                 ...    ...    ...    ...   \n",
              "141  https://uk.investing.com//news/stock-market-ne...  0.059  0.847  0.094   \n",
              "142  https://uk.investing.com//news/coronavirus/ast...  0.040  0.897  0.063   \n",
              "143                             https://invst.ly/zbmyz  0.304  0.497  0.199   \n",
              "144                             https://invst.ly/zcazg  0.172  0.828  0.000   \n",
              "145  https://uk.investing.com//news/stock-market-ne...  0.037  0.878  0.085   \n",
              "\n",
              "     compound                                      news_combined  \\\n",
              "0     -0.9274  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "1      0.7218  2/2 Â© Reuters. FILE PHOTO: Small toy figures ...   \n",
              "2     -0.3612  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "3      0.9566  Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...   \n",
              "4      0.6486  Â© Reuters. FILE PHOTO: A sign is pictured out...   \n",
              "..        ...                                                ...   \n",
              "141    0.6682  Â© Reuters AstraZeneca gets its third regulato...   \n",
              "142    0.9268  2/2 Â© Reuters. FILE PHOTO: A test tube labell...   \n",
              "143   -0.2263  AstraZeneca Touts Positive Data From Two Exper...   \n",
              "144   -0.4019  AstraZeneca's Ultomiris Showed Zero Relapses I...   \n",
              "145    0.9493  Â© Reuters.\\n \\n BATS +0.79% Add to/Remove fro...   \n",
              "\n",
              "                                          news_cleaned  subjectivity  polarity  \n",
              "0    Â Reuters    UK100 203 Add toRemove from a Por...      0.381333  0.045438  \n",
              "1    22 Â Reuters FILE PHOTO Small toy figures are ...      0.335507  0.077174  \n",
              "2    Â Reuters    UK100 203 Add toRemove from a Por...      0.539865  0.118784  \n",
              "3    Â Reuters    AVV 016 Add toRemove from a Portf...      0.425210  0.096054  \n",
              "4    Â Reuters FILE PHOTO A sign is pictured outsid...      0.321625  0.080579  \n",
              "..                                                 ...           ...       ...  \n",
              "141  Â Reuters AstraZeneca gets its third regulator...      0.515278  0.160516  \n",
              "142  22 Â Reuters FILE PHOTO A test tube labelled w...      0.390848  0.028757  \n",
              "143  AstraZeneca Touts Positive Data From Two Exper...      0.521307  0.187784  \n",
              "144  AstraZeneca's Ultomiris Showed Zero Relapses I...      0.000000  0.000000  \n",
              "145  Â Reuters    BATS 079 Add toRemove from a Port...      0.298024 -0.023781  \n",
              "\n",
              "[146 rows x 23 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-02465558-0371-4864-aab2-d9d3c8006f8f\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Date</th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>...</th>\n",
              "      <th>body_text</th>\n",
              "      <th>url</th>\n",
              "      <th>neg</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2020-01-10</td>\n",
              "      <td>7070.484375</td>\n",
              "      <td>1</td>\n",
              "      <td>7690.0</td>\n",
              "      <td>7717.000000</td>\n",
              "      <td>7608.000000</td>\n",
              "      <td>7645.0</td>\n",
              "      <td>7065.863770</td>\n",
              "      <td>1020795</td>\n",
              "      <td>331</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.073</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.027</td>\n",
              "      <td>-0.9274</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.381333</td>\n",
              "      <td>0.045438</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2020-02-10</td>\n",
              "      <td>7105.605957</td>\n",
              "      <td>0</td>\n",
              "      <td>7659.0</td>\n",
              "      <td>7710.000000</td>\n",
              "      <td>7610.000000</td>\n",
              "      <td>7710.0</td>\n",
              "      <td>7125.938965</td>\n",
              "      <td>1136979</td>\n",
              "      <td>324</td>\n",
              "      <td>...</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: Small toy figures ...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.058</td>\n",
              "      <td>0.872</td>\n",
              "      <td>0.070</td>\n",
              "      <td>0.7218</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: Small toy figures ...</td>\n",
              "      <td>22 Â Reuters FILE PHOTO Small toy figures are ...</td>\n",
              "      <td>0.335507</td>\n",
              "      <td>0.077174</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2020-03-12</td>\n",
              "      <td>5955.197266</td>\n",
              "      <td>1</td>\n",
              "      <td>6692.0</td>\n",
              "      <td>6778.000000</td>\n",
              "      <td>6314.000000</td>\n",
              "      <td>6314.0</td>\n",
              "      <td>5953.311523</td>\n",
              "      <td>4529777</td>\n",
              "      <td>248</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.055</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.045</td>\n",
              "      <td>-0.3612</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.539865</td>\n",
              "      <td>0.118784</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2020-05-11</td>\n",
              "      <td>8350.098633</td>\n",
              "      <td>1</td>\n",
              "      <td>8549.0</td>\n",
              "      <td>8719.000000</td>\n",
              "      <td>8522.000000</td>\n",
              "      <td>8707.0</td>\n",
              "      <td>8209.611328</td>\n",
              "      <td>1908220</td>\n",
              "      <td>283</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.028</td>\n",
              "      <td>0.895</td>\n",
              "      <td>0.077</td>\n",
              "      <td>0.9566</td>\n",
              "      <td>Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...</td>\n",
              "      <td>Â Reuters    AVV 016 Add toRemove from a Portf...</td>\n",
              "      <td>0.425210</td>\n",
              "      <td>0.096054</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>2020-06-10</td>\n",
              "      <td>7803.232422</td>\n",
              "      <td>0</td>\n",
              "      <td>8237.0</td>\n",
              "      <td>8444.219727</td>\n",
              "      <td>8170.000000</td>\n",
              "      <td>8404.0</td>\n",
              "      <td>7923.920410</td>\n",
              "      <td>2515293</td>\n",
              "      <td>310</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters. FILE PHOTO: A sign is pictured out...</td>\n",
              "      <td>https://uk.investing.com//news/coronavirus/eu-...</td>\n",
              "      <td>0.000</td>\n",
              "      <td>0.965</td>\n",
              "      <td>0.035</td>\n",
              "      <td>0.6486</td>\n",
              "      <td>Â© Reuters. FILE PHOTO: A sign is pictured out...</td>\n",
              "      <td>Â Reuters FILE PHOTO A sign is pictured outsid...</td>\n",
              "      <td>0.321625</td>\n",
              "      <td>0.080579</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141</th>\n",
              "      <td>2022-09-27</td>\n",
              "      <td>10076.000000</td>\n",
              "      <td>1</td>\n",
              "      <td>9897.0</td>\n",
              "      <td>9995.000000</td>\n",
              "      <td>9795.586914</td>\n",
              "      <td>9923.0</td>\n",
              "      <td>9923.000000</td>\n",
              "      <td>2973886</td>\n",
              "      <td>11</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters AstraZeneca gets its third regulato...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.059</td>\n",
              "      <td>0.847</td>\n",
              "      <td>0.094</td>\n",
              "      <td>0.6682</td>\n",
              "      <td>Â© Reuters AstraZeneca gets its third regulato...</td>\n",
              "      <td>Â Reuters AstraZeneca gets its third regulator...</td>\n",
              "      <td>0.515278</td>\n",
              "      <td>0.160516</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>142</th>\n",
              "      <td>2022-10-24</td>\n",
              "      <td>9753.000000</td>\n",
              "      <td>0</td>\n",
              "      <td>9594.0</td>\n",
              "      <td>9823.000000</td>\n",
              "      <td>9594.000000</td>\n",
              "      <td>9782.0</td>\n",
              "      <td>9782.000000</td>\n",
              "      <td>987863</td>\n",
              "      <td>285</td>\n",
              "      <td>...</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: A test tube labell...</td>\n",
              "      <td>https://uk.investing.com//news/coronavirus/ast...</td>\n",
              "      <td>0.040</td>\n",
              "      <td>0.897</td>\n",
              "      <td>0.063</td>\n",
              "      <td>0.9268</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: A test tube labell...</td>\n",
              "      <td>22 Â Reuters FILE PHOTO A test tube labelled w...</td>\n",
              "      <td>0.390848</td>\n",
              "      <td>0.028757</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143</th>\n",
              "      <td>2022-10-26</td>\n",
              "      <td>9951.000000</td>\n",
              "      <td>0</td>\n",
              "      <td>9800.0</td>\n",
              "      <td>10038.000000</td>\n",
              "      <td>9789.675781</td>\n",
              "      <td>10034.0</td>\n",
              "      <td>10034.000000</td>\n",
              "      <td>3656171</td>\n",
              "      <td>1</td>\n",
              "      <td>...</td>\n",
              "      <td>AstraZeneca Touts Positive Data From Two Exper...</td>\n",
              "      <td>https://invst.ly/zbmyz</td>\n",
              "      <td>0.304</td>\n",
              "      <td>0.497</td>\n",
              "      <td>0.199</td>\n",
              "      <td>-0.2263</td>\n",
              "      <td>AstraZeneca Touts Positive Data From Two Exper...</td>\n",
              "      <td>AstraZeneca Touts Positive Data From Two Exper...</td>\n",
              "      <td>0.521307</td>\n",
              "      <td>0.187784</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144</th>\n",
              "      <td>2022-10-27</td>\n",
              "      <td>10124.000000</td>\n",
              "      <td>1</td>\n",
              "      <td>10042.0</td>\n",
              "      <td>10100.000000</td>\n",
              "      <td>9899.000000</td>\n",
              "      <td>9951.0</td>\n",
              "      <td>9951.000000</td>\n",
              "      <td>1891142</td>\n",
              "      <td>2</td>\n",
              "      <td>...</td>\n",
              "      <td>AstraZeneca's Ultomiris Showed Zero Relapses I...</td>\n",
              "      <td>https://invst.ly/zcazg</td>\n",
              "      <td>0.172</td>\n",
              "      <td>0.828</td>\n",
              "      <td>0.000</td>\n",
              "      <td>-0.4019</td>\n",
              "      <td>AstraZeneca's Ultomiris Showed Zero Relapses I...</td>\n",
              "      <td>AstraZeneca's Ultomiris Showed Zero Relapses I...</td>\n",
              "      <td>0.000000</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>145</th>\n",
              "      <td>2022-11-02</td>\n",
              "      <td>10682.000000</td>\n",
              "      <td>1</td>\n",
              "      <td>10452.0</td>\n",
              "      <td>10560.000000</td>\n",
              "      <td>10424.000000</td>\n",
              "      <td>10520.0</td>\n",
              "      <td>10520.000000</td>\n",
              "      <td>1219515</td>\n",
              "      <td>77</td>\n",
              "      <td>...</td>\n",
              "      <td>Â© Reuters.\\n \\n BATS +0.79% Add to/Remove fro...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.037</td>\n",
              "      <td>0.878</td>\n",
              "      <td>0.085</td>\n",
              "      <td>0.9493</td>\n",
              "      <td>Â© Reuters.\\n \\n BATS +0.79% Add to/Remove fro...</td>\n",
              "      <td>Â Reuters    BATS 079 Add toRemove from a Port...</td>\n",
              "      <td>0.298024</td>\n",
              "      <td>-0.023781</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>146 rows × 23 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-02465558-0371-4864-aab2-d9d3c8006f8f')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-02465558-0371-4864-aab2-d9d3c8006f8f button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-02465558-0371-4864-aab2-d9d3c8006f8f');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "46Rad66hbnQI"
      },
      "source": [
        "## 4. Data Exploration\n",
        "\n",
        "Check data using info() method to show number of samples, columns, data types and any missing values.\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6g4mffdfw5Vh",
        "outputId": "070860a9-4340-407f-92a7-f27bc0ee9d4b"
      },
      "source": [
        "article_sentiments.info()"
      ],
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'pandas.core.frame.DataFrame'>\n",
            "RangeIndex: 146 entries, 0 to 145\n",
            "Data columns (total 23 columns):\n",
            " #   Column          Non-Null Count  Dtype  \n",
            "---  ------          --------------  -----  \n",
            " 0   Date            146 non-null    object \n",
            " 1   Adj Close Next  146 non-null    float64\n",
            " 2   Label           146 non-null    int64  \n",
            " 3   Open            146 non-null    float64\n",
            " 4   High            146 non-null    float64\n",
            " 5   Low             146 non-null    float64\n",
            " 6   Close           146 non-null    float64\n",
            " 7   Adj Close       146 non-null    float64\n",
            " 8   Volume          146 non-null    int64  \n",
            " 9   Unnamed: 0      146 non-null    int64  \n",
            " 10  ticker          146 non-null    object \n",
            " 11  publish_date    146 non-null    object \n",
            " 12  title           146 non-null    object \n",
            " 13  body_text       146 non-null    object \n",
            " 14  url             146 non-null    object \n",
            " 15  neg             146 non-null    float64\n",
            " 16  neu             146 non-null    float64\n",
            " 17  pos             146 non-null    float64\n",
            " 18  compound        146 non-null    float64\n",
            " 19  news_combined   146 non-null    object \n",
            " 20  news_cleaned    146 non-null    object \n",
            " 21  subjectivity    146 non-null    float64\n",
            " 22  polarity        146 non-null    float64\n",
            "dtypes: float64(12), int64(3), object(8)\n",
            "memory usage: 26.4+ KB\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "t4gOxXiALS6X"
      },
      "source": [
        "### 4.1 Data visualisation for price direction and sentiment label counts\n",
        "The Label column was created by calculating whether the next-day Adjusted Close price increased/held or decreased.\n",
        "\n",
        "Where prices either rose or held, the classes have been combined giving a value of '1' , and a value of '0' indicates where prices fell. "
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot showing whether Adjusted Close price increased/held or decreased\n",
        "\n",
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (8,5)\n",
        "\n",
        "# Plot the counts of observations in each categorical bin \n",
        "sns.countplot(article_sentiments.Label)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Next day Adjusted Close Price direction')\n",
        "plt.xlabel('0 = price fell, 1 = price rose/held');"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 372
        },
        "id": "UCq0EarpZ7Iu",
        "outputId": "ef6d30e2-a97d-43f4-bfeb-c33ac133d636"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 576x360 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "ta1B8GEQMIdV"
      },
      "source": [
        "Combining the increased and held classes gives a fairly even balance with the class where prices fell. We will convert the dataset into negative and neutral/positive sentiment so that a drop in price corresponds to negative sentiment and a rise or hold to positive sentiment."
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot showing Adjusted Close prices converted to sentiment\n",
        "\n",
        "def to_sentiment(label):\n",
        "  \"\"\"\n",
        "  Convert dataset into negative and neutral/positive sentiment\n",
        "  \"\"\"\n",
        "  label = int(label)\n",
        "  if label == 0:\n",
        "    return 0\n",
        "  else:\n",
        "    return 1\n",
        "\n",
        "article_sentiments['sentiment'] = article_sentiments.Label.apply(to_sentiment)\n",
        "\n",
        "class_names = ['negative', 'positive/neutral']\n",
        "\n",
        "# Plot the counts of observations in each categorical bin \n",
        "ax = sns.countplot(article_sentiments.sentiment)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Price direction converted to article sentiment')\n",
        "plt.xlabel('article sentiment')\n",
        "ax.set_xticklabels(class_names);"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 372
        },
        "id": "-XZN5sYye1JA",
        "outputId": "890dc069-f0c0-4c54-99df-e7c5854fb445"
      },
      "execution_count": 7,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 576x360 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "BQrH-vkGRTIn"
      },
      "source": [
        "The properties we are interested in are the individual articles (news_cleaned) and their label which we will now interpret as sentiment with '1' being neutral/positive and '0' being negative."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "gwKMnsGsXt9Y"
      },
      "source": [
        "# Extract the articles and their labels as numpy ndarrays \n",
        "\n",
        "articles = article_sentiments.news_cleaned.values\n",
        "labels = article_sentiments.Label.values\n"
      ],
      "execution_count": 8,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "yteAxv8nfADK"
      },
      "source": [
        "## 5. Text preprocessing\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 5.1 Tokensation\n",
        "\n",
        "Tokenisation is a way of separating text into smaller units called tokens, most commonly using space as a delimiter. Types can be broadly classified as word, character and subword (n-gram) tokenisation.\n",
        "\n",
        "Word tokenisation is the most commonly used tokenisation algorithm and splits words into their own strings to facilitate counting, for example."
      ],
      "metadata": {
        "id": "DgD1daDfu4Md"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Pq7lBkH0mufs",
        "outputId": "cd058ebc-26c1-4ea9-ab99-2dba4356c100"
      },
      "source": [
        "tokens = [word_tokenize(article) for article in articles]\n",
        "text = nltk.Text(tokens)\n",
        "text"
      ],
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Text: ['Â', 'Reuters', 'UK100', '203', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SHEL', '077', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RR', '617', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SN', '130', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'NG', '039', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'HBR', '142', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'DLAR', '010', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Oct', '1', 'Reuters', 'Britain', \"'s\", 'FTSE', '100', 'index', 'is', 'seen', 'opening', '25', 'points', 'higher', 'at', '5891', 'on', 'Thursday', 'according', 'to', 'financial', 'bookmakers', 'with', 'futures', 'up', '047', 'ahead', 'of', 'cash', 'market', 'open', 'Smith', 'Nephew', 'Medical', 'prosthetics', 'maker', 'Smith', 'Nephew', 'Plc', 'expects', 'its', 'decline', 'in', 'underlying', 'revenue', 'in', 'the', 'third', 'quarter', 'of', 'this', 'year', 'down', 'from', 'almost', '30', 'in', 'the', 'previous', 'three', 'months', 'when', 'it', 'was', 'suffering', 'heavily', 'from', 'the', 'impact', 'of', 'coronavirus', 'lockdowns', 'and', 'a', 'halt', 'in', 'elective', 'procedures', 'RollsRoyce', 'Britain', \"'s\", 'RollsRoyce', 'said', 'it', 'planned', 'to', 'from', 'shareholders', '1', 'billion', 'pounds', 'from', 'the', 'bond', 'market', 'and', 'secure', 'further', 'loans', 'to', 'rebuild', 'its', 'balance', 'sheet', 'after', 'COVID19', 'Premier', 'Oil', 'Creditors', 'of', 'North', 'Seafocused', 'Premier', 'Oil', 'have', 'extended', 'a', 'waiver', 'for', 'the', 'group', \"'s\", 'debt', 'covenant', 'test', 'giving', 'it', 'breathing', 'space', 'to', 'avoid', 'a', 'debt', 'crunch', 'the', 'company', 'said', 'on', 'Thursday', 'De', 'La', 'Rue', 'Banknote', 'printer', 'De', 'La', 'Rue', 'on', 'Thursday', 'named', 'Rob', 'Harding', 'after', 'appointing', 'him', 'as', 'the', 'interim', 'CFO', 'earlier', 'this', 'year', 'National', 'Grid', 'National', 'Grid', 'on', 'Thursday', 'pledged', 'to', 'by', '2030', 'which', 'will', 'see', 'it', 'reduce', 'emissions', 'relating', 'to', 'the', 'gas', 'and', 'electricity', 'it', 'sells', 'in', 'markets', 'such', 'as', 'the', 'United', 'States', 'and', 'Britain', 'AstraZeneca', 'The', 'US', 'Food', 'and', 'Drug', 'Administration', 'has', 'of', 'a', 'serious', 'illness', 'in', 'AstraZeneca', 'Plc', \"'s\", 'COVID19', 'vaccine', 'study', 'and', 'will', 'look', 'at', 'data', 'from', 'earlier', 'trials', 'of', 'similar', 'vaccines', 'developed', 'by', 'the', 'same', 'scientists', 'three', 'sources', 'familiar', 'with', 'the', 'details', 'told', 'Reuters', 'Woodford', 'The', 'collapsed', 'Woodford', 'equity', 'income', 'fund', 'has', '288', 'million', 'pounds', 'in', 'remaining', 'assets', 'its', 'authorised', 'corporate', 'director', 'said', 'on', 'Wednesday', 'The', 'UK', 'bluechip', 'index', 'closed', '05', 'lower', 'on', 'Wednesday', 'after', 'a', 'bleak', 'production', 'forecast', 'from', 'Shell', 'and', 'losses', 'in', 'consumer', 'stocks', 'weighed', 'on', 'the', 'index', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'with', 'the', 'Vaccine', 'is', 'seen', 'in', 'front', 'of', 'AstraZeneca', 'logo', 'in', 'this', 'illustration', 'taken', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '140', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'JNJ', '045', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'MRNA', '740', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Marisa', 'Taylor', 'and', 'Dan', 'Levine', 'WASHINGTON', 'Reuters', 'The', 'US', 'Food', 'and', 'Drug', 'Administration', 'has', 'broadened', 'its', 'investigation', 'of', 'a', 'serious', 'illness', 'in', 'AstraZeneca', 'Plc', \"'s\", 'L', 'COVID19', 'vaccine', 'study', 'and', 'will', 'look', 'at', 'data', 'from', 'earlier', 'trials', 'of', 'similar', 'vaccines', 'developed', 'by', 'the', 'same', 'scientists', 'three', 'sources', 'familiar', 'with', 'the', 'details', 'told', 'Reuters', 'AstraZeneca', \"'s\", 'large', 'latestage', 'US', 'trial', 'has', 'remained', 'on', 'hold', 'since', 'Sept', '6', 'after', 'a', 'study', 'participant', 'in', 'Britain', 'fell', 'ill', 'with', 'what', 'was', 'believed', 'to', 'be', 'a', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'The', 'widened', 'scope', 'of', 'the', 'FDA', 'probe', 'raises', 'the', 'likelihood', 'of', 'additional', 'delays', 'for', 'what', 'has', 'been', 'one', 'of', 'the', 'most', 'advanced', 'COVID19', 'vaccine', 'candidates', 'in', 'development', 'The', 'requested', 'data', 'was', 'expected', 'to', 'arrive', 'this', 'week', 'after', 'which', 'the', 'FDA', 'would', 'need', 'time', 'to', 'analyze', 'it', 'two', 'of', 'the', 'sources', 'said', 'Effective', 'vaccines', 'are', 'seen', 'as', 'essential', 'to', 'help', 'end', 'a', 'pandemic', 'that', 'has', 'killed', 'more', 'than', 'one', 'million', 'people', 'worldwide', 'The', 'administration', 'of', 'President', 'Donald', 'Trump', 'has', 'pledged', '12', 'billion', 'to', 'support', 'development', 'of', 'the', 'AstraZeneca', 'vaccine', 'and', 'secure', '300', 'million', 'doses', 'for', 'the', 'United', 'States', 'Other', 'leading', 'companies', 'in', 'the', 'US', 'vaccine', 'race', 'include', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'and', 'Johnson', 'Johnson', 'N', 'Regulators', 'in', 'the', 'UK', 'Brazil', 'India', 'and', 'South', 'Africa', 'have', 'allowed', 'AstraZeneca', 'to', 'resume', 'its', 'clinical', 'trials', 'there', 'The', 'FDA', 'however', 'wants', 'to', 'determine', 'whether', 'similar', 'side', 'effects', 'emerged', 'in', 'trials', 'of', 'other', 'vaccines', 'designed', 'by', 'AstraZeneca', \"'s\", 'coronavirus', 'vaccine', 'partner', 'researchers', 'at', 'Oxford', 'University', 'the', 'sources', 'said', 'That', 'does', 'not', 'mean', 'the', 'agency', 'believes', 'there', 'were', 'safety', 'issues', 'associated', 'with', 'any', 'of', 'these', 'vaccines', 'they', 'added', 'It', 'just', 'shows', 'that', 'the', 'FDA', 'is', 'being', 'thorough', 'said', 'one', 'of', 'the', 'sources', 'Further', 'complicating', 'the', 'situation', 'is', 'that', 'the', 'data', 'requested', 'by', 'FDA', 'is', 'in', 'a', 'different', 'format', 'than', 'what', 'the', 'US', 'regulator', 'requires', 'two', 'of', 'the', 'sources', 'said', 'The', 'FDA', 'declined', 'to', 'comment', 'on', 'discussions', 'involving', 'an', 'experimental', 'product', 'Oxford', 'did', 'not', 'respond', 'to', 'requests', 'for', 'comment', 'AstraZeneca', 'in', 'a', 'statement', 'said', 'We', 'are', 'continuing', 'to', 'work', 'with', 'the', 'FDA', 'to', 'facilitate', 'review', 'of', 'the', 'information', 'needed', 'to', 'make', 'a', 'decision', 'regarding', 'resumption', 'of', 'the', 'US', 'trial', 'VIRAL', 'VECTOR', 'All', 'of', 'the', 'vaccines', 'it', 'wants', 'to', 'review', 'use', 'a', 'modified', 'adenovirus', 'as', 'vectors', 'to', 'safely', 'deliver', 'genetic', 'material', 'from', 'the', 'target', 'illnesses', 'flu', 'Middle', 'East', 'Respiratory', 'Syndrome', 'and', 'other', 'diseases', 'into', 'the', 'body', 'to', 'stimulate', 'an', 'immune', 'system', 'response', 'to', 'fight', 'future', 'infection', 'While', 'other', 'vaccine', 'developers', 'have', 'used', 'human', 'adenoviruses', 'for', 'such', 'vaccines', 'the', 'Oxford', 'researchers', 'chose', 'an', 'adenovirus', 'found', 'in', 'chimpanzees', 'They', 'felt', 'this', 'would', 'reduce', 'the', 'likelihood', 'that', 'an', 'individual', \"'s\", 'immune', 'system', 'would', 'attack', 'the', 'vector', 'virus', 'due', 'to', 'prior', 'exposure', 'rather', 'than', 'the', 'intended', 'target', 'Reuters', 'reviewed', 'six', 'research', 'papers', 'that', 'detailed', 'safety', 'data', 'of', 'vaccines', 'using', 'the', 'engineered', 'chimpanzee', 'adenovirus', 'called', 'ChAdOx1', 'for', 'diseases', 'including', 'tuberculosis', 'prostate', 'cancer', 'and', 'influenza', 'In', 'one', 'of', 'those', 'trials', 'one', 'serious', 'adverse', 'event', 'cited', 'by', 'researchers', 'was', 'deemed', 'unrelated', 'to', 'the', 'vaccine', 'The', 'type', 'of', 'review', 'being', 'conducted', 'by', 'the', 'FDA', 'is', 'generally', 'intended', 'to', 'scrutinize', 'raw', 'data', 'for', 'other', 'side', 'effects', 'the', 'sources', 'said', 'The', 'US', 'government', \"'s\", 'effort', 'to', 'speed', 'development', 'of', 'a', 'COVID19', 'vaccine', 'and', 'promises', 'by', 'Trump', 'that', 'one', 'could', 'be', 'available', 'prior', 'to', 'the', 'Nov', '3', 'presidential', 'election', 'has', 'led', 'to', 'concerns', 'of', 'political', 'interference', 'in', 'the', 'regulatory', 'process', 'at', 'the', 'expense', 'of', 'safety', 'The', 'FDA', 'has', 'denied', 'this', 'AstraZeneca', \"'s\", 'vaccine', 'development', 'could', 'also', 'be', 'slowed', 'by', 'a', 'change', 'to', 'its', 'clinical', 'trial', 'protocols', 'to', 'show', 'that', 'it', 'has', 'met', 'predetermined', 'safety', 'and', 'efficacy', 'standards', 'Independent', 'safety', 'monitors', 'will', 'conduct', 'their', 'first', 'review', 'of', 'the', 'vaccine', \"'s\", 'safety', 'and', 'effectiveness', 'after', '75', 'trial', 'subjects', 'become', 'infected', 'with', 'COVID19', 'up', 'from', 'the', 'original', 'initial', 'review', 'plan', 'after', 'about', '40', 'infections', 'according', 'to', 'a', 'Reuters', 'review', 'of', 'protocol', 'documents', 'issued', 'in', 'July', 'and', 'amended', 'in', 'midSeptember', 'The', 'safety', 'monitors', 'could', 'decide', 'to', 'stop', 'the', 'trial', 'if', 'the', 'vaccine', 'proves', 'either', 'highly', 'effective', 'and', 'therefore', 'should', 'be', 'considered', 'for', 'public', 'use', 'before', 'the', 'trial', 'concludes', 'or', 'if', 'serious', 'safety', 'problems', 'appear', 'Safety', 'is', 'likely', 'to', 'have', 'been', 'a', 'major', 'reason', 'for', 'the', 'change', 'said', 'Thomas', 'Lumley', 'chair', 'of', 'biostatistics', 'at', 'the', 'University', 'of', 'Auckland', 'who', 'was', 'not', 'involved', 'with', 'the', 'study', 'AstraZeneca', 'would', 'not', 'say', 'why', 'it', 'had', 'made', 'the', 'change', 'to', 'its', 'protocol', 'Â', 'Reuters', 'A', 'test', 'tube', 'labelled', 'with', 'the', 'Vaccine', 'is', 'seen', 'in', 'front', 'of', 'AstraZeneca', 'logo', 'in', 'this', 'illustration', 'taken', 'GILD', '111', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'said', 'on', 'Thursday', 'it', 'had', 'started', 'a', 'rolling', 'review', 'of', 'the', 'experimental', 'COVID19', 'vaccine', 'from', 'AstraZeneca', 'L', 'and', 'Oxford', 'University', 'in', 'a', 'move', 'aimed', 'at', 'speeding', 'up', 'any', 'future', 'approval', 'process', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'its', 'human', 'medicines', 'committee', 'had', 'started', 'evaluating', 'the', 'first', 'batch', 'of', 'data', 'on', 'the', 'vaccine', 'and', 'will', 'continue', 'till', 'sufficient', 'data', 'is', 'available', 'and', 'a', 'formal', 'application', 'is', 'submitted', 'https', 'The', 'news', 'raises', 'the', 'chances', 'of', 'the', 'vaccine', 'being', 'the', 'first', 'to', 'be', 'approved', 'in', 'the', 'region', 'and', 'comes', 'just', 'weeks', 'after', 'several', 'global', 'trials', 'of', 'the', 'vaccine', 'were', 'halted', 'due', 'to', 'an', 'unexplained', 'illness', 'in', 'a', 'study', 'participant', 'US', 'trials', 'are', 'still', 'under', 'review', 'with', 'regulators', 'widening', 'their', 'probe', 'Reuters', 'reported', 'on', 'Wednesday', 'This', 'EMA', \"'s\", 'review', 'does', 'not', 'mean', 'that', 'a', 'conclusion', 'can', 'be', 'reached', 'yet', 'on', 'the', 'vaccine', \"'s\", 'safety', 'and', 'effectiveness', 'as', 'much', 'of', 'the', 'evidence', 'is', 'still', 'to', 'be', 'submitted', 'to', 'the', 'committee', 'the', 'watchdog', 'said', 'Earlystage', 'data', 'in', 'July', 'showed', 'the', 'vaccine', 'elicited', 'immune', 'responses', 'in', 'clinical', 'trials', 'and', 'produced', 'no', 'serious', 'side', 'effects', 'with', 'the', 'strongest', 'response', 'seen', 'in', 'people', 'who', 'received', 'two', 'doses', 'Data', 'on', 'latestage', 'trials', 'are', 'expected', 'soon', 'The', 'EMA', 'would', 'make', 'final', 'recommendations', 'once', 'the', 'review', 'is', 'completed', 'to', 'the', 'European', 'Commission', 'which', 'has', 'the', 'ultimate', 'say', 'over', 'approvals', 'The', 'commission', 'typically', 'follows', 'EMA', 'endorsements', 'The', 'EMA', 'began', 'a', 'similar', 'realtime', 'review', 'of', 'Gilead', \"'s\", 'O', 'Veklury', 'as', 'a', 'treatment', 'for', 'COVID19', 'earlier', 'this', 'year', 'and', 'the', 'antiviral', 'treatment', 'was', 'given', 'conditional', 'approval', 'for', 'use', 'just', 'months', 'later', 'in', 'July'] ['22', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Small', 'toy', 'figures', 'are', 'seen', 'in', 'front', 'of', 'a', 'Covid19', 'Vaccine', 'logo', 'in', 'this', 'illustration', 'taken', '22', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Reuters', 'Clinical', 'trials', 'of', 'AstraZeneca', 'L', 'and', 'Oxford', 'University', \"'s\", 'experimental', 'COVID19', 'vaccine', 'have', 'resumed', 'in', 'Japan', 'almost', 'a', 'month', 'after', 'being', 'put', 'on', 'hold', 'due', 'to', 'an', 'illness', 'of', 'a', 'British', 'volunteer', 'while', 'discussions', 'with', 'US', 'authorities', 'continue', 'The', 'British', 'drugmaker', 'said', 'on', 'Friday', 'the', 'earlytomidstage', 'trial', 'for', 'the', 'vaccine', 'against', 'the', 'novel', 'coronavirus', 'resumed', 'in', 'Japan', 'after', 'consultations', 'with', 'the', 'national', 'health', 'regulator', 'the', 'Japanese', 'Pharmaceuticals', 'and', 'Medical', 'Devices', 'Agency', 'Global', 'trials', 'of', 'the', 'vaccine', 'called', 'AZD1222', 'or', 'ChAdOx1', 'nCoV19', 'were', 'put', 'on', 'hold', 'on', 'Sept', '6', 'after', 'a', 'study', 'participant', 'fell', 'ill', 'with', 'what', 'was', 'believed', 'to', 'be', 'a', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'Trials', 'in', 'the', 'UK', 'Brazil', 'South', 'Africa', 'and', 'India', 'had', 'already', 'restarted', 'but', 'US', 'trials', 'remain', 'paused', 'as', 'regulators', 'widened', 'their', 'probe', 'Reuters', 'reported', 'on', 'Wednesday', 'AstraZeneca', 'has', 'called', 'the', 'halt', 'a', 'standard', 'review', 'procedure', 'and', 'a', 'document', 'posted', 'online', 'by', 'Oxford', 'university', 'last', 'month', 'stated', 'the', 'illness', 'may', 'not', 'have', 'been', 'associated', 'with', 'the', 'vaccine', 'However', 'the', 'incident', 'has', 'drawn', 'focus', 'on', 'the', 'safety', 'of', 'candidates', 'being', 'developed', 'in', 'the', 'race', 'for', 'a', 'successful', 'vaccine', 'against', 'the', 'illness', 'caused', 'by', 'the', 'novel', 'coronavirus', 'which', 'has', 'claimed', 'more', 'than', 'a', 'million', 'lives', 'globally', 'The', 'US', 'Food', 'and', 'Drug', 'Administration', 'FDA', 'broadened', 'its', 'investigation', 'of', 'the', 'illness', 'in', 'the', 'volunteer', 'and', 'would', 'look', 'at', 'data', 'from', 'earlier', 'trials', 'of', 'similar', 'vaccines', 'developed', 'by', 'the', 'same', 'scientists', 'three', 'sources', 'told', 'Reuters', 'In', 'Friday', \"'s\", 'statement', 'AstraZeneca', 'stressed', 'that', 'safety', 'of', 'the', 'participants', 'was', 'of', 'paramount', 'importance', 'and', 'that', 'it', 'was', 'applying', 'the', 'highest', 'standards', 'of', 'conduct', 'in', 'trials', 'Sources', 'had', 'told', 'Reuters', 'that', 'the', 'data', 'requested', 'by', 'the', 'FDA', 'for', 'one', 'of', 'the', 'most', 'advanced', 'COVID19', 'vaccine', 'candidates', 'in', 'development', 'was', 'expected', 'this', 'week'] ['Â', 'Reuters', 'UK100', '203', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GOG', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'CTH', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PAGPA', '177', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PHNX', '147', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'CSPC', '243', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AJBA', '249', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Dec', '3', 'Reuters', 'Britain', \"'s\", 'FTSE', '100', 'index', 'is', 'seen', 'opening', '14', 'points', 'lower', 'at', '6449', 'on', 'Thursday', 'according', 'to', 'financial', 'bookmakers', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'will', 'likely', 'get', 'results', 'of', 'its', 'US', 'COVID19', 'vaccine', 'trial', 'in', 'lateJanuary', 'and', 'could', 'potentially', 'file', 'for', 'an', 'emergency', 'authorization', 'the', 'chief', 'adviser', 'for', 'the', 'US', 'government', \"'s\", 'Operation', 'Warp', 'Speed', 'program', 'said', 'on', 'Wednesday', 'GOLD', 'Gold', 'rose', 'to', 'an', 'over', 'oneweek', 'high', 'as', 'the', 'dollar', 'weakened', 'on', 'hopes', 'of', 'coronavirus', 'vaccine', 'rollouts', 'while', 'investors', 'also', 'weighed', 'the', 'possibility', 'of', 'more', 'US', 'stimulus', 'OIL', 'Oil', 'prices', 'fell', 'as', 'producers', 'including', 'Saudi', 'Arabia', 'and', 'Russia', 'locked', 'horns', 'over', 'the', 'need', 'to', 'extend', 'record', 'production', 'cuts', 'set', 'in', 'place', 'in', 'the', 'first', 'wave', 'of', 'the', 'COVID19', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', '12', 'higher', 'on', 'Wednesday', 'as', 'the', 'sterling', 'weakened', 'on', 'doubts', 'of', 'whether', 'a', 'trade', 'deal', 'could', 'be', 'reached', 'by', 'Britain', 'and', 'the', 'European', 'Union', 'while', 'the', 'UK', \"'s\", 'approval', 'of', 'a', 'COVID19', 'vaccine', 'also', 'supported', 'sentiment', 'UK', 'CORPORATE', 'DIARY', 'Countryside', 'Properties', 'Plc', 'FY', 'earnings', 'Go', 'Ahead', 'Group', 'Trading', 'update', 'AJ', 'Bell', 'Plc', 'FY', 'earnings', 'Caretech', 'Holdings', 'Plc', 'FY', 'earnings', 'Paragon', 'Banking', 'Group', 'Plc', 'FY', 'earnings', 'Phoenix', 'Group', 'Holdings', 'Plc', 'Â', 'Reuters', 'UK', 'shares', 'higher', 'at', 'close', 'of', 'trade', 'Investingcom', 'United', 'Kingdom', '100', 'up', '036', 'TUIGn', '357', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RR', '617', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ULVR', '145', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BT', '198', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'FLTRF', '254', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'FTNMX', '109', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'FTNMX', '220', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'FTNMX', '295', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'invuk', '223', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'were', 'higher', 'at', 'the', 'close', 'on', 'Thursday', 'as', 'gains', 'in', 'the', 'and', 'sectors', 'propelled', 'shares', 'higher', 'At', 'the', 'close', 'in', 'London', 'the', 'added', '036', 'to', 'hit', 'a', 'new', '3month', 'high', 'The', 'biggest', 'gainers', 'of', 'the', 'session', 'on', 'the', 'were', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'which', 'rose', '1468', 'or', '1714', 'points', 'to', 'trade', 'at', '13389', 'at', 'the', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', '685', 'or', '865', 'points', 'to', 'end', 'at', '13500', 'and', 'Flutter', 'Entertainment', 'PLC', 'LON', 'was', 'up', '591', 'or', '7900', 'points', 'to', '141550', 'in', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'which', 'lost', '563', 'or', '2710', 'points', 'to', 'trade', 'at', '45440', 'in', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', '282', 'or', '2240', 'points', 'to', 'end', 'at', '77130', 'and', 'Unilever', 'PLC', 'LON', 'shed', '241', 'or', '1060', 'points', 'to', '42930', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'by', '1257', 'to', '1007', 'and', '77', 'ended', 'unchanged', 'on', 'the', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'for', 'February', 'delivery', 'was', 'up', '001', 'or', '025', 'to', '183045', 'a', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'for', 'delivery', 'in', 'January', 'rose', '007', 'or', '003', 'to', 'hit', '4531', 'a', 'barrel', 'while', 'the', 'February', 'Brent', 'oil', 'contract', 'rose', '017', 'or', '008', 'to', 'trade', 'at', '4833', 'a', 'barrel', 'GBPUSD', 'was', 'up', '089', 'to', '13481', 'while', 'EURGBP', 'fell', '052', 'to', '09015', 'The', 'US', 'Dollar', 'Index', 'Futures', 'was', 'down', '054', 'at', '90627'] ['Â', 'Reuters', 'AVV', '016', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'TRNT', '396', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BIFF', '029', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AUTOA', '235', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'JSAIY', '043', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RDI', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'KCT', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LRE', '224', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'DLN', '072', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'UK100', '203', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'INCH', '305', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'WIN', '263', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SBRY', '137', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RSAl', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'TATE', '066', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'HIK', '382', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BARC', '267', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Nov', '5', 'Britain', \"'s\", 'FTSE', '100', 'index', 'is', 'seen', 'opening', '2', 'points', 'lower', 'at', '5581', 'on', 'Thursday', 'according', 'to', 'financial', 'bookmakers', 'ASTRAZENECA', 'Chilean', 'President', 'Sebastian', 'Pinera', 'said', 'the', 'country', \"'s\", 'health', 'regulator', 'had', 'given', 'the', 'goahead', 'for', 'clinical', 'trials', 'of', 'AstraZeneca', 'PLC', \"'s\", 'COVID19', 'vaccine', 'SAINSBURY', 'British', 'supermarket', 'group', 'Sainsbury', 'will', 'announce', 'plans', 'to', 'cut', '3000', 'jobs', 'alongside', 'its', 'firsthalf', 'results', 'on', 'Thursday', 'The', 'Times', 'reported', 'BARCLAYS', 'A', 'former', 'Barclays', 'trader', 'who', 'fled', 'to', 'his', 'native', 'France', 'before', 'being', 'convicted', 'in', 'London', 'of', 'helping', 'rig', 'Euribor', 'interest', 'rates', 'has', 'won', 'a', 'court', 'battle', 'against', 'extradition', 'to', 'Britain', 'to', 'serve', 'an', 'eightyear', 'jail', 'sentence', 'his', 'lawyer', 'said', 'GOLD', 'Gold', 'firmed', 'as', 'investors', 'were', 'cautiously', 'optimistic', 'Democrat', 'Joe', 'Biden', 'would', 'edge', 'past', 'President', 'Donald', 'Trump', 'in', 'a', 'tight', 'race', 'to', 'the', 'White', 'House', 'boosting', 'the', 'likelihood', 'of', 'more', 'economic', 'stimulus', 'OIL', 'Oil', 'dropped', 'as', 'Democrat', 'Joe', 'Biden', 'edged', 'closer', 'to', 'the', 'White', 'House', 'but', 'the', 'Republicans', 'look', 'likely', 'to', 'retain', 'Senate', 'control', 'decreasing', 'the', 'chances', 'of', 'any', 'huge', 'COVID19', 'relief', 'package', 'The', 'UK', 'bluechip', 'index', 'closed', '17', 'higher', 'on', 'Wednesday', 'as', 'a', 'weaker', 'pound', 'boosted', 'shares', 'of', 'exporters', 'although', 'investors', 'remained', 'cautious', 'on', 'prospects', 'of', 'a', 'contested', 'outcome', 'to', 'the', 'US', 'presidential', 'elections', 'UK', 'CORPORATE', 'DIARY', 'Tate', 'Lyle', 'Plc', 'HY', 'results', 'RDI', 'Reit', 'Plc', 'FY', 'trading', 'statement', 'Biffa', 'Plc', 'HY', 'earnings', 'Wincanton', 'Plc', 'HY', 'earnings', 'Derwent', 'London', 'Plc', 'Q3', 'business', 'update', 'Kin', 'and', 'Carta', 'Plc', 'FY', 'earnings', 'AVEVA', 'Group', 'Plc', 'HY', 'earnings', 'AstraZeneca', 'Plc', 'Q3', 'earnings', 'RSA', 'Insurance', 'Group', 'Plc', 'Q3', 'trading', 'statement', 'J', 'Sainsbury', 'OTC', 'Plc', 'HY', 'earnings', 'Lancashire', 'Holdings', 'Ltd', 'Q3', 'trading', 'statement', 'Auto', 'Trader', 'Group', 'Plc', 'HY', 'earnings', 'Trainline', 'Plc', 'HY', 'earnings', 'Inchcape', 'Plc', 'Q3', 'trading', 'statement', 'Hikma', 'Pharmaceuticals', 'Plc', 'Trading', 'statement', 'RDI', 'Reit', 'Plc', 'FY', 'earnings', '22', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'for', 'pharmaceutical', 'company', 'AstraZeneca', 'is', 'displayed', 'on', 'a', 'screen', 'on', 'the', 'floor', 'at', 'the', 'NYSE', 'in', 'New', 'York', '22', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'and', 'Ludwig', 'Burger', 'Reuters', 'A', 'summer', 'dip', 'in', 'UK', 'coronavirus', 'infections', 'has', 'pushed', 'back', 'test', 'results', 'for', 'AstraZenca', \"'s\", 'potential', 'COVID19', 'vaccine', 'leading', 'the', 'drugmaker', 'to', 'delay', 'deliveries', 'of', 'shots', 'to', 'the', 'UK', 'government', 'Britain', \"'s\", 'vaccines', 'chief', 'said', 'on', 'Wednesday', 'it', 'would', 'receive', 'just', '4', 'million', 'doses', 'of', 'the', 'potential', 'vaccine', 'this', 'year', 'against', 'initial', 'estimates', 'for', '30', 'million', 'by', 'Sept', '30', 'AstraZeneca', 'L', 'said', 'on', 'Thursday', 'it', 'was', 'holding', 'back', 'deliveries', 'while', 'it', 'awaits', 'the', 'data', 'from', 'latestage', 'clinical', 'trials', 'in', 'order', 'to', 'maximise', 'the', 'shelflife', 'of', 'supplies', 'It', 'is', 'keeping', 'the', 'vaccine', 'frozen', 'in', 'large', 'containers', 'and', 'will', 'only', 'add', 'a', 'final', 'ingredient', 'put', 'it', 'into', 'vials', 'and', 'keep', 'it', 'at', 'fridge', 'temperature', 'when', 'the', 'vaccine', 'gets', 'closer', 'to', 'approval', 'We', 'are', 'a', 'little', 'bit', 'late', 'in', 'deliveries', 'which', 'is', 'why', 'the', 'vaccine', 'has', 'been', 'kept', 'in', 'frozen', 'form', 'CEO', 'Pascal', 'Soriot', 'said', 'on', 'a', 'conference', 'call', 'However', 'he', 'added', 'AstraZeneca', 'was', 'fully', 'prepared', 'to', 'launch', 'the', 'vaccine', 'when', 'it', 'is', 'ready', 'adding', 'the', 'company', \"'s\", 'weekly', 'delivery', 'schedule', 'should', 'roughly', 'match', 'what', 'the', 'UK', 'government', 'has', 'in', 'mind', 'for', 'its', 'vaccination', 'plans', 'AstraZeneca', 'and', 'its', 'partner', 'on', 'the', 'project', 'the', 'University', 'of', 'Oxford', 'said', 'data', 'from', 'latestage', 'trials', 'should', 'land', 'this', 'year', 'If', 'successful', 'the', 'pair', 'will', 'file', 'for', 'emergency', 'approvals', 'in', 'as', 'many', 'countries', 'as', 'possible', 'at', 'the', 'same', 'time', 'Soriot', 'said', 'The', 'British', 'duo', 'are', 'racing', 'with', 'PfizerBioNTech', 'Moderna', 'and', 'others', 'to', 'publish', 'the', 'first', 'detailed', 'results', 'from', 'large', 'COVID19', 'vaccine', 'trials', 'A', 'vaccine', 'is', 'seen', 'as', 'the', 'world', \"'s\", 'best', 'bet', 'for', 'beating', 'a', 'pandemic', 'that', 'has', 'led', 'to', 'more', 'than', '12', 'million', 'deaths', 'roiled', 'economies', 'and', 'disrupted', 'billions', 'of', 'lives', 'Earlier', 'this', 'year', 'AstraZeneca', 'also', 'agreed', 'to', 'start', 'supplying', 'millions', 'of', 'doses', 'by', 'the', 'end', 'of', '2020', 'to', 'the', 'United', 'States', 'the', 'European', 'Union', 'and', 'poorer', 'nations', 'through', 'epidemic', 'response', 'group', 'CEPI', 'and', 'vaccine', 'alliance', 'GAVI', 'subject', 'to', 'the', 'results', 'of', 'the', 'trials', 'and', 'regulatory', 'approval', 'The', 'company', 'hopes', 'the', 'shot', 'will', 'be', 'effective', 'for', 'at', 'least', 'a', 'year', 'but', 'only', 'trial', 'data', 'can', 'confirm', 'this', 'MIXED', 'RESULTS', 'While', 'working', 'on', 'the', 'vaccine', 'AstraZeneca', 'is', 'also', 'making', 'progress', 'on', 'its', 'pipeline', 'of', 'other', 'drugs', 'On', 'Thursday', 'the', 'company', 'said', 'two', 'of', 'its', 'main', 'drugs', 'cancer', 'treatment', 'Lynparza', 'and', 'diabetes', 'medicine', 'Forxiga', 'had', 'been', 'approved', 'for', 'wider', 'use', 'in', 'Europe', 'For', 'the', 'third', 'quarter', 'product', 'sales', 'of', '652', 'billion', '5', 'billion', 'pounds', 'were', 'ahead', 'of', 'a', 'companycompiled', 'consensus', 'of', '650', 'billion', 'The', 'number', 'excluded', 'payments', 'from', 'collaborations', 'However', 'core', 'earnings', 'of', '94', 'cents', 'per', 'share', 'for', 'the', 'three', 'months', 'ended', 'Sept', '30', 'missed', 'analysts', \"'\", 'expectations', 'of', '98', 'cents', 'Research', 'and', 'development', 'costs', 'jumped', '11', 'to', '15', 'billion', 'as', 'more', 'projects', 'moved', 'into', 'the', 'final', 'stage', 'of', 'testing', 'on', 'humans', 'typically', 'the', 'most', 'expensive', 'The', 'company', 'said', 'it', 'still', 'expected', 'total', 'revenue', 'in', '2020', 'to', 'increase', 'by', 'a', 'high', 'singledigit', 'to', 'a', 'low', 'doubledigit', 'percentage', 'and', 'core', 'earnings', 'per', 'share', 'to', 'increase', 'by', 'a', 'mid', 'to', 'highteens', 'percentage'] ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'is', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'in', 'the', 'Manhattan', 'borough', 'of', 'New', 'York', 'City', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '140', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BNTX', '624', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'has', 'started', 'a', 'realtime', 'review', 'of', 'the', 'COVID19', 'vaccine', 'being', 'developed', 'by', 'Pfizer', 'N', 'and', 'BioNTech', 'F', 'days', 'after', 'launching', 'a', 'similar', 'assessment', 'process', 'for', 'AstraZeneca', \"'s\", 'L', 'vaccine', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'on', 'Tuesday', 'its', 'human', 'medicines', 'committee', 'was', 'evaluating', 'the', 'first', 'batch', 'of', 'nonclinical', 'data', 'on', 'the', 'vaccine', 'from', 'laboratory', 'studies', 'and', 'will', 'continue', 'to', 'do', 'so', 'until', 'enough', 'data', 'is', 'available', 'for', 'a', 'final', 'decision', 'https', 'The', 'rolling', 'review', 'of', 'the', 'vaccine', 'called', 'BNT162b2', 'was', 'based', 'on', 'earlystage', 'studies', 'which', 'suggested', 'that', 'the', 'vaccine', 'triggered', 'immune', 'response', 'the', 'watchdog', 'said', 'as', 'it', 'moves', 'ahead', 'with', 'its', 'plan', 'to', 'speed', 'up', 'the', 'approval', 'process', 'for', 'COVID19', 'vaccine', 'candidates'] ['Â', 'Reuters', 'UK100', '203', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'TRYG', '043', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RSAl', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SBRY', '137', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SMT', '219', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BEZG', '054', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ICAG', '094', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'MGAMM', '1584', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'IFC', '173', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Nov', '6', 'Reuters', 'Britain', \"'s\", 'FTSE', '100', 'index', 'is', 'seen', 'opening', '21', 'points', 'lower', 'at', '5885', 'on', 'Friday', 'according', 'to', 'financial', 'bookmakers', 'SAINSBURY', 'British', 'supermarket', 'Sainsbury', \"'s\", 'said', 'it', 'could', 'have', 'to', 'cut', 'its', 'range', 'of', 'offering', 'in', 'Northern', 'Ireland', 'unless', 'it', 'gets', 'clarity', 'on', 'the', 'province', \"'s\", 'trading', 'status', 'after', 'the', 'end', 'of', 'Britain', \"'s\", 'Brexit', 'transition', 'period', 'on', 'Dec', '31', 'RSA', 'RSA', 'is', 'in', 'talks', 'with', 'a', 'consortium', 'of', 'Canadian', 'insurer', 'Intact', 'Financial', 'and', 'Danish', 'insurer', 'Tryg', 'about', 'a', 'possible', 'breakup', 'deal', 'that', 'values', 'the', 'British', 'firm', 'at', 'about', '72', 'billion', 'pounds', '946', 'billion', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'plans', 'to', 'start', 'early', 'and', 'midstage', 'clinical', 'trials', 'of', 'its', 'COVID19', 'vaccine', 'candidate', 'in', 'China', 'this', 'year', 'a', 'senior', 'executive', 'said', 'as', 'it', 'prepares', 'a', 'global', 'rollout', 'of', 'the', 'vaccine', 'BRITISH', 'AIRWAYS', 'British', 'Airways', 'part', 'of', 'the', 'International', 'Consolidated', 'Airlines', 'Group', 'will', 'reduce', 'its', 'flight', 'schedule', 'this', 'month', 'after', 'the', 'UK', 'government', 'put', 'further', 'restrictions', 'on', 'leisure', 'travel', 'to', 'try', 'to', 'curb', 'the', 'spread', 'of', 'coronavirus', 'GOLD', 'Gold', 'fell', 'after', 'surging', 'in', 'the', 'previous', 'session', 'as', 'the', 'dollar', 'gained', 'but', 'was', 'set', 'for', 'its', 'best', 'week', 'since', 'late', 'July', 'on', 'hopes', 'for', 'more', 'central', 'bank', 'economic', 'support', 'as', 'investors', 'bet', 'on', 'a', 'divided', 'US', 'Congress', 'under', 'a', 'Biden', 'presidency', 'OIL', 'US', 'oil', 'fell', 'nearly', '2', 'as', 'new', 'lockdowns', 'in', 'Europe', 'to', 'contain', 'the', 'spread', 'of', 'the', 'coronavirus', 'disease', 'raised', 'questions', 'about', 'the', 'outlook', 'for', 'crude', 'demand', 'while', 'markets', 'remained', 'on', 'edge', 'over', 'the', 'drawnout', 'vote', 'counting', 'in', 'the', 'US', 'election', 'The', 'UK', 'bluechip', 'index', 'closed', '04', 'higher', 'on', 'Thursday', 'after', 'the', 'government', 'and', 'Bank', 'of', 'England', 'both', 'ramped', 'up', 'stimulus', 'programmes', 'to', 'cushion', 'the', 'struggling', 'economy', 'as', 'England', 'goes', 'into', 'a', 'second', 'national', 'lockdown', 'UK', 'CORPORATE', 'DIARY', 'Scottish', 'Mortgage', 'Investment', 'Trust', 'Plc', 'HY', 'earnings', 'Morgan', 'Advanced', 'Materials', 'Plc', 'Q3', 'trading', 'statement', 'Beazley', 'Plc', 'Q3', 'earnings', 'TODAY', \"'S\", 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'] ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'with', 'the', 'vaccine', 'is', 'seen', 'in', 'front', 'of', 'AstraZeneca', 'logo', 'in', 'this', 'illustration', 'taken', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Reuters', 'AstraZeneca', 'could', 'start', 'profiting', 'from', 'its', 'COVID19', 'vaccine', 'as', 'soon', 'as', 'July', 'next', 'year', 'the', 'Financial', 'Times', 'reported', 'on', 'Wednesday', 'citing', 'a', 'memo', 'showing', 'the', 'British', 'drugmaker', 'can', 'declare', 'when', 'it', 'considers', 'the', 'pandemic', 'to', 'have', 'ended', 'The', 'Londonlisted', 'firm', 'previously', 'said', 'it', 'would', 'not', 'profit', 'from', 'the', 'vaccine', 'during', 'the', 'pandemic', 'and', 'the', 'report', 'attributes', 'the', 'development', 'to', 'a', 'memorandum', 'of', 'understanding', 'signed', 'this', 'year', 'between', 'AstraZeneca', 'and', 'Brazilian', 'public', 'health', 'organization', 'Fiocruz', 'httpsonftcom3lgC0Xo', 'AstraZeneca', 'which', 'developed', 'the', 'vaccine', 'with', 'Oxford', 'University', 'signed', 'multiple', 'supplyandmanufacture', 'deals', 'for', 'more', 'than', '3', 'billion', 'doses', 'globally', 'although', 'details', 'on', 'the', 'terms', 'have', 'been', 'scant', 'According', 'to', 'FT', 'the', 'Pandemic', 'Period', 'could', 'be', 'further', 'extended', 'beyond', 'July', '1', '2021', 'but', 'only', 'if', 'Cambridge', 'Englandbased', 'AstraZeneca', 'acting', 'in', 'good', 'faith', 'considers', 'that', 'the', 'SARSCoV2', 'pandemic', 'is', 'not', 'over', 'AstraZeneca', 'did', 'not', 'immediately', 'respond', 'to', 'a', 'Reuters', 'request', 'for', 'comment', 'Pricing', 'and', 'supply', 'of', 'experimental', 'COVID19', 'vaccines', 'have', 'been', 'widely', 'debated', 'as', 'richer', 'countries', 'pump', 'billions', 'of', 'dollars', 'into', 'funding', 'and', 'AstraZeneca', 'has', 'also', 'been', 'granted', 'protection', 'from', 'future', 'liability', 'claims'] ['Â', 'Reuters', 'UK100', '203', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'XAUUSD', '317', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BA', '208', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'EZJ', '248', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '056', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'IMB', '124', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'HRGV', '239', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LCL', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RS1R', '028', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'UTG', '182', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Gold', '336', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'CL', '502', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'RWA', '039', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ENT', '079', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'NRRT', '234', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'CMCX', '021', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Oct', '8', 'Britain', \"'s\", 'FTSE', '100', 'index', 'is', 'seen', 'opening', '13', 'points', 'higher', 'at', '5959', 'on', 'Thursday', 'according', 'to', 'financial', 'bookmakers', 'with', 'futures', 'up', '029', 'ahead', 'of', 'cash', 'market', 'open', 'CMC', 'Markets', 'CMC', 'Markets', 'said', 'its', 'annual', 'net', 'operating', 'income', 'would', 'be', 'of', 'the', 'current', 'market', 'consensus', 'as', 'trading', 'on', 'its', 'online', 'platform', 'benefited', 'from', 'this', 'year', \"'s\", 'coronavirusdriven', 'market', 'volatility', 'EasyJet', 'British', 'airline', 'warned', 'it', 'would', 'report', 'an', 'annual', 'loss', 'of', 'as', 'much', 'as', 'its', 'first', 'ever', 'and', 'said', 'it', 'kept', 'its', 'finances', 'under', 'review', 'as', 'the', 'pandemic', 'meant', 'it', 'was', 'only', 'flying', '25', 'of', 'planned', 'capacity', 'Hargreaves', 'Lansdown', 'British', 'fund', 'supermarket', 'Hargreaves', 'Lansdown', 'said', 'it', 'took', 'in', '800', 'million', 'pounds', 'of', 'net', 'new', 'business', 'in', 'the', 'quarter', 'to', 'Sept', '30', 'despite', 'what', 'it', 'described', 'as', 'weakening', 'investor', 'sentiment', 'arising', 'from', 'COVID19', 'and', 'fresh', 'Brexit', 'uncertainty', 'Home', 'REIT', 'Home', 'REIT', 'a', 'vehicle', 'for', 'investing', 'in', 'properties', 'that', 'provide', 'accommodation', 'to', 'homeless', 'people', 'said', 'on', 'Thursday', 'it', 'has', 'from', 'its', 'initial', 'public', 'offering', 'GVC', 'Holdings', 'Ladbrokes', 'LON', 'and', 'bwin', 'owner', 'GVC', 'Holdings', 'raised', 'its', 'outlook', 'for', 'annual', 'core', 'earnings', 'after', 'posting', 'a', '12', 'rise', 'in', 'thirdquarter', 'revenue', 'helped', 'by', 'a', 'surge', 'in', 'online', 'gaming', 'and', 'as', 'sports', 'events', 'such', 'as', 'the', 'English', 'Premier', 'League', 'resumed', 'Robert', 'Walters', 'British', 'recruiting', 'firm', 'Robert', 'Walters', 'Plc', 'in', 'thirdquarter', 'net', 'fee', 'income', 'on', 'Thursday', 'as', 'it', 'continued', 'to', 'tussle', 'with', 'a', 'hiring', 'slowdown', 'due', 'to', 'the', 'COVID19', 'pandemic', 'while', 'it', 'reinstated', 'its', 'interim', 'dividend', 'AstraZeneca', 'AstraZeneca', 'could', 'from', 'its', 'COVID19', 'vaccine', 'as', 'soon', 'as', 'July', 'next', 'year', 'the', 'Financial', 'Times', 'reported', 'on', 'Wednesday', 'citing', 'a', 'memo', 'showing', 'the', 'British', 'drugmaker', 'can', 'declare', 'when', 'it', 'considers', 'the', 'pandemic', 'to', 'have', 'ended', 'British', 'Airways', 'British', 'Airways', 'will', 'bid', 'farewell', 'to', 'its', 'final', 'Londonbased', 'Boeing', 'NYSE', '747s', 'on', 'Thursday', 'with', 'a', 'rare', 'synchronised', 'dual', 'take', 'off', 'for', 'the', 'Queen', 'of', 'the', 'Skies', 'the', 'jet', 'which', 'brought', 'longhaul', 'flights', 'to', 'the', 'masses', 'EasyJet', 'British', 'airline', 'easyJet', 'Plc', 'has', 'signalled', 'to', 'the', 'government', 'that', 'it', 'may', 'if', 'the', 'coronavirus', 'pandemic', 'continues', 'to', 'hinder', 'its', 'schedule', 'Sky', 'News', 'reported', 'on', 'Wednesday', 'Oil', 'prices', 'inched', 'up', 'on', 'Thursday', 'as', 'oil', 'workers', 'evacuated', 'rigs', 'in', 'the', 'US', 'Gulf', 'of', 'Mexico', 'ahead', 'of', 'Hurricane', 'Delta', 'though', 'fuel', 'demand', 'concerns', 'persisted', 'on', 'fading', 'chances', 'for', 'a', 'US', 'economic', 'stimulus', 'deal', 'and', 'a', 'build', 'in', 'Gold', 'prices', 'were', 'little', 'changed', 'on', 'Thursday', 'as', 'renewed', 'hopes', 'for', 'more', 'US', 'stimulus', 'kept', 'the', 'bullion', 'afloat', 'with', 'investors', 'eyeing', 'the', 'data', 'to', 'further', 'gauge', 'the', 'health', 'of', 'the', 'world', \"'s\", 'largest', 'economy', 'The', 'UK', 'bluechip', 'index', 'closed', 'down', '006', 'on', 'Wednesday', 'weighed', 'down', 'by', 'a', 'fall', 'in', 'energy', 'stocks', 'on', 'lower', 'oil', 'prices', 'with', 'investors', 'looking', 'for', 'clues', 'on', 'US', 'stimulus', 'measures', 'after', 'President', 'Donald', 'Trump', 'called', 'a', 'halt', 'to', 'talks', 'with', 'Congress', 'on', 'a', 'comprehensive', 'bill', 'UK', 'corporate', 'diary', 'Preclose', 'trading', 'statement', 'Trading', 'statement', 'Operational', 'Update', 'Q2', 'preclose', 'trading', 'statement', 'Q4', 'trading', 'statement', 'Trading', 'statement', 'Trading', 'statement']...>"
            ]
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "VZOtN3DYfK0y"
      },
      "source": [
        "### 5.2 Removing Stopwords\n",
        "\n",
        "Stopwords are some of the most common words and are necessary for sentences to be grammatically correct (e.g. a, is, an, the, and). However, they carry very little or no useful information and are filtered out as part of the text preprocessing stage to remove noise so that machine learning algorithms can better focus on the signal, or words which define the meaning of the text.\n",
        "\n",
        "We will use the list from nltk.corpus and exclude tokens with characters that are not alphabetical using the isalpha() method."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "dKmKXKvkQZSi",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c499fddb-5a62-4821-faba-2159490b1ffd"
      },
      "source": [
        "stop_words = set(stopwords.words('english'))\n",
        "\n",
        "#Iterate through all tokens for all articles \n",
        "filtered_articles = [[word for word in article if not word in stop_words if word.isalpha()] for article in tokens]\n",
        "print(stop_words)\n",
        "print(filtered_articles)"
      ],
      "execution_count": 10,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'into', 'through', 're', 'do', 'these', 'who', 'once', 'ourselves', 'her', 've', 'why', 'just', 'did', 'weren', \"wouldn't\", 'me', 'and', 'when', 'aren', 'further', 'own', \"shan't\", 'while', 'o', 'yours', 'ours', \"you'll\", 'what', 'only', 'out', 'there', 'nor', 't', 'd', 'same', \"you've\", 'not', 'both', 'under', 'on', \"mustn't\", 'or', 'don', \"should've\", 'being', 'very', 'herself', 'because', 'wouldn', 'am', 'each', 'themselves', 'between', 'having', 'over', 'too', 'needn', 'more', 'he', 'then', 'about', 'your', 'such', 'against', 'here', 'shan', 'in', 'has', 'until', 'we', 'ain', 'i', \"you're\", 'doing', 'the', 'of', 'haven', 'few', 'those', \"she's\", 'ma', 'mightn', \"couldn't\", 'yourselves', 'you', 'during', 's', 'our', 'an', \"aren't\", 'won', \"haven't\", 'for', \"needn't\", 'whom', 'at', 'above', 'its', 'after', \"didn't\", 'hasn', 'wasn', 'can', 'again', \"weren't\", \"wasn't\", \"won't\", 'if', 'isn', 'but', 'should', 'didn', 'does', 'been', 'be', 'are', 'have', 'him', 'his', 'other', 'll', 'hers', 'from', 'this', 'now', \"you'd\", 'had', 'them', 'to', 'before', 'were', 'up', 'any', 'itself', 'himself', 'down', 'myself', 'no', \"hasn't\", 'my', 'it', 'they', 'y', \"mightn't\", \"that'll\", 'by', \"it's\", 'their', 'was', 'some', 'she', 'a', 'doesn', 'theirs', 'couldn', \"doesn't\", 'yourself', 'than', \"isn't\", 'how', 'where', 'that', 'with', 'most', 'm', 'hadn', 'will', \"shouldn't\", 'which', 'so', 'off', 'shouldn', \"hadn't\", 'as', 'is', 'below', 'mustn', \"don't\", 'all'}\n",
            "[['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'HBR', 'Add', 'toRemove', 'Portfolio', 'DLAR', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Smith', 'Nephew', 'Medical', 'prosthetics', 'maker', 'Smith', 'Nephew', 'Plc', 'expects', 'decline', 'underlying', 'revenue', 'third', 'quarter', 'year', 'almost', 'previous', 'three', 'months', 'suffering', 'heavily', 'impact', 'coronavirus', 'lockdowns', 'halt', 'elective', 'procedures', 'RollsRoyce', 'Britain', 'RollsRoyce', 'said', 'planned', 'shareholders', 'billion', 'pounds', 'bond', 'market', 'secure', 'loans', 'rebuild', 'balance', 'sheet', 'Premier', 'Oil', 'Creditors', 'North', 'Seafocused', 'Premier', 'Oil', 'extended', 'waiver', 'group', 'debt', 'covenant', 'test', 'giving', 'breathing', 'space', 'avoid', 'debt', 'crunch', 'company', 'said', 'Thursday', 'De', 'La', 'Rue', 'Banknote', 'printer', 'De', 'La', 'Rue', 'Thursday', 'named', 'Rob', 'Harding', 'appointing', 'interim', 'CFO', 'earlier', 'year', 'National', 'Grid', 'National', 'Grid', 'Thursday', 'pledged', 'see', 'reduce', 'emissions', 'relating', 'gas', 'electricity', 'sells', 'markets', 'United', 'States', 'Britain', 'AstraZeneca', 'The', 'US', 'Food', 'Drug', 'Administration', 'serious', 'illness', 'AstraZeneca', 'Plc', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'Reuters', 'Woodford', 'The', 'collapsed', 'Woodford', 'equity', 'income', 'fund', 'million', 'pounds', 'remaining', 'assets', 'authorised', 'corporate', 'director', 'said', 'Wednesday', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'bleak', 'production', 'forecast', 'Shell', 'losses', 'consumer', 'stocks', 'weighed', 'index', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Marisa', 'Taylor', 'Dan', 'Levine', 'WASHINGTON', 'Reuters', 'The', 'US', 'Food', 'Drug', 'Administration', 'broadened', 'investigation', 'serious', 'illness', 'AstraZeneca', 'Plc', 'L', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'Reuters', 'AstraZeneca', 'large', 'latestage', 'US', 'trial', 'remained', 'hold', 'since', 'Sept', 'study', 'participant', 'Britain', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'The', 'widened', 'scope', 'FDA', 'probe', 'raises', 'likelihood', 'additional', 'delays', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'The', 'requested', 'data', 'expected', 'arrive', 'week', 'FDA', 'would', 'need', 'time', 'analyze', 'two', 'sources', 'said', 'Effective', 'vaccines', 'seen', 'essential', 'help', 'end', 'pandemic', 'killed', 'one', 'million', 'people', 'worldwide', 'The', 'administration', 'President', 'Donald', 'Trump', 'pledged', 'billion', 'support', 'development', 'AstraZeneca', 'vaccine', 'secure', 'million', 'doses', 'United', 'States', 'Other', 'leading', 'companies', 'US', 'vaccine', 'race', 'include', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'Johnson', 'Johnson', 'N', 'Regulators', 'UK', 'Brazil', 'India', 'South', 'Africa', 'allowed', 'AstraZeneca', 'resume', 'clinical', 'trials', 'The', 'FDA', 'however', 'wants', 'determine', 'whether', 'similar', 'side', 'effects', 'emerged', 'trials', 'vaccines', 'designed', 'AstraZeneca', 'coronavirus', 'vaccine', 'partner', 'researchers', 'Oxford', 'University', 'sources', 'said', 'That', 'mean', 'agency', 'believes', 'safety', 'issues', 'associated', 'vaccines', 'added', 'It', 'shows', 'FDA', 'thorough', 'said', 'one', 'sources', 'Further', 'complicating', 'situation', 'data', 'requested', 'FDA', 'different', 'format', 'US', 'regulator', 'requires', 'two', 'sources', 'said', 'The', 'FDA', 'declined', 'comment', 'discussions', 'involving', 'experimental', 'product', 'Oxford', 'respond', 'requests', 'comment', 'AstraZeneca', 'statement', 'said', 'We', 'continuing', 'work', 'FDA', 'facilitate', 'review', 'information', 'needed', 'make', 'decision', 'regarding', 'resumption', 'US', 'trial', 'VIRAL', 'VECTOR', 'All', 'vaccines', 'wants', 'review', 'use', 'modified', 'adenovirus', 'vectors', 'safely', 'deliver', 'genetic', 'material', 'target', 'illnesses', 'flu', 'Middle', 'East', 'Respiratory', 'Syndrome', 'diseases', 'body', 'stimulate', 'immune', 'system', 'response', 'fight', 'future', 'infection', 'While', 'vaccine', 'developers', 'used', 'human', 'adenoviruses', 'vaccines', 'Oxford', 'researchers', 'chose', 'adenovirus', 'found', 'chimpanzees', 'They', 'felt', 'would', 'reduce', 'likelihood', 'individual', 'immune', 'system', 'would', 'attack', 'vector', 'virus', 'due', 'prior', 'exposure', 'rather', 'intended', 'target', 'Reuters', 'reviewed', 'six', 'research', 'papers', 'detailed', 'safety', 'data', 'vaccines', 'using', 'engineered', 'chimpanzee', 'adenovirus', 'called', 'diseases', 'including', 'tuberculosis', 'prostate', 'cancer', 'influenza', 'In', 'one', 'trials', 'one', 'serious', 'adverse', 'event', 'cited', 'researchers', 'deemed', 'unrelated', 'vaccine', 'The', 'type', 'review', 'conducted', 'FDA', 'generally', 'intended', 'scrutinize', 'raw', 'data', 'side', 'effects', 'sources', 'said', 'The', 'US', 'government', 'effort', 'speed', 'development', 'vaccine', 'promises', 'Trump', 'one', 'could', 'available', 'prior', 'Nov', 'presidential', 'election', 'led', 'concerns', 'political', 'interference', 'regulatory', 'process', 'expense', 'safety', 'The', 'FDA', 'denied', 'AstraZeneca', 'vaccine', 'development', 'could', 'also', 'slowed', 'change', 'clinical', 'trial', 'protocols', 'show', 'met', 'predetermined', 'safety', 'efficacy', 'standards', 'Independent', 'safety', 'monitors', 'conduct', 'first', 'review', 'vaccine', 'safety', 'effectiveness', 'trial', 'subjects', 'become', 'infected', 'original', 'initial', 'review', 'plan', 'infections', 'according', 'Reuters', 'review', 'protocol', 'documents', 'issued', 'July', 'amended', 'midSeptember', 'The', 'safety', 'monitors', 'could', 'decide', 'stop', 'trial', 'vaccine', 'proves', 'either', 'highly', 'effective', 'therefore', 'considered', 'public', 'use', 'trial', 'concludes', 'serious', 'safety', 'problems', 'appear', 'Safety', 'likely', 'major', 'reason', 'change', 'said', 'Thomas', 'Lumley', 'chair', 'biostatistics', 'University', 'Auckland', 'involved', 'study', 'AstraZeneca', 'would', 'say', 'made', 'change', 'protocol', 'Â', 'Reuters', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'said', 'Thursday', 'started', 'rolling', 'review', 'experimental', 'vaccine', 'AstraZeneca', 'L', 'Oxford', 'University', 'move', 'aimed', 'speeding', 'future', 'approval', 'process', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'human', 'medicines', 'committee', 'started', 'evaluating', 'first', 'batch', 'data', 'vaccine', 'continue', 'till', 'sufficient', 'data', 'available', 'formal', 'application', 'submitted', 'https', 'The', 'news', 'raises', 'chances', 'vaccine', 'first', 'approved', 'region', 'comes', 'weeks', 'several', 'global', 'trials', 'vaccine', 'halted', 'due', 'unexplained', 'illness', 'study', 'participant', 'US', 'trials', 'still', 'review', 'regulators', 'widening', 'probe', 'Reuters', 'reported', 'Wednesday', 'This', 'EMA', 'review', 'mean', 'conclusion', 'reached', 'yet', 'vaccine', 'safety', 'effectiveness', 'much', 'evidence', 'still', 'submitted', 'committee', 'watchdog', 'said', 'Earlystage', 'data', 'July', 'showed', 'vaccine', 'elicited', 'immune', 'responses', 'clinical', 'trials', 'produced', 'serious', 'side', 'effects', 'strongest', 'response', 'seen', 'people', 'received', 'two', 'doses', 'Data', 'latestage', 'trials', 'expected', 'soon', 'The', 'EMA', 'would', 'make', 'final', 'recommendations', 'review', 'completed', 'European', 'Commission', 'ultimate', 'say', 'approvals', 'The', 'commission', 'typically', 'follows', 'EMA', 'endorsements', 'The', 'EMA', 'began', 'similar', 'realtime', 'review', 'Gilead', 'O', 'Veklury', 'treatment', 'earlier', 'year', 'antiviral', 'treatment', 'given', 'conditional', 'approval', 'use', 'months', 'later', 'July'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Small', 'toy', 'figures', 'seen', 'front', 'Vaccine', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Clinical', 'trials', 'AstraZeneca', 'L', 'Oxford', 'University', 'experimental', 'vaccine', 'resumed', 'Japan', 'almost', 'month', 'put', 'hold', 'due', 'illness', 'British', 'volunteer', 'discussions', 'US', 'authorities', 'continue', 'The', 'British', 'drugmaker', 'said', 'Friday', 'earlytomidstage', 'trial', 'vaccine', 'novel', 'coronavirus', 'resumed', 'Japan', 'consultations', 'national', 'health', 'regulator', 'Japanese', 'Pharmaceuticals', 'Medical', 'Devices', 'Agency', 'Global', 'trials', 'vaccine', 'called', 'put', 'hold', 'Sept', 'study', 'participant', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'Trials', 'UK', 'Brazil', 'South', 'Africa', 'India', 'already', 'restarted', 'US', 'trials', 'remain', 'paused', 'regulators', 'widened', 'probe', 'Reuters', 'reported', 'Wednesday', 'AstraZeneca', 'called', 'halt', 'standard', 'review', 'procedure', 'document', 'posted', 'online', 'Oxford', 'university', 'last', 'month', 'stated', 'illness', 'may', 'associated', 'vaccine', 'However', 'incident', 'drawn', 'focus', 'safety', 'candidates', 'developed', 'race', 'successful', 'vaccine', 'illness', 'caused', 'novel', 'coronavirus', 'claimed', 'million', 'lives', 'globally', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'broadened', 'investigation', 'illness', 'volunteer', 'would', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'told', 'Reuters', 'In', 'Friday', 'statement', 'AstraZeneca', 'stressed', 'safety', 'participants', 'paramount', 'importance', 'applying', 'highest', 'standards', 'conduct', 'trials', 'Sources', 'told', 'Reuters', 'data', 'requested', 'FDA', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'expected', 'week'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'CTH', 'Add', 'toRemove', 'Portfolio', 'PAGPA', 'Add', 'toRemove', 'Portfolio', 'PHNX', 'Add', 'toRemove', 'Portfolio', 'CSPC', 'Add', 'toRemove', 'Portfolio', 'AJBA', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'likely', 'get', 'results', 'US', 'vaccine', 'trial', 'lateJanuary', 'could', 'potentially', 'file', 'emergency', 'authorization', 'chief', 'adviser', 'US', 'government', 'Operation', 'Warp', 'Speed', 'program', 'said', 'Wednesday', 'GOLD', 'Gold', 'rose', 'oneweek', 'high', 'dollar', 'weakened', 'hopes', 'coronavirus', 'vaccine', 'rollouts', 'investors', 'also', 'weighed', 'possibility', 'US', 'stimulus', 'OIL', 'Oil', 'prices', 'fell', 'producers', 'including', 'Saudi', 'Arabia', 'Russia', 'locked', 'horns', 'need', 'extend', 'record', 'production', 'cuts', 'set', 'place', 'first', 'wave', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Wednesday', 'sterling', 'weakened', 'doubts', 'whether', 'trade', 'deal', 'could', 'reached', 'Britain', 'European', 'Union', 'UK', 'approval', 'vaccine', 'also', 'supported', 'sentiment', 'UK', 'CORPORATE', 'DIARY', 'Countryside', 'Properties', 'Plc', 'FY', 'earnings', 'Go', 'Ahead', 'Group', 'Trading', 'update', 'AJ', 'Bell', 'Plc', 'FY', 'earnings', 'Caretech', 'Holdings', 'Plc', 'FY', 'earnings', 'Paragon', 'Banking', 'Group', 'Plc', 'FY', 'earnings', 'Phoenix', 'Group', 'Holdings', 'Plc', 'Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'TUIGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Flutter', 'Entertainment', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Unilever', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'AVV', 'Add', 'toRemove', 'Portfolio', 'TRNT', 'Add', 'toRemove', 'Portfolio', 'BIFF', 'Add', 'toRemove', 'Portfolio', 'AUTOA', 'Add', 'toRemove', 'Portfolio', 'JSAIY', 'Add', 'toRemove', 'Portfolio', 'RDI', 'Add', 'toRemove', 'Portfolio', 'KCT', 'Add', 'toRemove', 'Portfolio', 'LRE', 'Add', 'toRemove', 'Portfolio', 'DLN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'INCH', 'Add', 'toRemove', 'Portfolio', 'WIN', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'TATE', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'Chilean', 'President', 'Sebastian', 'Pinera', 'said', 'country', 'health', 'regulator', 'given', 'goahead', 'clinical', 'trials', 'AstraZeneca', 'PLC', 'vaccine', 'SAINSBURY', 'British', 'supermarket', 'group', 'Sainsbury', 'announce', 'plans', 'cut', 'jobs', 'alongside', 'firsthalf', 'results', 'Thursday', 'The', 'Times', 'reported', 'BARCLAYS', 'A', 'former', 'Barclays', 'trader', 'fled', 'native', 'France', 'convicted', 'London', 'helping', 'rig', 'Euribor', 'interest', 'rates', 'court', 'battle', 'extradition', 'Britain', 'serve', 'eightyear', 'jail', 'sentence', 'lawyer', 'said', 'GOLD', 'Gold', 'firmed', 'investors', 'cautiously', 'optimistic', 'Democrat', 'Joe', 'Biden', 'would', 'edge', 'past', 'President', 'Donald', 'Trump', 'tight', 'race', 'White', 'House', 'boosting', 'likelihood', 'economic', 'stimulus', 'OIL', 'Oil', 'dropped', 'Democrat', 'Joe', 'Biden', 'edged', 'closer', 'White', 'House', 'Republicans', 'look', 'likely', 'retain', 'Senate', 'control', 'decreasing', 'chances', 'huge', 'relief', 'package', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Wednesday', 'weaker', 'pound', 'boosted', 'shares', 'exporters', 'although', 'investors', 'remained', 'cautious', 'prospects', 'contested', 'outcome', 'US', 'presidential', 'elections', 'UK', 'CORPORATE', 'DIARY', 'Tate', 'Lyle', 'Plc', 'HY', 'results', 'RDI', 'Reit', 'Plc', 'FY', 'trading', 'statement', 'Biffa', 'Plc', 'HY', 'earnings', 'Wincanton', 'Plc', 'HY', 'earnings', 'Derwent', 'London', 'Plc', 'business', 'update', 'Kin', 'Carta', 'Plc', 'FY', 'earnings', 'AVEVA', 'Group', 'Plc', 'HY', 'earnings', 'AstraZeneca', 'Plc', 'earnings', 'RSA', 'Insurance', 'Group', 'Plc', 'trading', 'statement', 'J', 'Sainsbury', 'OTC', 'Plc', 'HY', 'earnings', 'Lancashire', 'Holdings', 'Ltd', 'trading', 'statement', 'Auto', 'Trader', 'Group', 'Plc', 'HY', 'earnings', 'Trainline', 'Plc', 'HY', 'earnings', 'Inchcape', 'Plc', 'trading', 'statement', 'Hikma', 'Pharmaceuticals', 'Plc', 'Trading', 'statement', 'RDI', 'Reit', 'Plc', 'FY', 'earnings', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'A', 'summer', 'dip', 'UK', 'coronavirus', 'infections', 'pushed', 'back', 'test', 'results', 'AstraZenca', 'potential', 'vaccine', 'leading', 'drugmaker', 'delay', 'deliveries', 'shots', 'UK', 'government', 'Britain', 'vaccines', 'chief', 'said', 'Wednesday', 'would', 'receive', 'million', 'doses', 'potential', 'vaccine', 'year', 'initial', 'estimates', 'million', 'Sept', 'AstraZeneca', 'L', 'said', 'Thursday', 'holding', 'back', 'deliveries', 'awaits', 'data', 'latestage', 'clinical', 'trials', 'order', 'maximise', 'shelflife', 'supplies', 'It', 'keeping', 'vaccine', 'frozen', 'large', 'containers', 'add', 'final', 'ingredient', 'put', 'vials', 'keep', 'fridge', 'temperature', 'vaccine', 'gets', 'closer', 'approval', 'We', 'little', 'bit', 'late', 'deliveries', 'vaccine', 'kept', 'frozen', 'form', 'CEO', 'Pascal', 'Soriot', 'said', 'conference', 'call', 'However', 'added', 'AstraZeneca', 'fully', 'prepared', 'launch', 'vaccine', 'ready', 'adding', 'company', 'weekly', 'delivery', 'schedule', 'roughly', 'match', 'UK', 'government', 'mind', 'vaccination', 'plans', 'AstraZeneca', 'partner', 'project', 'University', 'Oxford', 'said', 'data', 'latestage', 'trials', 'land', 'year', 'If', 'successful', 'pair', 'file', 'emergency', 'approvals', 'many', 'countries', 'possible', 'time', 'Soriot', 'said', 'The', 'British', 'duo', 'racing', 'PfizerBioNTech', 'Moderna', 'others', 'publish', 'first', 'detailed', 'results', 'large', 'vaccine', 'trials', 'A', 'vaccine', 'seen', 'world', 'best', 'bet', 'beating', 'pandemic', 'led', 'million', 'deaths', 'roiled', 'economies', 'disrupted', 'billions', 'lives', 'Earlier', 'year', 'AstraZeneca', 'also', 'agreed', 'start', 'supplying', 'millions', 'doses', 'end', 'United', 'States', 'European', 'Union', 'poorer', 'nations', 'epidemic', 'response', 'group', 'CEPI', 'vaccine', 'alliance', 'GAVI', 'subject', 'results', 'trials', 'regulatory', 'approval', 'The', 'company', 'hopes', 'shot', 'effective', 'least', 'year', 'trial', 'data', 'confirm', 'MIXED', 'RESULTS', 'While', 'working', 'vaccine', 'AstraZeneca', 'also', 'making', 'progress', 'pipeline', 'drugs', 'On', 'Thursday', 'company', 'said', 'two', 'main', 'drugs', 'cancer', 'treatment', 'Lynparza', 'diabetes', 'medicine', 'Forxiga', 'approved', 'wider', 'use', 'Europe', 'For', 'third', 'quarter', 'product', 'sales', 'billion', 'billion', 'pounds', 'ahead', 'companycompiled', 'consensus', 'billion', 'The', 'number', 'excluded', 'payments', 'collaborations', 'However', 'core', 'earnings', 'cents', 'per', 'share', 'three', 'months', 'ended', 'Sept', 'missed', 'analysts', 'expectations', 'cents', 'Research', 'development', 'costs', 'jumped', 'billion', 'projects', 'moved', 'final', 'stage', 'testing', 'humans', 'typically', 'expensive', 'The', 'company', 'said', 'still', 'expected', 'total', 'revenue', 'increase', 'high', 'singledigit', 'low', 'doubledigit', 'percentage', 'core', 'earnings', 'per', 'share', 'increase', 'mid', 'highteens', 'percentage'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'started', 'realtime', 'review', 'vaccine', 'developed', 'Pfizer', 'N', 'BioNTech', 'F', 'days', 'launching', 'similar', 'assessment', 'process', 'AstraZeneca', 'L', 'vaccine', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'Tuesday', 'human', 'medicines', 'committee', 'evaluating', 'first', 'batch', 'nonclinical', 'data', 'vaccine', 'laboratory', 'studies', 'continue', 'enough', 'data', 'available', 'final', 'decision', 'https', 'The', 'rolling', 'review', 'vaccine', 'called', 'based', 'earlystage', 'studies', 'suggested', 'vaccine', 'triggered', 'immune', 'response', 'watchdog', 'said', 'moves', 'ahead', 'plan', 'speed', 'approval', 'process', 'vaccine', 'candidates'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'TRYG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'SMT', 'Add', 'toRemove', 'Portfolio', 'BEZG', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'MGAMM', 'Add', 'toRemove', 'Portfolio', 'IFC', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'SAINSBURY', 'British', 'supermarket', 'Sainsbury', 'said', 'could', 'cut', 'range', 'offering', 'Northern', 'Ireland', 'unless', 'gets', 'clarity', 'province', 'trading', 'status', 'end', 'Britain', 'Brexit', 'transition', 'period', 'Dec', 'RSA', 'RSA', 'talks', 'consortium', 'Canadian', 'insurer', 'Intact', 'Financial', 'Danish', 'insurer', 'Tryg', 'possible', 'breakup', 'deal', 'values', 'British', 'firm', 'billion', 'pounds', 'billion', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'plans', 'start', 'early', 'midstage', 'clinical', 'trials', 'vaccine', 'candidate', 'China', 'year', 'senior', 'executive', 'said', 'prepares', 'global', 'rollout', 'vaccine', 'BRITISH', 'AIRWAYS', 'British', 'Airways', 'part', 'International', 'Consolidated', 'Airlines', 'Group', 'reduce', 'flight', 'schedule', 'month', 'UK', 'government', 'put', 'restrictions', 'leisure', 'travel', 'try', 'curb', 'spread', 'coronavirus', 'GOLD', 'Gold', 'fell', 'surging', 'previous', 'session', 'dollar', 'gained', 'set', 'best', 'week', 'since', 'late', 'July', 'hopes', 'central', 'bank', 'economic', 'support', 'investors', 'bet', 'divided', 'US', 'Congress', 'Biden', 'presidency', 'OIL', 'US', 'oil', 'fell', 'nearly', 'new', 'lockdowns', 'Europe', 'contain', 'spread', 'coronavirus', 'disease', 'raised', 'questions', 'outlook', 'crude', 'demand', 'markets', 'remained', 'edge', 'drawnout', 'vote', 'counting', 'US', 'election', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Thursday', 'government', 'Bank', 'England', 'ramped', 'stimulus', 'programmes', 'cushion', 'struggling', 'economy', 'England', 'goes', 'second', 'national', 'lockdown', 'UK', 'CORPORATE', 'DIARY', 'Scottish', 'Mortgage', 'Investment', 'Trust', 'Plc', 'HY', 'earnings', 'Morgan', 'Advanced', 'Materials', 'Plc', 'trading', 'statement', 'Beazley', 'Plc', 'earnings', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'could', 'start', 'profiting', 'vaccine', 'soon', 'July', 'next', 'year', 'Financial', 'Times', 'reported', 'Wednesday', 'citing', 'memo', 'showing', 'British', 'drugmaker', 'declare', 'considers', 'pandemic', 'ended', 'The', 'Londonlisted', 'firm', 'previously', 'said', 'would', 'profit', 'vaccine', 'pandemic', 'report', 'attributes', 'development', 'memorandum', 'understanding', 'signed', 'year', 'AstraZeneca', 'Brazilian', 'public', 'health', 'organization', 'Fiocruz', 'AstraZeneca', 'developed', 'vaccine', 'Oxford', 'University', 'signed', 'multiple', 'supplyandmanufacture', 'deals', 'billion', 'doses', 'globally', 'although', 'details', 'terms', 'scant', 'According', 'FT', 'Pandemic', 'Period', 'could', 'extended', 'beyond', 'July', 'Cambridge', 'Englandbased', 'AstraZeneca', 'acting', 'good', 'faith', 'considers', 'pandemic', 'AstraZeneca', 'immediately', 'respond', 'Reuters', 'request', 'comment', 'Pricing', 'supply', 'experimental', 'vaccines', 'widely', 'debated', 'richer', 'countries', 'pump', 'billions', 'dollars', 'funding', 'AstraZeneca', 'also', 'granted', 'protection', 'future', 'liability', 'claims'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'UTG', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'RWA', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'NRRT', 'Add', 'toRemove', 'Portfolio', 'CMCX', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'CMC', 'Markets', 'CMC', 'Markets', 'said', 'annual', 'net', 'operating', 'income', 'would', 'current', 'market', 'consensus', 'trading', 'online', 'platform', 'benefited', 'year', 'coronavirusdriven', 'market', 'volatility', 'EasyJet', 'British', 'airline', 'warned', 'would', 'report', 'annual', 'loss', 'much', 'first', 'ever', 'said', 'kept', 'finances', 'review', 'pandemic', 'meant', 'flying', 'planned', 'capacity', 'Hargreaves', 'Lansdown', 'British', 'fund', 'supermarket', 'Hargreaves', 'Lansdown', 'said', 'took', 'million', 'pounds', 'net', 'new', 'business', 'quarter', 'Sept', 'despite', 'described', 'weakening', 'investor', 'sentiment', 'arising', 'fresh', 'Brexit', 'uncertainty', 'Home', 'REIT', 'Home', 'REIT', 'vehicle', 'investing', 'properties', 'provide', 'accommodation', 'homeless', 'people', 'said', 'Thursday', 'initial', 'public', 'offering', 'GVC', 'Holdings', 'Ladbrokes', 'LON', 'bwin', 'owner', 'GVC', 'Holdings', 'raised', 'outlook', 'annual', 'core', 'earnings', 'posting', 'rise', 'thirdquarter', 'revenue', 'helped', 'surge', 'online', 'gaming', 'sports', 'events', 'English', 'Premier', 'League', 'resumed', 'Robert', 'Walters', 'British', 'recruiting', 'firm', 'Robert', 'Walters', 'Plc', 'thirdquarter', 'net', 'fee', 'income', 'Thursday', 'continued', 'tussle', 'hiring', 'slowdown', 'due', 'pandemic', 'reinstated', 'interim', 'dividend', 'AstraZeneca', 'AstraZeneca', 'could', 'vaccine', 'soon', 'July', 'next', 'year', 'Financial', 'Times', 'reported', 'Wednesday', 'citing', 'memo', 'showing', 'British', 'drugmaker', 'declare', 'considers', 'pandemic', 'ended', 'British', 'Airways', 'British', 'Airways', 'bid', 'farewell', 'final', 'Londonbased', 'Boeing', 'NYSE', 'Thursday', 'rare', 'synchronised', 'dual', 'take', 'Queen', 'Skies', 'jet', 'brought', 'longhaul', 'flights', 'masses', 'EasyJet', 'British', 'airline', 'easyJet', 'Plc', 'signalled', 'government', 'may', 'coronavirus', 'pandemic', 'continues', 'hinder', 'schedule', 'Sky', 'News', 'reported', 'Wednesday', 'Oil', 'prices', 'inched', 'Thursday', 'oil', 'workers', 'evacuated', 'rigs', 'US', 'Gulf', 'Mexico', 'ahead', 'Hurricane', 'Delta', 'though', 'fuel', 'demand', 'concerns', 'persisted', 'fading', 'chances', 'US', 'economic', 'stimulus', 'deal', 'build', 'Gold', 'prices', 'little', 'changed', 'Thursday', 'renewed', 'hopes', 'US', 'stimulus', 'kept', 'bullion', 'afloat', 'investors', 'eyeing', 'data', 'gauge', 'health', 'world', 'largest', 'economy', 'The', 'UK', 'bluechip', 'index', 'closed', 'Wednesday', 'weighed', 'fall', 'energy', 'stocks', 'lower', 'oil', 'prices', 'investors', 'looking', 'clues', 'US', 'stimulus', 'measures', 'President', 'Donald', 'Trump', 'called', 'halt', 'talks', 'Congress', 'comprehensive', 'bill', 'UK', 'corporate', 'diary', 'Preclose', 'trading', 'statement', 'Trading', 'statement', 'Operational', 'Update', 'preclose', 'trading', 'statement', 'trading', 'statement', 'Trading', 'statement', 'Trading', 'statement'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Michael', 'Erman', 'Julie', 'Steenhuysen', 'Reuters', 'Pfizer', 'Inc', 'N', 'experimental', 'vaccine', 'effective', 'based', 'initial', 'trial', 'results', 'drugmaker', 'said', 'Monday', 'major', 'victory', 'war', 'virus', 'killed', 'million', 'people', 'battered', 'world', 'economy', 'Experts', 'welcomed', 'first', 'successful', 'interim', 'data', 'largescale', 'clinical', 'test', 'watershed', 'moment', 'showed', 'vaccines', 'could', 'help', 'halt', 'pandemic', 'although', 'mass', 'rollouts', 'needs', 'regulatory', 'approval', 'happen', 'year', 'Pfizer', 'German', 'partner', 'BioNTech', 'SE', 'F', 'said', 'found', 'serious', 'safety', 'concerns', 'yet', 'expected', 'seek', 'US', 'authorization', 'month', 'emergency', 'use', 'vaccine', 'raising', 'chance', 'regulatory', 'decision', 'soon', 'December', 'If', 'granted', 'companies', 'estimate', 'roll', 'million', 'doses', 'year', 'enough', 'protect', 'million', 'people', 'produce', 'billion', 'doses', 'Today', 'great', 'day', 'science', 'humanity', 'said', 'Pfizer', 'Chief', 'Executive', 'Albert', 'Bourla', 'We', 'reaching', 'critical', 'milestone', 'vaccine', 'development', 'program', 'time', 'world', 'needs', 'infection', 'rates', 'setting', 'new', 'records', 'hospitals', 'nearing', 'overcapacity', 'economies', 'struggling', 'reopen', 'said', 'Experts', 'said', 'still', 'wanted', 'see', 'full', 'trial', 'data', 'yet', 'peerreviewed', 'published', 'medical', 'journal', 'preliminary', 'results', 'looked', 'encouraging', 'This', 'news', 'made', 'smile', 'ear', 'ear', 'It', 'relief', 'see', 'positive', 'results', 'vaccine', 'bodes', 'well', 'vaccines', 'general', 'said', 'Peter', 'Horby', 'professor', 'emerging', 'infectious', 'diseases', 'University', 'Oxford', 'There', 'still', 'many', 'questions', 'effective', 'vaccine', 'ethnicity', 'age', 'long', 'provide', 'immunity', 'new', 'normal', 'social', 'distancing', 'face', 'covering', 'set', 'remain', 'foreseeable', 'future', 'Pfizer', 'expects', 'seek', 'US', 'emergency', 'use', 'authorization', 'people', 'aged', 'To', 'need', 'two', 'months', 'safety', 'data', 'half', 'study', 'participants', 'expected', 'third', 'week', 'November', 'US', 'Health', 'Human', 'Services', 'Secretary', 'Alex', 'Azar', 'said', 'would', 'take', 'several', 'weeks', 'US', 'regulators', 'receive', 'process', 'data', 'vaccine', 'government', 'could', 'potentially', 'approve', 'MARKETS', 'SURGE', 'The', 'prospect', 'vaccine', 'electrified', 'world', 'markets', 'SP', 'hitting', 'record', 'highs', 'shares', 'banks', 'oil', 'companies', 'travel', 'companies', 'soared', 'Shares', 'companies', 'thrived', 'lockdowns', 'conferencing', 'platform', 'Zoom', 'Video', 'O', 'online', 'retailers', 'tumbled', 'Pfizer', 'shares', 'jumped', 'highest', 'since', 'July', 'last', 'year', 'BioNTech', 'stock', 'hit', 'record', 'high', 'Shares', 'vaccine', 'developers', 'final', 'stage', 'testing', 'also', 'rose', 'Johnson', 'Johnson', 'N', 'Moderna', 'Inc', 'O', 'whose', 'vaccine', 'uses', 'similar', 'technology', 'Pfizer', 'shot', 'Britain', 'AstraZeneca', 'L', 'however', 'fell', 'Moderna', 'expected', 'report', 'results', 'largescale', 'trial', 'later', 'month', 'The', 'efficacy', 'data', 'really', 'impressive', 'This', 'better', 'us', 'anticipated', 'said', 'William', 'Schaffner', 'infectious', 'diseases', 'expert', 'Vanderbilt', 'University', 'School', 'Medicine', 'Nashville', 'Tennessee', 'The', 'study', 'completed', 'yet', 'nonetheless', 'data', 'look', 'solid', 'US', 'President', 'Donald', 'Trump', 'welcomed', 'test', 'results', 'market', 'boost', 'STOCK', 'MARKET', 'UP', 'BIG', 'VACCINE', 'COMING', 'SOON', 'REPORT', 'EFFECTIVE', 'SUCH', 'GREAT', 'NEWS', 'tweeted', 'Presidentelect', 'Joe', 'Biden', 'said', 'news', 'excellent', 'change', 'fact', 'face', 'masks', 'social', 'distancing', 'health', 'measures', 'would', 'needed', 'well', 'next', 'year', 'The', 'World', 'Health', 'Organization', 'said', 'results', 'positive', 'warned', 'funding', 'gap', 'billion', 'could', 'slow', 'access', 'tests', 'medicines', 'vaccines', 'low', 'middleincome', 'countries', 'ECSTATIC', 'I', 'near', 'ecstatic', 'Bill', 'Gruber', 'one', 'Pfizer', 'top', 'vaccine', 'scientists', 'said', 'interview', 'This', 'great', 'day', 'public', 'health', 'potential', 'get', 'us', 'circumstances', 'Between', 'population', 'need', 'vaccinated', 'break', 'dynamic', 'spread', 'said', 'Germany', 'health', 'minister', 'Jens', 'Spahn', 'adding', 'expect', 'shot', 'available', 'first', 'quarter', 'The', 'European', 'Union', 'said', 'Monday', 'would', 'soon', 'sign', 'contract', 'million', 'doses', 'Pfizer', 'BioNTech', 'vaccine', 'The', 'companies', 'billion', 'contract', 'US', 'government', 'deliver', 'million', 'vaccine', 'doses', 'beginning', 'year', 'They', 'receive', 'research', 'funding', 'Trump', 'administration', 'Operation', 'Warp', 'Speed', 'vaccine', 'program', 'The', 'drugmakers', 'also', 'reached', 'supply', 'agreements', 'United', 'Kingdom', 'Canada', 'Japan', 'Pfizer', 'said', 'interim', 'analysis', 'conducted', 'participants', 'trial', 'developed', 'examined', 'many', 'received', 'vaccine', 'versus', 'placebo', 'Pfizer', 'break', 'many', 'fell', 'ill', 'received', 'vaccine', 'Still', 'effectiveness', 'implies', 'given', 'vaccine', 'administered', 'two', 'shots', 'three', 'weeks', 'apart', 'The', 'efficacy', 'rate', 'could', 'drop', 'full', 'results', 'available', 'well', 'effectiveness', 'required', 'US', 'Food', 'Drug', 'Administration', 'coronavirus', 'vaccine', 'Shortly', 'Pfizer', 'announcement', 'Russia', 'said', 'Sputnik', 'V', 'vaccine', 'also', 'effective', 'based', 'data', 'collated', 'inoculations', 'public', 'Its', 'preliminary', 'Phase', 'III', 'trial', 'data', 'due', 'published', 'month', 'MORE', 'DATA', 'NEEDED', 'To', 'confirm', 'efficacy', 'rate', 'Pfizer', 'said', 'would', 'continue', 'trial', 'cases', 'among', 'volunteers', 'Bourla', 'told', 'CNBC', 'Monday', 'based', 'rising', 'infection', 'rates', 'trial', 'could', 'completed', 'end', 'November', 'Pfizer', 'said', 'data', 'would', 'peer', 'reviewed', 'results', 'entire', 'trial', 'These', 'interesting', 'first', 'signals', 'communicated', 'press', 'releases', 'said', 'Marylyn', 'Addo', 'head', 'tropical', 'medicine', 'University', 'Medical', 'Center', 'HamburgEppendorf', 'Germany', 'Dozens', 'drugmakers', 'research', 'groups', 'around', 'globe', 'racing', 'develop', 'vaccines', 'Sunday', 'exceeded', 'million', 'cases', 'since', 'new', 'coronavirus', 'first', 'emerged', 'late', 'last', 'year', 'China', 'The', 'Pfizer', 'BioNTech', 'vaccine', 'uses', 'messenger', 'RNA', 'mRNA', 'technology', 'relies', 'synthetic', 'genes', 'generated', 'manufactured', 'weeks', 'produced', 'scale', 'rapidly', 'conventional', 'vaccines', 'The', 'technology', 'designed', 'trigger', 'immune', 'response', 'without', 'using', 'pathogens', 'actual', 'virus', 'particles', 'The', 'Trump', 'administration', 'said', 'enough', 'vaccine', 'doses', 'million', 'US', 'residents', 'want', 'middle', 'Â', 'Reuters', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Coronavirus', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'WFC', 'Add', 'toRemove', 'Portfolio', 'PHPTHB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Tom', 'Westbrook', 'Elizabeth', 'Howcroft', 'SYDNEYLONDON', 'Reuters', 'Investors', 'expecting', 'imminent', 'vaccine', 'beginning', 'buy', 'bank', 'stocks', 'industrials', 'anticipation', 'roaring', 'return', 'consumer', 'confidence', 'though', 'many', 'remain', 'wary', 'risks', 'sectors', 'ravaged', 'pandemic', 'The', 'development', 'kind', 'preventative', 'medicine', 'seen', 'best', 'chance', 'halting', 'coronavirus', 'killed', 'million', 'people', 'top', 'issue', 'money', 'managers', 'eyeing', 'next', 'major', 'shift', 'financial', 'markets', 'As', 'market', 'hype', 'around', 'US', 'election', 'ebbs', 'investors', 'preparing', 'good', 'vaccine', 'news', 'believe', 'matter', 'It', 'going', 'absolutely', 'massive', 'said', 'Stuart', 'Oakley', 'head', 'cash', 'currency', 'trading', 'Nomura', 'London', 'If', 'get', 'vaccine', 'going', 'see', 'pent', 'demand', 'coming', 'Of', 'roughly', 'vaccines', 'undergoing', 'human', 'trials', 'Pfizer', 'N', 'Moderna', 'O', 'seen', 'possibly', 'winning', 'regulatory', 'approval', 'year', 'AstraZeneca', 'L', 'far', 'behind', 'Investors', 'looking', 'beyond', 'expected', 'excitement', 'rally', 'longerterm', 'beneficiaries', 'shortselling', 'opportunities', 'What', 'done', 'given', 'optionality', 'recovery', 'trade', 'vaccine', 'trade', 'exposure', 'financials', 'said', 'Binay', 'Chandgothia', 'Hong', 'Kongbased', 'portfolio', 'manager', 'Principal', 'Global', 'Investors', 'Banks', 'benefit', 'increased', 'economic', 'activity', 'would', 'helped', 'bond', 'yields', 'rose', 'said', 'adding', 'increased', 'exposure', 'growthsensitive', 'small', 'companies', 'would', 'buy', 'stocks', 'Singapore', 'Hong', 'Kong', 'trade', 'travel', 'pick', 'Brian', 'Jacobsen', 'senior', 'investment', 'strategist', 'Wells', 'Fargo', 'NYSE', 'Asset', 'Management', 'Wisconsin', 'said', 'industrials', 'offered', 'broad', 'exposure', 'rebound', 'confidence', 'areas', 'building', 'products', 'aviation', 'Deutsche', 'Bank', 'DE', 'manages', 'vaccine', 'basket', 'Singapore', 'dollars', 'Thai', 'baht', 'seen', 'benefitting', 'increased', 'trade', 'tourism', 'Philippine', 'peso', 'weighed', 'rising', 'imports', 'Financials', 'industrials', 'gained', 'broader', 'market', 'month', 'badly', 'lag', 'roughly', 'gain', 'world', 'stocks', 'year', 'The', 'baht', 'also', 'surged', 'recently', 'peso', 'THREAD', 'THE', 'NEEDLE', 'Investors', 'also', 'setting', 'short', 'positions', 'Shinji', 'Naito', 'Japan', 'SPARX', 'Asset', 'Management', 'billion', 'management', 'hopes', 'vaccine', 'could', 'trigger', 'payoff', 'shorts', 'stocks', 'pumped', 'pandemic', 'technology', 'firms', 'helping', 'long', 'investments', 'realtor', 'Tokyo', 'Tatemono', 'T', 'Dave', 'Wang', 'portfolio', 'manager', 'Nuvest', 'Capital', 'Singapore', 'said', 'longshort', 'pairs', 'could', 'wring', 'gains', 'likely', 'uneven', 'recovery', 'For', 'example', 'airports', 'charge', 'per', 'aircraft', 'regardless', 'loads', 'could', 'perform', 'better', 'airlines', 'hit', 'low', 'patronage', 'rising', 'fuel', 'costs', 'Of', 'course', 'everyone', 'scrambling', 'piece', 'action', 'amid', 'questions', 'timing', 'efficacy', 'distribution', 'vaccine', 'still', 'remaining', 'You', 'better', 'bit', 'late', 'early', 'said', 'Hugh', 'Dive', 'chief', 'investment', 'officer', 'Atlas', 'Funds', 'Management', 'Sydney', 'noting', 'delays', 'would', 'leave', 'underpressure', 'companies', 'needing', 'raise', 'money', 'quickly', 'Others', 'however', 'feel', 'safe', 'bet', 'global', 'rebound', 'vaccine', 'would', 'boost', 'I', 'think', 'two', 'different', 'trades', 'said', 'Sean', 'Taylor', 'chief', 'investment', 'officer', 'Asia', 'German', 'fund', 'manager', 'DWS', 'A', 'vaccine', 'trade', 'cyclical', 'trade', 'I', 'positioning', 'cyclicals', 'said', 'If', 'got', 'much', 'credible', 'data', 'vaccines', 'I', 'add', 'services'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Caroline', 'Copley', 'FRANKFURT', 'Reuters', 'AstraZeneca', 'L', 'still', 'waiting', 'US', 'drug', 'regulator', 'approve', 'restart', 'clinical', 'trial', 'potential', 'vaccine', 'United', 'States', 'almost', 'three', 'weeks', 'paused', 'due', 'safety', 'concerns', 'The', 'US', 'trial', 'AstraZeneca', 'vaccine', 'candidate', 'initially', 'developed', 'University', 'Oxford', 'remains', 'hold', 'regulators', 'investigate', 'illness', 'one', 'participants', 'even', 'British', 'study', 'programmes', 'outside', 'United', 'States', 'resumed', 'We', 'sponsor', 'US', 'study', 'We', 'provided', 'information', 'FDA', 'US', 'Food', 'Drug', 'Administration', 'waiting', 'hear', 'decision', 'Soriot', 'told', 'virtual', 'World', 'Economic', 'Forum', 'discussion', 'US', 'Health', 'Human', 'Services', 'Secretary', 'Alex', 'Azar', 'said', 'Wednesday', 'continued', 'suspension', 'showed', 'FDA', 'taking', 'vaccine', 'safety', 'seriously', 'A', 'document', 'posted', 'online', 'Oxford', 'university', 'last', 'week', 'stated', 'illness', 'British', 'participant', 'triggered', 'pause', 'Sept', 'may', 'associated', 'vaccine', 'Asked', 'company', 'disclosed', 'details', 'nature', 'illness', 'Soriot', 'said', 'clinical', 'trial', 'regulators', 'independent', 'supervisors', 'guarding', 'participants', 'privacy', 'Still', 'company', 'would', 'look', 'increasing', 'transparency', 'without', 'compromising', 'individual', 'rights', 'also', 'preventing', 'public', 'volunteers', 'drawing', 'wrong', 'conclusions', 'could', 'endanger', 'trial', 'enrollment', 'We', 'discussing', 'companies', 'industry', 'information', 'offer', 'without', 'compromising', 'patient', 'privacy', 'also', 'without', 'compromising', 'trial', 'said', 'CEO', 'Soriot', 'also', 'said', 'tests', 'vaccine', 'prototype', 'children', 'started', 'yet', 'The', 'British', 'trial', 'launched', 'May', 'seeking', 'volunteers', 'one', 'subgroups', 'children', 'years', 'age'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'PNN', 'Add', 'toRemove', 'Portfolio', 'RYA', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'AstraZeneca', 'European', 'governments', 'pay', 'claims', 'agreed', 'limit', 'AstraZeneca', 'potential', 'vaccine', 'different', 'terms', 'deal', 'struck', 'Sanofi', 'PA', 'EU', 'official', 'told', 'Reuters', 'Boohoo', 'Fashion', 'retailer', 'Boohoo', 'said', 'independent', 'review', 'allegations', 'working', 'conditions', 'low', 'pay', 'Leicester', 'supply', 'chain', 'recommended', 'improvements', 'company', 'corporate', 'governance', 'Borrowing', 'British', 'public', 'borrowing', 'August', 'government', 'dealt', 'economic', 'damage', 'coronavirus', 'pandemic', 'Kaspikz', 'Kazakhstan', 'bank', 'Kaspikz', 'KSPIKZ', 'announced', 'plans', 'reviving', 'plans', 'abandoned', 'year', 'ago', 'IPO', 'Buffettology', 'Smaller', 'Companies', 'Investment', 'Trust', 'intends', 'raise', 'via', 'initial', 'public', 'offering', 'London', 'Stock', 'Exchange', 'said', 'Airlines', 'Italy', 'antitrust', 'regulator', 'said', 'airlines', 'Easyjet', 'Ryanair', 'Blue', 'Panorama', 'Vueling', 'offering', 'vouchers', 'refunds', 'passengers', 'whose', 'flights', 'cancelled', 'due', 'Automobiles', 'British', 'car', 'production', 'August', 'sector', 'continues', 'suffer', 'due', 'pandemic', 'pushing', 'demand', 'industry', 'body', 'said', 'Consumer', 'sentiment', 'British', 'consumer', 'confidence', 'highest', 'level', 'since', 'coronavirus', 'lockdown', 'started', 'March', 'remains', 'well', 'prepandemic', 'levels', 'survey', 'showed', 'Brexit', 'France', 'week', 'dire', 'British', 'warnings', 'postBrexit', 'transport', 'delays', 'across', 'Channel', 'tactical', 'posturing', 'Financial', 'Times', 'reported', 'Friday', 'Morrisons', 'Morrisons', 'Thursday', 'became', 'first', 'major', 'British', 'supermarket', 'chain', 'purchases', 'key', 'items', 'government', 'imposed', 'new', 'measures', 'stem', 'second', 'wave', 'Banks', 'Britain', 'financial', 'industry', 'staff', 'work', 'home', 'possible', 'truly', 'essential', 'staff', 'going', 'office', 'Financial', 'Conduct', 'Authority', 'said', 'Thursday', 'Oil', 'prices', 'rose', 'track', 'weekly', 'fall', 'rising', 'concerns', 'global', 'resurgence', 'coronavirus', 'infections', 'effects', 'fuel', 'demand', 'Gold', 'inched', 'higher', 'renewed', 'hopes', 'US', 'stimulus', 'measures', 'though', 'bullion', 'track', 'biggest', 'weekly', 'decline', 'month', 'pressured', 'stronger', 'dollar', 'London', 'shares', 'dropped', 'Thursday', 'hitting', 'session', 'lows', 'Britain', 'scaledback', 'job', 'support', 'workers', 'hit', 'resurgent', 'coronavirus', 'pandemic', 'AstraZeneca', 'LON', 'slid', 'US', 'trials', 'vaccine', 'remained', 'hold', 'UK', 'corporate', 'diary', 'Trading', 'statement', 'Â', 'Reuters', 'Traders', 'look', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'MASM', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Reuters', 'London', 'FTSE', 'traded', 'flat', 'Friday', 'surge', 'cases', 'offset', 'support', 'techdriven', 'rally', 'Wall', 'Street', 'bluechip', 'index', 'set', 'record', 'second', 'straight', 'weekly', 'drop', 'fading', 'hopes', 'economic', 'recovery', 'The', 'FTSE', 'index', 'For', 'week', 'far', 'shed', 'stocks', 'auto', 'makers', 'travel', 'insurers', 'biggest', 'laggards', 'surging', 'infections', 'new', 'movement', 'curbs', 'The', 'midcap', 'index', 'Friday', 'The', 'general', 'retailers', 'index', 'sector', 'posting', 'weekly', 'gain', 'retail', 'sales', 'picked', 'consumer', 'confidence', 'index', 'September', 'rose', 'highest', 'level', 'since', 'March', 'survey', 'showed', 'The', 'possibility', 'severe', 'measures', 'adopted', 'UK', 'cases', 'spiral', 'keeping', 'sentiment', 'towards', 'UK', 'equities', 'largely', 'risk', 'averse', 'said', 'Keith', 'Temperton', 'sales', 'trader', 'Forte', 'Securities', 'Gains', 'bluechip', 'recorded', 'previous', 'month', 'begun', 'peter', 'rising', 'infections', 'economic', 'uncertainty', 'overshadowed', 'support', 'past', 'stimulus', 'measures', 'British', 'car', 'production', 'fell', 'nearly', 'half', 'August', 'sector', 'continued', 'suffer', 'due', 'pandemicled', 'impact', 'demand', 'industry', 'body', 'said', 'Vodafone', 'Group', 'Plc', 'L', 'rose', 'reports', 'telephone', 'operator', 'started', 'talks', 'buy', 'Spanish', 'rival', 'MasMovil', 'MC', 'three', 'buyout', 'funds', 'recently', 'took', 'A', 'broader', 'weakness', 'healthcare', 'stocks', 'sent', 'AstraZeneca', 'L', 'shares', 'marginally', 'lower', 'European', 'governments', 'said', 'pay', 'claims', 'agreed', 'limit', 'drugmaker', 'sideeffects', 'potential', 'vaccine', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Small', 'toy', 'figures', 'seen', 'front', 'Vaccine', 'logo', 'illustration', 'taken', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'European', 'governments', 'pay', 'claims', 'agreed', 'limit', 'AstraZeneca', 'sideeffects', 'potential', 'vaccine', 'different', 'terms', 'deal', 'struck', 'Sanofi', 'EU', 'official', 'told', 'Reuters', 'The', 'deals', 'reflect', 'different', 'strategies', 'two', 'world', 'top', 'drugmakers', 'protecting', 'debate', 'rages', 'liabilities', 'vaccines', 'aimed', 'ending', 'pandemic', 'AstraZeneca', 'L', 'secured', 'European', 'Union', 'backing', 'confidential', 'agreement', 'reflects', 'lower', 'price', 'sought', 'British', 'drugmaker', 'official', 'said', 'If', 'company', 'asks', 'higher', 'price', 'give', 'conditions', 'said', 'official', 'involved', 'talks', 'declined', 'identified', 'contracts', 'confidential', 'Unexpected', 'sideeffects', 'drug', 'regulatory', 'approval', 'rare', 'speed', 'vaccine', 'pursued', 'increases', 'risks', 'unforeseen', 'conditions', 'The', 'deal', 'AstraZeneca', 'shifts', 'risks', 'involved', 'rollout', 'vaccine', 'taxpayers', 'struck', 'August', 'liability', 'clauses', 'previously', 'reported', 'Under', 'deal', 'AstraZeneca', 'would', 'pay', 'legal', 'costs', 'certain', 'threshold', 'official', 'said', 'declining', 'elaborate', 'costs', 'would', 'shared', 'individual', 'European', 'governments', 'cap', 'The', 'financial', 'shield', 'would', 'cover', 'legal', 'costs', 'potential', 'compensation', 'rarer', 'potentially', 'much', 'bigger', 'outlay', 'event', 'something', 'going', 'wrong', 'In', 'return', 'higher', 'price', 'paid', 'vaccine', 'French', 'drugmaker', 'Sanofi', 'PA', 'working', 'GlaxoSmithKline', 'partner', 'get', 'liability', 'waiver', 'Spokespeople', 'AstraZeneca', 'Sanofi', 'European', 'Commission', 'declined', 'comment', 'specifics', 'deals', 'When', 'asked', 'AstraZeneca', 'relatively', 'low', 'price', 'spokesman', 'reiterated', 'company', 'pledge', 'share', 'vaccine', 'widely', 'turn', 'profit', 'pandemic', 'Under', 'AstraZeneca', 'deal', 'EU', 'countries', 'agreed', 'pay', 'euros', 'per', 'dose', 'Sanofi', 'negotiated', 'price', 'around', 'euros', 'official', 'said', 'SIDEEFFECTS', 'As', 'part', 'supply', 'deals', 'two', 'sealed', 'far', 'Brussels', 'EU', 'also', 'made', 'nonrefundable', 'downpayment', 'million', 'euros', 'AstraZeneca', 'secure', 'million', 'doses', 'proportionately', 'lower', 'million', 'euros', 'paid', 'Sanofi', 'secure', 'million', 'doses', 'The', 'EU', 'official', 'told', 'Reuters', 'contract', 'AstraZeneca', 'included', 'narrow', 'definition', 'sideeffects', 'could', 'limit', 'possibility', 'claiming', 'compensation', 'although', 'company', 'remains', 'liable', 'vaccine', 'The', 'deal', 'AstraZeneca', 'negotiated', 'paused', 'latestage', 'trials', 'vaccine', 'candidate', 'month', 'British', 'volunteer', 'developed', 'neurological', 'symptoms', 'Trials', 'resumed', 'Britain', 'United', 'States', 'EU', 'governments', 'would', 'share', 'compensation', 'costs', 'unexpected', 'sideeffects', 'emerged', 'AstraZeneca', 'vaccine', 'approved', 'Liability', 'key', 'stumbling', 'block', 'talks', 'vaccine', 'makers', 'EU', 'officials', 'said', 'companies', 'fear', 'risk', 'larger', 'legal', 'costs', 'usually', 'face', 'vaccines', 'developed', 'much', 'longer', 'trials', 'A', 'European', 'Commission', 'spokesman', 'said', 'advance', 'purchase', 'deals', 'provide', 'member', 'states', 'indemnify', 'manufacturer', 'certain', 'liabilities', 'incurred', 'specific', 'strict', 'conditions', 'liability', 'still', 'remains', 'companies', 'This', 'means', 'would', 'firm', 'responsibility', 'defend', 'shot', 'courts', 'Drugmakers', 'called', 'EU', 'regulators', 'set', 'Europewide', 'compensation', 'scheme', 'patients', 'organisations', 'calling', 'EUwide', 'fund', 'financed', 'pharmaceutical', 'firms', 'would', 'compensate', 'unexpected', 'sideeffects', 'The', 'EU', 'legal', 'regime', 'among', 'least', 'favourable', 'drugmakers', 'compensation', 'claims', 'although', 'plaintiffs', 'rarely', 'managed', 'win', 'law', 'requires', 'prove', 'link', 'illness', 'vaccine', 'may', 'caused', 'The', 'United', 'States', 'granted', 'immunity', 'liability', 'vaccines', 'receive', 'regulatory', 'approval', 'Meanwhile', 'Russia', 'said', 'would', 'shoulder', 'legal', 'liability', 'anything', 'go', 'wrong', 'vaccine', 'developed', 'Moscow', 'Gamaleya', 'Institute', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Canada', 'Prime', 'Minister', 'Justin', 'Trudeau', 'speaks', 'Question', 'Period', 'House', 'Commons', 'Parliament', 'Hill', 'Ottawa', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OTTAWA', 'Reuters', 'Canada', 'signed', 'deal', 'Cambridgebased', 'AstraZeneca', 'L', 'buy', 'million', 'doses', 'vaccine', 'candidate', 'Prime', 'Minister', 'Justin', 'Trudeau', 'told', 'reporters', 'Friday', 'The', 'medication', 'among', 'leading', 'candidates', 'global', 'race', 'vaccine', 'latestage', 'trials', 'Britain', 'South', 'Africa', 'elsewhere'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'World', 'Bank', 'Group', 'President', 'Malpass', 'attends', 'news', 'conference', 'meeting', 'Chancellery', 'Berlin', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'David', 'Lawder', 'WASHINGTON', 'Reuters', 'World', 'Bank', 'President', 'David', 'Malpass', 'said', 'Tuesday', 'seeking', 'board', 'approval', 'billion', 'coronavirus', 'vaccine', 'financing', 'plan', 'help', 'poor', 'developing', 'countries', 'secure', 'sufficient', 'share', 'vaccine', 'doses', 'become', 'available', 'coming', 'months', 'Malpass', 'told', 'Reuters', 'exclusive', 'interview', 'initiative', 'part', 'billion', 'coronavirus', 'aid', 'financing', 'pledged', 'multilateral', 'lender', 'aimed', 'helping', 'countries', 'procure', 'distribute', 'vaccines', 'early', 'health', 'care', 'essential', 'workers', 'expand', 'global', 'production', 'He', 'said', 'board', 'expected', 'consider', 'plan', 'early', 'October', 'Global', 'competition', 'early', 'coronairus', 'vaccine', 'doses', 'already', 'fierce', 'months', 'ahead', 'approvals', 'wealthy', 'countries', 'move', 'secure', 'supplies', 'The', 'US', 'government', 'pledged', 'billion', 'secure', 'hundreds', 'millions', 'doses', 'vaccines', 'development', 'Britain', 'AstraZeneca', 'L', 'US', 'drug', 'giant', 'Pfizer', 'NYSE', 'Germany', 'BioNTech', 'SE', 'F', 'Malpass', 'said', 'World', 'Bank', 'plan', 'aimed', 'put', 'poor', 'middleincome', 'countries', 'virus', 'spreading', 'rapidly', 'footing', 'richer', 'countries', 'ensuring', 'financing', 'secure', 'supplies', 'system', 'distribution', 'encourage', 'drug', 'makers', 'meet', 'demand', 'Without', 'early', 'doses', 'bring', 'outbreaks', 'control', 'many', 'countries', 'risk', 'economic', 'collapse', 'push', 'hundreds', 'millions', 'people', 'back', 'poverty', 'Our', 'goal', 'alter', 'course', 'pandemic', 'low', 'middle', 'income', 'developing', 'countries', 'Malpass', 'said', 'This', 'market', 'signal', 'manufacturers', 'financing', 'available', 'developing', 'countries', 'demand', 'We', 'begin', 'asking', 'manufacturers', 'begin', 'creating', 'allocations', 'countriesMalpass', 'said', 'World', 'Bank', 'also', 'asking', 'wealthy', 'countries', 'overreserved', 'doses', 'ultimately', 'need', 'release', 'doses', 'poorer', 'countries'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'FGP', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'SMDS', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'RWS', 'Add', 'toRemove', 'Portfolio', 'OTB', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'BREXIT', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'EU', 'chief', 'executive', 'gave', 'end', 'weekend', 'seal', 'new', 'trade', 'pact', 'failing', 'overcome', 'persistent', 'rifts', 'frank', 'lively', 'dinner', 'turbot', 'Wednesday', 'Britain', 'medicine', 'regulator', 'said', 'anyone', 'history', 'anaphylaxis', 'medicine', 'food', 'get', 'PfizerBioNTech', 'vaccine', 'giving', 'fuller', 'guidance', 'earlier', 'allergy', 'warning', 'shot', 'ASTRAZENECA', 'Jenner', 'Institute', 'Director', 'Adrian', 'Hill', 'oversees', 'OxfordAstraZeneca', 'vaccine', 'research', 'development', 'said', 'vaccine', 'would', 'available', 'United', 'States', 'middle', 'next', 'year', 'regulators', 'wait', 'end', 'vaccine', 'trial', 'HOUSE', 'PRICES', 'British', 'property', 'surveyors', 'reported', 'house', 'prices', 'increased', 'close', 'fastest', 'rate', 'years', 'last', 'month', 'extending', 'postlockdown', 'boom', 'expect', 'sales', 'fall', 'temporary', 'tax', 'break', 'expires', 'March', 'LONDON', 'STOCK', 'EXCHANGE', 'London', 'Stock', 'Exchange', 'Group', 'said', 'Wednesday', 'expects', 'green', 'light', 'outstanding', 'regulatory', 'scrutiny', 'billion', 'deal', 'buy', 'data', 'analytics', 'company', 'Refinitiv', 'GOLD', 'Gold', 'prices', 'little', 'changed', 'steep', 'selloff', 'previous', 'session', 'breakthrough', 'longrunning', 'negotiations', 'among', 'US', 'lawmakers', 'pandemic', 'relief', 'package', 'remained', 'elusive', 'OIL', 'Oil', 'prices', 'rose', 'early', 'trade', 'buoyed', 'vaccine', 'rollout', 'Britain', 'imminent', 'approval', 'vaccine', 'United', 'States', 'could', 'spur', 'rebound', 'fuel', 'demand', 'despite', 'large', 'build', 'stocks', 'last', 'week', 'The', 'UK', 'bluechip', 'index', 'edged', 'higher', 'Wednesday', 'ahead', 'talks', 'could', 'decide', 'whether', 'Britain', 'ends', 'messy', 'nodeal', 'exit', 'European', 'Union', 'UK', 'CORPORATE', 'DIARY', 'FirstGroup', 'Plc', 'HY', 'earnings', 'Marston', 'Plc', 'FY', 'earnings', 'DS', 'Smith', 'Plc', 'HY', 'earnings', 'On', 'The', 'Beach', 'Plc', 'FY', 'earnings', 'Ocado', 'Group', 'Plc', 'trading', 'statement', 'Frasers', 'Group', 'Plc', 'HY', 'earnings', 'RWS', 'Holdings', 'Plc'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'SMDS', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'ITV', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'EasyJet', 'PLC', 'LON', 'added', 'points', 'end', 'DS', 'Smith', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Standard', 'Chartered', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'HSBC', 'Holdings', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Â', 'Reuters', 'The', 'coronavirus', 'disease', 'outbreak', 'Barcelona', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Benoit', 'Van', 'Overstraeten', 'Jan', 'Lopatka', 'PARISPRAGUE', 'Reuters', 'France', 'imposed', 'curfews', 'European', 'nations', 'closing', 'schools', 'cancelling', 'surgeries', 'enlisting', 'student', 'medics', 'overwhelmed', 'authorities', 'face', 'nightmare', 'scenario', 'resurgence', 'onset', 'winter', 'With', 'new', 'cases', 'hitting', 'daily', 'Europe', 'wide', 'margin', 'overtaken', 'United', 'States', 'infections', 'reported', 'average', 'every', 'day', 'As', 'cases', 'France', 'climbed', 'rapidly', 'President', 'Emmanuel', 'Macron', 'announced', 'night', 'curfews', 'four', 'weeks', 'Saturday', 'Paris', 'major', 'cities', 'affecting', 'almost', 'onethird', 'country', 'million', 'people', 'Macron', 'said', 'interview', 'national', 'television', 'curfews', 'halt', 'temporarily', 'parties', 'moments', 'conviviality', 'people', 'festive', 'evenings', 'unfortunately', 'vectors', 'acceleration', 'disease', 'We', 'get', 'stick', 'together', 'said', 'Most', 'European', 'governments', 'eased', 'lockdowns', 'summer', 'start', 'reviving', 'economies', 'already', 'battered', 'first', 'wave', 'coronavirus', 'pandemic', 'But', 'return', 'normal', 'activity', 'packed', 'restaurants', 'new', 'university', 'terms', 'fuelled', 'sharp', 'spike', 'cases', 'continent', 'German', 'Chancellor', 'Angela', 'Merkel', 'said', 'leaders', 'Germany', 'states', 'agreed', 'Wednesday', 'tougher', 'measures', 'without', 'detailing', 'We', 'already', 'phase', 'exponential', 'growth', 'daily', 'numbers', 'show', 'said', 'Bars', 'pubs', 'among', 'first', 'shut', 'face', 'earlier', 'closing', 'new', 'lockdowns', 'surging', 'infection', 'rates', 'also', 'testing', 'governments', 'resolve', 'keep', 'schools', 'nonCOVID', 'medical', 'care', 'going', 'Even', 'Pope', 'Francis', 'subject', 'new', 'coronavirus', 'rules', 'staying', 'put', 'safe', 'distance', 'wellwishers', 'weekly', 'audience', 'Wednesday', 'In', 'Lisbon', 'football', 'fans', 'unsurprised', 'Portugal', 'captain', 'Cristiano', 'Ronaldo', 'tested', 'positive', 'virus', 'saying', 'simply', 'showed', 'everyone', 'risk', 'getting', 'infected', 'The', 'Czech', 'Republic', 'Europe', 'worst', 'rate', 'per', 'capita', 'shifted', 'schools', 'distance', 'learning', 'plans', 'call', 'thousands', 'medical', 'students', 'Hospitals', 'cutting', 'nonurgent', 'medical', 'procedures', 'free', 'beds', 'Sometimes', 'edge', 'crying', 'said', 'Lenka', 'Krejcova', 'head', 'nurse', 'Slany', 'hospital', 'near', 'Prague', 'builders', 'hurried', 'turn', 'general', 'ward', 'department', 'Poland', 'ramping', 'training', 'nurses', 'considering', 'creating', 'military', 'field', 'hospitals', 'Moscow', 'move', 'many', 'students', 'online', 'learning', 'Northern', 'Ireland', 'closing', 'schools', 'two', 'weeks', 'restaurants', 'four', 'Irish', 'Prime', 'Minister', 'Micheal', 'Martin', 'described', 'Northern', 'Ireland', 'rise', 'cases', 'hugely', 'worrying', 'government', 'increased', 'restrictions', 'three', 'counties', 'border', 'well', 'almost', 'visits', 'homes', 'across', 'country', 'We', 'brink', 'disaster', 'immunologist', 'Pawel', 'Grzesiowski', 'said', 'Poland', 'reported', 'record', 'infections', 'deaths', 'Wednesday', 'Efforts', 'develop', 'vaccine', 'hit', 'snags', 'areas', 'Johnson', 'Johnson', 'N', 'pausing', 'trial', 'unexplained', 'illness', 'study', 'participant', 'AstraZeneca', 'L', 'US', 'trial', 'remained', 'hold', 'month', 'Russia', 'recorded', 'record', 'daily', 'increase', 'cases', 'meanwhile', 'granted', 'regulatory', 'approval', 'second', 'vaccine', 'IMPOSSIBLE', 'CHOICES', 'Germany', 'England', 'France', 'far', 'resisted', 'pressure', 'close', 'schools', 'Germany', 'politicians', 'debating', 'whether', 'extend', 'ChristmasNew', 'Year', 'school', 'break', 'curb', 'contagion', 'The', 'Netherlands', 'returned', 'partial', 'lockdown', 'closing', 'bars', 'restaurants', 'kept', 'schools', 'open', 'European', 'infections', 'running', 'average', 'almost', 'day', 'third', 'global', 'total', 'forcing', 'governments', 'tighten', 'restrictions', 'attempting', 'avoid', 'destroying', 'livelihoods', 'The', 'United', 'Kingdom', 'France', 'Russia', 'Spain', 'accounted', 'half', 'Europe', 'new', 'cases', 'week', 'Oct', 'according', 'World', 'Health', 'Organization', 'In', 'United', 'States', 'world', 'highest', 'number', 'confirmed', 'infections', 'states', 'far', 'October', 'set', 'records', 'increases', 'new', 'cases', 'But', 'deaths', 'trending', 'downward', 'averaged', 'day', 'last', 'week', 'FIELD', 'HOSPITALS', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'faces', 'opposition', 'calls', 'another', 'national', 'lockdown', 'England', 'far', 'resisted', 'Hospital', 'admissions', 'however', 'climbing', 'field', 'hospitals', 'constructed', 'spring', 'readied', 'London', 'faces', 'tighter', 'restrictions', 'within', 'days', 'Financial', 'Times', 'reported', 'In', 'Spain', 'authorities', 'Catalonia', 'ordered', 'bars', 'restaurants', 'close', 'days', 'limited', 'numbers', 'people', 'allowed', 'shops', 'In', 'Belgium', 'Europe', 'second', 'worst', 'infection', 'rate', 'per', 'capita', 'hospitals', 'must', 'reserve', 'quarter', 'beds', 'patients', 'We', 'ca', 'see', 'end', 'tunnel', 'today', 'Renaud', 'Mazy', 'managing', 'director', 'University', 'Clinics', 'SaintLuc', 'Brussels', 'told', 'La', 'Premiere', 'radio', 'In', 'Australia', 'one', 'successful', 'countries', 'fighting', 'virus', 'clusters', 'emerged', 'two', 'populous', 'states', 'prompting', 'New', 'South', 'Wales', 'delay', 'relaxing', 'restrictions', 'And', 'new', 'curbs', 'imposed', 'Malaysia', 'royal', 'palace', 'postponed', 'meetings', 'two', 'weeks'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'INO', 'Add', 'toRemove', 'Portfolio', 'HVO', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'Human', 'challenge', 'trials', 'potential', 'vaccines', 'volunteers', 'deliberately', 'infected', 'disease', 'could', 'become', 'reality', 'British', 'biotech', 'firm', 'said', 'advanced', 'talks', 'government', 'create', 'provide', 'strains', 'virus', 'Preliminary', 'work', 'trials', 'aim', 'speed', 'process', 'determining', 'efficacy', 'vaccine', 'candidate', 'carried', 'hVIVO', 'unit', 'pharmaceutical', 'services', 'group', 'Open', 'Orphan', 'L', 'company', 'said', 'We', 'discussions', 'numerous', 'parties', 'including', 'UK', 'government', 'around', 'challenge', 'study', 'contracts', 'signed', 'make', 'announcement', 'said', 'Open', 'Orphan', 'executive', 'chairman', 'Cathal', 'Friel', 'If', 'agreed', 'would', 'involve', 'creating', 'human', 'challenge', 'study', 'model', 'could', 'used', 'trials', 'gain', 'ethical', 'safety', 'approval', 'regulators', 'A', 'government', 'spokesman', 'said', 'UK', 'working', 'partners', 'understand', 'might', 'collaborate', 'potential', 'development', 'vaccine', 'human', 'challenge', 'studies', 'Any', 'potential', 'study', 'must', 'meet', 'UKâs', 'robust', 'regulatory', 'ethical', 'frameworks', 'spokesman', 'added', 'Supporters', 'human', 'challenge', 'trials', 'say', 'good', 'way', 'cut', 'short', 'often', 'lengthy', 'process', 'testing', 'potential', 'vaccines', 'tens', 'thousands', 'volunteers', 'real', 'world', 'go', 'normal', 'life', 'monitored', 'see', 'contract', 'disease', 'protected', 'In', 'tightlycontrolled', 'trials', 'volunteers', 'given', 'vaccine', 'month', 'later', 'deliberately', 'infected', 'disease', 'controlled', 'conditions', 'They', 'isolated', 'quarantine', 'facility', 'monitored', 'see', 'become', 'sick', 'vaccine', 'protects', 'Critics', 'say', 'deliberately', 'infecting', 'someone', 'potentially', 'deadly', 'disease', 'currently', 'effective', 'treatment', 'unethical', 'Leading', 'vaccine', 'developers', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'BioNTech', 'O', 'Moderna', 'O', 'Inovio', 'O', 'said', 'last', 'month', 'respective', 'vaccine', 'candidates', 'involved', 'programme', 'Germany', 'CureVac', 'DE', 'Friday', 'said', 'participation', 'human', 'challenge', 'trial', 'decided', 'yet', 'circumstances', 'would', 'clearer', 'Johnson', 'Johnson', 'N', 'previously', 'said', 'evaluating', 'potential', 'benefit', 'trials', 'Any', 'human', 'challenge', 'trials', 'conducted', 'Britain', 'would', 'approved', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'healthcare', 'regulator', 'looks', 'safety', 'ethics', 'protocol'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'CBKG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IWG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AMGO', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Reuters', 'London', 'stocks', 'tracked', 'gains', 'Asian', 'markets', 'Monday', 'investors', 'hoped', 'vaccine', 'end', 'year', 'although', 'concerns', 'tougher', 'business', 'restrictions', 'UK', 'kept', 'demand', 'risky', 'assets', 'check', 'The', 'bluechip', 'FTSE', 'rose', 'led', 'autos', 'insurance', 'real', 'estate', 'stocks', 'A', 'gain', 'AstraZeneca', 'Plc', 'L', 'propped', 'pharmaceuticals', 'index', 'European', 'medicines', 'watchdog', 'recommended', 'approving', 'treatments', 'form', 'heart', 'failure', 'lung', 'disorder', 'The', 'midcap', 'FTSE', 'added', 'shares', 'flexible', 'office', 'space', 'provider', 'IWG', 'Plc', 'L', 'jumping', 'Berenberg', 'upgraded', 'stock', 'buy', 'Risk', 'assets', 'precariously', 'perched', 'shortage', 'uncertainty', 'clouding', 'background', 'said', 'Stephen', 'Innes', 'market', 'strategist', 'Axi', 'The', 'FTSE', 'midcap', 'index', 'recorded', 'first', 'weekly', 'declines', 'three', 'weeks', 'Friday', 'new', 'coronavirusinduced', 'lockdowns', 'London', 'well', 'uncertainty', 'postBrexit', 'trade', 'deal', 'sapped', 'demand', 'equities', 'Ratings', 'agency', 'Moody', 'cut', 'United', 'Kingdom', 'debt', 'rating', 'last', 'week', 'Bank', 'England', 'Governor', 'Andrew', 'Bailey', 'warned', 'significant', 'risk', 'disappointments', 'domestic', 'economic', 'growth', 'Investor', 'focus', 'later', 'day', 'Brexitrelated', 'news', 'Britain', 'European', 'Union', 'set', 'revive', 'negotiations', 'trade', 'deal', 'appeared', 'dead', 'last', 'week', 'side', 'telling', 'needed', 'fundamentally', 'change', 'course', 'What', 'decisive', 'market', 'fact', 'British', 'government', 'end', 'talks', 'EU', 'threatened', 'said', 'Commerzbank', 'DE', 'analyst', 'Esther', 'Reichelt', 'Amigo', 'Holdings', 'Plc', 'L', 'tumbled', 'saying', 'entered', 'Asset', 'Voluntary', 'Requirement', 'AVR', 'Britain', 'financial', 'watchdog', 'meaning', 'subprime', 'lender', 'need', 'approval', 'transfer', 'assets', 'outside', 'group'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'WMH', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'WIZZ', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'MHPCq', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Wednesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Antofagasta', 'Chilean', 'miner', 'Antofagasta', 'reported', 'drop', 'thirdquarter', 'output', 'previous', 'quarter', 'maintained', 'production', 'guidance', 'William', 'Hill', 'British', 'bookmaker', 'William', 'Hill', 'warned', 'local', 'lockdowns', 'triggered', 'fastspreading', 'second', 'coronavirus', 'wave', 'would', 'hit', 'core', 'earnings', 'due', 'fall', 'gaming', 'revenue', 'Metro', 'Bank', 'Britain', 'Metro', 'Bank', 'reported', 'increase', 'lending', 'third', 'quarter', 'capital', 'levels', 'remain', 'buffers', 'expected', 'regulators', 'grapples', 'impact', 'pandemic', 'FRC', 'Accounting', 'watchdog', 'Financial', 'Reporting', 'Council', 'ensure', 'reports', 'accounts', 'remain', 'clear', 'consistent', 'relevant', 'backdrop', 'increased', 'economic', 'uncertainty', 'brought', 'pandemic', 'Wizz', 'Air', 'The', 'world', 'result', 'coronavirus', 'crisis', 'many', 'privately', 'funded', 'carriers', 'set', 'go', 'governments', 'throwing', 'good', 'money', 'bad', 'keep', 'national', 'champions', 'afloat', 'Wizz', 'Air', 'CEO', 'said', 'GlaxoSmithKline', 'GlaxoSmithKline', 'said', 'would', 'move', 'experimental', 'vaccine', 'respiratory', 'syncytial', 'virus', 'cause', 'pneumonia', 'toddlers', 'elderly', 'final', 'stage', 'testing', 'encouraged', 'midstage', 'trial', 'results', 'AstraZeneca', 'AstraZeneca', 'Plc', 'vaccine', 'trial', 'United', 'States', 'expected', 'US', 'Food', 'Drug', 'Administration', 'completed', 'review', 'serious', 'illness', 'study', 'participant', 'four', 'sources', 'told', 'Reuters', 'Gold', 'prices', 'rose', 'Wednesday', 'optimism', 'US', 'lawmakers', 'could', 'reach', 'agreement', 'preelection', 'coronavirus', 'relief', 'package', 'pressured', 'dollar', 'bolstered', 'precious', 'metal', 'appeal', 'inflation', 'hedge', 'Oil', 'prices', 'eased', 'Wednesday', 'surprise', 'buildup', 'stoked', 'concerns', 'global', 'supply', 'glut', 'even', 'spike', 'global', 'cases', 'fuelled', 'fears', 'slower', 'recovery', 'fuel', 'demand', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Tuesday', 'investors', 'remained', 'hopeful', 'trade', 'deal', 'European', 'Union', 'yearend', 'although', 'gains', 'capped', 'concerns', 'tougher', 'coronavirus', 'lockdowns', 'parts', 'England', 'UK', 'corporate', 'diary', 'preclose', 'trading', 'update', 'trading', 'statement', 'production', 'report', 'Manchester', 'United', 'Plc', 'MANUN', 'results', 'Trading', 'statement', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Julie', 'Steenhuysen', 'Marisa', 'Taylor', 'CHICAGOWASHINGTON', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'vaccine', 'trial', 'United', 'States', 'expected', 'resume', 'early', 'week', 'US', 'Food', 'Drug', 'Administration', 'completed', 'review', 'serious', 'illness', 'study', 'participant', 'four', 'sources', 'told', 'Reuters', 'AstraZeneca', 'large', 'latestage', 'US', 'trial', 'hold', 'since', 'Sept', 'participant', 'company', 'UK', 'trial', 'fell', 'ill', 'suspected', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'The', 'sources', 'briefed', 'matter', 'asked', 'remain', 'anonymous', 'said', 'told', 'trial', 'could', 'resume', 'later', 'week', 'It', 'unclear', 'FDA', 'would', 'characterize', 'illness', 'said', 'An', 'FDA', 'spokeswoman', 'declined', 'comment', 'The', 'agency', 'requiring', 'researchers', 'conducting', 'trial', 'add', 'information', 'incident', 'consent', 'forms', 'signed', 'study', 'participants', 'according', 'one', 'sources', 'UK', 'regulatory', 'officials', 'previously', 'reviewed', 'illness', 'determined', 'âœinsufficient', 'evidence', 'say', 'certainâ', 'related', 'vaccine', 'It', 'permitted', 'trial', 'resume', 'UK', 'according', 'draft', 'updated', 'consent', 'form', 'shared', 'Reuters', 'âœIn', 'case', 'considering', 'information', 'independent', 'reviewers', 'MHRA', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'recommended', 'vaccinations', 'continueâ', 'draft', 'consent', 'form', 'stated', 'âœClose', 'monitoring', 'affected', 'individual', 'participants', 'continuedâ', 'Regulators', 'Brazil', 'India', 'South', 'Africa', 'also', 'previously', 'allowed', 'AstraZeneca', 'resume', 'vaccine', 'trials', 'AstraZeneca', 'developing', 'vaccine', 'Oxford', 'University', 'researchers', 'seen', 'frontrunner', 'race', 'produce', 'vaccine', 'trials', 'put', 'hold', 'investigate', 'illness', 'Early', 'data', 'largescale', 'trials', 'United', 'States', 'vaccines', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'expected', 'time', 'next', 'month', 'Johnson', 'Johnson', 'N', 'last', 'week', 'paused', 'Phase', 'III', 'vaccine', 'trial', 'investigate', 'unexplained', 'illness', 'study', 'participant', 'At', 'time', 'announcement', 'company', 'know', 'whether', 'volunteer', 'given', 'vaccine', 'placebo', 'A', 'JJ', 'spokesman', 'Tuesday', 'said', 'study', 'remains', 'pause', 'company', 'continues', 'review', 'medical', 'information', 'deciding', 'restart', 'trial', 'JJ', 'noted', 'last', 'week', 'study', 'pause', 'voluntary', 'By', 'contrast', 'AstraZeneca', 'trial', 'regulatory', 'hold', 'imposed', 'health', 'authorities', 'Vaccines', 'seen', 'essential', 'helping', 'end', 'pandemic', 'battered', 'economies', 'around', 'world', 'claimed', 'million', 'lives', 'United', 'States', 'Responding', 'request', 'AstraZeneca', 'trial', 'British', 'regulators', 'shared', 'Reuters', 'draft', 'form', 'letter', 'UK', 'vaccine', 'trial', 'participants', 'dated', 'Oct', 'signed', 'Oxford', 'Vaccine', 'Team', 'It', 'says', 'US', 'FDA', 'âœcompleted', 'analysisâ', 'said', 'vaccination', 'study', 'United', 'States', 'would', 'resume', 'shortly', 'FDA', 'come', 'conclusion', 'drug', 'regulators', 'including', 'MHRA', 'letter', 'states', 'The', 'Health', 'Research', 'Authority', 'helps', 'oversee', 'UK', 'medical', 'research', 'said', 'email', 'Reuters', 'vetted', 'communication', 'make', 'sure', 'suitable', 'ensure', 'informed', 'consent', 'among', 'study', 'volunteers', 'It', 'could', 'confirm', 'letter', 'issued', 'An', 'AstraZeneca', 'spokeswoman', 'said', 'communication', 'company', 'verify', 'content', 'referring', 'draft', 'letter', 'study', 'participants', 'We', 'also', 'comment', 'pending', 'FDA', 'decision', 'said', 'The', 'Oxford', 'study', 'team', 'respond', 'requests', 'comment', 'NOT', 'ENOUGH', 'EVIDENCE', 'In', 'another', 'documents', 'directed', 'trial', 'participants', 'Oxford', 'vaccine', 'study', 'team', 'noted', 'enough', 'evidence', 'link', 'neurological', 'problem', 'seen', 'UK', 'trial', 'vaccine', 'Dr', 'Paul', 'Offit', 'director', 'Vaccine', 'Education', 'Center', 'Childrenâs', 'Hospital', 'Philadelphia', 'reviewed', 'document', 'said', 'difficult', 'link', 'rare', 'side', 'effect', 'specifically', 'vaccine', 'exclusion', 'potential', 'causes', 'Transverse', 'myelitis', 'study', 'volunteer', 'believed', 'developed', 'typically', 'occurs', 'rate', 'people', 'Offit', 'said', 'would', 'unusual', 'see', 'trial', 'individuals', 'Other', 'viruses', 'including', 'cause', 'West', 'Nile', 'polio', 'trigger', 'condition', 'physical', 'trauma', 'The', 'regulators', 'weigh', 'whether', 'rare', 'side', 'effect', 'vaccinerelated', 'could', 'occur', 'sickness', 'deaths', 'linked', 'Offit', 'said', 'That', 'always', 'line', 'walk'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'TPK', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'MONY', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'POLYP', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Relx', 'European', 'information', 'business', 'Relx', 'Plc', 'said', 'annual', 'revenue', 'could', 'fall', 'much', 'million', 'pounds', 'short', 'costs', 'exhibitions', 'business', 'suffered', 'coronavirusdriven', 'halts', 'major', 'events', 'year', 'Rentokil', 'Initial', 'Rentokil', 'Initial', 'thirdquarter', 'revenue', 'higher', 'focus', 'hygiene', 'standards', 'due', 'pandemic', 'boosted', 'demand', 'disinfection', 'services', 'Unilever', 'Unilever', 'reported', 'third', 'quarter', 'led', 'emerging', 'markets', 'generates', 'bulk', 'revenue', 'IAG', 'British', 'Airwaysowner', 'IAG', 'reported', 'third', 'quarter', 'coronavirus', 'restrictions', 'continue', 'depress', 'travel', 'forcing', 'downgrade', 'capacity', 'outlook', 'rest', 'year', 'Anglo', 'American', 'Anglo', 'American', 'Plc', 'posted', 'yearonyear', 'fall', 'thirdquarter', 'output', 'reflecting', 'maintenance', 'MinasRio', 'iron', 'ore', 'mine', 'Brazil', 'suspension', 'Grosvenor', 'metallurgical', 'coal', 'operations', 'Australia', 'AstraZeneca', 'Brazilian', 'health', 'authority', 'Anvisa', 'said', 'Wednesday', 'volunteer', 'clinical', 'trial', 'vaccine', 'developed', 'AstraZeneca', 'Oxford', 'University', 'died', 'added', 'trial', 'would', 'continue', 'Gold', 'slipped', 'oneweek', 'high', 'hit', 'last', 'session', 'dollar', 'recovered', 'lost', 'ground', 'doubts', 'emerged', 'whether', 'agreement', 'new', 'US', 'fiscal', 'coronavirus', 'aid', 'package', 'could', 'reached', 'election', 'Oil', 'prices', 'dropped', 'early', 'trade', 'adding', 'heavy', 'losses', 'overnight', 'build', 'US', 'pointed', 'deteriorating', 'outlook', 'fuel', 'demand', 'coronavirus', 'cases', 'soar', 'North', 'America', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'jumped', 'hopes', 'Brexit', 'talks', 'set', 'resume', 'investors', 'remained', 'concerned', 'prospects', 'coronavirus', 'restrictions', 'England', 'UK', 'corporate', 'diary', 'trading', 'statement', 'production', 'report', 'trading', 'statement', 'production', 'results', 'trading', 'statement', 'trading', 'statement', 'trading', 'statement', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JDW', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'MAB', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Joice', 'Alves', 'Reuters', 'British', 'midcaps', 'jumped', 'Thursday', 'erasing', 'earlier', 'losses', 'positive', 'update', 'AstraZeneca', 'vaccine', 'candidate', 'finance', 'minister', 'Rishi', 'Sunak', 'unveiled', 'support', 'businesses', 'hit', 'pandemic', 'The', 'domesticallyfocussed', 'midcap', 'FTSE', 'rose', 'recoup', 'declines', 'earlier', 'week', 'pubs', 'restaurant', 'operators', 'Marston', 'Plc', 'L', 'J', 'D', 'Wetherspoon', 'Plc', 'L', 'Mitchells', 'Butlers', 'Plc', 'L', 'jumping', 'The', 'bluechip', 'FTSE', 'index', 'also', 'added', 'study', 'found', 'AstraZeneca', 'Plc', 'L', 'Oxford', 'vaccine', 'accurately', 'followed', 'genetic', 'instructions', 'programmed', 'successfully', 'provoke', 'strong', 'immune', 'response', 'Vaccine', 'news', 'tends', 'one', 'big', 'market', 'movers', 'looks', 'like', 'probably', 'combined', 'Sunak', 'announcement', 'seen', 'market', 'shift', 'green', 'said', 'Connor', 'Campbell', 'market', 'analyst', 'Spreadex', 'Fears', 'new', 'coronavirusled', 'restrictions', 'well', 'Brexitrelated', 'uncertainty', 'weighed', 'UK', 'stock', 'markets', 'recently', 'FTSE', 'still', 'course', 'second', 'straight', 'week', 'declines', 'The', 'new', 'measures', 'announced', 'Sunak', 'included', 'easing', 'eligibility', 'jobs', 'support', 'scheme', 'new', 'cash', 'grants', 'affected', 'businesses', 'In', 'company', 'news', 'Unilever', 'Plc', 'L', 'rose', 'reported', 'strongerthanexpected', 'return', 'sales', 'growth', 'third', 'quarter', 'led', 'emerging', 'markets', 'generates', 'bulk', 'revenue', 'Rentokil', 'Initial', 'Plc', 'L', 'gained', 'pest', 'control', 'firm', 'posted', 'rise', 'thirdquarter', 'revenue', 'due', 'higher', 'demand', 'disinfection', 'services', 'Britain', 'set', 'resume', 'talks', 'postBrexit', 'trade', 'deal', 'European', 'Union', 'Thursday', 'marking', 'new', 'push', 'two', 'sides', 'protect', 'billions', 'dollars', 'worth', 'trade', 'beginning', 'next', 'year', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'Thursday', 'said', 'would', 'partner', 'Oxfordbased', 'firm', 'provide', 'testing', 'T', 'cell', 'response', 'coronavirus', 'vaccine', 'candidates', 'try', 'assess', 'immune', 'responses', 'T', 'cell', 'immunity', 'thought', 'essential', 'protection', 'infection', 'coronavirus', 'could', 'provide', 'longer', 'term', 'immunity', 'antibodies', 'The', 'UK', 'Vaccine', 'Taskforce', 'chosen', 'Oxford', 'Immunotec', 'supply', 'T', 'cell', 'testing', 'assessment', 'different', 'vaccine', 'candidates', 'It', 'important', 'able', 'assess', 'different', 'vaccines', 'headtohead', 'T', 'cell', 'response', 'part', 'portfolio', 'accredited', 'assays', 'employing', 'cross', 'comparisons', 'Kate', 'Bingham', 'chair', 'UK', 'Vaccines', 'Taskforce', 'said', 'statement', 'Britain', 'signed', 'supply', 'deals', 'six', 'different', 'coronavirus', 'vaccine', 'candidates', 'including', 'made', 'AstraZeneca', 'L', 'Pfizer', 'N', 'BioNTech', 'F', 'seen', 'among', 'frontrunners', 'race', 'vaccine', 'Oxford', 'Immunotec', 'said', 'techonology', 'platform', 'enabled', 'centralisation', 'fresh', 'blood', 'samples', 'different', 'locations', 'measure', 'T', 'cell', 'response', 'standardised', 'way', 'It', 'said', 'platform', 'known', 'TSPOT', 'used', 'identify', 'T', 'cells', 'made', 'response', 'pathogen', 'causes', 'tuberculosis'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'IHG', 'Add', 'toRemove', 'Portfolio', 'SRG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ITM', 'Add', 'toRemove', 'Portfolio', 'AAF', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Futures', 'Britain', 'FTSE', 'index', 'seen', 'ahead', 'cash', 'market', 'open', 'Friday', 'according', 'financial', 'bookmakers', 'British', 'Retail', 'British', 'retail', 'sales', 'last', 'month', 'grew', 'fifth', 'month', 'row', 'taking', 'total', 'sales', 'volumes', 'level', 'pandemic', 'InterContinental', 'Hotels', 'Holiday', 'Innowner', 'InterContinental', 'Hotels', 'posted', 'hotel', 'room', 'revenue', 'RevPAR', 'pandemic', 'continued', 'ravage', 'travel', 'hospitality', 'industry', 'The', 'London', 'Stock', 'Exchange', 'The', 'London', 'Stock', 'Exchange', 'said', 'expects', 'data', 'analytics', 'firm', 'Refinitiv', 'first', 'quarter', 'posted', 'increase', 'thirdquarter', 'total', 'income', 'Barclays', 'Barclays', 'reported', 'third', 'quarter', 'earnings', 'consumer', 'businesses', 'swung', 'back', 'profit', 'provisions', 'bad', 'loans', 'fell', 'compared', 'previous', 'quarter', 'AstraZeneca', 'The', 'Peruvian', 'government', 'refused', 'sign', 'coronavirus', 'vaccine', 'purchase', 'agreement', 'AstraZeneca', 'PLC', 'provide', 'sufficient', 'data', 'studies', 'offered', 'minimal', 'amounts', 'inoculations', 'ITM', 'Power', 'Italian', 'gas', 'group', 'Snam', 'said', 'Thursday', 'would', 'buy', 'minority', 'stake', 'ITM', 'Power', 'part', 'broader', 'agreement', 'British', 'company', 'help', 'develop', 'green', 'hydrogen', 'business', 'Gold', 'edged', 'hopes', 'US', 'stimulus', 'package', 'would', 'eventually', 'passed', 'boosting', 'metal', 'appeal', 'inflation', 'hedge', 'although', 'stronger', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'held', 'gains', 'previous', 'session', 'Friday', 'Russian', 'President', 'Vladimir', 'Putin', 'indicated', 'would', 'prepared', 'extend', 'record', 'supply', 'cuts', 'face', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Thursday', 'positive', 'update', 'AstraZeneca', 'vaccine', 'candidate', 'UK', 'finance', 'minister', 'Rishi', 'Sunak', 'unveiled', 'support', 'businesses', 'hit', 'pandemic', 'UK', 'corporate', 'diary', 'trading', 'statement', 'earnings', 'trading', 'statement', 'HY', 'earnings', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Bloomberg', 'President', 'Donald', 'Trump', 'Democratic', 'nominee', 'Joe', 'Biden', 'faced', 'last', 'time', 'Nov', 'election', 'Bloomberg', 'News', 'checking', 'facts', 'behind', 'claims', 'Thursdayâs', 'debate', 'Trump', 'claims', 'Biden', 'got', 'money', 'China', 'Ukraine', 'son', 'Hunter', 'CLAIM', 'A', 'man', 'named', 'Tony', 'Bobulinski', 'told', 'reporters', 'Nashville', 'debate', 'Hunter', 'Biden', 'former', 'vice', 'presidentâs', 'son', 'recruited', 'chief', 'executive', 'officer', 'proposed', 'partnership', 'Chinese', 'company', 'Biden', 'family', 'At', 'event', 'called', 'Trump', 'campaign', 'Bobulinski', 'said', 'May', 'email', 'Hunter', 'Biden', 'called', 'providing', 'stake', 'company', 'âœthe', 'big', 'guyâ', 'said', 'nickname', 'Hunter', 'often', 'used', 'father', 'But', 'Bobulinski', 'invited', 'Trump', 'guest', 'debate', 'offered', 'evidence', 'took', 'questions', 'Bloomberg', 'News', 'canât', 'verify', 'Bobulinski', 'connection', 'Hunter', 'Biden', 'father', 'Biden', 'campaign', 'spokesman', 'Andrew', 'Bates', 'said', 'statement', 'âœJoe', 'Biden', 'never', 'even', 'considered', 'involved', 'business', 'family', 'overseas', 'business', 'whatsoever', 'He', 'never', 'held', 'stock', 'business', 'arrangements', 'family', 'member', 'person', 'ever', 'held', 'stock', 'himâ', 'On', 'Ukraine', 'Hunter', 'Biden', 'served', 'board', 'Burisma', 'energy', 'company', 'The', 'New', 'York', 'Post', 'says', 'laptop', 'allegedly', 'abandoned', 'Hunter', 'Biden', 'included', 'emails', 'suggesting', 'former', 'vice', 'president', 'met', 'senior', 'official', 'company', 'If', 'true', 'contradicts', 'Joe', 'Bidenâs', 'insistence', 'involvement', 'sonâs', 'business', 'dealings', 'never', 'discussed', 'Bloomberg', 'News', 'hasnât', 'verified', 'authenticity', 'emails', 'Biden', 'campaign', 'denied', 'meeting', 'ever', 'took', 'place', 'Biden', 'released', 'tax', 'returns', 'last', 'year', 'Thereâs', 'Jill', 'reported', 'taxable', 'income', 'paying', 'taxes', 'The', 'Bidens', 'earn', 'money', 'variety', 'ways', 'including', 'fees', 'speeches', 'royalties', 'books', 'salaries', 'teaching', 'roles', 'Biden', 'claims', 'Trump', 'hiding', 'Chinese', 'bank', 'account', 'A', 'report', 'New', 'York', 'Times', 'revealed', 'Chinese', 'bank', 'account', 'controlled', 'Trump', 'entity', 'called', 'Trump', 'International', 'Hotels', 'Management', 'LLC', 'The', 'paper', 'said', 'tax', 'records', 'show', 'paid', 'taxes', 'China', 'pursuing', 'licensing', 'deals', 'Trump', 'said', 'debate', 'business', 'account', 'considering', 'business', 'China', 'believes', 'account', 'closed', 'Trump', 'claims', 'US', 'response', 'virus', 'effective', 'By', 'measures', 'US', 'pandemic', 'response', 'chaotic', 'results', 'catastrophic', 'The', 'US', 'deaths', 'attributed', 'million', 'cases', 'Thatâs', 'cases', 'nation', 'including', 'India', 'population', 'four', 'times', 'US', 'It', 'true', 'US', 'hasnât', 'deaths', 'per', 'capita', 'according', 'Johns', 'Hopkins', 'University', 'Its', 'death', 'rate', 'behind', 'Peru', 'Belgium', 'Bolivia', 'Brazil', 'Spain', 'Chile', 'Ecuador', 'Mexico', 'Still', 'perhaps', 'developed', 'nation', 'US', 'coronavirus', 'response', 'marked', 'confusion', 'kept', 'countryâs', 'numbers', 'surging', 'many', 'nations', 'hit', 'virus', 'earlyon', 'seen', 'infection', 'rates', 'decline', 'Missteps', 'handling', 'virus', 'include', 'advising', 'public', 'initially', 'wear', 'masks', 'advising', 'donât', 'exhibit', 'symptoms', 'get', 'tested', 'continued', 'shortages', 'supplies', 'testing', 'backlogs', 'Seven', 'months', 'pandemic', 'US', 'still', 'streamlined', 'testing', 'efforts', 'countries', 'praised', 'virus', 'response', 'including', 'South', 'Korea', 'Germany', 'Trump', 'says', 'vaccine', 'ready', 'yearâs', 'end', 'Vaccines', 'typically', 'take', 'many', 'years', 'develop', 'part', 'must', 'proven', 'extremely', 'safe', 'theyâre', 'given', 'healthy', 'people', 'But', 'around', 'world', 'governments', 'pharmaceutical', 'companies', 'researchers', 'sought', 'expedite', 'process', 'coronavirus', 'There', 'currently', 'experimental', 'coronavirus', 'vaccines', 'development', 'according', 'World', 'Health', 'Organization', 'entered', 'human', 'studies', 'Experimental', 'shots', 'Pfizer', 'Inc', 'NYSE', 'partnership', 'BioNTech', 'SE', 'NASDAQ', 'University', 'Oxford', 'AstraZeneca', 'NYSE', 'Plc', 'Moderna', 'NASDAQ', 'Inc', 'among', 'vanguard', 'Pfizer', 'looking', 'file', 'application', 'late', 'November', 'Moderna', 'expects', 'interim', 'results', 'November', 'positive', 'emergency', 'use', 'authorization', 'December', 'Unfortunately', 'Astrazeneca', 'LON', 'Johnson', 'Johnson', 'pause', 'vaccine', 'trials', 'due', 'adverse', 'health', 'effects', 'Importantly', 'vaccine', 'approved', 'itâs', 'challenge', 'get', 'widely', 'distributed', 'Estimates', 'top', 'health', 'officials', 'ranged', 'end', 'March', 'end', 'Americans', 'would', 'access', 'Trump', 'said', 'assertion', 'Robert', 'Redfield', 'director', 'US', 'Centers', 'Disease', 'Control', 'Prevention', 'disbursement', 'vaccine', 'would', 'come', 'time', 'late', 'spring', 'summer', 'next', 'year', 'âœa', 'mistakeâ', 'Redfield', 'isnât', 'top', 'US', 'health', 'official', 'offering', 'less', 'ambitious', 'forecasts', 'getting', 'vaccine', 'public', 'Paul', 'Mango', 'deputy', 'chief', 'staff', 'policy', 'Department', 'Health', 'Human', 'Services', 'said', 'would', 'probably', 'widely', 'available', 'end', 'March', 'And', 'Anthony', 'Fauci', 'head', 'National', 'Institute', 'Allergy', 'Infectious', 'Diseases', 'forecast', 'timeline', 'similar', 'Redfieldâs', 'interview', 'Bloomberg', 'Television', 'Bloomberg', 'LP', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'INTC', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'SPCE', 'Add', 'toRemove', 'Portfolio', 'By', 'Yasin', 'Ebrahim', 'Investingcom', 'âThe', 'Dow', 'snapped', 'threeweek', 'win', 'streak', 'ending', 'flatline', 'Friday', 'investor', 'jitters', 'stimulus', 'slump', 'Intel', 'hurt', 'sentiment', 'stocks', 'The', 'fell', 'points', 'The', 'rose', 'Intel', 'NASDAQ', 'slumped', 'intraday', 'chipmakerâs', 'betterthanexpected', 'thirdquarter', 'earnings', 'revenue', 'overshadowed', 'weaker', 'margins', 'amid', 'wobble', 'data', 'center', 'business', 'Analysts', 'warned', 'Intel', 'unlikely', 'see', 'recovery', 'margins', 'immediate', 'future', 'âœDCG', 'fell', 'short', 'expectation', 'gross', 'margin', 'disappointed', 'basis', 'pointsâ', 'gross', 'margin', 'faces', 'multiple', 'mixrelated', 'headwinds', 'fourth', 'reflecting', 'lower', 'enterprise', 'government', 'internet', 'things', 'group', 'higher', 'consumer', 'education', 'NB', 'mixâ', 'Oppenheimer', 'said', 'The', 'fall', 'Intel', 'weighed', 'broader', 'tech', 'market', 'though', 'Fab', 'closed', 'mostly', 'green', 'keep', 'losses', 'check', 'Amazoncom', 'NASDAQ', 'Facebook', 'NASDAQ', 'Googleparent', 'Alphabet', 'NASDAQ', 'Microsoft', 'NASDAQ', 'ended', 'higher', 'Apple', 'NASDAQ', 'closed', 'red', 'And', 'stimulus', 'talk', 'weighed', 'sentiment', 'little', 'sign', 'rolled', 'Nov', 'election', 'US', 'Treasury', 'Secretary', 'Steven', 'Mnuchin', 'indicated', 'House', 'Speaker', 'Nancy', 'Pelosi', 'dragging', 'feet', 'key', 'differences', 'said', 'speaker', 'would', 'make', 'concessions', 'get', 'deal', 'line', 'âœWeâve', 'offered', 'compromisesâ', 'Mnuchin', 'told', 'reporters', 'White', 'House', 'according', 'Bloomberg', 'âœThe', 'speaker', 'number', 'issues', 'still', 'dug', 'If', 'wants', 'compromise', 'dealâ', 'Stocks', 'linked', 'progress', 'economy', 'including', 'financials', 'energy', 'industrials', 'red', 'Energy', 'fell', 'paced', 'decline', 'oil', 'prices', 'ongoing', 'demand', 'concerns', 'amid', 'rising', 'US', 'Europe', 'offset', 'prospect', 'extension', 'OPEC', 'allies', 'productioncut', 'accord', 'In', 'news', 'Virgin', 'Galactic', 'NYSE', 'fell', 'Goldman', 'initiated', 'coverage', 'stock', 'neutral', 'Tesla', 'NASDAQ', 'meanwhile', 'fell', 'reports', 'recalling', 'nearly', 'Model', 'S', 'Model', 'X', 'electric', 'vehicles', 'potential', 'suspension', 'defects', 'On', 'vaccine', 'front', 'AstraZeneca', 'PLC', 'LON', 'reportedly', 'received', 'green', 'light', 'US', 'Federal', 'Drug', 'Administration', 'resume', 'clinical', 'trials', 'vaccine', 'The', 'news', 'comes', 'day', 'Gilead', 'NASDAQ', 'antiviral', 'drug', 'remdesivir', 'given', 'full', 'authorization', 'treat', 'patients', 'hospitalized', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kanishka', 'Singh', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Friday', 'coronavirus', 'vaccine', 'deal', 'Oxford', 'University', 'allow', 'add', 'manufacturing', 'costs', 'cover', 'additional', 'expenses', 'required', 'incurred', 'British', 'drugmaker', 'In', 'addition', 'manufacturing', 'costs', 'company', 'incurring', 'costs', 'excess', 'billion', 'globally', 'include', 'clinical', 'development', 'regulatory', 'distribution', 'pharmacovigilance', 'expenses', 'AstraZeneca', 'spokesman', 'said', 'statement', 'To', 'cover', 'additional', 'expenses', 'company', 'add', 'amount', 'equivalent', 'maximum', 'manufacturing', 'costs', 'ensure', 'material', 'impact', 'finances', 'year', 'continuing', 'efforts', 'provide', 'vaccine', 'profit', 'pandemic', 'statement', 'added', 'AstraZeneca', 'previously', 'signed', 'multiple', 'supplyandmanufacture', 'deals', 'billion', 'doses', 'globally', 'These', 'agreements', 'companies', 'governments', 'company', 'gets', 'closer', 'reporting', 'early', 'results', 'latestage', 'clinical', 'trial', 'Developed', 'University', 'Oxford', 'licensed', 'AstraZeneca', 'April', 'vaccine', 'expected', 'one', 'first', 'big', 'pharma', 'secure', 'regulatory', 'approval', 'The', 'company', 'said', 'earlier', 'created', 'multiple', 'supply', 'chains', 'ensure', 'access', 'vaccine', 'timely', 'broad', 'equitable', 'high', 'lowincome', 'countries', 'alike', 'Pricing', 'supply', 'experimental', 'vaccines', 'widely', 'debated', 'richer', 'countries', 'pump', 'billions', 'dollars', 'funding', 'AstraZeneca', 'also', 'granted', 'protection', 'future', 'liability', 'claims', 'Separately', 'AstraZeneca', 'resumed', 'US', 'trial', 'experimental', 'vaccine', 'approval', 'regulators', 'company', 'said', 'Friday'], ['Â', 'Reuters', 'People', 'wearing', 'protective', 'face', 'masks', 'park', 'Brussels', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'James', 'Mackenzie', 'MILAN', 'Reuters', 'European', 'leaders', 'warned', 'difficult', 'months', 'ahead', 'resurgent', 'pandemic', 'forced', 'authorities', 'impose', 'new', 'restrictions', 'try', 'curb', 'spread', 'disease', 'Word', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'Plc', 'L', 'produced', 'immune', 'responses', 'elderly', 'young', 'people', 'offered', 'positive', 'news', 'However', 'British', 'Health', 'Secretary', 'Matt', 'Hancock', 'cautioned', 'vaccine', 'would', 'widely', 'available', 'next', 'year', 'said', 'yet', 'Elsewhere', 'picture', 'unrelentingly', 'grim', 'string', 'countries', 'reported', 'record', 'increases', 'led', 'France', 'posted', 'daily', 'cases', 'first', 'time', 'Sunday', 'continent', 'passed', 'threshold', 'deaths', 'Governments', 'desperate', 'avoid', 'lockdowns', 'curbed', 'disease', 'start', 'year', 'cost', 'shutting', 'entire', 'economies', 'But', 'steady', 'rise', 'new', 'cases', 'forced', 'ratchet', 'controls', 'steadily', 'We', 'facing', 'difficult', 'months', 'ahead', 'German', 'Chancellor', 'Angela', 'Merkel', 'told', 'meeting', 'leaders', 'Christian', 'Democrat', 'party', 'according', 'daily', 'Bild', 'Although', 'Germany', 'fared', 'relatively', 'well', 'compared', 'countries', 'Europe', 'seen', 'sharp', 'rise', 'cases', 'closely', 'watched', 'Ifo', 'business', 'climate', 'index', 'fell', 'Monday', 'reflecting', 'worries', 'virus', 'The', 'gloom', 'around', 'resurgent', 'virus', 'weighed', 'financial', 'markets', 'oil', 'prices', 'dropped', 'concerns', 'another', 'slide', 'demand', 'stock', 'markets', 'also', 'fell', 'In', 'Spain', 'million', 'cases', 'disease', 'Prime', 'Minister', 'Pedro', 'Sanchez', 'warned', 'country', 'facing', 'extreme', 'situation', 'announced', 'new', 'state', 'emergency', 'Sunday', 'imposing', 'local', 'nighttime', 'curfews', 'banning', 'travel', 'regions', 'cases', 'Italy', 'country', 'worst', 'hit', 'early', 'stages', 'crisis', 'March', 'also', 'imposed', 'new', 'curbs', 'ordering', 'restaurants', 'bars', 'close', 'pm', 'shutting', 'cinemas', 'gyms', 'imposing', 'local', 'curfews', 'several', 'regions', 'Street', 'clashes', 'small', 'groups', 'protestors', 'weekend', 'angry', 'criticism', 'restaurant', 'owners', 'business', 'groups', 'impact', 'measures', 'underlined', 'increasingly', 'tense', 'climate', 'facing', 'Prime', 'Minister', 'Giuseppe', 'Conte', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CCC', 'Add', 'toRemove', 'Portfolio', 'DLAR', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'CTEC', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'International', 'Consolidated', 'Airlines', 'British', 'Airwaysowner', 'IAG', 'said', 'called', 'governments', 'adopt', 'predeparture', 'testing', 'allow', 'travel', 'second', 'wave', 'infections', 'locked', 'Europe', 'Natwest', 'British', 'lender', 'NatWest', 'reported', 'setting', 'aside', 'smallerthenexpected', 'cash', 'pile', 'deal', 'likely', 'loan', 'defaults', 'due', 'coronavirus', 'pandemic', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'two', 'heart', 'failure', 'blood', 'pressure', 'medicines', 'German', 'pharmaceutical', 'company', 'Cheplapharm', 'Arzneimittel', 'GmbH', 'million', 'Vivo', 'Energy', 'Africafocussed', 'fuel', 'retailer', 'Vivo', 'Energy', 'VVOL', 'said', 'pay', 'previously', 'withdrawn', 'final', 'dividend', 'cents', 'per', 'share', 'volume', 'third', 'quarter', 'improved', 'compared', 'second', 'restrictions', 'began', 'ease', 'De', 'La', 'Rue', 'The', 'Bank', 'England', 'said', 'extended', 'banknote', 'printing', 'contract', 'De', 'La', 'Rue', 'BP', 'BP', 'plc', 'plans', 'convert', 'Kwinana', 'oil', 'refinery', 'biggest', 'country', 'four', 'fuel', 'import', 'terminal', 'thanks', 'tough', 'competition', 'Asian', 'market', 'global', 'major', 'said', 'Royal', 'Dutch', 'Shell', 'Royal', 'Dutch', 'Shell', 'Plc', 'said', 'ramping', 'production', 'Mars', 'Corridor', 'And', 'Appomattox', 'platforms', 'Gulf', 'Mexico', 'shut', 'due', 'Hurricane', 'Zeta', 'PizzaExpress', 'PizzaExpress', 'said', 'would', 'across', 'UK', 'restaurants', 'new', 'coronavirus', 'restrictions', 'especially', 'city', 'centres', 'kept', 'consumers', 'eating', 'Gold', 'prices', 'rose', 'dollar', 'retreated', 'supported', 'worries', 'soaring', 'coronavirus', 'cases', 'United', 'States', 'Europe', 'well', 'uncertainty', 'upcoming', 'US', 'presidential', 'election', 'Oil', 'prices', 'tumbled', 'touching', 'fivemonth', 'low', 'extending', 'previous', 'day', 'sharp', 'decline', 'impact', 'renewed', 'coronavirus', 'lockdowns', 'could', 'oil', 'demand', 'The', 'UK', 'bluechip', 'index', 'fell', 'Thursday', 'concerns', 'resurgence', 'coronavirus', 'cases', 'might', 'derail', 'fragile', 'economic', 'recovery', 'offsetting', 'clutch', 'positive', 'earnings', 'Royal', 'Dutch', 'Shell', 'Lloyds', 'Bank', 'LON', 'UK', 'CORPORATE', 'DIARY', 'ConvaTec', 'Group', 'Plc', 'trading', 'statement', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'earnings', 'Computacentre', 'Plc', 'trading', 'statement', 'Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'TUIGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Avast', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Carnival', 'PLC', 'LON', 'declined', 'points', 'end', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'RPS', 'Add', 'toRemove', 'Portfolio', 'PZC', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'CCEP', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'KCT', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'AstraZeneca', 'AstraZeneca', 'Plc', 'experimental', 'vaccine', 'approval', 'regulators', 'Johnson', 'Johnson', 'JNJN', 'preparing', 'resume', 'trial', 'Monday', 'Tuesday', 'companies', 'said', 'Friday', 'Rio', 'Tinto', 'Global', 'miner', 'Rio', 'Tinto', 'seeking', 'court', 'approval', 'sell', 'partner', 'share', 'diamonds', 'mine', 'Canada', 'Northwest', 'Territories', 'filing', 'week', 'showed', 'hoping', 'recover', 'around', 'million', 'plus', 'legal', 'fees', 'costs', 'Coca', 'Cola', 'Europeand', 'Partners', 'CocaCola', 'NYSE', 'Amatil', 'Ltd', 'said', 'CocaCola', 'European', 'Partners', 'offered', 'billion', 'billion', 'would', 'country', 'biggest', 'deal', 'year', 'UK', 'regulators', 'UK', 'regulators', 'considering', 'plans', 'allow', 'banks', 'start', 'paying', 'dividends', 'next', 'year', 'The', 'Times', 'newspaper', 'reported', 'Monday', 'Gold', 'prices', 'fell', 'oneweek', 'low', 'dollar', 'firmed', 'talks', 'new', 'US', 'coronavirus', 'aid', 'package', 'showed', 'signs', 'progress', 'Oil', 'extended', 'last', 'week', 'losses', 'falling', 'nearly', 'surge', 'infections', 'United', 'States', 'Europe', 'prompted', 'concern', 'crude', 'demand', 'prospect', 'increased', 'supply', 'also', 'hit', 'sentiment', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'boosted', 'upbeat', 'Barclays', 'LON', 'earnings', 'rising', 'hopes', 'Brexit', 'trade', 'deal', 'year', 'end', 'bluechip', 'FTSE', 'still', 'logged', 'second', 'weekly', 'decline', 'concerns', 'fresh', 'coronavirus', 'restrictions', 'UK', 'corporate', 'diary', 'FY', 'earnings', 'Trading', 'statement', 'trading', 'statement', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'CCEP', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Reuters', 'London', 'FTSE', 'pared', 'early', 'losses', 'Monday', 'surge', 'banks', 'following', 'report', 'central', 'bank', 'considering', 'allowing', 'dividend', 'payments', 'helped', 'offset', 'losses', 'energy', 'mining', 'stocks', 'due', 'weak', 'commodity', 'prices', 'Shares', 'Barclays', 'L', 'HSBC', 'L', 'Lloyds', 'Banking', 'LON', 'Group', 'L', 'rose', 'The', 'Times', 'newspaper', 'reported', 'Bank', 'England', 'BoE', 'commercial', 'banks', 'bartering', 'deal', 'allow', 'banks', 'make', 'shareholder', 'payouts', 'Having', 'declined', 'much', 'early', 'trading', 'FTSE', 'index', 'domesticallyfocussed', 'midcap', 'FTSE', 'index', 'lost', 'travel', 'leisure', 'industrial', 'stocks', 'fell', 'European', 'markets', 'broadly', 'weighed', 'fears', 'resurgence', 'coronavirus', 'cases', 'would', 'hamper', 'economic', 'recovery', 'government', 'tightens', 'restrictions', 'activity', 'There', 'fear', 'get', 'long', 'winter', 'restrictions', 'across', 'Europe', 'hobbles', 'consumer', 'demand', 'investor', 'confidence', 'said', 'Neil', 'Wilson', 'chief', 'market', 'analyst', 'Marketscom', 'After', 'stimulusbacked', 'sharp', 'rally', 'pandemic', 'lows', 'FTSE', 'trading', 'tight', 'ranges', 'since', 'June', 'due', 'Brexitrelated', 'uncertainty', 'concerns', 'coronavirus', 'curbs', 'AstraZeneca', 'Plc', 'L', 'rose', 'drugmaker', 'resumed', 'US', 'trial', 'experimental', 'vaccine', 'said', 'vaccine', 'developed', 'University', 'Oxford', 'produced', 'similar', 'immune', 'response', 'older', 'younger', 'adults', 'The', 'wider', 'sectoral', 'index', 'added', 'Educational', 'publisher', 'Pearson', 'Plc', 'L', 'added', 'UBS', 'upgraded', 'stock', 'buy', 'rating', 'CocaCola', 'NYSE', 'European', 'Partners', 'CCEP', 'L', 'surged', 'soft', 'drink', 'bottler', 'made', 'buyout', 'offer', 'billion', 'Australian', 'peer', 'CocaCola', 'Amatil', 'Ltd', 'AX'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Senior', 'sources', 'British', 'government', 'expect', 'verdict', 'whether', 'Pfizer', 'Incbacked', 'N', 'vaccine', 'works', 'available', 'results', 'AstraZeneca', 'Plc', 'L', 'competing', 'vaccine', 'Times', 'reported', 'Britain', 'believes', 'vaccine', 'Pfizer', 'codeveloping', 'Germany', 'BioNTech', 'SE', 'F', 'could', 'ready', 'distribute', 'Christmas', 'report', 'said', 'Pfizer', 'Chief', 'Executive', 'Albert', 'Bourla', 'previously', 'said', 'company', 'could', 'release', 'data', 'whether', 'vaccine', 'works', 'early', 'month', 'The', 'US', 'drugmaker', 'said', 'week', 'trials', 'successful', 'company', 'expects', 'file', 'emergency', 'authorization', 'vaccine', 'candidate', 'US', 'regulators', 'shortly', 'enough', 'safety', 'data', 'late', 'November', 'Britain', 'agreed', 'supply', 'deals', 'six', 'vaccine', 'candidates', 'including', 'frontrunners', 'Pfizer', 'AstraZeneca'], ['Â', 'Reuters', 'BT', 'Add', 'toRemove', 'Portfolio', 'UBER', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'BABA', 'Add', 'toRemove', 'Portfolio', 'AGLE', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'KAZ', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Royal', 'Dutch', 'Shell', 'Royal', 'Dutch', 'Shell', 'announced', 'increase', 'thirdquarter', 'dividend', 'reporting', 'quarter', 'SmithNephew', 'SmithNephew', 'said', 'revenue', 'recovered', 'strongly', 'third', 'quarter', 'second', 'hospitals', 'managed', 'carry', 'elective', 'surgeries', 'initial', 'wave', 'coronavirus', 'infections', 'WPP', 'The', 'world', 'biggest', 'advertising', 'company', 'WPP', 'said', 'client', 'wins', 'Uber', 'NYSE', 'Alibaba', 'NYSE', 'HSBC', 'LON', 'helped', 'report', 'underlying', 'trading', 'Lloyds', 'Lloyds', 'Banking', 'Group', 'posted', 'lowering', 'provisions', 'expected', 'bad', 'loans', 'due', 'pandemic', 'cashing', 'boom', 'demand', 'mortgages', 'BT', 'BT', 'Britain', 'biggest', 'fixedline', 'mobile', 'operator', 'said', 'first', 'half', 'given', 'challenges', 'raised', 'lower', 'limit', 'earnings', 'guidance', 'year', 'AstraZeneca', 'Senior', 'sources', 'British', 'government', 'expect', 'verdict', 'whether', 'Pfizer', 'NYSE', 'Incbacked', 'PFEN', 'available', 'results', 'AstraZeneca', 'Plc', 'competing', 'vaccine', 'Times', 'reported', 'Standard', 'Chartered', 'Standard', 'Chartered', 'said', 'thirdquarter', 'profit', 'slid', 'higher', 'credit', 'impairment', 'resulting', 'coronavirus', 'pandemic', 'lower', 'interest', 'rates', 'although', 'tighter', 'rein', 'costs', 'Aston', 'Martin', 'British', 'luxury', 'car', 'maker', 'Aston', 'Martin', 'testing', 'investor', 'appetite', 'risky', 'assets', 'days', 'US', 'election', 'one', 'largest', 'deals', 'kind', 'Europe', 'year', 'Gold', 'edged', 'plunge', 'previous', 'session', 'surging', 'global', 'coronavirus', 'cases', 'fears', 'contested', 'US', 'presidential', 'election', 'spurred', 'demand', 'although', 'strong', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'rose', 'early', 'trading', 'regaining', 'ground', 'lost', 'slump', 'overnight', 'amid', 'prospect', 'tighter', 'shortterm', 'supply', 'twothirds', 'US', 'output', 'shut', 'Gulf', 'Mexico', 'Hurricane', 'Zeta', 'slammed', 'Louisiana', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'investors', 'dumped', 'riskier', 'assets', 'fears', 'lockdowns', 'uncertainty', 'British', 'trade', 'deal', 'EU', 'UK', 'corporate', 'diary', 'EVRAZ', 'Plc', 'trading', 'update', 'HY', 'earnings', 'HY', 'earnings', 'Smith', 'Nephew', 'Plc', 'trading', 'statement', 'WPP', 'Plc', 'trading', 'statement', 'KAZ', 'Minerals', 'Plc', 'production', 'report', 'earnings'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Friday', 'would', 'sell', 'commercial', 'rights', 'two', 'drugs', 'German', 'pharmaceutical', 'company', 'million', 'British', 'drugmaker', 'looks', 'focus', 'newer', 'medicines', 'new', 'therapy', 'areas', 'AstraZeneca', 'said', 'would', 'sell', 'rights', 'heart', 'failure', 'blood', 'pressure', 'medicines', 'Atacand', 'Atacand', 'Plus', 'Germany', 'Cheplapharm', 'Arzneimittel', 'GmbH', 'AstraZeneca', 'among', 'frontrunners', 'race', 'develop', 'vaccine', 'novel', 'coronavirus', 'trying', 'focus', 'cancer', 'drug', 'portfolio', 'bid', 'streamline', 'business', 'The', 'agreement', 'Cheplapharm', 'supports', 'AstraZeneca', 'strategy', 'focusing', 'newer', 'medicines', 'main', 'therapy', 'areas', 'drugmaker', 'said', 'The', 'Londonlisted', 'company', 'seen', 'head', 'start', 'race', 'cancer', 'treatments', 'sales', 'medicines', 'including', 'blockbuster', 'lung', 'cancer', 'drug', 'Imfinzi', 'key', 'turnaround', 'Cheplapharm', 'held', 'European', 'rights', 'Atacand', 'Atacand', 'Plus', 'since', 'allowed', 'sell', 'around', 'countries', 'Atacand', 'prescription', 'drug', 'approved', 'treat', 'heart', 'failure', 'hypertension', 'Atacand', 'Plus', 'used', 'hypertension', 'The', 'transaction', 'expected', 'close', 'fourth', 'quarter', 'impact', 'financial', 'forecast', 'AstraZeneca', 'said', 'The', 'company', 'said', 'million', 'million', 'consideration', 'payable', 'deal', 'completion', 'remainder', 'first', 'half', 'AstraZeneca', 'manufacture', 'supply', 'medicines', 'commercialise', 'threeyear', 'transition', 'period', 'company', 'said', 'Last', 'year', 'AstraZeneca', 'sold', 'global', 'commercial', 'rights', 'drug', 'treat', 'acid', 'reflux', 'Cheplapharm', 'million', 'AstraZeneca', 'shares', 'trading', 'slightly', 'lower', 'GMT'], ['Â', 'Reuters', 'The', 'Pfizer', 'logo', 'seen', 'UK', 'commercial', 'headquarters', 'Walton', 'Oaks', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Union', 'struck', 'deal', 'initially', 'pay', 'less', 'Pfizer', 'N', 'vaccine', 'candidate', 'United', 'States', 'EU', 'official', 'told', 'Reuters', 'bloc', 'announced', 'Wednesday', 'secured', 'agreement', 'million', 'doses', 'The', 'experimental', 'drug', 'developed', 'conjunction', 'Germany', 'BioNTech', 'DE', 'frontrunner', 'global', 'race', 'produce', 'vaccine', 'interim', 'data', 'released', 'Monday', 'showing', 'effective', 'protecting', 'people', 'largescale', 'clinical', 'trial', 'Under', 'EU', 'deal', 'European', 'countries', 'could', 'buy', 'million', 'doses', 'option', 'purchase', 'another', 'million', 'The', 'bloc', 'pay', 'less', 'per', 'shot', 'senior', 'EU', 'official', 'involved', 'talks', 'vaccine', 'makers', 'told', 'Reuters', 'adding', 'partly', 'reflected', 'financial', 'support', 'given', 'EU', 'Germany', 'drug', 'development', 'The', 'official', 'requested', 'anonymity', 'terms', 'agreement', 'confidential', 'The', 'United', 'States', 'agreed', 'pay', 'per', 'shot', 'million', 'doses', 'smaller', 'volume', 'EU', 'But', 'option', 'buy', 'million', 'terms', 'negotiated', 'separately', 'price', 'pay', 'unclear', 'BioNTech', 'signalled', 'week', 'order', 'size', 'would', 'impact', 'perdose', 'price', 'developed', 'world', 'said', 'would', 'differentiate', 'pricing', 'countries', 'regions', 'potential', 'vaccine', 'The', 'EU', 'official', 'said', 'EU', 'agreed', 'price', 'closer', 'declined', 'give', 'precise', 'figure', 'Pfizer', 'BioNTech', 'declined', 'comment', 'pricing', 'A', 'spokesman', 'EU', 'Commission', 'negotiates', 'vaccine', 'agreements', 'behalf', 'EU', 'states', 'also', 'declined', 'comment', 'In', 'June', 'European', 'Investment', 'Bank', 'EU', 'financial', 'arm', 'granted', 'million', 'loan', 'BioNTech', 'development', 'manufacturing', 'vaccine', 'followed', 'September', 'another', 'funding', 'Germany', 'research', 'ministry', 'With', 'fourth', 'contract', 'consolidating', 'extremely', 'solid', 'vaccine', 'candidate', 'portfolio', 'advanced', 'trials', 'phase', 'President', 'European', 'Commission', 'Ursula', 'von', 'der', 'Leyen', 'said', 'announcing', 'Pfizer', 'deal', 'The', 'EU', 'already', 'signed', 'supply', 'deals', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'Johnson', 'Johnson', 'N', 'experimental', 'shots', 'talking', 'Moderna', 'O', 'CureVac', 'DE', 'Novavax', 'O', 'secure', 'vaccines', 'Under', 'EU', 'deals', 'vaccine', 'makers', 'bloc', 'offers', 'nonrefundable', 'payment', 'companies', 'exchange', 'right', 'book', 'doses', 'EU', 'states', 'could', 'buy', 'preagreed', 'price', 'vaccine', 'approved', 'effective', 'safe', 'EU', 'drug', 'regulator', 'The', 'Commission', 'disclose', 'payment', 'made', 'Pfizer', 'BioNTech', 'COPY', 'PASTE', 'ON', 'LIABILITY', 'TERMS', 'The', 'prices', 'agreed', 'EU', 'previous', 'deals', 'vaccine', 'makers', 'partly', 'influenced', 'liability', 'terms', 'could', 'cause', 'large', 'additional', 'legal', 'costs', 'inoculated', 'people', 'developed', 'unexpected', 'conditions', 'shots', 'Asked', 'liability', 'clauses', 'Pfizer', 'contract', 'bone', 'contention', 'EU', 'negotiators', 'drugmakers', 'EU', 'official', 'said', 'conditions', 'different', 'EU', 'agreed', 'companies', 'also', 'different', 'Pfizer', 'US', 'government', 'There', 'copy', 'paste', 'liability', 'terms', 'previous', 'contracts', 'official', 'said', 'French', 'drugmaker', 'Sanofi', 'working', 'GlaxoSmithKline', 'L', 'partner', 'agreed', 'EU', 'price', 'euros', 'per', 'dose', 'get', 'liability', 'waiver', 'AstraZeneca', 'would', 'pay', 'claims', 'certain', 'threshold', 'something', 'goes', 'wrong', 'vaccine', 'exchange', 'price', 'euro', 'per', 'dose', 'official', 'told', 'Reuters', 'September', 'Bad', 'sideeffects', 'vaccine', 'approved', 'rare', 'considered', 'likely', 'emergency', 'unprecedented', 'speed', 'vaccines', 'developed', 'The', 'United', 'States', 'granted', 'immunity', 'liability', 'vaccines', 'receive', 'regulatory', 'approval', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'uses', 'computer', 'keyboard', 'photo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'DAVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Sinead', 'Cruise', 'LONDON', 'Reuters', 'Bank', 'England', 'Chief', 'Economist', 'Andy', 'Haldane', 'signed', 'judge', 'winner', 'game', 'designed', 'help', 'firms', 'find', 'alternatives', 'mass', 'layoffs', 'face', 'coronavirusdriven', 'slowdown', 'Confronted', 'unpredictable', 'pandemic', 'memory', 'costconscious', 'firms', 'already', 'axed', 'millions', 'staff', 'worldwide', 'UK', 'redundancies', 'hit', 'record', 'high', 'quarter', 'Sept', 'official', 'data', 'showed', 'Tuesday', 'Unileverowned', 'AS', 'tech', 'firm', 'uFlexReward', 'created', 'War', 'Game', 'allow', 'executives', 'explore', 'impact', 'huge', 'job', 'cuts', 'future', 'earnings', 'prospects', 'Many', 'companies', 'across', 'UK', 'facing', 'financial', 'strains', 'result', 'COVID', 'crisis', 'Haldane', 'told', 'Reuters', 'Simulation', 'tools', 'help', 'us', 'understand', 'best', 'alleviate', 'strains', 'preserving', 'jobs', 'way', 'helps', 'businesses', 'making', 'difficult', 'commercial', 'decisions', 'policymakers', 'making', 'difficult', 'economic', 'decisions', 'The', 'game', 'designed', 'Britain', 'first', 'lockdown', 'year', 'available', 'free', 'play', 'uFlexReward', 'website', 'calls', 'players', 'devise', 'strategy', 'cut', 'people', 'costs', 'fictional', 'firm', 'Participants', 'weigh', 'pros', 'cons', 'largescale', 'redundancies', 'versus', 'alternatives', 'longterm', 'benefit', 'firm', 'well', 'broader', 'economy', 'It', 'collates', 'staff', 'salaries', 'pensions', 'bonuses', 'share', 'awards', 'one', 'realtime', 'costbase', 'helping', 'players', 'see', 'different', 'ways', 'trimming', 'overheads', 'clearly', 'This', 'include', 'making', 'lots', 'smaller', 'cost', 'cuts', 'socalled', 'approach', 'rather', 'one', 'large', 'saving', 'focused', 'cuts', 'like', 'scrapping', 'entire', 'business', 'units', 'staff', 'bonus', 'pool', 'Financial', 'firms', 'historically', 'slashed', 'highly', 'paid', 'workforces', 'eve', 'recession', 'rehire', 'rapidly', 'economy', 'rebounds', 'Swapping', 'convention', 'broadfront', 'approach', 'could', 'minimise', 'risks', 'employers', 'end', 'understaffed', 'underskilled', 'recovery', 'kicks', 'uFlexReward', 'Chief', 'Executive', 'Ken', 'Charman', 'said', 'IS', 'COMING', 'Employers', 'multiple', 'sectors', 'facing', 'prospect', 'broader', 'revolution', 'world', 'work', 'triggered', 'technology', 'mass', 'remote', 'working', 'We', 'still', 'stuck', 'Victorian', 'view', 'work', 'fixed', 'working', 'days', 'single', 'employer', 'typically', 'narrow', 'role', 'Charman', 'said', 'But', 'change', 'coming', 'allow', 'people', 'several', 'things', 'companies', 'lose', 'people', 'highly', 'trained', 'experienced', 'loyal', 'wo', 'get', 'back', 'said', 'Charman', 'hopes', 'game', 'might', 'persuade', 'employers', 'waive', 'cut', 'dividends', 'well', 'executive', 'pay', 'increases', 'offer', 'jobsharing', 'reduced', 'hours', 'parttime', 'roles', 'flexibility', 'work', 'elsewhere', 'staff', 'might', 'otherwise', 'end', 'unemployed', 'Pushing', 'alternatives', 'mass', 'layoffs', 'require', 'strong', 'leadership', 'communication', 'particularly', 'thousands', 'employee', 'contracts', 'need', 'renegotiated', 'retaining', 'staff', 'could', 'leave', 'firms', 'better', 'placed', 'recovery', 'begins', 'Charman', 'said', 'Executives', 'need', 'willing', 'abandon', 'old', 'conventions', 'resistance', 'got', 'able', 'convince', 'people', 'best', 'interests', 'said', 'Employers', 'big', 'companies', 'big', 'financial', 'institutions', 'part', 'critical', 'national', 'infrastructure', 'much', 'National', 'Grid', 'LON', 'They', 'engines', 'growth', 'threat', 'Judging', 'headtohead', 'version', 'game', 'featuring', 'teams', 'made', 'executives', 'Unilever', 'LON', 'NYSElisted', 'technology', 'services', 'provider', 'Endava', 'N', 'take', 'place', 'Dec', 'Together', 'Haldane', 'AstraZeneca', 'L', 'senior', 'vice', 'president', 'reward', 'inclusion', 'Rebekah', 'Martin', 'Unilever', 'head', 'global', 'reward', 'Constantina', 'Tribou', 'author', 'David', 'Goodhart', 'among', 'judging', 'strategies'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Employee', 'Philipp', 'Hoffmann', 'German', 'biopharmaceutical', 'company', 'CureVac', 'demonstrates', 'research', 'workflow', 'vaccine', 'coronavirus', 'disease', 'laboratory', 'Tuebingen', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Union', 'struck', 'deal', 'million', 'doses', 'German', 'biotech', 'firm', 'CureVac', 'DE', 'potential', 'vaccine', 'head', 'EU', 'executive', 'said', 'Monday', 'taking', 'total', 'supplies', 'secured', 'bloc', 'nearly', 'billion', 'doses', 'The', 'deal', 'CureVac', 'follows', 'EU', 'supply', 'agreements', 'AstraZeneca', 'L', 'Johnson', 'Johnson', 'N', 'Sanofi', 'PA', 'Pfizer', 'N', 'combined', 'billion', 'doses', 'potential', 'vaccines', 'I', 'glad', 'announce', 'new', 'agreement', 'buy', 'million', 'doses', 'vaccine', 'produced', 'European', 'company', 'CureVac', 'European', 'Commission', 'President', 'Ursula', 'von', 'der', 'Leyen', 'said', 'adding', 'contract', 'negotiated', 'EU', 'funding', 'company', 'develop', 'vaccine', 'The', 'EU', 'population', 'million', 'talks', 'CureVac', 'experimental', 'vaccine', 'least', 'since', 'July', 'internal', 'EU', 'document', 'seen', 'Reuters', 'shows', 'confirming', 'exclusive', 'Reuters', 'report', 'The', 'deal', 'authorised', 'Commission', 'Tuesday', 'von', 'der', 'Leyen', 'said', 'actual', 'signature', 'take', 'place', 'days', 'later', 'Under', 'advance', 'purchase', 'agreements', 'negotiated', 'EU', 'pandemic', 'bloc', 'makes', 'nonrefundable', 'payment', 'vaccine', 'maker', 'secure', 'certain', 'number', 'doses', 'agreed', 'price', 'paid', 'EU', 'states', 'willing', 'buy', 'shot', 'authorised', 'safe', 'effective', 'EU', 'drugs', 'regulator', 'The', 'price', 'agreed', 'vaccine', 'disclosed', 'The', 'deal', 'initially', 'cover', 'million', 'doses', 'option', 'buy', 'another', 'million', 'CureVac', 'immediately', 'available', 'comment', 'The', 'Commission', 'president', 'also', 'said', 'hoped', 'finalise', 'deal', 'soon', 'Moderna', 'O', 'vaccine', 'Monday', 'announced', 'positive', 'interim', 'results', 'largescale', 'clinical', 'trials', 'CureVac', 'approach', 'based', 'socalled', 'messenger', 'RNA', 'mRNA', 'pieces', 'genetic', 'code', 'prompt', 'human', 'cells', 'produce', 'therapeutic', 'proteins', 'technology', 'used', 'Moderna', 'also', 'PfizerBioNTech', 'major', 'potential', 'vaccine', 'reported', 'positive', 'latestage', 'trial', 'results', 'Â', 'Reuters', 'The', 'Pfizer', 'logo', 'seen', 'UK', 'commercial', 'headquarters', 'Walton', 'Oaks', 'JPM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'Shares', 'Pfizer', 'N', 'fell', 'Monday', 'rival', 'drugmaker', 'Moderna', 'O', 'said', 'experimental', 'vaccine', 'effective', 'stored', 'normal', 'fridge', 'temperatures', 'Moderna', 'second', 'US', 'company', 'report', 'encouraging', 'trial', 'results', 'vaccine', 'joining', 'Pfizer', 'N', 'said', 'vaccine', 'also', 'effective', 'But', 'Pfizer', 'vaccine', 'stored', 'shipped', 'ultracool', 'temperatures', 'Moderna', 'said', 'product', 'kept', 'normal', 'fridge', 'temperatures', 'This', 'important', 'perhaps', 'game', 'changer', 'said', 'Fawad', 'Razaqzada', 'analyst', 'ThinkMarkets', 'The', 'Pfizer', 'vaccine', 'kept', 'cold', 'temperatures', 'minus', 'degrees', 'Celsius', 'making', 'logistically', 'difficult', 'produce', 'transport', 'large', 'doses', 'vaccine', 'said', 'Pfizer', 'shares', 'Nov', 'hit', 'highest', 'levels', 'since', 'end', 'July', 'fell', 'GMT', 'shares', 'German', 'partner', 'BioNTech', 'JPMorgan', 'NYSE', 'analysts', 'said', 'logistics', 'Moderna', 'vaccine', 'clearly', 'less', 'onerous', 'although', 'expect', 'storage', 'requirements', 'vaccines', 'converge', 'Moderna', 'shares', 'hitting', 'record', 'high', 'earlier', 'Monday', 'shares', 'British', 'drugmaker', 'AstraZeneca', 'L', 'yet', 'release', 'results', 'latestage', 'vaccine', 'trials'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'People', 'walk', 'past', 'Pfizer', 'headquarters', 'building', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Michael', 'Erman', 'Ludwig', 'Burger', 'Reuters', 'Pfizer', 'Inc', 'N', 'BioNTech', 'O', 'could', 'secure', 'emergency', 'US', 'European', 'authorization', 'vaccine', 'next', 'month', 'final', 'trial', 'results', 'showed', 'success', 'rate', 'serious', 'side', 'effects', 'drugmakers', 'said', 'Wednesday', 'The', 'efficacy', 'shot', 'found', 'consistent', 'across', 'different', 'ages', 'ethnicities', 'promising', 'sign', 'given', 'disease', 'disproportionately', 'affected', 'elderly', 'certain', 'groups', 'including', 'Black', 'people', 'The', 'US', 'Food', 'Drug', 'Administration', 'could', 'grant', 'emergencyuse', 'approval', 'towards', 'end', 'first', 'half', 'December', 'early', 'second', 'half', 'BioNTech', 'Chief', 'Executive', 'Ugur', 'Sahin', 'told', 'Reuters', 'TV', 'Conditional', 'approval', 'European', 'Union', 'could', 'secured', 'second', 'half', 'December', 'added', 'If', 'goes', 'well', 'I', 'could', 'imagine', 'gain', 'approval', 'second', 'half', 'December', 'start', 'deliveries', 'Christmas', 'really', 'goes', 'positively', 'said', 'The', 'success', 'rate', 'vaccine', 'developed', 'US', 'firm', 'Pfizer', 'Germany', 'BioNTech', 'highest', 'candidate', 'latestage', 'clinical', 'trials', 'far', 'experts', 'said', 'significant', 'achievement', 'race', 'end', 'pandemic', 'Pfizer', 'said', 'volunteers', 'trial', 'involving', 'people', 'contracted', 'given', 'placebo', 'meaning', 'vaccine', 'effective', 'Of', 'people', 'severe', 'one', 'received', 'vaccine', 'A', 'first', 'history', 'mankind', 'less', 'year', 'sequence', 'virus', 'largescale', 'clinical', 'trial', 'vaccine', 'moreover', 'based', 'whole', 'new', 'technique', 'said', 'Enrico', 'Bucci', 'biologist', 'Temple', 'University', 'Philadelphia', 'Today', 'special', 'day', 'BioNTech', 'Sahin', 'said', 'US', 'emergency', 'authorization', 'would', 'applied', 'Friday', 'The', 'FDA', 'committee', 'tentatively', 'plans', 'meet', 'Dec', 'source', 'familiar', 'situation', 'said', 'though', 'dates', 'could', 'still', 'change', 'The', 'FDA', 'respond', 'requests', 'comment', 'RUNS', 'RAMPANT', 'The', 'final', 'trial', 'analysis', 'comes', 'week', 'initial', 'results', 'showed', 'vaccine', 'effective', 'Moderna', 'Inc', 'O', 'released', 'preliminary', 'data', 'vaccine', 'Monday', 'showing', 'effectiveness', 'The', 'betterthanexpected', 'results', 'two', 'vaccines', 'developed', 'new', 'messenger', 'RNA', 'mRNA', 'technology', 'raised', 'hopes', 'end', 'pandemic', 'killed', 'million', 'people', 'wreaked', 'havoc', 'upon', 'economies', 'daily', 'life', 'The', 'PfizerBioNTech', 'shot', 'found', 'efficacy', 'people', 'years', 'experts', 'said', 'crucial', 'time', 'running', 'rampant', 'around', 'world', 'record', 'numbers', 'new', 'cases', 'hospitalizations', 'This', 'evidence', 'needed', 'ensure', 'vulnerable', 'people', 'protected', 'said', 'Andrew', 'Hill', 'senior', 'visiting', 'research', 'fellow', 'University', 'Liverpool', 'department', 'pharmacology', 'Global', 'shares', 'rose', 'trial', 'results', 'countered', 'concerns', 'around', 'stubbornly', 'high', 'global', 'infection', 'rate', 'Pfizer', 'shares', 'BioNTech', 'jumped', 'United', 'States', 'By', 'contrast', 'Moderna', 'dropped', 'Investors', 'treated', 'vaccine', 'development', 'race', 'companies', 'although', 'likely', 'global', 'demand', 'much', 'vaccine', 'produced', 'foreseeable', 'future', 'DISTRIBUTING', 'SHOTS', 'Pfizer', 'says', 'expects', 'make', 'many', 'million', 'vaccine', 'doses', 'year', 'enough', 'protect', 'million', 'people', 'produce', 'billion', 'doses', 'While', 'groups', 'healthcare', 'workers', 'prioritized', 'United', 'States', 'Britain', 'vaccinations', 'year', 'months', 'largescale', 'rollouts', 'begin', 'either', 'country', 'Pfizer', 'also', 'agreements', 'European', 'Union', 'Germany', 'Japan', 'distribution', 'could', 'begin', 'next', 'year', 'Mike', 'Ryan', 'World', 'Health', 'Organization', 'top', 'emergency', 'expert', 'said', 'would', 'least', 'months', 'significant', 'levels', 'vaccination', 'taking', 'place', 'around', 'world', 'Distribution', 'PfizerBioNTech', 'shot', 'complicated', 'need', 'store', 'ultracold', 'temperatures', 'degrees', 'Celsius', 'It', 'however', 'kept', 'normal', 'fridge', 'five', 'days', 'days', 'thermal', 'shipping', 'box', 'Moderna', 'vaccine', 'stored', 'six', 'months', 'though', 'expected', 'stable', 'days', 'normal', 'fridge', 'temperatures', 'degrees', 'Celsius', 'FATIGUE', 'AND', 'HEADACHES', 'Pfizer', 'said', 'twodose', 'vaccine', 'called', 'welltolerated', 'side', 'effects', 'mostly', 'mild', 'moderate', 'cleared', 'quickly', 'It', 'said', 'severe', 'adverse', 'events', 'experienced', 'volunteers', 'fatigue', 'headaches', 'Out', 'participants', 'headaches', 'second', 'dose', 'experienced', 'fatigue', 'Older', 'adults', 'tended', 'report', 'fewer', 'milder', 'adverse', 'events', 'These', 'extraordinary', 'results', 'safety', 'data', 'look', 'good', 'said', 'David', 'Spiegelhalter', 'professor', 'expert', 'risk', 'evidence', 'communication', 'University', 'Cambridge', 'It', 'would', 'interesting', 'see', 'adverse', 'reactions', 'reported', 'group', 'getting', 'placebo', 'since', 'gives', 'idea', 'much', 'adverse', 'effects', 'due', 'vaccination', 'process', 'much', 'due', 'vaccine', 'Of', 'dozens', 'drugmakers', 'research', 'groups', 'racing', 'develop', 'vaccines', 'next', 'data', 'release', 'likely', 'AstraZeneca', 'Plc', 'L', 'University', 'Oxford', 'November', 'December', 'Johnson', 'Johnson', 'says', 'track', 'deliver', 'data', 'year', 'GRAPHICTracking', 'vaccine', 'race', 'Authorization', 'vaccines', 'children', 'take', 'longer', 'Only', 'Pfizer', 'started', 'vaccinating', 'volunteers', 'age', 'trials', 'giving', 'shots', 'children', 'young', 'Moderna', 'Johnson', 'Johnson', 'N', 'said', 'hope', 'start', 'testing', 'vaccine', 'younger', 'patients', 'soon'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Britain', 'Health', 'Secretary', 'Matt', 'Hancock', 'holds', 'media', 'briefing', 'Downing', 'Street', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'English', 'doctors', 'grappling', 'prospect', 'sevenday', 'service', 'degree', 'Celsius', 'freezers', 'vaccines', 'known', 'Talent', 'Courageous', 'prepare', 'unprecedented', 'logistical', 'challenge', 'rollout', 'vaccinations', 'Health', 'minister', 'Matt', 'Hancock', 'set', 'target', 'England', 'National', 'Health', 'Service', 'ready', 'administer', 'vaccines', 'Dec', 'although', 'said', 'central', 'expectation', 'bulk', 'rollout', 'happen', 'next', 'year', 'Any', 'distribution', 'vaccines', 'would', 'also', 'require', 'approval', 'country', 'medical', 'watchdog', 'MHRA', 'On', 'Wednesday', 'NHS', 'England', 'medical', 'director', 'Stephen', 'Powis', 'confirmed', 'general', 'practitioners', 'GPs', 'pharmacies', 'largescale', 'inoculation', 'centres', 'could', 'involved', 'vaccine', 'rollout', 'adding', 'details', 'would', 'given', 'coming', 'days', 'There', 'going', 'nationally', 'organised', 'vaccine', 'immunisation', 'centres', 'large', 'centres', 'probably', 'run', 'military', 'involved', 'etc', 'But', 'GPs', 'well', 'placed', 'Steve', 'Mowle', 'practising', 'GP', 'honorary', 'treasurer', 'Royal', 'College', 'General', 'Practitioners', 'told', 'Reuters', 'The', 'challenge', 'task', 'even', 'bigger', 'flu', 'immunisation', 'programme', 'But', 'I', 'sure', 'GPs', 'central', 'role', 'delivering', 'vaccine', 'Germany', 'scouting', 'trade', 'fair', 'halls', 'airport', 'terminals', 'possible', 'mass', 'vaccination', 'centres', 'Italy', 'plans', 'lean', 'existing', 'GP', 'network', 'But', 'many', 'countries', 'details', 'population', 'inoculated', 'scarce', 'A', 'spokesman', 'Britain', 'health', 'ministry', 'said', 'extra', 'logistical', 'expertise', 'transport', 'arrangements', 'equipment', 'put', 'place', 'workforce', 'expanded', 'million', 'pounds', 'given', 'GP', 'practices', 'An', 'enormous', 'amount', 'planning', 'taken', 'place', 'ensure', 'health', 'service', 'stands', 'ready', 'roll', 'vaccine', 'said', 'We', 'publish', 'details', 'deployment', 'plans', 'due', 'course', 'AND', 'Although', 'still', 'lack', 'clarity', 'details', 'doctors', 'expected', 'deliver', 'vaccines', 'briefed', 'broad', 'outlines', 'In', 'absence', 'trade', 'names', 'NHS', 'uses', 'codenames', 'refer', 'two', 'vaccine', 'candidates', 'expected', 'first', 'available', 'Pfizer', 'N', 'BioNTech', 'vaccine', 'candidate', 'uses', 'mRNA', 'platform', 'referred', 'Courageous', 'vaccine', 'University', 'Oxford', 'AstraZeneca', 'L', 'referred', 'Talent', 'vaccine', 'slides', 'webinar', 'health', 'professionals', 'given', 'NHS', 'England', 'last', 'week', 'reviewed', 'Reuters', 'Britain', 'ordered', 'million', 'doses', 'PfizerBioNTech', 'vaccine', 'candidate', 'efficacy', 'final', 'trial', 'results', 'published', 'Wednesday', 'million', 'doses', 'OxfordAstraZeneca', 'shot', 'expected', 'publish', 'efficacy', 'data', 'coming', 'weeks', 'In', 'webinar', 'doctors', 'told', 'would', 'doses', 'per', 'pack', 'Pfizer', 'vaccine', 'two', 'doses', 'needed', 'given', 'days', 'apart', 'line', 'US', 'drugmaker', 'design', 'specifications', 'Clinics', 'could', 'also', 'need', 'open', 'weekends', 'make', 'sure', 'doses', 'used', 'time', 'Potential', 'vaccines', 'could', 'need', 'delivered', 'within', 'certain', 'time', 'period', 'arrive', 'site', 'slide', 'said', 'So', 'necessary', 'otherwise', 'practices', 'need', 'ability', 'deliver', 'vaccinations', 'pm', 'seven', 'days', 'week', 'avoid', 'going', 'waste', 'TWIN', 'TRACK', 'The', 'urgency', 'getting', 'vaccines', 'delivered', 'people', 'promptly', 'received', 'stems', 'part', 'demanding', 'storage', 'requirements', 'PfizerBioNTech', 'vaccine', 'needs', 'kept', 'around', 'degrees', 'Celsius', 'It', 'stored', 'five', 'days', 'refrigeration', 'diluted', 'used', 'within', 'matter', 'hours', 'causes', 'headaches', 'distributing', 'vaccine', 'especially', 'rural', 'areas', 'There', 'real', 'challenges', 'around', 'might', 'used', 'Richard', 'Vautrey', 'doctor', 'chair', 'British', 'Medical', 'Association', 'GP', 'Committee', 'said', 'It', 'quite', 'different', 'would', 'normally', 'experience', 'say', 'flu', 'vaccine', 'said', 'adding', 'details', 'twin', 'track', 'strategy', 'active', 'discussion', 'The', 'onerous', 'storage', 'requirements', 'Pfizer', 'vaccine', 'mitigated', 'dry', 'ice', 'temporary', 'cooling', 'solutions', 'said', 'Anna', 'Blakney', 'research', 'fellow', 'Imperial', 'College', 'London', 'Between', 'purchase', 'new', 'freezers', 'space', 'addition', 'dry', 'ice', 'shipments', 'would', 'probably', 'able', 'accommodate', 'vaccines', 'receiving', 'said', 'Much', 'delivery', 'vaccines', 'determined', 'local', 'level', 'exact', 'practices', 'may', 'vary', 'different', 'parts', 'England', 'let', 'alone', 'Scotland', 'Wales', 'Northern', 'Ireland', 'health', 'policy', 'devolved', 'In', 'central', 'English', 'county', 'Nottinghamshire', 'health', 'officials', 'said', 'briefing', 'medical', 'professionals', 'planned', 'ready', 'start', 'vaccinating', 'frontline', 'staff', 'people', 'care', 'homes', 'Dec', 'largescale', 'COVID', 'vaccine', 'centres', 'operating', 'Jan', 'GP', 'practice', 'involvement', 'midJanuary', 'I', 'think', 'full', 'capacity', 'first', 'December', 'Obviously', 'gradual', 'rollout', 'Mowle', 'said', 'But', 'way', 'I', 'think', 'huge', 'willingness', 'GPs', 'engage', 'process', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'word', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Results', 'latestage', 'trials', 'University', 'Oxford', 'vaccine', 'candidate', 'definitely', 'known', 'Christmas', 'chief', 'investigator', 'study', 'said', 'Thursday', 'adding', 'early', 'know', 'efficacy', 'yet', 'Asked', 'early', 'say', 'whether', 'vaccine', 'licensed', 'AstraZeneca', 'L', 'stops', 'disease', 'developing', 'Andrew', 'Pollard', 'director', 'Oxford', 'Vaccine', 'Group', 'said', 'We', 'quite', 'got', 'point', 'yet', 'We', 'obviously', 'going', 'rush', 'We', 'getting', 'close', 'definitely', 'going', 'Christmas', 'based', 'progress', 'told', 'BBC', 'Radio', 'asked', 'trial', 'investigators', 'would', 'unblinded', 'efficacy', 'data', 'results', 'released', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'word', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'AstraZeneca', 'Oxford', 'University', 'potential', 'vaccine', 'produced', 'strong', 'immune', 'response', 'older', 'adults', 'data', 'published', 'Thursday', 'showed', 'researchers', 'expecting', 'release', 'latestage', 'trial', 'results', 'Christmas', 'The', 'data', 'reported', 'part', 'last', 'month', 'published', 'full', 'The', 'Lancet', 'medical', 'journal', 'Thursday', 'suggest', 'aged', 'higher', 'risk', 'serious', 'illness', 'death', 'could', 'build', 'robust', 'immunity', 'The', 'robust', 'antibody', 'Tcell', 'responses', 'seen', 'older', 'people', 'study', 'encouraging', 'said', 'Maheshi', 'Ramasamy', 'consultant', 'colead', 'investigator', 'Oxford', 'Vaccine', 'Group', 'We', 'hope', 'means', 'vaccine', 'help', 'protect', 'vulnerable', 'people', 'society', 'research', 'needed', 'sure', 'Latestage', 'Phase', 'III', 'trials', 'ongoing', 'confirm', 'findings', 'researchers', 'said', 'test', 'whether', 'vaccine', 'protects', 'infection', 'broad', 'range', 'people', 'including', 'people', 'underlying', 'health', 'conditions', 'Results', 'trials', 'definitely', 'known', 'Christmas', 'Oxford', 'Vaccine', 'Group', 'director', 'Andrew', 'Pollard', 'said', 'adding', 'early', 'know', 'whether', 'well', 'vaccine', 'works', 'preventing', 'disease', 'We', 'still', 'waiting', 'get', 'point', 'analysis', 'work', 'well', 'vaccine', 'protect', 'people', 'getting', 'ever', 'closer', 'told', 'journalists', 'We', 'optimistic', 'able', 'Christmas', 'obviously', 'share', 'soon', 'point', 'The', 'OxfordAstraZeneca', 'vaccine', 'candidate', 'called', 'among', 'frontrunners', 'global', 'efforts', 'develop', 'shots', 'protect', 'infection', 'novel', 'coronavirus', 'But', 'rival', 'drugmakers', 'Pfizer', 'Inc', 'N', 'BioNTech', 'F', 'Moderna', 'Inc', 'O', 'past', 'days', 'edged', 'ahead', 'releasing', 'data', 'latestage', 'vaccine', 'trials', 'shows', 'efficacy', 'We', 'rush', 'We', 'competition', 'developers', 'Oxford', 'Pollard', 'said', 'adding', 'AstraZeneca', 'would', 'release', 'headline', 'efficacy', 'data', 'published', 'academic', 'journal', 'Oxford', 'University', 'set', 'target', 'infections', 'start', 'interim', 'analysis', 'latestage', 'trial', 'results', 'though', 'lots', 'cases', 'trial', 'arms', 'Britain', 'South', 'Africa', 'Brazil', 'mean', 'exact', 'number', 'infections', 'reported', 'could', 'differ', 'Unlike', 'PfizerBioNTech', 'Moderna', 'shots', 'use', 'new', 'technology', 'known', 'messenger', 'RNA', 'mRNA', 'AstraZeneca', 'viral', 'vector', 'vaccine', 'made', 'weakened', 'version', 'common', 'cold', 'virus', 'found', 'chimpanzees', 'The', 'Phase', 'II', 'trial', 'reported', 'The', 'Lancet', 'involved', 'total', 'healthy', 'volunteers', 'aged', 'aged', 'aged', 'Volunteers', 'got', 'two', 'doses', 'vaccine', 'placebo', 'serious', 'side', 'effects', 'related', 'vaccine', 'reported', 'researchers', 'said', 'AstraZeneca', 'L', 'signed', 'several', 'supply', 'manufacturing', 'deals', 'companies', 'governments', 'around', 'world', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BBWI', 'Add', 'toRemove', 'Portfolio', 'JEF', 'Add', 'toRemove', 'Portfolio', 'M', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'SHOP', 'Add', 'toRemove', 'Portfolio', 'By', 'Yasin', 'Ebrahim', 'Investingcom', 'The', 'Dow', 'slipped', 'Thursday', 'investors', 'weighed', 'strength', 'tech', 'weakness', 'value', 'amid', 'concerns', 'economy', 'signs', 'slowdown', 'labor', 'market', 'surging', 'cases', 'The', 'fell', 'points', 'The', 'rose', 'The', 'Labor', 'Department', 'reported', 'people', 'filed', 'unemployment', 'insurance', 'week', 'ended', 'November', 'prior', 'week', 'economists', 'forecasts', 'claims', 'Signs', 'weakness', 'labor', 'market', 'likely', 'continue', 'weeks', 'ahead', 'surge', 'virus', 'prompts', 'parts', 'US', 'impose', 'restrictions', 'curb', 'virus', 'Overall', 'backup', 'claims', 'week', 'somewhat', 'troubling', 'likely', 'indicative', 'going', 'see', 'next', 'weeks', 'ahead', 'Jefferies', 'NYSE', 'Thomas', 'Simons', 'The', 'US', 'reported', 'daily', 'record', 'deaths', 'Wednesday', 'official', 'health', 'data', 'showed', 'hospitalizations', 'virus', 'nationwide', 'hitting', 'another', 'record', 'The', 'Centers', 'Disease', 'Control', 'Prevention', 'warned', 'travel', 'ahead', 'Thanksgiving', 'next', 'week', 'Value', 'stocks', 'like', 'financials', 'energy', 'industrials', 'fell', 'red', 'Still', 'optimism', 'vaccine', 'front', 'AstraZeneca', 'PLC', 'LON', 'said', 'coronavirus', 'vaccine', 'shown', 'signs', 'strong', 'immune', 'responses', 'among', 'older', 'adults', 'Consumer', 'discretionary', 'stocks', 'meanwhile', 'received', 'boost', 'surge', 'L', 'Brands', 'L', 'Brands', 'NYSE', 'rallied', 'following', 'earnings', 'topped', 'analyst', 'estimates', 'underpinned', 'strong', 'results', 'Bath', 'Body', 'Works', 'amid', 'pandemicfueled', 'demand', 'soap', 'hand', 'sanitizer', 'Macyâs', 'NYSE', 'reported', 'betterthanexpected', 'earnings', 'samestore', 'sales', 'fell', 'short', 'estimates', 'sending', 'shares', 'red', 'Tech', 'however', 'remained', 'flatline', 'Fab', 'traded', 'mostly', 'higher', 'Amazoncom', 'NASDAQ', 'Alphabet', 'NASDAQ', 'Microsoft', 'NASDAQ', 'traded', 'higher', 'Apple', 'NASDAQ', 'Facebook', 'NASDAQ', 'marginally', 'lower', 'In', 'news', 'Shopify', 'NYSE', 'climbed', 'Jefferies', 'upgraded', 'stock', 'buy', 'rating', 'expectations', 'strength', 'internet', 'shopping', 'continue', 'boost', 'demand'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'TUIGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'HLMA', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Tui', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fresnillo', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Halma', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'XOM', 'Add', 'toRemove', 'Portfolio', 'CRM', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'XRPUSD', 'Add', 'toRemove', 'Portfolio', 'WORK', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Germany', 'extends', 'lockdown', 'restrictions', 'December', 'â', 'doesnât', 'tighten', 'much', 'despite', 'failing', 'bring', 'infection', 'curve', 'Consumer', 'confidence', 'Europeâs', 'two', 'biggest', 'economies', 'falls', 'corrects', 'sharply', 'downward', 'corrects', 'even', 'sharply', 'Salesforce', 'reported', 'close', 'buying', 'Slack', 'Exxon', 'Mobil', 'gloomy', 'oil', 'Hereâs', 'need', 'know', 'financial', 'markets', 'Thursday', 'November', 'Germany', 'extends', 'restrictions', 'tighten', 'much', 'Germanyâs', 'federal', 'regional', 'governments', 'extended', 'current', 'restrictions', 'business', 'social', 'gatherings', 'December', 'expanded', 'restrictions', 'maskwearing', 'otherwise', 'shied', 'away', 'tightening', 'restrictions', 'tries', 'bring', 'second', 'wave', 'coronavirus', 'control', 'Europeâs', 'largest', 'economy', 'reported', 'recordhigh', 'new', 'cases', 'Wednesday', 'well', 'deaths', 'third', 'straight', 'day', 'Having', 'implemented', 'less', 'strict', 'lockdown', 'deal', 'second', 'wave', 'pandemic', 'far', 'failed', 'bring', 'virus', 'control', 'By', 'contrast', 'France', 'UK', 'started', 'relax', 'restrictions', 'ahead', 'hoping', 'guarantee', 'something', 'closer', 'normal', 'life', 'Christmas', 'Consumer', 'sentiment', 'surveys', 'fell', 'expected', 'November', 'data', 'released', 'Thursday', 'showed', 'AstraZeneca', 'NASDAQ', 'drug', 'doubts', 'Doubts', 'growing', 'reliability', 'data', 'provided', 'AstraZeneca', 'LON', 'University', 'Oxford', 'effectiveness', 'experimental', 'drug', 'fight', 'coronavirus', 'Moncef', 'Slaoui', 'head', 'US', 'Operation', 'Warp', 'Speed', 'team', 'tasked', 'funding', 'vaccine', 'development', 'said', 'Wednesday', 'subgroup', 'reported', 'highest', 'degree', 'efficacy', 'stage', 'trial', 'data', 'released', 'last', 'week', 'restricted', 'people', 'age', 'bracket', 'appears', 'case', 'resistant', 'disease', 'least', 'severe', 'manifestations', 'The', 'test', 'data', 'shown', 'drug', 'prevented', 'disease', 'people', 'received', 'two', 'full', 'doses', 'vaccine', 'received', 'half', 'dose', 'start', 'The', 'halfdose', 'experiment', 'started', 'mistake', 'extended', 'sake', 'consistency', 'Stocks', 'drift', 'Bitcoin', 'slumps', 'rally', 'Global', 'stocks', 'stayed', 'mostly', 'positive', 'territory', 'drifting', 'range', 'trading', 'US', 'Thanksgiving', 'Holiday', 'loomed', 'large', 'dayâs', 'proceedings', 'Weak', 'consumer', 'confidence', 'data', 'France', 'Germany', 'marginally', 'offset', 'strongerthanexpected', 'credit', 'growth', 'figures', 'European', 'Central', 'Bank', 'also', 'due', 'release', 'accounts', 'last', 'policy', 'meeting', 'later', 'By', 'AM', 'benchmark', 'index', 'less', 'index', 'closed', 'There', 'violent', 'correction', 'markets', 'Bitcoin', 'gave', 'equally', 'violent', 'rally', 'Ripple', 'another', 'popular', 'cryptocurrency', 'fell', 'Salesforce', 'talks', 'Slack', 'Slack', 'NYSE', 'stock', 'rose', 'Wednesday', 'close', 'near', 'alltime', 'high', 'reports', 'talks', 'acquired', 'software', 'giant', 'Salesforce', 'NYSE', 'Marc', 'Benioffâs', 'company', 'could', 'reach', 'deal', 'office', 'messaging', 'software', 'app', 'within', 'days', 'according', 'The', 'Wall', 'Street', 'Journal', 'itâs', 'unclear', 'deal', 'would', 'structured', 'Like', 'many', 'software', 'companies', 'valuation', 'far', 'excess', 'current', 'financials', 'would', 'usually', 'justify', 'For', 'popularity', 'Slackâs', 'shares', 'failed', 'capitalize', 'trend', 'away', 'email', 'offices', 'faces', 'increasingly', 'acute', 'strategic', 'challenge', 'Microsoftâs', 'Teams', 'application', 'Oil', 'steadies', 'rally', 'Exxon', 'gloomy', 'forecasts', 'Crude', 'oil', 'prices', 'also', 'retraced', 'slightly', 'stayed', 'close', 'postpandemic', 'highs', 'judicious', 'profittaking', 'By', 'AM', 'ET', 'GMT', 'US', 'futures', 'barrel', 'crude', 'futures', 'The', 'Wall', 'Street', 'Journal', 'reported', 'Wednesday', 'Exxon', 'Mobil', 'NYSE', 'revised', 'estimate', 'oil', 'prices', 'next', 'six', 'years', 'indicating', 'expectations', 'prolonged', 'impact', 'prices', 'pandemic', 'Shortterm', 'pressures', 'may', 'also', 'building', 'given', 'surprisingly', 'strong', 'build', 'US', 'last', 'week', 'according', 'US', 'government', 'data', 'released', 'Wednesday'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Adds', 'futures', 'news', 'items', 'Nov', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'ASTRAZENECA', 'The', 'situation', 'regarding', 'vaccine', 'developed', 'AstraZeneca', 'generally', 'encouraging', 'even', 'though', 'new', 'trial', 'needed', 'said', 'AstraZeneca', 'France', 'President', 'Olivier', 'Nataf', 'ASTRAZENECA', 'The', 'Philippines', 'get', 'million', 'shots', 'potential', 'vaccine', 'developed', 'AstraZeneca', 'country', 'first', 'supply', 'deal', 'coronavirus', 'vaccine', 'senior', 'officials', 'said', 'GOLD', 'Gold', 'eased', 'en', 'route', 'third', 'straight', 'weekly', 'drop', 'investors', 'weighed', 'doubts', 'leading', 'vaccine', 'candidate', 'optimism', 'vaccines', 'arrive', 'sooner', 'expected', 'OIL', 'Oil', 'prices', 'lower', 'quiet', 'trade', 'due', 'US', 'Thanksgiving', 'holiday', 'dropping', 'amid', 'concerns', 'oversupply', 'doubts', 'vaccine', 'end', 'coronavirus', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Thursday', 'amid', 'heightened', 'concerns', 'economic', 'growth', 'Health', 'Minister', 'Matt', 'Hancock', 'said', 'third', 'population', 'would', 'remain', 'tough', 'restrictions', 'end', 'national', 'lockdown', 'Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Peter', 'Nurse', 'Investingcom', 'AstraZeneca', 'PLC', 'LON', 'race', 'develop', 'effective', 'vaccine', 'goal', 'It', 'really', 'known', 'global', 'leader', 'cancer', 'treatments', 'winning', 'number', 'drug', 'approvals', 'recent', 'years', 'regulators', 'around', 'world', 'Earlier', 'week', 'UKbased', 'drug', 'maker', 'said', 'latestage', 'trials', 'vaccine', 'showed', 'efficacy', 'quickly', 'acknowledge', 'flaws', 'data', 'Investingcom', 'Geoffrey', 'Smith', 'explains', 'rare', 'misstep', 'wo', 'cause', 'lasting', 'damage', 'Peter', 'Nurse', 'says', 'fallout', 'real', 'reputational', 'risks', 'weigh', 'valuation', 'The', 'Bull', 'Case', 'The', 'bull', 'case', 'AstraZeneca', 'doesnât', 'need', 'contribution', 'experimental', 'vaccine', 'The', 'fact', 'company', 'global', 'powerhouse', 'oncology', 'drugs', 'others', 'treat', 'chronic', 'diseases', 'lungs', 'kidneys', 'It', 'earns', 'gross', 'margins', 'normal', 'year', 'expects', 'underlying', 'earnings', 'per', 'share', 'grow', 'year', 'worldâs', 'healthcare', 'systems', 'trouble', 'finding', 'resources', 'anything', 'treating', 'It', 'beyond', 'reasonable', 'doubt', 'wellrun', 'company', 'whose', 'shares', 'deserve', 'management', 'premium', 'In', 'barely', 'seven', 'years', 'CEO', 'Pascal', 'Soriot', 'raised', 'market', 'value', 'already', 'mature', 'business', 'pandemic', 'erupted', 'Soriot', 'quickly', 'addressed', 'weekâs', 'misstep', 'communicating', 'stage', 'trial', 'results', 'ordering', 'new', 'trial', 'responsible', 'CEO', 'might', 'Global', 'regulators', 'pleased', 'approve', 'string', 'drugs', 'recent', 'years', 'suggestions', 'vital', 'relationship', 'damaged', 'imperfect', 'trial', 'conducted', 'extraordinary', 'pressures', 'current', 'race', 'Covid', 'cure', 'alarmist', 'Barring', 'fiasco', 'wholly', 'character', 'rest', 'Soriotâs', 'career', 'downside', 'risk', 'share', 'price', 'even', 'drug', 'falls', 'short', 'AstraZenecaâs', 'share', 'price', 'almost', 'exactly', 'start', 'year', 'anyone', 'even', 'heard', 'dreaded', 'Cword', 'Given', 'cost', 'servicing', 'sizable', 'debt', 'pile', 'come', 'sharply', 'since', 'allowing', 'higher', 'stock', 'valuation', 'things', 'equal', 'even', 'argue', 'market', 'already', 'applying', 'discount', 'shares', 'whole', 'saga', 'Either', 'drug', 'writeoff', 'case', 'much', 'cost', 'remains', 'governments', 'helped', 'fund', 'development', 'actually', 'effective', 'allowing', 'worldwide', 'distribution', 'In', 'latter', 'case', 'fact', 'agreed', 'provide', 'drug', 'profit', 'seen', 'bugbear', 'many', 'investors', 'consider', 'Reports', 'citing', 'confidential', 'contracts', 'manufacturers', 'suggest', 'AZ', 'able', 'exercise', 'pricing', 'power', 'second', 'half', 'next', 'year', 'already', 'And', 'eschew', 'shortterm', 'profit', 'keeping', 'price', 'longterm', 'benefit', 'could', 'still', 'considerable', 'Cancer', 'true', 'specialism', 'rich', 'country', 'disease', 'spread', 'wealth', 'across', 'ever', 'parts', 'world', 'secular', 'positive', 'The', 'gain', 'goodwill', 'pricegouging', 'drug', 'everyone', 'wants', 'needs', 'intangible', 'immeasurable', 'The', 'Bear', 'Case', 'The', 'bear', 'case', 'surrounding', 'AstraZeneca', 'rests', 'largely', 'valuation', 'reputational', 'damage', 'may', 'incur', 'mess', 'itâs', 'making', 'getting', 'coronavirus', 'vaccine', 'candidate', 'approved', 'With', 'PE', 'ratio', 'around', 'companyâs', 'stock', 'priced', 'well', 'industry', 'average', 'historical', 'norm', 'suggesting', 'plenty', 'downside', 'potential', 'The', 'pharmaceutical', 'giant', 'released', 'interim', 'analysis', 'latestage', 'trials', 'vaccine', 'great', 'fanfare', 'Monday', 'stating', 'efficacy', 'reached', 'maximum', 'depending', 'dosage', 'regime', 'However', 'doubts', 'quickly', 'emerged', 'reliability', 'data', 'provided', 'AstraZeneca', 'partner', 'University', 'Oxford', 'regards', 'drugâs', 'effectiveness', 'Importantly', 'Moncef', 'Slaoui', 'head', 'US', 'Operation', 'Warp', 'Speed', 'team', 'tasked', 'funding', 'vaccine', 'development', 'pointed', 'potential', 'flaw', 'saying', 'subgroup', 'reported', 'highest', 'degree', 'efficacy', 'restricted', 'people', 'subjects', 'likely', 'resistant', 'disease', 'Geoffrey', 'Porges', 'Director', 'Therapeutics', 'Research', 'life', 'sciences', 'boutique', 'investment', 'bank', 'SVB', 'Leerink', 'widely', 'reported', 'predicting', 'vaccine', 'never', 'licensed', 'US', 'particularly', 'appear', 'viable', 'alternatives', 'form', 'Pfizer', 'Inc', 'NYSE', 'âs', 'Moderna', 'Inc', 'NASDAQ', 'âs', 'drugs', 'Promising', 'candidate', 'vaccines', 'Johnson', 'Johnson', 'NYSE', 'others', 'still', 'development', 'pipeline', 'AstraZeneca', 'promised', 'supply', 'vaccine', 'cost', 'price', 'long', 'pandemic', 'lasts', 'making', 'valuable', 'American', 'market', 'product', 'may', 'necessarily', 'big', 'thing', 'But', 'botched', 'communication', 'far', 'small', 'trial', 'could', 'far', 'difficult', 'ignore', 'lasting', 'damage', 'relationship', 'allimportant', 'Food', 'Drug', 'Administration', 'After', 'generated', 'almost', 'billion', 'revenue', 'US', 'last', 'year', 'biggest', 'single', 'market', 'far', 'Swiss', 'banking', 'giant', 'UBS', 'earlier', 'week', 'kept', 'âœsellâ', 'rating', 'AstraZeneca', 'citing', 'uncertainty', 'surrounding', 'vaccineâs', 'results', 'Earlier', 'month', 'also', 'noted', 'product', 'sales', 'emerging', 'markets', 'disappointed', 'third', 'quarter', 'results', 'whereas', 'US', 'business', 'surprised', 'positively', 'This', 'balance', 'may', 'change', 'Â', 'Reuters', 'DJI', 'Add', 'toRemove', 'Portfolio', 'BBVA', 'Add', 'toRemove', 'Portfolio', 'SABE', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'Black', 'Friday', 'shopping', 'season', 'likely', 'different', 'online', 'sales', 'likely', 'surge', 'European', 'banking', 'consolidation', 'put', 'hold', 'Spain', 'AstraZeneca', 'NASDAQ', 'unlikely', 'feel', 'much', 'love', 'Wall', 'Street', 'returns', 'Thanksgiving', 'holiday', 'Oil', 'trading', 'mixed', 'crucial', 'OPEC', 'meeting', 'looms', 'sterling', 'retains', 'strength', 'stocks', 'seen', 'continuing', 'recent', 'positive', 'trend', 'Hereâs', 'need', 'know', 'financial', 'markets', 'Friday', 'November', 'Black', 'Friday', 'arrives', 'difference', 'Itâs', 'Black', 'Friday', 'traditionally', 'busiest', 'shopping', 'day', 'United', 'States', 'things', 'set', 'different', 'Pictures', 'shoppers', 'fighting', 'get', 'shops', 'search', 'bargains', 'staple', 'news', 'channels', 'years', 'restrictions', 'forced', 'shops', 'divert', 'purchases', 'online', 'Many', 'major', 'retailers', 'hit', 'hard', 'pandemic', 'started', 'offering', 'Black', 'Friday', 'promotions', 'much', 'earlier', 'usual', 'taking', 'lead', 'Amazon', 'NASDAQ', 'hosting', 'Prime', 'Day', 'middle', 'October', 'order', 'capture', 'much', 'holidayrelated', 'possible', 'Itâs', 'still', 'likely', 'bumper', 'period', 'major', 'retailers', 'National', 'Retail', 'Federation', 'forecasting', 'US', 'holiday', 'retail', 'sales', 'increase', 'total', 'billion', 'billion', 'This', 'compares', 'average', 'annual', 'increase', 'past', 'five', 'years', 'BBVA', 'MC', 'Sabadell', 'MC', 'end', 'talks', 'Banco', 'Sabadell', 'stock', 'slumped', 'potential', 'merger', 'rival', 'BBVA', 'collapsed', 'two', 'weeks', 'two', 'Spanish', 'banks', 'announced', 'plans', 'tieup', 'The', 'disagreement', 'seems', 'center', 'around', 'price', 'deal', 'would', 'resulted', 'bank', 'market', 'capitalization', 'around', 'billion', 'euros', 'billion', 'BBVA', 'Spainâs', 'secondlargest', 'bank', 'said', 'rush', 'scale', 'operations', 'given', 'already', 'around', 'Spainâs', 'market', 'share', 'Sabadell', 'said', 'would', 'launch', 'new', 'strategy', 'prioritise', 'domestic', 'business', 'European', 'lenders', 'considerable', 'pressure', 'financial', 'challenges', 'surrounding', 'pandemic', 'adding', 'woes', 'Consolidation', 'regionâs', 'fragmented', 'banking', 'sector', 'seen', 'way', 'forward', 'even', 'CaixaBank', 'Bankia', 'announced', 'plans', 'merge', 'deal', 'would', 'create', 'Spainâs', 'largest', 'domestic', 'bank', 'combined', 'market', 'capitalisation', 'almost', 'billion', 'Stocks', 'seen', 'higher', 'AstraZeneca', 'focus', 'US', 'stocks', 'set', 'open', 'higher', 'Friday', 'although', 'gains', 'likely', 'limited', 'market', 'set', 'close', 'early', 'aftermath', 'Thanksgiving', 'Holiday', 'By', 'AM', 'contract', 'rose', 'points', 'traded', 'points', 'higher', 'climbed', 'points', 'Generally', 'positive', 'coronavirus', 'vaccine', 'news', 'emerging', 'political', 'certainty', 'US', 'prompted', 'strong', 'gains', 'Wall', 'Street', 'topping', 'mark', 'first', 'time', 'earlier', 'week', 'President', 'Donald', 'Trump', 'said', 'Thursday', 'leave', 'office', 'Electoral', 'College', 'votes', 'Presidentelect', 'Joe', 'Biden', 'This', 'closest', 'come', 'conceding', 'election', 'adds', 'feeling', 'normalcy', 'returning', 'US', 'political', 'circles', 'AstraZeneca', 'LON', 'focus', 'Wall', 'Street', 'opens', 'Moncef', 'Slaoui', 'head', 'Operation', 'Warp', 'Speed', 'expressed', 'concern', 'viability', 'data', 'used', 'create', 'efficacy', 'level', 'drug', 'makerâs', 'vaccine', 'candidate', 'Sterling', 'retains', 'strength', 'Sterling', 'remains', 'near', 'threemonth', 'highs', 'US', 'dollar', 'despite', 'UK', 'Finance', 'Minister', 'Rishi', 'Sunakâs', 'horrific', 'spending', 'review', 'couple', 'days', 'ago', 'Sunak', 'laid', 'bare', 'weak', 'state', 'UKâs', 'finances', 'saying', 'Britain', 'set', 'borrow', 'almost', 'billion', 'pounds', 'billion', 'year', 'equivalent', 'GDP', 'highest', 'ever', 'peacetime', 'He', 'added', 'British', 'economy', 'set', 'contract', 'largest', 'fall', 'years', 'Yet', 'despite', 'sterling', 'remains', 'relatively', 'strong', 'traders', 'continuing', 'expect', 'late', 'progress', 'Brexit', 'talks', 'UK', 'European', 'Union', 'EU', 'chief', 'negotiator', 'Michel', 'Barnier', 'traveling', 'London', 'late', 'Friday', 'two', 'sides', 'try', 'resolve', 'differences', 'fishing', 'competition', 'policy', 'âœOnce', 'makeorbreak', 'moment', 'sterling', 'asymmetrical', 'downside', 'risks', 'case', 'deal', 'looks', 'around', 'corner', 'timing', 'remains', 'big', 'question', 'markâ', 'said', 'analysts', 'ING', 'research', 'note', 'Oil', 'mixed', 'OPEC', 'meeting', 'seen', 'key', 'Crude', 'oil', 'prices', 'traded', 'mixed', 'Friday', 'still', 'close', 'postpandemic', 'highs', 'attention', 'turns', 'next', 'weekâs', 'crucial', 'meeting', 'OPEC', 'By', 'AM', 'ET', 'GMT', 'futures', 'barrel', 'futures', 'Reuters', 'reported', 'Friday', 'leading', 'oil', 'producing', 'countries', 'group', 'known', 'OPEC', 'hold', 'informal', 'online', 'talks', 'Saturday', 'prior', 'next', 'weekâs', 'key', 'meetings', 'The', 'group', 'come', 'pressure', 'maintain', 'current', 'level', 'oil', 'production', 'given', 'sluggish', 'oil', 'demand', 'fallout', 'coronavirus', 'pandemic', 'OPEC', 'previously', 'agreed', 'increase', 'output', 'million', 'barrels', 'day', 'January', 'part', 'steady', 'easing', 'record', 'supply', 'cuts', 'oil', 'prices', 'rose', 'However', 'decision', 'extend', 'current', 'production', 'levels', 'means', 'certain', 'number', 'countries', 'within', 'cartel', 'seeking', 'maximise', 'revenue', 'increasing', 'production', 'levels'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'GFSl', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'PETSP', 'Add', 'toRemove', 'Portfolio', 'VCP', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'GROW', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'Lloyds', 'LLoyds', 'Banking', 'Group', 'said', 'Charlie', 'Nunn', 'currently', 'head', 'wealth', 'personal', 'banking', 'HSBC', 'Frasers', 'Mike', 'Ashley', 'Frasers', 'Group', 'Philip', 'Green', 'Arcadia', 'fashion', 'group', 'brink', 'falling', 'administration', 'Pets', 'Home', 'Pets', 'Home', 'Group', 'Plc', 'said', 'The', 'Vet', 'Connection', 'million', 'pounds', 'million', 'looks', 'expand', 'digital', 'offerings', 'pandemic', 'Canadian', 'security', 'firm', 'Gardaworld', 'said', 'extended', 'cash', 'offer', 'larger', 'rival', 'repeatedly', 'rejected', 'hostile', 'bid', 'valuing', 'British', 'company', 'billion', 'pounds', 'billion', 'Indivior', 'British', 'drugmaker', 'Indivior', 'Plc', 'said', 'would', 'vigorously', 'defend', 'billion', 'pound', 'billion', 'legal', 'claim', 'consumer', 'good', 'maker', 'Reckitt', 'Benckiser', 'Group', 'relating', 'demerger', 'agreement', 'Rio', 'Tinto', 'Rio', 'Tinto', 'look', 'handful', 'external', 'candidates', 'narrowing', 'field', 'miner', 'tries', 'win', 'back', 'investors', 'dismayed', 'blasting', 'ancient', 'Australian', 'rock', 'shelter', 'bankers', 'investors', 'say', 'AstraZeneca', 'The', 'Indian', 'Council', 'Medical', 'Research', 'ICMR', 'assisting', 'inquiry', 'alleged', 'adverse', 'reaction', 'AstraZeneca', 'vaccine', 'trial', 'found', 'reason', 'recommend', 'halting', 'senior', 'official', 'regulator', 'said', 'Sunday', 'HSBC', 'HSBC', 'Holdings', 'Plc', 'considering', 'narrowing', 'options', 'improve', 'performance', 'struggling', 'North', 'America', 'business', 'Financial', 'Times', 'reported', 'Saturday', 'Gold', 'slipped', 'track', 'worst', 'month', 'four', 'years', 'optimism', 'coronavirus', 'vaccineled', 'economic', 'rebound', 'propelled', 'equities', 'record', 'highs', 'dulled', 'metal', 'safehaven', 'appeal', 'Oil', 'prices', 'fell', 'amid', 'investor', 'jitters', 'ahead', 'meeting', 'producer', 'group', 'OPEC', 'decide', 'whether', 'extend', 'large', 'output', 'cuts', 'balance', 'global', 'markets', 'vaccine', 'hopes', 'helped', 'keep', 'track', 'rise', 'fifth', 'November', 'The', 'UK', 'bluechip', 'index', 'rose', 'slightly', 'Friday', 'marked', 'first', 'weekly', 'loss', 'month', 'frictions', 'Brexit', 'process', 'gloomy', 'economic', 'outlook', 'due', 'coronavirus', 'weighed', 'sentiment', 'UK', 'corporate', 'diary', 'HY', 'earnings', 'HY', 'earnings'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'IAG', 'Airlines', 'group', 'IAG', 'named', 'Aer', 'Lingus', 'boss', 'Sean', 'Doyle', 'replacing', 'Alex', 'Cruz', 'top', 'job', 'one', 'number', 'management', 'changes', 'announced', 'IAG', 'new', 'chief', 'executive', 'month', 'job', 'Bank', 'England', 'The', 'Bank', 'England', 'asked', 'banks', 'Monday', 'information', 'readiness', 'following', 'announcement', 'last', 'month', 'considering', 'take', 'rates', 'zero', 'needed', 'Shell', 'Royal', 'Dutch', 'Shell', 'Plc', 'Saturday', 'said', 'mobile', 'drilling', 'units', 'returning', 'Gulf', 'Mexico', 'restart', 'operations', 'Hurricane', 'Delta', 'AstraZeneca', 'The', 'US', 'government', 'AstraZeneca', 'Plc', 'develop', 'secure', 'supplies', 'doses', 'antibody', 'treatment', 'similar', 'class', 'drug', 'used', 'treating', 'President', 'Donald', 'Trump', 'Marks', 'Spencer', 'British', 'retailer', 'Marks', 'Spencer', 'seeking', 'avoid', 'repeat', 'last', 'Christmas', 'performance', 'ruined', 'excessive', 'food', 'waste', 'rolling', 'supply', 'chain', 'programme', 'says', 'crack', 'problem', 'Oil', 'prices', 'dropped', 'second', 'straight', 'session', 'Monday', 'US', 'producers', 'began', 'restoring', 'output', 'Hurricane', 'Delta', 'weakened', 'strike', 'affected', 'production', 'Norway', 'came', 'end', 'Gold', 'fell', 'back', 'threeweek', 'high', 'Monday', 'dollar', 'firmed', 'although', 'hopes', 'new', 'US', 'coronavirus', 'aid', 'package', 'checked', 'precious', 'metal', 'losses', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'new', 'jobs', 'support', 'plan', 'advancements', 'Brexit', 'talks', 'eclipsed', 'worries', 'fresh', 'surge', 'cases'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'FILE', 'PHOTO', 'Vials', 'medical', 'syringe', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'BENGALURU', 'Reuters', 'Serum', 'Institute', 'India', 'world', 'largest', 'vaccine', 'producer', 'said', 'Thursday', 'made', 'million', 'doses', 'AstraZeneca', 'potential', 'vaccine', 'would', 'soon', 'begin', 'making', 'Novavax', 'rival', 'shot', 'seek', 'regulatory', 'approval', 'Serum', 'said', 'enrolled', 'participants', 'India', 'latestage', 'trials', 'AstraZeneca', 'L', 'candidate', 'also', 'plan', 'seek', 'regulatory', 'approval', 'run', 'latestage', 'trials', 'Novavax', 'O', 'vaccine', 'The', 'AstraZeneca', 'vaccine', 'codeveloped', 'Oxford', 'University', 'advanced', 'human', 'testing', 'India', 'Serum', 'said', 'adding', 'company', 'Indian', 'Council', 'Medical', 'Research', 'ICMR', 'pursue', 'early', 'availability', 'shot', 'India', 'Representatives', 'Serum', 'ICMR', 'declined', 'comment', 'whether', 'million', 'doses', 'AstraZeneca', 'vaccine', 'meant', 'supply', 'India', 'The', 'ICMR', 'federal', 'government', 'body', 'funded', 'clinical', 'trial', 'site', 'fees', 'AstraZeneca', 'vaccine', 'Serum', 'said', 'The', 'company', 'ICMR', 'currently', 'conducting', 'midstage', 'clinical', 'trials', 'shot', 'centres', 'across', 'India', 'The', 'news', 'came', 'coronavirus', 'infections', 'India', 'world', 'secondworst', 'hit', 'country', 'reached', 'million', 'Thursday', 'death', 'toll', 'increased', 'India', 'also', 'least', 'two', 'homegrown', 'vaccine', 'candidates', 'development', 'local', 'drugmaker', 'Dr', 'Reddy', 'Labs', 'NS', 'carrying', 'trial', 'country', 'Russia', 'vaccine', 'candidate', 'Earlier', 'week', 'Pfizer', 'N', 'partner', 'BioNTech', 'DE', 'said', 'vaccine', 'candidate', 'proven', 'effective', 'based', 'initial', 'trial', 'results', 'Pfizer', 'said', 'committed', 'advancing', 'engagement', 'India', 'government', 'supply', 'potential', 'vaccine', 'country', 'Â', 'Reuters', 'Reuters', 'journalist', 'Steve', 'Stecklow', 'participates', 'clinical', 'trial', 'experimental', 'Novavax', 'vaccine', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'By', 'Steve', 'Stecklow', 'LONDON', 'Reuters', 'So', 'I', 'volunteer', 'injected', 'experimental', 'vaccine', 'That', 'friends', 'wanted', 'know', 'I', 'told', 'I', 'Who', 'knows', 'long', 'term', 'texted', 'former', 'college', 'roommate', 'Seems', 'like', 'gamble', 'It', 'began', 'July', 'British', 'government', 'announced', 'seeking', 'lots', 'volunteers', 'largescale', 'clinical', 'trials', 'new', 'vaccines', 'Only', 'month', 'good', 'friend', 'mine', 'died', 'spending', 'weeks', 'ventilator', 'Curious', 'I', 'completed', 'online', 'form', 'figuring', 'I', 'committing', 'anything', 'In', 'late', 'September', 'email', 'informed', 'I', 'among', 'pioneers', 'fight', 'enlisted', 'cause', 'On', 'Oct', 'I', 'invited', 'apply', 'trial', 'vaccine', 'made', 'American', 'biotech', 'company', 'called', 'Novavax', 'Inc', 'O', 'It', 'seeking', 'time', 'volunteers', 'United', 'Kingdom', 'latestage', 'trial', 'determine', 'vaccine', 'safety', 'effectiveness', 'If', 'aged', 'good', 'health', 'could', 'eligible', 'participate', 'email', 'stated', 'The', 'study', 'involves', 'six', 'visits', 'period', 'around', 'months', 'Reasonable', 'travel', 'expenses', 'reimbursed', 'Now', 'time', 'decide', 'I', 'began', 'researching', 'Novavax', 'vaccine', 'received', 'less', 'attention', 'several', 'others', 'On', 'Monday', 'Pfizer', 'Inc', 'N', 'announced', 'vaccine', 'candidate', 'appeared', 'effective', 'In', 'September', 'latestage', 'trials', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'Plc', 'L', 'halted', 'report', 'serious', 'neurological', 'illness', 'volunteer', 'although', 'trials', 'later', 'permitted', 'resume', 'To', 'Novavax', 'vaccine', 'seemed', 'less', 'risky', 'Although', 'Marylandbased', 'company', 'never', 'received', 'approval', 'vaccine', 'employing', 'technology', 'create', 'candidate', 'used', 'promising', 'flu', 'shot', 'I', 'gotten', 'inoculated', 'flu', 'every', 'year', 'decades', 'never', 'adverse', 'reaction', 'The', 'published', 'results', 'first', 'phase', 'testing', 'Novavax', 'vaccine', 'also', 'showed', 'serious', 'side', 'effects', 'among', 'participants', 'injected', 'The', 'worst', 'case', 'someone', 'mild', 'fever', 'day', 'I', 'decided', 'go', 'I', 'figured', 'life', 'ever', 'going', 'return', 'normal', 'world', 'going', 'need', 'vaccines', 'volunteers', 'see', 'work', 'On', 'selfish', 'level', 'I', 'liked', 'idea', 'getting', 'inoculated', 'soon', 'possible', 'given', 'monotonous', 'â', 'sometimes', 'scary', 'â', 'daily', 'routine', 'become', 'I', 'become', 'riskaverse', 'wife', 'called', 'jailer', 'Another', 'attraction', 'If', 'I', 'catch', 'virus', 'researchers', 'would', 'carefully', 'monitor', 'In', 'UK', 'surge', 'new', 'cases', 'day', 'infected', 'people', 'essentially', 'unless', 'require', 'emergency', 'care', 'Of', 'course', 'chance', 'I', 'would', 'injected', 'placebo', 'â', 'saline', 'solution', 'â', 'would', 'protect', 'anything', 'In', 'testing', 'vaccines', 'placebos', 'used', 'control', 'see', 'whether', 'real', 'thing', 'effective', 'fending', 'virus', 'And', 'online', 'overthephone', 'screening', 'determine', 'I', 'medical', 'conditions', 'disqualified', 'study', 'I', 'given', 'appointment', 'first', 'two', 'injections', 'I', 'showed', 'one', 'recent', 'morning', 'clinical', 'research', 'facility', 'King', 'College', 'Hospital', 'south', 'London', 'â', 'small', 'drab', 'building', 'part', 'sprawling', 'medical', 'complex', 'To', 'surprise', 'receptionist', 'asked', 'take', 'Churchill', 'Pro', 'bike', 'mask', 'â', 'costs', 'uses', 'British', 'Military', 'Filtration', 'Technology', 'block', 'almost', 'viruses', 'â', 'replace', 'cheap', 'disposable', 'one', 'I', 'later', 'learned', 'superduper', 'mask', 'potentially', 'could', 'contaminated', 'Several', 'volunteers', 'already', 'large', 'room', 'getting', 'set', 'I', 'met', 'privately', 'doctor', 'asked', 'I', 'questions', 'I', 'What', 'Novavax', 'vaccine', 'proved', 'successful', 'trial', 'stopped', 'Would', 'I', 'told', 'whether', 'I', 'received', 'placebo', 'given', 'real', 'vaccine', 'The', 'doctor', 'told', 'I', 'gotten', 'placebo', 'I', 'would', 'wait', 'year', 'since', 'researchers', 'would', 'want', 'keep', 'monitoring', 'every', 'trial', 'participant', 'Not', 'I', 'wanted', 'hear', 'What', 'another', 'vaccine', 'approved', 'first', 'I', 'given', 'placebo', 'Would', 'I', 'allowed', 'take', 'The', 'doctor', 'suggested', 'possible', 'After', 'I', 'signed', 'consent', 'form', 'participate', 'trial', 'gave', 'brief', 'physical', 'exam', 'Back', 'large', 'room', 'nurse', 'gave', 'test', 'sticking', 'long', 'swab', 'throat', 'nostril', 'Then', 'prepared', 'draw', 'blood', 'I', 'warned', 'veins', 'thin', 'often', 'proved', 'problematic', 'He', 'proceeded', 'fail', 'twice', 'calling', 'colleague', 'better', 'luck', 'The', 'injection', 'uneventful', 'But', 'nurse', 'checked', 'blood', 'pressure', 'afterward', 'spiked', 'He', 'asked', 'wait', 'minutes', 'basically', 'calm', 'I', 'thought', 'meditation', 'exercises', 'I', 'always', 'scoffed', 'recently', 'tried', 'reduce', 'pandemicinduced', 'anxiety', 'â', 'breathe', 'breathe', 'It', 'worked', 'So', 'far', 'I', 'experienced', 'side', 'effects', 'awaiting', 'second', 'injection', 'three', 'weeks', 'passed', 'Curious', 'experience', 'I', 'spoke', 'James', 'Galloway', 'senior', 'clinical', 'lecturer', 'King', 'College', 'doctor', 'responsible', 'trial', 'He', 'told', 'decisions', 'made', 'volunteers', 'received', 'placebo', 'Novavax', 'shown', 'effective', 'another', 'vaccine', 'approved', 'first', 'He', 'later', 'added', 'If', 'get', 'another', 'vaccine', 'works', 'want', 'people', 'get', 'vaccine', 'placebo', 'We', 'want', 'anyone', 'suffer', 'participating', 'study', 'said', 'A', 'spokeswoman', 'Novavax', 'later', 'told', 'volunteers', 'would', 'discuss', 'options', 'clinicians', 'overseeing', 'trial', 'sites', 'Galloway', 'said', 'theoretical', 'risk', 'someone', 'got', 'Novavax', 'vaccine', 'injected', 'different', 'one', 'There', 'chance', 'reaction', 'He', 'know', 'UK', 'Novavax', 'trial', 'going', 'far', 'access', 'data', 'But', 'overall', 'remains', 'optimistic', 'effective', 'vaccines', 'arrive', 'As', 'happens', 'doctor', 'contracted', 'last', 'spring', 'He', 'said', 'fever', 'days', 'briefly', 'hospitalized', 'developing', 'heart', 'rhythm', 'problem', 'I', 'would', 'wish', 'anyone', 'said', 'reporting', 'Steve', 'Stecklow', 'editing', 'Janet', 'McBride'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Next', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Ocado', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Persimmon', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Centrica', 'PLC', 'LON', 'declined', 'points', 'end', 'Royal', 'Dutch', 'Shell', 'PLC', 'Class', 'A', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'ahead', 'cash', 'market', 'open', 'Monday', 'Royal', 'Dutch', 'Shell', 'said', 'value', 'oil', 'gas', 'assets', 'latest', 'string', 'impairments', 'year', 'adjusts', 'weaker', 'outlook', 'Vodafone', 'Vodafone', 'ended', 'talks', 'Saudi', 'Telecom', 'Company', 'sale', 'shareholding', 'Vodafone', 'Egypt', 'British', 'telecoms', 'group', 'said', 'Frasers', 'Mike', 'Ashley', 'Frasers', 'Group', 'sportswear', 'retailer', 'forced', 'shut', 'stores', 'London', 'South', 'East', 'East', 'England', 'fastspreading', 'new', 'strain', 'coronavirus', 'called', 'tougher', 'curbs', 'AstraZeneca', 'AstraZeneca', 'said', 'US', 'medicines', 'regulator', 'approved', 'British', 'drugmaker', 'lung', 'cancer', 'therapy', 'Tagrisso', 'treat', 'another', 'type', 'tumour', 'lungs', 'diagnosed', 'early', 'stage', 'Boohoo', 'British', 'online', 'fashion', 'retailer', 'Boohoo', 'Group', 'Plc', 'said', 'board', 'appointing', 'PKF', 'Littlejohn', 'group', 'auditor', 'immediate', 'effect', 'replacing', 'PwC', 'role', 'around', 'seven', 'years', 'Gold', 'climbed', 'sixweek', 'high', 'driven', 'news', 'US', 'congressional', 'leaders', 'aid', 'package', 'lockdowns', 'United', 'Kingdom', 'soured', 'appetite', 'riskier', 'assets', 'added', 'metal', 'support', 'Oil', 'prices', 'dropped', 'fastspreading', 'new', 'coronavirus', 'strain', 'shut', 'much', 'United', 'Kingdom', 'fuelled', 'worries', 'slower', 'recovery', 'fuel', 'demand', 'amid', 'tighter', 'restrictions', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'US', 'stocks', 'dipped', 'cooling', 'fiscal', 'stimulusled', 'rally', 'GBP', 'The', 'domestically', 'focused', 'FTSE', 'considered', 'barometer', 'Brexit', 'sentiment', 'dropped', 'finished', 'last', 'full', 'week', 'year', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'Monday', 'AstraZeneca', 'Malaysia', 'said', 'Saturday', 'secured', 'coronavirus', 'vaccine', 'AstraZeneca', 'Plc', 'heels', 'news', 'receive', 'PfizerBioNTech', 'vaccine', 'February', 'grapples', 'surge', 'infections', 'Royal', 'Dutch', 'Shell', 'Shell', 'said', 'sell', 'stake', 'Queensland', 'Curtis', 'LNG', 'QCLNG', 'facilities', 'Global', 'Infrastructure', 'Partners', 'Australia', 'billion', 'helping', 'oil', 'major', 'meet', 'annual', 'target', 'divestments', 'Royal', 'Mail', 'Royal', 'Mail', 'Plc', 'said', 'Friday', 'reached', 'inprinciple', 'agreement', 'largest', 'labour', 'union', 'Communication', 'Workers', 'Union', 'CWU', 'company', 'strategy', 'operational', 'change', 'pay', 'Metro', 'Banks', 'Britain', 'Metro', 'Bank', 'Plc', 'said', 'Friday', 'owneroccupied', 'residential', 'mortgages', 'NatWest', 'Group', 'Plc', 'billion', 'pounds', 'billion', 'looks', 'boost', 'capital', 'levels', 'hit', 'pandemic', 'Gold', 'climbed', 'sixweek', 'high', 'driven', 'news', 'US', 'congressional', 'leaders', 'aid', 'package', 'lockdowns', 'United', 'Kingdom', 'soured', 'appetite', 'riskier', 'assets', 'added', 'metal', 'support', 'Oil', 'prices', 'dropped', 'fastspreading', 'new', 'coronavirus', 'strain', 'shut', 'much', 'United', 'Kingdom', 'fuelled', 'worries', 'slower', 'recovery', 'fuel', 'demand', 'amid', 'tighter', 'restrictions', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'US', 'stocks', 'dipped', 'cooling', 'fiscal', 'stimulusled', 'rally', 'GBP', 'The', 'domestically', 'focused', 'FTSE', 'considered', 'barometer', 'Brexit', 'sentiment', 'dropped', 'finished', 'last', 'full', 'week', 'year'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AIR', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AMGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'BX', 'Add', 'toRemove', 'Portfolio', 'APGNA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'ahead', 'cash', 'market', 'open', 'Tuesday', 'Vodafone', 'Vodafone', 'Group', 'buy', 'remaining', 'shares', 'Kabel', 'Deutschland', 'Holding', 'already', 'deal', 'aimed', 'capping', 'remaining', 'risks', 'longrunning', 'legal', 'battle', 'takeover', 'company', 'Applegreen', 'Applegreen', 'said', 'bought', 'consortium', 'led', 'BJ', 'Holdings', 'Blackstone', 'NYSE', 'Infrastructure', 'Partners', 'deal', 'values', 'Irish', 'gas', 'station', 'operator', 'around', 'million', 'euros', 'AstraZeneca', 'Drugmakers', 'AstraZeneca', 'Amgen', 'said', 'experimental', 'asthma', 'drug', 'tezepelumab', 'failed', 'meet', 'main', 'goal', 'reducing', 'patients', 'dependence', 'steroids', 'keeping', 'condition', 'check', 'latestage', 'trial', 'EasyJet', 'British', 'airline', 'easyJet', 'whose', 'finances', 'come', 'severe', 'pressure', 'pandemic', 'agreed', 'Airbus', 'company', 'said', 'Economy', 'Britain', 'economic', 'recovery', 'coronavirus', 'crash', 'previously', 'thought', 'JulySeptember', 'period', 'according', 'official', 'data', 'also', 'showed', 'government', 'borrowing', 'soaring', 'pay', 'coronavirus', 'crisis', 'Gold', 'prices', 'fell', 'support', 'US', 'Congress', 'passing', 'longawaited', 'near', 'billion', 'coronavirus', 'aid', 'countered', 'stronger', 'dollar', 'profittaking', 'also', 'weighed', 'sentiment', 'Oil', 'prices', 'dropped', 'nearly', 'adding', 'steep', 'losses', 'previous', 'session', 'new', 'strain', 'novel', 'coronavirus', 'United', 'Kingdom', 'triggered', 'concerns', 'fuel', 'demand', 'recovery', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'several', 'nations', 'closed', 'borders', 'Britain', 'UK', 'midcap', 'stocks', 'suffered', 'worst', 'day', 'months', 'Monday', 'stricter', 'curbs', 'fight', 'fastspreading', 'new', 'strain', 'coronavirus', 'prompted', 'travel', 'bans', 'worries', 'food', 'shortages', 'economic', 'pain', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Britain', 'FTSE', 'futures', 'index', 'Tuesday', 'Tesco', 'British', 'supermarket', 'group', 'Tesco', 'warned', 'Monday', 'may', 'shortage', 'fruit', 'vegetables', 'later', 'week', 'transport', 'ties', 'quickly', 'restored', 'mainland', 'Europe', 'Royal', 'Mail', 'Royal', 'Mail', 'halted', 'deliveries', 'several', 'countries', 'result', 'port', 'closures', 'travel', 'tie', 'cuts', 'Britain', 'following', 'new', 'faster', 'spreading', 'strain', 'coronavirus', 'company', 'website', 'showed', 'Monday', 'AstraZeneca', 'Malaysia', 'signed', 'deal', 'procure', 'million', 'doses', 'AstraZeneca', 'coronavirus', 'vaccine', 'final', 'talks', 'Chinese', 'Russian', 'manufacturers', 'secure', 'said', 'Prime', 'Minister', 'Muhyiddin', 'Yassin', 'Centrica', 'Members', 'Britain', 'GMB', 'union', 'five', 'days', 'January', 'Centrica', 'Plc', 'British', 'Gas', 'company', 'refusal', 'remove', 'fire', 'rehire', 'threats', 'union', 'said', 'Monday', 'Brexit', 'The', 'European', 'Union', 'considering', 'new', 'proposal', 'fishing', 'rights', 'United', 'Kingdom', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'tries', 'secure', 'trade', 'deal', 'Bloomberg', 'news', 'reported', 'Monday', 'Gold', 'prices', 'gained', 'US', 'coronavirus', 'aid', 'package', 'set', 'Senate', 'approval', 'boosted', 'metal', 'appeal', 'inflation', 'hedge', 'new', 'coronavirus', 'strain', 'shutting', 'much', 'Britain', 'lent', 'support', 'Oil', 'prices', 'dropped', 'adding', 'steep', 'losses', 'previous', 'session', 'new', 'strain', 'novel', 'coronavirus', 'United', 'Kingdom', 'triggered', 'concerns', 'fuel', 'demand', 'recovery', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'several', 'nations', 'closed', 'borders', 'Britain', 'UK', 'midcap', 'stocks', 'suffered', 'worst', 'day', 'months', 'Monday', 'stricter', 'curbs', 'fight', 'fastspreading', 'new', 'strain', 'coronavirus', 'prompted', 'travel', 'bans', 'worries', 'food', 'shortages', 'economic', 'pain'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'EasyJet', 'PLC', 'LON', 'added', 'points', 'end', 'NatWest', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Reckitt', 'Benckiser', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Rentokil', 'Initial', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'ETHUSD', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Senate', 'Leader', 'Mitch', 'McConnell', 'thwarts', 'Donald', 'Trumpâs', 'plan', 'higher', 'stimulus', 'payments', 'UK', 'approves', 'AstraZenecaOxford', 'University', 'vaccine', 'reaches', 'another', 'alltime', 'high', 'Hereâs', 'need', 'know', 'financial', 'markets', 'Wednesday', 'December', 'McConnell', 'defies', 'Trumpâs', 'stimulus', 'call', 'President', 'Donald', 'Trumpâs', 'efforts', 'increase', 'part', 'recent', 'billion', 'stimulus', 'package', 'paid', 'directly', 'households', 'ran', 'sand', 'Senate', 'Majority', 'Leader', 'Mitch', 'McConnell', 'refused', 'schedule', 'quick', 'vote', 'motion', 'passed', 'House', 'Representatives', 'earlier', 'week', 'McConnell', 'combined', 'initiative', 'new', 'bill', 'would', 'combine', 'increased', 'payments', 'provisions', 'House', 'Democrats', 'sure', 'reject', 'repeal', 'Section', 'Communications', 'Decency', 'Act', 'gives', 'social', 'media', 'platforms', 'protection', 'legal', 'liability', 'content', 'posted', 'users', 'commission', 'look', 'Trumpâs', 'claims', 'election', 'fraud', 'thrown', 'courts', 'across', 'US', 'far', 'As', 'level', 'direct', 'payments', 'likely', 'stay', 'rather', 'demanded', 'Trump', 'approved', 'House', 'AstraZeneca', 'vaccine', 'gets', 'first', 'approval', 'The', 'UKâs', 'Medicines', 'Healthcare', 'Products', 'Regulatory', 'Agency', 'approved', 'use', 'vaccine', 'developed', 'AstraZeneca', 'LON', 'University', 'Oxford', 'Itâs', 'first', 'formal', 'approval', 'vaccine', 'appears', 'slightly', 'less', 'effective', 'disease', 'developed', 'PfizerBioNTech', 'Moderna', 'NASDAQ', 'set', 'play', 'much', 'broader', 'role', 'immunizing', 'worldâs', 'population', 'given', 'company', 'selling', 'cost', 'pandemic', 'continues', 'stored', 'normal', 'refrigeration', 'temperatures', 'easing', 'challenge', 'mass', 'distribution', 'The', 'move', 'comes', 'UK', 'hospitals', 'starting', 'run', 'capacity', 'patients', 'Germany', 'meanwhile', 'registered', 'deaths', 'single', 'day', 'first', 'time', 'Stocks', 'set', 'rebound', 'US', 'stock', 'markets', 'set', 'open', 'higher', 'modest', 'setback', 'late', 'Tuesday', 'response', 'Senate', 'Leader', 'McConnellâs', 'effective', 'blocking', 'higher', 'stimulus', 'payments', 'By', 'AM', 'ET', 'GMT', 'points', 'also', 'Corporate', 'newsflow', 'remains', 'trickle', 'US', 'data', 'shape', 'AM', 'ET', 'Novemberâs', 'figures', 'AM', 'Digital', 'currencies', 'set', 'fresh', 'highs', 'Bitcoin', 'continued', 'triumphant', 'march', 'higher', 'topping', 'first', 'time', 'background', 'fading', 'trust', 'dollar', 'whose', 'longterm', 'debasement', 'USâs', 'enduring', 'current', 'account', 'budget', 'deficits', 'set', 'accelerate', 'By', 'AM', 'ET', 'trading', 'day', 'earlier', 'traded', 'high', 'The', 'fundamentals', 'digital', 'asset', 'remain', 'country', 'accept', 'taxes', 'paid', 'merchants', 'overwhelmingly', 'refuse', 'set', 'prices', 'something', 'volatile', 'price', 'However', 'lack', 'practical', 'applications', 'overshadowed', 'everbroader', 'willingness', 'part', 'institutional', 'money', 'managers', 'speculate', 'reassured', 'prospect', 'Bitcoin', 'supply', 'remaining', 'essentially', 'fixed', 'Bitcoin', 'isnât', 'digital', 'asset', 'currently', 'enjoying', 'rallied', 'fivefold', 'year', 'although', 'essentially', 'flat', 'Wednesday', 'Last', 'US', 'oil', 'inventories', 'year', 'The', 'price', 'crude', 'oil', 'lots', 'practical', 'applications', 'rebounded', 'modestly', 'overnight', 'supported', 'American', 'Petroleum', 'Industry', 'data', 'showing', 'unexpectedly', 'large', 'drop', 'US', 'crude', 'The', 'US', 'governmentâs', 'data', 'due', 'AM', 'ET', 'usual', 'Analysts', 'warn', 'reading', 'much', 'last', 'weekly', 'data', 'year', 'tend', 'distorted', 'accounting', 'tax', 'issues', 'By', 'AM', 'barrel', 'futures', 'barrel'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'Thursday', 'ALDI', 'Britain', 'fifthbiggest', 'supermarket', 'Aldi', 'Wednesday', 'said', 'plans', 'increase', 'amount', 'food', 'drink', 'buys', 'British', 'suppliers', 'billion', 'pounds', 'billion', 'within', 'next', 'five', 'years', 'company', 'continues', 'rapid', 'expansion', 'across', 'United', 'Kingdom', 'The', 'EU', 'drug', 'watchdog', 'looking', 'people', 'given', 'second', 'dose', 'AstraZeneca', 'Oxford', 'University', 'vaccine', 'rather', 'size', 'first', 'dose', 'part', 'review', 'shot', 'source', 'agency', 'said', 'Wednesday', 'BREXIT', 'The', 'United', 'Kingdom', 'exits', 'European', 'Union', 'orbit', 'Thursday', 'turning', 'back', 'tempestuous', 'liaison', 'European', 'project', 'uncertain', 'Brexit', 'future', 'shape', 'fortunes', 'people', 'generations', 'come', 'OIL', 'Global', 'markets', 'lost', 'fifth', 'value', 'strict', 'coronavirus', 'lockdowns', 'paralysed', 'much', 'global', 'economy', 'prices', 'rebounded', 'strongly', 'lows', 'governments', 'rolled', 'stimulus', 'GOLD', 'Gold', 'prices', 'fell', 'Thursday', 'hopes', 'economic', 'recovery', 'next', 'year', 'increased', 'risk', 'appetite', 'although', 'precious', 'metal', 'set', 'wrap', 'year', 'best', 'performance', 'decade', 'The', 'UK', 'bluechip', 'index', 'lost', 'Wednesday', 'reversing', 'early', 'gains', 'fears', 'fastspreading', 'new', 'strain', 'coronavirus', 'led', 'country', 'placed', 'tighter', 'restrictions', 'even', 'Britain', 'approved', 'AstraZeneca', 'vaccine'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'Wisniewski', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'said', 'Monday', 'transfer', 'global', 'rights', 'respiratory', 'medicines', 'Eklira', 'Duaklir', 'Covis', 'Pharma', 'Group', 'million', 'AngloSwedish', 'drugmaker', 'looks', 'offload', 'older', 'portfolio', 'medicines', 'The', 'Londonlisted', 'company', 'also', 'said', 'deal', 'expected', 'close', 'fourth', 'quarter', 'Covis', 'also', 'cover', 'certain', 'ongoing', 'development', 'costs', 'related', 'medicines', 'AstraZeneca', 'NASDAQ', 'several', 'new', 'medicines', 'pharmaceutical', 'pipeline', 'including', 'drugs', 'vaccine', 'expects', 'agreement', 'help', 'sharpen', 'focus', 'priority', 'medicines', 'respiratory', 'immunology', 'portfolio', 'Covis', 'previously', 'acquired', 'rights', 'respiratory', 'medicines', 'Alvesco', 'Omnaris', 'Zetonna', 'AstraZeneca', 'Eklira', 'Duaklir', 'used', 'treat', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'smokers', 'lung', 'generated', 'revenues', 'million', 'AstraZeneca', 'geographies', 'covered', 'previous', 'deal', 'drugmaker', 'bought', 'rights'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'It', 'possible', 'get', 'extra', 'dose', 'vials', 'AstraZeneca', 'PLC', 'LON', 'vaccine', 'well', 'one', 'made', 'Pfizer', 'NYSE', 'head', 'immunisation', 'Public', 'Health', 'England', 'PHE', 'said', 'Wednesday', 'In', 'December', 'health', 'service', 'gave', 'doctors', 'advice', 'could', 'use', 'extra', 'doses', 'Pfizer', 'vaccine', 'discretion', 'could', 'extracted', 'Wednesday', 'Dr', 'Mary', 'Ramsay', 'said', 'happening', 'AstraZeneca', 'shot', 'We', 'able', 'get', 'vaccine', 'vial', 'happened', 'Pfizer', 'vaccine', 'also', 'happening', 'AstraZeneca', 'vaccine', 'So', 'means', 'overall', 'got', 'vaccines', 'go', 'around', 'told', 'lawmakers', 'adding', 'PHE', 'bought', 'necessary', 'needles', 'start', 'Really', 'early', 'discovered', 'able', 'get', 'vials', 'excellent', 'news', 'Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WCKH', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'The', 'pound', 'reached', 'highest', 'level', 'US', 'dollar', 'since', 'April', 'Thursday', 'continuing', 'strong', 'run', 'last', 'two', 'weeks', 'hit', 'morning', 'trade', 'factors', 'play', 'On', 'Wednesday', 'Bank', 'England', 'Governor', 'Bailey', 'reiterated', 'stance', 'negative', 'interest', 'rates', 'âœWe', 'taken', 'decision', 'fact', 'weâve', 'actually', 'discussed', 'whether', 'introduce', 'negative', 'ratesâ', 'Bailey', 'said', 'adding', 'uncertain', 'much', 'would', 'help', 'economy', 'VACCINES', 'Further', 'supporting', 'pound', 'UKâs', 'rollout', 'vaccines', 'happened', 'quicker', 'pace', 'neighbouring', 'countries', 'The', 'UK', 'benefitted', 'rapid', 'approval', 'various', 'vaccines', 'supply', 'relatively', 'stable', 'There', 'fears', 'factory', 'producing', 'supplies', 'OxfordAstraZeneca', 'PLC', 'LON', 'vaccines', 'Wales', 'could', 'flood', 'due', 'Storm', 'Christoph', 'local', 'emergency', 'services', 'prevented', 'serious', 'disruption', 'Wockhardt', 'Ltd', 'NS', 'company', 'produces', 'vaccine', 'facility', 'confirmed', 'site', 'operating', 'normal', 'German', 'investment', 'bank', 'Berenberg', 'optimistic', 'UK', 'vaccination', 'programme', 'saying', 'country', 'maintain', 'average', 'pace', 'daily', 'vaccinations', 'past', 'week', 'UK', 'could', 'reach', 'vaccination', 'rate', 'June', 'year', 'figure', 'rate', 'infection', 'would', 'slow', 'UK', 'would', 'close', 'herd', 'immunity', 'Infection', 'rates', 'also', 'appear', 'slowing', 'albeit', 'snailâs', 'pace', 'Imperial', 'College', 'London', 'professor', 'Paul', 'Elliott', 'told', 'BBC', 'current', 'R', 'rate', 'around', 'We', 'seeing', 'levelling', 'going', 'seeing', 'decline', 'really', 'need', 'seeâ', 'Elliott', 'said', 'Meanwhile', 'number', 'people', 'testing', 'positive', 'virus', 'last', 'seven', 'days', 'week', 'BREXIT', 'Finally', 'avoidance', 'socalled', 'âœhard', 'Brexitâ', 'also', 'lifted', 'pound', 'After', 'agreement', 'reached', 'UK', 'EU', 'towards', 'tail', 'end', 'last', 'year', 'investors', 'certainty', 'trading', 'relationship', 'first', 'time', 'years', 'even', 'teething', 'problems', 'since', 'introduction', 'new', 'trading', 'arrangement', 'Todayâs', 'report', 'showed', 'large', 'number', 'manufacturers', 'worried', 'supply', 'chain', 'disruption', 'said', 'border', 'challenges', 'customsrelated', 'delays', 'arising', 'Brexit', 'appeared', 'playing', 'role'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'AstraZeneca', 'logo', 'reflected', 'drop', 'syringe', 'needle', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'A', 'plant', 'Wales', 'produces', 'AstraZeneca', 'PLC', 'LON', 'vaccine', 'partially', 'evacuated', 'suspicious', 'package', 'received', 'company', 'operates', 'said', 'Wednesday', 'Wockhardt', 'UK', 'Wrexham', 'morning', 'received', 'suspicious', 'package', 'site', 'All', 'relevant', 'authorities', 'immediately', 'notified', 'engaged', 'company', 'said', 'referring', 'facility', 'Wales', 'Upon', 'expert', 'advice', 'partially', 'evacuated', 'site', 'pending', 'full', 'investigation', 'The', 'safety', 'employees', 'business', 'continuity', 'remain', 'paramount', 'importance', 'Earlier', 'BBC', 'reported', 'police', 'bomb', 'disposal', 'unit', 'sent', 'plant', 'We', 'currently', 'dealing', 'ongoing', 'incident', 'Wrexham', 'Industrial', 'Estate', 'local', 'police', 'said', 'statement', 'adding', 'public', 'avoid', 'area', 'Wockhardt', 'UK', 'provides', 'fillandfinish', 'capacity', 'AstraZeneca', 'UK', 'supply', 'chain', 'final', 'manufacturing', 'step', 'putting', 'vaccines', 'vials', 'syringes', 'packaging', 'AstraZeneca', 'agreed', 'supply', 'Britain', 'million', 'doses', 'vaccine', 'developed', 'Oxford', 'University'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'recommended', 'granting', 'conditional', 'marketing', 'authorisation', 'AstraZeneca', 'PLC', 'LON', 'âs', 'vaccine', 'prevent', 'people', 'years', 'age', 'The', 'EMA', 'added', 'scientific', 'experts', 'considered', 'vaccine', 'used', 'older', 'adults', 'The', 'agencyâs', 'human', 'medicines', 'committee', 'CHMP', 'assessed', 'vaccine', 'said', 'meets', 'EU', 'standards', 'puts', 'place', 'safeguards', 'controls', 'obligations', 'underpin', 'EUwide', 'vaccination', 'campaigns', 'OLDER', 'POPULATION', 'There', 'concern', 'EU', 'would', 'recommend', 'vaccine', 'taken', 'age', 'âœThere', 'yet', 'enough', 'results', 'older', 'participants', 'years', 'old', 'provide', 'figure', 'well', 'vaccine', 'work', 'groupâ', 'EMA', 'said', 'statement', 'âœHowever', 'protection', 'expected', 'given', 'immune', 'response', 'seen', 'age', 'group', 'based', 'experience', 'vaccines', 'reliable', 'information', 'safety', 'population', 'EMAâs', 'scientific', 'experts', 'considered', 'vaccine', 'used', 'older', 'adultsâ', 'EFFICACY', 'The', 'agency', 'based', 'calculation', 'efficacy', 'vaccine', 'results', 'two', 'studies', 'study', 'based', 'UK', 'study', 'based', 'Brazil', 'The', 'two', 'studies', 'involved', 'clinical', 'trial', 'fewer', 'six', 'cases', 'enough', 'measure', 'preventative', 'effect', 'vaccine', 'âœThese', 'studies', 'showed', 'reduction', 'number', 'symptomatic', 'cases', 'people', 'given', 'vaccine', 'got', 'symptoms', 'compared', 'people', 'given', 'control', 'injections', 'got', 'symptomsâ', 'EMA', 'said', 'âœThis', 'means', 'vaccine', 'demonstrated', 'around', 'efficacy', 'clinical', 'trialsâ', 'GERMANY', 'The', 'previous', 'day', 'issued', 'draft', 'recommendation', 'used', 'The', 'Robert', 'Koch', 'Institute', 'â', 'Germanyâs', 'federal', 'public', 'health', 'agency', 'â', 'said', 'insufficient', 'data', 'ascertain', 'effective', 'vaccine', 'would', 'This', 'followed', 'story', 'Handelsblatt', 'earlier', 'week', 'suggested', 'vaccine', 'unsafe', 'saying', 'efficacy', 'A', 'statement', 'German', 'health', 'ministry', 'later', 'clarified', 'publication', 'mixed', 'efficacy', 'rate', 'number', 'trial', 'PRODUCTION', 'There', 'still', 'question', 'marks', 'production', 'supply', 'vaccine', 'EU', 'member', 'countries', 'The', 'EU', 'vocally', 'unhappy', 'AstraZeneca', 'alleging', 'reneged', 'contracts', 'supply', 'vaccine', 'However', 'AstraZeneca', 'came', 'fighting', 'saying', 'supply', 'problems', 'fault', 'EU', 'time', 'took', 'agree', 'contract', 'For', 'context', 'UK', 'agreed', 'contract', 'full', 'three', 'months', 'European', 'Union', 'AstraZeneca', 'say', 'teething', 'problems', 'related', 'production', 'ironed', 'early', 'part', 'process', 'The', 'drug', 'company', 'previously', 'said', 'would', 'cut', 'supplies', 'bloc', 'today', 'reportedly', 'offered', 'EU', 'million', 'doses', 'vaccine', 'quarter', 'AstraZeneca', 'CEO', 'Pascal', 'Soriot', 'previously', 'said', 'legal', 'obligations', 'deliver', 'precise', 'timescale', 'committed', 'supply', 'âœbesteffortâ', 'clause', 'The', 'European', 'Union', 'today', 'published', 'contract', 'order', 'transparent', 'allege', 'contained', 'âœbinding', 'ordersâ', 'However', 'large', 'sections', 'â', 'including', 'pricing', 'guaranteed', 'delivery', 'dates', 'â', 'blanked', 'redacted'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'BHP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'HSX', 'Add', 'toRemove', 'Portfolio', 'RYA', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Ryanair', 'Ireland', 'Ryanair', 'Holdings', 'PLC', 'key', 'summer', 'period', 'first', 'time', 'decades', 'warned', 'crisis', 'could', 'force', 'cuts', 'leave', 'capacity', 'next', 'summer', 'little', 'half', 'normal', 'levels', 'Hiscox', 'Insurer', 'Hiscox', 'said', 'catastrophe', 'claims', 'third', 'quarter', 'active', 'North', 'American', 'wind', 'season', 'record', 'another', 'significant', 'wildfire', 'season', 'California', 'Ocado', 'Ocado', 'British', 'online', 'supermarket', 'technology', 'group', 'would', 'total', 'million', 'Associated', 'British', 'Foods', 'Associated', 'British', 'Foods', 'owner', 'clothing', 'retailer', 'Primark', 'said', 'estimated', 'would', 'million', 'sales', 'temporary', 'closures', 'stores', 'major', 'markets', 'due', 'restrictions', 'GVC', 'Ladbrokes', 'LON', 'bwin', 'owner', 'GVC', 'warned', 'gambling', 'stores', 'remained', 'closed', 'November', 'Britain', 'latest', 'coronavirus', 'lockdown', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'Britain', 'health', 'regulator', 'potential', 'coronavirus', 'vaccine', 'UK', 'regulator', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'impose', 'England', 'Dec', 'said', 'ITV', 'LON', 'political', 'editor', 'BHP', 'BHP', 'Group', 'Ltd', 'world', 'biggest', 'listed', 'miner', 'said', 'submitted', 'letter', 'commitment', 'responsible', 'production', 'Copper', 'Mark', 'framework', 'launched', 'International', 'Copper', 'Association', 'April', 'last', 'year', 'EasyJet', 'EasyJet', 'considering', 'options', 'bolster', 'finances', 'state', 'support', 'help', 'airline', 'get', 'coronavirus', 'pandemic', 'said', 'chief', 'executive', 'Johan', 'Lundgren', 'Gold', 'ticked', 'higher', 'caution', 'crept', 'ahead', 'Tuesday', 'hotly', 'contested', 'US', 'presidential', 'elections', 'sparking', 'bids', 'safehaven', 'metal', 'though', 'resilient', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'fell', 'worries', 'swathe', 'coronavirus', 'lockdowns', 'across', 'Europe', 'weaken', 'fuel', 'demand', 'traders', 'braced', 'turbulence', 'US', 'week', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'logging', 'biggest', 'monthly', 'drop', 'since', 'brutal', 'selloff', 'March', 'new', 'wave', 'regional', 'restrictions', 'threatened', 'nascent', 'economic', 'recovery', 'Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BNZL', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Bunzl', 'PLC', 'LON', 'added', 'points', 'end', 'Rentokil', 'Initial', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Standard', 'Chartered', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Flutter', 'Entertainment', 'PLC', 'LON', 'declined', 'points', 'end', 'Antofagasta', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'FERG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'TUIT', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Tui', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'Carnival', 'PLC', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Ferguson', 'Plc', 'LON', 'declined', 'points', 'end', 'RSA', 'Insurance', 'Group', 'PLC', 'LON', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'GBP', 'continues', 'strengthen', 'breaking', 'back', 'EURGBP', 'falling', 'lowest', 'level', 'since', 'April', 'last', 'year', 'The', 'pound', 'one', 'better', 'performing', 'currencies', 'UK', 'pushes', 'ahead', 'vaccination', 'programme', 'Bank', 'England', 'effectively', 'ruled', 'negative', 'interest', 'rates', 'near', 'term', 'February', 'meeting', 'The', 'pair', 'currently', 'tests', 'lows', 'April', 'seen', 'technical', 'analysts', 'suggested', 'firm', 'break', 'level', 'could', 'push', 'pair', 'towards', 'downside', 'momentum', 'accelerate', 'Of', 'note', 'large', 'sized', 'options', 'expiring', 'EURGBP', 'todayâs', 'NY', 'cut', 'As', 'mentioned', 'GBPUSD', 'trades', 'back', 'looks', 'set', 'test', 'high', 'seen', 'Tuesday', 'A', 'break', 'level', 'could', 'see', 'psychological', 'level', 'come', 'play', 'Vaccines', 'GBP', 'benefitted', 'UKâs', 'vaccination', 'effort', 'almost', 'people', 'given', 'least', 'one', 'dose', 'one', 'jabs', 'The', 'EUâs', 'rollout', 'less', 'successful', 'yesterday', 'reports', 'AstraZeneca', 'PLC', 'LON', 'vaccines', 'EU', 'going', 'unused', 'amid', 'concerns', 'health', 'workers', 'France', 'Germany', 'side', 'effects', 'If', 'UK', 'keeps', 'vaccinating', 'rate', 'hope', 'least', 'every', 'adult', 'wants', 'vaccine', 'may', 'able', 'one', 'summer', 'prompting', 'hopes', 'economy', 'reopen', 'sooner', 'rather', 'later', 'sense', 'normality', 'return', 'Bank', 'England', 'policymaker', 'Andy', 'Haldane', 'recently', 'spoken', 'huge', 'pentup', 'demand', 'waiting', 'released', 'The', 'recovery', 'one', 'remember', 'year', 'forget', 'Haldane', 'said', 'The', 'Bank', 'England', 'chief', 'economist', 'said', 'could', 'see', 'double', 'digit', 'annual', 'growth', 'inflation', 'target', 'If', 'right', 'GBP', 'could', 'still', 'run'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'ITRK', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'EXPN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Antofagasta', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Carnival', 'PLC', 'LON', 'added', 'points', 'end', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Experian', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Intertek', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'vaccinations', 'Stevenage', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MILAN', 'Reuters', 'AstraZeneca', 'NASDAQ', 'deliver', 'million', 'vaccines', 'Europe', 'second', 'quarter', 'million', 'Italy', 'head', 'Italian', 'unit', 'quoted', 'saying', 'Thursday', 'dismissing', 'reports', 'possible', 'shortfall', 'Lorenzo', 'Wittum', 'CEO', 'chairman', 'Astrazeneca', 'LON', 'Italy', 'told', 'daily', 'Il', 'Corriere', 'della', 'Sera', 'interview', 'Italy', 'would', 'receive', 'million', 'shots', 'end', 'March', 'fewer', 'million', 'previously', 'agreed', 'leading', 'total', 'million', 'doses', 'June', 'Reuters', 'reported', 'Tuesday', 'citing', 'EU', 'official', 'directly', 'involved', 'talks', 'AngloSwedish', 'drugmaker', 'AstraZeneca', 'expected', 'deliver', 'less', 'half', 'vaccines', 'contracted', 'supply', 'European', 'Union', 'second', 'quarter', 'Wittum', 'also', 'said', 'pharmaceutical', 'company', 'considering', 'possibility', 'administering', 'third', 'dose', 'working', 'new', 'versions', 'vaccine'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'trades', 'relatively', 'flat', 'midpoint', 'trading', 'day', 'despite', 'services', 'sector', 'activity', 'falling', 'lowest', 'level', 'since', 'May', 'The', 'IHS', 'Markit', 'survey', 'showed', 'businesses', 'struggling', 'latest', 'lockdown', 'particularly', 'hospitality', 'travel', 'leisure', 'sector', 'However', 'businesses', 'optimistic', 'growth', 'expectations', 'highest', 'level', 'since', 'prospects', 'strong', 'reopening', 'vaccine', 'effort', 'continues', 'Vodafone', 'Group', 'PLC', 'LON', 'shares', 'rose', 'top', 'bluechip', 'index', 'positive', 'trading', 'update', 'benefited', 'work', 'home', 'policies', 'Germany', 'Separately', 'announced', 'spinoff', 'towers', 'division', 'Vantage', 'Towers', 'track', 'early', 'Reuters', 'earlier', 'reported', 'company', 'expected', 'list', 'division', 'Frankfurt', 'March', 'year', 'Vaccine', 'Makers', 'AstraZeneca', 'PLC', 'LON', 'focus', 'early', 'studies', 'showed', 'single', 'dose', 'vaccine', 'effective', 'weeks', 'justifying', 'UKâs', 'decision', 'vaccinate', 'many', 'people', 'possible', 'quick', 'time', 'frame', 'feasible', 'The', 'data', 'published', 'Oxford', 'University', 'yet', 'peerreviewed', 'provide', 'UK', 'government', 'assurance', 'made', 'right', 'decision', 'On', 'hand', 'France', 'followed', 'Germanyâs', 'lead', 'recommended', 'OxfordAstraZeneca', 'jab', 'given', 'given', 'lack', 'data', 'early', 'trials', 'This', 'comes', 'despite', 'European', 'Medicines', 'Agency', 'authorising', 'use', 'jab', 'Another', 'UKbased', 'pharmaceutical', 'company', 'GlaxoSmithKline', 'PLC', 'LON', 'announced', 'deal', 'Germanyâs', 'CureVac', 'NV', 'NASDAQ', 'work', 'together', 'develop', 'vaccines', 'new', 'variants', 'virus', 'The', 'deal', 'worth', 'EUR', 'also', 'see', 'GlaxoSmithKline', 'assist', 'manufacturing', 'CureVacâs', 'current', 'vaccine', 'candidate', 'original', 'strain', 'Sterling', 'The', 'pound', 'fell', 'US', 'dollar', 'broadly', 'flat', 'Euro', 'markets', 'look', 'ahead', 'tomorrowâs', 'interest', 'rate', 'decision', 'Focus', 'whether', 'central', 'bank', 'sees', 'negative', 'rates', 'part', 'toolkit', 'economic', 'prospects', 'weaken', 'Trading', 'ranges', 'relatively', 'narrow', 'Â', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SIEGn', 'Add', 'toRemove', 'Portfolio', 'SAN', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'NVO', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'pushed', 'higher', 'Wednesday', 'helped', 'progress', 'towards', 'US', 'stimulus', 'Italian', 'political', 'developments', 'corporate', 'earnings', 'also', 'share', 'spotlight', 'At', 'AM', 'ET', 'GMT', 'Germany', 'traded', 'higher', 'France', 'rose', 'UK', 'index', 'climbed', 'Italyâs', 'rose', 'Former', 'European', 'Central', 'Bank', 'head', 'Mario', 'Draghi', 'set', 'meet', 'Italian', 'President', 'Sergio', 'Mattarella', 'later', 'Wednesday', 'view', 'heading', 'government', 'national', 'unity', 'something', 'would', 'end', 'latest', 'political', 'crisis', 'Rome', 'This', 'comes', 'party', 'leaders', 'failed', 'agree', 'new', 'coalition', 'following', 'resignation', 'Prime', 'Minister', 'Giuseppe', 'Conte', 'last', 'week', 'In', 'corporate', 'news', 'Siemens', 'DE', 'stock', 'rose', 'German', 'manufacturing', 'conglomerate', 'lifted', 'fullyear', 'guidance', 'citing', 'fasterthanexpected', 'recoveries', 'China', 'Germany', 'following', 'downturn', 'Banco', 'Santander', 'MC', 'stock', 'rose', 'Spanish', 'bank', 'declared', 'cash', 'dividend', 'maximum', 'level', 'allowed', 'accordance', 'limits', 'set', 'European', 'Central', 'Bank', 'despite', 'recording', 'first', 'ever', 'annual', 'loss', 'ever', 'Novo', 'Nordisk', 'AS', 'NYSE', 'stock', 'added', 'diabetes', 'drug', 'maker', 'gave', 'upbeat', 'sales', 'profit', 'forecasts', 'Swedish', 'truckmaker', 'Volvo', 'ST', 'stock', 'rose', 'raising', 'forecasts', 'main', 'markets', 'rolling', 'hefty', 'shareholder', 'payout', 'On', 'Tuesday', 'US', 'Senate', 'began', 'debating', 'budget', 'resolution', 'first', 'step', 'towards', 'passing', 'trillion', 'stimulus', 'package', 'proposed', 'President', 'Joe', 'Biden', 'without', 'Republican', 'support', 'Additionally', 'rollout', 'vaccines', 'many', 'countries', 'slowly', 'gathering', 'pace', 'UK', 'inoculated', 'million', 'population', 'although', 'health', 'authorities', 'remain', 'concerned', 'spread', 'new', 'variants', 'virus', 'AstraZeneca', 'LON', 'agreed', 'deliver', 'nine', 'million', 'doses', 'vaccine', 'European', 'Union', 'first', 'quarter', 'year', 'region', 'slow', 'inoculation', 'uptake', 'Oil', 'prices', 'edged', 'higher', 'still', 'around', 'highest', 'levels', 'year', 'unexpected', 'fall', 'oil', 'supply', 'The', 'reported', 'late', 'Tuesday', 'crude', 'inventories', 'fell', 'million', 'barrels', 'last', 'week', 'compared', 'expectations', 'small', 'build', 'Data', 'due', 'later', 'day', 'US', 'crude', 'futures', 'traded', 'higher', 'barrel', 'hitting', 'oneyear', 'high', 'Tuesday', 'The', 'international', 'benchmark', 'contract', 'rose', 'earlier', 'climbing', 'highest', 'months', 'Elsewhere', 'rose', 'traded', 'lower'], ['Â', 'Reuters', 'A', 'woman', 'looks', 'receives', 'booster', 'vaccine', 'amid', 'coronavirus', 'disease', 'pandemic', 'Midland', 'House', 'Derby', 'Britain', 'September', 'REUTERSCarl', 'Recine', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'vaccines', 'made', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'use', 'mRNA', 'technology', 'provide', 'biggest', 'boost', 'antibody', 'levels', 'given', 'weeks', 'second', 'dose', 'new', 'British', 'study', 'found', 'The', 'COVBoost', 'study', 'cited', 'British', 'officials', 'announced', 'Pfizer', 'Moderna', 'preferred', 'use', 'country', 'booster', 'campaign', 'data', 'made', 'publicly', 'available', 'The', 'study', 'found', 'six', 'seven', 'boosters', 'examined', 'enhanced', 'immunity', 'initial', 'vaccination', 'PfizerBioNTech', 'vaccine', 'seven', 'increased', 'immunity', 'given', 'two', 'doses', 'AstraZeneca', 'NASDAQ', 'vaccine', 'A', 'third', 'dose', 'effective', 'many', 'vaccines', 'tested', 'many', 'different', 'combinations', 'Professor', 'Saul', 'Faust', 'immunologist', 'University', 'Southampton', 'trial', 'lead', 'told', 'reporters', 'The', 'study', 'published', 'late', 'Thursday', 'found', 'full', 'dose', 'half', 'dose', 'Pfizer', 'full', 'dose', 'Moderna', 'gave', 'strong', 'boost', 'antibody', 'Tcell', 'levels', 'regardless', 'whether', 'person', 'initially', 'received', 'Pfizer', 'AstraZeneca', 'All', 'four', 'vaccination', 'regimes', 'widely', 'deployed', 'UK', 'lead', 'essentially', 'levels', 'immunity', 'likely', 'equally', 'effective', 'said', 'Professor', 'Eleanor', 'Riley', 'immunologist', 'University', 'Edinburgh', 'She', 'added', 'policy', 'change', 'booster', 'gaps', 'also', 'supported', 'data', 'These', 'data', 'support', 'JCVI', 'vaccine', 'committee', 'decision', 'earlier', 'week', 'bring', 'forward', 'booster', 'doses', 'months', 'second', 'vaccination', 'When', 'AstraZeneca', 'Novavax', 'Johnson', 'Johnson', 'NYSE', 'Curevac', 'given', 'boosters', 'increased', 'antibody', 'levels', 'either', 'initial', 'vaccine', 'albeit', 'smaller', 'degree', 'study', 'found', 'However', 'Valneva', 'boosted', 'antibodies', 'people', 'initially', 'vaccinated', 'AstraZeneca', 'provide', 'boost', 'Pfizer', 'The', 'COVBoost', 'study', 'predated', 'spread', 'emergent', 'Omicron', 'variant', 'concern', 'Faust', 'said', 'shared', 'samples', 'UK', 'Health', 'Security', 'Agency', 'generate', 'data', 'Omicron', 'The', 'study', 'however', 'find', 'booster', 'shots', 'also', 'helped', 'generate', 'broad', 'Tcell', 'response', 'Beta', 'Delta', 'variants', 'may', 'play', 'key', 'role', 'longerterm', 'protection', 'A', 'separate', 'study', 'Imperial', 'College', 'London', 'initial', 'exposure', 'shapes', 'immune', 'responses', 'also', 'published', 'late', 'Thursday', 'similarly', 'found', 'good', 'Tcell', 'response', 'Alpha', 'Delta', 'infection', 'followed', 'vaccination'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFG', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Key', 'Points', 'begins', 'week', 'back', 'foot', 'miners', 'oil', 'gas', 'companies', 'weigh', 'More', 'European', 'countries', 'stop', 'rollout', 'AstraZeneca', 'PLC', 'LON', 'NASDAQ', 'vaccine', 'GBP', 'weak', 'ahead', 'rate', 'decisions', 'retreats', 'alltime', 'high', 'amid', 'reported', 'ban', 'Investingcom', 'â', 'The', 'FTSE', 'finished', 'lower', 'Monday', 'opening', 'small', 'gains', 'ahead', 'busy', 'week', 'central', 'bank', 'events', 'On', 'Wednesday', 'announces', 'interest', 'rate', 'decision', 'Thursday', 'sees', 'Bank', 'England', 'Friday', 'Miners', 'oil', 'gas', 'companies', 'weak', 'commodity', 'prices', 'generally', 'softer', 'futures', 'fell', 'although', 'still', 'remained', 'higher', 'Betting', 'group', 'Flutter', 'Entertainment', 'PLC', 'LON', 'saw', 'shares', 'jump', 'top', 'FTSE', 'company', 'confirmed', 'media', 'reports', 'considering', 'spinoff', 'FanDuel', 'United', 'States', 'âœOptions', 'including', 'listing', 'US', 'small', 'shareholding', 'FanDuel', 'considered', 'decision', 'made', 'time', 'Flutter', 'Entertainment', 'said', 'statement', 'listed', 'Provident', 'Financial', 'LON', 'saw', 'shares', 'decline', 'company', 'announced', 'UKâs', 'Financial', 'Conduct', 'Authority', 'investigating', 'Consumer', 'Credit', 'Division', 'The', 'company', 'also', 'gave', 'details', 'plan', 'settle', 'increase', 'customer', 'complaints', 'claims', 'home', 'credit', 'business', 'last', 'year', 'warning', 'unit', 'could', 'collapse', 'scheme', 'approved', 'The', 'AstraZeneca', 'vaccine', 'rollout', 'Europe', 'continues', 'face', 'interruptions', 'Italy', 'Germany', 'France', 'confirming', 'suspend', 'giving', 'jab', 'amid', 'reports', 'thrombogenic', 'events', 'patients', 'taken', 'vaccine', 'AstraZeneca', 'continues', 'say', 'evidence', 'increased', 'risk', 'clotting', 'taking', 'vaccine', 'World', 'Health', 'Organization', 'said', 'indication', 'link', 'vaccine', 'reports', 'blood', 'clots', 'The', 'European', 'Medicines', 'Agency', 'set', 'give', 'assessment', 'vaccine', 'Tuesday', 'Currencies', 'Bonds', 'GBP', 'weaker', 'dropping', 'ahead', 'key', 'central', 'bank', 'meetings', 'week', 'The', 'Bank', 'England', 'Governor', 'Andrew', 'said', 'Monday', 'positive', 'large', 'dose', 'caution', 'UKâs', 'economic', 'recovery', 'Bailey', 'also', 'added', 'central', 'bank', 'policy', 'tools', 'could', 'introduce', 'needed', 'Yields', 'UK', 'US', 'pulled', 'back', 'somewhat', 'hitting', 'multimonth', 'highs', 'late', 'last', 'week', 'UK', 'gilts', 'underperforming', 'Baileyâs', 'comments', 'weighing', 'ahead', 'Bank', 'England', 'interest', 'rate', 'decision', 'Cryptocurrencies', 'Bitcoin', 'broke', 'weekend', 'hit', 'record', 'high', 'since', 'retreated', 'reports', 'India', 'announce', 'complete', 'ban', 'cryptocurrencies', 'The', 'wideranging', 'bill', 'would', 'reportedly', 'criminalise', 'possession', 'issuance', 'mining', 'trading', 'transferring', 'cryptocurrencies', 'This', 'would', 'much', 'stringent', 'law', 'Chinese', 'ban', 'currently', 'bans', 'mining', 'trading', 'cryptocurrencies'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'Crude', 'oil', 'prices', 'weakened', 'Tuesday', 'handing', 'back', 'recent', 'gains', 'amid', 'concerns', 'speed', 'global', 'oil', 'demand', 'recovery', 'ahead', 'latest', 'inventories', 'data', 'By', 'AM', 'ET', 'GMT', 'US', 'crude', 'futures', 'traded', 'lower', 'barrel', 'international', 'benchmark', 'contract', 'fell', 'US', 'Gasoline', 'RBOB', 'Futures', 'gallon', 'Weighing', 'prices', 'Tuesday', 'release', 'data', 'showing', 'US', 'declined', 'February', 'lot', 'drop', 'expected', 'winter', 'snap', 'sharply', 'reduced', 'economic', 'activity', 'This', 'followed', 'upwardly', 'revised', 'surge', 'January', 'strongest', 'advance', 'seven', 'months', 'This', 'added', 'concern', 'already', 'play', 'rising', 'number', 'cases', 'Europe', 'potential', 'extended', 'mobility', 'restrictions', 'German', 'coronavirus', 'infections', 'spreading', 'exponentially', 'last', 'week', 'expert', 'Robert', 'Koch', 'Institute', 'infectious', 'diseases', 'said', 'Tuesday', 'Italy', 'set', 'implement', 'new', 'lockdown', 'Easter', 'holiday', 'weekend', 'Throw', 'number', 'countries', 'including', 'Germany', 'France', 'Italy', 'suspending', 'use', 'AstraZeneca', 'PLC', 'LON', 'âs', 'vaccine', 'concerns', 'blood', 'clots', 'concerns', 'growing', 'slow', 'pace', 'vaccinations', 'region', 'may', 'delay', 'economic', 'recovery', 'pandemic', 'âœFor', 'oil', 'demand', 'fully', 'recover', 'successful', 'rapid', 'inoculation', 'global', 'population', 'needs', 'take', 'place', 'Before', 'recent', 'setback', 'positivity', 'campaigns', 'way', 'right', 'trackâ', 'said', 'Bjornar', 'Tonhaugen', 'head', 'oil', 'markets', 'Rystad', 'Energy', 'Back', 'US', 'attention', 'quickly', 'turn', 'release', 'American', 'Petroleum', 'Institute', 'industry', 'group', 'later', 'Tuesday', 'followed', 'official', 'numbers', 'Energy', 'Information', 'Administration', 'Wednesday', 'Crude', 'inventories', 'increased', 'million', 'barrels', 'week', 'March', 'analysts', 'expectations', 'rise', 'less', 'million', 'barrels', 'fears', 'growing', 'another', 'sharp', 'rise', 'stocks', 'âœIf', 'market', 'fears', 'turn', 'true', 'stocks', 'difficult', 'Brent', 'hit', 'per', 'barrel', 'soon', 'least', 'positive', 'news', 'comes', 'vaccination', 'front', 'âœ', 'added', 'Tonhaugen', 'Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'Key', 'Points', 'closes', 'higher', 'AstraZeneca', 'NASDAQ', 'shares', 'jump', 'despite', 'vaccine', 'concerns', 'NatWest', 'Group', 'PLC', 'LON', 'lower', 'FCA', 'launches', 'criminal', 'proceedings', 'money', 'laundering', 'Shell', 'LON', 'BP', 'LON', 'lower', 'oil', 'prices', 'fall', 'LON', 'lower', 'oil', 'prices', 'fall', 'GBP', 'flat', 'ahead', 'decisions', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'FTSE', 'finished', 'Tuesday', 'higher', 'ahead', 'key', 'interest', 'rate', 'decisions', 'Federal', 'Reserve', 'Bank', 'England', 'week', 'Vaccine', 'maker', 'AstraZeneca', 'PLC', 'LON', 'focus', 'number', 'European', 'countries', 'suspended', 'rollout', 'jab', 'amid', 'fears', 'increased', 'number', 'blood', 'clots', 'vaccine', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'forced', 'hold', 'press', 'conference', 'said', 'indication', 'vaccine', 'caused', 'blood', 'clot', 'incidents', 'reiterating', 'benefits', 'taking', 'vaccine', 'still', 'outweigh', 'risks', 'Nevertheless', 'time', 'publication', 'none', 'countries', 'suspended', 'AstraZeneca', 'vaccine', 'reversed', 'decision', 'The', 'EMA', 'state', 'investigating', 'reports', 'anticipate', 'coming', 'conclusion', 'Thursday', 'UK', 'bank', 'came', 'selling', 'pressure', 'underperformed', 'peers', 'Financial', 'Conduct', 'Authority', 'FCA', 'said', 'beginning', 'criminal', 'proceedings', 'company', 'money', 'laundering', 'The', 'allegations', 'date', 'back', 'probe', 'ongoing', 'since', 'Royal', 'Dutch', 'Shell', 'BP', 'propped', 'bluechip', 'index', 'oil', 'prices', 'fell', 'recovery', 'concerns', 'Weighing', 'prices', 'US', 'retail', 'sales', 'data', 'showed', 'decline', 'February', 'worse', 'expected', 'drop', 'Separately', 'cases', 'picking', 'various', 'European', 'countries', 'suspension', 'vaccine', 'rollout', 'could', 'harm', 'recovery', 'even', 'potentially', 'weighing', 'oil', 'demand', 'GBP', 'weak', 'staged', 'recovery', 'markets', 'await', 'two', 'central', 'bank', 'meetings', 'US', 'UK', 'Little', 'changed', 'UK', 'fundamental', 'perspective', 'suggestion', 'European', 'vaccine', 'suspension', 'could', 'harm', 'already', 'fragile', 'relations', 'UK', 'EU', 'potentially', 'weigh', 'GBP', 'found', 'support', 'ahead', 'jumped', 'EMA', 'press', 'conference', 'said', 'AstraZeneca', 'vaccine', 'safe', 'steady', 'remained', 'alltime', 'high', 'hit', 'weekend', 'The', 'stimulus', 'checks', 'due', 'hit', 'US', 'bank', 'accounts', 'next', 'days', 'could', 'next', 'catalyst', 'move', 'higher', 'suggesting', 'âœmeme', 'stocksâ', 'cryptocurrencies', 'could', 'benefit', 'slew', 'retail', 'money', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'Shares', 'AstraZeneca', 'PLC', 'LON', 'top', 'Tuesday', 'morning', 'company', 'shrugged', 'concerns', 'vaccine', 'At', 'shares', 'On', 'Monday', 'four', 'largest', 'countries', 'EU', 'â', 'Germany', 'France', 'Italy', 'Spain', 'â', 'suspended', 'rollout', 'Oxford', 'jab', 'amid', 'reports', 'several', 'people', 'received', 'jab', 'developed', 'blood', 'clots', 'What', 'know', 'far', 'The', 'big', 'EU', 'countries', 'ones', 'suspend', 'vaccine', 'Austria', 'Netherlands', 'Denmark', 'nonEU', 'countries', 'including', 'Iceland', 'Norway', 'Thailand', 'halted', 'use', 'vaccine', 'precautionary', 'measure', 'However', 'regulators', 'less', 'concerned', 'blood', 'clotting', 'events', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'yesterday', 'provided', 'update', 'socalled', 'thromboembolic', 'events', 'saying', 'investigating', 'situation', 'changing', 'view', 'whether', 'rollout', 'stopped', 'âœThe', 'benefits', 'AstraZeneca', 'vaccine', 'preventing', 'associated', 'risk', 'hospitalisation', 'death', 'outweigh', 'risks', 'side', 'effectsâ', 'EMA', 'said', 'statement', 'The', 'EMAâs', 'safety', 'committee', 'scheduled', 'meet', 'today', 'review', 'information', 'called', 'extraordinary', 'meeting', 'Thursday', 'conclude', 'information', 'gathered', 'whether', 'action', 'needs', 'taken', 'The', 'UKâs', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'MHRA', 'said', 'closely', 'reviewing', 'reports', 'evidence', 'available', 'suggest', 'vaccine', 'cause', 'The', 'World', 'Health', 'Organization', 'WHO', 'also', 'urged', 'countries', 'panic', 'pause', 'vaccination', 'programmes', 'adding', 'evidence', 'link', 'vaccine', 'blood', 'clots', 'The', 'WHO', 'vaccine', 'safety', 'experts', 'meeting', 'today', 'discuss', 'jab', 'Political', 'Decision', 'The', 'Director', 'General', 'Italyâs', 'medicines', 'authority', 'AIFA', 'said', 'decision', 'suspend', 'shots', 'number', 'European', 'countries', 'âœpolitical', 'oneâ', 'We', 'got', 'point', 'suspension', 'several', 'European', 'countries', 'including', 'Germany', 'France', 'preferred', 'interrupt', 'vaccinations', 'put', 'hold', 'order', 'carry', 'checks', 'The', 'choice', 'political', 'one', 'Nicola', 'Magrini', 'said', 'interview', 'Italian', 'newspaper', 'La', 'Repubblica', 'Magrini', 'expects', 'take', 'days', 'gather', 'data', 'doubts', 'cleared', 'vaccination', 'programme', 'carry', 'faster', 'speed', 'In', 'separate', 'news', 'company', 'announced', 'premarket', 'supply', 'United', 'States', 'additional', 'doses', 'potential', 'antibody', 'treatment', 'The', 'value', 'extended', 'agreement', 'contingent', 'receiving', 'FDA', 'Emergency', 'Use', 'Authorization'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'RollsRoyce', 'LON', 'shares', 'jumped', 'sixth', 'consecutive', 'day', 'time', 'rallying', 'upgrade', 'JPMorgan', 'âunderweightâ', 'âneutralâ', 'âœWhilst', 'international', 'airline', 'capacity', 'still', 'circa', 'versus', 'unlikely', 'get', 'worse', 'direction', 'travel', 'probably', 'one', 'slow', 'improvement', 'analysts', 'JPM', 'said', 'research', 'note', 'âœRollsRoyceâs', 'shares', 'significantly', 'underperformed', 'peers', 'since', 'attracting', 'investorsâ', 'Financial', 'Results', 'The', 'jet', 'engine', 'manufacturer', 'reported', 'earnings', 'Thursday', 'last', 'week', 'provided', 'upbeat', 'outlook', 'despite', 'struggles', 'currently', 'impacting', 'aviation', 'sector', 'âœThe', 'worst', 'well', 'behind', 'usâ', 'RollsRoyce', 'CEO', 'Warren', 'East', 'said', 'analyst', 'call', 'post', 'earnings', 'The', 'maintained', 'forecast', 'large', 'engine', 'flying', 'hours', 'increase', 'levels', 'last', 'year', 'The', 'company', 'reliant', 'effective', 'global', 'vaccination', 'effort', 'recent', 'suspension', 'AstraZeneca', 'PLC', 'LON', 'NASDAQ', 'jab', 'various', 'European', 'countries', 'could', 'set', 'Europe', 'behind', 'especially', 'damages', 'confidence', 'vaccine', 'Nevertheless', 'today', 'European', 'Commission', 'announced', 'plans', 'digital', 'certificates', 'would', 'prove', 'holders', 'vaccinated', 'recently', 'tested', 'negative', 'facilitate', 'leisure', 'trips', 'within', 'EU', 'outside', 'bloc', 'At', 'RollsRoyce', 'shares', 'top', 'trading', 'higher', 'Of', 'note', 'JPM', 'also', 'lifted', 'price', 'target', 'shares'], ['By', 'Reuters', 'BEIJING', 'Reuters', 'China', 'Sunday', 'reported', 'highest', 'number', 'new', 'infections', 'six', 'months', 'day', 'health', 'officials', 'said', 'sticking', 'strict'], ['Â', 'Reuters', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CWNHB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CP', 'Add', 'toRemove', 'Portfolio', 'KSU', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'USDTRY', 'Add', 'toRemove', 'Portfolio', 'BX', 'Add', 'toRemove', 'Portfolio', 'GME', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Rising', 'cases', 'Europe', 'India', 'South', 'America', 'stoke', 'fears', 'delay', 'global', 'economic', 'recovery', 'despite', 'AstraZeneca', 'publishing', 'upbeat', 'results', 'major', 'trial', 'vaccine', 'North', 'South', 'America', 'Turkey', 'currency', 'stock', 'market', 'tumble', 'President', 'Erdogan', 'fires', 'central', 'bank', 'chief', 'raising', 'interest', 'rates', 'sharply', 'Gamestop', 'reports', 'earnings', 'big', 'railroad', 'merger', 'works', 'Saudi', 'Aramco', 'borrowing', 'heavily', 'defend', 'billion', 'dividend', 'Here', 'need', 'know', 'financial', 'markets', 'Monday', 'March', 'US', 'trial', 'results', 'vindicate', 'AstraZeneca', 'European', 'vaccine', 'dispute', 'deepens', 'AstraZeneca', 'LON', 'cleared', 'major', 'hurdle', 'getting', 'vaccine', 'authorized', 'US', 'UK', 'EU', 'moved', 'closer', 'blocking', 'exports', 'vaccines', 'The', 'UKSwedish', 'company', 'said', 'vaccine', 'effective', 'stopping', 'symptomatic', 'effective', 'preventing', 'death', 'hospitalization', 'trial', 'covered', 'volunteers', 'US', 'The', 'test', 'results', 'also', 'showed', 'issues', 'blood', 'clotting', 'disorders', 'concerns', 'led', 'many', 'EU', 'countries', 'suspend', 'distribution', 'vaccine', 'earlier', 'month', 'The', 'news', 'comes', 'day', 'Europeâs', 'largest', 'economy', 'Germany', 'set', 'join', 'France', 'tightening', 'extending', 'lockdown', 'restrictions', 'middle', 'April', 'response', 'surge', 'new', 'infections', 'last', 'two', 'weeks', 'Outside', 'Europe', 'India', 'reported', 'highest', 'daily', 'death', 'count', 'two', 'months', 'new', 'infections', 'hit', 'alltime', 'record', 'Brazil', 'Chile', 'There', 'also', 'signs', 'hiccups', 'USâs', 'reopening', 'fights', 'among', 'massive', 'crowds', 'Spring', 'Break', 'tourists', 'led', 'Miami', 'Beach', 'declare', 'state', 'emergency', 'Third', 'time', 'lucky', 'CPR', 'Canadian', 'Pacific', 'NYSE', 'finally', 'succeeded', 'persuading', 'US', 'railroad', 'operator', 'merge', 'create', 'first', 'railroad', 'operator', 'link', 'three', 'major', 'markets', 'North', 'America', 'CPR', 'Kansas', 'City', 'Southern', 'NYSE', 'said', 'agreed', 'deal', 'valuing', 'KCSâs', 'debt', 'equity', 'around', 'billion', 'The', 'merger', 'still', 'need', 'antitrust', 'clearance', 'KCS', 'rejected', 'billion', 'bid', 'Blackstone', 'NYSE', 'Global', 'Infrastructure', 'Partners', 'September', 'Blackstone', 'acquisition', 'trail', 'elsewhere', 'weekend', 'proposing', 'buy', 'trouble', 'Australian', 'casino', 'operator', 'Crown', 'Resorts', 'ASX', 'billion', 'deal', 'would', 'offer', 'shareholders', 'Crown', 'exit', 'company', 'beset', 'moneylaundering', 'allegations', 'Semiconductor', 'stocks', 'also', 'focus', 'fire', 'factory', 'owned', 'Japan', 'Renesas', 'Electronics', 'T', 'threatens', 'aggravate', 'current', 'shortage', 'chips', 'worldwide', 'Stocks', 'set', 'open', 'mostly', 'lower', 'GameStop', 'earnings', 'eyed', 'The', 'bad', 'news', 'front', 'given', 'extra', 'leg', 'rebound', 'tech', 'stocks', 'setback', 'cyclicals', 'markets', 'around', 'world', 'reprice', 'reopening', 'bets', 'Yields', 'US', 'Treasuries', 'meanwhile', 'fell', 'back', 'AM', 'ET', 'GMT', 'consequently', 'underperforming', 'premarket', 'trade', 'falling', 'points', 'contrast', 'higher', 'Other', 'stocks', 'likely', 'focus', 'later', 'include', 'GameStop', 'NYSE', 'due', 'report', 'three', 'months', 'January', 'â', 'first', 'update', 'since', 'epic', 'shortsqueeze', 'earlier', 'year', 'Analysts', 'expect', 'profit', 'million', 'share', 'billion', 'revenue', 'Also', 'focus', 'Tesla', 'NASDAQ', 'whose', 'biggest', 'fund', 'manager', 'cheerleader', 'Cathie', 'Wood', 'put', 'new', 'target', 'price', 'weekend', 'data', 'February', 'also', 'due', 'Federal', 'Reserve', 'Randy', 'Quarles', 'Mary', 'Daly', 'Michelle', 'Bowman', 'speak', 'later', 'Turkey', 'turmoil', 'Turkish', 'financial', 'markets', 'went', 'meltdown', 'mode', 'President', 'Recep', 'Tayyip', 'Erdogan', 'fired', 'central', 'bank', 'chief', 'Naci', 'Agbul', 'weekend', 'two', 'days', 'raised', 'interest', 'rates', 'expected', 'Erdoganâs', 'intervention', 'revived', 'fears', 'return', 'previous', 'economic', 'policy', 'tolerated', 'sharp', 'currency', 'devaluation', 'raging', 'inflation', 'Erdogan', 'appointed', 'Naci', 'Agbal', 'last', 'year', 'seemed', 'decisive', 'return', 'orthodox', 'economic', 'policies', 'The', 'dollar', 'rose', 'early', 'trading', 'retraced', 'âonlyâ', 'AM', 'ET', 'government', 'officials', 'downplayed', 'suggestions', 'country', 'impose', 'capital', 'controls', 'support', 'currency', 'The', 'benchmark', 'stock', 'index', 'also', 'fell', 'yield', 'Turkeyâs', 'government', 'debt', 'soared', 'highest', 'since', 'Aramco', 'defends', 'dividend', 'price', 'Saudi', 'Aramco', 'SE', 'worldâs', 'biggest', 'oil', 'company', 'said', 'would', 'keep', 'dividend', 'payment', 'billion', 'despite', 'sharp', 'drop', 'profits', 'due', 'pandemic', 'The', 'decision', 'says', 'less', 'outlook', 'global', 'oil', 'industry', 'Saudi', 'budget', 'relies', 'Aramcoâs', 'dividend', 'resources', 'Free', 'cash', 'flow', 'fell', 'billion', 'meaning', 'company', 'borrow', 'cover', 'shortfall', 'Crude', 'prices', 'choppy', 'Monday', 'doubts', 'summer', 'tourism', 'season', 'northern', 'hemisphere', 'intensified', 'futures', 'flat', 'barrel', 'futures', 'barrel', 'Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'GME', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'CHWY', 'Add', 'toRemove', 'Portfolio', 'By', 'Liz', 'Moyer', 'Investingcom', 'The', 'rotation', 'growth', 'value', 'took', 'pause', 'Monday', 'interest', 'rates', 'let', 'steam', 'put', 'attention', 'back', 'big', 'tech', 'companies', 'As', 'evidence', 'US', 'economy', 'continues', 'reopen', 'Transportation', 'Security', 'Administration', 'screened', 'million', 'travelers', 'Sunday', 'since', 'March', 'last', 'year', 'Partiers', 'flocking', 'warmer', 'weather', 'climates', 'South', 'Florida', 'local', 'officials', 'impose', 'curfew', 'control', 'crowds', 'But', 'evidence', 'new', 'wave', 'infections', 'US', 'overseas', 'could', 'derail', 'progress', 'German', 'authorities', 'agreed', 'extend', 'another', 'national', 'lockdown', 'midApril', 'France', 'Poland', 'Italy', 'also', 'lockdowns', 'This', 'putting', 'damper', 'oil', 'prices', 'investors', 'worry', 'demand', 'fuel', 'Meanwhile', 'USChina', 'trade', 'tensions', 'appear', 'rise', 'US', 'imposed', 'sanctions', 'two', 'Chinese', 'officials', 'alleged', 'human', 'rights', 'abuses', 'Itâs', 'light', 'day', 'data', 'earnings', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'GameStop', 'earnings', 'compare', 'marketâs', 'valuation', 'The', 'muchfollowed', 'meme', 'stock', 'scheduled', 'report', 'first', 'quarter', 'earnings', 'closing', 'bell', 'Tuesday', 'Itâll', 'first', 'report', 'since', 'Reddit', 'stock', 'trading', 'crowd', 'anointed', 'video', 'game', 'retailer', 'granddaddy', 'short', 'squeezes', 'Analysts', 'tracked', 'Investingcom', 'expect', 'EPS', 'revenue', 'billion', 'GameStop', 'Corp', 'NYSE', 'shares', 'trade', 'nearly', 'times', 'start', 'year', 'based', 'Fridayâs', 'close', 'market', 'value', 'billion', 'It', 'new', 'strategy', 'focus', 'ecommerce', 'thanks', 'investor', 'board', 'member', 'Ryan', 'Cohen', 'founder', 'Chewy', 'Inc', 'NYSE', 'But', 'work', 'begun', 'More', 'home', 'sales', 'data', 'data', 'released', 'Tuesday', 'AM', 'ET', 'GMT', 'analysts', 'expect', 'February', 'numbers', 'show', 'decline', 'prior', 'month', 'Investors', 'looking', 'numbers', 'compare', 'Mondayâs', 'showed', 'drop', 'number', 'homebuyers', 'listing', 'homes', 'time', 'With', 'limited', 'supply', 'prices', 'jumped', 'February', 'median', 'price', 'home', 'sold', 'highest', 'February', 'price', 'ever', 'Pharma', 'stocks', 'get', 'look', 'AstraZeneca', 'PLC', 'LON', 'getting', 'chance', 'shine', 'rough', 'weeks', 'facing', 'questions', 'twodose', 'Covid', 'vaccine', 'On', 'Monday', 'company', 'said', 'late', 'stage', 'trial', 'proved', 'effective', 'overall', 'effective', 'preventing', 'serious', 'illness', 'hospitalization', 'It', 'plans', 'ask', 'Food', 'Drug', 'Administration', 'emergency', 'use', 'authorization', 'coming', 'weeks', 'That', 'would', 'make', 'fourth', 'vaccine', 'US', 'alongside', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'Johnson', 'Johnson', 'NYSE', 'millions', 'Americans', 'become', 'eligible', 'every', 'day', 'Shares', 'AstraZeneca', 'bounced', 'Monday'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'Testimony', 'Fed', 'chief', 'Jerome', 'Powell', 'Treasury', 'Secretary', 'Janet', 'Yellen', 'Congress', 'set', 'main', 'focus', 'markets', 'Tuesday', 'Ahead', 'rising', 'cases', 'Europe', 'resulting', 'Germany', 'extending', 'mobility', 'restrictions', 'putting', 'pressure', 'oil', 'prices', 'equities', 'Turkish', 'markets', 'remain', 'volatile', 'President', 'Erdoganâs', 'axing', 'central', 'bank', 'governor', 'hawkish', 'doubts', 'AstraZenecaâs', 'vaccine', 'reemerge', 'US', 'housing', 'data', 'due', 'release', 'UK', 'employment', 'data', 'surprised', 'upside', 'Here', 'need', 'know', 'financial', 'markets', 'Tuesday', 'March', 'Powell', 'Yellen', 'face', 'House', 'questions', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powell', 'Treasury', 'Secretary', 'Janet', 'Yellen', 'set', 'start', 'twoday', 'testimony', 'Congress', 'later', 'Tuesday', 'front', 'House', 'Financial', 'Services', 'Committee', 'They', 'set', 'discuss', 'health', 'US', 'economy', 'importance', 'fiscal', 'monetary', 'stimulus', 'recovery', 'pandemic', 'Yields', 'US', 'Treasuries', 'climbed', 'highest', 'levels', 'year', 'financial', 'markets', 'bet', 'US', 'economy', 'making', 'quicker', 'recovery', 'damage', 'caused', 'pandemic', 'central', 'bank', 'currently', 'predicts', 'And', 'pair', 'likely', 'get', 'plenty', 'questions', 'deeply', 'politically', 'divided', 'Congress', 'whether', 'yields', 'continue', 'rise', 'amid', 'fears', 'economy', 'overheat', 'However', 'judging', 'released', 'excerpts', 'prepared', 'testimony', 'Powell', 'reiterate', 'central', 'bank', 'plan', 'support', 'recovery', 'long', 'takes', 'economy', 'remains', 'prepandemic', 'levels', 'In', 'particular', 'labor', 'market', 'remains', 'concern', 'Federal', 'Reserve', 'unemployment', 'rate', 'labor', 'participation', 'rate', 'still', 'prepandemic', 'levels', 'Yellen', 'said', 'repeatedly', 'past', 'two', 'months', 'US', 'afford', 'borrow', 'interest', 'rates', 'historically', 'low', 'debt', 'level', 'large', 'cost', 'service', 'obligations', 'AstraZeneca', 'NASDAQ', 'vaccine', 'yet', 'fully', 'cleared', 'AstraZenecaâs', 'executives', 'must', 'felt', 'finally', 'caught', 'break', 'Monday', 'data', 'large', 'US', 'trial', 'showed', 'vaccine', 'proved', 'effective', 'overall', 'effective', 'preventing', 'serious', 'illness', 'hospitalization', 'However', 'proved', 'false', 'dawn', 'US', 'health', 'agency', 'questioned', 'Tuesday', 'whether', 'UKSwedish', 'company', 'provided', 'complete', 'view', 'efficacy', 'data', 'vaccine', 'trial', 'casting', 'doubt', 'plan', 'seek', 'US', 'emergency', 'use', 'authorization', 'vaccine', 'coming', 'weeks', 'The', 'Data', 'Safety', 'Monitoring', 'Board', 'expressed', 'concern', 'AstraZeneca', 'PLC', 'LON', 'may', 'included', 'outdated', 'information', 'trial', 'may', 'provided', 'incomplete', 'view', 'efficacy', 'data', 'US', 'National', 'Institute', 'Allergy', 'Infectious', 'Diseases', 'said', 'statement', 'AstraZenecaâs', 'vaccine', 'dogged', 'doubts', 'efficacy', 'dosing', 'regimen', 'possible', 'side', 'effects', 'Many', 'European', 'countries', 'including', 'Germany', 'France', 'halted', 'use', 'vaccine', 'earlier', 'month', 'reports', 'linked', 'rare', 'blood', 'clotting', 'disorder', 'US', 'stocks', 'set', 'open', 'lower', 'Europe', 'Covid', 'woes', 'US', 'stock', 'markets', 'look', 'set', 'open', 'marginally', 'lower', 'Tuesday', 'amid', 'cautious', 'trading', 'investors', 'await', 'comments', 'Fed', 'chief', 'Powell', 'Treasury', 'Secretary', 'Yellen', 'testify', 'front', 'Congress', 'At', 'AM', 'ET', 'GMT', 'points', 'Tuesday', 'marks', 'oneyear', 'anniversary', 'marketâs', 'nadir', 'pandemic', 'caused', 'stocks', 'plummet', 'Since', 'intraday', 'low', 'advanced', 'gained', 'These', 'expected', 'losses', 'Wall', 'Street', 'follow', 'weakness', 'Europe', 'European', 'equities', 'retreating', 'oneyear', 'peak', 'new', 'wave', 'coronavirus', 'cases', 'lockdown', 'extension', 'Germany', 'raised', 'fears', 'slow', 'economic', 'recovery', 'Additionally', 'Turkish', 'stocks', 'continued', 'fall', 'main', 'index', 'President', 'Tayyip', 'Erdogan', 'abruptly', 'fired', 'hawkish', 'central', 'bank', 'governor', 'weekend', 'installed', 'critic', 'country', 'tight', 'monetary', 'stance', 'The', 'countryâs', 'currency', 'lira', 'also', 'volatile', 'made', 'back', 'Mondayâs', 'sharp', 'losses', 'US', 'housing', 'data', 'focus', 'UK', 'jobless', 'rate', 'falls', 'With', 'minutes', 'last', 'Federal', 'Reserve', 'meeting', 'stating', 'central', 'bank', 'studying', 'actual', 'economic', 'data', 'monetary', 'policy', 'cues', 'focus', 'turn', 'Tuesday', 'release', 'latest', 'numbers', 'housing', 'market', 'This', 'sector', 'one', 'beneficiaries', 'pandemic', 'large', 'numbers', 'sought', 'sanctuary', 'suburbs', 'moving', 'away', 'highdensity', 'cities', 'However', 'things', 'started', 'cool', 'Monday', 'showed', 'drop', 'number', 'homebuyers', 'listing', 'homes', 'time', 'data', 'released', 'AM', 'ET', 'GMT', 'analysts', 'expect', 'February', 'numbers', 'show', 'decline', 'prior', 'month', 'Earlier', 'Tuesday', 'Britain', 'unexpectedly', 'fell', 'three', 'months', 'January', 'country', 'entered', 'new', 'lockdown', 'forecasts', 'rise', 'Oil', 'hit', 'European', 'coronavirus', 'restrictions', 'Crude', 'prices', 'weakened', 'Tuesday', 'amid', 'growing', 'concerns', 'flaring', 'cases', 'Europe', 'slow', 'recovery', 'demand', 'particularly', 'ahead', 'summer', 'tourism', 'season', 'At', 'AM', 'ET', 'GMT', 'futures', 'lower', 'barrel', 'futures', 'barrel', 'Germany', 'Europe', 'biggest', 'oil', 'consumer', 'Monday', 'extended', 'lockdown', 'April', 'asked', 'citizens', 'stay', 'home', 'Easter', 'holiday', 'period', 'try', 'combat', 'third', 'wave', 'infections', 'hitting', 'continent', 'In', 'blow', 'tourism', 'industry', 'fines', 'pounds', 'introduced', 'people', 'England', 'try', 'travel', 'abroad', 'end', 'June', 'tightening', 'country', 'border', 'controls', 'On', 'supply', 'side', 'Organization', 'Petroleum', 'Exporting', 'Countries', 'allies', 'OPEC', 'convene', 'April', 'determine', 'production', 'policy', 'May', 'âœThe', 'wobble', 'market', 'give', 'OPEC', 'something', 'think', 'ahead', 'meetingâ', 'said', 'analysts', 'ING', 'research', 'note', 'âœClearly', 'prior', 'recent', 'downward', 'pressure', 'expectations', 'OPEC', 'would', 'start', 'ease', 'cuts', 'However', 'group', 'may', 'hesitant', 'particularly', 'sentiment', 'shift', 'ahead', 'meeting', 'âœ', 'Ahead', 'US', 'crude', 'inventory', 'data', 'industry', 'body', 'released', 'later', 'Tuesday'], ['Â', 'Bloomberg', 'A', 'box', 'PfizerBioNTech', 'vaccines', 'opened', 'delivery', 'Ambroise', 'Pare', 'Clinic', 'Paris', 'France', 'Wednesday', 'Jan', 'The', 'French', 'government', 'trying', 'make', 'slow', 'start', 'vaccination', 'program', 'criticism', 'doctors', 'opposition', 'politicians', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Bloomberg', 'The', 'European', 'Union', 'announced', 'give', 'stronger', 'powers', 'stop', 'Covid', 'vaccine', 'exports', 'rest', 'world', 'setting', 'stage', 'escalation', 'tensions', 'allies', 'manufacturers', 'faces', 'third', 'wave', 'infections', 'The', 'EU', 'strengthening', 'existing', 'export', 'rules', 'demand', 'countries', 'received', 'doses', 'EU', 'also', 'allow', 'shots', 'sent', 'back', 'It', 'also', 'consider', 'nationâs', 'vaccination', 'rate', 'pandemic', 'situation', 'deciding', 'whether', 'green', 'light', 'shipments', 'The', 'mechanism', 'wonât', 'automatic', 'used', 'casebycase', 'basis', 'The', 'proposal', 'comes', 'bloc', 'struggles', 'turn', 'around', 'sluggish', 'inoculation', 'campaign', 'governments', 'Berlin', 'Paris', 'battle', 'rise', 'infections', 'year', 'since', 'started', 'The', 'situation', 'also', 'fueled', 'spat', 'UK', 'itâs', 'former', 'member', 'vaccine', 'supplies', 'Britain', 'âœWe', 'ensure', 'timely', 'sufficient', 'vaccine', 'deliveries', 'EU', 'citizensâ', 'European', 'Commission', 'President', 'Ursula', 'von', 'der', 'Leyen', 'said', 'statement', 'âœThe', 'EU', 'major', 'Organization', 'Economic', 'Cooperation', 'Development', 'producer', 'continues', 'export', 'vaccines', 'large', 'scale', 'dozens', 'countries', 'open', 'roads', 'run', 'directionsâ', 'The', 'new', 'export', 'rules', 'coincide', 'coronavirus', 'situation', 'Europe', 'getting', 'bleaker', 'governments', 'face', 'pressure', 'citizens', 'arenât', 'vaccinated', 'quickly', 'elsewhere', 'EU', 'finds', 'disputes', 'manufacturers', 'countries', 'When', 'leaders', 'hold', 'summit', 'Thursday', 'theyâll', 'discuss', 'blocâs', 'latest', 'powers', 'say', 'âœsituation', 'remains', 'seriousâ', 'âœrestrictions', 'including', 'nonessential', 'travel', 'must', 'therefore', 'upheldâ', 'according', 'EU', 'document', 'seen', 'Bloomberg', 'While', 'legislation', 'isnât', 'aimed', 'specific', 'countries', 'itâs', 'clear', 'UK', 'could', 'one', 'biggest', 'targets', 'adding', 'even', 'drama', 'increasingly', 'fraught', 'relationship', 'three', 'months', 'day', 'since', 'two', 'sides', 'signed', 'trade', 'deal', 'As', 'well', 'disagreements', 'export', 'Covid', 'vaccines', 'UK', 'refused', 'grant', 'full', 'rights', 'blocâs', 'ambassador', 'London', 'EU', 'still', 'smarting', 'UKâs', 'threat', 'later', 'withdrawn', 'break', 'international', 'law', 'last', 'year', 'rewrite', 'Brexit', 'agreement', 'The', 'European', 'Commissionâs', 'draft', 'legislation', 'published', 'Wednesday', 'said', 'governments', 'take', 'account', 'issues', 'including', 'whether', 'countries', 'exporting', 'vaccines', 'back', 'EU', 'well', 'epidemiological', 'vaccine', 'situation', 'The', 'measures', 'stay', 'place', 'least', 'end', 'June', 'According', 'document', 'vaccine', 'manufacturers', 'exported', 'âœlarge', 'quantitiesâ', 'âœcertain', 'countries', 'without', 'production', 'capacity', 'higher', 'vaccination', 'rateâ', 'EU', 'current', 'rate', 'Covid', 'infections', 'isnât', 'high', 'Exports', 'countries', 'may', 'âœthreaten', 'security', 'supplyâ', 'legislation', 'says', 'It', 'adds', 'manufacturers', 'exported', 'countries', 'âœhave', 'large', 'production', 'capacity', 'ownâ', 'yet', 'âœthose', 'countries', 'restrict', 'exportsâ', 'EU', 'The', 'plan', 'aimed', 'companies', 'Astrazeneca', 'Plc', 'LON', 'arenât', 'delivering', 'commitments', 'also', 'factors', 'possible', 'future', 'difficulties', 'companies', 'like', 'Pfizer', 'Inc', 'NYSE', 'meeting', 'obligations', 'according', 'official', 'familiar', 'proposal', 'asked', 'identified', 'plans', 'private', 'Slow', 'Rollout', 'In', 'effort', 'get', 'around', 'claims', 'governments', 'notably', 'UK', 'donât', 'formal', 'export', 'restrictions', 'legislation', 'makes', 'clear', 'come', 'âœeither', 'law', 'contractual', 'arrangements', 'concluded', 'vaccine', 'manufacturersâ', 'While', 'ban', 'exports', 'countries', 'wonât', 'automatic', 'âœmember', 'states', 'refuse', 'export', 'authorizations', 'accordinglyâ', 'draft', 'said', 'The', 'new', 'rules', 'could', 'consequences', 'UK', 'received', 'million', 'million', 'doses', 'shipped', 'EU', 'far', 'biggest', 'recipient', 'blocâs', 'vaccines', 'It', 'also', 'vaccinated', 'faster', 'rate', 'falling', 'infections', 'The', 'bloc', 'administered', 'doses', 'per', 'people', 'less', 'third', 'UK', 'managed', 'according', 'Bloombergâs', 'Coronavirus', 'Vaccine', 'Tracker', 'Israel', 'inoculated', 'half', 'population', 'Neighboring', 'countries', 'included', 'new', 'directive', 'due', 'increased', 'risk', 'third', 'parties', 'using', 'special', 'trade', 'privileges', 'help', 'circumvent', 'tighter', 'export', 'criteria', 'according', 'document', 'The', 'rules', 'include', 'European', 'Free', 'Trade', 'Association', 'countries', 'well', 'European', 'Economic', 'Area', 'Vaccine', 'âGreedâ', 'UK', 'Prime', 'Minister', 'Boris', 'Johnson', 'told', 'reporters', 'London', 'countries', 'âœfighting', 'pandemicâ', 'government', 'âœcontinue', 'work', 'European', 'partnersâ', 'Later', 'however', 'risked', 'inflaming', 'tensions', 'telling', 'group', 'Conservative', 'MPs', 'private', 'meeting', 'via', 'Zoom', 'UKâs', 'vaccine', 'success', 'âœgreedâ', 'The', 'government', 'sought', 'limit', 'damage', 'cabinet', 'minister', 'Priti', 'Patel', 'taking', 'rare', 'step', 'using', 'television', 'interviews', 'try', 'explain', 'premierâs', 'remarks', 'British', 'officials', 'usually', 'comment', 'public', 'private', 'discussions', 'meeting', 'Johnson', 'party', 'The', 'EU', 'UK', 'currently', 'negotiating', 'divide', 'stock', 'Astra', 'plant', 'Netherlands', 'due', 'come', 'stream', 'next', 'weeks', 'A', 'European', 'diplomat', 'said', 'scope', 'agreement', 'form', 'prorata', 'distribution', 'based', 'population', 'size', 'Meanwhile', 'Canadaâs', 'government', 'described', 'EUâs', 'proposals', 'âœconcerningâ', 'And', 'Australia', 'Health', 'Minister', 'Greg', 'Hunt', 'Wednesday', 'said', 'nation', 'received', 'less', 'fifth', 'million', 'doses', 'contracted', 'AstraZenecaâs', 'European', 'operations', 'Earlier', 'month', 'Italy', 'blocked', 'vaccine', 'shipments', 'Australia', 'using', 'EU', 'mechanism', 'Bloomberg', 'LP'], ['Â', 'Reuters', 'BAC', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'NKE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'More', 'ships', 'backed', 'waiting', 'get', 'Suez', 'Canal', 'may', 'remain', 'blocked', 'Sunday', 'The', 'EU', 'UK', 'dial', 'vaccine', 'war', 'ahead', 'summit', 'President', 'Joe', 'Biden', 'Zoom', 'call', 'united', 'front', 'China', 'government', 'medialed', 'backlash', 'Nike', 'NYSE', 'HM', 'ST', 'progress', 'companies', 'said', 'would', 'cut', 'ties', 'cotton', 'suppliers', 'Xinjiang', 'claims', 'forced', 'labour', 'AstraZeneca', 'NASDAQ', 'revises', 'assessment', 'efficacy', 'drug', 'much', 'enough', 'create', 'headscratching', 'And', 'jobless', 'claims', 'data', 'expected', 'show', 'downward', 'trend', 'unemployment', 'reasserting', 'Here', 'need', 'know', 'financial', 'markets', 'Thursday', 'March', 'Suez', 'still', 'blocked', 'The', 'Suez', 'Canal', 'one', 'important', 'arteries', 'global', 'trade', 'remained', 'blocked', 'third', 'day', 'massive', 'container', 'ship', 'jammed', 'walls', 'heavy', 'winds', 'Tuesday', 'Bloomberg', 'reported', 'elite', 'salvage', 'squad', 'due', 'arrive', 'site', 'later', 'Thursday', 'add', 'efforts', 'tugboats', 'diggers', 'far', 'failed', 'extract', 'ship', 'longer', 'Parisâs', 'Eiffel', 'Tower', 'tall', 'Dutch', 'state', 'TV', 'quoted', 'head', 'salvage', 'company', 'saying', 'might', 'take', 'weeks', 'unblock', 'canal', 'The', 'blockage', 'left', 'ships', 'stranded', 'waiting', 'entrance', 'Canal', 'disruption', 'promises', 'reflected', 'commodity', 'prices', 'trade', 'flows', 'least', 'month', 'The', 'Canal', 'acts', 'major', 'conduit', 'Persian', 'Gulf', 'Europe', 'US', 'east', 'coast', 'also', 'Russian', 'oil', 'shipped', 'Asia', 'Crude', 'futures', 'barrel', 'barrel', 'Europe', 'UK', 'dial', 'vaccine', 'war', 'AstraZeneca', 'revises', 'drug', 'data', 'The', 'UK', 'EU', 'signalled', 'truce', 'fight', 'vaccines', 'pledging', 'work', 'together', 'joint', 'statement', 'released', 'ahead', 'EU', 'summit', 'later', 'day', 'The', 'summit', 'also', 'attended', 'remotely', 'US', 'President', 'Joe', 'Biden', 'Overnight', 'AstraZeneca', 'PLC', 'LON', 'updated', 'US', 'trial', 'results', 'show', 'slightly', 'lower', 'efficacy', 'rate', 'vaccine', 'It', 'says', 'drug', 'effective', 'stopping', 'virus', 'repeated', 'successful', 'preventing', 'death', 'hospitalization', 'The', 'discrepancy', 'initial', 'results', 'nonetheless', 'sheds', 'unwelcome', 'light', 'AZâs', 'internal', 'processes', 'adding', 'previous', 'confusion', 'initial', 'test', 'results', 'Europe', 'The', 'AZ', 'virus', 'vital', 'part', 'global', 'vaccination', 'campaign', 'substantially', 'cheaper', 'offered', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'Thatâs', 'important', 'two', 'worst', 'outbreaks', 'world', 'present', 'raging', 'India', 'Brazil', 'Stocks', 'set', 'open', 'higher', 'jobless', 'claims', 'Fed', 'speakers', 'eyed', 'US', 'stocks', 'set', 'open', 'modestly', 'higher', 'declines', 'Wednesday', 'attention', 'likely', 'focused', 'weekly', 'report', 'AM', 'ET', 'GMT', 'By', 'AM', 'ET', 'GMT', 'points', 'Initial', 'claims', 'expected', 'fallen', 'previous', 'week', 'arguably', 'important', 'number', 'always', 'total', 'number', 'people', 'unemploymentrelated', 'benefits', 'The', 'final', 'reading', 'fourthquarter', 'GDP', 'also', 'due', 'time', 'There', 'speeches', 'Federal', 'Reserve', 'members', 'course', 'day', 'Emerging', 'central', 'banks', 'ponder', 'rising', 'inflation', 'slide', 'continues', 'Itâs', 'another', 'big', 'day', 'emerging', 'market', 'central', 'banks', 'due', 'announce', 'latest', 'monetary', 'policy', 'decisions', 'Inflationary', 'pressures', 'forced', 'Turkey', 'Russia', 'Brazil', 'raising', 'interest', 'rates', 'last', 'week', 'analysts', 'donât', 'expect', 'hike', 'either', 'meeting', 'Mexican', 'central', 'bank', 'particular', 'expected', 'move', 'hawkish', 'guidance', 'Overnight', 'Switzerland', 'left', 'monetary', 'policy', 'unchanged', 'toned', 'talk', 'possibly', 'intervening', 'cap', 'francâs', 'rise', 'In', 'digital', 'currency', 'space', 'Bitcoin', 'continued', 'slide', 'backdrop', 'negative', 'commentary', 'Teslaâs', 'embrace', 'Bank', 'America', 'NYSE', 'analysts', 'issued', 'note', 'highlighting', 'currencyâs', 'carbon', 'footprint', 'odds', 'Teslaâs', 'stated', 'goal', 'reducing', 'carbon', 'emissions', 'At', 'conference', 'held', 'Bank', 'International', 'Settlements', 'former', 'ECB', 'board', 'member', 'Benoit', 'Coeure', 'repeated', 'Bitcoin', 'âœfailedâ', 'establish', 'genuine', 'currency', 'Nike', 'HM', 'feel', 'Chinese', 'backlash', 'Xinjiang', 'cotton', 'boycott', 'Stocks', 'focus', 'later', 'may', 'include', 'Nike', 'facing', 'backlash', 'China', 'cutting', 'ties', 'cotton', 'suppliers', 'province', 'Xinjiang', 'Swedish', 'fashion', 'chain', 'HM', 'problem', 'The', 'companies', 'made', 'moves', 'US', 'EU', 'UK', 'imposed', 'sanctions', 'Chinese', 'officials', 'relation', 'allegations', 'human', 'rights', 'violations', 'Xinjiang', 'US', 'says', 'China', 'conducting', 'genocide', 'Muslim', 'Uighur', 'minority', 'China', 'angrily', 'responded', 'sees', 'interference', 'domestic', 'affairs', 'Bidenâs', 'participation', 'EU', 'summit', 'later', 'intended', 'reflect', 'united', 'stance', 'West', 'visÃ', 'vis', 'China', 'Â', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'traded', 'mixed', 'fashion', 'Thursday', 'investors', 'digested', 'regionâs', 'situation', 'ahead', 'meeting', 'EU', 'leaders', 'At', 'AM', 'ET', 'GMT', 'Germany', 'traded', 'lower', 'France', 'fell', 'UK', 'index', 'climbed', 'The', 'main', 'focus', 'European', 'markets', 'virtual', 'meeting', 'EU', 'leaders', 'discuss', 'third', 'wave', 'cases', 'hitting', 'region', 'well', 'associated', 'slow', 'vaccine', 'rollout', 'The', 'leaders', 'likely', 'discuss', 'possible', 'curbs', 'vaccine', 'exports', 'source', 'tension', 'neighboring', 'UK', 'whose', 'immunization', 'program', 'advanced', 'Germany', 'France', 'Italy', 'Netherlands', 'recently', 'tightened', 'restrictions', 'combat', 'increasing', 'number', 'infections', 'threatening', 'swamp', 'regionâs', 'hospitals', 'There', 'good', 'news', 'region', 'GfK', 'index', 'came', 'April', 'small', 'improvement', 'seen', 'March', 'still', 'indicative', 'pessimistic', 'consumer', 'regionâs', 'largest', 'domestic', 'market', 'lockdowns', 'weigh', 'Sentiment', 'French', 'manufacturing', 'sector', 'stabilized', 'Insee', 'monthly', 'survey', 'showing', 'sentiment', 'sector', 'remained', 'March', 'unchanged', 'Februaryâs', 'figure', 'In', 'corporate', 'news', 'AstraZeneca', 'LON', 'stock', 'rose', 'drugmaker', 'announced', 'late', 'Wednesday', 'Covid', 'vaccine', 'effective', 'preventing', 'symptomatic', 'illness', 'slight', 'drop', 'level', 'initially', 'reported', 'questions', 'raised', 'data', 'used', 'US', 'trial', 'Cineworld', 'LON', 'stock', 'fell', 'cinema', 'chain', 'reported', 'billion', 'loss', 'said', 'ask', 'shareholders', 'approve', 'raise', 'debt', 'ceiling', 'Hennes', 'Mauritz', 'ST', 'stock', 'dropped', 'Chinese', 'state', 'media', 'singled', 'Swedish', 'retailer', 'Wednesday', 'statement', 'last', 'year', 'company', 'said', 'deeply', 'concerned', 'reports', 'accusations', 'forced', 'labour', 'Xinjiang', 'Oil', 'prices', 'fell', 'Thursday', 'reversing', 'Wednesdayâs', 'gains', 'came', 'container', 'ship', 'got', 'stuck', 'Suez', 'Canal', 'blocking', 'one', 'important', 'supply', 'routes', 'world', 'This', 'passage', 'remains', 'plugged', 'demand', 'concerns', 'returned', 'fore', 'While', 'focus', 'lockdowns', 'Europe', 'crucial', 'developing', 'economies', 'like', 'India', 'Brazil', 'also', 'seen', 'rising', 'numbers', 'cases', 'Additionally', 'US', 'crude', 'stocks', 'jumped', 'million', 'barrels', 'last', 'week', 'according', 'official', 'data', 'traded', 'lower', 'barrel', 'contract', 'fell', 'Elsewhere', 'fell', 'traded', 'lower'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'SMIN', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'Key', 'Points', 'closing', 'price', 'GBP', 'strong', 'economy', 'hopes', 'Oil', 'jumps', 'Suez', 'Canal', 'still', 'blocked', 'Miners', 'rally', 'higher', 'metals', 'prices', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'FTSE', 'finished', 'Friday', 'higher', 'close', 'week', 'gain', 'Smiths', 'Group', 'PLC', 'LON', 'best', 'performing', 'stock', 'bluechip', 'index', 'company', 'reported', 'halfyear', 'results', 'premarket', 'The', 'company', 'boosted', 'dividend', 'said', 'confident', 'meeting', 'market', 'expectations', 'full', 'year', 'despite', 'uncertainty', 'Covid', 'Miners', 'particularly', 'strong', 'amid', 'increase', 'basic', 'resources', 'prices', 'jumped', 'back', 'due', 'optimism', 'US', 'growth', 'ahead', 'Bidenâs', 'infrastructure', 'plan', 'set', 'unveiled', 'next', 'week', 'Burberry', 'Group', 'PLC', 'LON', 'underperformed', 'company', 'became', 'latest', 'face', 'backlash', 'China', 'Xinjiang', 'cotton', 'row', 'The', 'fashion', 'company', 'member', 'Better', 'Cotton', 'Initiative', 'group', 'suspended', 'approval', 'cotton', 'Xinjiang', 'due', 'concerns', 'human', 'rights', 'The', 'Chinese', 'actress', 'Zhou', 'Dongyu', 'terminated', 'contract', 'Burberry', 'brand', 'ambassador', 'companyâs', 'famous', 'check', 'patter', 'removed', 'Tencentâs', 'video', 'game', 'Honor', 'Kings', 'due', 'backlash', 'Burberry', 'faced', 'China', 'strengthened', 'Friday', 'amid', 'general', 'vaccine', 'optimism', 'hopes', 'fast', 'economic', 'rebound', 'This', 'comes', 'despite', 'meeting', 'European', 'leaders', 'yesterday', 'agreed', 'AstraZeneca', 'PLC', 'LON', 'NASDAQ', 'could', 'export', 'Covid', 'vaccines', 'contract', 'EU', 'fulfilled', 'Reports', 'EU', 'UK', 'also', 'close', 'deal', 'financial', 'services', 'also', 'supported', 'GBP', 'âœThe', 'economic', 'wheel', 'fortune', 'seems', 'turning', 'back', 'UKâs', 'favourâ', 'said', 'Kallum', 'Pickering', 'Berenberg', 'âœWe', 'expect', 'strong', 'consumerled', 'recovery', 'spring', 'onwards', 'savings', 'normalise', 'facetoface', 'services', 'reopen', 'manufacturers', 'step', 'production', 'meet', 'rising', 'demandâ', 'The', 'UK', 'data', 'little', 'dampen', 'outlook', 'GBP', 'volumes', 'increasing', 'February', 'The', 'increase', 'partly', 'driven', 'increase', 'outdoor', 'furniture', 'purchases', 'Covid', 'restrictions', 'start', 'easing', 'next', 'week', 'UK', 'futures', 'benefitted', 'ongoing', 'blockage', 'Suez', 'Canal', 'Ever', 'Given', 'container', 'ship', 'It', 'still', 'unclear', 'long', 'ship', 'stranded', 'reports', 'shipping', 'companies', 'begun', 'reroute', 'tankers', 'around', 'Africa', 'adding', 'around', 'days', 'sailing', 'times', 'Europe', 'days', 'US', 'east', 'coast', 'jumped', 'finding', 'support', 'ahead', 'Thursday', 'The', 'worldâs', 'largest', 'cryptocurrency', 'still', 'remains', 'away', 'alltime', 'high', 'tumbling', 'week', 'market', 'cap'], ['Â', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Key', 'Points', 'FTSE', 'closing', 'price', 'AstraZeneca', 'NASDAQ', 'shares', 'rise', 'top', 'FTSE', 'Barclays', 'falls', 'despite', 'increased', 'profit', 'falls', 'despite', 'increased', 'profit', 'Darktrace', 'soars', 'trading', 'debut', 'USD', 'jumps', 'Fed', 'taper', 'comments', 'Oil', 'retreats', 'OPEC', 'production', 'due', 'come', 'back', 'online', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'finished', 'marginally', 'higher', 'Friday', 'still', 'closed', 'psychological', 'hawkish', 'comments', 'Fedâs', 'Kaplan', 'appeared', 'dampen', 'risk', 'appetite', 'Kaplan', 'traditionally', 'one', 'hawkish', 'members', 'FOMC', 'said', 'would', 'appropriate', 'start', 'talking', 'asset', 'purchases', 'Riskier', 'assets', 'also', 'dampened', 'study', 'Imperial', 'College', 'regarding', 'Pfizer', 'NYSE', 'vaccine', 'The', 'study', 'suggested', 'healthcare', 'workers', 'one', 'dose', 'jab', 'risk', 'Covid', 'variants', 'âœIn', 'previously', 'infected', 'far', 'received', 'one', 'dose', 'vaccine', 'immune', 'response', 'variants', 'concern', 'may', 'insufficientâ', 'Imperial', 'College', 'said', 'study', 'The', 'double', 'whammy', 'sent', 'fresh', 'session', 'highs', 'helped', 'weigh', 'GBPUSD', 'dropped', 'away', 'handle', 'EURUSD', 'dropped', 'back', 'towards', 'In', 'individual', 'stocks', 'news', 'AstraZeneca', 'LON', 'shares', 'led', 'FTSE', 'higher', 'recording', 'increase', 'revenue', 'first', 'quarter', 'The', 'company', 'sales', 'vaccine', 'aiming', 'deliver', 'doses', 'per', 'month', 'On', 'end', 'scale', 'Barclays', 'LON', 'The', 'company', 'still', 'recorded', 'mammoth', 'profit', 'failed', 'release', 'funds', 'expected', 'credit', 'losses', 'UK', 'peers', 'done', 'earlier', 'week', 'The', 'bank', 'reported', 'decline', 'FICC', 'income', 'also', 'seemed', 'drag', 'shares', 'lower', 'also', 'adding', 'costs', 'year', 'likely', 'higher', 'Shares', 'cyber', 'security', 'firm', 'Darktrace', 'jumped', 'much', 'first', 'day', 'trading', 'initial', 'listing', 'price', 'pence', 'per', 'share', 'valued', 'company', 'crude', 'futures', 'fell', 'Friday', 'amid', 'broad', 'riskoff', 'tone', 'stronger', 'USD', 'As', 'reminder', 'next', 'week', 'Saudi', 'Arabia', 'rest', 'OPEC', 'group', 'begin', 'roll', 'back', 'production', 'cuts', 'announced', 'start', 'pandemic'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'Jan', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'India', 'drugs', 'regulator', 'Sunday', 'approved', 'emergency', 'use', 'two', 'coronavirus', 'vaccines', 'one', 'developed', 'AstraZeneca', 'Oxford', 'University', 'local', 'company', 'Bharat', 'Biotech', 'staterun', 'institute', 'ENTAIN', 'MGM', 'Resorts', 'International', 'MGMN', 'seeking', 'buy', 'British', 'gaming', 'company', 'Entain', 'latest', 'move', 'casino', 'operator', 'double', 'onlinegambling', 'business', 'Wall', 'Street', 'Journal', 'reported', 'Sunday', 'ASTRAZENECA', 'About', 'two', 'million', 'doses', 'vaccine', 'developed', 'OxfordAstraZeneca', 'set', 'supplied', 'every', 'week', 'middle', 'January', 'United', 'Kingdom', 'The', 'Times', 'reported', 'TRADING', 'Europe', 'see', 'biggest', 'transfer', 'share', 'trading', 'two', 'decades', 'stock', 'exchanges', 'open', 'business', 'Brexit', 'shifting', 'centre', 'gravity', 'away', 'London', 'Britain', 'become', 'first', 'country', 'roll', 'low', 'cost', 'easily', 'transportable', 'AstraZeneca', 'Oxford', 'University', 'vaccine', 'Monday', 'another', 'step', 'forward', 'global', 'response', 'pandemic', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'Sunday', 'tougher', 'lockdown', 'restrictions', 'probably', 'way', 'cases', 'keep', 'rising', 'schools', 'safe', 'children', 'continue', 'attend', 'permitted', 'GOLD', 'Gold', 'prices', 'started', 'new', 'year', 'high', 'notching', 'eightweek', 'peak', 'surpassing', 'key', 'level', 'surge', 'cases', 'prospects', 'tougher', 'coronavirus', 'control', 'measures', 'lured', 'investors', 'safehaven', 'metal', 'OIL', 'Oil', 'prices', 'rose', 'expectations', 'OPEC', 'allied', 'producers', 'may', 'cap', 'output', 'current', 'levels', 'February', 'meeting', 'later', 'day', 'pandemic', 'keeps', 'worries', 'firsthalf', 'demand', 'elevated', 'The', 'UK', 'bluechip', 'index', 'fell', 'Thursday', 'trading', 'session', 'lower', 'clocked', 'worst', 'year', 'since', 'financial', 'crisis', 'United', 'Kingdom', 'widened', 'restrictions', 'stem', 'new', 'variant', 'coronavirus', 'raging', 'across', 'country'], ['Â', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WFC', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'US', 'stocks', 'seen', 'opening', 'marginally', 'lower', 'Tuesday', 'negative', 'news', 'front', 'weighing', 'ahead', 'highly', 'anticipated', 'inflation', 'report', 'could', 'guide', 'near', 'term', 'market', 'sentiment', 'At', 'AM', 'ET', 'GMT', 'contract', 'points', 'traded', 'largely', 'flat', 'dropped', 'points', 'All', 'three', 'contracts', 'slid', 'lower', 'New', 'York', 'Times', 'reported', 'US', 'authorities', 'set', 'call', 'pause', 'distributing', 'Johnson', 'Johnson', 'NYSE', 'vaccine', 'amid', 'worries', 'blood', 'clotting', 'issues', 'A', 'similar', 'problem', 'plagued', 'AstraZeneca', 'LON', 'NASDAQ', 'drug', 'This', 'cautious', 'trading', 'comes', 'ahead', 'release', 'March', 'reading', 'due', 'AM', 'ET', 'GMT', 'expected', 'rise', 'monthovermonth', 'yearoveryear', 'Stock', 'markets', 'climbed', 'record', 'levels', 'late', 'helped', 'expectations', 'strong', 'US', 'economic', 'recovery', 'But', 'concerns', 'increasing', 'combination', 'unprecedented', 'levels', 'fiscal', 'stimulus', 'pent', 'demand', 'lead', 'rampant', 'inflation', 'forcing', 'Federal', 'Reserve', 'tighten', 'monetary', 'policies', 'quickly', 'earlier', 'anticipated', 'Fed', 'officials', 'pains', 'point', 'see', 'bump', 'inflation', 'temporary', 'remain', 'committed', 'supporting', 'economic', 'recovery', 'jobs', 'picture', 'looks', 'better', 'hefty', 'CPI', 'jump', 'would', 'raise', 'pressure', 'especially', 'Fridayâs', 'sharp', 'rise', 'producer', 'prices', 'âœWith', 'commodity', 'prices', 'import', 'prices', 'continuing', 'surge', 'ISM', 'manufacturing', 'services', 'prices', 'paid', 'highest', 'level', 'since', 'increasing', 'pipeline', 'price', 'pressuresâ', 'said', 'analysts', 'ING', 'note', 'The', 'bond', 'market', 'also', 'traded', 'subdued', 'fashion', 'Tuesday', 'successful', 'Treasury', 'auction', 'benchmark', 'yield', 'edging', 'slightly', 'higher', 'trade', 'near', 'still', 'well', 'oneyear', 'high', 'around', 'seen', 'end', 'March', 'Corporate', 'news', 'set', 'pick', 'later', 'week', 'banking', 'giants', 'JPMorgan', 'Chase', 'NYSE', 'Goldman', 'Sachs', 'NYSE', 'Wells', 'Fargo', 'NYSE', 'set', 'report', 'quarterly', 'results', 'Wednesday', 'Ahead', 'Grab', 'likely', 'focus', 'Asian', 'ridehailing', 'food', 'delivery', 'firm', 'announced', 'intention', 'merge', 'Altimeter', 'leading', 'US', 'public', 'listing', 'valuing', 'company', 'nearly', 'billion', 'largest', 'ever', 'SPAC', 'deal', 'Oil', 'prices', 'edged', 'higher', 'Tuesday', 'helped', 'robust', 'Chinese', 'trade', 'data', 'indicating', 'continued', 'economic', 'recovery', 'worldâs', 'largest', 'crude', 'importer', 'tensions', 'Middle', 'East', 'Yemenbased', 'Houthi', 'movement', 'said', 'fired', 'missiles', 'Saudi', 'oil', 'sites', 'Attention', 'Tuesday', 'also', 'oil', 'supply', 'data', 'American', 'Petroleum', 'Institute', 'Organization', 'Petroleum', 'Exporting', 'Countries', 'set', 'release', 'monthly', 'report', 'oil', 'market', 'US', 'crude', 'futures', 'traded', 'higher', 'barrel', 'contract', 'rose', 'Elsewhere', 'fell', 'traded', 'lower'], ['Â', 'Reuters', 'Press', 'briefing', 'stopping', 'AstraZeneca', 'vaccine', 'Copenhagen', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Nikolaj', 'Skydsgaard', 'Jacob', 'GronholtPedersen', 'COPENHAGEN', 'Reuters', 'Denmark', 'Wednesday', 'became', 'first', 'country', 'stop', 'using', 'AstraZeneca', 'NASDAQ', 'vaccine', 'altogether', 'following', 'news', 'possible', 'link', 'rare', 'blood', 'clot', 'cases', 'health', 'authorities', 'said', 'The', 'decision', 'push', 'back', 'scheduled', 'conclusion', 'Denmark', 'vaccination', 'scheme', 'early', 'August', 'July', 'said', 'Results', 'investigations', 'blood', 'clots', 'showed', 'real', 'serious', 'side', 'effects', 'health', 'agency', 'head', 'Soren', 'Brostrom', 'said', 'statement', 'Based', 'overall', 'consideration', 'therefore', 'chosen', 'continue', 'vaccination', 'programme', 'target', 'groups', 'without', 'vaccine', 'The', 'European', 'Union', 'drug', 'watchdog', 'said', 'last', 'week', 'found', 'possible', 'link', 'AstraZeneca', 'vaccine', 'cerebral', 'venous', 'sinus', 'thrombosis', 'CVST', 'brain', 'blood', 'clot', 'said', 'risk', 'dying', 'much', 'greater', 'risk', 'mortality', 'rare', 'side', 'effects', 'As', 'April', 'European', 'Medicines', 'Agency', 'received', 'reports', 'cases', 'CVST', 'million', 'Astrazeneca', 'LON', 'doses', 'administered', 'European', 'Economic', 'Area', 'The', 'EU', 'regulator', 'however', 'left', 'individual', 'states', 'make', 'risk', 'assessments', 'decide', 'administer', 'vaccine', 'Many', 'countries', 'Europe', 'elsewhere', 'resumed', 'administering', 'shot', 'restricting', 'use', 'certain', 'age', 'groups', 'mostly', 'aged', 'Denmark', 'first', 'country', 'initially', 'suspend', 'usage', 'vaccine', 'March', 'safety', 'concerns', 'also', 'put', 'Johnson', 'Johnson', 'NYSE', 'vaccine', 'pause', 'pending', 'investigations', 'possible', 'similar', 'blood', 'clot', 'link', 'Almost', 'one', 'million', 'country', 'million', 'population', 'received', 'first', 'shots', 'getting', 'PfizerBioNTech', 'vaccine', 'Moderna', 'NASDAQ', 'AstraZeneca', 'Denmark', 'process', 'easing', 'restrictions', 'daily', 'infection', 'rate', 'slowed', 'several', 'thousand', 'December', 'Â', 'Reuters', 'WFC', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HOFT', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'ICE', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'INFY', 'Add', 'toRemove', 'Portfolio', 'BBBY', 'Add', 'toRemove', 'Portfolio', 'PRTP', 'Add', 'toRemove', 'Portfolio', 'LVMH', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Coinbase', 'set', 'go', 'public', 'via', 'direct', 'listing', 'reference', 'price', 'values', 'north', 'billion', 'Bitcoin', 'Dogecoin', 'basking', 'reflected', 'glory', 'JPMorgan', 'NYSE', 'Goldman', 'Sachs', 'NYSE', 'expected', 'report', 'banner', 'earnings', 'season', 'firstquarter', 'updates', 'kicks', 'earnest', 'French', 'luxury', 'groups', 'already', 'shown', 'way', 'Stocks', 'consolidating', 'wait', 'numbers', 'oil', 'highest', 'week', 'IEA', 'joined', 'OPEC', 'raising', 'demand', 'forecasts', 'year', 'Here', 'need', 'know', 'financial', 'markets', 'Wednesday', 'April', 'Coinbase', 'goes', 'public', 'Bitcoin', 'DogeCoin', 'hit', 'new', 'heights', 'Coinbase', 'worldâs', 'secondlargest', 'cryptocurrency', 'exchange', 'volume', 'set', 'go', 'public', 'via', 'direct', 'listing', 'later', 'landmark', 'development', 'arguably', 'pushes', 'cryptocurrencies', 'toward', 'financial', 'mainstream', 'The', 'reference', 'price', 'set', 'share', 'fully', 'diluted', 'share', 'count', 'million', 'would', 'value', 'company', 'billion', 'â', 'line', 'Intercontinental', 'Exchange', 'NYSE', 'London', 'Stock', 'Exchange', 'Group', 'LON', 'The', 'simpler', 'share', 'count', 'listed', 'prospectus', 'gives', 'valuation', 'billion', 'The', 'company', 'said', 'earlier', 'month', 'registered', 'around', 'billion', 'revenue', 'first', 'quarter', 'year', 'year', 'earlier', 'thanks', 'explosive', 'rise', 'prices', 'Bitcoin', 'Ether', 'digital', 'currencies', 'traded', 'first', 'time', 'overnight', 'DogeCoin', 'digital', 'currency', 'started', 'joke', 'touted', 'aggressively', 'Elon', 'Musk', 'recent', 'months', 'rose', 'sic', 'obvious', 'price', 'trigger', 'Banks', 'luxury', 'groups', 'kick', 'earnings', 'season', 'The', 'firstquarter', 'earnings', 'season', 'starts', 'earnest', 'JPMorgan', 'Wells', 'Fargo', 'NYSE', 'Goldman', 'Sachs', 'set', 'report', 'open', 'All', 'three', 'expected', 'report', 'sharp', 'increases', 'earnings', 'thanks', 'low', 'comparables', 'previous', 'year', 'JPMorgan', 'Goldman', 'expected', 'capitalized', 'also', 'favourable', 'capital', 'market', 'trends', 'least', 'massive', 'increase', 'SPAC', 'listings', 'turn', 'helped', 'MA', 'advisory', 'businesses', 'Overnight', 'French', 'luxury', 'groups', 'LVMH', 'PA', 'Christian', 'Dior', 'also', 'impressed', 'reporting', 'sharp', 'yearonyear', 'sales', 'increases', 'wealthy', 'clienteles', 'diverted', 'spending', 'travel', 'leisure', 'purses', 'fashion', 'Both', 'stocks', 'hit', 'record', 'highs', 'European', 'trading', 'Gucci', 'owner', 'Kering', 'PA', 'Stocks', 'drift', 'ahead', 'earnings', 'Coinbase', 'Powell', 'speaks', 'PM', 'ET', 'US', 'stock', 'markets', 'drifting', 'ahead', 'release', 'key', 'bank', 'earnings', 'later', 'JPMorgan', 'Wells', 'Fargo', 'particular', 'eyed', 'proxies', 'health', 'broader', 'US', 'economy', 'By', 'AM', 'ET', 'GMT', 'points', 'less', 'similar', 'amount', 'Nasdaq', 'futures', 'All', 'three', 'still', 'enjoying', 'supportive', 'tone', 'Tuesdayâs', 'rally', 'bonds', 'March', 'inflation', 'data', 'failed', 'generate', 'negative', 'shock', 'In', 'addition', 'banks', 'Bed', 'Bath', 'Beyond', 'NASDAQ', 'Hooker', 'Furniture', 'NASDAQ', 'Infosys', 'NYSE', 'also', 'set', 'report', 'earnings', 'open', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powellâs', 'address', 'Economic', 'Club', 'New', 'York', 'PM', 'ET', 'also', 'generate', 'headlines', 'unlikely', 'add', 'much', 'current', 'knowledge', 'central', 'bankâs', 'thinking', 'JJ', 'vaccine', 'hitch', 'poses', 'new', 'threat', 'EU', 'inoculation', 'progress', 'The', 'European', 'Commission', 'end', 'contracts', 'Johnson', 'Johnson', 'NYSE', 'AstraZeneca', 'LON', 'NASDAQ', 'expire', 'according', 'Italian', 'newspaper', 'La', 'Stampa', 'JJ', 'said', 'would', 'pause', 'rollout', 'vaccine', 'Europe', 'Tuesday', 'US', 'health', 'authorities', 'recommended', 'pause', 'administering', 'possible', 'links', 'rare', 'severe', 'blood', 'clots', 'investigated', 'Both', 'vaccines', 'based', 'adenovirusbased', 'technology', 'JJ', 'contracted', 'supply', 'enough', 'vaccine', 'protect', 'million', 'people', 'EU', 'second', 'quarter', 'quarter', 'blocâs', 'total', 'vaccination', 'schedule', 'next', 'three', 'months', 'As', 'threatens', 'delay', 'attainment', 'herd', 'immunity', 'something', 'could', 'seriously', 'undermined', 'blocâs', 'attempts', 'salvage', 'summer', 'tourism', 'season', 'EasyJet', 'said', 'earlier', 'expects', 'fly', 'total', 'capacity', 'three', 'months', 'June', 'winter', 'season', 'IEA', 'raises', 'oil', 'demand', 'forecasts', 'EIA', 'inventories', 'due', 'The', 'International', 'Energy', 'Agency', 'followed', 'OPEC', 'raising', 'forecasts', 'global', 'oil', 'demand', 'year', 'average', 'barrels', 'day', 'March', 'forecasts', 'However', 'pushed', 'increase', 'back', 'second', 'half', 'year', 'view', 'ongoing', 'pandemicrelated', 'headwinds', 'The', 'IEA', 'said', 'expects', 'million', 'barrels', 'day', 'capacity', 'needed', 'come', 'online', 'second', 'half', 'beyond', 'OPEC', 'group', 'already', 'agreed', 'release', 'By', 'AM', 'ET', 'futures', 'barrel', 'highest', 'days', 'barrel', 'US', 'government', 'inventory', 'data', 'due', 'AM', 'ET', 'usual', 'expected', 'show', 'million', 'barrel', 'decline', 'crude', 'stocks', 'last', 'week', 'Â', 'Reuters', 'FILE', 'PHOTO', 'OxfordAstraZeneca', 'vaccine', 'vaccination', 'centre', 'Antwerp', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'MILAN', 'Reuters', 'The', 'EU', 'Commission', 'decided', 'renew', 'vaccine', 'contracts', 'next', 'year', 'companies', 'Astrazeneca', 'LON', 'Johnson', 'Johnson', 'NYSE', 'JJ', 'Italian', 'daily', 'La', 'Stampa', 'reported', 'Wednesday', 'citing', 'source', 'Italian', 'Health', 'Ministry', 'The', 'European', 'Commission', 'agreement', 'leaders', 'many', 'EU', 'countries', 'decided', 'contracts', 'companies', 'produce', 'viral', 'vector', 'vaccines', 'valid', 'current', 'year', 'renewed', 'expiry', 'newspaper', 'reported', 'It', 'added', 'Brussels', 'would', 'rather', 'focus', 'vaccines', 'using', 'messenger', 'RNA', 'mRNA', 'technology', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'The', 'European', 'Commission', 'seeking', 'clarification', 'JJ', 'company', 'completely', 'unexpected', 'announcement', 'delays', 'vaccine', 'deliveries', 'EU', 'EU', 'official', 'told', 'Reuters', 'Tuesday'], ['UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'Segro', 'Plc', 'LON', 'rose', 'points', 'trade', 'close', 'Avast', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'British', 'American', 'Tobacco', 'PLC', 'LON', 'declined', 'points', 'end', 'Imperial', 'Brands', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'June', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'NILSY', 'Add', 'toRemove', 'Portfolio', 'VTBRq', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Bank', 'VTB', 'PAO', 'DRC', 'LON', 'added', 'points', 'end', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Barclays', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Ocado', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'GMK', 'Norilskiy', 'Nikel', 'PAO', 'DRC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'INF', 'Add', 'toRemove', 'Portfolio', 'AVV', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'VTBRq', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'gained', 'The', 'biggest', 'gainers', 'session', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'rose', 'points', 'trade', 'close', 'Bank', 'VTB', 'PAO', 'DRC', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AVEVA', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Informa', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'GRG', 'Add', 'toRemove', 'Portfolio', 'HOTC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SCSS', 'Add', 'toRemove', 'Portfolio', 'ICGT', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'AGRP', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'GPEG', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'services', 'composite', 'PMIs', 'Eurozone', 'US', 'US', 'Stocks', 'Greggs', 'LON', 'Twoyear', 'like', 'like', 'sales', 'despite', 'staffing', 'supply', 'chain', 'disruption', 'Subject', 'unexpected', 'COVID', 'disruption', 'expect', 'full', 'year', 'outcome', 'ahead', 'previous', 'expectations', 'BHP', 'LON', 'Reportedly', 'talks', 'Ivanhoe', 'Mines', 'buy', 'Western', 'Foreland', 'project', 'Democratic', 'Republic', 'Congo', 'Tesco', 'LON', 'Close', 'settling', 'final', 'meaningful', 'legal', 'action', 'shareholders', 'accounting', 'crisis', 'Could', 'announce', 'reached', 'agreement', 'group', 'institutional', 'investors', 'âœsubstantial', 'payoutâ', 'alongside', 'results', 'Wednesday', 'AstraZeneca', 'LON', 'Requested', 'Emergency', 'Use', 'Authorization', 'EUA', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'prophylaxis', 'Melrose', 'Industries', 'LON', 'Supply', 'constraints', 'automotive', 'industry', 'affects', 'performance', 'companyâs', 'Automotive', 'Powder', 'Metallurgy', 'divisions', 'At', 'present', 'timing', 'duration', 'constraints', 'uncertain', 'recently', 'consensus', 'view', 'lengthened', 'There', 'number', 'scenarios', 'possible', 'likely', 'previous', 'expectations', 'Melrose', 'confident', 'scale', 'impact', 'profitability', 'revenue', 'adjustment', 'previous', 'guidance', 'given', 'margin', 'dropthrough', 'underlining', 'good', 'progress', 'made', 'restructuring', 'businesses', 'Anglo', 'American', 'LON', 'Seamus', 'French', 'leave', 'end', 'replaced', 'CEO', 'Bulk', 'Commodities', 'Themba', 'Mkhwanazi', 'currently', 'CEO', 'Kumba', 'Mpumi', 'Zikalala', 'currently', 'Managing', 'Director', 'De', 'Beers', 'Managed', 'Operations', 'appointed', 'CEO', 'Kumba', 'Great', 'Portland', 'Estates', 'LON', 'million', 'new', 'annual', 'rent', 'signed', 'quarter', 'September', 'market', 'lettings', 'ahead', 'March', 'ERV', 'Sold', 'Old', 'Street', 'million', 'reflecting', 'premium', 'March', 'valuation', 'Expect', 'healthy', 'demand', 'persist', 'million', 'lettings', 'offer', 'ahead', 'ERV', 'million', 'new', 'annual', 'rent', 'negotiation', 'Assura', 'LON', 'Growing', 'portfolio', 'properties', 'current', 'annualised', 'rent', 'roll', 'million', 'Added', 'properties', 'portfolio', 'comprising', 'seven', 'new', 'development', 'completions', 'acquisitions', 'combined', 'total', 'cost', 'million', 'ICG', 'Enterprise', 'Trust', 'LON', 'NAV', 'per', 'Share', 'NAV', 'per', 'Share', 'Total', 'Return', 'Second', 'quarter', 'dividend', 'per', 'share', 'taking', 'total', 'period', 'Intention', 'reaffirmed', 'declare', 'total', 'dividends', 'least', 'per', 'share', 'financial', 'year', 'Scs', 'Group', 'LON', 'FY', 'gross', 'sales', 'increased', 'million', 'Underlying', 'profit', 'tax', 'million', 'million', 'One', 'year', 'likeforlike', 'order', 'intake', 'despite', 'closed', 'weeks', 'compared', 'weeks', 'Recommended', 'final', 'dividend', 'per', 'share', 'Year', 'date', 'trading', 'Board', 'expectations', 'Hotel', 'Chocolat', 'LON', 'â', 'FY', 'revenue', 'increase', 'million', 'Underlying', 'EBITDA', 'million', 'million', 'Group', 'trading', 'line', 'management', 'expectations', 'first', 'weeks'], ['DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'WMT', 'Add', 'toRemove', 'Portfolio', 'HD', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'M', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Liz', 'Moyer', 'Investingcom', 'Stocks', 'wobbled', 'Monday', 'good', 'news', 'vaccine', 'rollouts', 'reopenings', 'across', 'US', 'blunted', 'concerns', 'interest', 'rates', 'Energy', 'stocks', 'helped', 'overcome', 'losses', 'tech', 'side', 'oil', 'prices', 'climbed', 'even', 'Colonial', 'Pipeline', 'said', 'back', 'online', 'This', 'big', 'week', 'retail', 'earnings', 'Walmart', 'Inc', 'NYSE', 'kicking', 'things', 'President', 'Joe', 'Biden', 'announced', 'US', 'would', 'ship', 'million', 'doses', 'vaccine', 'abroad', 'including', 'million', 'doses', 'AstraZeneca', 'PLC', 'LON', 'âs', 'vaccine', 'still', 'awaits', 'approval', 'Some', 'million', 'doses', 'Pfizer', 'Inc', 'NYSE', 'Moderna', 'Inc', 'NASDAQ', 'Johnson', 'Johnson', 'NYSE', 'vaccines', 'sent', 'end', 'June', 'New', 'Yorkâs', 'Gov', 'Andrew', 'Cuomo', 'announced', 'state', 'would', 'lift', 'mask', 'mandate', 'Wednesday', 'The', 'Federal', 'Reserve', 'release', 'minutes', 'latest', 'meeting', 'Wednesday', 'investors', 'waiting', 'see', 'say', 'inflation', 'expectations', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'Walmart', 'earnings', 'Walmart', 'kicks', 'week', 'retail', 'earnings', 'Analysts', 'tracked', 'Investingcom', 'expect', 'profit', 'share', 'revenue', 'billion', 'Analysts', 'watching', 'trends', 'membership', 'service', 'Walmart', 'effect', 'stimulus', 'checks', 'sales', 'outlook', 'sales', 'given', 'rising', 'consumer', 'prices', 'Home', 'Depot', 'earnings', 'Home', 'Depot', 'Inc', 'NYSE', 'seen', 'reporting', 'earnings', 'share', 'revenue', 'billion', 'The', 'home', 'improvement', 'retailer', 'booming', 'year', 'pandemic', 'people', 'took', 'doityourself', 'projects', 'moved', 'houses', 'Analysts', 'listening', 'outlook', 'especially', 'given', 'redhot', 'housing', 'market', 'Macy', 'earnings', 'Macyâs', 'Inc', 'NYSE', 'expected', 'report', 'loss', 'cents', 'share', 'revenue', 'billion', 'according', 'analysts', 'tracked', 'Investingcom', 'Department', 'stores', 'malls', 'forced', 'shut', 'much', 'last', 'year', 'able', 'reopen', 'shoppers', 'last', 'months', 'analysts', 'listening', 'hear', 'whether', 'companyâs', 'executives', 'think', 'worst', 'behind'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Britain', 'Aug', 'REUTERSPeter', 'Nicholls', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'PAGE', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Bansari', 'Mayur', 'Kamdar', 'Reuters', 'London', 'bluechip', 'stocks', 'fell', 'Wednesday', 'pressured', 'fears', 'higher', 'inflation', 'supermarket', 'retailer', 'Tesco', 'LON', 'topped', 'index', 'raising', 'annual', 'outlook', 'strong', 'firsthalf', 'results', 'The', 'eased', 'recording', 'worst', 'session', 'since', 'August', 'weighed', 'energy', 'mining', 'stocks', 'respectively', 'A', 'recent', 'survey', 'found', 'British', 'manufacturers', 'plan', 'raise', 'prices', 'point', 'past', 'three', 'decades', 'cost', 'pressures', 'continue', 'build', 'Inflation', 'fears', 'rising', 'back', 'soaring', 'energy', 'costs', 'supply', 'side', 'labour', 'shortages', 'weighed', 'equities', 'central', 'banks', 'look', 'pull', 'back', 'pandemic', 'era', 'monetary', 'support', 'hike', 'rates', 'relieve', 'cost', 'pressures', 'There', 'big', 'concern', 'increasing', 'inflationary', 'pressures', 'coming', 'time', 'evidence', 'UK', 'recovery', 'slowing', 'fears', 'stagflation', 'understandably', 'growing', 'said', 'Stuart', 'Cole', 'head', 'macro', 'economics', 'Equiti', 'Capital', 'Banking', 'stocks', 'gained', 'bond', 'yields', 'surged', 'past', 'highest', 'level', 'since', 'spring', 'signs', 'rising', 'inflationary', 'pressures', 'The', 'FTSE', 'recovered', 'around', 'pandemic', 'lows', 'hit', 'March', 'around', 'far', 'year', 'rebounding', 'optimism', 'supportive', 'monetary', 'policies', 'HSBC', 'Holdings', 'LON', 'led', 'pack', 'UBS', 'raised', 'price', 'target', 'upgraded', 'stock', 'buy', 'neutral', 'The', 'domestically', 'focused', 'midcap', 'index', 'fell', 'near', 'threemonth', 'low', 'consumer', 'discretionary', 'stocks', 'leading', 'declines', 'Barclays', 'LON', 'downgraded', 'subindex', 'underweight', 'Tesco', 'rose', 'raising', 'fullyear', 'outlook', 'following', 'strong', 'profit', 'first', 'half', 'results', 'Global', 'recruitment', 'firm', 'PageGroup', 'climbed', 'raised', 'profit', 'forecast', 'Tobacco', 'group', 'Imperial', 'Brands', 'LON', 'fell', 'although', 'said', 'track', 'meet', 'fullyear', 'operating', 'profit', 'forecast'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'TWODY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DARK', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'UK', 'German', 'speech', 'Stocks', 'London', 'Stock', 'Exchange', 'Group', 'LON', 'To', 'acquire', 'Qunatile', 'Group', 'Limited', 'maximum', 'aggregate', 'consideration', 'million', 'Darktrace', 'LON', 'To', 'commence', 'share', 'buyback', 'programme', 'million', 'ordinary', 'shares', 'The', 'maximum', 'amount', 'allocated', 'Programme', 'million', 'BT', 'LON', 'Discovery', 'reportedly', 'talks', 'create', 'joint', 'venture', 'BT', 'Sport', 'move', 'would', 'hijack', 'sale', 'sports', 'streaming', 'service', 'DAZN', 'FT', 'AstraZeneca', 'LON', 'NASDAQ', 'Has', 'reportedly', 'studying', 'options', 'including', 'potential', 'listing', 'newlycreated', 'vaccine', 'division', 'seeks', 'boost', 'returns', 'Bloomberg', 'WPP', 'LON', 'Acquired', 'majority', 'stake', 'branding', 'design', 'agency', 'Made', 'Thought', 'Taylor', 'Wimpey', 'LON', 'Activist', 'investor', 'Elliott', 'Advisors', 'reportedly', 'built', 'âœsmallâ', 'stake', 'company', 'Times', 'Clarkson', 'LON', 'Results', 'year', 'ending', 'December', 'anticipated', 'ahead', 'current', 'market', 'expectations', 'underlying', 'profit', 'tax', 'expected', 'less', 'million', 'Thungela', 'Resources', 'LON', 'Export', 'saleable', 'production', 'expected', 'Mt', 'subject', 'deterioration', 'Transnet', 'Freight', 'Rail', 'performance', 'stringent', 'restrictions', 'December', 'Export', 'equity', 'sales', 'expected', 'Mt', 'The', 'Board', 'remains', 'committed', 'delivering', 'attractive', 'shareholder', 'returns', 'maintaining', 'disciplined', 'capital', 'allocation', 'Accordingly', 'Company', 'may', 'declare', 'additional', 'returns', 'targeted', 'minimum', 'payout', 'ratio', 'Adjusted', 'operating', 'free', 'cash', 'flow', 'Likely', 'return', 'profitability', 'respect', 'Earnings', 'per', 'share', 'Headline', 'earnings', 'per', 'share', 'financial', 'year', 'following', 'loss', 'financial', 'year', 'Infrastructure', 'LON', 'Agreed', 'invest', 'circa', 'million', 'acquire', 'stake', 'SRL', 'Traffic', 'Systems', 'market', 'leading', 'traffic', 'management', 'equipment', 'rental', 'company', 'UK', 'ContourGlobal', 'LON', 'Now', 'expects', 'FY', 'adjusted', 'EBITDA', 'million', 'million', 'guidance', 'range', 'communicated', 'October', 'million', 'Victrex', 'LON', 'FY', 'volumes', 'tonnes', 'Group', 'revenue', 'million', 'underlying', 'profit', 'tax', 'million', 'Increased', 'dividend', 'pence', 'per', 'share', 'Assume', 'year', 'year', 'progress', 'full', 'year', 'sales', 'volumes', 'Also', 'facing', 'sizeable', 'currency', 'headwind', 'increased', 'raw', 'material', 'energy', 'costs', 'Hammerson', 'LON', 'To', 'commence', 'share', 'repurchase', 'programme', 'shares', 'Marshall', 'Motor', 'Holdings', 'LON', 'Recommends', 'shareholders', 'accept', 'pence', 'per', 'share', 'offer', 'Constellation', 'AGBarr', 'PLC', 'LON', 'Has', 'bought', 'initial', 'circa', 'equity', 'stake', 'MOMA', 'Foods', 'Limited', 'agreed', 'path', 'full', 'ownership', 'next', 'years', 'The', 'transaction', 'expected', 'material', 'impact', 'Group', 'profits', 'current', 'financial', 'year', 'ending', 'January', 'Ted', 'Baker', 'LON', 'Chairman', 'John', 'Barton', 'died', 'Helena', 'Feltham', 'assume', 'role', 'Interim', 'Chairman', 'immediate', 'effect', 'Sectors', 'Housing', 'Names', 'The', 'Bank', 'England', 'said', 'poised', 'loosen', 'mortgage', 'lending', 'rules', 'bought', 'pandemic', 'Travel', 'Leisure', 'The', 'UK', 'government', 'introduced', 'predeparture', 'COVID', 'testing', 'passengers', 'arriving', 'England'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Avast', 'PLC', 'LON', 'added', 'points', 'end', 'Ocado', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Burberry', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'declined', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'FERG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BMEB', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Anglo', 'American', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Ferguson', 'Plc', 'LON', 'added', 'points', 'end', 'BHP', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'BM', 'European', 'Value', 'Retail', 'SA', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Reckitt', 'Benckiser', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Vials', 'PfizerBioNTech', 'AstraZeneca', 'Moderna', 'coronavirus', 'disease', 'vaccine', 'labels', 'seen', 'illustration', 'picture', 'taken', 'March', 'REUTERSDado', 'RuvicIllustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Lucy', 'Marks', 'Reuters', 'A', 'major', 'British', 'study', 'mixing', 'vaccines', 'found', 'people', 'better', 'immune', 'response', 'received', 'first', 'dose', 'AstraZeneca', 'NASDAQ', 'PfizerBioNTech', 'shots', 'followed', 'Moderna', 'NASDAQ', 'nine', 'weeks', 'later', 'according', 'results', 'Monday', 'We', 'found', 'really', 'good', 'immune', 'response', 'across', 'board', 'fact', 'higher', 'threshold', 'set', 'OxfordAstraZeneca', 'vaccine', 'two', 'doses', 'Matthew', 'Snape', 'Oxford', 'professor', 'behind', 'trial', 'dubbed', 'told', 'Reuters', 'The', 'findings', 'supporting', 'flexible', 'dosing', 'offer', 'hope', 'poor', 'middle', 'income', 'countries', 'may', 'need', 'combine', 'different', 'brands', 'first', 'second', 'shots', 'supplies', 'run', 'low', 'become', 'unstable', 'I', 'think', 'data', 'study', 'especially', 'interesting', 'valuable', 'low', 'middleincome', 'countries', 'still', 'rolling', 'first', 'two', 'doses', 'vaccines', 'Snape', 'said', 'We', 'showingyou', 'stick', 'rigidly', 'receiving', 'vaccine', 'second', 'doseand', 'programme', 'delivered', 'quickly', 'using', 'multiple', 'vaccines', 'okay', 'If', 'AstraZenecaOxford', 'vaccine', 'followed', 'Moderna', 'Novavax', 'shot', 'higher', 'antibodies', 'Tcell', 'responses', 'induced', 'versus', 'two', 'doses', 'AstraZenecaOxford', 'according', 'researchers', 'University', 'Oxford', 'The', 'study', 'volunteers', 'also', 'found', 'dose', 'PfizerBioNTech', 'vaccine', 'followed', 'Moderna', 'shot', 'better', 'two', 'doses', 'standard', 'PfizerBioNTech', 'course', 'PfizerBioNTech', 'followed', 'Novavax', 'induced', 'higher', 'antibodies', 'twodose', 'OxfordAstraZeneca', 'schedule', 'although', 'schedule', 'induced', 'lower', 'antibody', 'Tcell', 'responses', 'twodose', 'PfizerBioNTech', 'schedule', 'No', 'safety', 'concerns', 'raised', 'according', 'Oxford', 'University', 'study', 'published', 'Lancet', 'medical', 'journal', 'Many', 'countries', 'deploying', 'mix', 'match', 'well', 'robust', 'data', 'available', 'nations', 'faced', 'soaring', 'infection', 'numbers', 'low', 'supplies', 'slow', 'immunisation', 'safety', 'concerns', 'Longevity', 'protection', 'offered', 'vaccines', 'scrutiny', 'booster', 'doses', 'considered', 'well', 'amid', 'surging', 'cases', 'New', 'variants', 'including', 'Delta', 'Omicron', 'increased', 'pressure', 'speed', 'vaccination', 'campaigns', 'Blood', 'samples', 'participants', 'tested', 'WildType', 'Beta', 'Delta', 'variants', 'researchers', 'study', 'said', 'adding', 'vaccines', 'efficacy', 'variants', 'waned', 'consistent', 'across', 'mixed', 'courses', 'Deploying', 'vaccines', 'using', 'technology', 'different', 'platforms', 'like', 'Pfizer', 'NYSE', 'Moderna', 'mRNA', 'AstraZeneca', 'viral', 'vector', 'Novavax', 'proteinbased', 'shot', 'within', 'schedule', 'new', 'The', 'results', 'may', 'inform', 'new', 'approaches', 'immunisation', 'diseases', 'said', 'The', 'study', 'also', 'found', 'first', 'dose', 'AstraZenecaOxford', 'vaccine', 'followed', 'candidates', 'study', 'generated', 'particularly', 'robust', 'response', 'consistent', 'findings', 'June', 'The', 'study', 'designed', 'socalled', 'noninferiority', 'study', 'â', 'intent', 'demonstrate', 'mixing', 'substantially', 'worse', 'standard', 'schedules', 'compares', 'immune', 'system', 'responses', 'goldstandard', 'responses', 'reported', 'previous', 'clinical', 'trials', 'vaccine'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'EXPN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Avast', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Experian', 'PLC', 'LON', 'added', 'points', 'end', 'Samsung', 'Electronics', 'Co', 'Ltd', 'DRC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Next', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Taylor', 'Wimpey', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['AZN', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'NASDAQ', 'reported', 'Thursday', 'second', 'quarter', 'missed', 'analysts', 'forecasts', 'revenue', 'topped', 'expectations', 'AstraZeneca', 'announced', 'earnings', 'per', 'share', 'revenue', 'Analysts', 'polled', 'Investingcom', 'anticipated', 'EPS', 'revenue', 'AstraZeneca', 'shares', 'beginning', 'year', 'trading', 'underperforming', 'SP', 'Global', 'start', 'year', 'AstraZeneca', 'shares', 'gained', 'intraday', 'trade', 'report', 'AstraZeneca', 'follows', 'major', 'Healthcare', 'sector', 'earnings', 'month', 'AstraZeneca', 'report', 'follows', 'earnings', 'beat', 'GlaxoSmithKline', 'Wednesday', 'reported', 'EPS', 'revenue', 'compared', 'forecasts', 'EPS', 'revenue', 'ReNeuron', 'beat', 'expectations', 'July', 'second', 'quarter', 'EPS', 'revenue', 'compared', 'forecast', 'EPS', 'revenue', 'Stay', 'uptodate', 'upcoming', 'earnings', 'reports', 'visiting', 'Investingcom', 'earnings', 'calendar'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'wearing', 'facial', 'masks', 'reflected', 'electric', 'board', 'showing', 'stock', 'prices', 'outside', 'brokerage', 'business', 'district', 'Tokyo', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Stephen', 'Culp', 'NEW', 'YORK', 'Reuters', 'Wall', 'Street', 'edged', 'higher', 'dollar', 'dipped', 'lowest', 'two', 'years', 'Wednesday', 'penultimate', 'trading', 'day', 'remarkable', 'year', 'pandemic', 'recession', 'recovery', 'All', 'three', 'major', 'US', 'stock', 'indexes', 'modestly', 'recently', 'enacted', 'stimulus', 'ongoing', 'rollout', 'vaccines', 'fed', 'optimism', 'economic', 'recovery', 'going', 'beginning', 'said', 'Matthew', 'Keator', 'managing', 'partner', 'Keator', 'Group', 'wealth', 'management', 'firm', 'Lenox', 'Massachusetts', 'My', 'anticipation', 'probably', 'robust', 'latter', 'part', 'Once', 'sense', 'allclear', 'sign', 'would', 'anticipate', 'robust', 'response', 'consumer', 'Keator', 'added', 'For', 'Keator', 'suggests', 'markets', 'waitandsee', 'mode', 'The', 'markets', 'saying', 'done', 'lately', 'people', 'going', 'focusing', 'going', 'happen', 'see', 'restrictions', 'due', 'pandemic', 'said', 'Britain', 'approved', 'coronavirus', 'vaccine', 'developed', 'Oxford', 'University', 'AstraZeneca', 'latest', 'development', 'rapid', 'progression', 'testing', 'approval', 'deployment', 'drugs', 'battle', 'disease', 'The', 'rose', 'points', 'gained', 'points', 'added', 'points', 'European', 'stocks', 'reversed', 'gains', 'end', 'fiveday', 'winning', 'streak', 'closing', 'lower', 'investors', 'locked', 'yearend', 'gains', 'The', 'panEuropean', 'index', 'lost', 'MSCI', 'gauge', 'stocks', 'across', 'globe', 'gained', 'Emerging', 'market', 'stocks', 'rose', 'MSCI', 'broadest', 'index', 'AsiaPacific', 'shares', 'outside', 'Japan', 'closed', 'higher', 'lost', 'US', 'Treasury', 'yields', 'slightly', 'lower', 'thin', 'trading', 'investors', 'bet', 'Republicans', 'unlikely', 'approve', 'passage', 'proposed', 'stimulus', 'checks', 'Benchmark', 'notes', 'last', 'rose', 'price', 'yield', 'late', 'Tuesday', 'The', 'bond', 'last', 'rose', 'price', 'yield', 'late', 'Tuesday', 'The', 'dollar', 'fell', 'lowest', 'since', 'April', 'basket', 'world', 'currencies', 'investors', 'bet', 'fiscal', 'support', 'positioned', 'yearend', 'light', 'trading', 'volume', 'The', 'fell', 'euro', 'The', 'Japanese', 'yen', 'strengthened', 'versus', 'greenback', 'per', 'dollar', 'Sterling', 'last', 'trading', 'day', 'Crude', 'oil', 'prices', 'inched', 'higher', 'back', 'weaker', 'dollar', 'dip', 'US', 'inventories', 'gains', 'capped', 'dimming', 'hopes', 'demand', 'rebound', 'futures', 'gained', 'settle', 'per', 'barrel', 'settled', 'per', 'barrel', 'day', 'Gold', 'prices', 'rose', 'countering', 'dip', 'greenback', 'although', 'global', 'vaccine', 'rollouts', 'increased', 'risk', 'appetite', 'limited', 'safehaven', 'metal', 'gains', 'added', 'ounce', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'GFSl', 'Add', 'toRemove', 'Portfolio', 'DRX', 'Add', 'toRemove', 'Portfolio', 'AGGK', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'EXPN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'EBKG', 'Add', 'toRemove', 'Portfolio', 'PL', 'Add', 'toRemove', 'Portfolio', 'Adds', 'futures', 'news', 'items', 'Feb', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'BOOHOO', 'Boohoo', 'bought', 'Dorothy', 'Perkins', 'Wallis', 'Burton', 'brands', 'administrators', 'Arcadia', 'million', 'pounds', 'completing', 'breakup', 'Philip', 'Green', 'fallen', 'empire', 'DRAX', 'Drax', 'said', 'would', 'buy', 'Canadabased', 'Pinnacle', 'Renewable', 'Energy', 'Inc', 'deal', 'implied', 'enterprise', 'value', 'million', 'including', 'debt', 'EXPERIAN', 'Experian', 'said', 'continuing', 'investigate', 'whether', 'personal', 'data', 'millions', 'Brazilian', 'people', 'found', 'illegally', 'offered', 'sale', 'online', 'could', 'connected', 'Brazilian', 'business', 'Serasa', 'BP', 'BP', 'Germany', 'Energie', 'BadenWuerttemberg', 'AG', 'selected', 'together', 'preferred', 'bidder', 'two', 'major', 'leases', 'UK', 'offshore', 'wind', 'leasing', 'round', 'Londonlisted', 'company', 'said', 'ASTRAZENECA', 'There', 'evidence', 'Astrazeneca', 'vaccine', 'prevent', 'death', 'serious', 'illness', 'South', 'Africa', 'imposed', 'temporary', 'halt', 'using', 'vaccine', 'British', 'junior', 'health', 'minister', 'said', 'ROLLS', 'ROYCE', 'RollsRoyce', 'said', 'proposing', 'twoweek', 'operational', 'shutdown', 'civil', 'aerospace', 'unit', 'summer', 'CSE', 'hold', 'talks', 'City', 'takeover', 'panel', 'Telegraph', 'reported', 'Saturday', 'could', 'lead', 'headtohead', 'auction', 'GardaWorld', 'Allied', 'Universal', 'company', 'buyout', 'GOLD', 'Gold', 'prices', 'edged', 'higher', 'softer', 'US', 'jobs', 'data', 'cemented', 'hopes', 'fiscal', 'stimulus', 'pressured', 'dollar', 'OIL', 'Oil', 'prices', 'rose', 'futures', 'nudging', 'past', 'barrel', 'boosted', 'supply', 'cuts', 'among', 'key', 'producers', 'hopes', 'US', 'economic', 'stimulus', 'measures', 'boost', 'demand', 'The', 'UK', 'midcap', 'index', 'closed', 'higher', 'Friday', 'power', 'equipment', 'supplier', 'Aggreko', 'Plc', 'soared', 'following', 'buyout', 'proposal', 'faster', 'vaccine', 'rollouts', 'supported', 'hopes', 'brisk', 'economic', 'revival', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'GFSl', 'Add', 'toRemove', 'Portfolio', 'AGGK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ILND', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SONG', 'Add', 'toRemove', 'Portfolio', 'Feb', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'RIO', 'TINTO', 'Mongolia', 'government', 'seeking', 'agreement', 'Rio', 'Tinto', 'terminate', 'deal', 'expand', 'Oyu', 'Tolgoi', 'mine', 'Gobi', 'Desert', 'Financial', 'Times', 'said', 'ASTRAZENECA', 'South', 'Africa', 'put', 'hold', 'use', 'AstraZeneca', 'NASDAQ', 'shot', 'vaccination', 'programme', 'data', 'showed', 'gave', 'minimal', 'protection', 'mildtomoderate', 'infection', 'caused', 'country', 'dominant', 'coronavirus', 'variant', 'ROLLS', 'ROYCE', 'RollsRoyce', 'said', 'proposing', 'twoweek', 'operational', 'shutdown', 'civil', 'aerospace', 'unit', 'summer', 'CSE', 'hold', 'talks', 'City', 'takeover', 'panel', 'Telegraph', 'reported', 'Saturday', 'could', 'lead', 'headtohead', 'auction', 'GardaWorld', 'Allied', 'Universal', 'company', 'buyout', 'HIPGNOSIS', 'SONGS', 'FUND', 'Hipgnosis', 'Songs', 'Fund', 'said', 'Friday', 'raised', 'million', 'pounds', 'share', 'sale', 'investment', 'firm', 'seeks', 'cash', 'explosion', 'online', 'music', 'streaming', 'pandemic', 'Britain', 'plans', 'tax', 'retailers', 'tech', 'companies', 'whose', 'profits', 'soared', 'pandemic', 'Sunday', 'Times', 'reported', 'GOLD', 'Gold', 'prices', 'edged', 'higher', 'softer', 'US', 'jobs', 'data', 'cemented', 'hopes', 'fiscal', 'stimulus', 'pressured', 'dollar', 'OIL', 'Oil', 'prices', 'rose', 'futures', 'nudging', 'past', 'barrel', 'boosted', 'supply', 'cuts', 'among', 'key', 'producers', 'hopes', 'US', 'economic', 'stimulus', 'measures', 'boost', 'demand', 'The', 'UK', 'midcap', 'index', 'closed', 'higher', 'Friday', 'power', 'equipment', 'supplier', 'Aggreko', 'Plc', 'soared', 'following', 'buyout', 'proposal', 'faster', 'vaccine', 'rollouts', 'supported', 'hopes', 'brisk', 'economic', 'revival', 'UK', 'CORPORATE', 'DIARY', 'Electrocomponents', 'Plc', 'Trading', 'update', 'Inland', 'Homes', 'Plc', 'FY', 'results', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Â', 'Reuters', 'FILE', 'PHOTO', 'vaccinations', 'Basingstoke', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Revill', 'GENEVA', 'Reuters', 'Health', 'officials', 'around', 'world', 'gave', 'backing', 'AstraZeneca', 'NASDAQ', 'vaccine', 'study', 'showing', 'little', 'effect', 'mild', 'disease', 'caused', 'variant', 'spreading', 'quickly', 'South', 'Africa', 'rang', 'global', 'alarm', 'The', 'prospect', 'new', 'virus', 'variants', 'could', 'evolve', 'ability', 'elude', 'vaccines', 'one', 'main', 'risks', 'hanging', 'global', 'strategy', 'emerge', 'pandemic', 'rolling', 'vaccines', 'year', 'South', 'Africa', 'new', 'variant', 'accounts', 'vast', 'bulk', 'cases', 'initially', 'announced', 'pause', 'rollout', 'million', 'doses', 'AstraZeneca', 'vaccine', 'But', 'said', 'Monday', 'could', 'still', 'roll', 'stepped', 'manner', 'giving', 'doses', 'monitoring', 'see', 'prevents', 'hospitalisations', 'deaths', 'It', 'vastly', 'early', 'dismissing', 'vaccine', 'said', 'Richard', 'Hatchett', 'CEO', 'Coalition', 'Epidemic', 'Preparedness', 'Innovations', 'foundation', 'coleads', 'global', 'COVAX', 'programme', 'provide', 'vaccine', 'doses', 'poor', 'countries', 'More', 'million', 'doses', 'AstraZeneca', 'vaccine', 'form', 'overwhelming', 'majority', 'doses', 'COVAX', 'aims', 'begin', 'rolling', 'first', 'phase', 'poor', 'countries', 'beginning', 'soon', 'month', 'Obviously', 'world', 'full', 'wild', 'type', 'virus', 'Astrazeneca', 'LON', 'vaccine', 'known', 'work', 'Hatchett', 'said', 'Professor', 'Salim', 'Abdool', 'Karim', 'cochair', 'South', 'Africaâs', 'Ministerial', 'Advisory', 'Committee', 'said', 'early', 'conclude', 'AstraZeneca', 'would', 'prevent', 'serious', 'disease', 'caused', 'variant', 'prevalent', 'If', 'vaccine', 'work', 'well', 'new', 'evolving', 'variants', 'virus', 'could', 'ominous', 'sign', 'vaccines', 'well', 'showing', 'virus', 'potentially', 'thwart', 'efforts', 'scientists', 'fight', 'The', 'overall', 'message', 'World', 'Health', 'Organization', 'others', 'panic', 'Several', 'global', 'health', 'officials', 'noted', 'South', 'African', 'study', 'small', 'tested', 'vaccine', 'using', 'short', 'fourweek', 'interval', 'first', 'second', 'doses', 'despite', 'evidence', 'since', 'emerged', 'works', 'better', 'longer', 'wait', 'It', 'becoming', 'clear', 'longer', 'interval', 'two', 'doses', 'higher', 'efficacy', 'said', 'Kate', 'head', 'immunisations', 'WHO', 'The', 'lead', 'investigator', 'South', 'African', 'trial', 'told', 'Reuters', 'believed', 'vaccine', 'major', 'role', 'play', 'Africa', 'globally', 'million', 'doses', 'South', 'Africa', 'expire', 'April', 'rolled', 'quickly', 'wasted', 'SERIOUS', 'INFECTIONS', 'Western', 'governments', 'spoke', 'favour', 'vaccine', 'many', 'given', 'approval', 'The', 'vaccine', 'main', 'pillar', 'vaccination', 'programme', 'Britain', 'far', 'fastest', 'large', 'country', 'vaccinate', 'members', 'public', 'It', 'dealing', 'mainly', 'another', 'fastspreading', 'variant', 'vaccine', 'shown', 'work', 'well', 'We', 'think', 'vaccines', 'currently', 'using', 'effective', 'I', 'say', 'stopping', 'serious', 'disease', 'death', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'told', 'reporters', 'Britain', 'also', 'using', 'Pfizer', 'NYSE', 'vaccine', 'Olivier', 'Veran', 'health', 'minister', 'France', 'hoping', 'vaccine', 'held', 'speed', 'programme', 'lagged', 'behind', 'rich', 'countries', 'said', 'AstraZeneca', 'vaccine', 'provided', 'sufficient', 'protection', 'nearly', 'variants', 'virus', 'But', 'vaccines', 'work', 'effectively', 'hoped', 'new', 'emerging', 'variants', 'world', 'could', 'facing', 'much', 'longer', 'expensive', 'battle', 'virus', 'previously', 'thought', 'The', 'variant', 'dominant', 'South', 'Africa', 'circulating', 'least', 'countries', 'including', 'United', 'States', 'Austria', 'warned', 'nonessential', 'travel', 'Alpine', 'province', 'Tyrol', 'outbreak', 'South', 'African', 'variant', 'Cases', 'also', 'detected', 'north', 'Paris', 'forcing', 'one', 'school', 'close', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAGUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Silver', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'ODX', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'UKâs', 'higher', 'heading', 'towards', 'midday', 'miners', 'financials', 'push', 'index', 'upwards', 'Cyclical', 'sectors', 'firmly', 'green', 'prospects', 'higher', 'growth', 'coming', 'months', 'global', 'vaccine', 'effort', 'continues', 'pick', 'pace', 'Miners', 'lead', 'index', 'higher', 'Anglo', 'American', 'PLC', 'LON', 'EVRAZ', 'plc', 'LON', 'two', 'best', 'performing', 'stocks', 'UK', 'bluechip', 'index', 'Financials', 'also', 'strong', 'continuation', 'move', 'seen', 'end', 'last', 'week', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'benefitted', 'upgrade', 'Goldman', 'Sachs', 'took', 'rating', 'neutral', 'sell', 'NatWest', 'Group', 'PLC', 'LON', 'also', 'higher', 'HSBC', 'Holdings', 'PLC', 'LON', 'underperformed', 'banking', 'counterparts', 'Shares', 'flat', 'company', 'came', 'scrutiny', 'froze', 'accounts', 'Hong', 'Kong', 'activist', 'Ted', 'Hui', 'family', 'RollsRoyce', 'Jet', 'engine', 'manufacturer', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'props', 'index', 'reports', 'company', 'considering', 'plans', 'temporarily', 'close', 'jet', 'engine', 'plants', 'summer', 'amid', 'heavy', 'losses', 'A', 'decline', 'air', 'travel', 'impacted', 'sales', 'RollsRoyce', 'engines', 'travelled', 'fewer', 'miles', 'since', 'pandemic', 'began', 'AIMlisted', 'Omega', 'Diagnostics', 'Group', 'Plc', 'LON', 'one', 'best', 'performers', 'UK', 'company', 'selected', 'provide', 'additional', 'lateral', 'flow', 'tests', 'UK', 'AstraZeneca', 'PLC', 'LON', 'shares', 'relatively', 'unreactive', 'reports', 'vaccine', 'less', 'effective', 'new', 'South', 'African', 'variant', 'coronavirus', 'South', 'Africa', 'stopped', 'administering', 'vaccine', 'initial', 'data', 'government', 'tried', 'calm', 'situation', 'UK', 'emphasising', 'dominant', 'strains', 'UK', 'South', 'African', 'strains', 'Oil', 'prices', 'remain', 'elevated', 'crude', 'futures', 'trading', 'first', 'time', 'year', 'Precious', 'metals', 'remain', 'focus', 'particularly', 'recent', 'Reddit', 'squeeze', 'A', 'note', 'Bank', 'America', 'said', 'see', 'silver', 'averaging', 'year', 'next', 'year'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STZ', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'US', 'President', 'Joe', 'Bidenâs', 'tax', 'plans', 'may', 'hit', 'fewer', 'companies', 'campaign', 'promises', 'suggested', 'new', 'details', 'Treasury', 'supporting', 'tech', 'stocks', 'Wall', 'Street', 'gets', 'ready', 'open', 'US', 'jobless', 'claims', 'expected', 'resumed', 'downward', 'trend', 'last', 'week', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powell', 'speak', 'later', 'AstraZeneca', 'shares', 'rise', 'despite', 'fact', 'concerns', 'vaccineâs', 'safety', 'refuse', 'go', 'away', 'And', 'crude', 'oil', 'still', 'canât', 'get', 'barrel', 'Hereâs', 'need', 'know', 'financial', 'markets', 'Thursday', 'April', 'Biden', 'softens', 'tax', 'plan', 'President', 'Joe', 'Bidenâs', 'plans', 'tax', 'companies', 'turning', 'less', 'ambitious', 'election', 'campaign', 'promises', 'suggested', 'The', 'US', 'Treasury', 'released', 'details', 'plans', 'Wednesday', 'minimum', 'tax', 'proposed', 'last', 'week', 'Janet', 'Yellen', 'would', 'apply', 'companies', 'billion', 'annual', 'income', 'rather', 'million', 'touted', 'last', 'year', 'The', 'proposals', 'breathed', 'life', 'multilateral', 'push', 'agree', 'common', 'framework', 'corporate', 'taxation', 'finance', 'ministers', 'discussed', 'issue', 'Wednesday', 'aiming', 'agreement', 'July', 'The', 'initiative', 'nearly', 'decade', 'old', 'missed', 'many', 'deadlines', 'already', 'comes', 'fruition', 'could', 'avert', 'creation', 'national', 'taxes', 'digital', 'service', 'companies', 'removing', 'one', 'major', 'bone', 'contention', 'US', 'Europe', 'Jobless', 'claims', 'due', 'Powell', 'speech', 'eyed', 'The', 'latest', 'weekâs', 'jobless', 'claims', 'data', 'hit', 'wires', 'AM', 'ET', 'GMT', 'expected', 'resume', 'downward', 'trend', 'unexpected', 'jump', 'last', 'week', 'Analysts', 'expect', 'initial', 'jobless', 'claims', 'would', 'secondlowest', 'since', 'pandemic', 'started', 'The', 'data', 'suggested', 'pandemic', 'means', 'killing', 'jobs', 'across', 'country', 'steady', 'declines', 'broader', 'measures', 'continuing', 'claims', 'sharp', 'rise', 'hiring', 'job', 'vacancies', 'indicated', 'labor', 'market', 'clearly', 'building', 'momentum', 'Elsewhere', 'Federal', 'Reserve', 'Chairman', 'expected', 'speak', 'PM', 'ET', 'International', 'Monetary', 'Fundâs', 'virtual', 'spring', 'meeting', 'unlikely', 'add', 'much', 'minutes', 'last', 'Fed', 'policy', 'meeting', 'released', 'Wednesday', 'Stocks', 'set', 'open', 'higher', 'tech', 'supported', 'tax', 'plans', 'US', 'stock', 'markets', 'set', 'open', 'higher', 'later', 'two', 'days', 'drift', 'softening', 'President', 'Bidenâs', 'tax', 'plans', 'improving', 'sentiment', 'toward', 'Big', 'Tech', 'names', 'somewhat', 'By', 'AM', 'ET', 'effectively', 'flat', 'mere', 'points', 'Stocks', 'likely', 'focus', 'later', 'include', 'brewer', 'Constellation', 'Brands', 'NYSE', 'whose', 'outlook', 'colored', 'expected', 'impact', 'economic', 'reopening', 'food', 'company', 'The', 'two', 'scheduled', 'release', 'quarterly', 'earnings', 'AM', 'ET', 'AstraZeneca', 'stock', 'rises', 'even', 'vaccine', 'fears', 'refuse', 'go', 'away', 'Shares', 'AstraZeneca', 'NASDAQ', 'rose', 'London', 'trading', 'updated', 'statement', 'European', 'medical', 'regulators', 'turned', 'less', 'negatively', 'feared', 'The', 'European', 'Union', 'UK', 'acknowledge', 'possible', 'link', 'vaccine', 'potentially', 'dangerous', 'blot', 'clotting', 'disorders', 'still', 'argue', 'risks', 'taking', 'outweighed', 'benefits', 'The', 'UKâs', 'Medicines', 'Health', 'Regulatory', 'Agency', 'identified', 'deaths', 'blood', 'clots', 'dispensed', 'million', 'shots', 'AstraZeneca', 'PLC', 'LON', 'jab', 'The', 'vaccine', 'advance', 'orders', 'worldwide', 'drug', 'due', 'AZâs', 'policy', 'selling', 'cost', 'price', 'pandemic', 'lasts', 'As', 'evidence', 'fundamentally', 'unsafe', 'would', 'threat', 'vaccination', 'campaigns', 'poorer', 'countries', 'That', 'important', 'given', 'countries', 'India', 'Brazil', 'currently', 'experiencing', 'worst', 'wave', 'cases', 'Oil', 'struggles', 'despite', 'inventory', 'reports', 'Crude', 'oil', 'prices', 'continue', 'struggle', 'barrel', 'amid', 'fears', 'waves', 'India', 'South', 'America', 'slow', 'recovery', 'global', 'demand', 'Bullish', 'headlines', 'inventories', 'fell', 'expected', 'last', 'week', 'also', 'undermined', 'less', 'encouraging', 'developments', 'gasoline', 'trends', 'raising', 'questions', 'strength', 'final', 'demand', 'By', 'AM', 'ET', 'US', 'crude', 'futures', 'barrel', 'futures', 'barrel', 'Â', 'Reuters', 'C', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FGEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'Two', 'major', 'global', 'investment', 'banks', 'provided', 'updated', 'recommendations', 'AstraZeneca', 'LON', 'shares', 'wake', 'recent', 'news', 'regarding', 'vaccine', 'Both', 'Citigroup', 'NYSE', 'UBS', 'maintained', 'shares', 'âBuyâ', 'rating', 'Although', 'vaccine', 'maker', 'offered', 'sell', 'initial', 'vaccine', 'doses', 'cost', 'risk', 'reputational', 'damage', 'regarding', 'vaccine', 'safety', 'This', 'week', 'UK', 'EU', 'regulators', 'acknowledged', 'could', 'link', 'extremely', 'rare', 'potentially', 'fatal', 'blood', 'clots', 'AstraZeneca', 'jab', 'With', 'company', 'headlines', 'policymakers', 'officials', 'various', 'countries', 'defending', 'companyâs', 'vaccine', 'The', 'UK', 'Health', 'Secretary', 'Matt', 'Hancock', 'spoke', 'risk', 'blood', 'clot', 'vaccine', 'longhaul', 'flight', 'urged', 'people', 'continue', 'take', 'The', 'UK', 'Prime', 'Minister', 'Johnson', 'echoed', 'comments', 'despite', 'UK', 'vaccine', 'taskforce', 'recommending', 'aged', 'take', 'different', 'jab', 'It', 'officials', 'politicians', 'defending', 'company', 'also', 'big', 'banks', 'Citigroup', 'AstraZeneca', 'In', 'research', 'note', 'Thursday', 'Citigroup', 'maintained', 'âBuyâ', 'rating', 'stock', 'target', 'price', 'The', 'bank', 'said', 'also', 'going', 'maintain', 'forecast', 'worth', 'revenue', 'Roxadustat', 'This', 'news', 'comes', 'amid', 'admission', 'FibroGen', 'NASDAQ', 'earlier', 'week', 'misstated', 'data', 'anaemia', 'drug', 'two', 'companies', 'working', 'Fibrogen', 'shares', 'fell', 'Wednesday', 'following', 'announcement', 'UBS', 'Swiss', 'banking', 'giant', 'UBS', 'also', 'kept', 'âBuyâ', 'rating', 'shares', 'although', 'price', 'target', 'lower', 'At', 'AstraZeneca', 'shares', 'trading', 'higher'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'People', 'queue', 'receive', 'dose', 'Pfizer', 'BioNTech', 'vaccine', 'Central', 'Middlesex', 'Hospital', 'London', 'Britain', 'August', 'REUTERSHenry', 'Nicholls', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Reuters', 'A', 'British', 'public', 'health', 'study', 'found', 'protection', 'either', 'two', 'commonly', 'used', 'vaccines', 'prevalent', 'Delta', 'variant', 'coronavirus', 'weakens', 'within', 'three', 'months', 'It', 'also', 'found', 'get', 'infected', 'receiving', 'two', 'shots', 'either', 'PfizerBioNTech', 'AstraZeneca', 'NASDAQ', 'vaccine', 'may', 'greater', 'risk', 'others', 'previous', 'variants', 'coronavirus', 'Based', 'three', 'million', 'nose', 'throat', 'swabs', 'taken', 'across', 'Britain', 'Oxford', 'University', 'study', 'found', 'days', 'second', 'shot', 'Pfizer', 'NYSE', 'Astrazeneca', 'LON', 'vaccine', 'efficacy', 'preventing', 'infections', 'slipped', 'respectively', 'That', 'respectively', 'seen', 'two', 'weeks', 'second', 'dose', 'The', 'decline', 'efficacy', 'pronounced', 'among', 'aged', 'years', 'older', 'age', 'Both', 'vaccines', 'two', 'doses', 'still', 'really', 'well', 'Delta', 'When', 'start', 'high', 'got', 'long', 'way', 'go', 'said', 'Sarah', 'Walker', 'Oxford', 'professor', 'medical', 'statistics', 'chief', 'investigator', 'survey', 'Walker', 'involved', 'work', 'AstraZeneca', 'vaccine', 'initially', 'developed', 'immunology', 'experts', 'Oxford', 'The', 'researchers', 'would', 'project', 'much', 'protection', 'would', 'drop', 'time', 'suggested', 'efficacy', 'two', 'vaccines', 'studied', 'would', 'converge', 'within', 'months', 'second', 'shot', 'VIRAL', 'LOAD', 'Highlighting', 'increased', 'risk', 'contagion', 'Delta', 'variant', 'study', 'also', 'showed', 'get', 'infected', 'despite', 'fully', 'vaccinated', 'tend', 'viral', 'load', 'similar', 'unvaccinated', 'infection', 'clear', 'deterioration', 'Alpha', 'variant', 'still', 'dominant', 'Britain', 'The', 'Oxford', 'findings', 'line', 'analysis', 'US', 'Centers', 'Disease', 'Control', 'Prevention', 'CDC', 'come', 'US', 'government', 'outlines', 'plans', 'make', 'vaccine', 'booster', 'shots', 'widely', 'available', 'next', 'month', 'amid', 'rise', 'Delta', 'variant', 'infections', 'It', 'cited', 'data', 'indicating', 'diminishing', 'protection', 'vaccines', 'time', 'Israel', 'began', 'administering', 'third', 'Pfizer', 'doses', 'last', 'month', 'confront', 'surge', 'local', 'infections', 'driven', 'Delta', 'Several', 'European', 'countries', 'also', 'expected', 'begin', 'offering', 'boosters', 'elderly', 'people', 'weak', 'immune', 'systems', 'Pfizer', 'said', 'vaccine', 'efficacy', 'drops', 'time', 'Last', 'month', 'AstraZeneca', 'said', 'still', 'looking', 'long', 'vaccine', 'protection', 'lasts', 'whether', 'booster', 'dose', 'would', 'needed', 'keep', 'immunity', 'The', 'fact', 'see', 'viral', 'load', 'hints', 'indeed', 'herd', 'immunity', 'might', 'become', 'challenging', 'said', 'coauthor', 'Koen', 'Pouwels', 'also', 'Oxford', 'University', 'Herd', 'immunity', 'large', 'enough', 'portion', 'population', 'immune', 'pathogen', 'either', 'vaccination', 'prior', 'infection', 'stopping', 'infection', 'numbers', 'growing', 'Vaccines', 'probably', 'best', 'preventing', 'severe', 'disease', 'slightly', 'less', 'preventing', 'transmission', 'said', 'Pouwels', 'The', 'authors', 'cautioned', 'viral', 'concentration', 'throat', 'rough', 'proxy', 'severity', 'symptoms', 'new', 'data', 'duration', 'infections', 'The', 'survey', 'yet', 'peerreviewed', 'publication', 'scientific', 'journal', 'underscores', 'concerns', 'scientists', 'Delta', 'variant', 'first', 'identified', 'India', 'infect', 'fully', 'vaccinated', 'people', 'greater', 'rate', 'previous', 'lineages', 'vaccinated', 'could', 'easily', 'transmit', 'To', 'contrast', 'periods', 'Delta', 'became', 'prevalent', 'Oxford', 'researchers', 'analysed', 'million', 'swabs', 'taken', 'randomly', 'picked', 'adults', 'Dec', 'May', 'test', 'results', 'participants', 'May', 'Aug', 'The', 'study', 'conducted', 'partnership', 'Britain', 'Office', 'National', 'Statistics', 'ONS', 'Department', 'Health', 'Social', 'Care', 'DHSC'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'XAGUSD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Silver', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'The', 'trades', 'red', 'heading', 'towards', 'North', 'American', 'crossover', 'little', 'way', 'fresh', 'catalysts', 'drive', 'near', 'term', 'market', 'direction', 'The', 'said', 'European', 'bourses', 'major', 'bourses', 'trading', 'marginally', 'lower', 'The', 'current', 'situation', 'dominated', 'vaccine', 'rollout', 'ongoing', 'hopes', 'US', 'fiscal', 'stimulus', 'current', 'picture', 'effective', 'current', 'vaccines', 'new', 'strains', 'In', 'UK', 'picture', 'improving', 'albeit', 'slowly', 'vaccine', 'rollout', 'promising', 'far', 'Nevertheless', 'fears', 'OxfordAstraZeneca', 'PLC', 'LON', 'jab', 'less', 'effective', 'South', 'African', 'variant', 'The', 'director', 'Oxford', 'Vaccine', 'Group', 'Andrew', 'Pollard', 'spoke', 'BBC', 'earlier', 'tried', 'reassure', 'people', 'vaccine', 'still', 'effective', 'âœI', 'donât', 'think', 'thereâs', 'reason', 'alarm', 'todayâ', 'Pollard', 'said', 'In', 'individual', 'stocks', 'news', 'Ocado', 'Group', 'PLC', 'LON', 'props', 'bluechip', 'index', 'premarket', 'The', 'technologygrocery', 'delivery', 'company', 'provided', 'strong', 'retail', 'revenue', 'growth', 'announced', 'total', 'capex', 'expected', 'around', 'build', 'automated', 'warehouses', 'Oil', 'companies', 'strong', 'BP', 'PLC', 'LON', 'Royal', 'Dutch', 'Shell', 'PLC', 'Class', 'A', 'LON', 'higher', 'energy', 'prices', 'remain', 'elevated', 'hold', 'firm', 'although', 'trades', 'highest', 'levels', 'ahead', 'report', 'market', 'US', 'The', 'USD', 'weaker', 'providing', 'support', 'looking', 'test', 'upside', 'The', 'GBP', 'earlier', 'hit', 'highest', 'level', 'USD', 'since', 'April', 'although', 'weaker', 'EUR', 'today', 'Markets', 'still', 'pushing', 'back', 'expectations', 'rate', 'cut', 'Bank', 'England', 'following', 'central', 'bankâs', 'announcement', 'last', 'week', 'prices', 'continued', 'strong', 'start', 'week', 'precious', 'metal', 'almost', 'also', 'trading', 'gains', 'although', 'modest', 'yellow', 'metal', 'around', 'remains', 'asset', 'focus', 'Tesla', 'Inc', 'NASDAQ', 'cryptocurrency', 'Monday', 'The', 'largest', 'cryptocurrency', 'market', 'cap', 'touched', 'high', 'since', 'pared', 'back', 'around', 'markets', 'await', 'next', 'catalyst', 'move', 'higher'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'TUIGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'III', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'ICP', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'rose', 'points', 'trade', 'close', 'Tui', 'AG', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Persimmon', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Intermediate', 'Capital', 'Group', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'August', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Trucks', 'doses', 'Sinovac', 'CoronaVac', 'coronavirus', 'disease', 'vaccine', 'destined', 'health', 'ministry', 'National', 'Immunization', 'Program', 'Butantan', 'Institute', 'Sao', 'Paulo', 'Brazil', 'March', 'REUTERSCarla', 'CarnielFile', 'PhotoFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Pedro', 'Fonseca', 'Eduardo', 'SimÃµes', 'RIO', 'DE', 'JANEIROSAO', 'PAULO', 'Reuters', 'One', 'question', 'rippled', 'queue', 'outside', 'makeshift', 'inoculation', 'center', 'Rio', 'de', 'Janeiro', 'beachside', 'neighborhood', 'Copacabana', 'recent', 'morning', 'Which', 'vaccine', 'using', 'Despite', 'world', 'secondhighest', 'death', 'toll', 'infections', 'running', 'high', 'people', 'across', 'Brazil', 'refusing', 'receive', 'shot', 'vaccine', 'used', 'satisfaction', 'Local', 'media', 'dubbed', 'vaccine', 'sommeliers', 'There', 'official', 'figures', 'total', 'number', 'people', 'cherrypicking', 'vaccines', 'dozens', 'towns', 'Brazil', 'sought', 'crack', 'practice', 'taking', 'names', 'refuse', 'inoculated', 'shot', 'offer', 'moving', 'back', 'queue', 'Public', 'health', 'experts', 'Brazil', 'say', 'practice', 'misinformation', 'poorly', 'understood', 'information', 'fuels', 'threatening', 'undermine', 'country', 'vaccination', 'campaign', 'It', 'also', 'say', 'selfish', 'The', 'person', 'putting', 'risk', 'ends', 'putting', 'entire', 'system', 'danger', 'said', 'Alexandre', 'Naime', 'Barbosa', 'infectious', 'diseases', 'professor', 'SÃo', 'Paulo', 'State', 'University', 'It', 'shows', 'lack', 'empathy', 'enormous', 'selfishness', 'The', 'trend', 'comes', 'many', 'countries', 'already', 'vaccinated', 'populations', 'lifting', 'restrictions', 'The', 'Brazilian', 'Society', 'Immunizations', 'said', 'incidents', 'involve', 'people', 'refusing', 'vaccines', 'China', 'Sinovac', 'lesser', 'extent', 'Astrazeneca', 'LON', 'Instead', 'seek', 'shots', 'Pfizer', 'NYSE', 'Johnson', 'Johnson', 'NYSE', 'WhatsApp', 'groups', 'popped', 'people', 'swapping', 'tips', 'vaccination', 'centers', 'offering', 'soughtafter', 'shots', 'Some', 'worried', 'Sinovac', 'CoronaVac', 'work', 'well', 'others', 'fear', 'Europe', 'US', 'might', 'recognize', 'travel', 'restrictions', 'lifted', 'fully', 'vaccinated', 'Brazilian', 'health', 'experts', 'rushing', 'dispel', 'concerns', 'particularly', 'CoronaVac', 'fighting', 'wave', 'criticism', 'including', 'President', 'Jair', 'Bolsonaro', 'said', 'Chinese', 'vaccine', 'use', 'earlier', 'month', 'It', 'work', 'Latestage', 'trials', 'Brazil', 'found', 'CoronaVac', 'efficacy', 'preventing', 'symptomatic', 'infection', 'compared', 'Astrazeneca', 'Pfizer', 'But', 'realworld', 'context', 'public', 'health', 'experts', 'argue', 'CoronaVac', 'shown', 'effective', 'reducing', 'hospitalisation', 'death', 'When', 'look', 'really', 'matters', 'reducing', 'number', 'hospitalizations', 'deaths', 'vaccines', 'Brazil', 'high', 'efficacy', 'Barbosa', 'said', 'In', 'Serrana', 'town', 'Sao', 'Paulo', 'state', 'almost', 'entire', 'adult', 'population', 'vaccinated', 'CoronaVac', 'part', 'study', 'deaths', 'reduced', 'Hospitalizations', 'fell', 'symptomatic', 'infections', 'Public', 'health', 'experts', 'also', 'stressed', 'risk', 'developing', 'blood', 'clots', 'result', 'taking', 'Astrazeneca', 'vaccine', 'incredibly', 'rare', 'No', 'vaccine', 'scientists', 'stress', 'ever', 'entirely', 'removes', 'chance', 'death', 'Choosing', 'vaccine', 'ignorant', 'gesture', 'lacks', 'commitment', 'public', 'health', 'said', 'Dimas', 'Covas', 'president', 'Butantan', 'Institute', 'producing', 'CoronaVac', 'Brazil'], ['Â', 'Reuters', 'DX', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'CRN', 'Add', 'toRemove', 'Portfolio', 'SPI', 'Add', 'toRemove', 'Portfolio', 'STVG', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CZR', 'Add', 'toRemove', 'Portfolio', 'POLYP', 'Add', 'toRemove', 'Portfolio', 'LOOK', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'INPP', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'SDY', 'Add', 'toRemove', 'Portfolio', 'UTG', 'Add', 'toRemove', 'Portfolio', 'CCC', 'Add', 'toRemove', 'Portfolio', 'CRDA', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'GNS', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'lower', 'The', 'midcap', 'trading', 'lower', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'flat', 'Todayâs', 'calendar', 'highlights', 'include', 'US', 'weekly', 'inventory', 'data', 'Stocks', 'Holdings', 'LON', 'Confirms', 'agreement', 'Caesars', 'Entertainment', 'NASDAQ', 'acquire', 'William', 'Hillâs', 'nonUS', 'business', 'billion', 'Morrisons', 'LON', 'Two', 'year', 'group', 'likeforlike', 'sales', 'exfuelexVAT', 'Total', 'revenue', 'including', 'fuel', 'billion', 'Maintains', 'guidance', 'profit', 'tax', 'Continues', 'recommend', 'CDRâs', 'takeover', 'offer', 'pence', 'per', 'share', 'Shareholder', 'meeting', 'take', 'place', 'around', 'week', 'commencing', 'October', 'EasyJet', 'LON', 'Recently', 'received', 'unsolicited', 'preliminary', 'takeover', 'approach', 'unanimously', 'rejected', 'The', 'potential', 'bidder', 'since', 'confirmed', 'longer', 'considering', 'offer', 'Company', 'Separately', 'company', 'undertaken', 'fully', 'underwritten', 'rights', 'issue', 'raise', 'gross', 'proceeds', 'approximately', 'billion', 'JD', 'Sports', 'LON', 'â', 'Reportedly', 'considering', 'investment', 'online', 'fashion', 'website', 'Missguided', 'could', 'involve', 'outright', 'takeover', 'JD', 'Sports', 'proposal', 'said', 'involve', 'acquisition', 'controlling', 'interest', 'Missguided', 'Sky', 'News', 'AstraZeneca', 'LON', 'NASDAQ', 'Says', 'PhIII', 'asthma', 'trials', 'met', 'primary', 'endpoints', 'significantly', 'reduced', 'risk', 'severe', 'exacerbations', 'compared', 'albuterol', 'patients', 'moderate', 'severe', 'asthma', 'MANDALA', 'trial', 'used', 'rescue', 'medicine', 'response', 'symptoms', 'Genus', 'LON', 'FY', 'revenue', 'million', 'Adjusted', 'operating', 'profit', 'exJVs', 'million', 'Recent', 'volatility', 'Chinese', 'porcine', 'market', 'expected', 'continue', 'months', 'creating', 'shortterm', 'headwind', 'Computacenter', 'LON', 'revenue', 'increased', 'billion', 'Will', 'endeavour', 'beat', 'last', 'year', 'second', 'half', 'performance', 'match', 'Unite', 'Group', 'LON', 'Agreed', 'million', 'sustainabilitylinked', 'unsecured', 'revolving', 'credit', 'facility', 'HSBC', 'NatWest', 'Royal', 'Bank', 'Canada', 'Spire', 'Healthcare', 'LON', 'revenue', 'increased', 'vs', 'EBITDA', 'million', 'line', 'NHS', 'waiting', 'list', 'continues', 'rise', 'supporting', 'growth', 'selfpay', 'Nearterm', 'margins', 'impacted', 'measures', 'maintain', 'Covidsecure', 'environment', 'International', 'Public', 'Partnership', 'LON', 'Portfolio', 'continued', 'perform', 'line', 'expectations', 'Increases', 'dividend', 'pence', 'per', 'share', 'Lookers', 'LON', 'revenue', 'billion', 'Record', 'underlying', 'profit', 'tax', 'million', 'Intends', 'resume', 'dividend', 'payments', 'soon', 'possible', 'next', 'review', 'position', 'releasing', 'full', 'year', 'results', 'Trading', 'July', 'August', 'remained', 'strong', 'exceeding', 'expectations', 'Current', 'expectations', 'underlying', 'profit', 'tax', 'remain', 'unchanged', 'Cairn', 'Homes', 'LON', 'revenue', 'million', 'Operating', 'profit', 'doubles', 'million', 'Recommencing', 'annual', 'ordinary', 'dividend', 'programme', 'declared', 'interim', 'dividend', 'cent', 'per', 'ordinary', 'share', 'operating', 'profit', 'expected', 'c', 'million', 'increasing', 'c', 'million', 'STV', 'Group', 'LON', 'Advertising', 'recovery', 'continues', 'Total', 'Advertising', 'Revenue', 'expected', 'months', 'end', 'September', 'Board', 'proposes', 'interim', 'dividend', 'Speedy', 'Hire', 'LON', 'Continued', 'benefit', 'positive', 'momentum', 'experienced', 'start', 'current', 'financial', 'year', 'trading', 'line', 'Board', 'expectations', 'Boohoo', 'LON', 'â', 'Upgraded', 'outperform', 'neutral', 'Credit', 'Suisse', 'SIX', 'Croda', 'LON', 'Avast', 'LON', 'Polymetal', 'LON', 'CRH', 'LON', 'Melrose', 'Industries', 'LON', 'go', 'exdividend', 'today'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'PRU', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Centrica', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Prudential', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Standard', 'Chartered', 'PLC', 'LON', 'declined', 'points', 'end', 'Schroders', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'DX', 'Add', 'toRemove', 'Portfolio', 'MOONM', 'Add', 'toRemove', 'Portfolio', 'PRSMB', 'Add', 'toRemove', 'Portfolio', 'UKWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CBRO', 'Add', 'toRemove', 'Portfolio', 'BAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'SMIN', 'Add', 'toRemove', 'Portfolio', 'PNN', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FERG', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'lower', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'US', 'Stocks', 'Smiths', 'Group', 'LON', 'Entered', 'binding', 'agreement', 'ICU', 'Medical', 'sell', 'Smiths', 'Medical', 'unit', 'headline', 'enterprise', 'value', 'billion', 'plus', 'additional', 'billion', 'contingent', 'future', 'share', 'price', 'performance', 'Smiths', 'Group', 'also', 'said', 'entered', 'FY', 'good', 'order', 'book', 'momentum', 'expects', 'underlying', 'revenue', 'growth', 'return', 'aggregate', 'around', 'preCOVID', 'levels', 'operational', 'efficiency', 'benefits', 'good', 'cash', 'generation', 'Proposed', 'final', 'dividend', 'pence', 'per', 'share', 'fullyear', 'dividend', 'increased', 'AstraZeneca', 'LON', 'NASDAQ', 'Saphnelo', 'anifrolumab', 'approved', 'Japan', 'treatment', 'adult', 'patients', 'systemic', 'lupus', 'erythematosus', 'SLE', 'serious', 'autoimmune', 'disease', 'Moonpig', 'Group', 'LON', 'Raising', 'guidance', 'group', 'revenue', 'expected', 'approximately', 'million', 'million', 'Mediumterm', 'growth', 'margin', 'targets', 'remain', 'unchanged', 'EasyJet', 'LON', 'â', 'Receives', 'acceptances', 'shareholders', 'new', 'shares', 'sold', 'part', 'billion', 'rights', 'issue', 'Ferguson', 'LON', 'FY', 'revenue', 'billion', 'Records', 'final', 'dividend', 'cents', 'per', 'share', 'bringing', 'total', 'dividend', 'cents', 'increase', 'Expect', 'year', 'good', 'growth', 'overall', 'anticipate', 'tapering', 'second', 'half', 'tougher', 'prior', 'year', 'comparatives', 'Blue', 'Prism', 'LON', 'Agreed', 'taken', 'Vista', 'per', 'share', 'cash', 'valuing', 'company', 'billion', 'GoAhead', 'LON', 'â', 'UK', 'government', 'take', 'control', 'Southeastern', 'rail', 'franchise', 'company', 'admitted', 'making', 'errors', 'Finance', 'director', 'Elodie', 'Brian', 'resigned', 'immediate', 'effect', 'BHP', 'Group', 'LON', 'Proxy', 'adviser', 'Glass', 'Lewis', 'advises', 'shareholders', 'vote', 'companyâs', 'Climate', 'Transition', 'Action', 'Plan', 'citing', 'concerns', 'scope', 'alignment', 'latest', 'climate', 'science', 'Close', 'Brothers', 'LON', 'Adjusted', 'operating', 'profit', 'increased', 'million', 'Board', 'proposing', 'final', 'dividend', 'pence', 'per', 'share', 'resulting', 'fullyear', 'dividend', 'pence', 'Encouraged', 'improvement', 'economic', 'outlook', 'although', 'trajectory', 'remains', 'uncertain', 'Pennon', 'Group', 'LON', 'Overall', 'EBITDA', 'remains', 'line', 'management', 'expectations', 'increased', 'costs', 'offset', 'increased', 'revenues', 'Greencoat', 'LON', 'Agreed', 'acquire', 'Andershaw', 'wind', 'farm', 'Statkraft', 'total', 'consideration', 'million', 'AGBarr', 'LON', 'revenue', 'million', 'Announces', 'recommencement', 'dividends', 'comprising', 'interim', 'dividend', 'pence', 'per', 'share', 'plus', 'oneoff', 'special', 'dividend', 'pence', 'per', 'share', 'Remain', 'track', 'deliver', 'strong', 'fullyear', 'profit', 'performance', 'slightly', 'ahead', 'preCOVID', 'level', 'Flutter', 'Entertainment', 'LON', 'Upgraded', 'Buy', 'Hold', 'HSBC', 'Sectors', 'traded', 'yesterday', 'first', 'time', 'since', 'October'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ADML', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'gained', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Next', 'PLC', 'LON', 'added', 'points', 'end', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Taylor', 'Wimpey', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Admiral', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Smith', 'Nephew', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Â', 'Reuters', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'NETW', 'Add', 'toRemove', 'Portfolio', 'PRSMB', 'Add', 'toRemove', 'Portfolio', 'SSPG', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'ALXN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'SSE', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NXT', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'UK', 'Eurozone', 'US', 'weekly', 'data', 'Stocks', 'Next', 'LON', 'brand', 'full', 'price', 'sales', 'versus', 'Profit', 'tax', 'million', 'Full', 'price', 'sales', 'last', 'eight', 'weeks', 'versus', 'materially', 'exceeding', 'company', 'expectations', 'Increasing', 'full', 'price', 'sales', 'guidance', 'rest', 'year', 'Expects', 'profit', 'tax', 'million', 'million', 'ahead', 'previous', 'guidance', 'Unilever', 'LON', 'Has', 'reportedly', 'shortlisted', 'least', 'four', 'bidders', 'tea', 'unit', 'could', 'fetch', 'billion', 'Bidders', 'said', 'include', 'CVC', 'Capital', 'Partners', 'Carlyle', 'Advent', 'International', 'consortium', 'comprising', 'Cinven', 'Abu', 'Dhabi', 'Investment', 'Authroity', 'Sky', 'News', 'Morrisons', 'LON', 'An', 'auction', 'procedure', 'Morrisons', 'take', 'place', 'October', 'determine', 'winning', 'bidder', 'neither', 'CDR', 'offer', 'Fortress', 'offer', 'final', 'Each', 'Morrisons', 'Fortress', 'CDR', 'agreed', 'terms', 'auction', 'procedure', 'AstraZeneca', 'LON', 'Alexion', 'exercised', 'option', 'acquire', 'remaining', 'equity', 'Caelum', 'Biosciences', 'Alexion', 'NASDAQ', 'pay', 'Caelum', 'agreed', 'option', 'exercise', 'price', 'approximately', 'million', 'potential', 'additional', 'payments', 'million', 'upon', 'achievement', 'regulatory', 'commercial', 'milestones', 'Abrdn', 'LON', 'Has', 'sold', 'million', 'shares', 'HDFC', 'Asset', 'Management', 'Company', 'average', 'price', 'INR', 'result', 'receiving', 'approximately', 'INR', 'million', 'million', 'net', 'taxes', 'expenses', 'SSE', 'LON', 'SSE', 'Renewables', 'signs', 'agreement', 'Japanâs', 'Pacifico', 'Energy', 'create', 'joint', 'ownership', 'company', 'pursue', 'offshore', 'wind', 'energy', 'development', 'projects', 'Japan', 'SSE', 'Renewable', 'buy', 'interest', 'offshore', 'wind', 'development', 'platform', 'Pacifico', 'million', 'million', 'deferred', 'Separately', 'company', 'said', 'expects', 'report', 'adjusted', 'earnings', 'per', 'share', 'range', 'halfyear', 'SSE', 'expects', 'recommend', 'fullyear', 'dividend', 'pence', 'plus', 'RPI', 'inflation', 'BT', 'LON', 'The', 'company', 'facing', 'legal', 'bill', 'million', 'almost', 'million', 'customers', 'potentially', 'receiving', 'claims', 'overcharged', 'landline', 'telephone', 'services', 'SSP', 'Group', 'LON', 'revenue', 'expected', 'circa', 'levels', 'Group', 'expected', 'deliver', 'positive', 'EBITDA', 'broadly', 'breakeven', 'second', 'half', 'year', 'Base', 'case', 'scenario', 'return', 'preCovid', 'levels', 'likeforlike', 'revenue', 'EBITDA', 'margins', 'remains', 'unchanged', 'Current', 'planning', 'assumption', 'slightly', 'slower', 'recovery', 'sales', 'FY', 'Network', 'International', 'Holdings', 'LON', 'Completed', 'acquisition', 'DPO', 'Group', 'Continues', 'expect', 'doubledigit', 'ROCE', 'acquisition', 'within', 'three', 'years', 'completion', 'financial', 'guidance', 'remains', 'unchanged', 'Anglo', 'American', 'LON', 'Upgraded', 'Outperform', 'Sector', 'Perform', 'RBC', 'Blue', 'Prism', 'LON', 'Upgraded', 'Buy', 'Hold', 'HSBC', 'Lloyds', 'LON', 'Upgraded', 'Neutral', 'Sell', 'Goldman', 'Sachs', 'NYSE', 'IAG', 'LON', 'Upgraded', 'Buy', 'Hold', 'Deutsche', 'Bank', 'DE'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'healthcare', 'worker', 'prepares', 'Pfizer', 'coronavirus', 'disease', 'vaccination', 'Los', 'Angeles', 'California', 'US', 'January', 'REUTERSLucy', 'Nicholson', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'OSLO', 'Reuters', 'Pfizer', 'NYSE', 'cut', 'July', 'deliveries', 'vaccine', 'Norway', 'doses', 'delaying', 'Nordic', 'country', 'vaccine', 'rollout', 'company', 'Norwegian', 'Institute', 'Public', 'Health', 'FHI', 'told', 'Reuters', 'Thursday', 'The', 'news', 'first', 'reported', 'Norwegian', 'daily', 'VG', 'citing', 'Pfizer', 'Norwegian', 'arm', 'Geir', 'Bukholm', 'Director', 'Infection', 'Prevention', 'Control', 'Norwegian', 'Institute', 'Public', 'Health', 'Pfizer', 'major', 'provider', 'vaccines', 'Norway', 'dropped', 'Astrazeneca', 'LON', 'jab', 'offering', 'JJ', 'NYSE', 'Jenssen', 'vaccine', 'certain', 'conditions', 'provide', 'doses', 'July', 'earlier', 'estimated', 'million', 'doses', 'Pfizer', 'Norway', 'confirmed', 'Reuters', 'As', 'consequence', 'Norway', 'vaccination', 'programme', 'delayed', 'one', 'two', 'weeks', 'compared', 'earlier', 'estimate', 'FHI', 'said', 'Prime', 'Minister', 'Erna', 'Solberg', 'said', 'May', 'government', 'aimed', 'offer', 'first', 'dose', 'aged', 'July'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'company', 'logo', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'Britain', 'May', 'REUTERSPhil', 'Noble', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SINGAPORE', 'Reuters', 'AstraZeneca', 'NASDAQ', 'said', 'Friday', 'supply', 'Singapore', 'antibody', 'cocktail', 'Evusheld', 'end', 'year', 'Evusheld', 'act', 'another', 'layer', 'protection', 'alongside', 'vaccines', 'people', 'high', 'risk', 'infection', 'according', 'AstraZeneca', 'statement', 'The', 'company', 'specify', 'many', 'courses', 'treatment', 'would', 'supplied', 'Southeast', 'Asian', 'citystate', 'The', 'US', 'Food', 'Drug', 'Administration', 'Wednesday', 'authorised', 'use', 'Evusheld', 'prevent', 'infections', 'individuals', 'weak', 'immune', 'systems', 'history', 'severe', 'side', 'effects', 'coronavirus', 'vaccines'], ['Â', 'Reuters', 'CPG', 'Add', 'toRemove', 'Portfolio', 'LGRS', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRCM', 'Add', 'toRemove', 'Portfolio', 'JUP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HOCM', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'flat', 'Todayâs', 'calendar', 'highlights', 'include', 'Eurozone', 'US', 'Stocks', 'Rio', 'Tinto', 'LON', 'Cuts', 'iron', 'ore', 'shipments', 'forecast', 'tighter', 'labour', 'market', 'Now', 'expects', 'Pilbara', 'iron', 'ore', 'shipments', 'Also', 'cuts', 'refined', 'production', 'guidance', 'Pilbara', 'iron', 'ore', 'output', 'previously', 'Hargreaves', 'Lansdown', 'LON', 'Assets', 'administration', 'billion', 'September', 'since', 'June', 'Net', 'new', 'business', 'billion', 'period', 'Added', 'net', 'new', 'clients', 'Normalisation', 'revenues', 'post', 'pandemic', 'line', 'company', 'expectations', 'AstraZeneca', 'LON', 'NASDAQ', 'Imfinzi', 'plus', 'tremelimumab', 'significantly', 'improved', 'overall', 'survival', 'HIMALAYA', 'Phase', 'III', 'trial', 'unresectable', 'liver', 'cancer', 'Pearson', 'LON', 'Group', 'underlying', 'revenue', 'period', 'September', 'Strong', 'performance', 'Assessment', 'Qualifications', 'helps', 'offset', 'declining', 'enrolments', 'Higher', 'Education', 'Pearson', 'says', 'remains', 'track', 'deliver', 'adjusted', 'operating', 'profit', 'line', 'market', 'expectations', 'Hochschild', 'Mining', 'LON', 'Exercised', 'option', 'start', 'earning', 'interest', 'Snip', 'gold', 'project', 'located', 'Golden', 'Triangle', 'Tahltan', 'Territory', 'British', 'Columbia', 'Canada', 'held', 'Skeena', 'Resources', 'Jupiter', 'Fund', 'Management', 'LON', 'Assets', 'management', 'increased', 'billion', 'three', 'months', 'September', 'billion', 'Positive', 'market', 'movements', 'partially', 'offset', 'net', 'outflows', 'Land', 'Securities', 'LON', 'As', 'October', 'collection', 'day', 'net', 'rent', 'due', 'September', 'paid', 'compared', 'June', 'quarter', 'date', 'Compass', 'Group', 'LON', 'Announced', 'commitment', 'reach', 'Net', 'Zero', 'greenhouse', 'gas', 'emissions', 'across', 'global', 'operations', 'value', 'chain', 'Mercantile', 'Investment', 'Trust', 'LON', 'In', 'six', 'months', 'July', 'Company', 'produced', 'total', 'return', 'net', 'assets', 'Expect', 'revenue', 'financial', 'year', 'ending', 'January', 'significantly', 'higher', 'Declared', 'second', 'quarterly', 'interim', 'dividend', 'pence', 'per', 'share', 'Mediclinic', 'International', 'LON', 'group', 'revenue', 'ahead', 'prepandemic', 'levels', 'across', 'three', 'divisions', 'Material', 'recovery', 'Group', 'EBITDA', 'margin', 'around', 'Loungers', 'LON', 'Over', 'weeks', 'October', 'Group', 'delivered', 'like', 'like', 'sales', 'growth', 'using', 'period', 'May', 'October', 'comparator', 'National', 'Grid', 'LON', 'IFA', 'interconnector', 'come', 'back', 'service', 'October', 'ahead', 'previously', 'planned', 'October', 'Tullow', 'Oil', 'LON', 'Upgraded', 'Buy', 'Hold', 'Berenberg', 'Antofagasta', 'LON', 'Upgraded', 'Sector', 'Perform', 'Underperform', 'RBC'], ['Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SGXIO', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Global', 'markets', 'tumble', 'US', 'stocks', 'set', 'extend', 'losses', 'Federal', 'Reserve', 'latest', 'minutes', 'suggested', 'start', 'reducing', 'bond', 'purchases', 'year', 'Jobless', 'claims', 'due', 'provide', 'evidence', 'substantial', 'progress', 'toward', 'Fed', 'employment', 'goals', 'The', 'world', 'two', 'biggest', 'auto', 'groups', 'see', 'chiprelated', 'disruptions', 'continuing', 'new', 'study', 'supports', 'scientific', 'case', 'vaccine', 'booster', 'shots', 'And', 'China', 'country', 'biggest', 'investor', 'avoided', 'collapse', 'accepting', 'stateled', 'bailout', 'Here', 'need', 'know', 'financial', 'markets', 'Thursday', 'August', 'Global', 'markets', 'fall', 'Fed', 'minutes', 'point', 'early', 'tapering', 'Global', 'stock', 'markets', 'tumbled', 'taking', 'industrial', 'commodities', 'prospect', 'early', 'tapering', 'asset', 'purchases', 'Federal', 'Reserve', 'triggered', 'sharp', 'repricing', 'risk', 'worldwide', 'The', 'tracks', 'greenback', 'basket', 'six', 'developed', 'market', 'currencies', 'rose', 'highest', 'since', 'November', 'prices', 'fell', 'lowest', 'May', 'The', 'biggest', 'carnage', 'reserved', 'fell', 'Singapore', 'China', 'cut', 'steel', 'output', 'targets', 'effort', 'reduce', 'carbon', 'emissions', 'Other', 'base', 'metals', 'also', 'tumbled', 'US', 'stock', 'markets', 'set', 'extend', 'Wednesdayâs', 'losses', 'open', 'later', 'By', 'AM', 'ET', 'GMT', 'points', 'Jobless', 'claims', 'show', 'progress', 'The', 'market', 'nerves', 'add', 'extra', 'spice', 'release', 'US', 'numbers', 'AM', 'ET', 'Initial', 'claims', 'expected', 'fallen', 'new', 'postpandemic', 'low', 'last', 'week', 'The', 'numbers', 'uptotheminute', 'data', 'labour', 'market', 'Fedâs', 'chief', 'cause', 'concern', 'recent', 'months', 'â', 'least', 'banner', 'employment', 'report', 'July', 'leaped', 'nearly', 'million', 'The', 'Fedâs', 'minutes', 'released', 'late', 'Wednesday', 'suggested', 'majority', 'policymakers', 'thought', 'enough', 'progress', 'made', 'restoring', 'employment', 'start', 'reducing', 'rate', 'bond', 'purchases', 'early', 'year', 'Study', 'boosts', 'booster', 'shot', 'WHO', 'continues', 'rail', 'A', 'major', 'UK', 'study', 'showed', 'effectiveness', 'vaccines', 'stopping', 'disease', 'fades', 'quickly', 'thought', 'strengthening', 'scientific', 'case', 'booster', 'shots', 'planned', 'governments', 'US', 'UK', 'The', 'study', 'led', 'Oxford', 'University', 'found', 'efficacy', 'PfizerBioNTech', 'vaccine', 'fell', 'half', 'within', 'four', 'months', 'second', 'shot', 'administered', 'The', 'AstraZeneca', 'PLC', 'LON', 'NASDAQ', 'vaccineâs', 'protection', 'degraded', 'slightly', 'slower', 'rate', 'The', 'World', 'Health', 'Organization', 'remains', 'adamantly', 'opposed', 'plans', 'booster', 'shorts', 'saying', 'itâs', 'important', 'get', 'vaccines', 'parts', 'world', 'initial', 'vaccination', 'rates', 'still', 'low', 'Auto', 'giants', 'face', 'chip', 'disruption', 'The', 'impact', 'latest', 'wave', 'pandemic', 'evident', 'report', 'said', 'Toyota', 'forced', 'cut', 'production', 'planned', 'levels', 'September', 'Toyota', 'extensive', 'operations', 'Thailand', 'spread', 'virus', 'exploded', 'last', 'two', 'months', 'forcing', 'many', 'factories', 'suspend', 'production', 'According', 'report', 'worldâs', 'biggest', 'automotive', 'group', 'also', 'struggling', 'chip', 'shortages', 'negative', 'surprise', 'given', 'company', 'â', 'long', 'seen', 'best', 'supply', 'chain', 'manager', 'sector', 'â', 'largely', 'escaped', 'problems', 'chip', 'availability', 'first', 'half', 'In', 'Europe', 'meanwhile', 'Volkswagen', 'DE', 'said', 'expected', 'chip', 'availability', 'remain', 'volatile', 'next', 'months', 'Toyota', 'stock', 'fell', 'local', 'trading', 'VWâs', 'preferred', 'stock', 'fell', 'The', 'flip', 'side', 'chip', 'shortage', 'also', 'evident', 'Nvidiaâs', 'earnings', 'released', 'late', 'Wednesday', 'The', 'company', 'said', 'expects', 'raise', 'prices', 'gaming', 'chips', 'particular', 'thanks', 'rapid', 'growth', 'online', 'gaming', 'Chinese', 'state', 'bails', 'distressed', 'debt', 'investor', 'Huarong', 'The', 'excessive', 'debts', 'Chinese', 'companies', 'slowly', 'surely', 'finding', 'way', 'onto', 'stateâs', 'balance', 'sheet', 'Huarong', 'countryâs', 'largest', 'investor', 'distressed', 'debt', 'announced', 'Thursday', 'accept', 'bailout', 'handful', 'largely', 'stateowned', 'institutions', 'including', 'CITIC', 'China', 'Life', 'The', 'news', 'coincided', 'delayed', 'publication', 'record', 'loss', 'The', 'capital', 'injection', 'removes', 'threat', 'damaging', 'highprofile', 'default', 'local', 'bond', 'market', 'remains', 'plagued', 'fears', 'number', 'highlyleveraged', 'companies', 'â', 'especially', 'real', 'estate', 'sector', 'â', 'could', 'go', 'Huarongâs', 'former', 'chairman', 'Lai', 'Xiaomin', 'executed', 'financial', 'crimes', 'January'], ['WEIR', 'Add', 'toRemove', 'Portfolio', 'GLO', 'Add', 'toRemove', 'Portfolio', 'OTB', 'Add', 'toRemove', 'Portfolio', 'PLUSP', 'Add', 'toRemove', 'Portfolio', 'IPO', 'Add', 'toRemove', 'Portfolio', 'FSJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'RYA', 'Add', 'toRemove', 'Portfolio', 'POG', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BNPP', 'Add', 'toRemove', 'Portfolio', 'PRU', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'US', 'speech', 'Bank', 'Englandâs', 'Stocks', 'HSBC', 'LON', 'reported', 'profit', 'tax', 'billion', 'billion', 'Increase', 'driven', 'release', 'expected', 'credit', 'losses', 'credit', 'impairment', 'charges', 'higher', 'share', 'profit', 'associates', 'Net', 'interest', 'margin', 'broadly', 'stable', 'compared', 'Expect', 'net', 'release', 'ECL', 'potential', 'small', 'net', 'release', 'ECL', 'dependent', 'offsetting', 'levels', 'stage', 'charges', 'Expect', 'NIM', 'begin', 'increase', 'coming', 'quarters', 'lending', 'growth', 'earlier', 'anticipated', 'policy', 'rate', 'rises', 'Intend', 'initiate', 'share', 'buyback', 'billion', 'Tesco', 'LON', 'The', 'supermarketâs', 'online', 'store', 'hit', 'attempted', 'hack', 'weekend', 'leaving', 'shoppers', 'unable', 'amend', 'orders', 'book', 'new', 'deliveries', 'The', 'company', 'said', 'reason', 'believe', 'issue', 'impacted', 'customer', 'data', 'AstraZeneca', 'LON', 'Imfinzi', 'plus', 'chemotherapy', 'significantly', 'improved', 'overall', 'survival', 'advanced', 'biliary', 'tract', 'cancer', 'Phase', 'III', 'trial', 'interim', 'analysis', 'LON', 'revenue', 'million', 'EBITDA', 'million', 'Board', 'remains', 'confident', 'outlook', 'company', 'Expects', 'FY', 'revenue', 'EBITDA', 'ahead', 'current', 'compiled', 'analysts', 'consensus', 'forecasts', 'Tullow', 'Oil', 'LON', 'Phuthuma', 'Nhleko', 'appointed', 'independent', 'nonexecutive', 'Director', 'Chairmandesignate', 'Ryanair', 'LON', 'Is', 'sued', 'On', 'The', 'Beach', 'LON', 'blocking', 'booking', 'flights', 'airline', 'ContourGlobal', 'LON', 'Operational', 'performance', 'remained', 'strong', 'although', 'slightly', 'average', 'availability', 'factor', 'first', 'months', 'Adjusted', 'EBITDA', 'million', 'To', 'pay', 'dividend', 'pence', 'per', 'share', 'Petropavlovsk', 'LON', 'total', 'gold', 'production', 'fell', 'koz', 'Own', 'mined', 'gold', 'production', 'increased', 'gold', 'sales', 'totalled', 'koz', 'Affirms', 'full', 'year', 'production', 'guidance', 'koz', 'Prudential', 'LON', 'Mandated', 'banks', 'arrange', 'fixed', 'income', 'investor', 'calls', 'benchmark', 'USDdenominated', 'transaction', 'IP', 'Group', 'LON', 'Following', 'completion', 'funding', 'round', 'portfolio', 'company', 'top', 'valuable', 'holdings', 'company', 'recorded', 'net', 'realised', 'realised', 'fair', 'value', 'gain', 'approximately', 'million', 'James', 'Fisher', 'Sons', 'LON', 'Improvement', 'Fendercare', 'shiptoship', 'transfer', 'business', 'remains', 'rate', 'previously', 'expected', 'A', 'recent', 'deterioration', 'condition', 'financially', 'distressed', 'customer', 'increased', 'bad', 'debt', 'risk', 'circa', 'million', 'Now', 'anticipates', 'Underlying', 'Operating', 'Profit', 'full', 'year', 'separately', 'disclosed', 'items', 'range', 'million', 'Management', 'performing', 'detailed', 'review', 'Group', 'cost', 'base', 'balance', 'sheet', 'continuing', 'advance', 'pace', 'divestment', 'noncore', 'businesses', 'assets', 'aimed', 'generating', 'significant', 'proceeds', 'next', 'year', 'EasyJet', 'LON', 'Upgraded', 'hold', 'sell', 'Stifel', 'Weir', 'Group', 'LON', 'Upgraded', 'outperform', 'neutral', 'BNP', 'Paribas', 'PA'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'TUIGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPG', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BMEB', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'Samsung', 'Electronics', 'Co', 'Ltd', 'DRC', 'LON', 'rose', 'points', 'trade', 'close', 'BM', 'European', 'Value', 'Retail', 'SA', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Compass', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Land', 'Securities', 'Group', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'March', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Flutter', 'Entertainment', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Anglo', 'American', 'PLC', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'HSBC', 'Holdings', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Persimmon', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'April', 'rose', 'hit', 'barrel', 'May', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'By', 'Dhirendra', 'Tripathi', 'Investingcom', 'Stocks', 'reversed', 'tech', 'slide', 'Disneyâs', 'disappointing', 'earnings', 'weighed', 'Thursday', 'Though', 'investors', 'still', 'digesting', 'news', 'inflation', 'running', 'pace', 'seen', 'years', 'positive', 'sentiment', 'enough', 'lift', 'tech', 'sector', 'The', 'rose', 'nearly', 'boosted', 'chip', 'stocks', 'Nvidia', 'NASDAQ', 'Shares', 'ofWalt', 'Disney', 'Company', 'NYSE', 'lead', 'declines', 'among', 'Dow', 'components', 'reported', 'smallest', 'rise', 'subscriptions', 'video', 'streaming', 'service', 'since', 'start', 'And', 'second', 'day', 'trading', 'shares', 'Rivian', 'Automotive', 'Inc', 'NASDAQ', 'surged', 'another', 'Market', 'participants', 'also', 'watching', 'developments', 'around', 'nomination', 'Federal', 'Reserve', 'Chair', 'President', 'Joe', 'Biden', 'still', 'weighing', 'whether', 'keep', 'Jerome', 'Powell', 'second', 'term', 'nominate', 'Fed', 'Governor', 'Lael', 'Brainard', 'post', 'The', 'bond', 'markets', 'closed', 'US', 'Thursday', 'Veterans', 'Day', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'AstraZeneca', 'earnings', 'AstraZeneca', 'PLC', 'ADR', 'NASDAQ', 'expected', 'report', 'thirdquarter', 'profit', 'per', 'share', 'cents', 'revenue', 'billion', 'Job', 'openings', 'The', 'number', 'US', 'likely', 'dropped', 'million', 'September', 'million', 'August', 'Its', 'alltime', 'high', 'Julyâs', 'Consumer', 'sentiment', 'The', 'preliminary', 'reading', 'US', 'consumer', 'sentiment', 'November', 'reflected', 'University', 'Michigan', 'Index', 'seen', 'improving', 'Octoberâs', 'Reuters', 'contributed', 'report'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Britain', 'August', 'REUTERSNeil', 'HallFile', 'Photo', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTSE', 'Add', 'toRemove', 'Portfolio', 'By', 'Bansari', 'Mayur', 'Kamdar', 'Devik', 'Jain', 'Reuters', 'London', 'slipped', 'Tuesday', 'weighed', 'weaker', 'shares', 'AstraZeneca', 'NASDAQ', 'heavyweight', 'consumer', 'staples', 'stocks', 'although', 'upbeat', 'earnings', 'updates', 'Vodafone', 'LON', 'spirits', 'maker', 'Diageo', 'LON', 'limited', 'overall', 'declines', 'The', 'bluechip', 'index', 'closed', 'lower', 'drugmakers', 'AstraZeneca', 'GlaxoSmithKline', 'respectively', 'Large', 'dollarearning', 'companies', 'including', 'British', 'American', 'Tobacco', 'LON', 'Reckitt', 'Benckiser', 'Unilever', 'LON', 'fell', 'among', 'biggest', 'drags', 'index', 'Vodafone', 'jumped', 'top', 'FTSE', 'mobile', 'operator', 'increased', 'free', 'cash', 'flow', 'outlook', 'reported', 'solid', 'growth', 'earnings', 'first', 'half', 'The', 'domestically', 'focussed', 'midcap', 'ended', 'lower', 'shrugging', 'data', 'showed', 'UK', 'economy', 'withstood', 'end', 'government', 'furlough', 'scheme', 'last', 'month', 'cementing', 'expectations', 'interest', 'rate', 'hike', 'December', 'We', 'still', 'seem', 'caught', 'two', 'strong', 'counterforces', 'strong', 'earnings', 'season', 'providing', 'bullish', 'case', 'long', 'list', 'downside', 'risks', 'notably', 'inflation', 'interest', 'rates', 'continue', 'weigh', 'sentiment', 'said', 'Craig', 'Erlam', 'senior', 'market', 'analyst', 'UK', 'EMEA', 'OANDA', 'What', 'see', 'report', 'relation', 'October', 'payrolls', 'encouraging', 'makes', 'December', 'BoE', 'meeting', 'much', 'live', 'one', 'Financial', 'markets', 'currently', 'priced', 'near', 'chance', 'Bank', 'England', 'BoeE', 'raise', 'rates', 'December', 'Bogged', 'inflationary', 'pressures', 'supply', 'chain', 'problems', 'FTSE', 'gained', 'year', 'underperforming', 'European', 'US', 'peers', 'The', 'focus', 'consumer', 'prices', 'data', 'Wednesday', 'Among', 'stocks', 'Diageo', 'added', 'Johnnie', 'Walker', 'whisky', 'maker', 'forecast', 'double', 'digit', 'sales', 'growth', 'first', 'half', 'Restaurant', 'Group', 'Plc', 'LON', 'climbed', 'Wagamama', 'owner', 'raised', 'annual', 'profit', 'outlook', 'Land', 'Securities', 'Group', 'gained', 'UK', 'largest', 'commercial', 'property', 'firm', 'swung', 'halfyear', 'profit', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'reacts', 'receives', 'AstraZenecaOxford', 'coronavirus', 'disease', 'vaccine', 'donated', 'Kenya', 'UK', 'government', 'Nairobi', 'Kenya', 'August', 'REUTERSBaz', 'Ratner', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Two', 'billion', 'doses', 'AstraZenecaOxford', 'University', 'vaccine', 'supplied', 'worldwide', 'AngloSwedish', 'drugmaker', 'partner', 'said', 'Tuesday', 'year', 'since', 'first', 'approval', 'The', 'shot', 'biggest', 'contributor', 'COVAX', 'vaccine', 'sharing', 'scheme', 'backed', 'World', 'Health', 'Organization', 'made', 'countries', 'supply', 'countries', 'Londonlisted', 'AstraZeneca', 'NASDAQ', 'Oxford', 'University', 'said', 'joint', 'statement', 'AstraZeneca', 'June', 'last', 'year', 'signed', 'India', 'Serum', 'Institute', 'world', 'biggest', 'manufacturer', 'vaccines', 'volume', 'help', 'double', 'vaccine', 'manufacturing', 'capacity', 'two', 'billion', 'doses', 'The', 'shot', 'sold', 'brand', 'names', 'Vaxzevria', 'Covishield', 'faced', 'challenges', 'around', 'efficacy', 'data', 'supplies', 'links', 'rare', 'blood', 'clots', 'AstraZeneca', 'last', 'week', 'said', 'world', 'learns', 'live', 'coronavirus', 'causes', 'would', 'begin', 'earn', 'modest', 'profit', 'shot', 'made', 'commitment', 'sell', 'cost', 'pandemic', 'The', 'company', 'chief', 'executive', 'officer', 'Pascal', 'Soriot', 'however', 'reassured', 'lowincome', 'countries', 'would', 'continue', 'receive', 'vaccines', 'nonprofit', 'basis'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Vials', 'labelled', 'Astra', 'Zeneca', 'Coronavirus', 'Vaccine', 'syringe', 'seen', 'front', 'displayed', 'AstraZeneca', 'logo', 'illustration', 'photo', 'taken', 'March', 'REUTERSDado', 'Ruvic', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'AstraZeneca', 'NASDAQ', 'Thursday', 'cemented', 'lead', 'bringing', 'preventative', 'shot', 'market', 'saying', 'antibody', 'cocktail', 'offered', 'protection', 'six', 'months', 'providing', 'another', 'possible', 'weapon', 'fight', 'pandemic', 'The', 'therapy', 'called', 'Evusheld', 'previously', 'shown', 'confer', 'protection', 'symptomatic', 'illness', 'three', 'months', 'earlier', 'readout', 'latestage', 'PROVENT', 'trial', 'August', 'The', 'data', 'give', 'hope', 'additional', 'protection', 'people', 'respond', 'well', 'vaccines', 'cancer', 'patients', 'The', 'AngloSwedish', 'company', 'also', 'said', 'separate', 'study', 'patients', 'mildtomoderate', 'showed', 'higher', 'dose', 'cut', 'risk', 'symptoms', 'worsening', 'given', 'within', 'three', 'days', 'first', 'symptoms', 'The', 'antibody', 'treatment', 'enhanced', 'remain', 'intact', 'body', 'months', 'given', 'one', 'go', 'two', 'sequential', 'shots', 'arm', 'The', 'latest', 'results', 'longerterm', 'followups', 'potentially', 'position', 'AstraZeneca', 'like', 'rival', 'Pfizer', 'NYSE', 'future', 'supplier', 'vaccines', 'treatments', 'AstraZeneca', 'said', 'therapy', 'real', 'advantage', 'preventative', 'shot', 'The', 'full', 'results', 'submitted', 'publication', 'peerreviewed', 'medical', 'journal', 'Pfizer', 'presented', 'promising', 'efficacy', 'data', 'oral', 'treatment', 'candidate', 'easily', 'distributed', 'injections', 'also', 'leading', 'vaccine', 'supplier', 'partner', 'BioNTech', 'These', 'new', 'data', 'add', 'growing', 'body', 'evidence', 'supporting', 'potential', 'We', 'progressing', 'regulatory', 'filings', 'around', 'world', 'look', 'forward', 'providing', 'important', 'new', 'option', 'quickly', 'possible', 'AstraZeneca', 'Executive', 'Vice', 'President', 'Mene', 'Pangalos', 'said', 'statement', 'referring', 'coronavirus', 'causes', 'The', 'group', 'last', 'month', 'sought', 'approval', 'medicine', 'US', 'European', 'authorities', 'Monoclonal', 'antibodies', 'Regeneron', 'Lilly', 'GSKVir', 'approved', 'US', 'regulators', 'treating', 'unhospitalised', 'patients', 'Earlier', 'month', 'Regeneron', 'said', 'single', 'dose', 'antibody', 'cocktail', 'reduced', 'risk', 'contracting', 'latestage', 'trial', 'LONGTERM', 'This', 'important', 'addition', 'therapeutic', 'armamentarium', 'COVID', 'published', 'study', 'confirms', 'data', 'released', 'Thursday', 'said', 'Penny', 'Ward', 'visiting', 'professor', 'pharmaceutical', 'medicine', 'King', 'College', 'London', 'While', 'injection', 'may', 'seen', 'potential', 'alternative', 'vaccines', 'antibody', 'drugs', 'cost', 'significantly', 'may', 'limit', 'use', 'particularly', 'highrisk', 'groups', 'Antibody', 'cocktails', 'typically', 'cost', 'per', 'dose', 'shots', 'average', 'sold', 'per', 'dose', 'Astra', 'Executive', 'Vice', 'President', 'vaccines', 'immune', 'therapies', 'Iskra', 'Reic', 'said', 'call', 'media', 'unlike', 'vaccine', 'drug', 'would', 'priced', 'commercially', 'negotiates', 'supply', 'contracts', 'governments', 'around', 'globe', 'Chief', 'executive', 'Pascal', 'Soriot', 'said', 'treatment', 'complicated', 'produce', 'vaccine', 'would', 'enough', 'production', 'capacity', 'around', 'world', 'meet', 'demand', 'Monoclonal', 'antibody', 'drugs', 'deliver', 'labmade', 'versions', 'body', 'natural', 'antibodies', 'fight', 'infection', 'vaccines', 'spur', 'body', 'make', 'antibodies', 'build', 'immunity', 'AstraZeneca', 'said', 'shot', 'primarily', 'meant', 'help', 'immunocompromised', 'atrisk', 'individuals', 'point', 'wider', 'group', 'could', 'benefit', 'military', 'personnel', 'tours', 'duty', 'cruise', 'ship', 'passengers', 'It', 'would', 'administered', 'addition', 'vaccines', 'company', 'said', 'It', 'added', 'global', 'population', 'considered', 'inadequately', 'respond', 'vaccine', 'For', 'AstraZeneca', 'PROVENT', 'trial', 'close', 'participants', 'without', 'infection', 'randomly', 'split', 'two', 'groups', 'one', 'volunteer', 'receiving', 'ineffective', 'placebo', 'without', 'knowing', 'every', 'two', 'receiving', 'Evusheld', 'Participants', 'risk', 'suffering', 'severe', 'infected', 'immunocompromised', 'meaning', 'cancer', 'care', 'receiving', 'drugs', 'due', 'autoimmune', 'disease', 'organ', 'transplant', 'The', 'trial', 'volunteers', 'vaccinated', 'even', 'though', 'highrisk', 'groups', 'prioritised', 'global', 'vaccination', 'campaigns', 'Anyone', 'opting', 'get', 'vaccinated', 'trial', 'excluded', 'analysis', 'Trial', 'volunteers', 'followed', 'months', 'provide', 'evidence', 'longerlasting', 'protection'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Vials', 'labelled', 'Astra', 'Zeneca', 'Coronavirus', 'Vaccine', 'syringe', 'seen', 'front', 'displayed', 'AstraZeneca', 'logo', 'illustration', 'photo', 'taken', 'March', 'REUTERSDado', 'RuvicFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'CAMBRIDGE', 'England', 'Reuters', 'Britain', 'Prince', 'Charles', 'formally', 'opened', 'new', 'billion', 'pound', 'billion', 'AstraZeneca', 'NASDAQ', 'research', 'development', 'RD', 'facility', 'Cambridge', 'eastern', 'England', 'Tuesday', 'company', 'aims', 'fuel', 'growth', 'drug', 'pipeline', 'AstraZeneca', 'supplied', 'two', 'billion', 'doses', 'vaccine', 'developed', 'Oxford', 'University', 'also', 'looking', 'bring', 'preventative', 'antibody', 'cocktail', 'market', 'Prince', 'Charles', 'son', 'Queen', 'Elizabeth', 'heir', 'throne', 'saw', 'exhibit', 'pandemic', 'demonstration', 'augmented', 'reality', 'headsets', 'help', 'lab', 'work', 'hearing', 'company', 'netzero', 'targets', 'The', 'last', 'two', 'years', 'difficult', 'generation', 'Prince', 'Charles', 'said', 'speech', 'But', 'quite', 'literally', 'turbocharge', 'sustainable', 'action', 'desperately', 'needed', 'create', 'greener', 'healthier', 'future', 'â', 'people', 'Nature', 'one', 'planet', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'centre', 'would', 'power', 'next', 'stage', 'company', 'growth', 'The', 'plans', 'AstraZeneca', 'new', 'headquarters', 'large', 'RD', 'campus', 'Cambridge', 'unveiled', 'costs', 'timeframe', 'exceeded', 'initial', 'estimate', 'million', 'pounds', 'aimed', 'completion', 'date', 'AstraZeneca', 'large', 'portfolio', 'treatments', 'diseases', 'cancer', 'heart', 'disease', 'diabetes', 'said', 'centre', 'would', 'support', 'research', 'specialised', 'medicines', 'nextgeneration', 'therapeutics', 'including', 'geneediting', 'cell', 'therapies', 'We', 'advances', 'could', 'come', 'clinic', 'next', 'three', 'four', 'years', 'lead', 'really', 'effective', 'new', 'drugs', 'various', 'aspects', 'treating', 'cancer', 'Dr', 'Susan', 'Galbraith', 'AstraZeneca', 'Executive', 'Vice', 'President', 'Oncology', 'Research', 'Development', 'told', 'Reuters', 'interview', 'I', 'optimistic', 'fact', 'make', 'big', 'difference', 'disease', 'coming', 'decade', 'pounds'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Test', 'tubes', 'seen', 'front', 'displayed', 'AstraZeneca', 'logo', 'illustration', 'taken', 'May', 'REUTERSDado', 'RuvicIllustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'said', 'Friday', 'examining', 'impact', 'new', 'coronavirus', 'variant', 'spreading', 'rapidly', 'South', 'Africa', 'vaccine', 'antibody', 'cocktail', 'adding', 'hopeful', 'combination', 'drug', 'would', 'retain', 'efficacy', 'The', 'World', 'Health', 'Organization', 'WHO', 'Friday', 'designated', 'new', 'variant', 'detected', 'South', 'Africa', 'large', 'number', 'mutations', 'concern', 'AstraZeneca', 'NASDAQ', 'distributed', 'billion', 'doses', 'vaccine', 'worldwide', 'although', 'rollout', 'shot', 'paused', 'South', 'Africa', 'February', 'shown', 'offer', 'minimal', 'protection', 'mild', 'moderate', 'illness', 'caused', 'Beta', 'variant', 'dominant', 'country', 'time', 'As', 'new', 'emerging', 'variants', 'looking', 'understand', 'impact', 'vaccine', 'AstraZeneca', 'said', 'statement', 'adding', 'conducting', 'research', 'Botswana', 'Eswatini', 'collect', 'data', 'That', 'enable', 'us', 'collect', 'real', 'world', 'data', 'Vaxzevria', 'new', 'virus', 'variant', 'The', 'AngloSwedish', 'pharmaceutical', 'firm', 'emphasised', 'vaccine', 'shown', 'effective', 'variants', 'concern', 'AstraZeneca', 'said', 'developed', 'vaccine', 'platform', 'respond', 'quickly', 'new', 'variants', 'Oxford', 'University', 'vaccine', 'created', 'It', 'previously', 'said', 'working', 'variant', 'vaccine', 'better', 'target', 'Beta', 'variant', 'The', 'company', 'also', 'developed', 'antibody', 'cocktail', 'used', 'prevent', 'treat', 'Although', 'scientists', 'expressed', 'concern', 'spike', 'protein', 'mutations', 'might', 'hinder', 'effectiveness', 'monoclonal', 'antibody', 'drugs', 'combination', 'drug', 'made', 'AstraZeneca', 'might', 'retain', 'efficacy', 'company', 'said', 'We', 'also', 'testing', 'longacting', 'antibody', 'combination', 'new', 'variant', 'hopeful', 'retain', 'efficacy', 'since', 'comprises', 'two', 'potent', 'antibodies', 'different', 'complementary', 'activities', 'virus', 'said'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HMSO', 'Add', 'toRemove', 'Portfolio', 'FVIG', 'Add', 'toRemove', 'Portfolio', 'AJBA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'UK', 'Eurozone', 'German', 'Canadian', 'US', 'Fed', 'Chair', 'Powell', 'Speaks', 'Coronavirus', 'The', 'World', 'Health', 'Organization', 'designated', 'Variant', 'Concern', 'named', 'Omicron', 'WHO', 'said', 'primary', 'evidence', 'suggests', 'Omicron', 'carries', 'greater', 'risk', 'infection', 'UK', 'announced', 'temporary', 'measures', 'including', 'mandatory', 'face', 'covering', 'shops', 'public', 'transport', 'All', 'international', 'arrivals', 'must', 'take', 'PCR', 'test', 'selfisolate', 'receive', 'negative', 'result', 'The', 'UK', 'recorded', 'three', 'cases', 'new', 'variant', 'Stocks', 'BT', 'LON', 'Indiaâs', 'Reliance', 'Industries', 'reportedly', 'considering', 'bid', 'BT', 'Reliance', 'may', 'also', 'propose', 'partner', 'BTâs', 'fibre', 'optic', 'arm', 'Openreach', 'fund', 'expansion', 'plans', 'Economic', 'Times', 'AstraZeneca', 'LON', 'Said', 'conducting', 'research', 'Botswana', 'Eswatini', 'obtain', 'real', 'world', 'data', 'vaccine', 'performs', 'Omicron', 'variant', 'AJ', 'Bell', 'LON', 'To', 'launch', 'new', 'commissionfree', 'mobile', 'app', 'called', 'Dodl', 'AJ', 'Bell', 'aimed', 'competing', 'low', 'cost', 'investment', 'platforms', 'straightforward', 'accessible', 'retail', 'traders', 'The', 'app', 'commission', 'free', 'annual', 'charge', 'Hammerson', 'LON', 'Confirms', 'discussions', 'terms', 'possible', 'disposal', 'Silverburn', 'flagship', 'destination', 'near', 'Glasgow', 'The', 'site', 'currently', 'held', 'joint', 'venture', 'CPPIB', 'The', 'Company', 'confirms', 'pricing', 'discussion', 'million', 'AGBarr', 'LON', 'Positive', 'momentum', 'reported', 'September', 'continued', 'sales', 'grown', 'ahead', 'expectations', 'As', 'result', 'continued', 'strong', 'volume', 'performance', 'despite', 'ongoing', 'near', 'term', 'operating', 'cost', 'pressures', 'anticipate', 'revenue', 'profit', 'tax', 'full', 'year', 'ahead', 'current', 'market', 'expectations', 'Assuming', 'significant', 'changes', 'current', 'market', 'conditions', 'expect', 'revenue', 'order', 'million', 'profit', 'tax', 'around', 'million', 'Marshall', 'Motor', 'Holdings', 'LON', 'Constellation', 'Automotive', 'Holdings', 'made', 'offer', 'Marshall', 'Motor', 'Holdings', 'pence', 'per', 'share', 'cash', 'approximately', 'million', 'Constellation', 'received', 'undertaking', 'accept', 'offer', 'shareholder', 'Marshall', 'Cambridge', 'Molten', 'Ventures', 'LON', 'Gross', 'Portfolio', 'fair', 'value', 'growth', 'sixmonth', 'period', 'September', 'NAV', 'per', 'share', 'increased', 'pence', 'pence', 'Anticipate', 'fair', 'value', 'growth', 'region', 'full', 'year', 'March', 'subject', 'wider', 'market', 'conditions', 'IP', 'Group', 'LON', 'Following', 'completion', 'funding', 'round', 'portfolio', 'company', 'top', 'twenty', 'valuable', 'holdings', 'recorded', 'net', 'unrealised', 'fair', 'value', 'gain', 'approximately', 'million', 'per', 'share', 'McColl', 'LON', 'Terms', 'agreed', 'Morrisons', 'extend', 'number', 'Morrisons', 'Daily', 'conversions', 'stores', 'Separately', 'agreement', 'reached', 'defer', 'financial', 'covenant', 'test', 'due', 'November', 'December', 'thereafter', 'expected', 'roll', 'monthly', 'basis', 'Amigo', 'Holdings', 'LON', 'Board', 'continues', 'pursue', 'new', 'Scheme', 'address', 'complaints', 'liability', 'provide', 'solution', 'customers', 'valid', 'complaint', 'A', 'revised', 'offer', 'incorporates', 'two', 'Scheme', 'options', 'submitted', 'Independent', 'Customer', 'Committee', 'November', 'The', 'Board', 'view', 'Scheme', 'contingent', 'continuing', 'business', 'provide', 'creditors', 'value', 'certain', 'outcome', 'Neither', 'proposed', 'Schemes', 'expected', 'satisfy', 'liability', 'owed', 'redress', 'creditors', 'valid', 'claims', 'full', 'contribution', 'new', 'Scheme', 'significantly', 'increased', 'Without', 'approved', 'Scheme', 'Amigo', 'expects', 'file', 'administration', 'insolvency', 'process'], ['EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JDW', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'GLNCY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'lower', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'German', 'Unemployment', 'Eurozone', 'CPI', 'Canadian', 'GDP', 'US', 'House', 'Price', 'Index', 'Chicago', 'PMI', 'Fed', 'Chair', 'Powell', 'testifies', 'Stocks', 'EasyJet', 'LON', 'FY', 'headline', 'loss', 'tax', 'billion', 'ahead', 'consensus', 'estimates', 'Summer', 'Current', 'revenue', 'booked', 'ahead', 'level', 'Too', 'soon', 'say', 'impact', 'Omicron', 'may', 'European', 'travel', 'shortterm', 'restrictions', 'may', 'result', 'Capacity', 'expected', 'Expect', 'fly', 'circa', 'capacity', 'expect', 'summer', 'capacity', 'near', 'levels', 'Glencore', 'LON', 'Activist', 'hedge', 'fund', 'Bluebell', 'Capital', 'Partners', 'asked', 'Glencore', 'separate', 'thermal', 'coal', 'business', 'become', 'barrier', 'investment', 'AstraZeneca', 'LON', 'Companyâs', 'supplemental', 'New', 'Drug', 'Application', 'Lynparza', 'accepted', 'granted', 'Priority', 'Review', 'US', 'FDA', 'adjuvant', 'treatment', 'patients', 'BRCAmutated', 'highrisk', 'early', 'breast', 'cancer', 'Shaftesbury', 'LON', 'Sustained', 'recovery', 'footfall', 'weekends', 'currently', 'back', 'levels', 'weekdays', 'circa', 'Leasing', 'transactions', 'rental', 'value', 'million', 'completed', 'year', 'Momentum', 'continued', 'million', 'lettings', 'renewals', 'two', 'months', 'since', 'September', 'Net', 'property', 'income', 'million', 'Whollyowned', 'portfolio', 'valuation', 'billion', 'full', 'year', 'likeforlike', 'decrease', 'WPP', 'LON', 'Acquired', 'technology', 'company', 'Cloud', 'Commerce', 'Group', 'financial', 'terms', 'disclosed', 'Future', 'PLC', 'LON', 'FY', 'revenue', 'million', 'FY', 'adjusted', 'operating', 'profit', 'million', 'The', 'proposed', 'dividend', 'year', 'per', 'share', 'yearonyear', 'Upgrading', 'outlook', 'full', 'year', 'expect', 'adjusted', 'results', 'FY', 'materially', 'current', 'expectations', 'Holdings', 'LON', 'All', 'mandatory', 'antitrust', 'gaming', 'regulatory', 'clearances', 'received', 'takeover', 'William', 'Hill', 'International', 'Completion', 'expected', 'occur', 'subject', 'satisfaction', 'remaining', 'conditions', 'completion', 'New', 'equity', 'issued', 'via', 'capital', 'raise', 'expected', 'occur', 'prior', 'completion', 'acquisition', 'Micro', 'Focus', 'LON', 'To', 'set', 'plan', 'exit', 'flat', 'better', 'yearonyear', 'revenue', 'trajectory', 'Also', 'provide', 'update', 'progress', 'made', 'transformation', 'date', 'Diversified', 'Energy', 'Company', 'LON', 'Engaged', 'Bridger', 'Photonics', 'leading', 'provider', 'methane', 'leak', 'detection', 'technology', 'perform', 'multiyear', 'aerial', 'scans', 'Company', 'production', 'distribution', 'assets', 'starting', 'Appalachian', 'region', 'Countryside', 'Properties', 'LON', 'FY', 'completions', 'Adjusted', 'revenue', 'billion', 'Adjusted', 'operating', 'profit', 'million', 'Countryside', 'forward', 'sold', 'including', 'million', 'private', 'sales', 'September', 'private', 'net', 'reservation', 'rate', 'nine', 'weeks', 'November', 'Expect', 'deliver', 'adjusted', 'operating', 'profit', 'range', 'million', 'year', 'September', 'including', 'million', 'contribution', 'legacy', 'housebuilding', 'operations', 'DiscoverIE', 'Group', 'PLC', 'LON', 'revenue', 'million', 'Underlying', 'operating', 'profit', 'million', 'Interim', 'dividend', 'increased', 'pence', 'per', 'share', 'On', 'track', 'deliver', 'full', 'year', 'underlying', 'earnings', 'continuing', 'operations', 'ahead', 'Board', 'previous', 'expectations', 'despite', 'ongoing', 'supply', 'chain', 'foreign', 'exchange', 'headwinds', 'Hochschild', 'Mining', 'LON', 'To', 'acquire', 'Amarillo', 'Gold', 'Corporation', 'price', 'per', 'share', 'cash', 'J', 'D', 'Wetherspoon', 'PLC', 'LON', 'Chairman', 'Tim', 'Martin', 'criticised', 'shareholder', 'Fidelity', 'voting', 'two', 'companyâs', 'nonexecutive', 'directors', 'Greencore', 'LON', 'FY', 'group', 'revenue', 'billion', 'Adjusted', 'Operating', 'Profit', 'million', 'Continued', 'positive', 'revenue', 'momentum', 'across', 'business', 'start', 'Expects', 'generate', 'outturn', 'line', 'current', 'market', 'expectations', 'Tritax', 'EuroBox', 'LON', 'Acquired', 'million', 'asset', 'Piacenza', 'Northern', 'Italy', 'part', 'major', 'logistics', 'hub', 'Marstonâs', 'LON', 'Likeforlike', 'sales', 'since', 'restrictions', 'lifted', 'July', 'Current', 'trading', 'encouraging', 'total', 'LFL', 'sales', 'versus', 'despite', 'reduction', 'VAT', 'relief', 'John', 'Menzies', 'LON', 'Expects', 'trading', 'full', 'year', 'least', 'line', 'market', 'expectations', 'stronger', 'expected', 'trading', 'recent', 'months', 'Currently', 'forecast', 'flight', 'volumes', 'around', 'volumes', 'Topps', 'Tiles', 'LON', 'FY', 'group', 'revenue', 'million', 'Total', 'dividend', 'pence', 'per', 'share', 'Twoyear', 'Retail', 'likeforlike', 'sales', 'growth', 'first', 'eight', 'weeks', 'new', 'financial', 'year', 'Continued', 'trading', 'headwinds', 'reduced', 'consumer', 'confidence', 'global', 'supply', 'chain', 'challenges', 'cost', 'inflation'], ['AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Samsung', 'LON', 'Biologics', 'Co', 'Ltd', 'said', 'Monday', 'would', 'continue', 'partnership', 'AstraZeneca', 'NASDAQ', 'Plc', 'manufacturing', 'biopharmaceuticals', 'Samsung', 'said', 'production', 'drug', 'substance', 'drug', 'product', 'valued', 'million', 'initial', 'million', 'companies', 'expanded', 'deal', 'year', 'May', 'The', 'company', 'said', 'would', 'start', 'manufacture', 'cancer', 'immunotherapy', 'product', 'next', 'year', 'along', 'AstraZeneca', 'longacting', 'antibody', 'LAAB', 'combination', 'Samsung', 'Biologics', 'CEO', 'John', 'Rim', 'said', 'We', 'delighted', 'continue', 'expanding', 'strategic', 'collaboration', 'AstraZeneca', 'valuable', 'partner', 'witnessed', 'firsthand', 'strong', 'commitment', 'saving', 'lives', 'patients'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'health', 'worker', 'shows', 'woman', 'vial', 'containing', 'vaccine', 'administering', 'Penda', 'health', 'center', 'Nairobi', 'Kenya', 'December', 'REUTERSBaz', 'Ratner', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'Pfizer', 'NYSE', 'BioNtech', 'set', 'displace', 'AstraZeneca', 'NASDAQ', 'main', 'suppliers', 'vaccines', 'global', 'COVAX', 'programme', 'start', 'shift', 'shows', 'increasing', 'importance', 'shot', 'poorer', 'states', 'The', 'expected', 'change', 'comes', 'headaches', 'receiving', 'countries', 'lack', 'sufficient', 'cold', 'storage', 'capacity', 'handle', 'Pfizer', 'vaccine', 'amid', 'risks', 'shortage', 'syringes', 'needed', 'administer', 'shot', 'AstraZeneca', 'currently', 'distributed', 'vaccine', 'COVAX', 'according', 'data', 'Gavi', 'vaccine', 'alliance', 'comanages', 'programme', 'World', 'Health', 'Organization', 'WHO', 'The', 'programme', 'far', 'delivered', 'million', 'shots', 'nearly', 'countries', 'million', 'AstraZeneca', 'million', 'Pfizer', 'But', 'first', 'quarter', 'next', 'year', 'Pfizer', 'set', 'take', 'according', 'Gavi', 'WHO', 'figures', 'doses', 'assigned', 'COVAX', 'programme', 'future', 'supplies', 'By', 'end', 'March', 'another', 'million', 'Pfizer', 'doses', 'distributed', 'COVAX', 'WHO', 'document', 'shows', 'A', 'spokesperson', 'Gavi', 'confirmed', 'Pfizer', 'far', 'ahead', 'terms', 'allocated', 'jabs', 'million', 'doses', 'delivered', 'readied', 'delivery', 'million', 'AstraZeneca', 'Pfizer', 'first', 'provider', 'vaccines', 'European', 'Union', 'United', 'States', 'Japan', 'It', 'bilateral', 'agreements', 'billion', 'doses', 'making', 'far', 'largest', 'supplier', 'vaccines', 'according', 'data', 'UNICEF', 'UN', 'agency', 'But', 'AstraZeneca', 'seen', 'crucial', 'supplier', 'less', 'developed', 'countries', 'shot', 'cheaper', 'easier', 'deliver', 'COVAX', 'bet', 'heavily', 'AstraZeneca', 'beginning', 'pandemic', 'supply', 'problems', 'export', 'restrictions', 'top', 'producer', 'India', 'gradually', 'reduced', 'reliance', 'AngloSwedish', 'shot', 'As', 'programme', 'faced', 'problems', 'securing', 'doses', 'directly', 'vaccine', 'makers', 'amid', 'global', 'scramble', 'shots', 'donations', 'rich', 'nations', 'became', 'important', 'turning', 'Pfizer', 'main', 'supplier', 'COVAX', 'The', 'United', 'States', 'donating', 'mostly', 'Pfizer', 'shots', 'programme', 'COLD', 'CHAIN', 'AND', 'SYRINGES', 'The', 'change', 'forced', 'Gavi', 'rush', 'invest', 'cold', 'chain', 'capacity', 'receiving', 'countries', 'enough', 'refrigerators', 'cold', 'transport', 'equipment', 'handle', 'Pfizer', 'shot', 'requires', 'lower', 'storage', 'temperatures', 'AstraZeneca', 'vaccine', 'The', 'organization', 'warned', 'insufficient', 'cold', 'chain', 'capacity', 'countries', 'according', 'internal', 'report', 'submitted', 'Gavi', 'board', 'beginning', 'December', 'seen', 'Reuters', 'The', 'problem', 'compounded', 'risk', 'shortages', 'special', 'syringes', 'needed', 'administer', 'Pfizer', 'vaccine', 'Gavi', 'warned', 'document', 'The', 'Pfizer', 'jab', 'hardest', 'deliver', 'given', 'ultracold', 'chain', 'special', 'syringe', 'requirements', 'Gavi', 'says', 'internal', 'document', 'It', 'also', 'hardest', 'plan', 'donated', 'vaccines', 'often', 'come', 'earmarking', 'little', 'notice', 'staggered', 'manner', 'small', 'volumes', 'short', 'shelf', 'lives', 'document', 'says', 'Wealthy', 'countries', 'donating', 'vaccines', 'relatively', 'short', 'shelf', 'life', 'major', 'problem', 'COVAX', 'WHO', 'official', 'said', 'last', 'week', 'many', 'doses', 'wasted', 'An', 'EU', 'official', 'told', 'news', 'briefing', 'last', 'week', 'EU', 'donations', 'Pfizer', 'vaccines', 'COVAX', 'slowed', 'lack', 'syringes', 'A', 'second', 'official', 'familiar', 'issue', 'told', 'Reuters', 'Gavi', 'postpone', 'delivery', 'Pfizer', 'doses', 'Europe', 'lack', 'syringes', 'Pfizer', 'declined', 'comment', 'syringes', 'said', 'produce', 'buy', 'directly', 'As', 'doses', 'made', 'available', 'poorer', 'nations', 'UNICEF', 'WHO', 'long', 'warning', 'insufficient', 'supply', 'autodisable', 'syringes', 'crucial', 'inoculations', 'poorer', 'nations', 'Autodisable', 'syringes', 'lock', 'automatically', 'prevent', 'reuse', 'otherwise', 'common', 'poorer', 'nations', 'could', 'spread', 'diseases', 'To', 'make', 'things', 'complicated', 'autodisable', 'syringes', 'needed', 'Pfizer', 'vaccine', 'different', 'standard', 'syringes', 'UNICEF', 'said', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Adar', 'Poonawalla', 'Chief', 'Executive', 'Officer', 'CEO', 'Serum', 'Institute', 'India', 'poses', 'picture', 'Serum', 'Institute', 'India', 'Pune', 'India', 'November', 'Picture', 'taken', 'November', 'REUTERSFrancis', 'MascarenhasFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Vaccine', 'maker', 'Serum', 'Institute', 'India', 'SII', 'pledged', 'million', 'pounds', 'million', 'University', 'Oxford', 'setting', 'research', 'campus', 'would', 'also', 'house', 'institute', 'behind', 'AstraZenecaOxford', 'shot', 'The', 'investment', 'made', 'Indian', 'company', 'Serum', 'Life', 'Sciences', 'unit', 'Oxford', 'University', 'said', 'Wednesday', 'The', 'research', 'building', 'would', 'named', 'Serum', 'billionaire', 'owners', 'Poonawalla', 'family', 'The', 'pledge', 'builds', 'collaboration', 'Oxford', 'University', 'AstraZeneca', 'NASDAQ', 'SII', 'world', 'largest', 'maker', 'vaccines', 'producer', 'version', 'British', 'duo', 'shot', 'low', 'middleincome', 'countries', 'SII', 'also', 'agreed', 'Jenner', 'Institute', 'behind', 'OxfordAstraZeneca', 'vaccine', 'produce', 'develop', 'Jenner', 'malaria', 'shot', 'large', 'scale', 'The', 'shot', 'currently', 'latestage', 'trials', 'SII', 'founded', 'Western', 'Indian', 'city', 'Pune', 'Cyrus', 'Poonawalla', 'son', 'horse', 'breeder', 'India', 'fifthrichest', 'person', 'according', 'Forbes', 'In', 'Cyrus', 'also', 'conferred', 'honorary', 'degree', 'Oxford', 'University', 'It', 'currently', 'run', 'son', 'Adar', 'Poonawalla', 'whose', 'wife', 'Natasha', 'Poonawalla', 'heads', 'Serum', 'Life', 'Sciences', 'With', 'penchant', 'luxury', 'cars', 'racehorses', 'pair', 'often', 'seen', 'rubbing', 'shoulders', 'Hollywood', 'Bollywood', 'stars', 'The', 'Poonawallas', 'September', 'invested', 'million', 'pounds', 'Oxford', 'Biomedica', 'help', 'fund', 'development', 'plant', 'manufactures', 'shots', 'pounds'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'Wisniewski', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Mrinalika', 'Roy', 'Pushkala', 'Aripaka', 'Reuters', 'AstraZeneca', 'NASDAQ', 'Regeneron', 'Thursday', 'reported', 'contrasting', 'data', 'effectiveness', 'antibody', 'therapies', 'Omicron', 'variant', 'coronavirus', 'underscoring', 'major', 'challenges', 'ahead', 'drugmakers', 'USbased', 'Regeneron', 'said', 'REGENCOV', 'therapy', 'also', 'called', 'Ronapreve', 'less', 'effective', 'Omicron', 'though', 'still', 'active', 'Delta', 'variant', 'confirming', 'indications', 'lab', 'tests', 'computer', 'modelling', 'late', 'last', 'month', 'AngloSwedish', 'rival', 'AstraZeneca', 'however', 'said', 'lab', 'study', 'found', 'antibody', 'cocktail', 'Evusheld', 'retained', 'neutralising', 'activity', 'Omicron', 'first', 'data', 'treatment', 'The', 'new', 'variant', 'detected', 'countries', 'since', 'first', 'identified', 'three', 'weeks', 'ago', 'fuelling', 'concerns', 'large', 'number', 'mutations', 'help', 'spread', 'faster', 'evade', 'protection', 'provided', 'vaccines', 'therapeutics', 'Earlier', 'week', 'German', 'researchers', 'found', 'therapies', 'developed', 'Eli', 'Lilly', 'NYSE', 'Regeneron', 'lose', 'effectiveness', 'exposed', 'laboratory', 'tests', 'Omicron', 'But', 'lab', 'studies', 'week', 'showed', 'GSKVir', 'antibody', 'treatment', 'retains', 'neutralizing', 'activity', 'tested', 'coronavirus', 'variants', 'including', 'Omicron', 'The', 'study', 'Evusheld', 'done', 'independent', 'investigators', 'US', 'Food', 'Drug', 'Administration', 'using', 'socalled', 'pseudoviruses', 'feature', 'major', 'coronavirus', 'mutations', 'across', 'suspicious', 'variants', 'emerged', 'far', 'ROAD', 'AHEAD', 'The', 'researchers', 'found', 'potency', 'Evusheld', 'within', 'ranges', 'seen', 'previously', 'infected', 'showing', 'promise', 'wide', 'use', 'therapy', 'first', 'preventative', 'shot', 'vaccines', 'coronavirus', 'AstraZeneca', 'said', 'analyses', 'Evusheld', 'Omicron', 'conducted', 'company', 'third', 'parties', 'data', 'expected', 'soon', 'Regeneron', 'said', 'REGENCOV', 'still', 'active', 'Delta', 'currently', 'prevalent', 'variant', 'United', 'States', 'The', 'European', 'Union', 'public', 'health', 'body', 'however', 'warned', 'Wednesday', 'high', 'risk', 'Omicron', 'would', 'become', 'dominant', 'Europe', 'early', 'next', 'year', 'REGENCOV', 'currently', 'authorized', 'use', 'United', 'States', 'treat', 'people', 'mildtomoderate', 'prevention', 'infection', 'exposed', 'infected', 'individuals', 'others', 'high', 'risk', 'exposure', 'Evusheld', 'granted', 'authorisation', 'prevent', 'infections', 'individuals', 'weak', 'immune', 'systems', 'history', 'severe', 'sideeffects', 'coronavirus', 'vaccines', 'Both', 'treatments', 'belong', 'class', 'medicines', 'called', 'monoclonal', 'antibodies', 'mimic', 'natural', 'antibodies', 'fighting', 'infections', 'Unlike', 'vaccines', 'rely', 'body', 'create', 'immune', 'response', 'therefore', 'help', 'individuals', 'weak', 'compromised', 'immune', 'systems', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'undergoes', 'health', 'screening', 'receiving', 'dose', 'vaccine', 'coronavirus', 'disease', 'mass', 'vaccination', 'program', 'asylum', 'seekers', 'refugees', 'sports', 'hall', 'Jakarta', 'Indonesia', 'October', 'REU', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'Panu', 'Wongchaum', 'BRUSSELSBANGKOK', 'Reuters', 'Tens', 'millions', 'migrants', 'may', 'denied', 'vaccines', 'global', 'programme', 'major', 'manufacturers', 'worried', 'legal', 'risks', 'harmful', 'side', 'effects', 'according', 'officials', 'internal', 'documents', 'Gavi', 'charity', 'operating', 'programme', 'reviewed', 'Reuters', 'Nearly', 'two', 'years', 'pandemic', 'already', 'killed', 'million', 'people', 'people', 'lowincome', 'countries', 'received', 'dose', 'Vaccine', 'deliveries', 'worldwide', 'delayed', 'production', 'problems', 'hoarding', 'rich', 'countries', 'export', 'restrictions', 'red', 'tape', 'Many', 'programmes', 'also', 'hampered', 'hesitancy', 'among', 'public', 'The', 'legal', 'concerns', 'additional', 'hurdle', 'public', 'health', 'officials', 'tackling', 'coronavirus', 'â', 'even', 'officials', 'say', 'unvaccinated', 'people', 'offer', 'ideal', 'environment', 'mutate', 'new', 'variants', 'threaten', 'hardwon', 'immunity', 'around', 'world', 'Many', 'vaccine', 'manufacturers', 'required', 'countries', 'indemnify', 'adverse', 'events', 'suffered', 'individuals', 'result', 'vaccines', 'United', 'Nations', 'says', 'Where', 'governments', 'control', 'possible', 'The', 'concerns', 'affect', 'people', 'displaced', 'Myanmar', 'Afghanistan', 'Ethiopian', 'crises', 'beyond', 'reach', 'national', 'governments', 'vaccination', 'schemes', 'For', 'refugees', 'migrants', 'asylumseekers', 'well', 'people', 'afflicted', 'natural', 'disasters', 'events', 'put', 'reach', 'government', 'help', 'global', 'programme', 'known', 'COVAX', 'created', 'Humanitarian', 'Buffer', 'â', 'lastresort', 'reserve', 'shots', 'administered', 'humanitarian', 'groups', 'Gavi', 'vaccine', 'alliance', 'publicprivate', 'partnership', 'set', 'promote', 'vaccination', 'around', 'world', 'But', 'buffer', 'mechanism', 'offer', 'compensation', 'Gavi', 'operates', 'COVAX', 'World', 'Health', 'Organization', 'WHO', 'says', 'applying', 'doses', 'mainly', 'NGOs', 'ca', 'bear', 'legal', 'risks', 'deliveries', 'stockpile', 'made', 'vaccinemakers', 'accept', 'liability', 'The', 'companies', 'willing', 'circumstances', 'provide', 'minority', 'programme', 'vaccines', 'according', 'people', 'familiar', 'matter', 'documents', 'written', 'Gavi', 'staff', 'board', 'meeting', 'starting', 'end', 'November', 'More', 'twothirds', 'COVAX', 'doses', 'come', 'Pfizer', 'Inc', 'NYSE', 'partner', 'BioNTech', 'SE', 'AstraZeneca', 'NASDAQ', 'PLC', 'Moderna', 'NASDAQ', 'Inc', 'Gavi', 'says', 'Moderna', 'declined', 'comment', 'AstraZeneca', 'Pfizer', 'said', 'talks', 'Gavi', 'declined', 'comment', 'All', 'three', 'said', 'committed', 'making', 'doses', 'available', 'poorer', 'nations', 'relatively', 'low', 'prices', 'Pfizer', 'said', 'collaborating', 'directly', 'governments', 'Jordan', 'Lebanon', 'donate', 'doses', 'refugees', 'Mainly', 'legal', 'concerns', 'less', 'million', 'doses', 'far', 'sent', 'buffer', 'Gavi', 'says', 'About', 'million', 'people', 'risk', 'excluded', 'national', 'programmes', 'according', 'United', 'Nations', 'data', 'cited', 'documents', 'Unless', 'firms', 'accept', 'legal', 'liability', 'access', 'vaccines', 'populations', 'remain', 'challenge', 'Gavi', 'documents', 'say', 'adding', 'new', 'crises', 'generate', 'additional', 'demand', 'cover', 'displaced', 'populations', 'The', 'vaccine', 'makers', 'reluctance', 'take', 'legal', 'risks', 'major', 'hurdle', 'attempts', 'provide', 'vaccines', 'buffer', 'spokesperson', 'Gavi', 'told', 'Reuters', 'Gavi', 'comment', 'details', 'documents', 'said', 'applications', 'vaccines', 'confidential', 'doses', 'delivered', 'In', 'September', 'Gavi', 'CEO', 'Seth', 'Berkley', 'tweeted', 'appeal', 'drugmakers', 'waive', 'requirements', 'legal', 'indemnity', 'Three', 'Chinese', 'drugmakers', 'agreed', 'shoulder', 'legal', 'risks', 'shots', 'delivered', 'buffer', 'SinoVac', 'Biotech', 'Ltd', 'Sinopharm', 'Group', 'Co', 'Ltd', 'Clover', 'Biopharmaceuticals', 'Co', 'Ltd', 'according', 'Gavi', 'document', 'The', 'drugmakers', 'respond', 'requests', 'comment', 'Johnson', 'Johnson', 'NYSE', 'United', 'States', 'confirmed', 'would', 'waive', 'requirement', 'indemnity', 'deliveries', 'buffer', 'We', 'proud', 'part', 'effort', 'protect', 'world', 'vulnerable', 'people', 'said', 'Paul', 'Stoffels', 'Vice', 'Chairman', 'Executive', 'Committee', 'Chief', 'Scientific', 'Officer', 'He', 'elaborate', 'However', 'less', 'onethird', 'COVAX', 'supplies', 'come', 'four', 'firms', 'COVAX', 'data', 'shows', 'Clover', 'shot', 'yet', 'approved', 'use', 'The', 'global', 'industry', 'association', 'International', 'Federation', 'Pharmaceutical', 'Manufacturers', 'Associations', 'IFPMA', 'said', 'company', 'refused', 'consider', 'taking', 'legal', 'risk', 'However', 'case', 'shots', 'delivered', 'buffer', 'said', 'firms', 'felt', 'could', 'without', 'full', 'knowledge', 'vaccines', 'would', 'used', 'It', 'would', 'hard', 'continuously', 'monitor', 'vaccines', 'safety', 'refugee', 'camps', 'delivery', 'logistically', 'challenging', 'suitable', 'types', 'said', 'European', 'Federation', 'Pharmaceutical', 'Industries', 'Associations', 'EFPIA', 'represents', 'large', 'pharmaceutical', 'companies', 'Europe', 'People', 'may', 'blame', 'vaccines', 'problems', 'emerge', 'afterwards', 'even', 'unrelated', 'said', 'This', 'could', 'lead', 'increased', 'number', 'litigation', 'cases', 'safety', 'efficacy', 'vaccine', 'would', 'publicly', 'questioned', 'said', 'statement', 'Reuters', 'That', 'might', 'lead', 'increased', 'vaccine', 'hesitancy', 'slower', 'recovery', 'pandemic', 'said', 'So', 'far', 'scant', 'information', 'COVID', 'vaccine', 'litigation', 'claims', 'made', 'outofcourt', 'compensation', 'programmes', 'one', 'measure', 'risk', 'A', 'programme', 'United', 'States', 'far', 'paid', 'anything', 'public', 'data', 'show', 'neither', 'one', 'set', 'WHO', 'lower', 'income', 'countries', 'WHO', 'said', 'In', 'Europe', 'handful', 'compensation', 'awards', 'granted', 'undisclosed', 'amounts', 'money', 'official', 'data', 'Denmark', 'Germany', 'Norway', 'Switzerland', 'show', 'Globally', 'reported', 'COVID', 'infections', 'among', 'refugees', 'migrants', 'asylumseekers', 'â', 'testing', 'always', 'systematic', 'infections', 'generate', 'mild', 'symptoms', 'especially', 'younger', 'people', 'But', 'cramped', 'conditions', 'weak', 'healthcare', 'expose', 'high', 'infection', 'risk', 'This', 'combined', 'low', 'levels', 'vaccination', 'mobile', 'population', 'could', 'favour', 'emergence', 'new', 'variants', 'vector', 'infection', 'said', 'Mireille', 'Lembwadio', 'Global', 'Vaccination', 'Coordinator', 'International', 'Organization', 'Migration', 'IOM', 'UNrelated', 'body', 'advises', 'governments', 'migrants', 'Leaving', 'unvaccinated', 'could', 'help', 'spread', 'virus', 'variants', 'across', 'world', 'said', 'WAITING', 'FOR', 'DOSES', 'Francois', 'Nosten', 'French', 'professor', 'helps', 'coordinate', 'healthcare', 'people', 'Myanmar', 'living', 'border', 'Thailand', 'one', 'waiting', 'vaccines', 'In', 'June', 'put', 'request', 'Humanitarian', 'Buffer', 'doses', 'â', 'sheltering', 'camps', 'along', 'border', 'unregistered', 'migrants', 'border', 'town', 'Mae', 'Sot', 'nearby', 'villages', 'Nosten', 'whose', 'main', 'work', 'researching', 'malaria', 'expecting', 'doses', 'fraction', 'billion', 'administered', 'worldwide', 'month', 'He', 'told', 'come', 'Sinopharm', 'hopes', 'help', 'inoculate', 'key', 'atrisk', 'groups', 'Thailand', 'Tak', 'province', 'Gavi', 'said', 'delivery', 'arrangements', 'still', 'finalised', 'About', 'doses', 'given', 'people', 'camps', 'International', 'Rescue', 'Committee', 'IRC', 'humanitarian', 'group', 'working', 'Nosten', 'At', 'point', 'whatever', 'vaccine', 'secure', 'grateful', 'said', 'Thailand', 'Director', 'Darren', 'Hertz', 'He', 'added', 'IRC', 'believed', 'likelihood', 'member', 'refugee', 'population', 'would', 'attempt', 'take', 'legal', 'action', 'case', 'sideeffects', 'extremely', 'low', 'Hertz', 'said', 'IRC', 'received', 'handful', 'ad', 'hoc', 'vaccine', 'donations', 'Thai', 'government', 'currently', 'tackling', 'significant', 'outbreaks', 'five', 'nine', 'camps', 'border', 'cases', 'confirmed', 'including', 'least', 'deaths', 'A', 'Thai', 'foreign', 'ministry', 'spokesperson', 'confirmed', 'government', 'working', 'IRC', 'providing', 'vaccinations', 'shelters', 'along', 'border', 'Nosten', 'charity', 'Border', 'Health', 'Foundation', 'BHF', 'one', 'eight', 'organisations', 'worldwide', 'applied', 'distribute', 'shots', 'Humanitarian', 'Buffer', 'one', 'three', 'approved', 'Gavi', 'said', 'Ann', 'Burton', 'Chief', 'Public', 'Health', 'UN', 'refugee', 'agency', 'UNHCR', 'said', 'liability', 'issue', 'one', 'reason', 'agencies', 'slow', 'apply', 'The', 'programme', 'also', 'delayed', 'general', 'shortage', 'vaccines', 'administrative', 'hurdles', 'Organisations', 'applying', 'supplies', 'buffer', 'may', 'choose', 'vaccines', 'receive', 'Working', 'displaced', 'people', 'Nosten', 'said', 'would', 'convenient', 'give', 'Johnson', 'Johnson', 'vaccine', 'offers', 'protection', 'single', 'dose', 'instead', 'two', 'doses', 'needed', 'Sinopharm', 'But', 'Sinopharm', 'version', 'better', 'nothing', 'said', 'More', 'national', 'governments', 'promised', 'offer', 'vaccines', 'possible', 'displaced', 'people', 'soil', 'according', 'IOM', 'However', 'UN', 'group', 'says', 'migrants', 'refugees', 'often', 'effectively', 'excluded', 'schemes', 'administrative', 'cultural', 'hurdles', 'In', 'cases', 'governments', 'charge', 'agreed', 'vaccinate', 'migrants', 'COVAX', 'Humanitarian', 'Buffer', 'option', 'At', 'least', 'countries', 'yet', 'include', 'unauthorised', 'migrants', 'vaccination', 'programmes', 'according', 'IOM', 'â', 'UNHCR', 'declined', 'name', 'countries', 'Gavi', 'set', 'buffer', 'March', 'planning', 'reserve', 'vaccine', 'doses', 'become', 'available', 'COVAX', 'would', 'amount', 'roughly', 'million', 'doses', 'far', 'The', 'shots', 'delivered', 'buffer', 'far', 'million', 'Sinopharm', 'doses', 'â', 'landed', 'Iran', 'November', 'high', 'numbers', 'displaced', 'Afghans', 'arrived', 'UNICEF', 'Iran', 'said', 'That', 'enough', 'inoculate', 'people', 'likely', 'needed', 'UNICEF', 'said', 'NEED', 'FOR', 'SPEED', 'The', 'vaccine', 'makers', 'legal', 'concern', 'rooted', 'unprecedented', 'speed', 'effort', 'develop', 'COVID', 'shots', 'EFPIA', 'said', 'In', 'normal', 'circumstances', 'drugmakers', 'buy', 'insurance', 'cover', 'liability', 'vaccines', 'potential', 'adverse', 'effects', 'But', 'COVID', 'forced', 'develop', 'drugs', 'quickly', 'side', 'effects', 'instance', 'rare', 'bloodclotting', 'condition', 'took', 'AstraZeneca', 'vaccine', 'emerging', 'shots', 'go', 'people', 'arms', 'Many', 'governments', 'international', 'agencies', 'set', 'compensation', 'schemes', 'reimburse', 'victims', 'avoid', 'lengthy', 'litigation', 'An', 'emergency', 'law', 'invoked', 'US', 'government', 'provides', 'legal', 'immunity', 'drug', 'companies', 'side', 'effects', 'vaccines', 'used', 'country', 'The', 'exception', 'instances', 'wilful', 'misconduct', 'For', 'drug', 'companies', 'accepting', 'potential', 'liability', 'runs', 'counter', 'standard', 'practice', 'Vaccine', 'manufacturers', 'try', 'minimize', 'legal', 'risks', 'almost', 'every', 'setting', 'said', 'John', 'T', 'Monahan', 'Professor', 'Georgetown', 'University', 'The', 'gold', 'standard', 'full', 'immunity', 'lawsuits', 'If', 'accept', 'carveouts', 'may', 'become', 'difficult', 'reach', 'goal', 'Edited', 'Jospehone', 'Mason', 'Sara', 'Ledwith'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'doctor', 'shows', 'vials', 'AstraZeneca', 'vaccine', 'general', 'practice', 'facility', 'spread', 'coronavirus', 'disease', 'continues', 'Vienna', 'Austria', 'May', 'REUTERSLeonhard', 'Foeger', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'said', 'Tuesday', 'working', 'Oxford', 'University', 'produce', 'vaccine', 'Omicron', 'coronavirus', 'variant', 'joining', 'vaccinemakers', 'looking', 'develop', 'variantspecific', 'vaccine', 'Together', 'Oxford', 'University', 'taken', 'preliminary', 'steps', 'producing', 'Omicron', 'variant', 'vaccine', 'case', 'needed', 'informed', 'emerging', 'data', 'spokesperson', 'company', 'said', 'statement', 'Oxford', 'immediately', 'respond', 'request', 'comment', 'outside', 'business', 'hours', 'The', 'Financial', 'Times', 'first', 'reported', 'news', 'citing', 'Sandy', 'Douglas', 'research', 'group', 'leader', 'Oxford', 'Adenovirusbased', 'vaccines', 'made', 'OxfordAstraZeneca', 'could', 'principle', 'used', 'respond', 'new', 'variant', 'rapidly', 'may', 'previously', 'realised', 'Douglas', 'told', 'FT', 'A', 'labstudy', 'last', 'week', 'found', 'AstraZeneca', 'NASDAQ', 'antibody', 'cocktail', 'Evusheld', 'retained', 'neutralising', 'activity', 'Omicron', 'variant', 'Vaccine', 'makers', 'PfizerBioNTech', 'Moderna', 'NASDAQ', 'also', 'previously', 'said', 'working', 'Omicron', 'specific', 'vaccines', 'Moderna', 'said', 'hopes', 'start', 'clinical', 'trials', 'early', 'next', 'year', 'Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'lower', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'Eurozone', 'UK', 'US', 'Coronavirus', 'Stock', 'futures', 'lower', 'early', 'trade', 'Omicron', 'variant', 'forced', 'European', 'countries', 'announce', 'new', 'restrictions', 'UK', 'Deputy', 'Prime', 'Minister', 'Dominic', 'Raab', 'said', 'UK', 'hospitalisations', 'deaths', 'Omicron', 'Raab', 'added', 'make', 'guarantees', 'pandemic', 'restrictions', 'Stocks', 'Rio', 'Tinto', 'LON', 'Dominic', 'Barton', 'succeed', 'Simon', 'Thompson', 'company', 'new', 'Chair', 'AstraZeneca', 'LON', 'Saphnelo', 'recommended', 'approval', 'EU', 'CHMP', 'treatment', 'patients', 'systemic', 'lupus', 'erythematosus', 'Separately', 'Tezspire', 'tezepelumab', 'approved', 'US', 'severe', 'asthma', 'GlaxoSmithKline', 'LON', 'Sir', 'Dave', 'Lewis', 'appointed', 'NonExecutive', 'Chair', 'Designate', 'new', 'Consumer', 'Healthcare', 'company', 'result', 'proposed', 'demerger', 'GSK', 'His', 'appointment', 'take', 'effect', 'January', 'RollsRoyce', 'LON', 'Reached', 'agreement', 'Qatar', 'Investment', 'Authority', 'invest', 'GBP', 'million', 'RollsRoyce', 'SMR', 'Limited', 'RollsRoyce', 'SMR', 'building', 'new', 'technology', 'solution', 'deliver', 'affordable', 'low', 'carbon', 'nuclear', 'power', 'Standard', 'Chartered', 'LON', 'â', 'Bank', 'England', 'fined', 'Standard', 'Chartered', 'million', 'failing', 'open', 'cooperative', 'Bodycote', 'LON', 'Appointed', 'Daniel', 'Dayan', 'NonExecutive', 'Chair', 'effect', 'January', 'J', 'D', 'Wetherspoon', 'LON', 'Appointed', 'two', 'employee', 'directors', 'full', 'plc', 'director', 'status', 'two', 'associate', 'employee', 'directors', 'The', 'employee', 'directors', 'Debbie', 'Whittingham', 'regional', 'manager', 'West', 'Midlands', 'Hudson', 'Simmons', 'area', 'manager', 'Sheffield', 'Frasers', 'LON', 'CEO', 'Mike', 'Ashley', 'reportedly', 'considering', 'move', 'take', 'Frasers', 'private', 'Telegraph', 'Marks', 'Spencer', 'LON', 'Reportedly', 'hired', 'MWM', 'Consulting', 'help', 'benchmark', 'three', 'internal', 'contenders', 'vying', 'become', 'next', 'CEO', 'Sources', 'added', 'formal', 'search', 'process', 'yet', 'get', 'underway', 'current', 'CEO', 'Rowe', 'could', 'stay', 'another', 'couple', 'years', 'Sky', 'News', 'Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SDRt', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'FOXT', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'Todayâs', 'calendar', 'highlights', 'include', 'UK', 'Canadian', 'US', 'Data', 'UK', 'November', 'billion', 'expectations', 'billion', 'Public', 'sector', 'net', 'borrowing', 'April', 'November', 'billion', 'around', 'billion', 'period', 'last', 'year', 'However', 'figure', 'almost', 'three', 'times', 'large', 'period', 'Stocks', 'AstraZeneca', 'LON', 'Ultomiris', 'regulatory', 'submission', 'accepted', 'FDA', 'Priority', 'Review', 'US', 'adults', 'generalised', 'myasthenia', 'gravis', 'Schroders', 'LON', 'Reached', 'agreement', 'acquire', 'shareholding', 'renewable', 'infrastructure', 'manager', 'Greencoat', 'Capital', 'Holdings', 'Limited', 'initial', 'consideration', 'million', 'GlaxoSmithKline', 'PLC', 'LON', 'ViiV', 'Healthcare', 'majority', 'owned', 'GSK', 'announced', 'US', 'FDA', 'approval', 'Apretude', 'cabotegravir', 'extendedrelease', 'injectable', 'suspension', 'first', 'longacting', 'injectable', 'option', 'HIV', 'prevention', 'BHP', 'Group', 'LON', 'Confirmed', 'regulatory', 'competition', 'approvals', 'unification', 'received', 'including', 'approval', 'National', 'Treasury', 'South', 'Africa', 'If', 'approved', 'shareholders', 'conditions', 'satisfied', 'waived', 'including', 'UK', 'court', 'sanction', 'scheme', 'arrangement', 'admission', 'Limited', 'shares', 'standard', 'segment', 'FCA', 'official', 'list', 'trading', 'LSE', 'listing', 'JSE', 'unification', 'expected', 'complete', 'January', 'Playtech', 'LON', 'Due', 'recent', 'COVID', 'development', 'possibility', 'revised', 'guidance', 'issued', 'new', 'restrictions', 'imposed', 'Playtech', 'decided', 'implement', 'certain', 'additional', 'arrangements', 'allow', 'Scheme', 'Shareholders', 'participate', 'vote', 'virtually', 'Court', 'Meeting', 'Playtech', 'Shareholders', 'watch', 'submit', 'questions', 'General', 'Meeting', 'virtual', 'platform', 'Johnson', 'Matthey', 'LON', 'To', 'commence', 'first', 'tranche', 'million', 'share', 'buyback', 'programme', 'today', 'Hiscox', 'LON', 'To', 'appoint', 'Paul', 'Cooper', 'Group', 'Chief', 'Financial', 'Officer', 'subject', 'regulatory', 'approval', 'HarbourVest', 'LON', 'Credit', 'facility', 'increased', 'million', 'million', 'immediate', 'effect', 'Foxtons', 'LON', 'To', 'appoint', 'Chris', 'Hough', 'Chief', 'Financial', 'Officer', 'Executive', 'Director', 'Chris', 'succeed', 'Richard', 'Harris', 'tendered', 'resignation', 'order', 'take', 'position', 'Chief', 'Financial', 'Officer', 'The', 'Rank', 'Group', 'LON'], ['Â', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BALF', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'HLMA', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'INPP', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'IHPI', 'Add', 'toRemove', 'Portfolio', 'FNTL', 'Add', 'toRemove', 'Portfolio', 'ROO', 'Add', 'toRemove', 'Portfolio', 'LIFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'flat', 'Todayâs', 'calendar', 'highlights', 'include', 'US', 'Stocks', 'Flutter', 'Entertainment', 'LON', 'Announces', 'acquisition', 'Italian', 'gaming', 'operator', 'Sisal', 'CVC', 'Capital', 'Partners', 'consideration', 'billion', 'billion', 'The', 'transaction', 'likely', 'complete', 'expected', 'accretive', 'adjusted', 'earnings', 'first', 'months', 'postcompletion', 'BHP', 'Group', 'LON', 'BHP', 'Noront', 'terminated', 'support', 'agreement', 'In', 'accordance', 'terms', 'support', 'agreement', 'Noront', 'made', 'CAD', 'million', 'termination', 'payment', 'BHP', 'Balfour', 'Beatty', 'LON', 'Reached', 'resolution', 'US', 'Department', 'Justice', 'DoJ', 'resolves', 'DoJ', 'criminal', 'civil', 'investigations', 'specific', 'performance', 'incentive', 'fees', 'improperly', 'claimed', 'subsidiary', 'Balfour', 'Beatty', 'Communities', 'related', 'maintenance', 'work', 'certain', 'United', 'States', 'military', 'housing', 'installations', 'Balfour', 'Beatty', 'Communities', 'pay', 'total', 'resolution', 'amount', 'million', 'million', 'current', 'exchange', 'rate', 'comprising', 'approximately', 'million', 'penalties', 'million', 'restitution', 'The', 'company', 'also', 'pleaded', 'guilty', 'one', 'count', 'fraud', 'AstraZeneca', 'PLC', 'LON', 'â', 'The', 'company', 'said', 'vaccine', 'effective', 'Omicron', 'following', 'third', 'dose', 'according', 'new', 'laboratory', 'study', 'results', 'International', 'Public', 'Partnerships', 'LON', 'Agreed', 'acquire', 'small', 'portfolio', 'UK', 'PPP', 'investments', 'comprising', 'initially', 'interests', 'Townlands', 'Community', 'Hospital', 'Henley', 'Eltham', 'Community', 'Hospital', 'minority', 'interests', 'Building', 'Schools', 'Future', 'projects', 'STaG', 'The', 'interests', 'acquired', 'Amber', 'Infrastructure', 'million', 'Deliveroo', 'LON', 'Love', 'Hemp', 'AQUIS', 'launched', 'trial', 'basis', 'Deliveroo', 'London', 'Fintel', 'LON', 'Premier', 'Milton', 'Carmignac', 'joined', 'growing', 'number', 'firms', 'committed', 'multiyear', 'agreements', 'managed', 'distribution', 'service', 'launched', 'earlier', 'year', 'Ex', 'Dividends', 'British', 'American', 'Tobacco', 'LON', 'EVRAZ', 'LON', 'Halma', 'LON', 'IntegraFin', 'LON', 'trade', 'exdividend', 'today', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Vials', 'labelled', 'Astra', 'Zeneca', 'Coronavirus', 'Vaccine', 'syringe', 'seen', 'front', 'displayed', 'AstraZeneca', 'logo', 'illustration', 'photo', 'taken', 'March', 'REUTERSDado', 'Ruvic', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Reuters', 'A', 'threedose', 'course', 'AstraZeneca', 'NASDAQ', 'vaccine', 'effective', 'rapidlyspreading', 'Omicron', 'coronavirus', 'variant', 'pharmaceutical', 'company', 'said', 'Thursday', 'citing', 'data', 'Oxford', 'University', 'lab', 'study', 'Findings', 'study', 'yet', 'published', 'peerreviewed', 'medical', 'journal', 'match', 'rivals', 'PfizerBioNTech', 'Moderna', 'NASDAQ', 'also', 'found', 'third', 'dose', 'shots', 'works', 'Omicron', 'The', 'study', 'AstraZeneca', 'vaccine', 'Vaxzevria', 'showed', 'threedose', 'course', 'vaccine', 'neutralising', 'levels', 'Omicron', 'broadly', 'similar', 'virus', 'Delta', 'variant', 'two', 'doses', 'The', 'Londonlisted', 'company', 'said', 'researchers', 'Oxford', 'University', 'carried', 'study', 'independent', 'worked', 'vaccine', 'AstraZeneca', 'As', 'better', 'understand', 'Omicron', 'believe', 'find', 'Tcell', 'response', 'provides', 'durable', 'protection', 'severe', 'disease', 'hospitalisations', 'Mene', 'Pangalos', 'head', 'AstraZeneca', 'biopharmaceuticals', 'RD', 'said', 'referring', 'critical', 'component', 'immune', 'system', 'respond', 'fight', 'infection', 'Antibody', 'levels', 'Omicron', 'booster', 'shot', 'higher', 'antibodies', 'people', 'infected', 'recovered', 'naturally', 'AngloSwedish', 'drugmaker', 'added', 'Although', 'early', 'data', 'positive', 'company', 'AstraZeneca', 'said', 'Tuesday', 'working', 'partner', 'Oxford', 'University', 'produce', 'vaccine', 'tailored', 'Omicron', 'joining', 'similar', 'efforts', 'vaccinemakers', 'The', 'Oxford', 'study', 'analysed', 'blood', 'samples', 'infected', 'vaccinated', 'two', 'doses', 'booster', 'previously', 'infected', 'variants', 'concern', 'It', 'included', 'samples', 'people', 'given', 'three', 'doses', 'Vaxzevria', 'Scientists', 'governments', 'scrambling', 'bolster', 'defences', 'Omicron', 'shots', 'therapies', 'variant', 'threatens', 'become', 'dominant', 'globally', 'prompted', 'renewed', 'curbs', 'ahead', 'holidays', 'contain', 'infections', 'Britain', 'earlier', 'month', 'backed', 'use', 'boosters', 'found', 'third', 'dose', 'significantly', 'restored', 'protection', 'mild', 'disease', 'caused', 'Omicron', 'part', 'reversing', 'otherwise', 'steep', 'drop', 'vaccine', 'effectiveness'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'NGLOY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'flat', 'Todayâs', 'calendar', 'highlights', 'include', 'Eurozone', 'US', 'Coronavirus', 'Daily', 'COVID', 'cases', 'England', 'hit', 'another', 'record', 'high', 'festive', 'period', 'surge', 'cases', 'far', 'led', 'similarly', 'large', 'increase', 'hospital', 'admissions', 'The', 'government', 'far', 'refrained', 'introducing', 'new', 'restrictions', 'England', 'hospitality', 'large', 'events', 'Stocks', 'AstraZeneca', 'LON', 'Closed', 'global', 'development', 'commercialisation', 'deal', 'Ionis', 'Pharmaceuticals', 'eplontersen', 'The', 'upfront', 'payment', 'AstraZeneca', 'Ionis', 'million', 'AstraZeneca', 'make', 'additional', 'conditional', 'payments', 'million', 'following', 'regulatory', 'approvals', 'It', 'also', 'pay', 'billion', 'salesrelated', 'milestones', 'plus', 'royalties', 'range', 'low', 'doubledigit', 'midtwenties', 'percentage', 'depending', 'region', 'Anglo', 'American', 'LON', 'Held', 'preliminary', 'discussions', 'Vale', 'possibility', 'jointly', 'develop', 'Valeâs', 'Serpentina', 'iron', 'ore', 'resource', 'contiguous', 'Anglo', 'American', 'integrated', 'MinasRio', 'iron', 'ore', 'operation', 'Brazil', 'Fresnillo', 'LON', 'Provides', 'update', 'Juanicipio', 'project', 'The', 'team', 'delivered', 'project', 'plant', 'commissioning', 'schedule', 'However', 'Federal', 'de', 'Electricidad', 'stateowned', 'electrical', 'company', 'notified', 'Fresnillo', 'approval', 'complete', 'tiein', 'national', 'power', 'grid', 'yet', 'granted', 'mill', 'commissioning', 'timeline', 'therefore', 'extended', 'approximately', 'six', 'months', 'Diversified', 'Energy', 'Company', 'LON', 'Closed', 'sale', 'predominantly', 'undeveloped', 'Haynesville', 'acreage', 'Texas', 'total', 'cash', 'consideration', 'approximately', 'million'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'NYSE', 'New', 'York', 'US', 'April', 'REUTERSBrendan', 'McDermid', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'agreed', 'develop', 'antibodybased', 'therapy', 'Swiss', 'biotechnology', 'firm', 'Neurimmune', 'rare', 'underdiagnosed', 'condition', 'lead', 'heart', 'failure', 'deal', 'valued', 'million', 'drugmaker', 'said', 'Tuesday', 'AstraZeneca', 'NASDAQ', 'rare', 'diseases', 'unit', 'Alexion', 'NASDAQ', 'Neurimmune', 'firm', 'behind', 'discovery', 'Biogen', 'NASDAQ', 'Alzheimer', 'drug', 'aducanumab', 'work', 'evaluating', 'monoclonal', 'antibody', 'treatment', 'transthyretin', 'amyloid', 'cardiomyopathy', 'The', 'potentially', 'fatal', 'condition', 'characterised', 'deposits', 'proteins', 'called', 'amyloid', 'fibrils', 'walls', 'heart', 'causes', 'become', 'stiff', 'result', 'organ', 'unable', 'pump', 'circulate', 'blood', 'effectively', 'Under', 'agreement', 'Alexion', 'would', 'pay', 'Neurimmune', 'upfront', 'payment', 'million', 'would', 'eligible', 'payments', 'million', 'upon', 'completion', 'targets', 'plus', 'royalties', 'sales', 'AstraZeneca', 'said', 'statement', 'Neurimmune', 'candidate', 'belongs', 'class', 'therapies', 'called', 'monoclonal', 'antibodies', 'labgenerated', 'compounds', 'mimicking', 'body', 'natural', 'defences', 'targets', 'protein', 'deposits', 'breaks', 'AngloSwedish', 'drugmaker', 'AstraZeneca', 'made', 'billion', 'bet', 'Alexion', 'rare', 'diseases', 'portfolio', 'major', 'success', 'monoclonal', 'antibodies', 'recent', 'times', 'Evusheld', 'treatment'], ['AstraZeneca', 'NASDAQ', 'AZN', 'announced', 'Tuesday', 'vaccine', 'Vaxzevria', 'Recombinant', 'given', 'full', 'Marketing', 'Authorisation', 'MA', 'European', 'Union', 'EU', 'Vaxzevria', 'originally', 'granted', 'conditional', 'Marketing', 'Authorisation', 'cMA', 'EU', 'AstraZeneca', 'stated', 'âœAs', 'continues', 'sufficient', 'evidence', 'safety', 'efficacy', 'confirming', 'benefits', 'Vaxzevria', 'European', 'Medicines', 'Agency', 'EMA', 'granted', 'full', 'MAâ', 'Iskra', 'Reic', 'EVP', 'Vaccines', 'Immune', 'Therapies', 'AstraZeneca', 'commented', 'âœThe', 'move', 'conditional', 'full', 'marketing', 'authorisation', 'Vaxzevria', 'important', 'confirmation', 'EMA', 'safety', 'efficacy', 'Vaxzevria', 'demonstrating', 'benefits', 'continue', 'outweigh', 'potential', 'risks', 'Vaxzevria', 'estimated', 'helped', 'save', 'six', 'million', 'lives', 'first', 'year', 'vaccination', 'reflects', 'strength', 'evidence', 'showing', 'Vaxzevriaâs', 'protection', 'severe', 'disease', 'death', 'caused', 'Tesla', 'Shifts', 'China', 'Factory', 'Workers', 'To', 'US', 'Plant', 'Complete', 'European', 'Approval', 'For', 'AstraZeneca', 'Shot', 'Tesla', 'Eyes', 'Cybertruck', 'Commercialization', 'Next', 'Year', 'Top', 'Stories', 'Tuesday', 'Nov', 'Â', 'Reuters', 'AstraZeneca', 'shares', 'get', 'lift', 'heartburn', 'drug', 'litigation', 'closure', 'says', 'Citi', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LFCOF', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'PLC', 'NASDAQ', 'get', 'boost', 'probability', 'close', 'US', 'kidney', 'damage', 'lawsuit', 'New', 'Jersey', 'prior', 'first', 'bellwether', 'case', 'March', 'according', 'analysts', 'Citi', 'The', 'UK', 'pharma', 'one', 'several', 'firms', 'embroiled', 'US', 'legal', 'action', 'possible', 'damage', 'caused', 'proton', 'pump', 'inhibitor', 'PPI', 'heartburn', 'drugs', 'Nexium', 'launched', 'Astra', 'US', 'The', 'Citi', 'analysts', 'believe', 'likely', 'outcome', 'judge', 'delaying', 'response', 'Defendant', 'Motion', 'summary', 'judgement', 'grounds', 'preemption', 'encourage', 'plaintiffs', 'settle', 'âœAlternatively', 'lower', 'probability', 'Judge', 'Cecchi', 'may', 'delayed', 'start', 'bellwether', 'cases', 'disagrees', 'conclusions', 'Special', 'Master', 'Reisman', 'grants', 'defendant', 'motion', 'dismiss', 'grounds', 'preemption', 'said', 'Either', 'scenario', 'would', 'materially', 'positive', 'Astra', 'depressed', 'share', 'price', 'US', 'bank', 'analysts', 'added', 'would', 'positive', 'interim', 'data', 'Enhertu', 'yearend', 'positive', 'data', 'March', 'The', 'Citi', 'analysts', 'said', 'core', 'EPS', 'forecasts', 'Astra', 'consensus', 'repeated', 'alongside', 'price', 'target', 'recommendation', 'Shares', 'Astra', 'rose', 'Read', 'Proactive', 'Investors', 'UK', 'Disclaimer'], ['Â', 'Reuters', 'A', 'nurse', 'prepares', 'dose', 'AstraZeneca', 'coronavirus', 'disease', 'vaccine', 'Mexicali', 'Mexico', 'January', 'REUTERSVictor', 'Medina', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'NASDAQ', 'said', 'Thursday', 'preliminary', 'data', 'trial', 'conducted', 'shot', 'Vaxzevria', 'showed', 'generated', 'higher', 'antibody', 'response', 'Omicron', 'variant', 'others', 'including', 'Beta', 'Delta', 'Alpha', 'Gamma', 'given', 'third', 'booster', 'dose', 'The', 'increased', 'response', 'seen', 'people', 'previously', 'vaccinated', 'either', 'Vaxzevria', 'mRNA', 'vaccine', 'drugmaker', 'said', 'adding', 'would', 'submit', 'data', 'regulators', 'worldwide', 'given', 'urgent', 'need', 'boosters', 'AstraZeneca', 'developed', 'vaccine', 'researchers', 'University', 'Oxford', 'lab', 'studies', 'last', 'month', 'found', 'threedose', 'course', 'Vaxzevria', 'effective', 'rapidly', 'spreading', 'new', 'variant', 'The', 'data', 'first', 'released', 'company', 'trials', 'boosters', 'vaccine', 'The', 'company', 'said', 'adds', 'growing', 'evidence', 'supports', 'third', 'dose', 'vaccine', 'irrespective', 'primary', 'vaccination', 'schedule', 'These', 'important', 'studies', 'show', 'third', 'dose', 'Vaxzevria', 'two', 'initial', 'doses', 'vaccine', 'mRNA', 'inactivated', 'vaccines', 'strongly', 'boosts', 'immunity', 'Oxford', 'Vaccine', 'Group', 'chief', 'Andrew', 'Pollard', 'said', 'statement', 'A', 'major', 'British', 'trial', 'December', 'found', 'AstraZeneca', 'shot', 'increased', 'antibodies', 'given', 'booster', 'initial', 'vaccination', 'shot', 'Pfizer', 'NYSE', 'based', 'mRNA', 'technology', 'However', 'study', 'concluded', 'mRNA', 'vaccines', 'made', 'Pfizer', 'Moderna', 'NASDAQ', 'gave', 'biggest', 'boost', 'antibodies', 'given', 'booster', 'dose'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'UL', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'TWODY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'flat', 'trading', 'Todayâs', 'calendar', 'highlights', 'include', 'Stocks', 'Unilever', 'LON', 'GlaxoSmithKline', 'LON', 'Unilever', 'confirms', 'approached', 'GSK', 'Pfizer', 'NYSE', 'potential', 'acquisition', 'GSK', 'Consumer', 'Healthcare', 'unit', 'The', 'latest', 'proposal', 'total', 'acquisition', 'value', 'billion', 'comprising', 'billion', 'cash', 'billion', 'Unilever', 'shares', 'GSK', 'rejected', 'three', 'proposals', 'made', 'basis', 'fundamentally', 'undervalued', 'Consumer', 'Healthcare', 'business', 'future', 'prospects', 'Unilever', 'As', 'result', 'reporting', 'interest', 'GSKâs', 'Consumer', 'Health', 'unit', 'Unilever', 'brought', 'forward', 'planned', 'strategic', 'update', 'Unilever', 'said', 'future', 'strategic', 'direction', 'lies', 'materially', 'expanding', 'presence', 'Health', 'Beauty', 'Hygiene', 'The', 'board', 'concluded', 'major', 'acquisitions', 'accompanied', 'accelerated', 'divestment', 'intrinsically', 'lower', 'growth', 'brands', 'businesses', 'Taylor', 'Wimpey', 'LON', 'total', 'UK', 'home', 'completions', 'increased', 'Net', 'private', 'reservation', 'rate', 'homes', 'per', 'outlet', 'per', 'week', 'Average', 'selling', 'prices', 'private', 'completions', 'increased', 'overall', 'average', 'selling', 'price', 'increasing', 'Will', 'announce', 'level', 'excess', 'cash', 'return', 'respect', 'company', 'full', 'year', 'results', 'March', 'forward', 'sold', 'Confident', 'achieving', 'primary', 'performance', 'target', 'return', 'business', 'operating', 'margin', 'AstraZeneca', 'LON', 'Enhertu', 'granted', 'Priority', 'Review', 'US', 'patients', 'metastatic', 'breast', 'cancer', 'treated', 'prior', 'regimen', 'Ashmore', 'LON', 'Total', 'assets', 'management', 'estimated', 'December', 'fell', 'September', 'billion', 'Assets', 'management', 'declined', 'billion', 'period', 'comprising', 'net', 'outflows', 'billion', 'negative', 'investment', 'performance', 'billion', 'Hikma', 'Pharmaceuticals', 'LON', 'Agreed', 'acquire', 'Canadian', 'assets', 'Teligent', 'million', 'The', 'transaction', 'expected', 'completed', 'end', 'first', 'quarter', 'Oxford', 'BioMedica', 'LON', 'Chief', 'Executive', 'Officer', 'John', 'Dawson', 'signalled', 'Board', 'intention', 'retire', 'Company', 'Accordingly', 'Board', 'initiated', 'formal', 'search', 'successor', 'Qinetiq', 'LON', 'Names', 'Shawn', 'Purvis', 'President', 'CEO', 'QinetiQ', 'US', 'effective', 'February', 'Capital', 'Counties', 'Properties', 'LON', 'As', 'December', 'independent', 'property', 'valuation', 'Covent', 'Garden', 'billion', 'representing', 'likeforlike', 'increase', 'second', 'half', 'year', 'overall', 'movement', 'full', 'year', 'Rent', 'collection', 'relation', 'first', 'quarter', 'invoiced', 'December', 'currently', 'Tritax', 'EuroBox', 'LON', 'Completed', 'acquisition', 'land', 'agreed', 'fund', 'development', 'sqm', 'prime', 'sustainable', 'logistics', 'asset', 'Sweden', 'SEK', 'million', 'Big', 'Yellow', 'Group', 'LON', 'total', 'revenue', 'increased', 'million', 'Occupancy', 'across', 'stores', 'decreased', 'sq', 'ft', 'compared', 'loss', 'sq', 'ft', 'Moveouts', 'higher', 'quarter', 'reflective', 'record', 'first', 'quarter', 'occupancy', 'gain', 'leading', 'tapering', 'stamp', 'duty', 'holiday', 'Endeavour', 'Mining', 'LON', 'Announced', 'discovery', 'million', 'ounces', 'Measured', 'Indicated', 'resources', 'million', 'ounces', 'Inferred', 'resources', 'across', 'flagship', 'Ity', 'HoundÃ', 'SabodalaMassawa', 'mines', 'well', 'LafiguÃ', 'deposit', 'Fetekro', 'property', 'Micro', 'Focus', 'LON', 'Announced', 'successfully', 'priced', 'allocated', 'million', 'million', 'Senior', 'Secured', 'Term', 'Loan', 'B', 'Clinigen', 'LON', 'Agrees', 'taken', 'Triton', 'deal', 'worth', 'pence', 'per', 'share', 'ASOS', 'LON', 'Former', 'Farfetch', 'executive', 'Andrew', 'Robb', 'reportedly', 'among', 'candidates', 'CEO', 'position', 'ASOS', 'LON', 'Sky', 'News', 'Darktrace', 'LON', 'Short', 'seller', 'ShadowFall', 'launched', 'short', 'attack', 'Darktrace', 'doubts', 'company', 'âœwill', 'stand', 'test', 'timeâ'], ['Â', 'Reuters', 'AstraZenecaMerck', 'Prostate', 'Cancer', 'Combo', 'Drug', 'Try', 'For', 'scPharma', 'FDA', 'Panel', 'Decisions', 'And', 'More', 'October', 'Key', 'PDUFA', 'Catalysts', 'Biotech', 'Investors', 'Must', 'Know', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'KECR', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Most', 'FDA', 'decisions', 'scheduled', 'September', 'yielded', 'positive', 'results', 'stray', 'disappointments', 'well', 'Seven', 'new', 'molecular', 'entities', 'NMEs', 'approved', 'month', 'taking', 'total', 'NME', 'approvals', 'year', 'This', 'far', 'less', 'approvals', 'received', 'time', 'last', 'year', 'NMEs', 'considered', 'measure', 'innovation', 'drug', 'research', 'contain', 'active', 'moieties', 'ingredients', 'havenât', 'previously', 'approved', 'Food', 'Drug', 'Administration', 'Among', 'positive', 'verdicts', 'bluebird', 'bio', 'Incâs', 'NASDAQ', 'BLUE', 'million', 'gene', 'therapy', 'Skysona', 'approved', 'treating', 'rare', 'neurodegenerative', 'disorder', 'boys', 'Amylyx', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'AMLX', 'scored', 'win', 'amyotrophic', 'sclerosis', 'treatment', 'Revance', 'Therapeutics', 'Incâs', 'NASDAQ', 'RVNC', 'Botox', 'rival', 'Daxxify', 'approved', 'treating', 'frown', 'lines', 'Spectrum', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'SPPI', 'mixed', 'month', 'Rolvedon', 'approved', 'treating', 'chemotherapyinduced', 'neutropenia', 'lung', 'cancer', 'drug', 'get', 'backing', 'FDA', 'panel', 'Here', 'key', 'PDUFA', 'dates', 'scheduled', 'October', 'Will', 'Theratech', 'Score', 'A', 'Win', 'For', 'A', 'More', 'Convenient', 'Formulation', 'Of', 'Its', 'HIV', 'Drug', 'Company', 'Theratechnologies', 'Inc', 'NASDAQ', 'THTX', 'Type', 'Application', 'supplemental', 'biologic', 'license', 'application', 'Candidate', 'Trogarzo', 'Indication', 'Date', 'Oct', 'In', 'fourth', 'quarter', 'company', 'filed', 'sBLA', 'intravenous', 'push', 'mode', 'administration', 'Trogarzo', 'treating', 'human', 'immunodeficiency', 'virus', 'type', 'Trogarzo', 'first', 'approved', 'FDA', 'March', 'treat', 'adult', 'patients', 'multidrugresistant', 'HIV', 'In', 'quarter', 'ended', 'May', 'drug', 'generated', 'sales', 'million', 'Theratech', 'Alnylam', 'On', 'Course', 'For', 'Snagging', 'Label', 'Expansion', 'For', 'Oxlumo', 'Company', 'Alnylam', 'Inc', 'NASDAQ', 'ALNY', 'Type', 'Application', 'supplemental', 'new', 'drug', 'application', 'Candidate', 'Oxlumo', 'Indication', 'hyperoxaluria', 'Type', 'Date', 'Oct', 'Oxlumo', 'goes', 'generic', 'name', 'lumasiran', 'RNAi', 'therapeutic', 'evaluated', 'reduction', 'plasma', 'oxalate', 'patients', 'advanced', 'hyperoxaluria', 'type', 'â', 'rare', 'disorder', 'mainly', 'affects', 'kidneys', 'due', 'accumulation', 'substance', 'called', 'oxalate', 'normally', 'filtered', 'kidneys', 'excreted', 'urine', 'This', 'therapy', 'first', 'approved', 'lowering', 'urinary', 'oxalate', 'labels', 'pediatric', 'adult', 'patients', 'In', 'second', 'quarter', 'fetched', 'company', 'million', 'sales', 'sequentially', 'See', 'also', 'Alzheimer', 'Progression', 'Slowed', 'Down', 'By', 'Biogen', 'NASDAQ', 'New', 'Drug', 'In', 'LateStage', 'Study', 'Analyst', 'Sees', 'Can', 'Third', 'Time', 'Be', 'Charm', 'For', 'scPharma', 'Company', 'scPharmaceuticals', 'Inc', 'NASDAQ', 'SCPH', 'Type', 'Application', 'NDA', 'Candidate', 'Furoscix', 'Indication', 'worsening', 'heart', 'failure', 'due', 'congestion', 'Date', 'Oct', 'Furoscix', 'proprietary', 'subcutaneouslydelivered', 'furosemide', 'solution', 'evaluated', 'outpatient', 'alternative', 'treatment', 'worsening', 'congestive', 'heart', 'failure', 'This', 'scPharma', 'third', 'try', 'Furoscix', 'following', 'complete', 'response', 'letter', 'âGoâ', 'ânoGoâ', 'Amicusâs', 'Pome', 'Disease', 'Treatment', 'Company', 'Amicus', 'Therapeutics', 'Inc', 'NASDAQ', 'FOLD', 'Type', 'Application', 'BLA', 'Candidate', 'cipaglucosidase', 'alfa', 'Indication', 'Pompe', 'disease', 'Date', 'Oct', 'ATGAA', 'investigational', 'therapy', 'consists', 'cipaglucosidase', 'alfa', 'administered', 'conjunction', 'miglustat', 'yet', 'approved', 'FDA', 'The', 'therapy', 'evaluated', 'inherited', 'lysosomal', 'disorder', 'called', 'Pome', 'disease', 'The', 'disease', 'debilitating', 'characterized', 'severe', 'muscle', 'weakness', 'worsens', 'time', 'It', 'ranges', 'rapidly', 'fatal', 'infantile', 'form', 'significant', 'impacts', 'heart', 'function', 'slowly', 'progressive', 'lateonset', 'form', 'primarily', 'affecting', 'skeletal', 'muscle', 'It', 'estimated', 'Pompe', 'disease', 'affects', 'approximately', 'people', 'worldwide', 'Supernus', 'Hopes', 'For', 'No', 'Hiccups', 'In', 'Parkinson', 'Disease', 'Drug', 'Approval', 'Company', 'Supernus', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'SUPN', 'Type', 'Application', 'NDA', 'Candidate', 'apomorphine', 'infusion', 'device', 'Indication', 'OFF', 'episodes', 'Parkinsonâs', 'disease', 'Date', 'Early', 'October', 'Supernusâs', 'initial', 'application', 'seeking', 'approval', 'shot', 'refusetofile', 'letter', 'November', 'citing', 'insufficiently', 'completed', 'application', 'allow', 'substantiative', 'review', 'Following', 'resubmission', 'FDA', 'accepted', 'application', 'assigned', 'PDUFA', 'date', 'sometime', 'early', 'October', 'Also', 'read', 'Best', 'Biotech', 'Stocks', 'Right', 'Now', 'AstraZeneca', 'NASDAQ', 'Knocks', 'At', 'FDA', 'Altar', 'For', 'Liver', 'Cancer', 'Combo', 'Treatment', 'Company', 'AstraZeneca', 'plc', 'NASDAQ', 'AZN', 'Type', 'Application', 'BLAsBLA', 'Candidate', 'Tremelimumab', 'Imfinzi', 'Indication', 'Unresectable', 'hepatocellular', 'carcinoma', 'Date', 'The', 'FDA', 'accepted', 'AstraZenecaâs', 'BLA', 'tremelimumab', 'priority', 'review', 'supporting', 'indication', 'single', 'priming', 'dose', 'antibody', 'added', 'Imfinzi', 'treating', 'patients', 'unresectable', 'hepatocellular', 'carcinoma', 'A', 'sBLA', 'also', 'submitted', 'Imfinzi', 'indication', 'This', 'novel', 'dose', 'schedule', 'combination', 'called', 'STRIDE', 'regimen', 'Single', 'Tremelimumab', 'Regular', 'Interval', 'Durvalumab', 'HCC', 'according', 'company', 'common', 'type', 'liver', 'cancer', 'people', 'US', 'afflicted', 'advanced', 'unresectable', 'HCC', 'year', 'MerckAstraZeneca', 'Await', 'Approval', 'For', 'Prostate', 'Cancer', 'Como', 'Therapy', 'Company', 'Merck', 'Co', 'Inc', 'NYSE', 'MRK', 'AstraZeneca', 'Type', 'Application', 'sNDA', 'Candidate', 'Lynparza', 'combination', 'Abiraterone', 'Prednisone', 'Prednisolone', 'Indication', 'prostate', 'cancer', 'Date', 'The', 'application', 'accepted', 'granted', 'priority', 'review', 'FDA', 'treatment', 'adult', 'patients', 'metastatic', 'castrationresistant', 'prostate', 'cancer', 'Adcom', 'Calendar', 'FDAâs', 'Cardiovascular', 'Renal', 'Drugs', 'Advisory', 'Committee', 'meet', 'Oct', 'discuss', 'GlaxoSmithKline', 'plcâs', 'NYSE', 'GSK', 'NDA', 'hypoxiainducible', 'factor', 'prolyl', 'hydroxylase', 'inhibitor', 'daprodustat', 'tablets', 'treatment', 'option', 'anemia', 'resulting', 'chronic', 'kidney', 'disease', 'The', 'Oncologic', 'Drugs', 'Advisory', 'Committee', 'scheduled', 'meet', 'Oct', 'discuss', 'BLA', 'submitted', 'YmAbs', 'Therapeutics', 'Inc', 'NASDAQ', 'YMAB', 'solution', 'injectable', 'formulation', 'treating', 'neuroblastoma', 'central', 'nervous', 'systemleptomeningeal', 'metastases', 'On', 'Oct', 'Endocrinologic', 'Metabolic', 'Drugs', 'Advisory', 'Committee', 'deliberate', 'Ispen', 'SAâsOTC', 'IPSEY', 'palovarotene', 'capsules', 'proposed', 'indication', 'heterotopic', 'ossification', 'adults', 'children', 'It', 'condition', 'muscle', 'tissue', 'connective', 'tissue', 'tendons', 'ligaments', 'gradually', 'replaced', 'bones', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'original', 'article', 'Benzinga'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'shelters', 'umbrella', 'walks', 'past', 'London', 'Stock', 'Exchange', 'London', 'Britain', 'August', 'REUTERSSuzanne', 'Plunkett', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTSE', 'Add', 'toRemove', 'Portfolio', 'GLNCY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ambar', 'Warrick', 'Reuters', 'British', 'stocks', 'rose', 'Tuesday', 'global', 'risk', 'sentiment', 'improved', 'reports', 'Moscow', 'withdrawing', 'troops', 'near', 'Ukraine', 'calmed', 'fears', 'potential', 'Russian', 'invasion', 'positive', 'data', 'AstraZeneca', 'NASDAQ', 'strong', 'earnings', 'mining', 'company', 'Glencore', 'LON', 'lifted', 'sentiment', 'The', 'bluechip', 'ended', 'higher', 'midcap', 'stocks', 'added', 'Both', 'indexes', 'slumped', 'nearly', 'Monday', 'United', 'States', 'warned', 'Russia', 'could', 'invade', 'Ukraine', 'moment', 'Defensive', 'sectors', 'including', 'healthcare', 'consumer', 'staples', 'top', 'performers', 'Tuesday', 'AstraZeneca', 'jumped', 'biggest', 'boost', 'FTSE', 'positive', 'results', 'latestage', 'trial', 'drugmaker', 'prostate', 'cancer', 'treatment', 'Glencore', 'BHP', 'Group', 'firms', 'announced', 'large', 'dividend', 'payouts', 'following', 'recent', 'strength', 'commodity', 'prices', 'Glencore', 'shares', 'rose', 'steep', 'losses', 'iron', 'prices', 'weighed', 'BHP', 'Chinese', 'iron', 'ore', 'prices', 'slumped', 'traders', 'feared', 'government', 'crackdown', 'Beijing', 'warned', 'would', 'act', 'spread', 'misinformation', 'prices', 'IRONORE', 'Strong', 'earnings', 'helped', 'local', 'stocks', 'weather', 'geopolitical', 'tensions', 'well', 'jitters', 'tightening', 'monetary', 'policy', 'across', 'globe', 'Corporate', 'earnings', 'remained', 'strong', 'despite', 'multitude', 'inflation', 'headwinds', 'The', 'reporting', 'season', 'continue', 'provide', 'support', 'banks', 'energy', 'materials', 'showing', 'particularly', 'strong', 'increases', 'earnings', 'Elisa', 'Belgacem', 'senior', 'credit', 'strategist', 'Generali', 'MI', 'Investments', 'wrote', 'note', 'The', 'FTSE', 'one', 'major', 'stock', 'indexes', 'trading', 'positive', 'year', 'relatively', 'low', 'exposure', 'technology', 'firms', 'helped', 'sidestep', 'global', 'rout', 'sector', 'Â', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SBNCyq', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Sberbank', 'Of', 'Russia', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Melrose', 'Industries', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fresnillo', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Anglo', 'American', 'PLC', 'LON', 'declined', 'points', 'end', 'BHP', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'healthcare', 'professional', 'prepares', 'dose', 'AstraZeneca', 'vaccine', 'Narok', 'County', 'Referral', 'Hospital', 'Narok', 'Kenya', 'December', 'REUTERSBaz', 'Ratner', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'Jennifer', 'Rigby', 'BRUSSELSLONDON', 'Reuters', 'The', 'relatively', 'short', 'shelf', 'life', 'AstraZeneca', 'NASDAQ', 'Plc', 'vaccine', 'complicating', 'rollout', 'world', 'poorest', 'nations', 'according', 'officials', 'internal', 'World', 'Health', 'Organization', 'documents', 'reviewed', 'Reuters', 'It', 'latest', 'headache', 'plague', 'COVAX', 'vaccinesharing', 'project', 'coled', 'WHO', 'aimed', 'getting', 'shots', 'world', 'neediest', 'people', 'Initially', 'poorer', 'countries', 'COVAX', 'lagged', 'richer', 'countries', 'securing', 'vaccine', 'supplies', 'wealthier', 'nations', 'used', 'financial', 'might', 'acquire', 'first', 'available', 'doses', 'As', 'vaccine', 'production', 'ramped', 'richer', 'states', 'began', 'donating', 'excess', 'doses', 'countries', 'particularly', 'Africa', 'â', 'struggling', 'administer', 'big', 'shipments', 'The', 'need', 'turn', 'vaccines', 'short', 'shelf', 'lives', 'along', 'initial', 'inequality', 'hesitancy', 'barriers', 'contributed', 'much', 'lower', 'vaccination', 'rate', 'Africa', 'around', 'people', 'immunised', 'compared', 'richer', 'nations', 'Many', 'vaccines', 'arriving', 'months', 'sometimes', 'weeks', 'useby', 'date', 'adding', 'scramble', 'get', 'shots', 'arms', 'Some', 'countries', 'destroy', 'expired', 'doses', 'including', 'Nigeria', 'dumped', 'million', 'AstraZeneca', 'vaccines', 'November', 'The', 'problem', 'short', 'shelf', 'life', 'largely', 'concerns', 'AstraZeneca', 'according', 'COVAX', 'data', 'officials', 'An', 'internal', 'WHO', 'document', 'reviewed', 'Reuters', 'detailing', 'vaccine', 'stocks', 'several', 'central', 'west', 'African', 'countries', 'week', 'ending', 'Feb', 'highlighted', 'problem', 'Most', 'listed', 'African', 'nations', 'expired', 'AstraZeneca', 'doses', 'compared', 'handful', 'countries', 'expired', 'doses', 'manufacturers', 'Of', 'total', 'expired', 'doses', 'declared', 'countries', 'week', 'million', 'AstraZeneca', 'Johnson', 'Johnson', 'NYSE', 'Moderna', 'NASDAQ', 'Russia', 'Sputnik', 'document', 'shows', 'Many', 'vaccines', 'expected', 'rejected', 'African', 'nations', 'COVAX', 'said', 'January', 'would', 'accept', 'vaccines', 'less', 'twoandahalf', 'months', 'shelf', 'life', 'Yet', 'Benin', 'received', 'AstraZeneca', 'doses', 'COVAX', 'Jan', 'set', 'expire', 'Feb', 'It', 'also', 'got', 'doses', 'Sputnik', 'Light', 'vaccine', 'Russia', 'expiry', 'date', 'outside', 'COVAX', 'initiative', 'Vaccines', 'manufacturers', 'much', 'longer', 'shelf', 'life', 'according', 'document', 'Since', 'January', 'COVAX', 'shipping', 'vaccines', 'countries', 'demand', 'ensuring', 'countries', 'get', 'right', 'volume', 'right', 'time', 'said', 'Phiona', 'Atuhebwe', 'vaccine', 'expert', 'WHO', 'Africa', 'Asked', 'internal', 'document', 'seen', 'Reuters', 'said', 'WHO', 'fully', 'cognizant', 'pressure', 'short', 'shelf', 'life', 'doses', 'put', 'delivery', 'strategies', 'systems', 'amid', 'weak', 'infrastructure', 'low', 'demand', 'Two', 'half', 'months', 'shelf', 'life', 'minimum', 'duration', 'African', 'countries', 'reckon', 'need', 'administer', 'shots', 'AstraZeneca', 'COVAX', 'secondbiggest', 'supplier', 'Pfizer', 'NYSE', 'said', 'since', 'start', 'global', 'rollout', 'million', 'shots', 'left', 'factories', 'less', 'twoandahalf', 'months', 'expiry', 'Short', 'shelf', 'life', 'generally', 'problem', 'wealthy', 'country', 'expertise', 'infrastructure', 'But', 'without', 'systems', 'place', 'insurmountable', 'A', 'spokesperson', 'AngloSwedish', 'AstraZeneca', 'said', 'vaccines', 'undergo', 'scrupulous', 'quality', 'checks', 'pointed', 'fact', 'company', 'major', 'player', 'supporting', 'vaccination', 'drives', 'poorer', 'nations', 'With', 'donations', 'rich', 'countries', 'included', 'AstraZeneca', 'vaccines', 'distributed', 'COVAX', 'shot', 'AstraZeneca', 'supplied', 'billion', 'vaccine', 'doses', 'globally', 'approximately', 'two', 'thirds', 'gone', 'low', 'lower', 'middleincome', 'countries', 'spokesperson', 'said', 'Almost', 'nine', 'doses', 'released', 'manufacturing', 'sites', 'ready', 'donation', 'shelf', 'life', 'least', 'two', 'half', 'months', 'consistent', 'rest', 'supply', 'chains', 'spokesperson', 'added', 'CLOCK', 'TICKING', 'The', 'volumes', 'delivered', 'vaccines', 'vastly', 'outnumber', 'wasted', 'doses', 'losses', 'substantial', 'thanks', 'part', 'time', 'pressures', 'This', 'led', 'AstraZeneca', 'shots', 'turned', 'even', 'shipped', 'Taking', 'account', 'donated', 'doses', 'represent', 'nearly', 'half', 'billion', 'vaccines', 'distributed', 'COVAX', 'million', 'AstraZeneca', 'shots', 'rejected', 'deferred', 'last', 'year', 'poor', 'nations', 'said', 'Gavi', 'nonprofit', 'coruns', 'COVAX', 'alongside', 'WHO', 'That', 'amounts', 'quarter', 'AstraZeneca', 'donated', 'shots', 'via', 'COVAX', 'Many', 'later', 'reassigned', 'countries', 'Gavi', 'added', 'noting', 'AstraZeneca', 'It', 'say', 'Millions', 'additional', 'AstraZeneca', 'doses', 'shared', 'EU', 'COVAX', 'biggest', 'donor', 'distributed', 'yet', 'according', 'EU', 'internal', 'document', 'reviewed', 'Reuters', 'The', 'main', 'problem', 'vaccine', 'shelf', 'life', 'six', 'months', 'date', 'bottling', 'shortest', 'among', 'COVAX', 'top', 'suppliers', 'several', 'COVAX', 'EU', 'officials', 'told', 'Reuters', 'In', 'addition', 'company', 'quality', 'checks', 'sometimes', 'take', 'months', 'COVAX', 'complex', 'system', 'assign', 'doses', 'countries', 'donors', 'requests', 'deliver', 'selected', 'nations', 'often', 'eat', 'vaccine', 'short', 'life', 'leaving', 'sometimes', 'weeks', 'expire', 'Quality', 'checks', 'conducted', 'vaccine', 'makers', 'time', 'constraints', 'less', 'issue', 'COVAX', 'top', 'suppliers', 'Johnson', 'Johnson', 'vaccines', 'last', 'two', 'years', 'frozen', 'Pfizer', 'last', 'nine', 'months', 'Moderna', 'seven', 'months', 'according', 'storage', 'instructions', 'approved', 'WHO', 'Millions', 'Moderna', 'Pfizer', 'vaccines', 'could', 'also', 'go', 'wasted', 'African', 'countries', 'warned', 'WHO', 'document', 'problem', 'linked', 'usually', 'low', 'vaccine', 'uptake', 'insufficient', 'coldchain', 'equipment', 'distribute', 'shots', 'remote', 'regions', 'EXTENDING', 'SHELF', 'LIFE', 'Gavi', 'said', 'encouraged', 'AstraZeneca', 'apply', 'WHO', 'extension', 'expiration', 'date', 'talks', 'led', 'yet', 'formal', 'application', 'AstraZeneca', 'said', 'process', 'complex', 'due', 'vast', 'global', 'network', 'companies', 'manufacturing', 'vaccine', 'One', 'production', 'partners', 'Serum', 'Institute', 'India', 'granted', 'WHO', 'approval', 'ninemonth', 'shelf', 'life', 'initially', 'authorised', 'six', 'But', 'batches', 'produced', 'AstraZeneca', 'rest', 'world', 'six', 'We', 'currently', 'discussions', 'World', 'Health', 'Organisation', 'complex', 'task', 'requires', 'data', 'collected', 'across', 'global', 'manufacturing', 'network', 'spokesperson', 'AstraZeneca', 'said', 'A', 'WHO', 'spokesperson', 'comment', 'talks', 'On', 'average', 'African', 'countries', 'used', 'twothirds', 'received', 'doses', 'drops', 'Burundi', 'Congo', 'large', 'countries', 'including', 'Madagascar', 'Zambia', 'Somalia', 'Uganda', 'used', 'onethird', 'Gavi', 'said', 'citing', 'figures', 'late', 'January', 'Gavi', 'said', 'total', 'wastage', 'rate', 'around', 'doses', 'delivered', 'midDecember', 'It', 'declined', 'share', 'updated', 'figures', 'said', 'rate', 'expected', 'rise'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SBNCyq', 'Add', 'toRemove', 'Portfolio', 'VTBRq', 'Add', 'toRemove', 'Portfolio', 'ROSNq', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Hargreaves', 'Lansdown', 'PLC', 'LON', 'added', 'points', 'end', 'Fresnillo', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Sberbank', 'Of', 'Russia', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'NK', 'Rosneft', 'PAO', 'DRC', 'LON', 'declined', 'points', 'end', 'Bank', 'VTB', 'PAO', 'DRC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'April', 'rose', 'hit', 'barrel', 'May', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'vial', 'labelled', 'AstraZeneca', 'Vaccine', 'seen', 'illustration', 'taken', 'January', 'REUTERSDado', 'RuvicIllustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Reuters', 'A', 'large', 'study', 'rare', 'blood', 'clots', 'linked', 'AstraZeneca', 'NASDAQ', 'vaccine', 'found', 'one', 'three', 'cases', 'per', 'million', 'first', 'dose', 'shedding', 'fresh', 'light', 'sideeffects', 'shot', 'Researchers', 'sought', 'analyse', 'link', 'vaccines', 'rare', 'blood', 'clots', 'brain', 'arteries', 'veins', 'sometimes', 'accompanied', 'low', 'platelets', 'reports', 'led', 'many', 'nations', 'last', 'year', 'pause', 'use', 'AstraZeneca', 'shot', 'developed', 'Oxford', 'University', 'A', 'study', 'published', 'PLOS', 'Medicine', 'journal', 'Tuesday', 'looked', 'health', 'records', 'million', 'adults', 'England', 'December', 'March', 'assess', 'risk', 'clots', 'month', 'vaccination', 'either', 'PfizerBioNTech', 'vaccine', 'AstraZenecaOxford', 'shot', 'compared', 'unvaccinated', 'It', 'carried', 'William', 'Whiteley', 'University', 'Edinburgh', 'Britain', 'BHF', 'Data', 'Science', 'Centre', 'It', 'found', 'risk', 'major', 'arterial', 'venous', 'thrombotic', 'events', 'aged', 'either', 'vaccines', 'And', 'risk', 'intracranial', 'venous', 'thrombosis', 'ICVT', 'following', 'AstraZenecaOxford', 'vaccine', 'nearly', 'double', 'equal', 'one', 'three', 'cases', 'per', 'million', 'The', 'risks', 'ICVT', 'hospitalisation', 'thrombocytopenia', 'likely', 'outweighed', 'vaccines', 'effect', 'reducing', 'mortality', 'morbidity', 'study', 'authors', 'said', 'Cases', 'rare', 'blood', 'clotting', 'emerged', 'early', 'last', 'year', 'rollout', 'AstraZenecaOxford', 'vaccine', 'began', 'Europe', 'Johnson', 'Johnson', 'NYSE', 'vaccine', 'based', 'similar', 'platform', 'AstraZenecaOxford', 'shot', 'also', 'associated', 'rare', 'combination', 'blood', 'clotting', 'low', 'platelet', 'counts', 'Some', 'countries', 'restricted', 'suspended', 'use', 'vaccines', 'EU', 'drug', 'regulator', 'confirmed', 'possible', 'links', 'shots', 'conditions', 'International', 'drug', 'regulators', 'said', 'benefits', 'vaccines', 'outweigh', 'risks', 'The', 'study', 'line', 'review', 'EU', 'drug', 'regulator', 'said', 'last', 'month', 'fewer', 'side', 'effects', 'observed', 'second', 'AstraZeneca', 'dose', 'AstraZeneca', 'said', 'statement', 'study', 'confirmed', 'already', 'known', 'extremely', 'rare', 'blood', 'disorders', 'following', 'vaccination', 'The', 'risk', 'developing', 'rare', 'condition', 'remains', 'substantially', 'higher', 'added', 'Last', 'year', 'study', 'led', 'funded', 'AstraZeneca', 'found', 'vaccine', 'carried', 'small', 'additional', 'risk', 'thrombosis', 'thrombocytopenia', 'syndrome', 'first', 'dose', 'none', 'second', 'AstraZenecaOxford', 'shot', 'sold', 'brands', 'Vaxzevria', 'Covishield', 'billion', 'doses', 'supplied', 'globally', 'February', 'remains', 'key', 'weapon', 'pandemic', 'middleincome', 'countries', 'A', 'second', 'peerreviewed', 'British', 'study', 'also', 'released', 'Tuesday', 'found', 'risk', 'cerebral', 'venous', 'sinus', 'thrombosis', 'CVST', 'four', 'weeks', 'receiving', 'AstraZenecaOxford', 'shot', 'roughly', 'twice', 'high', 'vaccination', 'still', 'implied', 'one', 'four', 'million', 'people', 'could', 'sideeffect', 'The', 'study', 'assessed', 'data', 'million', 'people', 'England', 'Scotland', 'Wales', 'spanning', 'nearly', 'seven', 'months', 'December', 'June', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Britain', 'Prince', 'Charles', 'AstraZeneca', 'Chairman', 'Leif', 'Johansson', 'smile', 'visit', 'AstraZeneca', 'global', 'RD', 'facility', 'Cambridge', 'Biomedical', 'Campus', 'Cambridge', 'Britain', 'November', 'Chris', 'JacksonPool', 'via', 'REUTERS', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Reuters', 'AstraZeneca', 'nonexecutive', 'Chairman', 'Leif', 'Johansson', 'retire', 'next', 'year', 'serving', 'years', 'role', 'AngloSwedish', 'drugmaker', 'said', 'Tuesday', 'moves', 'onto', 'next', 'stage', 'growth', 'led', 'newer', 'therapies', 'including', 'cancer', 'The', 'Swedish', 'businessman', 'became', 'chairman', 'around', 'time', 'Frenchman', 'Pascal', 'Soriot', 'took', 'charge', 'chief', 'executive', 'Soriot', 'interview', 'Financial', 'Times', 'last', 'May', 'hinted', 'succession', 'planning', 'begun', 'Johansson', 'The', 'Londonlisted', 'drugmaker', 'said', 'Tuesday', 'Johansson', 'would', 'step', 'following', 'annual', 'general', 'meeting', 'search', 'chair', 'successor', 'proceeding', 'well', 'AstraZeneca', 'NASDAQ', 'last', 'year', 'asked', 'Johansson', 'continue', 'role', 'oversee', 'nowcompleted', 'billion', 'acquisition', 'rare', 'diseases', 'drug', 'maker', 'Alexion', 'NASDAQ', 'biggest', 'deal', 'record', 'also', 'navigated', 'developments', 'around', 'shot', 'He', 'also', 'served', 'chairman', 'telecommunications', 'firm', 'Ericsson', 'BS', 'New', 'governance', 'codes', 'introduced', 'diversify', 'talent', 'said', 'chair', 'firm', 'Britain', 'remain', 'post', 'beyond', 'nine', 'years', 'companies', 'must', 'carefully', 'consider', 'extension', 'beyond', 'limited', 'period', 'AstraZeneca', 'said', 'Tuesday', 'asked', 'Johansson', 'reached', 'nine', 'years', 'tenure', 'continue', 'another', 'year', 'facilitate', 'succession', 'planning', 'The', 'Board', 'believes', 'would', 'best', 'interests', 'shareholders', 'Mr', 'Johansson', 'seek', 'reelection', 'AGM', 'April', 'continue', 'serve', 'Chair', 'one', 'year', 'said', 'statement', 'Following', 'confirmation', 'Johansson', 'retirement', 'plans', 'Soriot', 'tenure', 'could', 'come', 'back', 'investor', 'focus', 'leaves', 'behind', 'old', 'guard', 'top', 'Former', 'finance', 'chief', 'Marc', 'Dunoyer', 'moved', 'new', 'role', 'lead', 'Alexion'], ['Â', 'Reuters', 'AstraZeneca', 'Stock', 'Gain', 'After', 'Enhertu', 'Meets', 'Primary', 'Endpoint', 'In', 'Breast', 'Cancer', 'Setting', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'plc', 'NASDAQ', 'said', 'Enhertu', 'prolonged', 'survival', 'slowed', 'progression', 'metastatic', 'breast', 'cancer', 'low', 'levels', 'protein', 'known', 'Data', 'pivotal', 'Phase', 'trial', 'showed', 'Enhertu', 'trastuzumab', 'deruxtecan', 'demonstrated', 'statistically', 'significant', 'clinically', 'meaningful', 'improvement', 'progressionfree', 'survival', 'PFS', 'overall', 'survival', 'OS', 'patients', 'versus', 'physician', 'choice', 'chemotherapy', 'The', 'improvement', 'clinically', 'meaningful', 'compared', 'standard', 'chemotherapy', 'said', 'adding', 'detailed', 'results', 'latestage', 'trial', 'would', 'presented', 'asyetundisclosed', 'medical', 'conference', 'Related', 'AstraZenecaDaiichi', 'Sankyo', 'Share', 'Detailed', 'Enhertu', 'Data', 'In', 'Gastric', 'Cancer', 'Enhertu', 'antibodydrug', 'conjugate', 'ADC', 'jointly', 'developed', 'AstraZeneca', 'Daiichi', 'Sankyo', 'OTC', 'DSNKY', 'The', 'trial', 'met', 'key', 'secondary', 'endpoint', 'PFS', 'patients', 'metastatic', 'breast', 'cancer', 'regardless', 'HR', 'status', 'The', 'safety', 'profile', 'Enhertu', 'consistent', 'previous', 'clinical', 'trials', 'new', 'safety', 'concerns', 'identified', 'Overall', 'interstitial', 'lung', 'disease', 'ILD', 'rates', 'consistent', 'observed', 'lateline', 'breast', 'cancer', 'trials', 'Enhertu', 'lower', 'rate', 'Grade', 'ILD', 'observed', 'Price', 'Action', 'AZN', 'shares', 'premarket', 'session', 'last', 'check', 'Tuesday', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'Wisniewski', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'NASDAQ', 'plc', 'signed', 'agreement', 'Canada', 'doses', 'antibody', 'therapy', 'prevention', 'highrisk', 'patients', 'country', 'government', 'said', 'Wednesday', 'AstraZeneca', 'Evusheld', 'review', 'Health', 'Canada', 'use', 'preventive', 'treatment', 'disease', 'immunocompromised', 'While', 'vaccines', 'provide', 'excellent', 'protection', 'people', 'immunocompromised', 'may', 'need', 'additional', 'protection', 'said', 'Canadian', 'health', 'minister', 'JeanYves', 'Duclos', 'Initial', 'deliveries', 'antibody', 'expected', 'arrive', 'Canada', 'within', 'month', 'authorization', 'government', 'said', 'The', 'company', 'said', 'doses', 'Evusheld', 'delivered', 'year'], ['Â', 'Reuters', 'AstraZeneca', 'GSK', 'Therapies', 'Lose', 'Efficacy', 'Against', 'Omicron', 'Subvariants', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'The', 'FDA', 'authorized', 'increased', 'dose', 'case', 'AstraZeneca', 'Plc', 'NASDAQ', 'preexposure', 'prophylaxis', 'drug', 'Evusheld', 'tixagevimab', 'cilgavimab', 'Based', 'recent', 'information', 'data', 'available', 'Evusheld', 'may', 'less', 'active', 'certain', 'Omicron', 'subvariants', 'The', 'dosing', 'regimen', 'revised', 'available', 'data', 'indicate', 'higher', 'dose', 'Evusheld', 'may', 'likely', 'prevent', 'infection', 'Omicron', 'subvariants', 'originally', 'authorized', 'Evusheld', 'dose', 'FDA', 'said', 'statement', 'The', 'revised', 'EUA', 'doubles', 'initial', 'authorized', 'dose', 'mg', 'tixagevimab', 'mg', 'cilgavimab', 'The', 'FDA', 'recommends', 'patients', 'previously', 'received', 'Evusheld', 'get', 'additional', 'doses', 'ASAP', 'nonclinical', 'data', 'indicate', 'neutralizing', 'activity', 'Evusheld', 'decreases', 'fold', 'Omicron', 'subvariants', 'Meanwhile', 'earlier', 'week', 'FDA', 'updated', 'fact', 'sheet', 'GlaxoSmithKline', 'Plc', 'NYSE', 'GSK', 'Vir', 'Biotechnology', 'Inc', 'NASDAQ', 'VIR', 'sotrovimab', 'Omicron', 'subvariant', 'less', 'susceptible', 'sotrovimab', 'original', 'virus', 'The', 'agency', 'added', 'unknown', 'whether', 'reduced', 'potency', 'impact', 'effectiveness', 'In', 'addition', 'updated', 'document', 'adds', 'vague', 'language', 'sotrovimab', 'authorized', 'treatment', 'geographic', 'regions', 'infection', 'likely', 'caused', 'nonsusceptible', 'variant', 'Related', 'Preprint', 'Suggests', 'VirGSK', 'Antibody', 'Can', 'Evade', 'Omicron', 'SubVariant', 'Price', 'Action', 'AZN', 'shares', 'GSK', 'stock', 'market', 'session', 'last', 'check', 'Friday', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga'], ['Â', 'Reuters', 'AstraZeneca', 'says', 'ImjudoImfinzi', 'combination', 'approved', 'advanced', 'liver', 'cancer', 'US', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'PLC', 'LON', 'announced', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'approved', 'company', 'Imjudo', 'tremelimumab', 'drug', 'combination', 'Imfinzi', 'durvalumab', 'treatment', 'adult', 'patients', 'unresectable', 'hepatocellular', 'carcinoma', 'HCC', 'common', 'type', 'liver', 'cancer', 'The', 'approval', 'based', 'results', 'HIMALAYA', 'Phase', 'III', 'trial', 'showed', 'single', 'priming', 'dose', 'antibody', 'Imjudo', 'added', 'antibody', 'Imfinzi', 'reduced', 'risk', 'death', 'compared', 'sorafenib', 'pharmaceuticals', 'company', 'said', 'Liver', 'cancer', 'thirdleading', 'cause', 'cancer', 'death', 'sixth', 'commonly', 'diagnosed', 'cancer', 'worldwide', 'It', 'fastestrising', 'cause', 'cancerrelated', 'deaths', 'US', 'approximately', 'new', 'diagnoses', 'year', 'company', 'said', 'In', 'statement', 'Dave', 'Fredrickson', 'executive', 'vice', 'president', 'oncology', 'business', 'unit', 'AstraZeneca', 'commented', 'With', 'first', 'regulatory', 'approval', 'Imjudo', 'patients', 'unresectable', 'liver', 'cancer', 'US', 'approved', 'dual', 'immunotherapy', 'treatment', 'regimen', 'harnesses', 'potential', 'inhibition', 'unique', 'combination', 'inhibitor', 'enhance', 'immune', 'response', 'cancer', 'Dr', 'Ghassan', 'AbouAlfa', 'attending', 'physician', 'Memorial', 'Sloan', 'Kettering', 'Cancer', 'Center', 'MSK', 'principal', 'investigator', 'HIMALAYA', 'Phase', 'III', 'trial', 'said', 'Patients', 'unresectable', 'liver', 'cancer', 'need', 'welltolerated', 'treatments', 'meaningfully', 'extend', 'overall', 'survival', 'In', 'addition', 'regimen', 'demonstrating', 'favourable', 'threeyear', 'survival', 'rate', 'HIMALAYA', 'trial', 'safety', 'data', 'showed', 'increase', 'severe', 'liver', 'toxicity', 'bleeding', 'risk', 'combination', 'important', 'factors', 'patients', 'liver', 'cancer', 'also', 'advanced', 'liver', 'disease', 'Regulatory', 'applications', 'Imjudo', 'combination', 'Imfinzi', 'currently', 'review', 'Europe', 'Japan', 'several', 'countries', 'treatment', 'patients', 'advanced', 'liver', 'cancer', 'based', 'HIMALAYA', 'results', 'AstraZeneca', 'said', 'Read', 'Proactive', 'Investors', 'UK', 'Disclaimer', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'US', 'April', 'REUTERSBrendan', 'McDermidFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Shares', 'LogicBio', 'Therapeutics', 'skyrocketed', 'Monday', 'Britain', 'AstraZeneca', 'NASDAQ', 'said', 'would', 'buy', 'USbased', 'gene', 'therapy', 'developer', 'rare', 'premium', 'million', 'LoigBio', 'shares', 'traded', 'since', 'February', 'bell', 'close', 'AstraZeneca', 'offer', 'price', 'per', 'share', 'LogicBio', 'developing', 'gene', 'editing', 'therapies', 'treat', 'pediatric', 'rare', 'disease', 'like', 'methylmalonic', 'acidemia', 'body', 'break', 'certain', 'proteins', 'fats', 'AstraZeneca', 'said', 'deal', 'would', 'accelerate', 'growth', 'Alexion', 'NASDAQ', 'unit', 'acquired', 'billion', 'last', 'year', 'field', 'genomic', 'medicine'], ['By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter'], ['The', 'European', 'Commission', 'approved', 'AstraZeneca', 'plc', 'AZN', 'Sanofi', 'SAâs', 'SNY', 'Beyfortus', 'nirsevimab', 'longacting', 'antibody', 'prevent', 'respiratory', 'syncytial', 'virus', 'RSV', 'lower', 'respiratory', 'tract', 'disease', 'newborns', 'infants', 'first', 'RSV', 'season', 'Beyfortus', 'nirsevimab', 'longacting', 'antibody', 'prevent', 'respiratory', 'syncytial', 'virus', 'RSV', 'lower', 'respiratory', 'tract', 'disease', 'newborns', 'infants', 'first', 'RSV', 'season', 'Beyfortus', 'first', 'singledose', 'RSV', 'passive', 'immunization', 'broad', 'infant', 'population', 'including', 'born', 'healthy', 'term', 'preterm', 'specific', 'health', 'conditions', 'In', 'pivotal', 'MELODY', 'efficacy', 'trial', 'Beyfortus', 'met', 'primary', 'endpoint', 'reducing', 'incidence', 'medically', 'attended', 'lower', 'respiratory', 'tract', 'infections', 'LRTI', 'caused', 'RSV', 'vs', 'placebo', 'day', 'single', 'dose', 'Beyfortus', 'also', 'demonstrated', 'comparable', 'safety', 'tolerability', 'profile', 'Swedish', 'Orphan', 'Biovitrum', 'AB', 'BIOVF', 'Synagis', 'palivizumab', 'MEDLEY', 'Phase', 'trial', 'Synagis', 'palivizumab', 'MEDLEY', 'Phase', 'trial', 'Globally', 'approximately', 'million', 'cases', 'acute', 'lower', 'respiratory', 'infections', 'leading', 'three', 'million', 'hospitalizations', 'It', 'estimated', 'inhospital', 'deaths', 'children', 'younger', 'five', 'years', 'Price', 'Action', 'SNY', 'shares', 'AZN', 'shares', 'premarket', 'session', 'last', 'check', 'Friday', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'granted', 'full', 'Marketing', 'Authorisation', 'AstraZeneca', 'Plc', 'AZN', 'vaccine', 'Vaxzevria', 'Recombinant', 'vaccine', 'Vaxzevria', 'Recombinant', 'Vaxzevria', 'initially', 'granted', 'conditional', 'Marketing', 'Authorisation', 'due', 'urgency', 'pandemic', 'As', 'continues', 'sufficient', 'evidence', 'safety', 'efficacy', 'confirming', 'benefits', 'Vaxzevria', 'EMA', 'granted', 'full', 'approval', 'The', 'approval', 'covers', 'use', 'Vaxzevria', 'primary', 'vaccination', 'series', 'heterologous', 'approved', 'mRNA', 'vaccine', 'homologous', 'vaccine', 'thirddose', 'booster', 'Related', 'AstraZenecaOxford', 'University', 'Partnered', 'Nasal', 'Vaccine', 'Flunks', 'Human', 'Trial', 'AstraZenecaOxford', 'University', 'Partnered', 'Nasal', 'Vaccine', 'Flunks', 'Human', 'Trial', 'Vaxzevria', 'demonstrated', 'effective', 'forms', 'mild', 'symptomatic', 'severe', 'disease', 'including', 'hospitalization', 'death', 'according', 'clinical', 'studies', 'realworld', 'evidence', 'These', 'include', 'expert', 'review', 'data', 'realworld', 'studies', 'showed', 'Vaxzevria', 'available', 'mRNA', 'vaccines', 'provide', 'equally', 'effective', 'protection', 'hospitalization', 'death', 'following', 'three', 'doses', 'There', 'also', 'substantial', 'body', 'evidence', 'supporting', 'boosting', 'Vaxzevria', 'following', 'primary', 'vaccination', 'schedules', 'tested', 'date', 'Price', 'Action', 'AZN', 'shares', 'premarket', 'session', 'last', 'check', 'Tuesday', 'AZN', 'shares', 'premarket', 'session', 'last', 'check', 'Tuesday', 'Photo', 'Paul', 'McManus', 'Pixabay', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Astrazeneca', 'Beyfortus', 'receives', 'EU', 'approval', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'NASDAQ', 'stated', 'Beyfortus', 'first', 'singledose', 'RSV', 'passive', 'immunisation', 'broad', 'infant', 'population', 'including', 'born', 'healthy', 'term', 'preterm', 'specific', 'health', 'conditions', 'The', 'group', 'said', 'European', 'Commission', 'first', 'regulatory', 'body', 'grant', 'approval', 'Beyfortus', 'approval', 'based', 'results', 'drug', 'clinical', 'development', 'programme', 'follows', 'recommendation', 'The', 'Committee', 'Medicinal', 'Products', 'Human', 'Use', 'European', 'Medicines', 'Agency', 'September', 'In', 'AZN', 'pivotal', 'MELODY', 'efficacy', 'trial', 'Beyfortus', 'met', 'primary', 'endpoint', 'reducing', 'incidence', 'medically', 'attended', 'lower', 'respiratory', 'tract', 'infections', 'caused', 'RSV', 'versus', 'placebo', 'day', 'single', 'dose', 'Iskra', 'Eric', 'AZN', 'executive', 'vice', 'president', 'vaccines', 'immune', 'therapies', 'said', 'Beyfortus', 'first', 'singledose', 'preventative', 'option', 'respiratory', 'syncytial', 'virus', 'gain', 'approval', 'Europe', 'also', 'first', 'preventative', 'option', 'approved', 'broad', 'infant', 'population', 'Today', 'marketing', 'authorisation', 'Beyfortus', 'marks', 'significant', 'achievement', 'scientific', 'community', 'addresses', 'persistent', 'global', 'unmet', 'need', 'RSV', 'prevention', 'Reporting', 'Iain', 'Gilbert', 'Sharecastcom', 'Read', 'Sharecastcom'], ['Â', 'Reuters', 'Jim', 'Cramer', 'Gives', 'His', 'Opinion', 'On', 'AstraZeneca', 'Intuitive', 'Surgical', 'And', 'More', 'ISRG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'IIG', 'Add', 'toRemove', 'Portfolio', 'IX', 'Add', 'toRemove', 'Portfolio', 'On', 'CNBCâs', 'Mad', 'Money', 'Lightning', 'Round', 'Jim', 'Cramer', 'said', 'Energy', 'Corp', 'NYSE', 'UEC', 'speculative', 'stock', 'He', 'added', 'stock', 'big', 'run', 'might', 'get', 'cut', 'half', 'double', 'And', 'typically', 'kinds', 'stocks', 'I', 'recommend', 'Cramer', 'recommended', 'looking', 'Intuitive', 'Surgical', 'Inc', 'NASDAQ', 'daytoday', 'basis', 'You', 'look', 'yeartoyear', 'basis', 'thatâs', 'good', 'machines', 'said', 'The', 'Mad', 'Money', 'host', 'said', 'looked', 'Banco', 'Santander', 'SA', 'NYSE', 'BME', 'multiple', 'times', 'Charitable', 'Trust', 'I', 'canât', 'summon', 'pull', 'trigger', 'Cramer', 'said', 'needs', 'research', 'Atlantica', 'Sustainable', 'Infrastructure', 'plc', 'NASDAQ', 'AY', 'Check', 'premarket', 'coverage', 'Although', 'US', 'Bancorp', 'NYSE', 'USB', 'wellrun', 'bank', 'Cramer', 'prefers', 'Morgan', 'Stanley', 'NYSE', 'NYSE', 'Cramer', 'said', 'market', 'doesnât', 'like', 'Brunswick', 'Corporation', 'NYSE', 'BC', 'doesnât', 'believe', 'come', 'back', 'However', 'commented', 'Iâm', 'trying', 'disagree', 'market', 'I', 'think', 'itâs', 'good', 'company', 'Axon', 'Enterprise', 'Inc', 'NASDAQ', 'AXON', 'wellrun', 'terrific', 'company', 'said', 'When', 'asked', 'AstraZeneca', 'PLC', 'NASDAQ', 'NASDAQ', 'Cramer', 'said', 'I', 'canât', 'chase', 'I', 'think', 'itâs', 'gotten', 'expensive', 'versus', 'good', 'drug', 'companies', 'So', 'Iâm', 'going', 'say', 'take', 'pass', 'Cramer', 'said', 'OneMain', 'Holdings', 'Inc', 'NYSE', 'OMF', 'risky', 'point', 'cycle', 'particularly', 'Fed', 'really', 'give', 'us', 'real', 'slowdown', 'Regions', 'Financial', 'Corporation', 'NYSE', 'NYSE', 'smart', 'well', 'run', 'bank', 'He', 'added', 'Believe', 'wonât', 'stay', 'independent', 'forever', 'stays', 'price', 'Itâs', 'way', 'good', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga'], ['AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'NASDAQ', 'reported', 'Friday', 'first', 'quarter', 'beat', 'analysts', 'forecasts', 'revenue', 'topped', 'expectations', 'AstraZeneca', 'announced', 'earnings', 'per', 'share', 'revenue', 'Analysts', 'polled', 'Investingcom', 'anticipated', 'EPS', 'revenue', 'AstraZeneca', 'shares', 'beginning', 'year', 'trading', 'outperforming', 'start', 'year', 'AstraZeneca', 'shares', 'gained', 'intraday', 'trade', 'report', 'AstraZeneca', 'follows', 'major', 'Healthcare', 'sector', 'earnings', 'month', 'AstraZeneca', 'report', 'follows', 'earnings', 'beat', 'GlaxoSmithKline', 'Wednesday', 'reported', 'EPS', 'revenue', 'compared', 'forecasts', 'EPS', 'revenue', 'Oxford', 'BioMedica', 'missed', 'expectations', 'April', 'first', 'quarter', 'EPS', 'revenue', 'compared', 'forecast', 'EPS', 'revenue', 'Stay', 'uptodate', 'upcoming', 'earnings', 'reports', 'visiting', 'Investingcom', 'earnings', 'calendar', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'NASDAQ', 'ADR', 'reported', 'Friday', 'first', 'quarter', 'beat', 'analysts', 'forecasts', 'revenue', 'topped', 'expectations', 'AstraZeneca', 'ADR', 'announced', 'earnings', 'per', 'share', 'revenue', 'Analysts', 'polled', 'Investingcom', 'anticipated', 'EPS', 'revenue', 'AstraZeneca', 'ADR', 'shares', 'beginning', 'year', 'trading', 'outperforming', 'start', 'year', 'AstraZeneca', 'ADR', 'follows', 'major', 'Healthcare', 'sector', 'earnings', 'month', 'AstraZeneca', 'ADR', 'report', 'follows', 'earnings', 'beat', 'UnitedHealth', 'April', 'reported', 'EPS', 'revenue', 'compared', 'forecasts', 'EPS', 'revenue', 'JJ', 'beat', 'expectations', 'April', 'first', 'quarter', 'EPS', 'revenue', 'compared', 'forecast', 'EPS', 'revenue', 'Stay', 'uptodate', 'upcoming', 'earnings', 'reports', 'visiting', 'Investingcom', 'earnings', 'calendar', 'Â', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CVX', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'XOM', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSEC', 'Add', 'toRemove', 'Portfolio', 'KECR', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'ETHUSD', 'Add', 'toRemove', 'Portfolio', 'By', 'Laura', 'Sanchez', 'Investingcom', 'Today', 'investors', 'focus', 'important', 'macro', 'data', 'eurozone', 'inflation', 'GDP', 'different', 'European', 'countries', 'We', 'also', 'keep', 'eye', 'corporate', 'earnings', 'season', 'Oil', 'trading', 'higher', 'Cryptocurrencies', 'mixed', 'morning', 'Here', 'five', 'factors', 'investors', 'consider', 'making', 'decisions', 'today', 'CPI', 'GDP', 'data', 'Europe', 'This', 'Friday', 'get', 'inflation', 'data', 'eurozone', 'An', 'increase', 'expected', 'We', 'also', 'follow', 'GDP', 'data', 'Corporate', 'results', 'The', 'corporate', 'earnings', 'season', 'continues', 'Today', 'NYSE', 'NYSE', 'NASDAQ', 'among', 'others', 'present', 'quarterly', 'figures', 'Cryptos', 'hold', 'ground', 'The', 'cryptocurrency', 'sector', 'trading', 'mixed', 'today', 'trading', 'dollars', 'Asia', 'American', 'stock', 'market', 'Positive', 'signs', 'today', 'main', 'Asian', 'indices', 'Hong', 'Kong', 'On', 'Wall', 'Street', 'market', 'closed', 'green', 'yesterday', 'well', 'The', 'closed', 'higher', 'Macroeconomic', 'data', 'Key', 'macroeconomic', 'releases', 'include', 'Spain', 'eurozone', 'In', 'US', 'University', 'released', 'Follow', 'day', 'events', 'economic', 'calendar', 'httpsukinvestingcomeconomiccalendar', 'Â', 'Reuters', 'The', 'Daily', 'Biotech', 'Pulse', 'FDA', 'Approves', 'Bristol', 'Myers', 'Oral', 'Heart', 'Disease', 'Drug', 'European', 'Approval', 'For', 'Merck', 'Keytruda', 'Genocea', 'Restructures', 'Zymeworks', 'Takeover', 'Bid', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'UZE', 'Add', 'toRemove', 'Portfolio', 'Here', 'roundup', 'top', 'developments', 'biotech', 'space', 'last', 'hours', 'Stocks', 'In', 'Focus', 'Bristol', 'Myers', 'Oral', 'Heart', 'Disease', 'Drug', 'Scores', 'FDA', 'Approval', 'The', 'FDA', 'approved', 'Bristol', 'Myers', 'Squibb', 'Co', 'NYSE', 'BMY', 'Camzyos', 'mavacamten', 'obstructive', 'hypertrophic', 'cardiomyopathy', 'obstructive', 'HCM', 'improve', 'functional', 'capacity', 'symptoms', 'Camzyos', 'first', 'FDAapproved', 'allosteric', 'reversible', 'inhibitor', 'selective', 'cardiac', 'myosin', 'targets', 'underlying', 'pathophysiology', 'obstructive', 'HCM', 'BackToBack', 'European', 'Approval', 'For', 'Merck', 'Keytruda', 'In', 'Various', 'Cancer', 'Indications', 'The', 'European', 'Commission', 'approved', 'Merck', 'Co', 'Inc', 'NYSE', 'MRK', 'Keytruda', 'plus', 'chemo', 'without', 'bevacizumab', 'persistent', 'recurrent', 'metastatic', 'cervical', 'cancer', 'adults', 'whose', 'tumors', 'express', 'Europe', 'also', 'approved', 'Keytruda', 'monotherapy', 'microsatellite', 'instabilityhigh', 'deficient', 'mismatch', 'repair', 'tumors', 'five', 'different', 'types', 'cancer', 'The', 'approval', 'covers', 'patients', 'disease', 'progression', 'following', 'prior', 'treatment', 'platinumcontaining', 'therapy', 'setting', 'candidates', 'curative', 'surgery', 'radiation', 'Zymeworks', 'Confirms', 'Takeover', 'Bid', 'Zymeworks', 'Inc', 'NYSE', 'ZYME', 'confirmed', 'received', 'unsolicited', 'nonbinding', 'proposal', 'All', 'Blue', 'Falcons', 'FZE', 'affiliates', 'purchase', 'company', 'per', 'share', 'The', 'Zymeworks', 'board', 'directors', 'carefully', 'review', 'proposal', 'Shares', 'premarket', 'session', 'Click', 'access', 'Benzinga', 'FDA', 'Calendar', 'Genocea', 'Initiates', 'Restructuring', 'Explores', 'Strategic', 'Alternatives', 'Genocea', 'Biosciences', 'Inc', 'GNCA', 'exploring', 'strategic', 'alternatives', 'engaged', 'professional', 'advisors', 'including', 'investment', 'bank', 'act', 'strategic', 'advisor', 'process', 'The', 'company', 'reduce', 'workforce', 'approximately', 'second', 'quarter', 'reviewing', 'clinical', 'research', 'programs', 'Shares', 'closed', 'lower', 'cents', 'afterhours', 'trading', 'Annovis', 'Bio', 'Inks', 'CRADA', 'Agreement', 'To', 'Develop', 'Pharmacodynamic', 'Biomarkers', 'Buntanetap', 'Annovis', 'Bio', 'Inc', 'NYSE', 'ANVS', 'announced', 'Cooperative', 'Research', 'Development', 'Agreement', 'CRADA', 'National', 'Institute', 'Aging', 'NIA', 'part', 'National', 'Institutes', 'Health', 'Under', 'CRADA', 'NIA', 'Annovis', 'collaborate', 'develop', 'pharmacodynamic', 'biomarkers', 'buntanetap', 'focusing', 'isolating', 'brainderived', 'extracellular', 'vesicles', 'containing', 'potential', 'neuronal', 'function', 'viability', 'biomarkers', 'FDA', 'Removes', 'Clinical', 'Hold', 'On', 'Finch', 'Therapeutics', 'C', 'difficile', 'infection', 'The', 'FDA', 'removed', 'clinical', 'hold', 'Finch', 'Therapeutics', 'Group', 'Inc', 'NASDAQ', 'NASDAQ', 'investigational', 'new', 'drug', 'application', 'orally', 'administered', 'microbiome', 'therapeutic', 'Phase', 'study', 'recurrent', 'C', 'difficile', 'infection', 'The', 'FDA', 'lifted', 'clinical', 'hold', 'following', 'review', 'information', 'Finch', 'provided', 'related', 'screening', 'procedures', 'associated', 'informed', 'consent', 'language', 'Shares', 'trading', 'higher', 'premarket', 'session', 'Aldeyra', 'CFO', 'Transition', 'Aldeyra', 'Therapeutics', 'Inc', 'NASDAQ', 'ALDX', 'CFO', 'Treasurer', 'Joshua', 'Reed', 'tendered', 'resignation', 'pursue', 'career', 'opportunities', 'He', 'continue', 'serve', 'current', 'role', 'May', 'Effective', 'Resignation', 'Date', 'Aldeyra', 'plans', 'appoint', 'current', 'Vice', 'President', 'Controller', 'Bruce', 'Greenberg', 'serve', 'Vice', 'President', 'Finance', 'Interim', 'CFO', 'Treasurer', 'Dosing', 'In', 'Monalizumab', 'Lung', 'Cancer', 'Trial', 'Triggers', 'Payment', 'From', 'AstraZeneca', 'NASDAQ', 'To', 'Innate', 'Pharma', 'Innate', 'Pharma', 'SA', 'NASDAQ', 'IPHA', 'announced', 'AstraZeneca', 'Plc', 'NASDAQ', 'AZN', 'started', 'dosing', 'Phase', 'trial', 'evaluating', 'durvalumab', 'combined', 'monalizumab', 'AstraZeneca', 'oleclumab', 'nonsmall', 'cell', 'lung', 'cancer', 'Insider', 'Trading', 'Vaxxinity', 'Inc', 'NASDAQ', 'VAXX', 'Executive', 'chairman', 'Lou', 'Reese', 'purchased', 'shares', 'Offering', 'Abeona', 'Therapeutics', 'Inc', 'NASDAQ', 'ABEO', 'announced', 'private', 'placement', 'convertible', 'redeemable', 'preferred', 'stock', 'million', 'including', 'million', 'shares', 'Series', 'A', 'convertible', 'redeemable', 'preferred', 'stock', 'shares', 'Series', 'B', 'convertible', 'redeemable', 'preferred', 'stock', 'Each', 'share', 'Series', 'A', 'Series', 'B', 'preferred', 'stock', 'purchase', 'price', 'Each', 'share', 'Series', 'A', 'Series', 'B', 'preferred', 'stock', 'convertible', 'initial', 'conversion', 'price', 'cents', 'per', 'share', 'On', 'The', 'Radar', 'Data', 'Presentation', 'ProQR', 'Therapeutics', 'NV', 'NASDAQ', 'PRQR', 'Several', 'presentations', 'Retinal', 'Cell', 'Gene', 'Therapy', 'Innovation', 'Summit', 'PDUFA', 'Dates', 'The', 'FDA', 'scheduled', 'decide', 'expanded', 'use', 'Supernus', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'SUPN', 'Qelbree', 'viloxazine', 'extendedrelease', 'capsules', 'attentiondeficit', 'hyperactivity', 'disorder', 'ADHD', 'adult', 'patients', 'IPOs', 'Belite', 'Bio', 'Inc', 'NASDAQ', 'BLTE', 'Hillevax', 'Inc', 'NASDAQ', 'HLVX', 'Earnings', 'BristolMyers', 'Squibb', 'Co', 'NYSE', 'NYSE', 'Before', 'Market', 'Open', 'AstraZeneca', 'plc', 'NASDAQ', 'AZN', 'Before', 'Market', 'Open', 'AbbVie', 'Inc', 'NYSE', 'NYSE', 'Before', 'Market', 'Open', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'NASDAQ', 'reported', 'EPS', 'better', 'analyst', 'estimate', 'Revenue', 'quarter', 'came', 'billion', 'versus', 'consensus', 'estimate', 'billion', 'For', 'earnings', 'history', 'earningsrelated', 'data', 'AstraZeneca', 'AZN', 'click', 'By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'Wisniewski', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CHNA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Natalie', 'Grover', 'Pushkala', 'Aripaka', 'Reuters', 'AstraZeneca', 'vaccine', 'still', 'role', 'play', 'fight', 'pandemic', 'even', 'sales', 'slow', 'company', 'charges', 'places', 'CEO', 'Pascal', 'Soriot', 'said', 'Friday', 'latest', 'drugmaker', 'warn', 'global', 'supply', 'glut', 'The', 'comments', 'come', 'company', 'reported', 'betterthanexpected', 'firstquarter', 'profit', 'sales', 'driven', 'vaccine', 'second', 'bestseller', 'last', 'year', 'raking', 'billion', 'It', 'also', 'confirmed', 'forecast', 'sales', 'shot', 'would', 'fall', 'The', 'vaccine', 'branded', 'Vaxzevria', 'Covishield', 'struggled', 'compete', 'rivals', 'made', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'using', 'mRNA', 'technology', 'hit', 'setbacks', 'production', 'rare', 'sideeffects', 'relatively', 'limited', 'shelf', 'life', 'Approval', 'United', 'States', 'delayed', 'Soriot', 'said', 'shot', 'seen', 'early', 'pandemic', 'inoculation', 'choice', 'lowincome', 'countries', 'remain', 'relevant', 'easy', 'administer', 'distribute', 'Volume', 'ease', 'though', 'people', 'probably', 'need', 'one', 'booster', 'We', 'longer', 'period', 'scarcity', 'vaccine', 'supply', 'oversupply', 'everywhere', 'around', 'world', 'So', 'needs', 'used', 'course', 'able', 'get', 'better', 'sense', 'reordering', 'said', 'media', 'call', 'Rival', 'Johnson', 'Johnson', 'NYSE', 'month', 'pulled', 'sales', 'forecast', 'vaccine', 'blaming', 'oversupply', 'hesitancy', 'developing', 'countries', 'So', 'far', 'billion', 'shots', 'AstraZeneca', 'NASDAQ', 'vaccine', 'delivered', 'globally', 'In', 'first', 'quarter', 'company', 'recorded', 'billion', 'sales', 'product', 'majority', 'came', 'initial', 'contracts', 'number', 'eclipsed', 'analysts', 'consensus', 'forecast', 'million', 'cited', 'Credit', 'Suisse', 'SIX', 'AstraZeneca', 'shares', 'early', 'afternoon', 'trading', 'underperfoming', 'London', 'bluechip', 'index', 'The', 'company', 'started', 'earning', 'modest', 'profit', 'vaccine', 'initially', 'sold', 'atcost', 'continue', 'selling', 'lowincome', 'countries', 'nonprofit', 'basis', 'Apart', 'vaccine', 'AstraZeneca', 'also', 'treatment', 'Evusheld', 'authorised', 'many', 'regions', 'including', 'United', 'States', 'United', 'Kingdom', 'European', 'Union', 'preventing', 'infections', 'people', 'whose', 'immune', 'system', 'weak', 'respond', 'vaccines', 'The', 'drug', 'generated', 'million', 'firstquarter', 'revenue', 'consensus', 'forecast', 'million', 'cited', 'Credit', 'Suisse', 'Access', 'drug', 'United', 'States', 'limited', 'logistical', 'bottlenecks', 'addressed', 'Soriot', 'said', 'adding', 'Britain', 'one', 'developed', 'countries', 'ordered', 'Evusheld', 'It', 'sad', 'situation', 'quite', 'frankly', 'people', 'immunocompromised', 'really', 'suffering', 'COVID', 'crisis', 'CANCER', 'AstraZeneca', 'unveiled', 'plans', 'open', 'RD', 'centre', 'Cambridge', 'Massachusetts', 'designed', 'serve', 'new', 'headquarters', 'rare', 'disease', 'unit', 'Alexion', 'NASDAQ', 'bought', 'last', 'summer', 'relies', 'cancer', 'drugs', 'third', 'total', 'product', 'sales', 'Even', 'though', 'levels', 'beginning', 'wane', 'access', 'cancer', 'diagnoses', 'treatment', 'still', 'rebounded', 'prepandemic', 'levels', 'Things', 'normalise', 'next', 'months', 'Soriot', 'predicted', 'Meanwhile', 'company', 'pared', 'back', 'expectations', 'China', 'accounted', 'total', 'revenue', 'last', 'year', 'The', 'AngloSwedish', 'drugmaker', 'said', 'expected', 'sales', 'decline', 'midsingledigit', 'percentage', 'largely', 'due', 'impact', 'programme', 'designed', 'bring', 'prices', 'offpatent', 'drugs', 'country', 'The', 'future', 'China', 'believe', 'still', 'strong', 'expect', 'return', 'growth', 'next', 'couple', 'years', 'Soriot', 'said', 'cautioning', 'lockdowns', 'China', 'year', 'could', 'hurt', 'uptake', 'cancer', 'drugs'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'WisniewskiFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Natalie', 'Grover', 'LONDON', 'Reuters', 'AstraZeneca', 'NASDAQ', 'Daiichi', 'Sankyo', 'Enhertu', 'extended', 'survival', 'six', 'months', 'patients', 'form', 'advanced', 'breast', 'cancer', 'compared', 'standard', 'chemotherapy', 'according', 'data', 'presented', 'Sunday', 'The', 'data', 'unveiled', 'American', 'Society', 'Clinical', 'Oncology', 'ASCO', 'meeting', 'Chicago', 'could', 'open', 'large', 'new', 'multibilliondollar', 'patient', 'population', 'drug', 'US', 'approval', 'late', 'thirdline', 'treatment', 'breast', 'cancer', 'patients', 'disease', 'The', 'ongoing', 'phase', 'III', 'trial', 'involves', 'patients', 'socalled', 'breast', 'cancer', 'tumours', 'hormonesensitive', 'whose', 'disease', 'spread', 'undergone', 'least', 'one', 'round', 'chemotherapy', 'The', 'interim', 'analysis', 'showed', 'Enhertu', 'prolonged', 'survival', 'additional', 'months', 'patients', 'hormonesensitive', 'tumours', 'Patients', 'group', 'lived', 'median', 'months', 'versus', 'months', 'chemotherapy', 'In', 'small', 'group', 'patients', 'hormoneinsensitive', 'tumours', 'patients', 'Enhertu', 'lived', 'months', 'longer', 'That', 'benefit', 'overall', 'survival', 'apparent', 'even', 'point', 'interim', 'analysis', 'surprising', 'David', 'Fredrickson', 'executive', 'vice', 'president', 'AstraZeneca', 'oncology', 'unit', 'told', 'Reuters', 'That', 'really', 'puts', 'lot', 'confidence', 'benefit', 'seeing', 'absolutely', 'real', 'A', 'host', 'targeted', 'therapies', 'greatly', 'improved', 'prognosis', 'patients', 'advanced', 'breast', 'cancer', 'But', 'half', 'women', 'whose', 'breast', 'cancer', 'spread', 'organs', 'express', 'little', 'referred', 'status', 'limited', 'treatment', 'options', 'Hormonesensitive', 'patients', 'received', 'Enhertu', 'also', 'went', 'average', 'months', 'disease', 'began', 'worsen', 'measure', 'known', 'progression', 'free', 'survival', 'PFS', 'compared', 'months', 'chemotherapy', 'statistically', 'significant', 'Enhertu', 'doubled', 'PFS', 'hormoneinsensitive', 'patients', 'months', 'versus', 'months', 'chemotherapy', 'AstraZeneca', 'discussions', 'regulators', 'globally', 'approval', 'population', 'Jefferies', 'analysts', 'last', 'month', 'forecast', 'billion', 'annual', 'global', 'peak', 'Enhertu', 'sales', 'patients', 'billion', 'across', 'indications', 'The', 'drug', 'administered', 'intravenous', 'infusion', 'without', 'safety', 'concerns', 'It', 'linked', 'type', 'lung', 'scarring', 'called', 'interstitial', 'lung', 'disease', 'ILD', 'Fortyfive', 'Enhertu', 'patients', 'trial', 'varying', 'degrees', 'ILD', 'versus', 'one', 'chemotherapy', 'group', 'Enhertu', 'belongs', 'class', 'therapies', 'called', 'antibody', 'drug', 'conjugates', 'ADC', 'engineered', 'antibodies', 'bind', 'tumour', 'cells', 'release', 'cellkilling', 'chemicals', 'Last', 'month', 'gained', 'approval', 'secondline', 'treatment', 'option', 'study', 'showed', 'reduced', 'risk', 'disease', 'progression', 'death', 'compared', 'Roche', 'Kadcyla', 'standard', 'treatment', 'Enhertu', 'evaluated', 'use', 'earlier', 'stages', 'breast', 'cancer', 'well', 'lung', 'colorectal', 'cancers', 'among', 'others', 'It', 'secured', 'approval', 'gastric', 'cancer', 'As', 'far', 'breast', 'cancer', 'goes', 'I', 'say', 'least', 'next', 'years', 'I', 'pretty', 'sure', 'Enhertu', 'going', 'kind', 'finish', 'revolutionising', 'treatment', 'paradigm', 'Tara', 'Hansen', 'consultant', 'Informa', 'Pharma', 'Custom', 'Intelligence', 'told', 'Reuters', 'Enhertu', 'sales', 'million', 'AstraZeneca', 'secured', 'partial', 'rights', 'Daiichi', 'Sankyo', 'compound', 'three', 'years', 'ago', 'deal', 'worth', 'billion'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'NYSE', 'New', 'York', 'US', 'April', 'REUTERSBrendan', 'McDermid', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Reuters', 'Britain', 'medicines', 'regulator', 'approved', 'AstraZeneca', 'NASDAQ', 'antibodybased', 'treatment', 'preventing', 'infections', 'adults', 'poor', 'immune', 'response', 'marking', 'major', 'step', 'fight', 'pandemic', 'infections', 'surge', 'globally', 'The', 'decision', 'grant', 'approval', 'treatment', 'Evusheld', 'endorsed', 'government', 'independent', 'scientific', 'advisory', 'body', 'Britain', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'MHRA', 'said', 'Thursday', 'Figures', 'showing', 'global', 'rise', 'cases', 'could', 'herald', 'much', 'bigger', 'problem', 'World', 'Health', 'Organization', 'said', 'week', 'warning', 'nations', 'remain', 'vigilant', 'Although', 'Britons', 'age', 'vaccinated', 'two', 'doses', 'immune', 'compromised', 'individuals', 'history', 'severe', 'adverse', 'reactions', 'vaccine', 'may', 'need', 'alternative', 'prevention', 'option', 'While', 'vaccines', 'continue', 'firstline', 'defence', 'know', 'people', 'may', 'respond', 'adequately', 'vaccines', 'MHRA', 'chief', 'June', 'Raine', 'said', 'Vaccines', 'rely', 'intact', 'immune', 'system', 'develop', 'targeted', 'antibodies', 'infectionfighting', 'cells', 'Evusheld', 'contains', 'labmade', 'antibodies', 'designed', 'linger', 'body', 'months', 'contain', 'virus', 'case', 'infection', 'The', 'therapy', 'found', 'cut', 'risk', 'developing', 'symptomatic', 'trials', 'protection', 'lasting', 'least', 'six', 'months', 'single', 'dose', 'MHRA', 'said', 'Evusheld', 'also', 'shown', 'save', 'lives', 'prevent', 'disease', 'progression', 'given', 'within', 'week', 'first', 'symptoms', 'Britain', 'AstraZeneca', 'currently', 'agreement', 'supply', 'Evusheld', 'AstraZeneca', 'statement', 'said', 'hopes', 'see', 'therapy', 'made', 'available', 'Britons', 'quickly', 'possible', 'Evusheld', 'European', 'review', 'authorised', 'United', 'States', 'prevent', 'infections', 'individuals', 'weak', 'immune', 'systems', 'history', 'severe', 'side', 'effects', 'coronavirus', 'vaccines', 'The', 'MHRA', 'said', 'treatment', 'given', 'intramuscular', 'shot', 'administered', 'people', 'infected', 'COVIDcausing', 'virus', 'recent', 'exposure', 'someone', 'virus', 'However', 'regulator', 'cautioned', 'insufficient', 'data', 'evaluate', 'fully', 'Evusheld', 'effectiveness', 'highly', 'contagious', 'Omicron', 'variant', 'adding', 'liaising', 'AstraZeneca', 'AstraZeneca', 'December', 'said', 'lab', 'study', 'found', 'treatment', 'retained', 'neutralising', 'activity', 'Omicron', 'Eli', 'Lilly', 'NYSE', 'Regeneron', 'GSK', 'drugmakers', 'working', 'antibodybased', 'therapies', 'Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'company', 'logo', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'Britain', 'May', 'REUTERSPhil', 'Noble', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Natalie', 'Grover', 'LONDON', 'Reuters', 'AstraZeneca', 'NASDAQ', 'moved', 'bolster', 'portfolio', 'antibodies', 'Tuesday', 'million', 'licensing', 'deal', 'experimental', 'therapies', 'developed', 'newlylaunched', 'biotech', 'RQ', 'Bio', 'In', 'addition', 'initial', 'sum', 'AngloSwedish', 'drugmaker', 'faces', 'possible', 'royalty', 'payments', 'part', 'exclusive', 'licence', 'develop', 'preclinical', 'COVID', 'antibodies', 'engineered', 'RQ', 'Bio', 'startup', 'said', 'AstraZeneca', 'announced', 'deal', 'size', 'The', 'antibodies', 'include', 'designed', 'target', 'people', 'compromised', 'immune', 'systems', 'AstraZeneca', 'antibody', 'cocktail', 'Evusheld', 'already', 'approved', 'multiple', 'countries', 'The', 'deal', 'gives', 'AstraZeneca', 'rights', 'develop', 'sell', 'six', 'antibodies', 'none', 'tested', 'humans', 'far', 'RQ', 'Bio', 'CEO', 'Hugo', 'Fry', 'said', 'interview', 'Reuters', 'In', 'lab', 'studies', 'antibodies', 'shown', 'work', 'known', 'variants', 'including', 'Omicron', 'said', 'Access', 'fresh', 'crop', 'COVID', 'antibodies', 'bolster', 'AstraZeneca', 'COVID', 'portfolio', 'expecting', 'see', 'rapid', 'decline', 'COVID', 'vaccine', 'sales', 'The', 'AngloSwedish', 'drugmaker', 'vaccine', 'second', 'bestseller', 'last', 'year', 'struggled', 'compete', 'rivals', 'made', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'hit', 'setbacks', 'production', 'rare', 'sideeffects', 'relatively', 'limited', 'shelf', 'life', 'AstraZeneca', 'Evusheld', 'designed', 'prevent', 'symptomatic', 'COVID', 'infections', 'people', 'unable', 'derive', 'maximum', 'benefit', 'vaccines', 'expected', 'partially', 'offset', 'waning', 'vaccine', 'sales', 'It', 'possible', 'manufacture', 'antibodies', 'proteins', 'latch', 'thwart', 'body', 'assailants', 'foreign', 'viruses', 'bacteria', 'domestic', 'like', 'cancer', 'cells', 'time', 'Their', 'use', 'however', 'limited', 'relatively', 'niche', 'conditions', 'patients', 'certain', 'cancers', 'Fry', 'said', 'More', 'recently', 'particularly', 'COVID', 'crisis', 'unfolded', 'scientific', 'understanding', 'antibodies', 'ability', 'make', 'cheaply', 'consistently', 'increased', 'We', 'tipping', 'point', 'nowwhere', 'use', 'lot', 'broadly', 'said', 'Fry', 'RQ', 'Bio', 'hoping', 'capitalise', 'opportunity', 'scientists', 'anticipate', 'recurrent', 'antiCOVID', 'shots', 'Founded', 'scientists', 'formerly', 'Britain', 'COVID', 'antibody', 'taskforce', 'company', 'launched', 'Tuesday', 'funding', 'AstraZeneca', 'deal', 'It', 'aims', 'make', 'antibodies', 'vulnerable', 'people', 'risk', 'severe', 'disease', 'death', 'range', 'viral', 'infections'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labelled', 'Coronavirus', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'taken', 'October', 'REUTERSDado', 'Ruvic', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Natalie', 'Grover', 'LONDON', 'Reuters', 'The', 'European', 'health', 'regulator', 'Thursday', 'endorsed', 'use', 'AstraZeneca', 'NASDAQ', 'COVID', 'vaccine', 'Vaxzevria', 'booster', 'The', 'recommendation', 'made', 'committee', 'European', 'Medicines', 'Agency', 'EMA', 'encompasses', 'adults', 'either', 'previously', 'vaccinated', 'Vaxzevria', 'mRNA', 'vaccine', 'ones', 'made', 'Pfizer', 'NYSE', 'BioNTech', 'Moderna', 'NASDAQ', 'The', 'recommendation', 'comes', 'weeks', 'EMA', 'backed', 'use', 'PfizerBioNTech', 'Comirnaty', 'booster', 'adults', 'previously', 'inoculated', 'vaccines', 'Vaccine', 'makers', 'including', 'Pfizer', 'Moderna', 'indicated', 'vaccinations', 'year', 'booster', 'shots', 'first', 'inoculations', 'children', 'still', 'gaining', 'regulatory', 'approvals', 'around', 'world', 'It', 'unclear', 'many', 'boosters', 'needed', 'globally', 'many', 'developed', 'countries', 'already', 'begun', 'roll', 'In', 'countries', 'even', 'second', 'booster', 'campaigns', 'highrisk', 'groups', 'begun', 'Meanwhile', 'vaccine', 'makers', 'also', 'developing', 'variantspecific', 'vaccines', 'Earlier', 'month', 'EMA', 'said', 'hoped', 'vaccines', 'adapted', 'address', 'coronavirus', 'variants', 'Omicron', 'approved', 'September', 'Although', 'Vaxzevria', 'AstraZeneca', 'second', 'best', 'seller', 'last', 'year', 'struggled', 'compete', 'mRNA', 'rivals', 'In', 'late', 'April', 'AstraZeneca', 'CEO', 'Pascal', 'Soriot', 'asserted', 'shot', 'still', 'role', 'fighting', 'pandemic', 'We', 'believe', 'vaccine', 'still', 'potential', 'easy', 'administer', 'distribute', 'said', 'The', 'volume', 'future', 'less', 'people', 'probably', 'need', 'one', 'booster', 'per', 'year', 'everybody', 'take', 'About', 'half', 'EU', 'citizens', 'fully', 'vaccinated', 'boosted', 'received', 'even', 'one', 'vaccine', 'shot', 'said', 'Marco', 'Cavaleri', 'EMA', 'head', 'biological', 'health', 'threats', 'vaccines', 'strategy', 'May'], ['By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'NYSE', 'New', 'York', 'US', 'April', 'REUTERSBrendan', 'McDermid', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Drugmaker', 'AstraZeneca', 'NASDAQ', 'said', 'Monday', 'vaccine', 'Vaxzevria', 'approved', 'European', 'Union', 'bloc', 'drugs', 'regulator', 'thirddose', 'booster', 'adults', 'following', 'committee', 'endorsement', 'last', 'week', 'The', 'vaccine', 'used', 'booster', 'following', 'twodose', 'Vaxzevria', 'schedule', 'previously', 'vaccinated', 'mRNA', 'vaccine', 'ones', 'made', 'Pfizer', 'NYSE', 'BioNTech', 'Moderna', 'NASDAQ', 'Ensuring', 'longer', 'duration', 'immune', 'protection', 'essential', 'longterm', 'management', 'globally', 'boosters', 'address', 'waning', 'protection', 'time', 'seen', 'primary', 'vaccine', 'schedules', 'date', 'Mene', 'Pangalos', 'executive', 'vice', 'president', 'biopharmaceuticals', 'RD', 'AstraZeneca', 'said', 'A', 'committee', 'European', 'Medicines', 'Agency', 'endorsed', 'Vaxzevria', 'booster', 'last', 'Thursday', 'weeks', 'regulator', 'backed', 'use', 'PfizerBioNTech', 'Comirnaty', 'booster', 'adults', 'previously', 'inoculated', 'vaccines', 'Several', 'vaccine', 'makers', 'indicated', 'vaccinations', 'year', 'booster', 'shots', 'first', 'inoculations', 'children', 'still', 'gaining', 'regulatory', 'approvals', 'globally', 'Typically', 'final', 'say', 'products', 'use', 'European', 'Union', 'decided', 'European', 'Commission'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'Wisniewski', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Divya', 'Chowdhury', 'Lisa', 'Pauline', 'Mattackal', 'DAVOS', 'Switzerland', 'Reuters', 'Although', 'cancer', 'screening', 'diagnosis', 'hit', 'coronavirus', 'pandemic', 'resulting', 'advances', 'medical', 'technology', 'greater', 'diversity', 'clinical', 'trials', 'could', 'help', 'treatments', 'future', 'AstraZeneca', 'NASDAQ', 'executive', 'said', 'Testing', 'diagnosis', 'rates', 'cancer', 'dropped', 'past', 'two', 'years', 'people', 'skipped', 'routine', 'checkups', 'Dave', 'Fredrickson', 'executive', 'vice', 'president', 'oncology', 'AstraZeneca', 'told', 'Reuters', 'Global', 'Markets', 'Forum', 'Davos', 'What', 'means', 'diagnosing', 'cancer', 'patients', 'late', 'Fredrickson', 'said', 'week', 'cancer', 'outcomes', 'best', 'diagnosed', 'early', 'Efforts', 'minimise', 'patients', 'go', 'healthcare', 'facilities', 'wider', 'adoption', 'telemedicine', 'bringing', 'trials', 'patients', 'rather', 'patients', 'come', 'trials', 'particularly', 'important', 'Fredrickson', 'said', 'Clinical', 'trial', 'diversity', 'one', 'important', 'steps', 'deliver', 'cancer', 'therapies', 'equitable', 'way', 'across', 'globe', 'said', 'Fredrickson', 'said', 'optimistic', 'detection', 'treatment', 'lung', 'breast', 'cancer', 'new', 'drugs', 'treatment', 'plans', 'improved', 'survival', 'rates', 'certain', 'settings', 'Publicprivate', 'partnerships', 'important', 'improving', 'cancer', 'diagnosis', 'survival', 'rates', 'said', 'pointing', 'Egypt', 'strategy', 'tackle', 'prevalent', 'cancers', 'US', 'President', 'Joe', 'Biden', 'revival', 'Cancer', 'Moonshot', 'initiative', 'The', 'programme', 'Obama', 'administration', 'initiative', 'revived', 'Biden', 'February', 'aims', 'improve', 'cancer', 'detection', 'prevention', 'encouraging', 'cancer', 'research', 'This', 'interview', 'conducted', 'Reuters', 'Global', 'Markets', 'Forum', 'Join', 'GMF', 'Refinitiv', 'Messenger'], ['By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter'], ['Â', 'Reuters', 'The', 'Daily', 'Biotech', 'Pulse', 'Thumbs', 'Down', 'For', 'Acadia', 'Pimavanserin', 'Pfizer', 'Buys', 'Stake', 'In', 'Valneva', 'AstraZeneca', 'Ionis', 'Eplontersen', 'Aces', 'Rare', 'Disease', 'Trial', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'VLS', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Here', 'roundup', 'top', 'developments', 'biotech', 'space', 'last', 'hours', 'Stocks', 'In', 'Focus', 'FDA', 'AdComm', 'Gives', 'Thumbs', 'Down', 'To', 'Acadia', 'Pimavanserin', 'A', 'panel', 'FDA', 'outside', 'experts', 'voted', 'Acadia', 'Pharmaceuticals', 'Inc', 'ACAD', 'pimavanserin', 'appear', 'effective', 'treating', 'patients', 'psychosis', 'The', 'drug', 'Nuplazid', 'already', 'indicated', 'psychosis', 'Acadia', 'tried', 'failed', 'last', 'year', 'get', 'another', 'FDA', 'approval', 'Alzheimer', 'psychosis', 'Shares', 'premarket', 'session', 'AstraZeneca', 'NASDAQ', 'Ionis', 'Eplontersen', 'Achieves', 'Positive', 'Data', 'In', 'Rare', 'Disease', 'Trial', 'AstraZeneca', 'plc', 'NASDAQ', 'AZN', 'partner', 'Ionis', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'IONS', 'announced', 'positive', 'interim', 'analysis', 'eplontersen', 'hereditary', 'transthyretinmediated', 'amyloid', 'polyneuropathy', 'ATTRvPN', 'In', 'Phase', 'NEUROTTRansform', 'study', 'eplontersen', 'met', 'main', 'goals', 'Eplontersen', 'also', 'showed', 'significantly', 'improved', 'patientreported', 'quality', 'life', 'versus', 'historical', 'placebo', 'group', 'Pharma', 'Giant', 'Pfizer', 'Buys', 'Stake', 'In', 'Valneva', 'Pfizer', 'Inc', 'NYSE', 'NYSE', 'invest', 'million', 'million', 'stake', 'Valneva', 'SE', 'NASDAQ', 'VALN', 'companies', 'updated', 'terms', 'agreement', 'Lyme', 'disease', 'vaccine', 'candidate', 'Under', 'revised', 'deal', 'Valneva', 'fund', 'remaining', 'shared', 'development', 'costs', 'compared', 'Pfizer', 'pay', 'Valneva', 'tiered', 'royalties', 'ranging', 'In', 'addition', 'royalties', 'complemented', 'million', 'milestones', 'payable', 'Valneva', 'based', 'cumulative', 'sales', 'VALN', 'shares', 'premarket', 'session', 'Recursion', 'Pharma', 'Starts', 'LateStage', 'Brain', 'Cancer', 'Trial', 'Of', 'Recursion', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'RXRX', 'initiated', 'Phase', 'trial', 'progressive', 'neurofibromatosis', 'type', 'meningiomas', 'tumors', 'form', 'membrane', 'covers', 'brain', 'spinal', 'cord', 'The', 'trial', 'designed', 'investigate', 'safety', 'efficacy', 'pharmacokinetics', 'The', 'study', 'expected', 'enroll', 'approximately', 'participants', 'Hepion', 'Pharma', 'Liver', 'Cancer', 'Candidate', 'Secures', 'Orphan', 'Drug', 'Tag', 'The', 'FDA', 'granted', 'Orphan', 'Drug', 'Designation', 'Hepion', 'Pharmaceuticals', 'Inc', 'NASDAQ', 'HEPA', 'rencofilstat', 'livertargeting', 'orallyadministered', 'novel', 'cyclophilin', 'inhibitor', 'hepatocellular', 'carcinoma', 'In', 'addition', 'two', 'Phase', 'studies', 'patients', 'NASH', 'remain', 'track', 'initiate', 'patient', 'enrollment', 'Phase', 'study', 'rencofilstat', 'HCC', 'third', 'quarter', 'said', 'Robert', 'Foster', 'Hepion', 'CEO', 'Iktos', 'Zealand', 'Pharma', 'Ink', 'AI', 'Technology', 'Pact', 'For', 'Peptide', 'Drug', 'Design', 'Iktos', 'specialized', 'Artificial', 'Intelligence', 'company', 'new', 'drug', 'design', 'announced', 'research', 'collaboration', 'Zealand', 'Pharma', 'AS', 'NASDAQ', 'ZEAL', 'codevelop', 'generative', 'predictive', 'AI', 'technologies', 'peptide', 'drug', 'design', 'Iktos', 'AI', 'technology', 'based', 'comprehensive', 'datadriven', 'chemical', 'structure', 'generation', 'technology', 'automatically', 'designs', 'virtual', 'novel', 'molecules', 'characteristics', 'successful', 'drug', 'molecule', 'XBiotech', 'Concludes', 'Phase', 'Portion', 'Pancreatic', 'Cancer', 'Study', 'XBiotech', 'Inc', 'NASDAQ', 'XBIT', 'completed', 'Phase', 'portion', 'study', 'Phase', 'evaluate', 'anticancer', 'drug', 'Natrunix', 'combination', 'chemotherapy', 'pancreatic', 'cancer', 'Enrollment', 'Phase', 'portion', 'commencing', 'immediately', 'Key', 'endpoints', 'Phase', 'portion', 'progressionfree', 'survival', 'overall', 'survival', 'timetotreatmentfailure', 'The', 'Phase', 'portion', 'enrolling', 'subjects', 'Midatech', 'Pharma', 'Pediatric', 'Brain', 'Cancer', 'Candidate', 'Gets', 'Orphan', 'Drug', 'Status', 'In', 'Europe', 'The', 'European', 'Medicines', 'Agency', 'granted', 'orphan', 'drug', 'designation', 'Midatech', 'Pharma', 'PLC', 'NASDAQ', 'MTP', 'glioma', 'Midatech', 'developing', 'recurrent', 'glioblastoma', 'adult', 'patients', 'diffuse', 'intrinsic', 'pontine', 'glioma', 'medulloblastoma', 'pediatric', 'patients', 'Edgewise', 'Dystrophy', 'Candidate', 'Lowers', 'Muscle', 'Damage', 'Biomarkers', 'Edgewise', 'Therapeutics', 'Inc', 'NASDAQ', 'EWTX', 'announced', 'interim', 'results', 'ARCH', 'study', 'adults', 'Becker', 'Muscular', 'Dystrophy', 'mg', 'showed', 'significant', 'decrease', 'key', 'biomarkers', 'muscle', 'damage', 'Notably', 'creatine', 'kinase', 'fast', 'skeletal', 'muscle', 'troponin', 'I', 'reduced', 'average', 'respectively', 'All', 'patients', 'subsequently', 'doseescalated', 'mg', 'daily', 'per', 'protocol', 'Clinical', 'ReadoutsPresentations', 'Krystal', 'Biotech', 'Inc', 'NASDAQ', 'KRYS', 'Phase', 'safety', 'immunogenicity', 'results', 'beremagene', 'geperpavec', 'BVEC', 'topical', 'gene', 'therapy', 'dystrophic', 'epidermolysis', 'bullosa', 'Society', 'Investigative', 'Dermatology', 'Annual', 'Meeting', 'Aura', 'Biosciences', 'Inc', 'NASDAQ', 'AURA', 'Final', 'safety', 'efficacy', 'data', 'phase', 'trial', 'choroidal', 'melanoma', 'via', 'intravitreal', 'administration', 'International', 'Society', 'Ocular', 'Oncology', 'On', 'The', 'Radar', 'Earnings', 'Acasti', 'Pharma', 'Inc', 'NASDAQ', 'ACST', 'Before', 'market', 'open', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga'], ['Â', 'Reuters', 'Short', 'Volatility', 'Alert', 'AstraZeneca', 'PLC', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'On', 'Tuesday', 'shares', 'AstraZeneca', 'PLC', 'NASDAQ', 'experienced', 'volatile', 'short', 'activity', 'After', 'activity', 'stock', 'price', 'went', 'The', 'overall', 'sentiment', 'AZN', 'Bullish', 'The', 'signal', 'volatility', 'alert', 'trending', 'Bullish', 'Therefore', 'recommendation', 'Strong', 'Buy', 'The', 'volatility', 'alert', 'produced', 'prior', 'trading', 'date', 'volatility', 'change', 'The', 'current', 'volatility', 'indicator', 'stands', 'Overview', 'The', 'securities', 'lending', 'volatility', 'indicator', 'produced', 'Tidal', 'Markets', 'partnership', 'Benzinga', 'Insights', 'Securities', 'lending', 'primarily', 'serves', 'purpose', 'providing', 'liquidity', 'short', 'sellers', 'When', 'unusual', 'activity', 'occurs', 'securities', 'lending', 'markets', 'acts', 'upstream', 'indicator', 'likely', 'occur', 'downstream', 'regular', 'stock', 'market', 'Understanding', 'Volatility', 'Alert', 'Overall', 'sentiment', 'considered', 'bear', 'broad', 'market', 'activity', 'stock', 'shown', 'indicate', 'negative', 'directional', 'basis', 'considered', 'bull', 'indicating', 'positive', 'directional', 'basis', 'The', 'securities', 'lending', 'volatility', 'indicator', 'provides', 'signal', 'detects', 'unusual', 'short', 'activity', 'Unusual', 'short', 'activity', 'based', 'computer', 'generated', 'algorithmic', 'formula', 'utilizing', 'securities', 'lending', 'trade', 'details', 'volume', 'shares', 'shorted', 'rate', 'paid', 'short', 'shares', 'type', 'collateral', 'posted', 'amongst', 'variables', 'The', 'current', 'volatility', 'respective', 'trading', 'day', 'calculated', 'securities', 'lending', 'volatility', 'value', 'The', 'volatility', 'percentage', 'change', 'percentage', 'difference', 'volatility', 'two', 'recent', 'days', 'The', 'recommendation', 'suggestive', 'strategy', 'inferred', 'strength', 'Signal', 'Trending', 'Current', 'Volatility', 'Volatility', 'Change', 'Recommendations', 'may', 'include', 'Strong', 'Buy', 'Strong', 'Sell', 'Increase', 'Short', 'Exposure', 'Decrease', 'Short', 'Exposure', 'Market', 'Neutral', 'ANY', 'INFORMATION', 'CONTAINED', 'HEREIN', 'DOES', 'NOT', 'CONSTITUTE', 'OR', 'IMPLY', 'INVESTMENT', 'ADVICE', 'Â', 'Benzingacom', 'Benzinga', 'provide', 'investment', 'advice', 'All', 'rights', 'reserved', 'Read', 'Benzinga', 'Read', 'original', 'article', 'Benzinga'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'WisniewskiFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'said', 'Monday', 'two', 'existing', 'therapies', 'recommended', 'treating', 'patients', 'forms', 'highrisk', 'breast', 'cancers', 'European', 'Union', 'boost', 'company', 'oncology', 'portfolio', 'Lynparza', 'cancer', 'drug', 'developed', 'jointly', 'USbased', 'Merck', 'backed', 'standalone', 'use', 'combination', 'endocrine', 'therapy', 'adults', 'form', 'genetically', 'mutated', 'earlystage', 'breast', 'cancer', 'The', 'drug', 'received', 'similar', 'recommendation', 'United', 'States', 'March', 'key', 'asset', 'AstraZeneca', 'NASDAQ', 'It', 'recommended', 'patients', 'lowtonormal', 'levels', 'protein', 'known', 'target', 'several', 'new', 'therapies', 'Enhertu', 'developed', 'jointly', 'Japan', 'Daiichi', 'Sankyo', 'drug', 'endorsed', 'European', 'Medicines', 'Agency', 'treating', 'aggressive', 'form', 'breast', 'cancer', 'characterised', 'high', 'rate', 'Enhertu', 'seen', 'major', 'growth', 'driver', 'AstraZeneca', 'analysts', 'expecting', 'peaks', 'sales', 'billion', 'The', 'drug', 'also', 'expected', 'cleared', 'patients', 'low', 'levels', 'month', 'recent', 'success', 'trial'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'WisniewskiFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'NASDAQ', 'said', 'Thursday', 'combination', 'cancer', 'drug', 'Imfinzi', 'chemotherapy', 'showed', 'promise', 'latestage', 'trial', 'patients', 'aggressive', 'form', 'lung', 'cancer', 'given', 'surgery', 'Data', 'showed', 'combination', 'effective', 'removing', 'cancer', 'cells', 'tissue', 'samples', 'taken', 'surgery', 'compared', 'chemotherapy', 'patients', 'nonsmall', 'cell', 'lung', 'cancer', 'AngloSwedish', 'drugmaker', 'said', 'The', 'interim', 'result', 'boost', 'company', 'oncology', 'efforts', 'major', 'area', 'focus', 'following', 'disappointing', 'data', 'Imfinzi', 'earlier', 'year', 'another', 'area', 'therapy', 'AstraZeneca', 'added', 'trial', 'would', 'continue', 'planned', 'assess', 'additional', 'main', 'goal', 'eventfree', 'survival', 'interim', 'data', 'would', 'shared', 'health', 'authorities', 'globally', 'Imfinzi', 'belongs', 'immunotherapy', 'class', 'treatments', 'boost', 'body', 'defences', 'fight', 'cancer', 'using', 'antibodies', 'block', 'bind', 'foreign', 'substances', 'body', 'The', 'treatment', 'generated', 'billion', 'sales', 'Engaging', 'immune', 'response', 'Imfinzi', 'surgery', 'exciting', 'new', 'strategy', 'said', 'Susan', 'Galbraith', 'executive', 'vice', 'president', 'oncology', 'RD', 'AstraZeneca', 'Nonsmall', 'cell', 'lung', 'cancer', 'common', 'form', 'lung', 'cancer', 'accounting', 'estimated', 'million', 'new', 'cases', 'disease', 'diagnosed', 'year', 'worldwide', 'according', 'World', 'Health', 'Organization'], ['Â', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GCC', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'higher', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'lower', 'trading', 'Todayâs', 'calendar', 'highlights', 'include', 'UK', 'Eurozone', 'Eurozone', 'US', 'Canadian', 'Data', 'UK', 'rose', 'December', 'year', 'earlier', 'according', 'Halifax', 'largest', 'annual', 'increase', 'since', 'July', 'Stocks', 'Royal', 'Dutch', 'Shell', 'LON', 'The', 'remaining', 'billion', 'proceeds', 'Permian', 'divestment', 'distributed', 'form', 'share', 'buybacks', 'pace', 'integrated', 'gas', 'production', 'expected', 'thousand', 'barrels', 'oil', 'equivalent', 'per', 'day', 'Upstream', 'production', 'expected', 'thousand', 'barrels', 'oil', 'equivalent', 'per', 'day', 'Oil', 'products', 'marketing', 'results', 'expected', 'line', 'fourth', 'quarter', 'lower', 'compared', 'third', 'quarter', 'due', 'seasonal', 'trends', 'demand', 'impact', 'due', 'Omicron', 'virus', 'foreign', 'exchange', 'impacts', 'Turkey', 'AstraZeneca', 'LON', 'Entered', 'exclusive', 'global', 'collaboration', 'licence', 'agreement', 'Neurimmune', 'AG', 'investigational', 'human', 'monoclonal', 'antibody', 'currently', 'Phase', 'Ib', 'development', 'treatment', 'transthyretin', 'amyloid', 'cardiomyopathy', 'Under', 'agreement', 'AstraZenecaâs', 'Alexion', 'NASDAQ', 'granted', 'exclusive', 'worldwide', 'licence', 'develop', 'manufacture', 'commercialise', 'Aston', 'Martin', 'Lagonda', 'LON', 'FY', 'wholesales', 'grew', 'Aston', 'Martin', 'Valkyrie', 'Valkyrie', 'AMR', 'Pro', 'vehicles', 'shipped', 'This', 'fewer', 'previously', 'planned', 'accordingly', 'adjusted', 'EBITDA', 'anticipated', 'circa', 'million', 'lower', 'expected', 'An', 'associated', 'reduction', 'depreciation', 'amortisation', 'expected', 'result', 'broadly', 'net', 'neutral', 'impact', 'adjusted', 'operating', 'profit', 'Taylor', 'Wimpey', 'LON', 'Elliott', 'Advisors', 'demanding', 'leadership', 'change', 'Taylor', 'Wimpey', 'told', 'shareholders', 'would', 'back', 'Persimmon', 'LON', 'boss', 'Dave', 'Jenkinson', 'take', 'CEO', 'Times', 'Smiths', 'Group', 'LON', 'Completed', 'sale', 'Smiths', 'Medical', 'ICU', 'Medical', 'Smiths', 'intends', 'return', 'amount', 'representing', 'initial', 'cash', 'proceeds', 'equating', 'billion', 'million', 'shareholders', 'form', 'share', 'buyback', 'programme', 'Smiths', 'initiated', 'programme', 'November', 'purchased', 'million', 'shares', 'date', 'total', 'consideration', 'million', 'Essentra', 'LON', 'Strategic', 'reviews', 'Filters', 'Packaging', 'divisions', 'progressing', 'planned', 'following', 'Board', 'decision', 'become', 'pure', 'play', 'Components', 'business', 'revenue', 'increased', 'YoY', 'like', 'like', 'basis', 'Expects', 'deliver', 'FY', 'operating', 'profit', 'range', 'analysts', 'forecasts', 'Clarkson', 'LON', 'Trading', 'December', 'stronger', 'anticipated', 'underlying', 'profit', 'tax', 'subject', 'audit', 'expected', 'less', 'million', 'CC', 'Group', 'LON', 'Trading', 'September', 'November', 'modestly', 'ahead', 'expectations', 'previously', 'stated', 'guidance', 'In', 'December', 'trading', 'conditions', 'ontrade', 'business', 'significantly', 'impacted', 'renewed', 'government', 'restrictions', 'across', 'UK', 'Ireland', 'The', 'operating', 'profit', 'outcome', 'period', 'affected', 'nature', 'extent', 'duration', 'government', 'restrictions', 'In', 'December', 'CC', 'traded', 'directly', 'ontrade', 'outlets', 'vs', 'delivering', 'volume', 'expectation', 'respectively', 'Lookers', 'LON', 'Expects', 'record', 'underlying', 'profit', 'tax', 'ahead', 'company', 'compiled', 'market', 'consensus', 'million', 'Confident', 'Group', 'remains', 'well', 'positioned', 'capitalise', 'opportunities', 'ahead', 'achieve', 'financial', 'expectations'], ['Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'The', 'biggest', 'gainers', 'session', 'Ocado', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'J', 'Sainsbury', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Aviva', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Barratt', 'Developments', 'PLC', 'LON', 'declined', 'points', 'end', 'Abrdn', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'June', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'unchanged', 'EURGBP', 'unchanged', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter'], ['Â', 'Reuters', 'CVX', 'Add', 'toRemove', 'Portfolio', 'LLY', 'Add', 'toRemove', 'Portfolio', 'SBUX', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'XOM', 'Add', 'toRemove', 'Portfolio', 'CVS', 'Add', 'toRemove', 'Portfolio', 'AMD', 'Add', 'toRemove', 'Portfolio', 'PG', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Liz', 'Moyer', 'Investingcom', 'Stocks', 'notched', 'twoday', 'rally', 'investors', 'believe', 'Federal', 'Reserve', 'could', 'slow', 'pace', 'interest', 'rate', 'increases', 'new', 'data', 'showed', 'economy', 'slowed', 'The', 'Fed', 'another', 'points', 'Wednesday', 'stocks', 'rallied', 'anyway', 'especially', 'tech', 'They', 'continued', 'climb', 'Thursday', 'earnings', 'continue', 'pour', 'especially', 'big', 'tech', 'names', 'While', 'news', 'always', 'strong', 'week', 'tech', 'stocks', 'holding', 'On', 'Friday', 'new', 'data', 'inflation', 'form', 'expenditure', 'index', 'come', 'That', 'Fed', 'preferred', 'measure', 'inflation', 'Other', 'data', 'expected', 'show', 'rose', 'June', 'expected', 'rise', 'Earnings', 'continue', 'next', 'week', 'reports', 'AMD', 'NASDAQ', 'Starbucks', 'NASDAQ', 'CVS', 'Health', 'NYSE', 'Eli', 'Lilly', 'NYSE', 'among', 'others', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'Oil', 'earnings', 'Big', 'producers', 'reporting', 'tomorrow', 'Chevron', 'Corp', 'NYSE', 'expected', 'report', 'earnings', 'per', 'share', 'billion', 'revenue', 'Exxon', 'Mobil', 'Corp', 'NYSE', 'expected', 'report', 'EPS', 'revenue', 'billion', 'Procter', 'Gamble', 'earnings', 'Procter', 'Gamble', 'Company', 'NYSE', 'expected', 'report', 'earnings', 'per', 'share', 'revenue', 'billion', 'AstraZeneca', 'earnings', 'AstraZeneca', 'NASDAQ', 'expected', 'report', 'EPS', 'cents', 'revenue', 'billion'], ['AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'NASDAQ', 'reported', 'Friday', 'second', 'quarter', 'beat', 'analysts', 'forecasts', 'revenue', 'topped', 'expectations', 'AstraZeneca', 'announced', 'earnings', 'per', 'share', 'revenue', 'Analysts', 'polled', 'Investingcom', 'anticipated', 'EPS', 'revenue', 'AstraZeneca', 'shares', 'beginning', 'year', 'trading', 'outperforming', 'TR', 'UK', 'start', 'year', 'AstraZeneca', 'follows', 'major', 'Healthcare', 'sector', 'earnings', 'month', 'AstraZeneca', 'report', 'follows', 'earnings', 'beat', 'GSK', 'plc', 'Wednesday', 'reported', 'EPS', 'revenue', 'compared', 'forecasts', 'EPS', 'revenue', 'Renalytix', 'AI', 'missed', 'expectations', 'June', 'fourth', 'quarter', 'EPS', 'revenue', 'compared', 'forecast', 'EPS', 'revenue', 'Stay', 'uptodate', 'upcoming', 'earnings', 'reports', 'visiting', 'Investingcom', 'earnings', 'calendar', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'NASDAQ', 'ADR', 'reported', 'Friday', 'second', 'quarter', 'beat', 'analysts', 'forecasts', 'revenue', 'topped', 'expectations', 'AstraZeneca', 'ADR', 'announced', 'earnings', 'per', 'share', 'revenue', 'Analysts', 'polled', 'Investingcom', 'anticipated', 'EPS', 'revenue', 'AstraZeneca', 'ADR', 'shares', 'beginning', 'year', 'trading', 'outperforming', 'Nasdaq', 'start', 'year', 'AstraZeneca', 'ADR', 'follows', 'major', 'Healthcare', 'sector', 'earnings', 'month', 'AstraZeneca', 'ADR', 'report', 'follows', 'earnings', 'beat', 'UnitedHealth', 'July', 'reported', 'EPS', 'revenue', 'compared', 'forecasts', 'EPS', 'revenue', 'JJ', 'beat', 'expectations', 'July', 'second', 'quarter', 'EPS', 'revenue', 'compared', 'forecast', 'EPS', 'revenue', 'Stay', 'uptodate', 'upcoming', 'earnings', 'reports', 'visiting', 'Investingcom', 'earnings', 'calendar', 'Â', 'Reuters', 'FILE', 'PHOTO', 'Pascal', 'Soriot', 'chief', 'executive', 'pharmaceuticals', 'company', 'AstraZeneca', 'attends', 'interview', 'Reuters', 'Shanghai', 'China', 'November', 'REUTERSBrenda', 'GohFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FRANKFURT', 'Reuters', 'Longserving', 'AstraZeneca', 'NASDAQ', 'boss', 'Pascal', 'Soriot', 'said', 'Friday', 'expects', 'work', 'new', 'chairmandesignate', 'Londonlisted', 'drugmaker', 'take', 'many', 'years', 'come', 'suggesting', 'ready', 'retire', 'The', 'company', 'said', 'Friday', 'Michel', 'Demare', 'take', 'outgoing', 'Chairman', 'Leif', 'Johansson', 'like', 'Soriot', 'leadership', 'position', 'decade', 'Michel', 'I', 'working', 'together', 'forming', 'excellent', 'team', 'many', 'years', 'come', 'Soriot', 'said', 'analyst', 'call', 'company', 'released', 'quarterly', 'results', 'Â', 'Reuters', 'AstraZeneca', 'follows', 'trend', 'sector', 'upgrade', 'guidance', 'Covid', 'vaccines', 'sales', 'show', 'resilience', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'PLC', 'LSENASDAQ', 'followed', 'smaller', 'rival', 'GSK', 'PLC', 'LSEGSK', 'NYSEGSK', 'upgrading', 'guidance', 'full', 'year', 'bumper', 'first', 'half', 'exceeded', 'expectations', 'The', 'key', 'driver', 'outperformance', 'appears', 'sales', 'groupâs', 'Covid', 'vaccine', 'jointly', 'developed', 'University', 'Oxford', 'The', 'drugs', 'giant', 'expected', 'revenues', 'jab', 'decline', 'year', 'reckons', 'flat', 'As', 'result', 'AngloSwedish', 'company', 'reckons', 'top', 'line', 'growth', 'low', 'twenties', 'per', 'cent', 'high', 'teens', 'Core', 'EPS', 'meanwhile', 'grow', 'midtohigh', 'twenties', 'per', 'cent', 'unchanged', 'previous', 'guidance', 'reflects', 'AZâs', 'resolve', 'spend', 'research', 'development', 'first', 'planned', 'Sales', 'six', 'months', 'ended', 'June', 'core', 'per', 'share', 'earnings', 'matching', 'advance', 'While', 'performance', 'vaccines', 'business', 'stood', 'pharma', 'group', 'said', 'oncology', 'franchise', 'also', 'performed', 'strongly', 'âœGiven', 'ongoing', 'performance', 'underlying', 'business', 'contribution', 'medicines', 'updating', 'revenue', 'guidance', 'said', 'chief', 'executive', 'Pascal', 'Soriot', 'âœThis', 'enabled', 'us', 'increase', 'RD', 'investment', 'exciting', 'number', 'pipeline', 'opportunities', 'benefit', 'patients', 'drive', 'longterm', 'sustainable', 'growth', 'companyâ', 'In', 'separate', 'announcement', 'group', 'said', 'former', 'UBS', 'vice', 'chairman', 'current', 'AZ', 'independent', 'director', 'Mark', 'DemarÃ', 'succeed', 'Leif', 'Johansson', 'chairman', 'biggest', 'company', 'Read', 'Proactive', 'Investors', 'UK', 'Disclaimer', 'Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'outside', 'North', 'America', 'headquarters', 'Wilmington', 'Delaware', 'US', 'March', 'REUTERSRachel', 'WisniewskiFile', 'Photo', 'GLOBAL', 'BUSINESS', 'WEEK', 'AHEAD', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Natalie', 'Grover', 'Ludwig', 'Burger', 'Reuters', 'AstraZeneca', 'said', 'expected', 'prescriptions', 'COVID', 'therapy', 'drive', 'sales', 'growth', 'year', 'company', 'reported', 'secondquarter', 'profit', 'topped', 'analyst', 'estimates', 'The', 'injection', 'called', 'Evusheld', 'designed', 'protect', 'COVID', 'infection', 'least', 'six', 'months', 'deployed', 'many', 'countries', 'people', 'compromised', 'immune', 'systems', 'see', 'little', 'benefit', 'vaccines', 'The', 'longacting', 'antibody', 'therapy', 'launched', 'December', 'last', 'year', 'generated', 'sales', 'million', 'quarter', 'Realworld', 'evidence', 'shown', 'COVID', 'hospitalisations', 'immunocompromised', 'patients', 'real', 'need', 'Evusheld', 'right', 'finance', 'chief', 'Aradhana', 'Sarin', 'told', 'Reuters', 'The', 'Londonlisted', 'company', 'increased', 'fullyear', 'revenue', 'guidance', 'saying', 'expects', 'rise', 'percentage', 'low', 'twenties', 'rather', 'high', 'teens', 'forecast', 'previously', 'It', 'kept', 'forecast', 'gain', 'adjusted', 'earnings', 'per', 'share', 'midtohigh', 'twenties', 'percentage', 'unchanged', 'partly', 'bigger', 'budget', 'drug', 'research', 'development', 'marketing', 'distribution', 'Evusheld', 'The', 'company', 'also', 'felt', 'impact', 'inflation', 'distribution', 'costs', 'like', 'freight', 'rates', 'CFO', 'Sarin', 'said', 'media', 'briefing', 'Analysts', 'brokerages', 'Jefferies', 'JPMorgan', 'NYSE', 'said', 'investors', 'unlikely', 'impressed', 'earnings', 'outlook', 'shares', 'fell', 'much', 'GMT', 'underperforming', 'STOXX', 'Europe', 'Health', 'Care', 'index', 'slipped', 'Secondquarter', 'adjusted', 'earnings', 'almost', 'doubled', 'cents', 'per', 'share', 'three', 'months', 'ended', 'June', 'revenue', 'billion', 'Analysts', 'average', 'expected', 'profit', 'cents', 'per', 'share', 'revenue', 'around', 'billion', 'Refinitiv', 'data', 'showed', 'On', 'Friday', 'company', 'also', 'said', 'Michel', 'DemarÃ', 'take', 'nonexecutive', 'Chairman', 'Leif', 'Johansson', 'retires', 'next', 'year', 'DemarÃ', 'currently', 'serves', 'chair', 'AstraZeneca', 'NASDAQ', 'remuneration', 'committee', 'Johansson', 'became', 'chairman', 'around', 'time', 'Frenchman', 'Pascal', 'Soriot', 'took', 'charge', 'chief', 'executive', 'The', 'move', 'rules', 'Soriot', 'fended', 'takeover', 'approach', 'Pfizer', 'NYSE', 'chairman', 'candidate', 'As', 'past', 'chairman', 'Syngenta', 'DemarÃ', 'led', 'Swiss', 'crop', 'chemicals', 'maker', 'successful', 'defence', 'unwanted', 'takeover', 'approach', 'US', 'rival', 'Monsanto', 'NYSE', 'resulted', 'agreed', 'acquisition', 'Syngenta', 'ChemChina', 'AstraZeneca', 'said', 'expects', 'increasing', 'sales', 'Evusheld', 'offset', 'decline', 'sales', 'vaccine', 'Vaxzevria', 'developed', 'Oxford', 'University', 'face', 'growing', 'competition', 'The', 'company', 'previously', 'expected', 'Evusheld', 'growth', 'would', 'make', 'decline', 'Vaxzevria', 'sales', 'Sales', 'key', 'market', 'China', 'accounted', 'close', 'fifth', 'sales', 'last', 'year', 'slipped', 'billion', 'lower', 'prices', 'COVID', 'lockdown', 'measures', 'kept', 'patients', 'seeking', 'cancer', 'care', 'Astra', 'bestselling', 'product', 'Tagrisso', 'lung', 'cancer', 'quarterly', 'increase', 'revenues', 'billion', 'sales', 'cardiovascular', 'diabetes', 'treatment', 'Farxiga', 'jumped', 'billion', 'quarter', 'slightly', 'ahead', 'market', 'expectations', 'Â', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'BLND', 'Add', 'toRemove', 'Portfolio', 'SVT', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'â', 'UK', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'Standard', 'Chartered', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Severn', 'Trent', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Carnival', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'British', 'Land', 'Company', 'PLC', 'LON', 'declined', 'points', 'end', 'Ocado', 'Group', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'unchanged', 'The', 'US', 'Dollar', 'Index', 'Futures', 'By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Britain', 'Aug', 'REUTERSPeter', 'NichollsFile', 'Photo', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTSE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ENRY', 'Add', 'toRemove', 'Portfolio', 'By', 'Sruthi', 'Shankar', 'Reuters', 'UK', 'edged', 'Monday', 'gains', 'drugmaker', 'AstraZeneca', 'NASDAQ', 'consumer', 'stocks', 'relieved', 'pressure', 'mining', 'oil', 'heavyweights', 'data', 'showed', 'China', 'economy', 'unexpectedly', 'slowed', 'last', 'month', 'The', 'bluechip', 'FTSE', 'added', 'hold', 'near', 'highs', 'midcap', 'inched', 'Investors', 'awaiting', 'UK', 'employment', 'report', 'well', 'consumer', 'prices', 'data', 'later', 'week', 'gauge', 'state', 'labour', 'market', 'inflation', 'The', 'data', 'could', 'offer', 'clues', 'whether', 'Bank', 'England', 'opts', 'second', 'consecutive', 'hike', 'September', 'meeting', 'The', 'mood', 'dull', 'Asian', 'European', 'stock', 'markets', 'investors', 'turning', 'defensive', 'sectors', 'healthcare', 'consumer', 'staples', 'amid', 'worries', 'health', 'world', 'secondlargest', 'economy', 'AstraZeneca', 'gained', 'drugmaker', 'said', 'cancer', 'drug', 'Enhertu', 'developed', 'Japan', 'Daiichi', 'Sankyo', 'delayed', 'progression', 'form', 'advanced', 'breast', 'cancer', 'previously', 'treated', 'patients', 'Oil', 'major', 'Shell', 'LON', 'miners', 'Rio', 'Tinto', 'LON', 'Anglo', 'American', 'LON', 'slipped', 'tandem', 'weaker', 'commodity', 'prices', 'release', 'China', 'data', 'OR', 'METL', 'The', 'FTSE', 'outperformed', 'global', 'peers', 'year', 'due', 'large', 'exposure', 'commodity', 'stocks', 'surged', 'back', 'jump', 'oil', 'metal', 'prices', 'A', 'weakening', 'pound', 'also', 'boosted', 'dollar', 'earners', 'index', 'Whether', 'trend', 'continue', 'ultimately', 'hinges', 'outlook', 'global', 'energy', 'stocks', 'relative', 'broad', 'market', 'BCA', 'Research', 'analysts', 'wrote', 'note', 'The', 'FTSE', 'nearly', 'far', 'year', 'MSCI', 'world', 'equities', 'index', 'shed', 'almost', 'Our', 'energy', 'strategists', 'remain', 'bullish', 'oil', 'Their', 'expectation', 'breach', 'average', 'suggests', 'overweight', 'energy', 'sector', 'â', 'extension', 'UK', 'equities', 'â', 'remains', 'appropriate', 'Â', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'largely', 'edged', 'higher', 'Monday', 'starting', 'new', 'week', 'cautious', 'note', 'investors', 'digested', 'weak', 'Chinese', 'economic', 'data', 'By', 'ET', 'GMT', 'Germany', 'traded', 'lower', 'France', 'rose', 'UKâs', 'traded', 'higher', 'Economic', 'data', 'released', 'earlier', 'Monday', 'showed', 'Chinaâs', 'economic', 'growth', 'rate', 'unexpectedly', 'slowing', 'July', 'prompting', 'countryâs', 'central', 'bank', 'surprise', 'move', 'grew', 'July', 'year', 'earlier', 'growth', 'rate', 'increase', 'expected', 'rose', 'year', 'ago', 'missing', 'forecasts', 'growth', 'growth', 'seen', 'June', 'China', 'economy', 'worldâs', 'second', 'largest', 'struggling', 'shake', 'June', 'quarter', 'hit', 'growth', 'strict', 'COVID', 'restrictions', 'On', 'flip', 'side', 'back', 'Europe', 'Denmarkâs', 'economy', 'grew', 'faster', 'expected', 'second', 'quarter', 'expanding', 'first', 'three', 'months', 'year', 'contracted', 'first', 'quarter', 'The', 'raised', 'interest', 'rates', 'halfpoint', 'July', 'expected', 'September', 'even', 'though', 'risk', 'Eurozone', 'recession', 'reached', 'highest', 'level', 'since', 'November', 'energy', 'shortages', 'threaten', 'drive', 'already', 'record', 'inflation', 'higher', 'still', 'In', 'corporate', 'news', 'AstraZeneca', 'LON', 'NASDAQ', 'stock', 'rose', 'drugmaker', 'said', 'cancer', 'drug', 'Enhertu', 'delayed', 'progression', 'form', 'advanced', 'breast', 'cancer', 'previously', 'treated', 'patients', 'boosting', 'prospects', 'regulatory', 'approvals', 'Henkel', 'ETR', 'stock', 'rose', 'German', 'consumergoods', 'company', 'said', 'sales', 'rose', 'first', 'half', 'year', 'earnings', 'fell', 'hurt', 'increasing', 'rawmaterial', 'logistics', 'prices', 'Oil', 'prices', 'fell', 'Monday', 'weighed', 'potential', 'increase', 'supply', 'oil', 'giant', 'Saudi', 'Aramco', 'TADAWUL', 'well', 'concerns', 'slowing', 'growth', 'China', 'world', 'secondlargest', 'economy', 'Saudi', 'Aramco', 'stands', 'ready', 'raise', 'crude', 'oil', 'output', 'maximum', 'capacity', 'million', 'barrels', 'per', 'day', 'requested', 'Saudi', 'Arabian', 'government', 'Chief', 'Executive', 'Amin', 'Nasser', 'said', 'Sunday', 'stateowned', 'energy', 'firm', 'announced', 'one', 'largest', 'quarterly', 'profits', 'history', 'By', 'ET', 'futures', 'traded', 'lower', 'barrel', 'contract', 'fell', 'Additionally', 'fell', 'traded', 'lower'], ['AVEPp', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'RHHVF', 'Add', 'toRemove', 'Portfolio', 'SNY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'By', 'Scott', 'Kanowsky', 'Investingcom', 'Sanofi', 'SA', 'EPA', 'shares', 'slid', 'Wednesday', 'French', 'drugmaker', 'announced', 'halt', 'trials', 'new', 'treatment', 'patients', 'battling', 'advanced', 'breast', 'cancer', 'In', 'statement', 'company', 'said', 'would', 'stop', 'global', 'clinical', 'development', 'medicine', 'known', 'amcenestrant', 'phase', 'study', 'showed', 'effective', 'enough', 'warrant', 'research', 'All', 'studies', 'amcenestrant', 'including', 'earlystage', 'breast', 'cancer', 'also', 'discontinued', 'Sanofi', 'added', 'âœWhile', 'disappointed', 'outcome', 'research', 'scientific', 'understanding', 'endocrine', 'therapies', 'people', 'breast', 'cancer', 'said', 'John', 'Reed', 'global', 'head', 'research', 'development', 'Sanofi', 'In', 'note', 'analysts', 'Morgan', 'Stanley', 'called', 'decision', 'setback', 'innovation', 'narrative', 'put', 'forward', 'Sanofi', 'saying', 'amcenestrant', 'flagged', 'potentially', 'lucrative', 'piece', 'group', 'drug', 'pipeline', 'The', 'end', 'Sanofi', 'amcenestrant', 'trials', 'expected', 'lead', 'negative', 'impact', 'company', 'estimated', 'discounted', 'cash', 'flow', 'according', 'Morgan', 'Stanley', 'analysts', 'The', 'decision', 'could', 'also', 'knockon', 'effect', 'studies', 'conducted', 'similar', 'breast', 'cancer', 'drugs', 'Sanofi', 'rivals', 'Roche', 'SIX', 'AstraZeneca', 'PLC', 'LON', 'analysts', 'added'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'Pascal', 'Soriot', 'chief', 'executive', 'pharmaceuticals', 'company', 'AstraZeneca', 'attends', 'interview', 'Reuters', 'Shanghai', 'China', 'November', 'REUTERSBrenda', 'GohFile', 'Photo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Aimee', 'Donnellan', 'Natalie', 'Grover', 'LONDON', 'Reuters', 'AstraZeneca', 'NASDAQ', 'may', 'stay', 'vaccine', 'business', 'long', 'run', 'CEO', 'told', 'Reuters', 'Tuesday', 'showing', 'quickly', 'fortunes', 'changed', 'drugmaker', 'produced', 'one', 'first', 'shots', 'since', 'lost', 'rivals', 'Production', 'delays', 'probes', 'regulators', 'following', 'rare', 'cases', 'severe', 'side', 'effects', 'concerns', 'relatively', 'short', 'shelf', 'life', 'compared', 'shots', 'stymied', 'adoption', 'company', 'vaccine', 'Now', 'third', 'year', 'pandemic', 'amid', 'global', 'vaccine', 'supply', 'glut', 'use', 'diminished', 'much', 'developed', 'world', 'countries', 'inoculated', 'large', 'numbers', 'people', 'prefer', 'Pfizer', 'NYSE', 'Moderna', 'NASDAQ', 'mRNA', 'vaccines', 'boosters', 'AstraZeneca', 'COVID', 'vaccine', 'still', 'US', 'approval', 'The', 'Londonlisted', 'company', 'building', 'portfolio', 'antibody', 'therapies', 'including', 'respiratory', 'virus', 'RSV', 'viruses', 'Soriot', 'said', 'Reuters', 'Newsmaker', 'interview', 'Tuesday', 'But', 'future', 'COVID', 'vaccines', 'business', 'said', 'I', 'ca', 'sure', 'He', 'also', 'said', 'sure', 'AstraZeneca', 'would', 'broaden', 'roster', 'vaccines', 'infections', 'either', 'adding', 'company', 'looking', 'Investors', 'speculated', 'future', 'vaccine', 'business', 'given', 'slowing', 'sales', 'COVID', 'shot', 'initial', 'sales', 'contracts', 'fulfilled', 'stiff', 'competition', 'mRNA', 'vaccines', 'relatively', 'little', 'expertise', 'field', 'The', 'company', 'created', 'separate', 'division', 'vaccines', 'antibody', 'therapies', 'late', 'last', 'year', 'Still', 'Soriot', 'said', 'regret', 'company', 'work', 'Oxford', 'University', 'develop', 'COVID', 'vaccine', 'given', 'delivered', 'billions', 'doses', 'saved', 'estimated', 'million', 'lives', 'across', 'globe', 'The', 'inoculation', 'AstraZeneca', 'second', 'bestselling', 'product', 'sales', 'billion', 'AstraZeneca', 'also', 'looking', 'bolton', 'acquisitions', 'including', 'small', 'midsized', 'companies', 'specialising', 'oncology', 'cardiovascular', 'treatments', 'Soriot', 'added', 'We', 'always', 'look', 'external', 'opportunities', 'said', 'KEEP', 'ON', 'DOING', 'THIS', 'JOB', 'The', 'CEO', 'presided', 'quadrupling', 'AstraZeneca', 'share', 'price', 'decade', 'helm', 'I', 'keep', 'job', 'many', 'years', 'said', 'The', 'old', 'seen', 'natural', 'successor', 'outgoing', 'Chairman', 'Leif', 'Johansson', 'But', 'July', 'Soriot', 'quashed', 'speculation', 'planning', 'retire', 'time', 'soon', 'saying', 'expected', 'work', 'company', 'newly', 'announced', 'chairmandesignate', 'Michel', 'Demare', 'many', 'years', 'come', 'Soriot', 'tasked', 'turning', 'around', 'troubled', 'AstraZeneca', 'hit', 'string', 'key', 'patent', 'losses', 'spate', 'clinical', 'trial', 'failures', 'October', 'following', 'stint', 'pharma', 'peer', 'Roche', 'With', 'Frenchman', 'helm', 'fortunes', 'AngloSwedish', 'drugmaker', 'changed', 'dramatically', 'He', 'sharpened', 'focus', 'speciality', 'medicines', 'lucrative', 'field', 'oncology', 'made', 'acquisitions', 'refill', 'company', 'medicine', 'cabinet', 'fended', 'hostile', 'takeover', 'US', 'pharma', 'giant', 'Pfizer', 'invested', 'heavily', 'RD', 'improve', 'company', 'lacklustre', 'drug', 'development', 'success', 'rate', 'However', 'warned', 'Tuesday', 'fewer', 'new', 'medicines', 'would', 'developed', 'going', 'forward', 'due', 'US', 'drug', 'price', 'laws', 'passed', 'last', 'week', 'Asked', 'inflationary', 'pressures', 'Soriot', 'said', 'We', 'going', 'become', 'innovative', 'productive', 'We', 'ca', 'expect', 'selling', 'prices', 'go', 'Sales', 'China', 'account', 'close', 'fifth', 'company', 'total', 'annual', 'revenue', 'dipped', 'recent', 'quarters', 'due', 'lower', 'drug', 'prices', 'COVID', 'lockdown', 'measures', 'kept', 'patients', 'diagnosed', 'seeking', 'cancer', 'care', 'On', 'Tuesday', 'Soriot', 'said', 'sales', 'picking', 'third', 'quarter', 'world', 'secondlargest', 'market', 'pharmaceuticals', 'expected', 'country', 'play', 'significant', 'role', 'global', 'market', 'next', 'decade', 'Graphic', 'AstraZeneca', 'shares', 'CEO', 'Soriot', 'helm', 'httpsfingfxthomsonreuterscomgfxmktzjvqkblqgvxAZPNG'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'US', 'April', 'REUTERSBrendan', 'McDermid', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'said', 'Friday', 'drug', 'preventing', 'infant', 'RSV', 'Beyfortus', 'nirsevimab', 'recommended', 'approval', 'European', 'Union', 'European', 'Medicines', 'Agency', 'committee', 'The', 'drugmaker', 'also', 'said', 'Beyfortus', 'approved', 'would', 'become', 'first', 'protective', 'option', 'newborn', 'infant', 'population', 'RSV', 'lower', 'respiratory', 'tract', 'disease', 'Â', 'Reuters', 'People', 'pose', 'syringe', 'needle', 'front', 'displayed', 'AstraZeneca', 'logo', 'illustration', 'taken', 'December', 'REUTERSDado', 'RuvicIllustrationFiles', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Natalie', 'Grover', 'LONDON', 'Reuters', 'Europe', 'medicines', 'regulator', 'backed', 'using', 'AstraZeneca', 'NASDAQ', 'preventative', 'therapy', 'treatment', 'disease', 'also', 'endorsed', 'another', 'medicine', 'preventative', 'option', 'another', 'common', 'virus', 'The', 'regulator', 'recommendations', 'usually', 'followed', 'European', 'Commission', 'takes', 'final', 'decision', 'drug', 'approvals', 'AstraZeneca', 'said', 'Friday', 'European', 'Medicines', 'Agency', 'EMA', 'backed', 'Evusheld', 'treatment', 'adults', 'adolescents', 'COVID', 'need', 'supplemental', 'oxygen', 'increased', 'risk', 'disease', 'worsening', 'Last', 'month', 'Japan', 'became', 'first', 'country', 'approve', 'longacting', 'antibody', 'treatment', 'COVID', 'making', 'Evusheld', 'first', 'therapy', 'authorised', 'prevention', 'treatment', 'viral', 'disease', 'Evusheld', 'previously', 'largely', 'secured', 'global', 'approvals', 'including', 'Europe', 'preventative', 'therapy', 'people', 'compromised', 'immune', 'systems', 'see', 'little', 'benefit', 'COVID', 'vaccines', 'AstraZeneca', 'leaning', 'Evusheld', 'help', 'offset', 'tepid', 'sales', 'COVID', 'vaccine', 'rapidly', 'lost', 'ground', 'mRNA', 'shots', 'fight', 'rapidly', 'evolving', 'virus', 'Evusheld', 'first', 'launched', 'December', 'generated', 'million', 'first', 'half', 'AngloSwedish', 'drugmaker', 'Separately', 'Friday', 'EMA', 'also', 'endorsed', 'AstraZeneca', 'partner', 'Sanofi', 'EPA', 'experimental', 'longacting', 'therapy', 'Beyfortus', 'prevention', 'lower', 'respiratory', 'tract', 'infections', 'caused', 'respiratory', 'syncytial', 'virus', 'RSV', 'RSV', 'causes', 'thousands', 'hospitalisations', 'deaths', 'globally', 'year', 'toddlers', 'elderly', 'complex', 'molecular', 'structure', 'virus', 'safety', 'concerns', 'stymied', 'efforts', 'develop', 'vaccine', 'since', 'virus', 'first', 'discovered', 'But', 'one', 'therapy', 'Synagis', 'also', 'developed', 'AstraZeneca', 'sold', 'Swedish', 'Orphan', 'Biovitrum', 'United', 'States', 'It', 'designed', 'prevent', 'lower', 'respiratory', 'tract', 'infections', 'caused', 'RSV', 'highrisk', 'infants', 'requires', 'five', 'injections', 'cover', 'typical', 'RSV', 'season', 'Meanwhile', 'Beyfortus', 'approved', 'would', 'first', 'singledose', 'preventative', 'RSV', 'therapy', 'broad', 'infant', 'population', 'including', 'born', 'healthy', 'deemed', 'highrisk', 'first', 'RSV', 'season'], ['Â', 'Reuters', 'AstraZeneca', 'says', 'Evusheld', 'approved', 'treatment', 'EU', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'said', 'longacting', 'antibody', 'combination', 'Evusheld', 'tixagevimab', 'cilgavimab', 'formerly', 'approved', 'EU', 'treatment', 'The', 'approval', 'European', 'Commission', 'covers', 'people', 'age', 'years', 'require', 'supplemental', 'oxygen', 'increased', 'risk', 'progressing', 'severe', 'pharmaceuticals', 'group', 'said', 'The', 'European', 'Commissionâs', 'approval', 'based', 'results', 'TACKLE', 'phase', 'III', 'treatment', 'trial', 'showed', 'Evusheld', 'significantly', 'reduced', 'risk', 'severe', 'death', 'The', 'recommended', 'dose', 'Evusheld', 'treatment', 'Europe', 'tixagevimab', 'cilgavimab', 'administered', 'two', 'separate', 'sequential', 'IM', 'injections', 'AstraZeneca', 'NASDAQ', 'noted', 'Many', 'people', 'including', 'immunocompromised', 'older', 'adults', 'underlying', 'health', 'conditions', 'high', 'risk', 'severe', 'disease', 'hospitalisation', 'death', 'become', 'infected', 'Evusheld', 'delivered', 'convenient', 'intramuscular', 'formulation', 'muchneeded', 'new', 'treatment', 'option', 'vulnerable', 'populations', 'commented', 'Dr', 'Michel', 'Goldman', 'professor', 'Institute', 'Interdisciplinary', 'Innovation', 'Healthcare', 'UniversitÃ', 'Libre', 'de', 'Bruxelles', 'former', 'executive', 'director', 'European', 'Innovative', 'Medicines', 'Initiative', 'statement', 'Iskra', 'Reic', 'executive', 'vice', 'president', 'vaccines', 'immune', 'therapies', 'AstraZeneca', 'added', 'remains', 'ongoing', 'health', 'concern', 'millions', 'Europeans', 'around', 'world', 'especially', 'may', 'wellprotected', 'virus', 'vaccination', 'With', 'approval', 'Evusheld', 'longacting', 'antibody', 'combination', 'available', 'prevention', 'treatment', 'Europe', 'allowing', 'us', 'protect', 'even', 'people', 'devastating', 'disease', 'Read', 'Proactive', 'Investors', 'UK', 'Disclaimer'], ['By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter'], ['Â', 'Reuters', 'AstraZeneca', 'gets', 'third', 'regulatory', 'green', 'light', 'matter', 'weeks', 'asthma', 'drug', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AstraZeneca', 'PLC', 'LON', 'said', 'Tezspire', 'treatment', 'approved', 'Japan', 'severe', 'bronchial', 'asthma', 'highdose', 'traditional', 'corticosteroids', 'donât', 'work', 'It', 'third', 'approval', 'matter', 'weeks', 'product', 'potential', 'challenger', 'market', 'leader', 'Dupxient', 'It', 'developed', 'collaboration', 'US', 'giant', 'Amgen', 'NASDAQ', 'In', 'clinical', 'trials', 'drug', 'shown', 'lower', 'researchers', 'called', 'âasthma', 'exacerbationsâ', 'Tezspire', 'first', 'biologic', 'approved', 'Japanese', 'Ministry', 'Health', 'Labour', 'Welfare', 'shown', 'consistently', 'significantly', 'reduce', 'attacks', 'exacerbation', 'trials', 'broad', 'population', 'severe', 'asthma', 'patients', 'irrespective', 'biomarker', 'levelsâ', 'Mene', 'Pangalos', 'head', 'biopharmaceutical', 'research', 'AZ', 'âœTezspire', 'potential', 'improve', 'outcomes', 'many', 'patients', 'severe', 'asthma', 'working', 'make', 'important', 'medicine', 'available', 'Japan', 'quickly', 'possibleâ', 'Analysts', 'believe', 'Tezspire', 'could', 'big', 'seller', 'peak', 'sales', 'projected', 'order', 'Read', 'Proactive', 'Investors', 'UK', 'Disclaimer'], ['Â', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Julie', 'Steenhuysen', 'Carl', 'Vishwadha', 'Chander', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'resumed', 'US', 'trial', 'experimental', 'vaccine', 'approval', 'regulators', 'Johnson', 'Johnson', 'N', 'preparing', 'resume', 'trial', 'Monday', 'Tuesday', 'companies', 'said', 'Friday', 'The', 'news', 'signaled', 'progress', 'novel', 'coronavirus', 'infected', 'million', 'globally', 'including', 'million', 'Americans', 'comes', 'days', 'US', 'presidential', 'election', 'may', 'hinge', 'plans', 'fight', 'pandemic', 'AstraZeneca', 'one', 'leading', 'vaccine', 'developers', 'paused', 'US', 'trial', 'Sept', 'report', 'serious', 'neurological', 'illness', 'believed', 'transverse', 'myelitis', 'participant', 'company', 'UK', 'trial', 'JJ', 'paused', 'large', 'latestage', 'trial', 'last', 'week', 'study', 'participant', 'became', 'ill', 'Both', 'companies', 'contracts', 'provide', 'vaccine', 'United', 'States', 'governments', 'cleared', 'regulators', 'Officials', 'experts', 'expressed', 'concern', 'regulatory', 'approval', 'process', 'overseen', 'Food', 'Drug', 'Administration', 'FDA', 'undermined', 'political', 'pressure', 'around', 'quarter', 'Americans', 'say', 'hesitant', 'take', 'vaccine', 'As', 'trial', 'resumes', 'I', 'hoping', 'message', 'communicated', 'public', 'following', 'procedures', 'highest', 'ethical', 'standard', 'interfering', 'FDA', 'regulatory', 'process', 'said', 'Matthew', 'Hepburn', 'head', 'vaccine', 'development', 'Operation', 'Warp', 'Speed', 'publicprivate', 'partnership', 'speed', 'inoculation', 'efforts', 'Infections', 'rising', 'countries', 'httpsgraphicsreuterscomworldcoronavirustrackerandmapsindexhtml', 'people', 'northern', 'hemisphere', 'spend', 'time', 'indoors', 'winter', 'approaching', 'JJ', 'said', 'Friday', 'safety', 'panel', 'called', 'Data', 'Safety', 'Monitoring', 'Board', 'recommended', 'drugmaker', 'resume', 'trial', 'recruitment', 'finding', 'evidence', 'vaccine', 'caused', 'volunteer', 'fall', 'ill', 'JJ', 'expects', 'resume', 'trial', 'United', 'States', 'Monday', 'Tuesday', 'remains', 'track', 'produce', 'data', 'trial', 'vaccines', 'effectiveness', 'end', 'early', 'JJ', 'chief', 'scientific', 'officer', 'Paul', 'Stoffels', 'said', 'JJ', 'also', 'discussions', 'regulators', 'resume', 'trial', 'outside', 'United', 'States', 'company', 'said', 'So', 'far', 'medical', 'board', 'identified', 'clear', 'cause', 'patients', 'illness', 'JJ', 'reveal', 'details', 'patient', 'sickness', 'patient', 'privacy', 'rules', 'Stoffels', 'said', 'AstraZeneca', 'said', 'unusual', 'trial', 'participants', 'fall', 'ill', 'large', 'scale', 'vaccine', 'trials', 'US', 'Food', 'Drug', 'Administration', 'reviewed', 'safety', 'data', 'trials', 'globally', 'deemed', 'safe', 'continue', 'testing', 'vaccine', 'AstraZeneca', 'trials', 'United', 'Kingdom', 'Brazil', 'South', 'Africa', 'resumed', 'last', 'month', 'even', 'US', 'Food', 'Drug', 'Administration', 'continued', 'investigation', 'case', 'Reuters', 'earlier', 'week', 'reported', 'FDA', 'completed', 'review', 'AstraZeneca', 'US', 'trial', 'set', 'resume', 'early', 'week', 'citing', 'four', 'sources', 'familiar', 'situation', 'AstraZeneca', 'vaccine', 'developed', 'along', 'researchers', 'Oxford', 'University'], ['AstraZeneca', 'Touts', 'Positive', 'Data', 'From', 'Two', 'Experimental', 'Drugs', 'In', 'Breast', 'Cancer', 'Settings', 'By', 'Benzinga', 'With', 'ongoing', 'layoff', 'fiasco', 'happening', 'Twitter', 'cofounder', 'Jack', 'Dorsey', 'come', 'forward', 'take', 'responsibility', 'saying', 'one', 'blame', 'In', 'recent', 'Twitter', 'AstraZeneca', 'PLC', 'said', 'Wednesday', 'Capivasertib', 'plus', 'Faslodex', 'significantly', 'improved', 'progressionfree', 'survival', 'compared', 'Faslodex', 'combined', 'placebo', 'Phase', 'trial', 'advanced', 'hormone', 'receptorpositive', 'breast', 'cancer', 'The', 'AngloSwedish', 'pharma', 'giant', 'AZN', 'AZN', 'said', 'trial', 'met', 'primary', 'endpoints', 'improving', 'progressionfree', 'survival', 'overall', 'patient', 'population', 'prespecified', 'biomarker', 'subgroup', 'patients', 'whose', 'tumors', 'qualifying', 'alterations'], ['AstraZeneca', 'Ultomiris', 'Showed', 'Zero', 'Relapses', 'In', 'Patients', 'With', 'Chronic', 'Disorder', 'Of', 'Brain', 'Spinal', 'Cord'], ['Â', 'Reuters', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BTI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Samuel', 'Indyk', 'Investingcom', 'â', 'At', 'trading', 'lower', 'In', 'FX', 'markets', 'trading', 'trading', 'The', 'trading', 'Todayâs', 'calendar', 'highlights', 'include', 'Data', 'UK', 'grew', 'still', 'prepandemic', 'peak', 'seen', 'Analysts', 'expected', 'GDP', 'grow', 'quarter', 'In', 'December', 'declined', 'âœGDP', 'fell', 'back', 'slightly', 'December', 'Omicron', 'wave', 'hit', 'retail', 'hospitality', 'seeing', 'biggest', 'impactsâ', 'ONS', 'Director', 'Economic', 'Statistics', 'Darren', 'Morgan', 'said', 'âœHowever', 'partially', 'offset', 'increases', 'Test', 'Trace', 'service', 'vaccination', 'programmesâ', 'Stocks', 'British', 'American', 'Tobacco', 'LON', 'FY', 'adjusted', 'revenue', 'billion', 'Revenue', 'new', 'categories', 'Adjusted', 'profit', 'operations', 'includes', 'negative', 'transactional', 'FX', 'impact', 'Increased', 'dividend', 'pence', 'per', 'share', 'Announced', 'billion', 'share', 'repurchase', 'programme', 'Outlook', 'constant', 'currency', 'revenue', 'growth', 'Highsingle', 'figure', 'constant', 'currency', 'adjusted', 'EPS', 'growth', 'growth', 'second', 'half', 'weighted', 'AstraZeneca', 'LON', 'AstraZeneca', 'ADRs', 'NASDAQ', 'become', 'member', 'prior', 'market', 'open', 'February', 'replacing', 'Xilinx', 'Tate', 'Lyle', 'LON', 'revenue', 'continuing', 'operations', 'trading', 'line', 'expectations', 'The', 'outlook', 'financial', 'year', 'total', 'operations', 'current', 'Tate', 'Lyle', 'remains', 'unchanged', 'performance', 'continuing', 'operations', 'expected', 'stronger', 'discontinued', 'operations', 'weaker', 'Deliveroo', 'LON', 'Partnered', 'Waitrose', 'rapid', 'âœHopâ', 'delivery', 'service', 'Victrex', 'LON', 'group', 'revenue', 'million', 'group', 'sales', 'volume', 'tonnes', 'Expectations', 'full', 'year', 'unchanged', 'Helios', 'Towers', 'LON', 'Longstop', 'date', 'acquisition', 'Omantelâs', 'passive', 'tower', 'infrastructure', 'portfolio', 'extended', 'July', 'Lancashire', 'Holdings', 'LON', 'gross', 'premiums', 'written', 'increased', 'yearonyear', 'record', 'billion', 'Final', 'dividend', 'declared', 'per', 'common', 'share']]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_EgBjK4EM3co",
        "outputId": "e5bc7b1c-94eb-42f2-c87b-5db2774d7a3e"
      },
      "source": [
        "# Join the tokens back into a list of articles\n",
        "\n",
        "filtered_articles_joined = [','.join(article).replace(',', ' ') for article in filtered_articles]\n",
        "filtered_articles_joined"
      ],
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['Â Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio NG Add toRemove Portfolio HBR Add toRemove Portfolio DLAR Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open Smith Nephew Medical prosthetics maker Smith Nephew Plc expects decline underlying revenue third quarter year almost previous three months suffering heavily impact coronavirus lockdowns halt elective procedures RollsRoyce Britain RollsRoyce said planned shareholders billion pounds bond market secure loans rebuild balance sheet Premier Oil Creditors North Seafocused Premier Oil extended waiver group debt covenant test giving breathing space avoid debt crunch company said Thursday De La Rue Banknote printer De La Rue Thursday named Rob Harding appointing interim CFO earlier year National Grid National Grid Thursday pledged see reduce emissions relating gas electricity sells markets United States Britain AstraZeneca The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production forecast Shell losses consumer stocks weighed index Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Marisa Taylor Dan Levine WASHINGTON Reuters The US Food Drug Administration broadened investigation serious illness AstraZeneca Plc L vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters AstraZeneca large latestage US trial remained hold since Sept study participant Britain fell ill believed rare spinal inflammatory disorder called transverse myelitis The widened scope FDA probe raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United States Other leading companies US vaccine race include Pfizer Inc N Moderna Inc O Johnson Johnson N Regulators UK Brazil India South Africa allowed AstraZeneca resume clinical trials The FDA however wants determine whether similar side effects emerged trials vaccines designed AstraZeneca coronavirus vaccine partner researchers Oxford University sources said That mean agency believes safety issues associated vaccines added It shows FDA thorough said one sources Further complicating situation data requested FDA different format US regulator requires two sources said The FDA declined comment discussions involving experimental product Oxford respond requests comment AstraZeneca statement said We continuing work FDA facilitate review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus found chimpanzees They felt would reduce likelihood individual immune system would attack vector virus due prior exposure rather intended target Reuters reviewed six research papers detailed safety data vaccines using engineered chimpanzee adenovirus called diseases including tuberculosis prostate cancer influenza In one trials one serious adverse event cited researchers deemed unrelated vaccine The type review conducted FDA generally intended scrutinize raw data side effects sources said The US government effort speed development vaccine promises Trump one could available prior Nov presidential election led concerns political interference regulatory process expense safety The FDA denied AstraZeneca vaccine development could also slowed change clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered public use trial concludes serious safety problems appear Safety likely major reason change said Thomas Lumley chair biostatistics University Auckland involved study AstraZeneca would say made change protocol Â Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken GILD Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The European health regulator said Thursday started rolling review experimental vaccine AstraZeneca L Oxford University move aimed speeding future approval process The European Medicines Agency EMA said human medicines committee started evaluating first batch data vaccine continue till sufficient data available formal application submitted https The news raises chances vaccine first approved region comes weeks several global trials vaccine halted due unexplained illness study participant US trials still review regulators widening probe Reuters reported Wednesday This EMA review mean conclusion reached yet vaccine safety effectiveness much evidence still submitted committee watchdog said Earlystage data July showed vaccine elicited immune responses clinical trials produced serious side effects strongest response seen people received two doses Data latestage trials expected soon The EMA would make final recommendations review completed European Commission ultimate say approvals The commission typically follows EMA endorsements The EMA began similar realtime review Gilead O Veklury treatment earlier year antiviral treatment given conditional approval use months later July',\n",
              " 'Â Reuters FILE PHOTO Small toy figures seen front Vaccine logo illustration taken AZN Add toRemove Portfolio Reuters Clinical trials AstraZeneca L Oxford University experimental vaccine resumed Japan almost month put hold due illness British volunteer discussions US authorities continue The British drugmaker said Friday earlytomidstage trial vaccine novel coronavirus resumed Japan consultations national health regulator Japanese Pharmaceuticals Medical Devices Agency Global trials vaccine called put hold Sept study participant fell ill believed rare spinal inflammatory disorder called transverse myelitis Trials UK Brazil South Africa India already restarted US trials remain paused regulators widened probe Reuters reported Wednesday AstraZeneca called halt standard review procedure document posted online Oxford university last month stated illness may associated vaccine However incident drawn focus safety candidates developed race successful vaccine illness caused novel coronavirus claimed million lives globally The US Food Drug Administration FDA broadened investigation illness volunteer would look data earlier trials similar vaccines developed scientists three sources told Reuters In Friday statement AstraZeneca stressed safety participants paramount importance applying highest standards conduct trials Sources told Reuters data requested FDA one advanced vaccine candidates development expected week',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio GOG Add toRemove Portfolio CTH Add toRemove Portfolio PAGPA Add toRemove Portfolio PHNX Add toRemove Portfolio CSPC Add toRemove Portfolio AJBA Add toRemove Portfolio Dec Reuters Britain FTSE index seen opening points lower Thursday according financial bookmakers ASTRAZENECA AstraZeneca Plc likely get results US vaccine trial lateJanuary could potentially file emergency authorization chief adviser US government Operation Warp Speed program said Wednesday GOLD Gold rose oneweek high dollar weakened hopes coronavirus vaccine rollouts investors also weighed possibility US stimulus OIL Oil prices fell producers including Saudi Arabia Russia locked horns need extend record production cuts set place first wave pandemic The UK bluechip index closed higher Wednesday sterling weakened doubts whether trade deal could reached Britain European Union UK approval vaccine also supported sentiment UK CORPORATE DIARY Countryside Properties Plc FY earnings Go Ahead Group Trading update AJ Bell Plc FY earnings Caretech Holdings Plc FY earnings Paragon Banking Group Plc FY earnings Phoenix Group Holdings Plc Â Reuters UK shares higher close trade Investingcom United Kingdom TUIGn Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio ULVR Add toRemove Portfolio BT Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Thursday gains sectors propelled shares higher At close London added hit new high The biggest gainers session RollsRoyce Holdings PLC LON rose points trade close BT Group PLC LON added points end Flutter Entertainment PLC LON points late trade Biggest losers included Tui AG LON lost points trade late trade AstraZeneca PLC LON declined points end Unilever PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery January rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters AVV Add toRemove Portfolio TRNT Add toRemove Portfolio BIFF Add toRemove Portfolio AUTOA Add toRemove Portfolio JSAIY Add toRemove Portfolio RDI Add toRemove Portfolio KCT Add toRemove Portfolio LRE Add toRemove Portfolio DLN Add toRemove Portfolio Add toRemove Portfolio INCH Add toRemove Portfolio WIN Add toRemove Portfolio SBRY Add toRemove Portfolio RSAl Add toRemove Portfolio TATE Add toRemove Portfolio HIK Add toRemove Portfolio AZN Add toRemove Portfolio BARC Add toRemove Portfolio Nov Britain FTSE index seen opening points lower Thursday according financial bookmakers ASTRAZENECA Chilean President Sebastian Pinera said country health regulator given goahead clinical trials AstraZeneca PLC vaccine SAINSBURY British supermarket group Sainsbury announce plans cut jobs alongside firsthalf results Thursday The Times reported BARCLAYS A former Barclays trader fled native France convicted London helping rig Euribor interest rates court battle extradition Britain serve eightyear jail sentence lawyer said GOLD Gold firmed investors cautiously optimistic Democrat Joe Biden would edge past President Donald Trump tight race White House boosting likelihood economic stimulus OIL Oil dropped Democrat Joe Biden edged closer White House Republicans look likely retain Senate control decreasing chances huge relief package The UK bluechip index closed higher Wednesday weaker pound boosted shares exporters although investors remained cautious prospects contested outcome US presidential elections UK CORPORATE DIARY Tate Lyle Plc HY results RDI Reit Plc FY trading statement Biffa Plc HY earnings Wincanton Plc HY earnings Derwent London Plc business update Kin Carta Plc FY earnings AVEVA Group Plc HY earnings AstraZeneca Plc earnings RSA Insurance Group Plc trading statement J Sainsbury OTC Plc HY earnings Lancashire Holdings Ltd trading statement Auto Trader Group Plc HY earnings Trainline Plc HY earnings Inchcape Plc trading statement Hikma Pharmaceuticals Plc Trading statement RDI Reit Plc FY earnings Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters A summer dip UK coronavirus infections pushed back test results AstraZenca potential vaccine leading drugmaker delay deliveries shots UK government Britain vaccines chief said Wednesday would receive million doses potential vaccine year initial estimates million Sept AstraZeneca L said Thursday holding back deliveries awaits data latestage clinical trials order maximise shelflife supplies It keeping vaccine frozen large containers add final ingredient put vials keep fridge temperature vaccine gets closer approval We little bit late deliveries vaccine kept frozen form CEO Pascal Soriot said conference call However added AstraZeneca fully prepared launch vaccine ready adding company weekly delivery schedule roughly match UK government mind vaccination plans AstraZeneca partner project University Oxford said data latestage trials land year If successful pair file emergency approvals many countries possible time Soriot said The British duo racing PfizerBioNTech Moderna others publish first detailed results large vaccine trials A vaccine seen world best bet beating pandemic led million deaths roiled economies disrupted billions lives Earlier year AstraZeneca also agreed start supplying millions doses end United States European Union poorer nations epidemic response group CEPI vaccine alliance GAVI subject results trials regulatory approval The company hopes shot effective least year trial data confirm MIXED RESULTS While working vaccine AstraZeneca also making progress pipeline drugs On Thursday company said two main drugs cancer treatment Lynparza diabetes medicine Forxiga approved wider use Europe For third quarter product sales billion billion pounds ahead companycompiled consensus billion The number excluded payments collaborations However core earnings cents per share three months ended Sept missed analysts expectations cents Research development costs jumped billion projects moved final stage testing humans typically expensive The company said still expected total revenue increase high singledigit low doubledigit percentage core earnings per share increase mid highteens percentage',\n",
              " 'Â Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters The European health regulator started realtime review vaccine developed Pfizer N BioNTech F days launching similar assessment process AstraZeneca L vaccine The European Medicines Agency EMA said Tuesday human medicines committee evaluating first batch nonclinical data vaccine laboratory studies continue enough data available final decision https The rolling review vaccine called based earlystage studies suggested vaccine triggered immune response watchdog said moves ahead plan speed approval process vaccine candidates',\n",
              " 'Â Reuters Add toRemove Portfolio TRYG Add toRemove Portfolio AZN Add toRemove Portfolio RSAl Add toRemove Portfolio SBRY Add toRemove Portfolio SMT Add toRemove Portfolio BEZG Add toRemove Portfolio ICAG Add toRemove Portfolio MGAMM Add toRemove Portfolio IFC Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Friday according financial bookmakers SAINSBURY British supermarket Sainsbury said could cut range offering Northern Ireland unless gets clarity province trading status end Britain Brexit transition period Dec RSA RSA talks consortium Canadian insurer Intact Financial Danish insurer Tryg possible breakup deal values British firm billion pounds billion ASTRAZENECA AstraZeneca Plc plans start early midstage clinical trials vaccine candidate China year senior executive said prepares global rollout vaccine BRITISH AIRWAYS British Airways part International Consolidated Airlines Group reduce flight schedule month UK government put restrictions leisure travel try curb spread coronavirus GOLD Gold fell surging previous session dollar gained set best week since late July hopes central bank economic support investors bet divided US Congress Biden presidency OIL US oil fell nearly new lockdowns Europe contain spread coronavirus disease raised questions outlook crude demand markets remained edge drawnout vote counting US election The UK bluechip index closed higher Thursday government Bank England ramped stimulus programmes cushion struggling economy England goes second national lockdown UK CORPORATE DIARY Scottish Mortgage Investment Trust Plc HY earnings Morgan Advanced Materials Plc trading statement Beazley Plc earnings TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Â Reuters FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio Reuters AstraZeneca could start profiting vaccine soon July next year Financial Times reported Wednesday citing memo showing British drugmaker declare considers pandemic ended The Londonlisted firm previously said would profit vaccine pandemic report attributes development memorandum understanding signed year AstraZeneca Brazilian public health organization Fiocruz AstraZeneca developed vaccine Oxford University signed multiple supplyandmanufacture deals billion doses globally although details terms scant According FT Pandemic Period could extended beyond July Cambridge Englandbased AstraZeneca acting good faith considers pandemic AstraZeneca immediately respond Reuters request comment Pricing supply experimental vaccines widely debated richer countries pump billions dollars funding AstraZeneca also granted protection future liability claims',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio HRGV Add toRemove Portfolio LCL Add toRemove Portfolio Add toRemove Portfolio UTG Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio RWA Add toRemove Portfolio ENT Add toRemove Portfolio NRRT Add toRemove Portfolio CMCX Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open CMC Markets CMC Markets said annual net operating income would current market consensus trading online platform benefited year coronavirusdriven market volatility EasyJet British airline warned would report annual loss much first ever said kept finances review pandemic meant flying planned capacity Hargreaves Lansdown British fund supermarket Hargreaves Lansdown said took million pounds net new business quarter Sept despite described weakening investor sentiment arising fresh Brexit uncertainty Home REIT Home REIT vehicle investing properties provide accommodation homeless people said Thursday initial public offering GVC Holdings Ladbrokes LON bwin owner GVC Holdings raised outlook annual core earnings posting rise thirdquarter revenue helped surge online gaming sports events English Premier League resumed Robert Walters British recruiting firm Robert Walters Plc thirdquarter net fee income Thursday continued tussle hiring slowdown due pandemic reinstated interim dividend AstraZeneca AstraZeneca could vaccine soon July next year Financial Times reported Wednesday citing memo showing British drugmaker declare considers pandemic ended British Airways British Airways bid farewell final Londonbased Boeing NYSE Thursday rare synchronised dual take Queen Skies jet brought longhaul flights masses EasyJet British airline easyJet Plc signalled government may coronavirus pandemic continues hinder schedule Sky News reported Wednesday Oil prices inched Thursday oil workers evacuated rigs US Gulf Mexico ahead Hurricane Delta though fuel demand concerns persisted fading chances US economic stimulus deal build Gold prices little changed Thursday renewed hopes US stimulus kept bullion afloat investors eyeing data gauge health world largest economy The UK bluechip index closed Wednesday weighed fall energy stocks lower oil prices investors looking clues US stimulus measures President Donald Trump called halt talks Congress comprehensive bill UK corporate diary Preclose trading statement Trading statement Operational Update preclose trading statement trading statement Trading statement Trading statement',\n",
              " 'Â Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City DJI Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Michael Erman Julie Steenhuysen Reuters Pfizer Inc N experimental vaccine effective based initial trial results drugmaker said Monday major victory war virus killed million people battered world economy Experts welcomed first successful interim data largescale clinical test watershed moment showed vaccines could help halt pandemic although mass rollouts needs regulatory approval happen year Pfizer German partner BioNTech SE F said found serious safety concerns yet expected seek US authorization month emergency use vaccine raising chance regulatory decision soon December If granted companies estimate roll million doses year enough protect million people produce billion doses Today great day science humanity said Pfizer Chief Executive Albert Bourla We reaching critical milestone vaccine development program time world needs infection rates setting new records hospitals nearing overcapacity economies struggling reopen said Experts said still wanted see full trial data yet peerreviewed published medical journal preliminary results looked encouraging This news made smile ear ear It relief see positive results vaccine bodes well vaccines general said Peter Horby professor emerging infectious diseases University Oxford There still many questions effective vaccine ethnicity age long provide immunity new normal social distancing face covering set remain foreseeable future Pfizer expects seek US emergency use authorization people aged To need two months safety data half study participants expected third week November US Health Human Services Secretary Alex Azar said would take several weeks US regulators receive process data vaccine government could potentially approve MARKETS SURGE The prospect vaccine electrified world markets SP hitting record highs shares banks oil companies travel companies soared Shares companies thrived lockdowns conferencing platform Zoom Video O online retailers tumbled Pfizer shares jumped highest since July last year BioNTech stock hit record high Shares vaccine developers final stage testing also rose Johnson Johnson N Moderna Inc O whose vaccine uses similar technology Pfizer shot Britain AstraZeneca L however fell Moderna expected report results largescale trial later month The efficacy data really impressive This better us anticipated said William Schaffner infectious diseases expert Vanderbilt University School Medicine Nashville Tennessee The study completed yet nonetheless data look solid US President Donald Trump welcomed test results market boost STOCK MARKET UP BIG VACCINE COMING SOON REPORT EFFECTIVE SUCH GREAT NEWS tweeted Presidentelect Joe Biden said news excellent change fact face masks social distancing health measures would needed well next year The World Health Organization said results positive warned funding gap billion could slow access tests medicines vaccines low middleincome countries ECSTATIC I near ecstatic Bill Gruber one Pfizer top vaccine scientists said interview This great day public health potential get us circumstances Between population need vaccinated break dynamic spread said Germany health minister Jens Spahn adding expect shot available first quarter The European Union said Monday would soon sign contract million doses Pfizer BioNTech vaccine The companies billion contract US government deliver million vaccine doses beginning year They receive research funding Trump administration Operation Warp Speed vaccine program The drugmakers also reached supply agreements United Kingdom Canada Japan Pfizer said interim analysis conducted participants trial developed examined many received vaccine versus placebo Pfizer break many fell ill received vaccine Still effectiveness implies given vaccine administered two shots three weeks apart The efficacy rate could drop full results available well effectiveness required US Food Drug Administration coronavirus vaccine Shortly Pfizer announcement Russia said Sputnik V vaccine also effective based data collated inoculations public Its preliminary Phase III trial data due published month MORE DATA NEEDED To confirm efficacy rate Pfizer said would continue trial cases among volunteers Bourla told CNBC Monday based rising infection rates trial could completed end November Pfizer said data would peer reviewed results entire trial These interesting first signals communicated press releases said Marylyn Addo head tropical medicine University Medical Center HamburgEppendorf Germany Dozens drugmakers research groups around globe racing develop vaccines Sunday exceeded million cases since new coronavirus first emerged late last year China The Pfizer BioNTech vaccine uses messenger RNA mRNA technology relies synthetic genes generated manufactured weeks produced scale rapidly conventional vaccines The technology designed trigger immune response without using pathogens actual virus particles The Trump administration said enough vaccine doses million US residents want middle Â Reuters A woman holds small bottle labeled Coronavirus Vaccine sticker medical syringe illustration DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio WFC Add toRemove Portfolio PHPTHB Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio MRNA Add toRemove Portfolio By Tom Westbrook Elizabeth Howcroft SYDNEYLONDON Reuters Investors expecting imminent vaccine beginning buy bank stocks industrials anticipation roaring return consumer confidence though many remain wary risks sectors ravaged pandemic The development kind preventative medicine seen best chance halting coronavirus killed million people top issue money managers eyeing next major shift financial markets As market hype around US election ebbs investors preparing good vaccine news believe matter It going absolutely massive said Stuart Oakley head cash currency trading Nomura London If get vaccine going see pent demand coming Of roughly vaccines undergoing human trials Pfizer N Moderna O seen possibly winning regulatory approval year AstraZeneca L far behind Investors looking beyond expected excitement rally longerterm beneficiaries shortselling opportunities What done given optionality recovery trade vaccine trade exposure financials said Binay Chandgothia Hong Kongbased portfolio manager Principal Global Investors Banks benefit increased economic activity would helped bond yields rose said adding increased exposure growthsensitive small companies would buy stocks Singapore Hong Kong trade travel pick Brian Jacobsen senior investment strategist Wells Fargo NYSE Asset Management Wisconsin said industrials offered broad exposure rebound confidence areas building products aviation Deutsche Bank DE manages vaccine basket Singapore dollars Thai baht seen benefitting increased trade tourism Philippine peso weighed rising imports Financials industrials gained broader market month badly lag roughly gain world stocks year The baht also surged recently peso THREAD THE NEEDLE Investors also setting short positions Shinji Naito Japan SPARX Asset Management billion management hopes vaccine could trigger payoff shorts stocks pumped pandemic technology firms helping long investments realtor Tokyo Tatemono T Dave Wang portfolio manager Nuvest Capital Singapore said longshort pairs could wring gains likely uneven recovery For example airports charge per aircraft regardless loads could perform better airlines hit low patronage rising fuel costs Of course everyone scrambling piece action amid questions timing efficacy distribution vaccine still remaining You better bit late early said Hugh Dive chief investment officer Atlas Funds Management Sydney noting delays would leave underpressure companies needing raise money quickly Others however feel safe bet global rebound vaccine would boost I think two different trades said Sean Taylor chief investment officer Asia German fund manager DWS A vaccine trade cyclical trade I positioning cyclicals said If got much credible data vaccines I add services',\n",
              " 'Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio By Ludwig Burger Caroline Copley FRANKFURT Reuters AstraZeneca L still waiting US drug regulator approve restart clinical trial potential vaccine United States almost three weeks paused due safety concerns The US trial AstraZeneca vaccine candidate initially developed University Oxford remains hold regulators investigate illness one participants even British study programmes outside United States resumed We sponsor US study We provided information FDA US Food Drug Administration waiting hear decision Soriot told virtual World Economic Forum discussion US Health Human Services Secretary Alex Azar said Wednesday continued suspension showed FDA taking vaccine safety seriously A document posted online Oxford university last week stated illness British participant triggered pause Sept may associated vaccine Asked company disclosed details nature illness Soriot said clinical trial regulators independent supervisors guarding participants privacy Still company would look increasing transparency without compromising individual rights also preventing public volunteers drawing wrong conclusions could endanger trial enrollment We discussing companies industry information offer without compromising patient privacy also without compromising trial said CEO Soriot also said tests vaccine prototype children started yet The British trial launched May seeking volunteers one subgroups children years age',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio MRW Add toRemove Portfolio PNN Add toRemove Portfolio RYA Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio BOOH Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points higher Friday according financial bookmakers futures ahead cash market open AstraZeneca European governments pay claims agreed limit AstraZeneca potential vaccine different terms deal struck Sanofi PA EU official told Reuters Boohoo Fashion retailer Boohoo said independent review allegations working conditions low pay Leicester supply chain recommended improvements company corporate governance Borrowing British public borrowing August government dealt economic damage coronavirus pandemic Kaspikz Kazakhstan bank Kaspikz KSPIKZ announced plans reviving plans abandoned year ago IPO Buffettology Smaller Companies Investment Trust intends raise via initial public offering London Stock Exchange said Airlines Italy antitrust regulator said airlines Easyjet Ryanair Blue Panorama Vueling offering vouchers refunds passengers whose flights cancelled due Automobiles British car production August sector continues suffer due pandemic pushing demand industry body said Consumer sentiment British consumer confidence highest level since coronavirus lockdown started March remains well prepandemic levels survey showed Brexit France week dire British warnings postBrexit transport delays across Channel tactical posturing Financial Times reported Friday Morrisons Morrisons Thursday became first major British supermarket chain purchases key items government imposed new measures stem second wave Banks Britain financial industry staff work home possible truly essential staff going office Financial Conduct Authority said Thursday Oil prices rose track weekly fall rising concerns global resurgence coronavirus infections effects fuel demand Gold inched higher renewed hopes US stimulus measures though bullion track biggest weekly decline month pressured stronger dollar London shares dropped Thursday hitting session lows Britain scaledback job support workers hit resurgent coronavirus pandemic AstraZeneca LON slid US trials vaccine remained hold UK corporate diary Trading statement Â Reuters Traders look financial information computer screens IG Index trading floor Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio MASM Add toRemove Portfolio By Shashank Nayar Reuters London FTSE traded flat Friday surge cases offset support techdriven rally Wall Street bluechip index set record second straight weekly drop fading hopes economic recovery The FTSE index For week far shed stocks auto makers travel insurers biggest laggards surging infections new movement curbs The midcap index Friday The general retailers index sector posting weekly gain retail sales picked consumer confidence index September rose highest level since March survey showed The possibility severe measures adopted UK cases spiral keeping sentiment towards UK equities largely risk averse said Keith Temperton sales trader Forte Securities Gains bluechip recorded previous month begun peter rising infections economic uncertainty overshadowed support past stimulus measures British car production fell nearly half August sector continued suffer due pandemicled impact demand industry body said Vodafone Group Plc L rose reports telephone operator started talks buy Spanish rival MasMovil MC three buyout funds recently took A broader weakness healthcare stocks sent AstraZeneca L shares marginally lower European governments said pay claims agreed limit drugmaker sideeffects potential vaccine Â Reuters FILE PHOTO Small toy figures seen front Vaccine logo illustration taken SASY Add toRemove Portfolio AZN Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters European governments pay claims agreed limit AstraZeneca sideeffects potential vaccine different terms deal struck Sanofi EU official told Reuters The deals reflect different strategies two world top drugmakers protecting debate rages liabilities vaccines aimed ending pandemic AstraZeneca L secured European Union backing confidential agreement reflects lower price sought British drugmaker official said If company asks higher price give conditions said official involved talks declined identified contracts confidential Unexpected sideeffects drug regulatory approval rare speed vaccine pursued increases risks unforeseen conditions The deal AstraZeneca shifts risks involved rollout vaccine taxpayers struck August liability clauses previously reported Under deal AstraZeneca would pay legal costs certain threshold official said declining elaborate costs would shared individual European governments cap The financial shield would cover legal costs potential compensation rarer potentially much bigger outlay event something going wrong In return higher price paid vaccine French drugmaker Sanofi PA working GlaxoSmithKline partner get liability waiver Spokespeople AstraZeneca Sanofi European Commission declined comment specifics deals When asked AstraZeneca relatively low price spokesman reiterated company pledge share vaccine widely turn profit pandemic Under AstraZeneca deal EU countries agreed pay euros per dose Sanofi negotiated price around euros official said SIDEEFFECTS As part supply deals two sealed far Brussels EU also made nonrefundable downpayment million euros AstraZeneca secure million doses proportionately lower million euros paid Sanofi secure million doses The EU official told Reuters contract AstraZeneca included narrow definition sideeffects could limit possibility claiming compensation although company remains liable vaccine The deal AstraZeneca negotiated paused latestage trials vaccine candidate month British volunteer developed neurological symptoms Trials resumed Britain United States EU governments would share compensation costs unexpected sideeffects emerged AstraZeneca vaccine approved Liability key stumbling block talks vaccine makers EU officials said companies fear risk larger legal costs usually face vaccines developed much longer trials A European Commission spokesman said advance purchase deals provide member states indemnify manufacturer certain liabilities incurred specific strict conditions liability still remains companies This means would firm responsibility defend shot courts Drugmakers called EU regulators set Europewide compensation scheme patients organisations calling EUwide fund financed pharmaceutical firms would compensate unexpected sideeffects The EU legal regime among least favourable drugmakers compensation claims although plaintiffs rarely managed win law requires prove link illness vaccine may caused The United States granted immunity liability vaccines receive regulatory approval Meanwhile Russia said would shoulder legal liability anything go wrong vaccine developed Moscow Gamaleya Institute Â Reuters FILE PHOTO Canada Prime Minister Justin Trudeau speaks Question Period House Commons Parliament Hill Ottawa AZN Add toRemove Portfolio OTTAWA Reuters Canada signed deal Cambridgebased AstraZeneca L buy million doses vaccine candidate Prime Minister Justin Trudeau told reporters Friday The medication among leading candidates global race vaccine latestage trials Britain South Africa elsewhere',\n",
              " 'Â Reuters FILE PHOTO World Bank Group President Malpass attends news conference meeting Chancellery Berlin AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio By David Lawder WASHINGTON Reuters World Bank President David Malpass said Tuesday seeking board approval billion coronavirus vaccine financing plan help poor developing countries secure sufficient share vaccine doses become available coming months Malpass told Reuters exclusive interview initiative part billion coronavirus aid financing pledged multilateral lender aimed helping countries procure distribute vaccines early health care essential workers expand global production He said board expected consider plan early October Global competition early coronairus vaccine doses already fierce months ahead approvals wealthy countries move secure supplies The US government pledged billion secure hundreds millions doses vaccines development Britain AstraZeneca L US drug giant Pfizer NYSE Germany BioNTech SE F Malpass said World Bank plan aimed put poor middleincome countries virus spreading rapidly footing richer countries ensuring financing secure supplies system distribution encourage drug makers meet demand Without early doses bring outbreaks control many countries risk economic collapse push hundreds millions people back poverty Our goal alter course pandemic low middle income developing countries Malpass said This market signal manufacturers financing available developing countries demand We begin asking manufacturers begin creating allocations countriesMalpass said World Bank also asking wealthy countries overreserved doses ultimately need release doses poorer countries',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio LSEG Add toRemove Portfolio FGP Add toRemove Portfolio FRAS Add toRemove Portfolio SMDS Add toRemove Portfolio MARS Add toRemove Portfolio CL Add toRemove Portfolio OCDO Add toRemove Portfolio RWS Add toRemove Portfolio OTB Add toRemove Portfolio Dec Britain FTSE index seen opening points higher Thursday according financial bookmakers BREXIT British Prime Minister Boris Johnson EU chief executive gave end weekend seal new trade pact failing overcome persistent rifts frank lively dinner turbot Wednesday Britain medicine regulator said anyone history anaphylaxis medicine food get PfizerBioNTech vaccine giving fuller guidance earlier allergy warning shot ASTRAZENECA Jenner Institute Director Adrian Hill oversees OxfordAstraZeneca vaccine research development said vaccine would available United States middle next year regulators wait end vaccine trial HOUSE PRICES British property surveyors reported house prices increased close fastest rate years last month extending postlockdown boom expect sales fall temporary tax break expires March LONDON STOCK EXCHANGE London Stock Exchange Group said Wednesday expects green light outstanding regulatory scrutiny billion deal buy data analytics company Refinitiv GOLD Gold prices little changed steep selloff previous session breakthrough longrunning negotiations among US lawmakers pandemic relief package remained elusive OIL Oil prices rose early trade buoyed vaccine rollout Britain imminent approval vaccine United States could spur rebound fuel demand despite large build stocks last week The UK bluechip index edged higher Wednesday ahead talks could decide whether Britain ends messy nodeal exit European Union UK CORPORATE DIARY FirstGroup Plc HY earnings Marston Plc FY earnings DS Smith Plc HY earnings On The Beach Plc FY earnings Ocado Group Plc trading statement Frasers Group Plc HY earnings RWS Holdings Plc',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom HSBA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio ITV Add toRemove Portfolio SMDS Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Wednesday losses sectors propelled shares lower At close London fell The biggest gainers session ITV PLC LON rose points trade close EasyJet PLC LON added points end DS Smith PLC LON points late trade Biggest losers included Standard Chartered PLC LON lost points trade late trade AstraZeneca PLC LON declined points end HSBC Holdings PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November rose hit barrel December Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Â Reuters The coronavirus disease outbreak Barcelona AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Benoit Van Overstraeten Jan Lopatka PARISPRAGUE Reuters France imposed curfews European nations closing schools cancelling surgeries enlisting student medics overwhelmed authorities face nightmare scenario resurgence onset winter With new cases hitting daily Europe wide margin overtaken United States infections reported average every day As cases France climbed rapidly President Emmanuel Macron announced night curfews four weeks Saturday Paris major cities affecting almost onethird country million people Macron said interview national television curfews halt temporarily parties moments conviviality people festive evenings unfortunately vectors acceleration disease We get stick together said Most European governments eased lockdowns summer start reviving economies already battered first wave coronavirus pandemic But return normal activity packed restaurants new university terms fuelled sharp spike cases continent German Chancellor Angela Merkel said leaders Germany states agreed Wednesday tougher measures without detailing We already phase exponential growth daily numbers show said Bars pubs among first shut face earlier closing new lockdowns surging infection rates also testing governments resolve keep schools nonCOVID medical care going Even Pope Francis subject new coronavirus rules staying put safe distance wellwishers weekly audience Wednesday In Lisbon football fans unsurprised Portugal captain Cristiano Ronaldo tested positive virus saying simply showed everyone risk getting infected The Czech Republic Europe worst rate per capita shifted schools distance learning plans call thousands medical students Hospitals cutting nonurgent medical procedures free beds Sometimes edge crying said Lenka Krejcova head nurse Slany hospital near Prague builders hurried turn general ward department Poland ramping training nurses considering creating military field hospitals Moscow move many students online learning Northern Ireland closing schools two weeks restaurants four Irish Prime Minister Micheal Martin described Northern Ireland rise cases hugely worrying government increased restrictions three counties border well almost visits homes across country We brink disaster immunologist Pawel Grzesiowski said Poland reported record infections deaths Wednesday Efforts develop vaccine hit snags areas Johnson Johnson N pausing trial unexplained illness study participant AstraZeneca L US trial remained hold month Russia recorded record daily increase cases meanwhile granted regulatory approval second vaccine IMPOSSIBLE CHOICES Germany England France far resisted pressure close schools Germany politicians debating whether extend ChristmasNew Year school break curb contagion The Netherlands returned partial lockdown closing bars restaurants kept schools open European infections running average almost day third global total forcing governments tighten restrictions attempting avoid destroying livelihoods The United Kingdom France Russia Spain accounted half Europe new cases week Oct according World Health Organization In United States world highest number confirmed infections states far October set records increases new cases But deaths trending downward averaged day last week FIELD HOSPITALS British Prime Minister Boris Johnson faces opposition calls another national lockdown England far resisted Hospital admissions however climbing field hospitals constructed spring readied London faces tighter restrictions within days Financial Times reported In Spain authorities Catalonia ordered bars restaurants close days limited numbers people allowed shops In Belgium Europe second worst infection rate per capita hospitals must reserve quarter beds patients We ca see end tunnel today Renaud Mazy managing director University Clinics SaintLuc Brussels told La Premiere radio In Australia one successful countries fighting virus clusters emerged two populous states prompting New South Wales delay relaxing restrictions And new curbs imposed Malaysia royal palace postponed meetings two weeks',\n",
              " 'Â Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration SASY Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio INO Add toRemove Portfolio HVO Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio CVAC Add toRemove Portfolio By Kate Kelland LONDON Reuters Human challenge trials potential vaccines volunteers deliberately infected disease could become reality British biotech firm said advanced talks government create provide strains virus Preliminary work trials aim speed process determining efficacy vaccine candidate carried hVIVO unit pharmaceutical services group Open Orphan L company said We discussions numerous parties including UK government around challenge study contracts signed make announcement said Open Orphan executive chairman Cathal Friel If agreed would involve creating human challenge study model could used trials gain ethical safety approval regulators A government spokesman said UK working partners understand might collaborate potential development vaccine human challenge studies Any potential study must meet UKâs robust regulatory ethical frameworks spokesman added Supporters human challenge trials say good way cut short often lengthy process testing potential vaccines tens thousands volunteers real world go normal life monitored see contract disease protected In tightlycontrolled trials volunteers given vaccine month later deliberately infected disease controlled conditions They isolated quarantine facility monitored see become sick vaccine protects Critics say deliberately infecting someone potentially deadly disease currently effective treatment unethical Leading vaccine developers AstraZeneca L Sanofi PA BioNTech O Moderna O Inovio O said last month respective vaccine candidates involved programme Germany CureVac DE Friday said participation human challenge trial decided yet circumstances would clearer Johnson Johnson N previously said evaluating potential benefit trials Any human challenge trials conducted Britain would approved Medicines Healthcare products Regulatory Agency healthcare regulator looks safety ethics protocol',\n",
              " 'Â Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio CBKG Add toRemove Portfolio AZN Add toRemove Portfolio IWG Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio AMGO Add toRemove Portfolio By Devik Jain Reuters London stocks tracked gains Asian markets Monday investors hoped vaccine end year although concerns tougher business restrictions UK kept demand risky assets check The bluechip FTSE rose led autos insurance real estate stocks A gain AstraZeneca Plc L propped pharmaceuticals index European medicines watchdog recommended approving treatments form heart failure lung disorder The midcap FTSE added shares flexible office space provider IWG Plc L jumping Berenberg upgraded stock buy Risk assets precariously perched shortage uncertainty clouding background said Stephen Innes market strategist Axi The FTSE midcap index recorded first weekly declines three weeks Friday new coronavirusinduced lockdowns London well uncertainty postBrexit trade deal sapped demand equities Ratings agency Moody cut United Kingdom debt rating last week Bank England Governor Andrew Bailey warned significant risk disappointments domestic economic growth Investor focus later day Brexitrelated news Britain European Union set revive negotiations trade deal appeared dead last week side telling needed fundamentally change course What decisive market fact British government end talks EU threatened said Commerzbank DE analyst Esther Reichelt Amigo Holdings Plc L tumbled saying entered Asset Voluntary Requirement AVR Britain financial watchdog meaning subprime lender need approval transfer assets outside group',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio ANTO Add toRemove Portfolio WMH Add toRemove Portfolio SGRO Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio WIZZ Add toRemove Portfolio MTRO Add toRemove Portfolio MHPCq Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Wednesday according financial bookmakers futures ahead cash market open Antofagasta Chilean miner Antofagasta reported drop thirdquarter output previous quarter maintained production guidance William Hill British bookmaker William Hill warned local lockdowns triggered fastspreading second coronavirus wave would hit core earnings due fall gaming revenue Metro Bank Britain Metro Bank reported increase lending third quarter capital levels remain buffers expected regulators grapples impact pandemic FRC Accounting watchdog Financial Reporting Council ensure reports accounts remain clear consistent relevant backdrop increased economic uncertainty brought pandemic Wizz Air The world result coronavirus crisis many privately funded carriers set go governments throwing good money bad keep national champions afloat Wizz Air CEO said GlaxoSmithKline GlaxoSmithKline said would move experimental vaccine respiratory syncytial virus cause pneumonia toddlers elderly final stage testing encouraged midstage trial results AstraZeneca AstraZeneca Plc vaccine trial United States expected US Food Drug Administration completed review serious illness study participant four sources told Reuters Gold prices rose Wednesday optimism US lawmakers could reach agreement preelection coronavirus relief package pressured dollar bolstered precious metal appeal inflation hedge Oil prices eased Wednesday surprise buildup stoked concerns global supply glut even spike global cases fuelled fears slower recovery fuel demand The UK bluechip index closed higher Tuesday investors remained hopeful trade deal European Union yearend although gains capped concerns tougher coronavirus lockdowns parts England UK corporate diary preclose trading update trading statement production report Manchester United Plc MANUN results Trading statement Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Julie Steenhuysen Marisa Taylor CHICAGOWASHINGTON Reuters AstraZeneca Plc L vaccine trial United States expected resume early week US Food Drug Administration completed review serious illness study participant four sources told Reuters AstraZeneca large latestage US trial hold since Sept participant company UK trial fell ill suspected rare spinal inflammatory disorder called transverse myelitis The sources briefed matter asked remain anonymous said told trial could resume later week It unclear FDA would characterize illness said An FDA spokeswoman declined comment The agency requiring researchers conducting trial add information incident consent forms signed study participants according one sources UK regulatory officials previously reviewed illness determined âœinsufficient evidence say certainâ related vaccine It permitted trial resume UK according draft updated consent form shared Reuters âœIn case considering information independent reviewers MHRA Medicines Healthcare products Regulatory Agency recommended vaccinations continueâ draft consent form stated âœClose monitoring affected individual participants continuedâ Regulators Brazil India South Africa also previously allowed AstraZeneca resume vaccine trials AstraZeneca developing vaccine Oxford University researchers seen frontrunner race produce vaccine trials put hold investigate illness Early data largescale trials United States vaccines Pfizer Inc N Moderna Inc O expected time next month Johnson Johnson N last week paused Phase III vaccine trial investigate unexplained illness study participant At time announcement company know whether volunteer given vaccine placebo A JJ spokesman Tuesday said study remains pause company continues review medical information deciding restart trial JJ noted last week study pause voluntary By contrast AstraZeneca trial regulatory hold imposed health authorities Vaccines seen essential helping end pandemic battered economies around world claimed million lives United States Responding request AstraZeneca trial British regulators shared Reuters draft form letter UK vaccine trial participants dated Oct signed Oxford Vaccine Team It says US FDA âœcompleted analysisâ said vaccination study United States would resume shortly FDA come conclusion drug regulators including MHRA letter states The Health Research Authority helps oversee UK medical research said email Reuters vetted communication make sure suitable ensure informed consent among study volunteers It could confirm letter issued An AstraZeneca spokeswoman said communication company verify content referring draft letter study participants We also comment pending FDA decision said The Oxford study team respond requests comment NOT ENOUGH EVIDENCE In another documents directed trial participants Oxford vaccine study team noted enough evidence link neurological problem seen UK trial vaccine Dr Paul Offit director Vaccine Education Center Childrenâs Hospital Philadelphia reviewed document said difficult link rare side effect specifically vaccine exclusion potential causes Transverse myelitis study volunteer believed developed typically occurs rate people Offit said would unusual see trial individuals Other viruses including cause West Nile polio trigger condition physical trauma The regulators weigh whether rare side effect vaccinerelated could occur sickness deaths linked Offit said That always line walk',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio AAL Add toRemove Portfolio ULVR Add toRemove Portfolio TPK Add toRemove Portfolio RTO Add toRemove Portfolio MONY Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio POLYP Add toRemove Portfolio ULVR Add toRemove Portfolio Oct Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open Relx European information business Relx Plc said annual revenue could fall much million pounds short costs exhibitions business suffered coronavirusdriven halts major events year Rentokil Initial Rentokil Initial thirdquarter revenue higher focus hygiene standards due pandemic boosted demand disinfection services Unilever Unilever reported third quarter led emerging markets generates bulk revenue IAG British Airwaysowner IAG reported third quarter coronavirus restrictions continue depress travel forcing downgrade capacity outlook rest year Anglo American Anglo American Plc posted yearonyear fall thirdquarter output reflecting maintenance MinasRio iron ore mine Brazil suspension Grosvenor metallurgical coal operations Australia AstraZeneca Brazilian health authority Anvisa said Wednesday volunteer clinical trial vaccine developed AstraZeneca Oxford University died added trial would continue Gold slipped oneweek high hit last session dollar recovered lost ground doubts emerged whether agreement new US fiscal coronavirus aid package could reached election Oil prices dropped early trade adding heavy losses overnight build US pointed deteriorating outlook fuel demand coronavirus cases soar North America Europe The UK bluechip index closed lower Wednesday jumped hopes Brexit talks set resume investors remained concerned prospects coronavirus restrictions England UK corporate diary trading statement production report trading statement production results trading statement trading statement trading statement Â Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio AZN Add toRemove Portfolio JDW Add toRemove Portfolio ULVR Add toRemove Portfolio MAB Add toRemove Portfolio RTO Add toRemove Portfolio MARS Add toRemove Portfolio FTMC Add toRemove Portfolio By Devik Jain Joice Alves Reuters British midcaps jumped Thursday erasing earlier losses positive update AstraZeneca vaccine candidate finance minister Rishi Sunak unveiled support businesses hit pandemic The domesticallyfocussed midcap FTSE rose recoup declines earlier week pubs restaurant operators Marston Plc L J D Wetherspoon Plc L Mitchells Butlers Plc L jumping The bluechip FTSE index also added study found AstraZeneca Plc L Oxford vaccine accurately followed genetic instructions programmed successfully provoke strong immune response Vaccine news tends one big market movers looks like probably combined Sunak announcement seen market shift green said Connor Campbell market analyst Spreadex Fears new coronavirusled restrictions well Brexitrelated uncertainty weighed UK stock markets recently FTSE still course second straight week declines The new measures announced Sunak included easing eligibility jobs support scheme new cash grants affected businesses In company news Unilever Plc L rose reported strongerthanexpected return sales growth third quarter led emerging markets generates bulk revenue Rentokil Initial Plc L gained pest control firm posted rise thirdquarter revenue due higher demand disinfection services Britain set resume talks postBrexit trade deal European Union Thursday marking new push two sides protect billions dollars worth trade beginning next year Â Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio LONDON Reuters Britain Thursday said would partner Oxfordbased firm provide testing T cell response coronavirus vaccine candidates try assess immune responses T cell immunity thought essential protection infection coronavirus could provide longer term immunity antibodies The UK Vaccine Taskforce chosen Oxford Immunotec supply T cell testing assessment different vaccine candidates It important able assess different vaccines headtohead T cell response part portfolio accredited assays employing cross comparisons Kate Bingham chair UK Vaccines Taskforce said statement Britain signed supply deals six different coronavirus vaccine candidates including made AstraZeneca L Pfizer N BioNTech F seen among frontrunners race vaccine Oxford Immunotec said techonology platform enabled centralisation fresh blood samples different locations measure T cell response standardised way It said platform known TSPOT used identify T cells made response pathogen causes tuberculosis',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BARC Add toRemove Portfolio IHG Add toRemove Portfolio SRG Add toRemove Portfolio AZN Add toRemove Portfolio LSEG Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio ITM Add toRemove Portfolio AAF Add toRemove Portfolio Oct Reuters Futures Britain FTSE index seen ahead cash market open Friday according financial bookmakers British Retail British retail sales last month grew fifth month row taking total sales volumes level pandemic InterContinental Hotels Holiday Innowner InterContinental Hotels posted hotel room revenue RevPAR pandemic continued ravage travel hospitality industry The London Stock Exchange The London Stock Exchange said expects data analytics firm Refinitiv first quarter posted increase thirdquarter total income Barclays Barclays reported third quarter earnings consumer businesses swung back profit provisions bad loans fell compared previous quarter AstraZeneca The Peruvian government refused sign coronavirus vaccine purchase agreement AstraZeneca PLC provide sufficient data studies offered minimal amounts inoculations ITM Power Italian gas group Snam said Thursday would buy minority stake ITM Power part broader agreement British company help develop green hydrogen business Gold edged hopes US stimulus package would eventually passed boosting metal appeal inflation hedge although stronger dollar capped gains Oil prices held gains previous session Friday Russian President Vladimir Putin indicated would prepared extend record supply cuts face pandemic The UK bluechip index closed higher Thursday positive update AstraZeneca vaccine candidate UK finance minister Rishi Sunak unveiled support businesses hit pandemic UK corporate diary trading statement earnings trading statement HY earnings AZN Add toRemove Portfolio PFE Add toRemove Portfolio AZN Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio Bloomberg President Donald Trump Democratic nominee Joe Biden faced last time Nov election Bloomberg News checking facts behind claims Thursdayâs debate Trump claims Biden got money China Ukraine son Hunter CLAIM A man named Tony Bobulinski told reporters Nashville debate Hunter Biden former vice presidentâs son recruited chief executive officer proposed partnership Chinese company Biden family At event called Trump campaign Bobulinski said May email Hunter Biden called providing stake company âœthe big guyâ said nickname Hunter often used father But Bobulinski invited Trump guest debate offered evidence took questions Bloomberg News canât verify Bobulinski connection Hunter Biden father Biden campaign spokesman Andrew Bates said statement âœJoe Biden never even considered involved business family overseas business whatsoever He never held stock business arrangements family member person ever held stock himâ On Ukraine Hunter Biden served board Burisma energy company The New York Post says laptop allegedly abandoned Hunter Biden included emails suggesting former vice president met senior official company If true contradicts Joe Bidenâs insistence involvement sonâs business dealings never discussed Bloomberg News hasnât verified authenticity emails Biden campaign denied meeting ever took place Biden released tax returns last year Thereâs Jill reported taxable income paying taxes The Bidens earn money variety ways including fees speeches royalties books salaries teaching roles Biden claims Trump hiding Chinese bank account A report New York Times revealed Chinese bank account controlled Trump entity called Trump International Hotels Management LLC The paper said tax records show paid taxes China pursuing licensing deals Trump said debate business account considering business China believes account closed Trump claims US response virus effective By measures US pandemic response chaotic results catastrophic The US deaths attributed million cases Thatâs cases nation including India population four times US It true US hasnât deaths per capita according Johns Hopkins University Its death rate behind Peru Belgium Bolivia Brazil Spain Chile Ecuador Mexico Still perhaps developed nation US coronavirus response marked confusion kept countryâs numbers surging many nations hit virus earlyon seen infection rates decline Missteps handling virus include advising public initially wear masks advising donât exhibit symptoms get tested continued shortages supplies testing backlogs Seven months pandemic US still streamlined testing efforts countries praised virus response including South Korea Germany Trump says vaccine ready yearâs end Vaccines typically take many years develop part must proven extremely safe theyâre given healthy people But around world governments pharmaceutical companies researchers sought expedite process coronavirus There currently experimental coronavirus vaccines development according World Health Organization entered human studies Experimental shots Pfizer Inc NYSE partnership BioNTech SE NASDAQ University Oxford AstraZeneca NYSE Plc Moderna NASDAQ Inc among vanguard Pfizer looking file application late November Moderna expects interim results November positive emergency use authorization December Unfortunately Astrazeneca LON Johnson Johnson pause vaccine trials due adverse health effects Importantly vaccine approved itâs challenge get widely distributed Estimates top health officials ranged end March end Americans would access Trump said assertion Robert Redfield director US Centers Disease Control Prevention disbursement vaccine would come time late spring summer next year âœa mistakeâ Redfield isnât top US health official offering less ambitious forecasts getting vaccine public Paul Mango deputy chief staff policy Department Health Human Services said would probably widely available end March And Anthony Fauci head National Institute Allergy Infectious Diseases forecast timeline similar Redfieldâs interview Bloomberg Television Bloomberg LP Â Reuters Add toRemove Portfolio DJI Add toRemove Portfolio INTC Add toRemove Portfolio MSFT Add toRemove Portfolio GILD Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio TSLA Add toRemove Portfolio IXIC Add toRemove Portfolio META Add toRemove Portfolio GOOG Add toRemove Portfolio SPCE Add toRemove Portfolio By Yasin Ebrahim Investingcom âThe Dow snapped threeweek win streak ending flatline Friday investor jitters stimulus slump Intel hurt sentiment stocks The fell points The rose Intel NASDAQ slumped intraday chipmakerâs betterthanexpected thirdquarter earnings revenue overshadowed weaker margins amid wobble data center business Analysts warned Intel unlikely see recovery margins immediate future âœDCG fell short expectation gross margin disappointed basis pointsâ gross margin faces multiple mixrelated headwinds fourth reflecting lower enterprise government internet things group higher consumer education NB mixâ Oppenheimer said The fall Intel weighed broader tech market though Fab closed mostly green keep losses check Amazoncom NASDAQ Facebook NASDAQ Googleparent Alphabet NASDAQ Microsoft NASDAQ ended higher Apple NASDAQ closed red And stimulus talk weighed sentiment little sign rolled Nov election US Treasury Secretary Steven Mnuchin indicated House Speaker Nancy Pelosi dragging feet key differences said speaker would make concessions get deal line âœWeâve offered compromisesâ Mnuchin told reporters White House according Bloomberg âœThe speaker number issues still dug If wants compromise dealâ Stocks linked progress economy including financials energy industrials red Energy fell paced decline oil prices ongoing demand concerns amid rising US Europe offset prospect extension OPEC allies productioncut accord In news Virgin Galactic NYSE fell Goldman initiated coverage stock neutral Tesla NASDAQ meanwhile fell reports recalling nearly Model S Model X electric vehicles potential suspension defects On vaccine front AstraZeneca PLC LON reportedly received green light US Federal Drug Administration resume clinical trials vaccine The news comes day Gilead NASDAQ antiviral drug remdesivir given full authorization treat patients hospitalized Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Kanishka Singh Reuters AstraZeneca Plc L said Friday coronavirus vaccine deal Oxford University allow add manufacturing costs cover additional expenses required incurred British drugmaker In addition manufacturing costs company incurring costs excess billion globally include clinical development regulatory distribution pharmacovigilance expenses AstraZeneca spokesman said statement To cover additional expenses company add amount equivalent maximum manufacturing costs ensure material impact finances year continuing efforts provide vaccine profit pandemic statement added AstraZeneca previously signed multiple supplyandmanufacture deals billion doses globally These agreements companies governments company gets closer reporting early results latestage clinical trial Developed University Oxford licensed AstraZeneca April vaccine expected one first big pharma secure regulatory approval The company said earlier created multiple supply chains ensure access vaccine timely broad equitable high lowincome countries alike Pricing supply experimental vaccines widely debated richer countries pump billions dollars funding AstraZeneca also granted protection future liability claims Separately AstraZeneca resumed US trial experimental vaccine approval regulators company said Friday',\n",
              " 'Â Reuters People wearing protective face masks park Brussels AZN Add toRemove Portfolio By James Mackenzie MILAN Reuters European leaders warned difficult months ahead resurgent pandemic forced authorities impose new restrictions try curb spread disease Word vaccine developed University Oxford AstraZeneca Plc L produced immune responses elderly young people offered positive news However British Health Secretary Matt Hancock cautioned vaccine would widely available next year said yet Elsewhere picture unrelentingly grim string countries reported record increases led France posted daily cases first time Sunday continent passed threshold deaths Governments desperate avoid lockdowns curbed disease start year cost shutting entire economies But steady rise new cases forced ratchet controls steadily We facing difficult months ahead German Chancellor Angela Merkel told meeting leaders Christian Democrat party according daily Bild Although Germany fared relatively well compared countries Europe seen sharp rise cases closely watched Ifo business climate index fell Monday reflecting worries virus The gloom around resurgent virus weighed financial markets oil prices dropped concerns another slide demand stock markets also fell In Spain million cases disease Prime Minister Pedro Sanchez warned country facing extreme situation announced new state emergency Sunday imposing local nighttime curfews banning travel regions cases Italy country worst hit early stages crisis March also imposed new curbs ordering restaurants bars close pm shutting cinemas gyms imposing local curfews several regions Street clashes small groups protestors weekend angry criticism restaurant owners business groups impact measures underlined increasingly tense climate facing Prime Minister Giuseppe Conte Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BP Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio CCC Add toRemove Portfolio DLAR Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio CTEC Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Friday according financial bookmakers futures ahead cash market open International Consolidated Airlines British Airwaysowner IAG said called governments adopt predeparture testing allow travel second wave infections locked Europe Natwest British lender NatWest reported setting aside smallerthenexpected cash pile deal likely loan defaults due coronavirus pandemic AstraZeneca AstraZeneca Plc said two heart failure blood pressure medicines German pharmaceutical company Cheplapharm Arzneimittel GmbH million Vivo Energy Africafocussed fuel retailer Vivo Energy VVOL said pay previously withdrawn final dividend cents per share volume third quarter improved compared second restrictions began ease De La Rue The Bank England said extended banknote printing contract De La Rue BP BP plc plans convert Kwinana oil refinery biggest country four fuel import terminal thanks tough competition Asian market global major said Royal Dutch Shell Royal Dutch Shell Plc said ramping production Mars Corridor And Appomattox platforms Gulf Mexico shut due Hurricane Zeta PizzaExpress PizzaExpress said would across UK restaurants new coronavirus restrictions especially city centres kept consumers eating Gold prices rose dollar retreated supported worries soaring coronavirus cases United States Europe well uncertainty upcoming US presidential election Oil prices tumbled touching fivemonth low extending previous day sharp decline impact renewed coronavirus lockdowns could oil demand The UK bluechip index fell Thursday concerns resurgence coronavirus cases might derail fragile economic recovery offsetting clutch positive earnings Royal Dutch Shell Lloyds Bank LON UK CORPORATE DIARY ConvaTec Group Plc trading statement International Consolidated Airlines Group SA earnings Computacentre Plc trading statement Â Reuters UK shares lower close trade Investingcom United Kingdom TUIGn Add toRemove Portfolio AZN Add toRemove Portfolio BT Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London fell The biggest gainers session AstraZeneca PLC LON rose points trade close BT Group PLC LON added points end Avast PLC LON points late trade Biggest losers included Tui AG LON lost points trade late trade Carnival PLC LON declined points end International Consolidated Airlines Group SA LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio KO Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio RPS Add toRemove Portfolio PZC Add toRemove Portfolio CCL Add toRemove Portfolio CCEP Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio KCT Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers AstraZeneca AstraZeneca Plc experimental vaccine approval regulators Johnson Johnson JNJN preparing resume trial Monday Tuesday companies said Friday Rio Tinto Global miner Rio Tinto seeking court approval sell partner share diamonds mine Canada Northwest Territories filing week showed hoping recover around million plus legal fees costs Coca Cola Europeand Partners CocaCola NYSE Amatil Ltd said CocaCola European Partners offered billion billion would country biggest deal year UK regulators UK regulators considering plans allow banks start paying dividends next year The Times newspaper reported Monday Gold prices fell oneweek low dollar firmed talks new US coronavirus aid package showed signs progress Oil extended last week losses falling nearly surge infections United States Europe prompted concern crude demand prospect increased supply also hit sentiment The UK bluechip index closed higher Friday boosted upbeat Barclays LON earnings rising hopes Brexit trade deal year end bluechip FTSE still logged second weekly decline concerns fresh coronavirus restrictions UK corporate diary FY earnings Trading statement trading statement Â Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio KO Add toRemove Portfolio HSBA Add toRemove Portfolio BARC Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio PSON Add toRemove Portfolio CCL Add toRemove Portfolio CCEP Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio By Devik Jain Reuters London FTSE pared early losses Monday surge banks following report central bank considering allowing dividend payments helped offset losses energy mining stocks due weak commodity prices Shares Barclays L HSBC L Lloyds Banking LON Group L rose The Times newspaper reported Bank England BoE commercial banks bartering deal allow banks make shareholder payouts Having declined much early trading FTSE index domesticallyfocussed midcap FTSE index lost travel leisure industrial stocks fell European markets broadly weighed fears resurgence coronavirus cases would hamper economic recovery government tightens restrictions activity There fear get long winter restrictions across Europe hobbles consumer demand investor confidence said Neil Wilson chief market analyst Marketscom After stimulusbacked sharp rally pandemic lows FTSE trading tight ranges since June due Brexitrelated uncertainty concerns coronavirus curbs AstraZeneca Plc L rose drugmaker resumed US trial experimental vaccine said vaccine developed University Oxford produced similar immune response older younger adults The wider sectoral index added Educational publisher Pearson Plc L added UBS upgraded stock buy rating CocaCola NYSE European Partners CCEP L surged soft drink bottler made buyout offer billion Australian peer CocaCola Amatil Ltd AX',\n",
              " 'Â Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters Senior sources British government expect verdict whether Pfizer Incbacked N vaccine works available results AstraZeneca Plc L competing vaccine Times reported Britain believes vaccine Pfizer codeveloping Germany BioNTech SE F could ready distribute Christmas report said Pfizer Chief Executive Albert Bourla previously said company could release data whether vaccine works early month The US drugmaker said week trials successful company expects file emergency authorization vaccine candidate US regulators shortly enough safety data late November Britain agreed supply deals six vaccine candidates including frontrunners Pfizer AstraZeneca',\n",
              " 'Â Reuters BT Add toRemove Portfolio UBER Add toRemove Portfolio AML Add toRemove Portfolio INDV Add toRemove Portfolio BABA Add toRemove Portfolio AGLE Add toRemove Portfolio EVRE Add toRemove Portfolio CL Add toRemove Portfolio Gold Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio SN Add toRemove Portfolio STAN Add toRemove Portfolio KAZ Add toRemove Portfolio WPP Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio LLOY Add toRemove Portfolio HSBA Add toRemove Portfolio XAUUSD Add toRemove Portfolio Oct Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open Royal Dutch Shell Royal Dutch Shell announced increase thirdquarter dividend reporting quarter SmithNephew SmithNephew said revenue recovered strongly third quarter second hospitals managed carry elective surgeries initial wave coronavirus infections WPP The world biggest advertising company WPP said client wins Uber NYSE Alibaba NYSE HSBC LON helped report underlying trading Lloyds Lloyds Banking Group posted lowering provisions expected bad loans due pandemic cashing boom demand mortgages BT BT Britain biggest fixedline mobile operator said first half given challenges raised lower limit earnings guidance year AstraZeneca Senior sources British government expect verdict whether Pfizer NYSE Incbacked PFEN available results AstraZeneca Plc competing vaccine Times reported Standard Chartered Standard Chartered said thirdquarter profit slid higher credit impairment resulting coronavirus pandemic lower interest rates although tighter rein costs Aston Martin British luxury car maker Aston Martin testing investor appetite risky assets days US election one largest deals kind Europe year Gold edged plunge previous session surging global coronavirus cases fears contested US presidential election spurred demand although strong dollar capped gains Oil prices rose early trading regaining ground lost slump overnight amid prospect tighter shortterm supply twothirds US output shut Gulf Mexico Hurricane Zeta slammed Louisiana The UK bluechip index closed lower Wednesday investors dumped riskier assets fears lockdowns uncertainty British trade deal EU UK corporate diary EVRAZ Plc trading update HY earnings HY earnings Smith Nephew Plc trading statement WPP Plc trading statement KAZ Minerals Plc production report earnings',\n",
              " 'Â Reuters FILE PHOTO FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Friday would sell commercial rights two drugs German pharmaceutical company million British drugmaker looks focus newer medicines new therapy areas AstraZeneca said would sell rights heart failure blood pressure medicines Atacand Atacand Plus Germany Cheplapharm Arzneimittel GmbH AstraZeneca among frontrunners race develop vaccine novel coronavirus trying focus cancer drug portfolio bid streamline business The agreement Cheplapharm supports AstraZeneca strategy focusing newer medicines main therapy areas drugmaker said The Londonlisted company seen head start race cancer treatments sales medicines including blockbuster lung cancer drug Imfinzi key turnaround Cheplapharm held European rights Atacand Atacand Plus since allowed sell around countries Atacand prescription drug approved treat heart failure hypertension Atacand Plus used hypertension The transaction expected close fourth quarter impact financial forecast AstraZeneca said The company said million million consideration payable deal completion remainder first half AstraZeneca manufacture supply medicines commercialise threeyear transition period company said Last year AstraZeneca sold global commercial rights drug treat acid reflux Cheplapharm million AstraZeneca shares trading slightly lower GMT',\n",
              " 'Â Reuters The Pfizer logo seen UK commercial headquarters Walton Oaks SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio NVAX Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio CVAC Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Union struck deal initially pay less Pfizer N vaccine candidate United States EU official told Reuters bloc announced Wednesday secured agreement million doses The experimental drug developed conjunction Germany BioNTech DE frontrunner global race produce vaccine interim data released Monday showing effective protecting people largescale clinical trial Under EU deal European countries could buy million doses option purchase another million The bloc pay less per shot senior EU official involved talks vaccine makers told Reuters adding partly reflected financial support given EU Germany drug development The official requested anonymity terms agreement confidential The United States agreed pay per shot million doses smaller volume EU But option buy million terms negotiated separately price pay unclear BioNTech signalled week order size would impact perdose price developed world said would differentiate pricing countries regions potential vaccine The EU official said EU agreed price closer declined give precise figure Pfizer BioNTech declined comment pricing A spokesman EU Commission negotiates vaccine agreements behalf EU states also declined comment In June European Investment Bank EU financial arm granted million loan BioNTech development manufacturing vaccine followed September another funding Germany research ministry With fourth contract consolidating extremely solid vaccine candidate portfolio advanced trials phase President European Commission Ursula von der Leyen said announcing Pfizer deal The EU already signed supply deals AstraZeneca L Sanofi PA Johnson Johnson N experimental shots talking Moderna O CureVac DE Novavax O secure vaccines Under EU deals vaccine makers bloc offers nonrefundable payment companies exchange right book doses EU states could buy preagreed price vaccine approved effective safe EU drug regulator The Commission disclose payment made Pfizer BioNTech COPY PASTE ON LIABILITY TERMS The prices agreed EU previous deals vaccine makers partly influenced liability terms could cause large additional legal costs inoculated people developed unexpected conditions shots Asked liability clauses Pfizer contract bone contention EU negotiators drugmakers EU official said conditions different EU agreed companies also different Pfizer US government There copy paste liability terms previous contracts official said French drugmaker Sanofi working GlaxoSmithKline L partner agreed EU price euros per dose get liability waiver AstraZeneca would pay claims certain threshold something goes wrong vaccine exchange price euro per dose official told Reuters September Bad sideeffects vaccine approved rare considered likely emergency unprecedented speed vaccines developed The United States granted immunity liability vaccines receive regulatory approval Â Reuters FILE PHOTO A woman uses computer keyboard photo illustration AZN Add toRemove Portfolio ULVR Add toRemove Portfolio NG Add toRemove Portfolio ULVR Add toRemove Portfolio DAVA Add toRemove Portfolio By Sinead Cruise LONDON Reuters Bank England Chief Economist Andy Haldane signed judge winner game designed help firms find alternatives mass layoffs face coronavirusdriven slowdown Confronted unpredictable pandemic memory costconscious firms already axed millions staff worldwide UK redundancies hit record high quarter Sept official data showed Tuesday Unileverowned AS tech firm uFlexReward created War Game allow executives explore impact huge job cuts future earnings prospects Many companies across UK facing financial strains result COVID crisis Haldane told Reuters Simulation tools help us understand best alleviate strains preserving jobs way helps businesses making difficult commercial decisions policymakers making difficult economic decisions The game designed Britain first lockdown year available free play uFlexReward website calls players devise strategy cut people costs fictional firm Participants weigh pros cons largescale redundancies versus alternatives longterm benefit firm well broader economy It collates staff salaries pensions bonuses share awards one realtime costbase helping players see different ways trimming overheads clearly This include making lots smaller cost cuts socalled approach rather one large saving focused cuts like scrapping entire business units staff bonus pool Financial firms historically slashed highly paid workforces eve recession rehire rapidly economy rebounds Swapping convention broadfront approach could minimise risks employers end understaffed underskilled recovery kicks uFlexReward Chief Executive Ken Charman said IS COMING Employers multiple sectors facing prospect broader revolution world work triggered technology mass remote working We still stuck Victorian view work fixed working days single employer typically narrow role Charman said But change coming allow people several things companies lose people highly trained experienced loyal wo get back said Charman hopes game might persuade employers waive cut dividends well executive pay increases offer jobsharing reduced hours parttime roles flexibility work elsewhere staff might otherwise end unemployed Pushing alternatives mass layoffs require strong leadership communication particularly thousands employee contracts need renegotiated retaining staff could leave firms better placed recovery begins Charman said Executives need willing abandon old conventions resistance got able convince people best interests said Employers big companies big financial institutions part critical national infrastructure much National Grid LON They engines growth threat Judging headtohead version game featuring teams made executives Unilever LON NYSElisted technology services provider Endava N take place Dec Together Haldane AstraZeneca L senior vice president reward inclusion Rebekah Martin Unilever head global reward Constantina Tribou author David Goodhart among judging strategies',\n",
              " 'Â Reuters FILE PHOTO Employee Philipp Hoffmann German biopharmaceutical company CureVac demonstrates research workflow vaccine coronavirus disease laboratory Tuebingen SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio CVAC Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Union struck deal million doses German biotech firm CureVac DE potential vaccine head EU executive said Monday taking total supplies secured bloc nearly billion doses The deal CureVac follows EU supply agreements AstraZeneca L Johnson Johnson N Sanofi PA Pfizer N combined billion doses potential vaccines I glad announce new agreement buy million doses vaccine produced European company CureVac European Commission President Ursula von der Leyen said adding contract negotiated EU funding company develop vaccine The EU population million talks CureVac experimental vaccine least since July internal EU document seen Reuters shows confirming exclusive Reuters report The deal authorised Commission Tuesday von der Leyen said actual signature take place days later Under advance purchase agreements negotiated EU pandemic bloc makes nonrefundable payment vaccine maker secure certain number doses agreed price paid EU states willing buy shot authorised safe effective EU drugs regulator The price agreed vaccine disclosed The deal initially cover million doses option buy another million CureVac immediately available comment The Commission president also said hoped finalise deal soon Moderna O vaccine Monday announced positive interim results largescale clinical trials CureVac approach based socalled messenger RNA mRNA pieces genetic code prompt human cells produce therapeutic proteins technology used Moderna also PfizerBioNTech major potential vaccine reported positive latestage trial results Â Reuters The Pfizer logo seen UK commercial headquarters Walton Oaks JPM Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio By Danilo Masoni MILAN Reuters Shares Pfizer N fell Monday rival drugmaker Moderna O said experimental vaccine effective stored normal fridge temperatures Moderna second US company report encouraging trial results vaccine joining Pfizer N said vaccine also effective But Pfizer vaccine stored shipped ultracool temperatures Moderna said product kept normal fridge temperatures This important perhaps game changer said Fawad Razaqzada analyst ThinkMarkets The Pfizer vaccine kept cold temperatures minus degrees Celsius making logistically difficult produce transport large doses vaccine said Pfizer shares Nov hit highest levels since end July fell GMT shares German partner BioNTech JPMorgan NYSE analysts said logistics Moderna vaccine clearly less onerous although expect storage requirements vaccines converge Moderna shares hitting record high earlier Monday shares British drugmaker AstraZeneca L yet release results latestage vaccine trials',\n",
              " 'Â Reuters FILE PHOTO People walk past Pfizer headquarters building AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Michael Erman Ludwig Burger Reuters Pfizer Inc N BioNTech O could secure emergency US European authorization vaccine next month final trial results showed success rate serious side effects drugmakers said Wednesday The efficacy shot found consistent across different ages ethnicities promising sign given disease disproportionately affected elderly certain groups including Black people The US Food Drug Administration could grant emergencyuse approval towards end first half December early second half BioNTech Chief Executive Ugur Sahin told Reuters TV Conditional approval European Union could secured second half December added If goes well I could imagine gain approval second half December start deliveries Christmas really goes positively said The success rate vaccine developed US firm Pfizer Germany BioNTech highest candidate latestage clinical trials far experts said significant achievement race end pandemic Pfizer said volunteers trial involving people contracted given placebo meaning vaccine effective Of people severe one received vaccine A first history mankind less year sequence virus largescale clinical trial vaccine moreover based whole new technique said Enrico Bucci biologist Temple University Philadelphia Today special day BioNTech Sahin said US emergency authorization would applied Friday The FDA committee tentatively plans meet Dec source familiar situation said though dates could still change The FDA respond requests comment RUNS RAMPANT The final trial analysis comes week initial results showed vaccine effective Moderna Inc O released preliminary data vaccine Monday showing effectiveness The betterthanexpected results two vaccines developed new messenger RNA mRNA technology raised hopes end pandemic killed million people wreaked havoc upon economies daily life The PfizerBioNTech shot found efficacy people years experts said crucial time running rampant around world record numbers new cases hospitalizations This evidence needed ensure vulnerable people protected said Andrew Hill senior visiting research fellow University Liverpool department pharmacology Global shares rose trial results countered concerns around stubbornly high global infection rate Pfizer shares BioNTech jumped United States By contrast Moderna dropped Investors treated vaccine development race companies although likely global demand much vaccine produced foreseeable future DISTRIBUTING SHOTS Pfizer says expects make many million vaccine doses year enough protect million people produce billion doses While groups healthcare workers prioritized United States Britain vaccinations year months largescale rollouts begin either country Pfizer also agreements European Union Germany Japan distribution could begin next year Mike Ryan World Health Organization top emergency expert said would least months significant levels vaccination taking place around world Distribution PfizerBioNTech shot complicated need store ultracold temperatures degrees Celsius It however kept normal fridge five days days thermal shipping box Moderna vaccine stored six months though expected stable days normal fridge temperatures degrees Celsius FATIGUE AND HEADACHES Pfizer said twodose vaccine called welltolerated side effects mostly mild moderate cleared quickly It said severe adverse events experienced volunteers fatigue headaches Out participants headaches second dose experienced fatigue Older adults tended report fewer milder adverse events These extraordinary results safety data look good said David Spiegelhalter professor expert risk evidence communication University Cambridge It would interesting see adverse reactions reported group getting placebo since gives idea much adverse effects due vaccination process much due vaccine Of dozens drugmakers research groups racing develop vaccines next data release likely AstraZeneca Plc L University Oxford November December Johnson Johnson says track deliver data year GRAPHICTracking vaccine race Authorization vaccines children take longer Only Pfizer started vaccinating volunteers age trials giving shots children young Moderna Johnson Johnson N said hope start testing vaccine younger patients soon',\n",
              " 'Â Reuters FILE PHOTO Britain Health Secretary Matt Hancock holds media briefing Downing Street London AZN Add toRemove Portfolio PFE Add toRemove Portfolio By Alistair Smout LONDON Reuters English doctors grappling prospect sevenday service degree Celsius freezers vaccines known Talent Courageous prepare unprecedented logistical challenge rollout vaccinations Health minister Matt Hancock set target England National Health Service ready administer vaccines Dec although said central expectation bulk rollout happen next year Any distribution vaccines would also require approval country medical watchdog MHRA On Wednesday NHS England medical director Stephen Powis confirmed general practitioners GPs pharmacies largescale inoculation centres could involved vaccine rollout adding details would given coming days There going nationally organised vaccine immunisation centres large centres probably run military involved etc But GPs well placed Steve Mowle practising GP honorary treasurer Royal College General Practitioners told Reuters The challenge task even bigger flu immunisation programme But I sure GPs central role delivering vaccine Germany scouting trade fair halls airport terminals possible mass vaccination centres Italy plans lean existing GP network But many countries details population inoculated scarce A spokesman Britain health ministry said extra logistical expertise transport arrangements equipment put place workforce expanded million pounds given GP practices An enormous amount planning taken place ensure health service stands ready roll vaccine said We publish details deployment plans due course AND Although still lack clarity details doctors expected deliver vaccines briefed broad outlines In absence trade names NHS uses codenames refer two vaccine candidates expected first available Pfizer N BioNTech vaccine candidate uses mRNA platform referred Courageous vaccine University Oxford AstraZeneca L referred Talent vaccine slides webinar health professionals given NHS England last week reviewed Reuters Britain ordered million doses PfizerBioNTech vaccine candidate efficacy final trial results published Wednesday million doses OxfordAstraZeneca shot expected publish efficacy data coming weeks In webinar doctors told would doses per pack Pfizer vaccine two doses needed given days apart line US drugmaker design specifications Clinics could also need open weekends make sure doses used time Potential vaccines could need delivered within certain time period arrive site slide said So necessary otherwise practices need ability deliver vaccinations pm seven days week avoid going waste TWIN TRACK The urgency getting vaccines delivered people promptly received stems part demanding storage requirements PfizerBioNTech vaccine needs kept around degrees Celsius It stored five days refrigeration diluted used within matter hours causes headaches distributing vaccine especially rural areas There real challenges around might used Richard Vautrey doctor chair British Medical Association GP Committee said It quite different would normally experience say flu vaccine said adding details twin track strategy active discussion The onerous storage requirements Pfizer vaccine mitigated dry ice temporary cooling solutions said Anna Blakney research fellow Imperial College London Between purchase new freezers space addition dry ice shipments would probably able accommodate vaccines receiving said Much delivery vaccines determined local level exact practices may vary different parts England let alone Scotland Wales Northern Ireland health policy devolved In central English county Nottinghamshire health officials said briefing medical professionals planned ready start vaccinating frontline staff people care homes Dec largescale COVID vaccine centres operating Jan GP practice involvement midJanuary I think full capacity first December Obviously gradual rollout Mowle said But way I think huge willingness GPs engage process Â Reuters FILE PHOTO A test tube labelled word Vaccine seen front AstraZeneca logo illustration AZN Add toRemove Portfolio LONDON Reuters Results latestage trials University Oxford vaccine candidate definitely known Christmas chief investigator study said Thursday adding early know efficacy yet Asked early say whether vaccine licensed AstraZeneca L stops disease developing Andrew Pollard director Oxford Vaccine Group said We quite got point yet We obviously going rush We getting close definitely going Christmas based progress told BBC Radio asked trial investigators would unblinded efficacy data results released Â Reuters FILE PHOTO A test tube labelled word Vaccine seen front AstraZeneca logo illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Kate Kelland Alistair Smout LONDON Reuters AstraZeneca Oxford University potential vaccine produced strong immune response older adults data published Thursday showed researchers expecting release latestage trial results Christmas The data reported part last month published full The Lancet medical journal Thursday suggest aged higher risk serious illness death could build robust immunity The robust antibody Tcell responses seen older people study encouraging said Maheshi Ramasamy consultant colead investigator Oxford Vaccine Group We hope means vaccine help protect vulnerable people society research needed sure Latestage Phase III trials ongoing confirm findings researchers said test whether vaccine protects infection broad range people including people underlying health conditions Results trials definitely known Christmas Oxford Vaccine Group director Andrew Pollard said adding early know whether well vaccine works preventing disease We still waiting get point analysis work well vaccine protect people getting ever closer told journalists We optimistic able Christmas obviously share soon point The OxfordAstraZeneca vaccine candidate called among frontrunners global efforts develop shots protect infection novel coronavirus But rival drugmakers Pfizer Inc N BioNTech F Moderna Inc O past days edged ahead releasing data latestage vaccine trials shows efficacy We rush We competition developers Oxford Pollard said adding AstraZeneca would release headline efficacy data published academic journal Oxford University set target infections start interim analysis latestage trial results though lots cases trial arms Britain South Africa Brazil mean exact number infections reported could differ Unlike PfizerBioNTech Moderna shots use new technology known messenger RNA mRNA AstraZeneca viral vector vaccine made weakened version common cold virus found chimpanzees The Phase II trial reported The Lancet involved total healthy volunteers aged aged aged Volunteers got two doses vaccine placebo serious side effects related vaccine reported researchers said AstraZeneca L signed several supply manufacturing deals companies governments around world Add toRemove Portfolio DJI Add toRemove Portfolio MSFT Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio BBWI Add toRemove Portfolio JEF Add toRemove Portfolio M Add toRemove Portfolio IXIC Add toRemove Portfolio META Add toRemove Portfolio GOOG Add toRemove Portfolio SHOP Add toRemove Portfolio By Yasin Ebrahim Investingcom The Dow slipped Thursday investors weighed strength tech weakness value amid concerns economy signs slowdown labor market surging cases The fell points The rose The Labor Department reported people filed unemployment insurance week ended November prior week economists forecasts claims Signs weakness labor market likely continue weeks ahead surge virus prompts parts US impose restrictions curb virus Overall backup claims week somewhat troubling likely indicative going see next weeks ahead Jefferies NYSE Thomas Simons The US reported daily record deaths Wednesday official health data showed hospitalizations virus nationwide hitting another record The Centers Disease Control Prevention warned travel ahead Thanksgiving next week Value stocks like financials energy industrials fell red Still optimism vaccine front AstraZeneca PLC LON said coronavirus vaccine shown signs strong immune responses among older adults Consumer discretionary stocks meanwhile received boost surge L Brands L Brands NYSE rallied following earnings topped analyst estimates underpinned strong results Bath Body Works amid pandemicfueled demand soap hand sanitizer Macyâs NYSE reported betterthanexpected earnings samestore sales fell short estimates sending shares red Tech however remained flatline Fab traded mostly higher Amazoncom NASDAQ Alphabet NASDAQ Microsoft NASDAQ traded higher Apple NASDAQ Facebook NASDAQ marginally lower In news Shopify NYSE climbed Jefferies upgraded stock buy rating expectations strength internet shopping continue boost demand',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom EZJ Add toRemove Portfolio TUIGn Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio HLMA Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Tui AG LON rose points trade close RollsRoyce Holdings PLC LON added points end EasyJet PLC LON points late trade Biggest losers included Fresnillo PLC LON lost points trade late trade Halma PLC LON declined points end AstraZeneca PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery January rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters AZN Add toRemove Portfolio XOM Add toRemove Portfolio CRM Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio AZN Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio BTCUSD Add toRemove Portfolio XRPUSD Add toRemove Portfolio WORK Add toRemove Portfolio By Geoffrey Smith Investingcom Germany extends lockdown restrictions December â doesnât tighten much despite failing bring infection curve Consumer confidence Europeâs two biggest economies falls corrects sharply downward corrects even sharply Salesforce reported close buying Slack Exxon Mobil gloomy oil Hereâs need know financial markets Thursday November Germany extends restrictions tighten much Germanyâs federal regional governments extended current restrictions business social gatherings December expanded restrictions maskwearing otherwise shied away tightening restrictions tries bring second wave coronavirus control Europeâs largest economy reported recordhigh new cases Wednesday well deaths third straight day Having implemented less strict lockdown deal second wave pandemic far failed bring virus control By contrast France UK started relax restrictions ahead hoping guarantee something closer normal life Christmas Consumer sentiment surveys fell expected November data released Thursday showed AstraZeneca NASDAQ drug doubts Doubts growing reliability data provided AstraZeneca LON University Oxford effectiveness experimental drug fight coronavirus Moncef Slaoui head US Operation Warp Speed team tasked funding vaccine development said Wednesday subgroup reported highest degree efficacy stage trial data released last week restricted people age bracket appears case resistant disease least severe manifestations The test data shown drug prevented disease people received two full doses vaccine received half dose start The halfdose experiment started mistake extended sake consistency Stocks drift Bitcoin slumps rally Global stocks stayed mostly positive territory drifting range trading US Thanksgiving Holiday loomed large dayâs proceedings Weak consumer confidence data France Germany marginally offset strongerthanexpected credit growth figures European Central Bank also due release accounts last policy meeting later By AM benchmark index less index closed There violent correction markets Bitcoin gave equally violent rally Ripple another popular cryptocurrency fell Salesforce talks Slack Slack NYSE stock rose Wednesday close near alltime high reports talks acquired software giant Salesforce NYSE Marc Benioffâs company could reach deal office messaging software app within days according The Wall Street Journal itâs unclear deal would structured Like many software companies valuation far excess current financials would usually justify For popularity Slackâs shares failed capitalize trend away email offices faces increasingly acute strategic challenge Microsoftâs Teams application Oil steadies rally Exxon gloomy forecasts Crude oil prices also retraced slightly stayed close postpandemic highs judicious profittaking By AM ET GMT US futures barrel crude futures The Wall Street Journal reported Wednesday Exxon Mobil NYSE revised estimate oil prices next six years indicating expectations prolonged impact prices pandemic Shortterm pressures may also building given surprisingly strong build US last week according US government data released Wednesday',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio Adds futures news items Nov Britain FTSE index seen opening points lower Friday according financial bookmakers futures ahead cash market open ASTRAZENECA The situation regarding vaccine developed AstraZeneca generally encouraging even though new trial needed said AstraZeneca France President Olivier Nataf ASTRAZENECA The Philippines get million shots potential vaccine developed AstraZeneca country first supply deal coronavirus vaccine senior officials said GOLD Gold eased en route third straight weekly drop investors weighed doubts leading vaccine candidate optimism vaccines arrive sooner expected OIL Oil prices lower quiet trade due US Thanksgiving holiday dropping amid concerns oversupply doubts vaccine end coronavirus pandemic The UK bluechip index closed lower Thursday amid heightened concerns economic growth Health Minister Matt Hancock said third population would remain tough restrictions end national lockdown Â Reuters AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Geoffrey Smith Peter Nurse Investingcom AstraZeneca PLC LON race develop effective vaccine goal It really known global leader cancer treatments winning number drug approvals recent years regulators around world Earlier week UKbased drug maker said latestage trials vaccine showed efficacy quickly acknowledge flaws data Investingcom Geoffrey Smith explains rare misstep wo cause lasting damage Peter Nurse says fallout real reputational risks weigh valuation The Bull Case The bull case AstraZeneca doesnât need contribution experimental vaccine The fact company global powerhouse oncology drugs others treat chronic diseases lungs kidneys It earns gross margins normal year expects underlying earnings per share grow year worldâs healthcare systems trouble finding resources anything treating It beyond reasonable doubt wellrun company whose shares deserve management premium In barely seven years CEO Pascal Soriot raised market value already mature business pandemic erupted Soriot quickly addressed weekâs misstep communicating stage trial results ordering new trial responsible CEO might Global regulators pleased approve string drugs recent years suggestions vital relationship damaged imperfect trial conducted extraordinary pressures current race Covid cure alarmist Barring fiasco wholly character rest Soriotâs career downside risk share price even drug falls short AstraZenecaâs share price almost exactly start year anyone even heard dreaded Cword Given cost servicing sizable debt pile come sharply since allowing higher stock valuation things equal even argue market already applying discount shares whole saga Either drug writeoff case much cost remains governments helped fund development actually effective allowing worldwide distribution In latter case fact agreed provide drug profit seen bugbear many investors consider Reports citing confidential contracts manufacturers suggest AZ able exercise pricing power second half next year already And eschew shortterm profit keeping price longterm benefit could still considerable Cancer true specialism rich country disease spread wealth across ever parts world secular positive The gain goodwill pricegouging drug everyone wants needs intangible immeasurable The Bear Case The bear case surrounding AstraZeneca rests largely valuation reputational damage may incur mess itâs making getting coronavirus vaccine candidate approved With PE ratio around companyâs stock priced well industry average historical norm suggesting plenty downside potential The pharmaceutical giant released interim analysis latestage trials vaccine great fanfare Monday stating efficacy reached maximum depending dosage regime However doubts quickly emerged reliability data provided AstraZeneca partner University Oxford regards drugâs effectiveness Importantly Moncef Slaoui head US Operation Warp Speed team tasked funding vaccine development pointed potential flaw saying subgroup reported highest degree efficacy restricted people subjects likely resistant disease Geoffrey Porges Director Therapeutics Research life sciences boutique investment bank SVB Leerink widely reported predicting vaccine never licensed US particularly appear viable alternatives form Pfizer Inc NYSE âs Moderna Inc NASDAQ âs drugs Promising candidate vaccines Johnson Johnson NYSE others still development pipeline AstraZeneca promised supply vaccine cost price long pandemic lasts making valuable American market product may necessarily big thing But botched communication far small trial could far difficult ignore lasting damage relationship allimportant Food Drug Administration After generated almost billion revenue US last year biggest single market far Swiss banking giant UBS earlier week kept âœsellâ rating AstraZeneca citing uncertainty surrounding vaccineâs results Earlier month also noted product sales emerging markets disappointed third quarter results whereas US business surprised positively This balance may change Â Reuters DJI Add toRemove Portfolio BBVA Add toRemove Portfolio SABE Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio By Peter Nurse Investingcom Black Friday shopping season likely different online sales likely surge European banking consolidation put hold Spain AstraZeneca NASDAQ unlikely feel much love Wall Street returns Thanksgiving holiday Oil trading mixed crucial OPEC meeting looms sterling retains strength stocks seen continuing recent positive trend Hereâs need know financial markets Friday November Black Friday arrives difference Itâs Black Friday traditionally busiest shopping day United States things set different Pictures shoppers fighting get shops search bargains staple news channels years restrictions forced shops divert purchases online Many major retailers hit hard pandemic started offering Black Friday promotions much earlier usual taking lead Amazon NASDAQ hosting Prime Day middle October order capture much holidayrelated possible Itâs still likely bumper period major retailers National Retail Federation forecasting US holiday retail sales increase total billion billion This compares average annual increase past five years BBVA MC Sabadell MC end talks Banco Sabadell stock slumped potential merger rival BBVA collapsed two weeks two Spanish banks announced plans tieup The disagreement seems center around price deal would resulted bank market capitalization around billion euros billion BBVA Spainâs secondlargest bank said rush scale operations given already around Spainâs market share Sabadell said would launch new strategy prioritise domestic business European lenders considerable pressure financial challenges surrounding pandemic adding woes Consolidation regionâs fragmented banking sector seen way forward even CaixaBank Bankia announced plans merge deal would create Spainâs largest domestic bank combined market capitalisation almost billion Stocks seen higher AstraZeneca focus US stocks set open higher Friday although gains likely limited market set close early aftermath Thanksgiving Holiday By AM contract rose points traded points higher climbed points Generally positive coronavirus vaccine news emerging political certainty US prompted strong gains Wall Street topping mark first time earlier week President Donald Trump said Thursday leave office Electoral College votes Presidentelect Joe Biden This closest come conceding election adds feeling normalcy returning US political circles AstraZeneca LON focus Wall Street opens Moncef Slaoui head Operation Warp Speed expressed concern viability data used create efficacy level drug makerâs vaccine candidate Sterling retains strength Sterling remains near threemonth highs US dollar despite UK Finance Minister Rishi Sunakâs horrific spending review couple days ago Sunak laid bare weak state UKâs finances saying Britain set borrow almost billion pounds billion year equivalent GDP highest ever peacetime He added British economy set contract largest fall years Yet despite sterling remains relatively strong traders continuing expect late progress Brexit talks UK European Union EU chief negotiator Michel Barnier traveling London late Friday two sides try resolve differences fishing competition policy âœOnce makeorbreak moment sterling asymmetrical downside risks case deal looks around corner timing remains big question markâ said analysts ING research note Oil mixed OPEC meeting seen key Crude oil prices traded mixed Friday still close postpandemic highs attention turns next weekâs crucial meeting OPEC By AM ET GMT futures barrel futures Reuters reported Friday leading oil producing countries group known OPEC hold informal online talks Saturday prior next weekâs key meetings The group come pressure maintain current level oil production given sluggish oil demand fallout coronavirus pandemic OPEC previously agreed increase output million barrels day January part steady easing record supply cuts oil prices rose However decision extend current production levels means certain number countries within cartel seeking maximise revenue increasing production levels',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio HSBA Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio RIO Add toRemove Portfolio GFSl Add toRemove Portfolio FRAS Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio PETSP Add toRemove Portfolio VCP Add toRemove Portfolio INDV Add toRemove Portfolio GROW Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers Lloyds LLoyds Banking Group said Charlie Nunn currently head wealth personal banking HSBC Frasers Mike Ashley Frasers Group Philip Green Arcadia fashion group brink falling administration Pets Home Pets Home Group Plc said The Vet Connection million pounds million looks expand digital offerings pandemic Canadian security firm Gardaworld said extended cash offer larger rival repeatedly rejected hostile bid valuing British company billion pounds billion Indivior British drugmaker Indivior Plc said would vigorously defend billion pound billion legal claim consumer good maker Reckitt Benckiser Group relating demerger agreement Rio Tinto Rio Tinto look handful external candidates narrowing field miner tries win back investors dismayed blasting ancient Australian rock shelter bankers investors say AstraZeneca The Indian Council Medical Research ICMR assisting inquiry alleged adverse reaction AstraZeneca vaccine trial found reason recommend halting senior official regulator said Sunday HSBC HSBC Holdings Plc considering narrowing options improve performance struggling North America business Financial Times reported Saturday Gold slipped track worst month four years optimism coronavirus vaccineled economic rebound propelled equities record highs dulled metal safehaven appeal Oil prices fell amid investor jitters ahead meeting producer group OPEC decide whether extend large output cuts balance global markets vaccine hopes helped keep track rise fifth November The UK bluechip index rose slightly Friday marked first weekly loss month frictions Brexit process gloomy economic outlook due coronavirus weighed sentiment UK corporate diary HY earnings HY earnings',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio MKS Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Monday according financial bookmakers IAG Airlines group IAG named Aer Lingus boss Sean Doyle replacing Alex Cruz top job one number management changes announced IAG new chief executive month job Bank England The Bank England asked banks Monday information readiness following announcement last month considering take rates zero needed Shell Royal Dutch Shell Plc Saturday said mobile drilling units returning Gulf Mexico restart operations Hurricane Delta AstraZeneca The US government AstraZeneca Plc develop secure supplies doses antibody treatment similar class drug used treating President Donald Trump Marks Spencer British retailer Marks Spencer seeking avoid repeat last Christmas performance ruined excessive food waste rolling supply chain programme says crack problem Oil prices dropped second straight session Monday US producers began restoring output Hurricane Delta weakened strike affected production Norway came end Gold fell back threeweek high Monday dollar firmed although hopes new US coronavirus aid package checked precious metal losses The UK bluechip index closed higher Friday new jobs support plan advancements Brexit talks eclipsed worries fresh surge cases',\n",
              " 'Â Reuters FILE PHOTO FILE PHOTO Vials medical syringe seen front AstraZeneca logo illustration AZN Add toRemove Portfolio NVAX Add toRemove Portfolio BENGALURU Reuters Serum Institute India world largest vaccine producer said Thursday made million doses AstraZeneca potential vaccine would soon begin making Novavax rival shot seek regulatory approval Serum said enrolled participants India latestage trials AstraZeneca L candidate also plan seek regulatory approval run latestage trials Novavax O vaccine The AstraZeneca vaccine codeveloped Oxford University advanced human testing India Serum said adding company Indian Council Medical Research ICMR pursue early availability shot India Representatives Serum ICMR declined comment whether million doses AstraZeneca vaccine meant supply India The ICMR federal government body funded clinical trial site fees AstraZeneca vaccine Serum said The company ICMR currently conducting midstage clinical trials shot centres across India The news came coronavirus infections India world secondworst hit country reached million Thursday death toll increased India also least two homegrown vaccine candidates development local drugmaker Dr Reddy Labs NS carrying trial country Russia vaccine candidate Earlier week Pfizer N partner BioNTech DE said vaccine candidate proven effective based initial trial results Pfizer said committed advancing engagement India government supply potential vaccine country Â Reuters Reuters journalist Steve Stecklow participates clinical trial experimental Novavax vaccine London AZN Add toRemove Portfolio PFE Add toRemove Portfolio NVAX Add toRemove Portfolio By Steve Stecklow LONDON Reuters So I volunteer injected experimental vaccine That friends wanted know I told I Who knows long term texted former college roommate Seems like gamble It began July British government announced seeking lots volunteers largescale clinical trials new vaccines Only month good friend mine died spending weeks ventilator Curious I completed online form figuring I committing anything In late September email informed I among pioneers fight enlisted cause On Oct I invited apply trial vaccine made American biotech company called Novavax Inc O It seeking time volunteers United Kingdom latestage trial determine vaccine safety effectiveness If aged good health could eligible participate email stated The study involves six visits period around months Reasonable travel expenses reimbursed Now time decide I began researching Novavax vaccine received less attention several others On Monday Pfizer Inc N announced vaccine candidate appeared effective In September latestage trials vaccine developed University Oxford AstraZeneca Plc L halted report serious neurological illness volunteer although trials later permitted resume To Novavax vaccine seemed less risky Although Marylandbased company never received approval vaccine employing technology create candidate used promising flu shot I gotten inoculated flu every year decades never adverse reaction The published results first phase testing Novavax vaccine also showed serious side effects among participants injected The worst case someone mild fever day I decided go I figured life ever going return normal world going need vaccines volunteers see work On selfish level I liked idea getting inoculated soon possible given monotonous â sometimes scary â daily routine become I become riskaverse wife called jailer Another attraction If I catch virus researchers would carefully monitor In UK surge new cases day infected people essentially unless require emergency care Of course chance I would injected placebo â saline solution â would protect anything In testing vaccines placebos used control see whether real thing effective fending virus And online overthephone screening determine I medical conditions disqualified study I given appointment first two injections I showed one recent morning clinical research facility King College Hospital south London â small drab building part sprawling medical complex To surprise receptionist asked take Churchill Pro bike mask â costs uses British Military Filtration Technology block almost viruses â replace cheap disposable one I later learned superduper mask potentially could contaminated Several volunteers already large room getting set I met privately doctor asked I questions I What Novavax vaccine proved successful trial stopped Would I told whether I received placebo given real vaccine The doctor told I gotten placebo I would wait year since researchers would want keep monitoring every trial participant Not I wanted hear What another vaccine approved first I given placebo Would I allowed take The doctor suggested possible After I signed consent form participate trial gave brief physical exam Back large room nurse gave test sticking long swab throat nostril Then prepared draw blood I warned veins thin often proved problematic He proceeded fail twice calling colleague better luck The injection uneventful But nurse checked blood pressure afterward spiked He asked wait minutes basically calm I thought meditation exercises I always scoffed recently tried reduce pandemicinduced anxiety â breathe breathe It worked So far I experienced side effects awaiting second injection three weeks passed Curious experience I spoke James Galloway senior clinical lecturer King College doctor responsible trial He told decisions made volunteers received placebo Novavax shown effective another vaccine approved first He later added If get another vaccine works want people get vaccine placebo We want anyone suffer participating study said A spokeswoman Novavax later told volunteers would discuss options clinicians overseeing trial sites Galloway said theoretical risk someone got Novavax vaccine injected different one There chance reaction He know UK Novavax trial going far access data But overall remains optimistic effective vaccines arrive As happens doctor contracted last spring He said fever days briefly hospitalized developing heart rhythm problem I would wish anyone said reporting Steve Stecklow editing Janet McBride',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom NXT Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio CNA Add toRemove Portfolio PSN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Next PLC LON rose points trade close Ocado Group PLC LON added points end Persimmon PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Centrica PLC LON declined points end Royal Dutch Shell PLC Class A LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery January fell hit barrel February Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio FRAS Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio FTMC Add toRemove Portfolio BOOH Add toRemove Portfolio Dec Reuters Britain FTSE futures index ahead cash market open Monday Royal Dutch Shell said value oil gas assets latest string impairments year adjusts weaker outlook Vodafone Vodafone ended talks Saudi Telecom Company sale shareholding Vodafone Egypt British telecoms group said Frasers Mike Ashley Frasers Group sportswear retailer forced shut stores London South East East England fastspreading new strain coronavirus called tougher curbs AstraZeneca AstraZeneca said US medicines regulator approved British drugmaker lung cancer therapy Tagrisso treat another type tumour lungs diagnosed early stage Boohoo British online fashion retailer Boohoo Group Plc said board appointing PKF Littlejohn group auditor immediate effect replacing PwC role around seven years Gold climbed sixweek high driven news US congressional leaders aid package lockdowns United Kingdom soured appetite riskier assets added metal support Oil prices dropped fastspreading new coronavirus strain shut much United Kingdom fuelled worries slower recovery fuel demand amid tighter restrictions Europe The UK bluechip index closed lower Friday US stocks dipped cooling fiscal stimulusled rally GBP The domestically focused FTSE considered barometer Brexit sentiment dropped finished last full week year Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio FTMC Add toRemove Portfolio IDSI Add toRemove Portfolio MTRO Add toRemove Portfolio Dec Reuters Britain FTSE futures index Monday AstraZeneca Malaysia said Saturday secured coronavirus vaccine AstraZeneca Plc heels news receive PfizerBioNTech vaccine February grapples surge infections Royal Dutch Shell Shell said sell stake Queensland Curtis LNG QCLNG facilities Global Infrastructure Partners Australia billion helping oil major meet annual target divestments Royal Mail Royal Mail Plc said Friday reached inprinciple agreement largest labour union Communication Workers Union CWU company strategy operational change pay Metro Banks Britain Metro Bank Plc said Friday owneroccupied residential mortgages NatWest Group Plc billion pounds billion looks boost capital levels hit pandemic Gold climbed sixweek high driven news US congressional leaders aid package lockdowns United Kingdom soured appetite riskier assets added metal support Oil prices dropped fastspreading new coronavirus strain shut much United Kingdom fuelled worries slower recovery fuel demand amid tighter restrictions Europe The UK bluechip index closed lower Friday US stocks dipped cooling fiscal stimulusled rally GBP The domestically focused FTSE considered barometer Brexit sentiment dropped finished last full week year',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio AIR Add toRemove Portfolio VOD Add toRemove Portfolio AMGN Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio BX Add toRemove Portfolio APGNA Add toRemove Portfolio Add toRemove Portfolio Dec Reuters Britain FTSE futures index ahead cash market open Tuesday Vodafone Vodafone Group buy remaining shares Kabel Deutschland Holding already deal aimed capping remaining risks longrunning legal battle takeover company Applegreen Applegreen said bought consortium led BJ Holdings Blackstone NYSE Infrastructure Partners deal values Irish gas station operator around million euros AstraZeneca Drugmakers AstraZeneca Amgen said experimental asthma drug tezepelumab failed meet main goal reducing patients dependence steroids keeping condition check latestage trial EasyJet British airline easyJet whose finances come severe pressure pandemic agreed Airbus company said Economy Britain economic recovery coronavirus crash previously thought JulySeptember period according official data also showed government borrowing soaring pay coronavirus crisis Gold prices fell support US Congress passing longawaited near billion coronavirus aid countered stronger dollar profittaking also weighed sentiment Oil prices dropped nearly adding steep losses previous session new strain novel coronavirus United Kingdom triggered concerns fuel demand recovery The UK bluechip index closed lower Monday several nations closed borders Britain UK midcap stocks suffered worst day months Monday stricter curbs fight fastspreading new strain coronavirus prompted travel bans worries food shortages economic pain Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio CNA Add toRemove Portfolio TSCO Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio IDSI Add toRemove Portfolio Dec Britain FTSE futures index Tuesday Tesco British supermarket group Tesco warned Monday may shortage fruit vegetables later week transport ties quickly restored mainland Europe Royal Mail Royal Mail halted deliveries several countries result port closures travel tie cuts Britain following new faster spreading strain coronavirus company website showed Monday AstraZeneca Malaysia signed deal procure million doses AstraZeneca coronavirus vaccine final talks Chinese Russian manufacturers secure said Prime Minister Muhyiddin Yassin Centrica Members Britain GMB union five days January Centrica Plc British Gas company refusal remove fire rehire threats union said Monday Brexit The European Union considering new proposal fishing rights United Kingdom British Prime Minister Boris Johnson tries secure trade deal Bloomberg news reported Monday Gold prices gained US coronavirus aid package set Senate approval boosted metal appeal inflation hedge new coronavirus strain shutting much Britain lent support Oil prices dropped adding steep losses previous session new strain novel coronavirus United Kingdom triggered concerns fuel demand recovery The UK bluechip index closed lower Monday several nations closed borders Britain UK midcap stocks suffered worst day months Monday stricter curbs fight fastspreading new strain coronavirus prompted travel bans worries food shortages economic pain',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom LLOY Add toRemove Portfolio EZJ Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio RTO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Wednesday gains sectors propelled shares higher At close London rose The biggest gainers session Lloyds Banking Group PLC LON rose points trade close EasyJet PLC LON added points end NatWest Group PLC LON points late trade Biggest losers included Reckitt Benckiser Group PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Rentokil Initial PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters AZN Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio BTCUSD Add toRemove Portfolio BTCUSD Add toRemove Portfolio ETHUSD Add toRemove Portfolio MRNA Add toRemove Portfolio By Geoffrey Smith Investingcom Senate Leader Mitch McConnell thwarts Donald Trumpâs plan higher stimulus payments UK approves AstraZenecaOxford University vaccine reaches another alltime high Hereâs need know financial markets Wednesday December McConnell defies Trumpâs stimulus call President Donald Trumpâs efforts increase part recent billion stimulus package paid directly households ran sand Senate Majority Leader Mitch McConnell refused schedule quick vote motion passed House Representatives earlier week McConnell combined initiative new bill would combine increased payments provisions House Democrats sure reject repeal Section Communications Decency Act gives social media platforms protection legal liability content posted users commission look Trumpâs claims election fraud thrown courts across US far As level direct payments likely stay rather demanded Trump approved House AstraZeneca vaccine gets first approval The UKâs Medicines Healthcare Products Regulatory Agency approved use vaccine developed AstraZeneca LON University Oxford Itâs first formal approval vaccine appears slightly less effective disease developed PfizerBioNTech Moderna NASDAQ set play much broader role immunizing worldâs population given company selling cost pandemic continues stored normal refrigeration temperatures easing challenge mass distribution The move comes UK hospitals starting run capacity patients Germany meanwhile registered deaths single day first time Stocks set rebound US stock markets set open higher modest setback late Tuesday response Senate Leader McConnellâs effective blocking higher stimulus payments By AM ET GMT points also Corporate newsflow remains trickle US data shape AM ET Novemberâs figures AM Digital currencies set fresh highs Bitcoin continued triumphant march higher topping first time background fading trust dollar whose longterm debasement USâs enduring current account budget deficits set accelerate By AM ET trading day earlier traded high The fundamentals digital asset remain country accept taxes paid merchants overwhelmingly refuse set prices something volatile price However lack practical applications overshadowed everbroader willingness part institutional money managers speculate reassured prospect Bitcoin supply remaining essentially fixed Bitcoin isnât digital asset currently enjoying rallied fivefold year although essentially flat Wednesday Last US oil inventories year The price crude oil lots practical applications rebounded modestly overnight supported American Petroleum Industry data showing unexpectedly large drop US crude The US governmentâs data due AM ET usual Analysts warn reading much last weekly data year tend distorted accounting tax issues By AM barrel futures barrel',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Dec Reuters Britain FTSE futures index Thursday ALDI Britain fifthbiggest supermarket Aldi Wednesday said plans increase amount food drink buys British suppliers billion pounds billion within next five years company continues rapid expansion across United Kingdom The EU drug watchdog looking people given second dose AstraZeneca Oxford University vaccine rather size first dose part review shot source agency said Wednesday BREXIT The United Kingdom exits European Union orbit Thursday turning back tempestuous liaison European project uncertain Brexit future shape fortunes people generations come OIL Global markets lost fifth value strict coronavirus lockdowns paralysed much global economy prices rebounded strongly lows governments rolled stimulus GOLD Gold prices fell Thursday hopes economic recovery next year increased risk appetite although precious metal set wrap year best performance decade The UK bluechip index lost Wednesday reversing early gains fears fastspreading new strain coronavirus led country placed tighter restrictions even Britain approved AstraZeneca vaccine',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel Wisniewski AZN Add toRemove Portfolio Reuters AstraZeneca said Monday transfer global rights respiratory medicines Eklira Duaklir Covis Pharma Group million AngloSwedish drugmaker looks offload older portfolio medicines The Londonlisted company also said deal expected close fourth quarter Covis also cover certain ongoing development costs related medicines AstraZeneca NASDAQ several new medicines pharmaceutical pipeline including drugs vaccine expects agreement help sharpen focus priority medicines respiratory immunology portfolio Covis previously acquired rights respiratory medicines Alvesco Omnaris Zetonna AstraZeneca Eklira Duaklir used treat chronic obstructive pulmonary disease COPD smokers lung generated revenues million AstraZeneca geographies covered previous deal drugmaker bought rights',\n",
              " 'Â Reuters AZN Add toRemove Portfolio PFE Add toRemove Portfolio LONDON Reuters It possible get extra dose vials AstraZeneca PLC LON vaccine well one made Pfizer NYSE head immunisation Public Health England PHE said Wednesday In December health service gave doctors advice could use extra doses Pfizer vaccine discretion could extracted Wednesday Dr Mary Ramsay said happening AstraZeneca shot We able get vaccine vial happened Pfizer vaccine also happening AstraZeneca vaccine So means overall got vaccines go around told lawmakers adding PHE bought necessary needles start Really early discovered able get vials excellent news Â Reuters GBPUSD Add toRemove Portfolio AZN Add toRemove Portfolio WCKH Add toRemove Portfolio By Samuel Indyk Investingcom The pound reached highest level US dollar since April Thursday continuing strong run last two weeks hit morning trade factors play On Wednesday Bank England Governor Bailey reiterated stance negative interest rates âœWe taken decision fact weâve actually discussed whether introduce negative ratesâ Bailey said adding uncertain much would help economy VACCINES Further supporting pound UKâs rollout vaccines happened quicker pace neighbouring countries The UK benefitted rapid approval various vaccines supply relatively stable There fears factory producing supplies OxfordAstraZeneca PLC LON vaccines Wales could flood due Storm Christoph local emergency services prevented serious disruption Wockhardt Ltd NS company produces vaccine facility confirmed site operating normal German investment bank Berenberg optimistic UK vaccination programme saying country maintain average pace daily vaccinations past week UK could reach vaccination rate June year figure rate infection would slow UK would close herd immunity Infection rates also appear slowing albeit snailâs pace Imperial College London professor Paul Elliott told BBC current R rate around We seeing levelling going seeing decline really need seeâ Elliott said Meanwhile number people testing positive virus last seven days week BREXIT Finally avoidance socalled âœhard Brexitâ also lifted pound After agreement reached UK EU towards tail end last year investors certainty trading relationship first time years even teething problems since introduction new trading arrangement Todayâs report showed large number manufacturers worried supply chain disruption said border challenges customsrelated delays arising Brexit appeared playing role',\n",
              " 'Â Reuters FILE PHOTO AstraZeneca logo reflected drop syringe needle illustration AZN Add toRemove Portfolio LONDON Reuters A plant Wales produces AstraZeneca PLC LON vaccine partially evacuated suspicious package received company operates said Wednesday Wockhardt UK Wrexham morning received suspicious package site All relevant authorities immediately notified engaged company said referring facility Wales Upon expert advice partially evacuated site pending full investigation The safety employees business continuity remain paramount importance Earlier BBC reported police bomb disposal unit sent plant We currently dealing ongoing incident Wrexham Industrial Estate local police said statement adding public avoid area Wockhardt UK provides fillandfinish capacity AstraZeneca UK supply chain final manufacturing step putting vaccines vials syringes packaging AstraZeneca agreed supply Britain million doses vaccine developed Oxford University',\n",
              " 'Â Reuters AZN Add toRemove Portfolio By Samuel Indyk Investingcom â The European Medicines Agency EMA recommended granting conditional marketing authorisation AstraZeneca PLC LON âs vaccine prevent people years age The EMA added scientific experts considered vaccine used older adults The agencyâs human medicines committee CHMP assessed vaccine said meets EU standards puts place safeguards controls obligations underpin EUwide vaccination campaigns OLDER POPULATION There concern EU would recommend vaccine taken age âœThere yet enough results older participants years old provide figure well vaccine work groupâ EMA said statement âœHowever protection expected given immune response seen age group based experience vaccines reliable information safety population EMAâs scientific experts considered vaccine used older adultsâ EFFICACY The agency based calculation efficacy vaccine results two studies study based UK study based Brazil The two studies involved clinical trial fewer six cases enough measure preventative effect vaccine âœThese studies showed reduction number symptomatic cases people given vaccine got symptoms compared people given control injections got symptomsâ EMA said âœThis means vaccine demonstrated around efficacy clinical trialsâ GERMANY The previous day issued draft recommendation used The Robert Koch Institute â Germanyâs federal public health agency â said insufficient data ascertain effective vaccine would This followed story Handelsblatt earlier week suggested vaccine unsafe saying efficacy A statement German health ministry later clarified publication mixed efficacy rate number trial PRODUCTION There still question marks production supply vaccine EU member countries The EU vocally unhappy AstraZeneca alleging reneged contracts supply vaccine However AstraZeneca came fighting saying supply problems fault EU time took agree contract For context UK agreed contract full three months European Union AstraZeneca say teething problems related production ironed early part process The drug company previously said would cut supplies bloc today reportedly offered EU million doses vaccine quarter AstraZeneca CEO Pascal Soriot previously said legal obligations deliver precise timescale committed supply âœbesteffortâ clause The European Union today published contract order transparent allege contained âœbinding ordersâ However large sections â including pricing guaranteed delivery dates â blanked redacted',\n",
              " 'Â Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio BHP Add toRemove Portfolio AZN Add toRemove Portfolio LCL Add toRemove Portfolio ABF Add toRemove Portfolio ITV Add toRemove Portfolio HSX Add toRemove Portfolio RYA Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio CL Add toRemove Portfolio OCDO Add toRemove Portfolio ENT Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers futures ahead cash market open Ryanair Ireland Ryanair Holdings PLC key summer period first time decades warned crisis could force cuts leave capacity next summer little half normal levels Hiscox Insurer Hiscox said catastrophe claims third quarter active North American wind season record another significant wildfire season California Ocado Ocado British online supermarket technology group would total million Associated British Foods Associated British Foods owner clothing retailer Primark said estimated would million sales temporary closures stores major markets due restrictions GVC Ladbrokes LON bwin owner GVC warned gambling stores remained closed November Britain latest coronavirus lockdown AstraZeneca AstraZeneca Plc said Britain health regulator potential coronavirus vaccine UK regulator British Prime Minister Boris Johnson impose England Dec said ITV LON political editor BHP BHP Group Ltd world biggest listed miner said submitted letter commitment responsible production Copper Mark framework launched International Copper Association April last year EasyJet EasyJet considering options bolster finances state support help airline get coronavirus pandemic said chief executive Johan Lundgren Gold ticked higher caution crept ahead Tuesday hotly contested US presidential elections sparking bids safehaven metal though resilient dollar capped gains Oil prices fell worries swathe coronavirus lockdowns across Europe weaken fuel demand traders braced turbulence US week The UK bluechip index closed lower Friday logging biggest monthly drop since brutal selloff March new wave regional restrictions threatened nascent economic recovery Â Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio BNZL Add toRemove Portfolio ANTO Add toRemove Portfolio STAN Add toRemove Portfolio RTO Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Tuesday losses sectors propelled shares lower At close London lost The biggest gainers session AstraZeneca PLC LON rose points trade close Bunzl PLC LON added points end Rentokil Initial PLC LON points late trade Biggest losers included Standard Chartered PLC LON lost points trade late trade Flutter Entertainment PLC LON declined points end Antofagasta PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom EZJ Add toRemove Portfolio FERG Add toRemove Portfolio AZN Add toRemove Portfolio RSAl Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio TUIT Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Monday gains sectors propelled shares higher At close London added hit new high The biggest gainers session Tui AG LON rose points trade close Carnival PLC LON added points end EasyJet PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Ferguson Plc LON declined points end RSA Insurance Group PLC LON gained points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March rose hit barrel April Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio EURGBP Add toRemove Portfolio AZN Add toRemove Portfolio By Samuel Indyk Investingcom â GBP continues strengthen breaking back EURGBP falling lowest level since April last year The pound one better performing currencies UK pushes ahead vaccination programme Bank England effectively ruled negative interest rates near term February meeting The pair currently tests lows April seen technical analysts suggested firm break level could push pair towards downside momentum accelerate Of note large sized options expiring EURGBP todayâs NY cut As mentioned GBPUSD trades back looks set test high seen Tuesday A break level could see psychological level come play Vaccines GBP benefitted UKâs vaccination effort almost people given least one dose one jabs The EUâs rollout less successful yesterday reports AstraZeneca PLC LON vaccines EU going unused amid concerns health workers France Germany side effects If UK keeps vaccinating rate hope least every adult wants vaccine may able one summer prompting hopes economy reopen sooner rather later sense normality return Bank England policymaker Andy Haldane recently spoken huge pentup demand waiting released The recovery one remember year forget Haldane said The Bank England chief economist said could see double digit annual growth inflation target If right GBP could still run',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio ANTO Add toRemove Portfolio RR Add toRemove Portfolio ITRK Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio EXPN Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Friday gains sectors propelled shares higher At close London rose The biggest gainers session Antofagasta PLC LON rose points trade close Carnival PLC LON added points end RollsRoyce Holdings PLC LON points late trade Biggest losers included Experian PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Intertek Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March fell hit barrel April Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters FILE PHOTO vaccinations Stevenage AZN Add toRemove Portfolio AZN Add toRemove Portfolio MILAN Reuters AstraZeneca NASDAQ deliver million vaccines Europe second quarter million Italy head Italian unit quoted saying Thursday dismissing reports possible shortfall Lorenzo Wittum CEO chairman Astrazeneca LON Italy told daily Il Corriere della Sera interview Italy would receive million shots end March fewer million previously agreed leading total million doses June Reuters reported Tuesday citing EU official directly involved talks AngloSwedish drugmaker AstraZeneca expected deliver less half vaccines contracted supply European Union second quarter Wittum also said pharmaceutical company considering possibility administering third dose working new versions vaccine',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio EURGBP Add toRemove Portfolio Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio CVAC Add toRemove Portfolio By Samuel Indyk Investingcom â The trades relatively flat midpoint trading day despite services sector activity falling lowest level since May The IHS Markit survey showed businesses struggling latest lockdown particularly hospitality travel leisure sector However businesses optimistic growth expectations highest level since prospects strong reopening vaccine effort continues Vodafone Group PLC LON shares rose top bluechip index positive trading update benefited work home policies Germany Separately announced spinoff towers division Vantage Towers track early Reuters earlier reported company expected list division Frankfurt March year Vaccine Makers AstraZeneca PLC LON focus early studies showed single dose vaccine effective weeks justifying UKâs decision vaccinate many people possible quick time frame feasible The data published Oxford University yet peerreviewed provide UK government assurance made right decision On hand France followed Germanyâs lead recommended OxfordAstraZeneca jab given given lack data early trials This comes despite European Medicines Agency authorising use jab Another UKbased pharmaceutical company GlaxoSmithKline PLC LON announced deal Germanyâs CureVac NV NASDAQ work together develop vaccines new variants virus The deal worth EUR also see GlaxoSmithKline assist manufacturing CureVacâs current vaccine candidate original strain Sterling The pound fell US dollar broadly flat Euro markets look ahead tomorrowâs interest rate decision Focus whether central bank sees negative rates part toolkit economic prospects weaken Trading ranges relatively narrow Â Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio SIEGn Add toRemove Portfolio SAN Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio NVO Add toRemove Portfolio By Peter Nurse Investingcom European stock markets pushed higher Wednesday helped progress towards US stimulus Italian political developments corporate earnings also share spotlight At AM ET GMT Germany traded higher France rose UK index climbed Italyâs rose Former European Central Bank head Mario Draghi set meet Italian President Sergio Mattarella later Wednesday view heading government national unity something would end latest political crisis Rome This comes party leaders failed agree new coalition following resignation Prime Minister Giuseppe Conte last week In corporate news Siemens DE stock rose German manufacturing conglomerate lifted fullyear guidance citing fasterthanexpected recoveries China Germany following downturn Banco Santander MC stock rose Spanish bank declared cash dividend maximum level allowed accordance limits set European Central Bank despite recording first ever annual loss ever Novo Nordisk AS NYSE stock added diabetes drug maker gave upbeat sales profit forecasts Swedish truckmaker Volvo ST stock rose raising forecasts main markets rolling hefty shareholder payout On Tuesday US Senate began debating budget resolution first step towards passing trillion stimulus package proposed President Joe Biden without Republican support Additionally rollout vaccines many countries slowly gathering pace UK inoculated million population although health authorities remain concerned spread new variants virus AstraZeneca LON agreed deliver nine million doses vaccine European Union first quarter year region slow inoculation uptake Oil prices edged higher still around highest levels year unexpected fall oil supply The reported late Tuesday crude inventories fell million barrels last week compared expectations small build Data due later day US crude futures traded higher barrel hitting oneyear high Tuesday The international benchmark contract rose earlier climbing highest months Elsewhere rose traded lower',\n",
              " 'Â Reuters A woman looks receives booster vaccine amid coronavirus disease pandemic Midland House Derby Britain September REUTERSCarl Recine AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Alistair Smout LONDON Reuters vaccines made Pfizer NYSE Moderna NASDAQ use mRNA technology provide biggest boost antibody levels given weeks second dose new British study found The COVBoost study cited British officials announced Pfizer Moderna preferred use country booster campaign data made publicly available The study found six seven boosters examined enhanced immunity initial vaccination PfizerBioNTech vaccine seven increased immunity given two doses AstraZeneca NASDAQ vaccine A third dose effective many vaccines tested many different combinations Professor Saul Faust immunologist University Southampton trial lead told reporters The study published late Thursday found full dose half dose Pfizer full dose Moderna gave strong boost antibody Tcell levels regardless whether person initially received Pfizer AstraZeneca All four vaccination regimes widely deployed UK lead essentially levels immunity likely equally effective said Professor Eleanor Riley immunologist University Edinburgh She added policy change booster gaps also supported data These data support JCVI vaccine committee decision earlier week bring forward booster doses months second vaccination When AstraZeneca Novavax Johnson Johnson NYSE Curevac given boosters increased antibody levels either initial vaccine albeit smaller degree study found However Valneva boosted antibodies people initially vaccinated AstraZeneca provide boost Pfizer The COVBoost study predated spread emergent Omicron variant concern Faust said shared samples UK Health Security Agency generate data Omicron The study however find booster shots also helped generate broad Tcell response Beta Delta variants may play key role longerterm protection A separate study Imperial College London initial exposure shapes immune responses also published late Thursday similarly found good Tcell response Alpha Delta infection followed vaccination',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio PFG Add toRemove Portfolio FLTRF Add toRemove Portfolio Copper Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio FTMC Add toRemove Portfolio AZN Add toRemove Portfolio BTCUSD Add toRemove Portfolio By Samuel Indyk Key Points begins week back foot miners oil gas companies weigh More European countries stop rollout AstraZeneca PLC LON NASDAQ vaccine GBP weak ahead rate decisions retreats alltime high amid reported ban Investingcom â The FTSE finished lower Monday opening small gains ahead busy week central bank events On Wednesday announces interest rate decision Thursday sees Bank England Friday Miners oil gas companies weak commodity prices generally softer futures fell although still remained higher Betting group Flutter Entertainment PLC LON saw shares jump top FTSE company confirmed media reports considering spinoff FanDuel United States âœOptions including listing US small shareholding FanDuel considered decision made time Flutter Entertainment said statement listed Provident Financial LON saw shares decline company announced UKâs Financial Conduct Authority investigating Consumer Credit Division The company also gave details plan settle increase customer complaints claims home credit business last year warning unit could collapse scheme approved The AstraZeneca vaccine rollout Europe continues face interruptions Italy Germany France confirming suspend giving jab amid reports thrombogenic events patients taken vaccine AstraZeneca continues say evidence increased risk clotting taking vaccine World Health Organization said indication link vaccine reports blood clots The European Medicines Agency set give assessment vaccine Tuesday Currencies Bonds GBP weaker dropping ahead key central bank meetings week The Bank England Governor Andrew said Monday positive large dose caution UKâs economic recovery Bailey also added central bank policy tools could introduce needed Yields UK US pulled back somewhat hitting multimonth highs late last week UK gilts underperforming Baileyâs comments weighing ahead Bank England interest rate decision Cryptocurrencies Bitcoin broke weekend hit record high since retreated reports India announce complete ban cryptocurrencies The wideranging bill would reportedly criminalise possession issuance mining trading transferring cryptocurrencies This would much stringent law Chinese ban currently bans mining trading cryptocurrencies',\n",
              " 'Â Reuters AZN Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio By Peter Nurse Investingcom Crude oil prices weakened Tuesday handing back recent gains amid concerns speed global oil demand recovery ahead latest inventories data By AM ET GMT US crude futures traded lower barrel international benchmark contract fell US Gasoline RBOB Futures gallon Weighing prices Tuesday release data showing US declined February lot drop expected winter snap sharply reduced economic activity This followed upwardly revised surge January strongest advance seven months This added concern already play rising number cases Europe potential extended mobility restrictions German coronavirus infections spreading exponentially last week expert Robert Koch Institute infectious diseases said Tuesday Italy set implement new lockdown Easter holiday weekend Throw number countries including Germany France Italy suspending use AstraZeneca PLC LON âs vaccine concerns blood clots concerns growing slow pace vaccinations region may delay economic recovery pandemic âœFor oil demand fully recover successful rapid inoculation global population needs take place Before recent setback positivity campaigns way right trackâ said Bjornar Tonhaugen head oil markets Rystad Energy Back US attention quickly turn release American Petroleum Institute industry group later Tuesday followed official numbers Energy Information Administration Wednesday Crude inventories increased million barrels week March analysts expectations rise less million barrels fears growing another sharp rise stocks âœIf market fears turn true stocks difficult Brent hit per barrel soon least positive news comes vaccination front âœ added Tonhaugen Â Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio BP Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio AZN Add toRemove Portfolio BTCUSD Add toRemove Portfolio Key Points closes higher AstraZeneca NASDAQ shares jump despite vaccine concerns NatWest Group PLC LON lower FCA launches criminal proceedings money laundering Shell LON BP LON lower oil prices fall LON lower oil prices fall GBP flat ahead decisions By Samuel Indyk Investingcom â The FTSE finished Tuesday higher ahead key interest rate decisions Federal Reserve Bank England week Vaccine maker AstraZeneca PLC LON focus number European countries suspended rollout jab amid fears increased number blood clots vaccine The European Medicines Agency EMA forced hold press conference said indication vaccine caused blood clot incidents reiterating benefits taking vaccine still outweigh risks Nevertheless time publication none countries suspended AstraZeneca vaccine reversed decision The EMA state investigating reports anticipate coming conclusion Thursday UK bank came selling pressure underperformed peers Financial Conduct Authority FCA said beginning criminal proceedings company money laundering The allegations date back probe ongoing since Royal Dutch Shell BP propped bluechip index oil prices fell recovery concerns Weighing prices US retail sales data showed decline February worse expected drop Separately cases picking various European countries suspension vaccine rollout could harm recovery even potentially weighing oil demand GBP weak staged recovery markets await two central bank meetings US UK Little changed UK fundamental perspective suggestion European vaccine suspension could harm already fragile relations UK EU potentially weigh GBP found support ahead jumped EMA press conference said AstraZeneca vaccine safe steady remained alltime high hit weekend The stimulus checks due hit US bank accounts next days could next catalyst move higher suggesting âœmeme stocksâ cryptocurrencies could benefit slew retail money Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio By Samuel Indyk Investingcom â Shares AstraZeneca PLC LON top Tuesday morning company shrugged concerns vaccine At shares On Monday four largest countries EU â Germany France Italy Spain â suspended rollout Oxford jab amid reports several people received jab developed blood clots What know far The big EU countries ones suspend vaccine Austria Netherlands Denmark nonEU countries including Iceland Norway Thailand halted use vaccine precautionary measure However regulators less concerned blood clotting events The European Medicines Agency EMA yesterday provided update socalled thromboembolic events saying investigating situation changing view whether rollout stopped âœThe benefits AstraZeneca vaccine preventing associated risk hospitalisation death outweigh risks side effectsâ EMA said statement The EMAâs safety committee scheduled meet today review information called extraordinary meeting Thursday conclude information gathered whether action needs taken The UKâs Medicines Healthcare products Regulatory Agency MHRA said closely reviewing reports evidence available suggest vaccine cause The World Health Organization WHO also urged countries panic pause vaccination programmes adding evidence link vaccine blood clots The WHO vaccine safety experts meeting today discuss jab Political Decision The Director General Italyâs medicines authority AIFA said decision suspend shots number European countries âœpolitical oneâ We got point suspension several European countries including Germany France preferred interrupt vaccinations put hold order carry checks The choice political one Nicola Magrini said interview Italian newspaper La Repubblica Magrini expects take days gather data doubts cleared vaccination programme carry faster speed In separate news company announced premarket supply United States additional doses potential antibody treatment The value extended agreement contingent receiving FDA Emergency Use Authorization',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio AZN Add toRemove Portfolio By Samuel Indyk Investingcom â RollsRoyce LON shares jumped sixth consecutive day time rallying upgrade JPMorgan âunderweightâ âneutralâ âœWhilst international airline capacity still circa versus unlikely get worse direction travel probably one slow improvement analysts JPM said research note âœRollsRoyceâs shares significantly underperformed peers since attracting investorsâ Financial Results The jet engine manufacturer reported earnings Thursday last week provided upbeat outlook despite struggles currently impacting aviation sector âœThe worst well behind usâ RollsRoyce CEO Warren East said analyst call post earnings The maintained forecast large engine flying hours increase levels last year The company reliant effective global vaccination effort recent suspension AstraZeneca PLC LON NASDAQ jab various European countries could set Europe behind especially damages confidence vaccine Nevertheless today European Commission announced plans digital certificates would prove holders vaccinated recently tested negative facilitate leisure trips within EU outside bloc At RollsRoyce shares top trading higher Of note JPM also lifted price target shares',\n",
              " 'By Reuters BEIJING Reuters China Sunday reported highest number new infections six months day health officials said sticking strict',\n",
              " 'Â Reuters TSLA Add toRemove Portfolio Add toRemove Portfolio CWNHB Add toRemove Portfolio Add toRemove Portfolio CP Add toRemove Portfolio KSU Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio USDTRY Add toRemove Portfolio BX Add toRemove Portfolio GME Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio AZN Add toRemove Portfolio By Geoffrey Smith Investingcom Rising cases Europe India South America stoke fears delay global economic recovery despite AstraZeneca publishing upbeat results major trial vaccine North South America Turkey currency stock market tumble President Erdogan fires central bank chief raising interest rates sharply Gamestop reports earnings big railroad merger works Saudi Aramco borrowing heavily defend billion dividend Here need know financial markets Monday March US trial results vindicate AstraZeneca European vaccine dispute deepens AstraZeneca LON cleared major hurdle getting vaccine authorized US UK EU moved closer blocking exports vaccines The UKSwedish company said vaccine effective stopping symptomatic effective preventing death hospitalization trial covered volunteers US The test results also showed issues blood clotting disorders concerns led many EU countries suspend distribution vaccine earlier month The news comes day Europeâs largest economy Germany set join France tightening extending lockdown restrictions middle April response surge new infections last two weeks Outside Europe India reported highest daily death count two months new infections hit alltime record Brazil Chile There also signs hiccups USâs reopening fights among massive crowds Spring Break tourists led Miami Beach declare state emergency Third time lucky CPR Canadian Pacific NYSE finally succeeded persuading US railroad operator merge create first railroad operator link three major markets North America CPR Kansas City Southern NYSE said agreed deal valuing KCSâs debt equity around billion The merger still need antitrust clearance KCS rejected billion bid Blackstone NYSE Global Infrastructure Partners September Blackstone acquisition trail elsewhere weekend proposing buy trouble Australian casino operator Crown Resorts ASX billion deal would offer shareholders Crown exit company beset moneylaundering allegations Semiconductor stocks also focus fire factory owned Japan Renesas Electronics T threatens aggravate current shortage chips worldwide Stocks set open mostly lower GameStop earnings eyed The bad news front given extra leg rebound tech stocks setback cyclicals markets around world reprice reopening bets Yields US Treasuries meanwhile fell back AM ET GMT consequently underperforming premarket trade falling points contrast higher Other stocks likely focus later include GameStop NYSE due report three months January â first update since epic shortsqueeze earlier year Analysts expect profit million share billion revenue Also focus Tesla NASDAQ whose biggest fund manager cheerleader Cathie Wood put new target price weekend data February also due Federal Reserve Randy Quarles Mary Daly Michelle Bowman speak later Turkey turmoil Turkish financial markets went meltdown mode President Recep Tayyip Erdogan fired central bank chief Naci Agbul weekend two days raised interest rates expected Erdoganâs intervention revived fears return previous economic policy tolerated sharp currency devaluation raging inflation Erdogan appointed Naci Agbal last year seemed decisive return orthodox economic policies The dollar rose early trading retraced âonlyâ AM ET government officials downplayed suggestions country impose capital controls support currency The benchmark stock index also fell yield Turkeyâs government debt soared highest since Aramco defends dividend price Saudi Aramco SE worldâs biggest oil company said would keep dividend payment billion despite sharp drop profits due pandemic The decision says less outlook global oil industry Saudi budget relies Aramcoâs dividend resources Free cash flow fell billion meaning company borrow cover shortfall Crude prices choppy Monday doubts summer tourism season northern hemisphere intensified futures flat barrel futures barrel Â Reuters AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio GME Add toRemove Portfolio MRNA Add toRemove Portfolio CHWY Add toRemove Portfolio By Liz Moyer Investingcom The rotation growth value took pause Monday interest rates let steam put attention back big tech companies As evidence US economy continues reopen Transportation Security Administration screened million travelers Sunday since March last year Partiers flocking warmer weather climates South Florida local officials impose curfew control crowds But evidence new wave infections US overseas could derail progress German authorities agreed extend another national lockdown midApril France Poland Italy also lockdowns This putting damper oil prices investors worry demand fuel Meanwhile USChina trade tensions appear rise US imposed sanctions two Chinese officials alleged human rights abuses Itâs light day data earnings Here three things could affect markets tomorrow GameStop earnings compare marketâs valuation The muchfollowed meme stock scheduled report first quarter earnings closing bell Tuesday Itâll first report since Reddit stock trading crowd anointed video game retailer granddaddy short squeezes Analysts tracked Investingcom expect EPS revenue billion GameStop Corp NYSE shares trade nearly times start year based Fridayâs close market value billion It new strategy focus ecommerce thanks investor board member Ryan Cohen founder Chewy Inc NYSE But work begun More home sales data data released Tuesday AM ET GMT analysts expect February numbers show decline prior month Investors looking numbers compare Mondayâs showed drop number homebuyers listing homes time With limited supply prices jumped February median price home sold highest February price ever Pharma stocks get look AstraZeneca PLC LON getting chance shine rough weeks facing questions twodose Covid vaccine On Monday company said late stage trial proved effective overall effective preventing serious illness hospitalization It plans ask Food Drug Administration emergency use authorization coming weeks That would make fourth vaccine US alongside Pfizer NYSE Moderna NASDAQ Johnson Johnson NYSE millions Americans become eligible every day Shares AstraZeneca bounced Monday',\n",
              " 'Â Reuters Add toRemove Portfolio DJI Add toRemove Portfolio AZN Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio IXIC Add toRemove Portfolio AZN Add toRemove Portfolio By Peter Nurse Investingcom Testimony Fed chief Jerome Powell Treasury Secretary Janet Yellen Congress set main focus markets Tuesday Ahead rising cases Europe resulting Germany extending mobility restrictions putting pressure oil prices equities Turkish markets remain volatile President Erdoganâs axing central bank governor hawkish doubts AstraZenecaâs vaccine reemerge US housing data due release UK employment data surprised upside Here need know financial markets Tuesday March Powell Yellen face House questions Federal Reserve Chairman Jerome Powell Treasury Secretary Janet Yellen set start twoday testimony Congress later Tuesday front House Financial Services Committee They set discuss health US economy importance fiscal monetary stimulus recovery pandemic Yields US Treasuries climbed highest levels year financial markets bet US economy making quicker recovery damage caused pandemic central bank currently predicts And pair likely get plenty questions deeply politically divided Congress whether yields continue rise amid fears economy overheat However judging released excerpts prepared testimony Powell reiterate central bank plan support recovery long takes economy remains prepandemic levels In particular labor market remains concern Federal Reserve unemployment rate labor participation rate still prepandemic levels Yellen said repeatedly past two months US afford borrow interest rates historically low debt level large cost service obligations AstraZeneca NASDAQ vaccine yet fully cleared AstraZenecaâs executives must felt finally caught break Monday data large US trial showed vaccine proved effective overall effective preventing serious illness hospitalization However proved false dawn US health agency questioned Tuesday whether UKSwedish company provided complete view efficacy data vaccine trial casting doubt plan seek US emergency use authorization vaccine coming weeks The Data Safety Monitoring Board expressed concern AstraZeneca PLC LON may included outdated information trial may provided incomplete view efficacy data US National Institute Allergy Infectious Diseases said statement AstraZenecaâs vaccine dogged doubts efficacy dosing regimen possible side effects Many European countries including Germany France halted use vaccine earlier month reports linked rare blood clotting disorder US stocks set open lower Europe Covid woes US stock markets look set open marginally lower Tuesday amid cautious trading investors await comments Fed chief Powell Treasury Secretary Yellen testify front Congress At AM ET GMT points Tuesday marks oneyear anniversary marketâs nadir pandemic caused stocks plummet Since intraday low advanced gained These expected losses Wall Street follow weakness Europe European equities retreating oneyear peak new wave coronavirus cases lockdown extension Germany raised fears slow economic recovery Additionally Turkish stocks continued fall main index President Tayyip Erdogan abruptly fired hawkish central bank governor weekend installed critic country tight monetary stance The countryâs currency lira also volatile made back Mondayâs sharp losses US housing data focus UK jobless rate falls With minutes last Federal Reserve meeting stating central bank studying actual economic data monetary policy cues focus turn Tuesday release latest numbers housing market This sector one beneficiaries pandemic large numbers sought sanctuary suburbs moving away highdensity cities However things started cool Monday showed drop number homebuyers listing homes time data released AM ET GMT analysts expect February numbers show decline prior month Earlier Tuesday Britain unexpectedly fell three months January country entered new lockdown forecasts rise Oil hit European coronavirus restrictions Crude prices weakened Tuesday amid growing concerns flaring cases Europe slow recovery demand particularly ahead summer tourism season At AM ET GMT futures lower barrel futures barrel Germany Europe biggest oil consumer Monday extended lockdown April asked citizens stay home Easter holiday period try combat third wave infections hitting continent In blow tourism industry fines pounds introduced people England try travel abroad end June tightening country border controls On supply side Organization Petroleum Exporting Countries allies OPEC convene April determine production policy May âœThe wobble market give OPEC something think ahead meetingâ said analysts ING research note âœClearly prior recent downward pressure expectations OPEC would start ease cuts However group may hesitant particularly sentiment shift ahead meeting âœ Ahead US crude inventory data industry body released later Tuesday',\n",
              " 'Â Bloomberg A box PfizerBioNTech vaccines opened delivery Ambroise Pare Clinic Paris France Wednesday Jan The French government trying make slow start vaccination program criticism doctors opposition politicians AZN Add toRemove Portfolio PFE Add toRemove Portfolio Bloomberg The European Union announced give stronger powers stop Covid vaccine exports rest world setting stage escalation tensions allies manufacturers faces third wave infections The EU strengthening existing export rules demand countries received doses EU also allow shots sent back It also consider nationâs vaccination rate pandemic situation deciding whether green light shipments The mechanism wonât automatic used casebycase basis The proposal comes bloc struggles turn around sluggish inoculation campaign governments Berlin Paris battle rise infections year since started The situation also fueled spat UK itâs former member vaccine supplies Britain âœWe ensure timely sufficient vaccine deliveries EU citizensâ European Commission President Ursula von der Leyen said statement âœThe EU major Organization Economic Cooperation Development producer continues export vaccines large scale dozens countries open roads run directionsâ The new export rules coincide coronavirus situation Europe getting bleaker governments face pressure citizens arenât vaccinated quickly elsewhere EU finds disputes manufacturers countries When leaders hold summit Thursday theyâll discuss blocâs latest powers say âœsituation remains seriousâ âœrestrictions including nonessential travel must therefore upheldâ according EU document seen Bloomberg While legislation isnât aimed specific countries itâs clear UK could one biggest targets adding even drama increasingly fraught relationship three months day since two sides signed trade deal As well disagreements export Covid vaccines UK refused grant full rights blocâs ambassador London EU still smarting UKâs threat later withdrawn break international law last year rewrite Brexit agreement The European Commissionâs draft legislation published Wednesday said governments take account issues including whether countries exporting vaccines back EU well epidemiological vaccine situation The measures stay place least end June According document vaccine manufacturers exported âœlarge quantitiesâ âœcertain countries without production capacity higher vaccination rateâ EU current rate Covid infections isnât high Exports countries may âœthreaten security supplyâ legislation says It adds manufacturers exported countries âœhave large production capacity ownâ yet âœthose countries restrict exportsâ EU The plan aimed companies Astrazeneca Plc LON arenât delivering commitments also factors possible future difficulties companies like Pfizer Inc NYSE meeting obligations according official familiar proposal asked identified plans private Slow Rollout In effort get around claims governments notably UK donât formal export restrictions legislation makes clear come âœeither law contractual arrangements concluded vaccine manufacturersâ While ban exports countries wonât automatic âœmember states refuse export authorizations accordinglyâ draft said The new rules could consequences UK received million million doses shipped EU far biggest recipient blocâs vaccines It also vaccinated faster rate falling infections The bloc administered doses per people less third UK managed according Bloombergâs Coronavirus Vaccine Tracker Israel inoculated half population Neighboring countries included new directive due increased risk third parties using special trade privileges help circumvent tighter export criteria according document The rules include European Free Trade Association countries well European Economic Area Vaccine âGreedâ UK Prime Minister Boris Johnson told reporters London countries âœfighting pandemicâ government âœcontinue work European partnersâ Later however risked inflaming tensions telling group Conservative MPs private meeting via Zoom UKâs vaccine success âœgreedâ The government sought limit damage cabinet minister Priti Patel taking rare step using television interviews try explain premierâs remarks British officials usually comment public private discussions meeting Johnson party The EU UK currently negotiating divide stock Astra plant Netherlands due come stream next weeks A European diplomat said scope agreement form prorata distribution based population size Meanwhile Canadaâs government described EUâs proposals âœconcerningâ And Australia Health Minister Greg Hunt Wednesday said nation received less fifth million doses contracted AstraZenecaâs European operations Earlier month Italy blocked vaccine shipments Australia using EU mechanism Bloomberg LP',\n",
              " 'Â Reuters BAC Add toRemove Portfolio HMb Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio NKE Add toRemove Portfolio AZN Add toRemove Portfolio BTCUSD Add toRemove Portfolio MRNA Add toRemove Portfolio By Geoffrey Smith Investingcom More ships backed waiting get Suez Canal may remain blocked Sunday The EU UK dial vaccine war ahead summit President Joe Biden Zoom call united front China government medialed backlash Nike NYSE HM ST progress companies said would cut ties cotton suppliers Xinjiang claims forced labour AstraZeneca NASDAQ revises assessment efficacy drug much enough create headscratching And jobless claims data expected show downward trend unemployment reasserting Here need know financial markets Thursday March Suez still blocked The Suez Canal one important arteries global trade remained blocked third day massive container ship jammed walls heavy winds Tuesday Bloomberg reported elite salvage squad due arrive site later Thursday add efforts tugboats diggers far failed extract ship longer Parisâs Eiffel Tower tall Dutch state TV quoted head salvage company saying might take weeks unblock canal The blockage left ships stranded waiting entrance Canal disruption promises reflected commodity prices trade flows least month The Canal acts major conduit Persian Gulf Europe US east coast also Russian oil shipped Asia Crude futures barrel barrel Europe UK dial vaccine war AstraZeneca revises drug data The UK EU signalled truce fight vaccines pledging work together joint statement released ahead EU summit later day The summit also attended remotely US President Joe Biden Overnight AstraZeneca PLC LON updated US trial results show slightly lower efficacy rate vaccine It says drug effective stopping virus repeated successful preventing death hospitalization The discrepancy initial results nonetheless sheds unwelcome light AZâs internal processes adding previous confusion initial test results Europe The AZ virus vital part global vaccination campaign substantially cheaper offered Pfizer NYSE Moderna NASDAQ Thatâs important two worst outbreaks world present raging India Brazil Stocks set open higher jobless claims Fed speakers eyed US stocks set open modestly higher declines Wednesday attention likely focused weekly report AM ET GMT By AM ET GMT points Initial claims expected fallen previous week arguably important number always total number people unemploymentrelated benefits The final reading fourthquarter GDP also due time There speeches Federal Reserve members course day Emerging central banks ponder rising inflation slide continues Itâs another big day emerging market central banks due announce latest monetary policy decisions Inflationary pressures forced Turkey Russia Brazil raising interest rates last week analysts donât expect hike either meeting Mexican central bank particular expected move hawkish guidance Overnight Switzerland left monetary policy unchanged toned talk possibly intervening cap francâs rise In digital currency space Bitcoin continued slide backdrop negative commentary Teslaâs embrace Bank America NYSE analysts issued note highlighting currencyâs carbon footprint odds Teslaâs stated goal reducing carbon emissions At conference held Bank International Settlements former ECB board member Benoit Coeure repeated Bitcoin âœfailedâ establish genuine currency Nike HM feel Chinese backlash Xinjiang cotton boycott Stocks focus later may include Nike facing backlash China cutting ties cotton suppliers province Xinjiang Swedish fashion chain HM problem The companies made moves US EU UK imposed sanctions Chinese officials relation allegations human rights violations Xinjiang US says China conducting genocide Muslim Uighur minority China angrily responded sees interference domestic affairs Bidenâs participation EU summit later intended reflect united stance West visÃ vis China Â Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio HMb Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio CINE Add toRemove Portfolio By Peter Nurse Investingcom European stock markets traded mixed fashion Thursday investors digested regionâs situation ahead meeting EU leaders At AM ET GMT Germany traded lower France fell UK index climbed The main focus European markets virtual meeting EU leaders discuss third wave cases hitting region well associated slow vaccine rollout The leaders likely discuss possible curbs vaccine exports source tension neighboring UK whose immunization program advanced Germany France Italy Netherlands recently tightened restrictions combat increasing number infections threatening swamp regionâs hospitals There good news region GfK index came April small improvement seen March still indicative pessimistic consumer regionâs largest domestic market lockdowns weigh Sentiment French manufacturing sector stabilized Insee monthly survey showing sentiment sector remained March unchanged Februaryâs figure In corporate news AstraZeneca LON stock rose drugmaker announced late Wednesday Covid vaccine effective preventing symptomatic illness slight drop level initially reported questions raised data used US trial Cineworld LON stock fell cinema chain reported billion loss said ask shareholders approve raise debt ceiling Hennes Mauritz ST stock dropped Chinese state media singled Swedish retailer Wednesday statement last year company said deeply concerned reports accusations forced labour Xinjiang Oil prices fell Thursday reversing Wednesdayâs gains came container ship got stuck Suez Canal blocking one important supply routes world This passage remains plugged demand concerns returned fore While focus lockdowns Europe crucial developing economies like India Brazil also seen rising numbers cases Additionally US crude stocks jumped million barrels last week according official data traded lower barrel contract fell Elsewhere fell traded lower',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio BRBY Add toRemove Portfolio SMIN Add toRemove Portfolio Copper Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio AZN Add toRemove Portfolio BTCUSD Add toRemove Portfolio Key Points closing price GBP strong economy hopes Oil jumps Suez Canal still blocked Miners rally higher metals prices By Samuel Indyk Investingcom â The FTSE finished Friday higher close week gain Smiths Group PLC LON best performing stock bluechip index company reported halfyear results premarket The company boosted dividend said confident meeting market expectations full year despite uncertainty Covid Miners particularly strong amid increase basic resources prices jumped back due optimism US growth ahead Bidenâs infrastructure plan set unveiled next week Burberry Group PLC LON underperformed company became latest face backlash China Xinjiang cotton row The fashion company member Better Cotton Initiative group suspended approval cotton Xinjiang due concerns human rights The Chinese actress Zhou Dongyu terminated contract Burberry brand ambassador companyâs famous check patter removed Tencentâs video game Honor Kings due backlash Burberry faced China strengthened Friday amid general vaccine optimism hopes fast economic rebound This comes despite meeting European leaders yesterday agreed AstraZeneca PLC LON NASDAQ could export Covid vaccines contract EU fulfilled Reports EU UK also close deal financial services also supported GBP âœThe economic wheel fortune seems turning back UKâs favourâ said Kallum Pickering Berenberg âœWe expect strong consumerled recovery spring onwards savings normalise facetoface services reopen manufacturers step production meet rising demandâ The UK data little dampen outlook GBP volumes increasing February The increase partly driven increase outdoor furniture purchases Covid restrictions start easing next week UK futures benefitted ongoing blockage Suez Canal Ever Given container ship It still unclear long ship stranded reports shipping companies begun reroute tankers around Africa adding around days sailing times Europe days US east coast jumped finding support ahead Thursday The worldâs largest cryptocurrency still remains away alltime high tumbling week market cap',\n",
              " 'Â Reuters EURUSD Add toRemove Portfolio GBPUSD Add toRemove Portfolio Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio DX Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio AZN Add toRemove Portfolio Key Points FTSE closing price AstraZeneca NASDAQ shares rise top FTSE Barclays falls despite increased profit falls despite increased profit Darktrace soars trading debut USD jumps Fed taper comments Oil retreats OPEC production due come back online By Samuel Indyk Investingcom â The finished marginally higher Friday still closed psychological hawkish comments Fedâs Kaplan appeared dampen risk appetite Kaplan traditionally one hawkish members FOMC said would appropriate start talking asset purchases Riskier assets also dampened study Imperial College regarding Pfizer NYSE vaccine The study suggested healthcare workers one dose jab risk Covid variants âœIn previously infected far received one dose vaccine immune response variants concern may insufficientâ Imperial College said study The double whammy sent fresh session highs helped weigh GBPUSD dropped away handle EURUSD dropped back towards In individual stocks news AstraZeneca LON shares led FTSE higher recording increase revenue first quarter The company sales vaccine aiming deliver doses per month On end scale Barclays LON The company still recorded mammoth profit failed release funds expected credit losses UK peers done earlier week The bank reported decline FICC income also seemed drag shares lower also adding costs year likely higher Shares cyber security firm Darktrace jumped much first day trading initial listing price pence per share valued company crude futures fell Friday amid broad riskoff tone stronger USD As reminder next week Saudi Arabia rest OPEC group begin roll back production cuts announced start pandemic',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio ENT Add toRemove Portfolio Jan Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers ASTRAZENECA India drugs regulator Sunday approved emergency use two coronavirus vaccines one developed AstraZeneca Oxford University local company Bharat Biotech staterun institute ENTAIN MGM Resorts International MGMN seeking buy British gaming company Entain latest move casino operator double onlinegambling business Wall Street Journal reported Sunday ASTRAZENECA About two million doses vaccine developed OxfordAstraZeneca set supplied every week middle January United Kingdom The Times reported TRADING Europe see biggest transfer share trading two decades stock exchanges open business Brexit shifting centre gravity away London Britain become first country roll low cost easily transportable AstraZeneca Oxford University vaccine Monday another step forward global response pandemic British Prime Minister Boris Johnson said Sunday tougher lockdown restrictions probably way cases keep rising schools safe children continue attend permitted GOLD Gold prices started new year high notching eightweek peak surpassing key level surge cases prospects tougher coronavirus control measures lured investors safehaven metal OIL Oil prices rose expectations OPEC allied producers may cap output current levels February meeting later day pandemic keeps worries firsthalf demand elevated The UK bluechip index fell Thursday trading session lower clocked worst year since financial crisis United Kingdom widened restrictions stem new variant coronavirus raging across country',\n",
              " 'Â Reuters EURUSD Add toRemove Portfolio XAUUSD Add toRemove Portfolio GS Add toRemove Portfolio JPM Add toRemove Portfolio AZN Add toRemove Portfolio WFC Add toRemove Portfolio JNJ Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio By Peter Nurse Investingcom US stocks seen opening marginally lower Tuesday negative news front weighing ahead highly anticipated inflation report could guide near term market sentiment At AM ET GMT contract points traded largely flat dropped points All three contracts slid lower New York Times reported US authorities set call pause distributing Johnson Johnson NYSE vaccine amid worries blood clotting issues A similar problem plagued AstraZeneca LON NASDAQ drug This cautious trading comes ahead release March reading due AM ET GMT expected rise monthovermonth yearoveryear Stock markets climbed record levels late helped expectations strong US economic recovery But concerns increasing combination unprecedented levels fiscal stimulus pent demand lead rampant inflation forcing Federal Reserve tighten monetary policies quickly earlier anticipated Fed officials pains point see bump inflation temporary remain committed supporting economic recovery jobs picture looks better hefty CPI jump would raise pressure especially Fridayâs sharp rise producer prices âœWith commodity prices import prices continuing surge ISM manufacturing services prices paid highest level since increasing pipeline price pressuresâ said analysts ING note The bond market also traded subdued fashion Tuesday successful Treasury auction benchmark yield edging slightly higher trade near still well oneyear high around seen end March Corporate news set pick later week banking giants JPMorgan Chase NYSE Goldman Sachs NYSE Wells Fargo NYSE set report quarterly results Wednesday Ahead Grab likely focus Asian ridehailing food delivery firm announced intention merge Altimeter leading US public listing valuing company nearly billion largest ever SPAC deal Oil prices edged higher Tuesday helped robust Chinese trade data indicating continued economic recovery worldâs largest crude importer tensions Middle East Yemenbased Houthi movement said fired missiles Saudi oil sites Attention Tuesday also oil supply data American Petroleum Institute Organization Petroleum Exporting Countries set release monthly report oil market US crude futures traded higher barrel contract rose Elsewhere fell traded lower',\n",
              " 'Â Reuters Press briefing stopping AstraZeneca vaccine Copenhagen AZN Add toRemove Portfolio JNJ Add toRemove Portfolio AZN Add toRemove Portfolio MRNA Add toRemove Portfolio By Nikolaj Skydsgaard Jacob GronholtPedersen COPENHAGEN Reuters Denmark Wednesday became first country stop using AstraZeneca NASDAQ vaccine altogether following news possible link rare blood clot cases health authorities said The decision push back scheduled conclusion Denmark vaccination scheme early August July said Results investigations blood clots showed real serious side effects health agency head Soren Brostrom said statement Based overall consideration therefore chosen continue vaccination programme target groups without vaccine The European Union drug watchdog said last week found possible link AstraZeneca vaccine cerebral venous sinus thrombosis CVST brain blood clot said risk dying much greater risk mortality rare side effects As April European Medicines Agency received reports cases CVST million Astrazeneca LON doses administered European Economic Area The EU regulator however left individual states make risk assessments decide administer vaccine Many countries Europe elsewhere resumed administering shot restricting use certain age groups mostly aged Denmark first country initially suspend usage vaccine March safety concerns also put Johnson Johnson NYSE vaccine pause pending investigations possible similar blood clot link Almost one million country million population received first shots getting PfizerBioNTech vaccine Moderna NASDAQ AstraZeneca Denmark process easing restrictions daily infection rate slowed several thousand December Â Reuters WFC Add toRemove Portfolio BTCUSD Add toRemove Portfolio AZN Add toRemove Portfolio HOFT Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio JNJ Add toRemove Portfolio GS Add toRemove Portfolio ICE Add toRemove Portfolio LSEG Add toRemove Portfolio AZN Add toRemove Portfolio INFY Add toRemove Portfolio BBBY Add toRemove Portfolio PRTP Add toRemove Portfolio LVMH Add toRemove Portfolio JPM Add toRemove Portfolio By Geoffrey Smith Investingcom Coinbase set go public via direct listing reference price values north billion Bitcoin Dogecoin basking reflected glory JPMorgan NYSE Goldman Sachs NYSE expected report banner earnings season firstquarter updates kicks earnest French luxury groups already shown way Stocks consolidating wait numbers oil highest week IEA joined OPEC raising demand forecasts year Here need know financial markets Wednesday April Coinbase goes public Bitcoin DogeCoin hit new heights Coinbase worldâs secondlargest cryptocurrency exchange volume set go public via direct listing later landmark development arguably pushes cryptocurrencies toward financial mainstream The reference price set share fully diluted share count million would value company billion â line Intercontinental Exchange NYSE London Stock Exchange Group LON The simpler share count listed prospectus gives valuation billion The company said earlier month registered around billion revenue first quarter year year earlier thanks explosive rise prices Bitcoin Ether digital currencies traded first time overnight DogeCoin digital currency started joke touted aggressively Elon Musk recent months rose sic obvious price trigger Banks luxury groups kick earnings season The firstquarter earnings season starts earnest JPMorgan Wells Fargo NYSE Goldman Sachs set report open All three expected report sharp increases earnings thanks low comparables previous year JPMorgan Goldman expected capitalized also favourable capital market trends least massive increase SPAC listings turn helped MA advisory businesses Overnight French luxury groups LVMH PA Christian Dior also impressed reporting sharp yearonyear sales increases wealthy clienteles diverted spending travel leisure purses fashion Both stocks hit record highs European trading Gucci owner Kering PA Stocks drift ahead earnings Coinbase Powell speaks PM ET US stock markets drifting ahead release key bank earnings later JPMorgan Wells Fargo particular eyed proxies health broader US economy By AM ET GMT points less similar amount Nasdaq futures All three still enjoying supportive tone Tuesdayâs rally bonds March inflation data failed generate negative shock In addition banks Bed Bath Beyond NASDAQ Hooker Furniture NASDAQ Infosys NYSE also set report earnings open Federal Reserve Chairman Jerome Powellâs address Economic Club New York PM ET also generate headlines unlikely add much current knowledge central bankâs thinking JJ vaccine hitch poses new threat EU inoculation progress The European Commission end contracts Johnson Johnson NYSE AstraZeneca LON NASDAQ expire according Italian newspaper La Stampa JJ said would pause rollout vaccine Europe Tuesday US health authorities recommended pause administering possible links rare severe blood clots investigated Both vaccines based adenovirusbased technology JJ contracted supply enough vaccine protect million people EU second quarter quarter blocâs total vaccination schedule next three months As threatens delay attainment herd immunity something could seriously undermined blocâs attempts salvage summer tourism season EasyJet said earlier expects fly total capacity three months June winter season IEA raises oil demand forecasts EIA inventories due The International Energy Agency followed OPEC raising forecasts global oil demand year average barrels day March forecasts However pushed increase back second half year view ongoing pandemicrelated headwinds The IEA said expects million barrels day capacity needed come online second half beyond OPEC group already agreed release By AM ET futures barrel highest days barrel US government inventory data due AM ET usual expected show million barrel decline crude stocks last week Â Reuters FILE PHOTO OxfordAstraZeneca vaccine vaccination centre Antwerp AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio MILAN Reuters The EU Commission decided renew vaccine contracts next year companies Astrazeneca LON Johnson Johnson NYSE JJ Italian daily La Stampa reported Wednesday citing source Italian Health Ministry The European Commission agreement leaders many EU countries decided contracts companies produce viral vector vaccines valid current year renewed expiry newspaper reported It added Brussels would rather focus vaccines using messenger RNA mRNA technology Pfizer NYSE Moderna NASDAQ The European Commission seeking clarification JJ company completely unexpected announcement delays vaccine deliveries EU EU official told Reuters Tuesday',\n",
              " 'UK shares lower close trade Investingcom United Kingdom BATS Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio SGRO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom â UK equities lower close Tuesday losses sectors propelled shares lower At close London fell The biggest gainers session Segro Plc LON rose points trade close Avast PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included International Consolidated Airlines Group SA LON lost points trade late trade British American Tobacco PLC LON declined points end Imperial Brands PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery June fell hit barrel June Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom BARC Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio NILSY Add toRemove Portfolio VTBRq Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Friday gains sectors propelled shares higher At close London added The biggest gainers session AstraZeneca PLC LON rose points trade close Bank VTB PAO DRC LON added points end Hikma Pharmaceuticals PLC LON points late trade Biggest losers included Barclays PLC LON lost points trade late trade Ocado Group PLC LON declined points end GMK Norilskiy Nikel PAO DRC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery June fell hit barrel July Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom EZJ Add toRemove Portfolio AZN Add toRemove Portfolio INF Add toRemove Portfolio AVV Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio FTNMX Add toRemove Portfolio VTBRq Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Monday gains sectors propelled shares higher At close London gained The biggest gainers session International Consolidated Airlines Group SA LON rose points trade close Bank VTB PAO DRC LON added points end EasyJet PLC LON points late trade Biggest losers included AVEVA Group PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Informa PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August rose hit barrel September Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters GRG Add toRemove Portfolio HOTC Add toRemove Portfolio Add toRemove Portfolio SCSS Add toRemove Portfolio ICGT Add toRemove Portfolio Add toRemove Portfolio Copper Add toRemove Portfolio DX Add toRemove Portfolio AGRP Add toRemove Portfolio GBPUSD Add toRemove Portfolio MRON Add toRemove Portfolio GPEG Add toRemove Portfolio BHPB Add toRemove Portfolio AAL Add toRemove Portfolio TSCO Add toRemove Portfolio AZN Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include services composite PMIs Eurozone US US Stocks Greggs LON Twoyear like like sales despite staffing supply chain disruption Subject unexpected COVID disruption expect full year outcome ahead previous expectations BHP LON Reportedly talks Ivanhoe Mines buy Western Foreland project Democratic Republic Congo Tesco LON Close settling final meaningful legal action shareholders accounting crisis Could announce reached agreement group institutional investors âœsubstantial payoutâ alongside results Wednesday AstraZeneca LON Requested Emergency Use Authorization EUA US Food Drug Administration FDA prophylaxis Melrose Industries LON Supply constraints automotive industry affects performance companyâs Automotive Powder Metallurgy divisions At present timing duration constraints uncertain recently consensus view lengthened There number scenarios possible likely previous expectations Melrose confident scale impact profitability revenue adjustment previous guidance given margin dropthrough underlining good progress made restructuring businesses Anglo American LON Seamus French leave end replaced CEO Bulk Commodities Themba Mkhwanazi currently CEO Kumba Mpumi Zikalala currently Managing Director De Beers Managed Operations appointed CEO Kumba Great Portland Estates LON million new annual rent signed quarter September market lettings ahead March ERV Sold Old Street million reflecting premium March valuation Expect healthy demand persist million lettings offer ahead ERV million new annual rent negotiation Assura LON Growing portfolio properties current annualised rent roll million Added properties portfolio comprising seven new development completions acquisitions combined total cost million ICG Enterprise Trust LON NAV per Share NAV per Share Total Return Second quarter dividend per share taking total period Intention reaffirmed declare total dividends least per share financial year Scs Group LON FY gross sales increased million Underlying profit tax million million One year likeforlike order intake despite closed weeks compared weeks Recommended final dividend per share Year date trading Board expectations Hotel Chocolat LON â FY revenue increase million Underlying EBITDA million million Group trading line management expectations first weeks',\n",
              " 'DJI Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio WMT Add toRemove Portfolio HD Add toRemove Portfolio JNJ Add toRemove Portfolio M Add toRemove Portfolio MRNA Add toRemove Portfolio By Liz Moyer Investingcom Stocks wobbled Monday good news vaccine rollouts reopenings across US blunted concerns interest rates Energy stocks helped overcome losses tech side oil prices climbed even Colonial Pipeline said back online This big week retail earnings Walmart Inc NYSE kicking things President Joe Biden announced US would ship million doses vaccine abroad including million doses AstraZeneca PLC LON âs vaccine still awaits approval Some million doses Pfizer Inc NYSE Moderna Inc NASDAQ Johnson Johnson NYSE vaccines sent end June New Yorkâs Gov Andrew Cuomo announced state would lift mask mandate Wednesday The Federal Reserve release minutes latest meeting Wednesday investors waiting see say inflation expectations Here three things could affect markets tomorrow Walmart earnings Walmart kicks week retail earnings Analysts tracked Investingcom expect profit share revenue billion Analysts watching trends membership service Walmart effect stimulus checks sales outlook sales given rising consumer prices Home Depot earnings Home Depot Inc NYSE seen reporting earnings share revenue billion The home improvement retailer booming year pandemic people took doityourself projects moved houses Analysts listening outlook especially given redhot housing market Macy earnings Macyâs Inc NYSE expected report loss cents share revenue billion according analysts tracked Investingcom Department stores malls forced shut much last year able reopen shoppers last months analysts listening hear whether companyâs executives think worst behind',\n",
              " 'Â Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Britain Aug REUTERSPeter Nicholls Add toRemove Portfolio HSBA Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio TSCO Add toRemove Portfolio DGE Add toRemove Portfolio ULVR Add toRemove Portfolio PAGE Add toRemove Portfolio By Shashank Nayar Bansari Mayur Kamdar Reuters London bluechip stocks fell Wednesday pressured fears higher inflation supermarket retailer Tesco LON topped index raising annual outlook strong firsthalf results The eased recording worst session since August weighed energy mining stocks respectively A recent survey found British manufacturers plan raise prices point past three decades cost pressures continue build Inflation fears rising back soaring energy costs supply side labour shortages weighed equities central banks look pull back pandemic era monetary support hike rates relieve cost pressures There big concern increasing inflationary pressures coming time evidence UK recovery slowing fears stagflation understandably growing said Stuart Cole head macro economics Equiti Capital Banking stocks gained bond yields surged past highest level since spring signs rising inflationary pressures The FTSE recovered around pandemic lows hit March around far year rebounding optimism supportive monetary policies HSBC Holdings LON led pack UBS raised price target upgraded stock buy neutral The domestically focused midcap index fell near threemonth low consumer discretionary stocks leading declines Barclays LON downgraded subindex underweight Tesco rose raising fullyear outlook following strong profit first half results Global recruitment firm PageGroup climbed raised profit forecast Tobacco group Imperial Brands LON fell although said track meet fullyear operating profit forecast',\n",
              " 'Â Reuters AZN Add toRemove Portfolio WPP Add toRemove Portfolio TW Add toRemove Portfolio WPP Add toRemove Portfolio TWODY Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio DARK Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include UK German speech Stocks London Stock Exchange Group LON To acquire Qunatile Group Limited maximum aggregate consideration million Darktrace LON To commence share buyback programme million ordinary shares The maximum amount allocated Programme million BT LON Discovery reportedly talks create joint venture BT Sport move would hijack sale sports streaming service DAZN FT AstraZeneca LON NASDAQ Has reportedly studying options including potential listing newlycreated vaccine division seeks boost returns Bloomberg WPP LON Acquired majority stake branding design agency Made Thought Taylor Wimpey LON Activist investor Elliott Advisors reportedly built âœsmallâ stake company Times Clarkson LON Results year ending December anticipated ahead current market expectations underlying profit tax expected less million Thungela Resources LON Export saleable production expected Mt subject deterioration Transnet Freight Rail performance stringent restrictions December Export equity sales expected Mt The Board remains committed delivering attractive shareholder returns maintaining disciplined capital allocation Accordingly Company may declare additional returns targeted minimum payout ratio Adjusted operating free cash flow Likely return profitability respect Earnings per share Headline earnings per share financial year following loss financial year Infrastructure LON Agreed invest circa million acquire stake SRL Traffic Systems market leading traffic management equipment rental company UK ContourGlobal LON Now expects FY adjusted EBITDA million million guidance range communicated October million Victrex LON FY volumes tonnes Group revenue million underlying profit tax million Increased dividend pence per share Assume year year progress full year sales volumes Also facing sizeable currency headwind increased raw material energy costs Hammerson LON To commence share repurchase programme shares Marshall Motor Holdings LON Recommends shareholders accept pence per share offer Constellation AGBarr PLC LON Has bought initial circa equity stake MOMA Foods Limited agreed path full ownership next years The transaction expected material impact Group profits current financial year ending January Ted Baker LON Chairman John Barton died Helena Feltham assume role Interim Chairman immediate effect Sectors Housing Names The Bank England said poised loosen mortgage lending rules bought pandemic Travel Leisure The UK government introduced predeparture COVID testing passengers arriving England',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom EZJ Add toRemove Portfolio AZN Add toRemove Portfolio BRBY Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London fell The biggest gainers session AstraZeneca PLC LON rose points trade close Avast PLC LON added points end Ocado Group PLC LON points late trade Biggest losers included Burberry Group PLC LON lost points trade late trade International Consolidated Airlines Group SA LON declined points end EasyJet PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom FERG Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio AAL Add toRemove Portfolio BHPB Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio BMEB Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Tuesday gains sectors propelled shares higher At close London added The biggest gainers session Anglo American PLC LON rose points trade close Ferguson Plc LON added points end BHP Group PLC LON points late trade Biggest losers included BM European Value Retail SA LON lost points trade late trade AstraZeneca PLC LON declined points end Reckitt Benckiser Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery January rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Â Reuters FILE PHOTO Vials PfizerBioNTech AstraZeneca Moderna coronavirus disease vaccine labels seen illustration picture taken March REUTERSDado RuvicIllustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Lucy Marks Reuters A major British study mixing vaccines found people better immune response received first dose AstraZeneca NASDAQ PfizerBioNTech shots followed Moderna NASDAQ nine weeks later according results Monday We found really good immune response across board fact higher threshold set OxfordAstraZeneca vaccine two doses Matthew Snape Oxford professor behind trial dubbed told Reuters The findings supporting flexible dosing offer hope poor middle income countries may need combine different brands first second shots supplies run low become unstable I think data study especially interesting valuable low middleincome countries still rolling first two doses vaccines Snape said We showingyou stick rigidly receiving vaccine second doseand programme delivered quickly using multiple vaccines okay If AstraZenecaOxford vaccine followed Moderna Novavax shot higher antibodies Tcell responses induced versus two doses AstraZenecaOxford according researchers University Oxford The study volunteers also found dose PfizerBioNTech vaccine followed Moderna shot better two doses standard PfizerBioNTech course PfizerBioNTech followed Novavax induced higher antibodies twodose OxfordAstraZeneca schedule although schedule induced lower antibody Tcell responses twodose PfizerBioNTech schedule No safety concerns raised according Oxford University study published Lancet medical journal Many countries deploying mix match well robust data available nations faced soaring infection numbers low supplies slow immunisation safety concerns Longevity protection offered vaccines scrutiny booster doses considered well amid surging cases New variants including Delta Omicron increased pressure speed vaccination campaigns Blood samples participants tested WildType Beta Delta variants researchers study said adding vaccines efficacy variants waned consistent across mixed courses Deploying vaccines using technology different platforms like Pfizer NYSE Moderna mRNA AstraZeneca viral vector Novavax proteinbased shot within schedule new The results may inform new approaches immunisation diseases said The study also found first dose AstraZenecaOxford vaccine followed candidates study generated particularly robust response consistent findings June The study designed socalled noninferiority study â intent demonstrate mixing substantially worse standard schedules compares immune system responses goldstandard responses reported previous clinical trials vaccine',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom NXT Add toRemove Portfolio AZN Add toRemove Portfolio TW Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio EXPN Add toRemove Portfolio Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom â UK equities lower close Thursday losses sectors propelled shares lower At close London fell hit new low The biggest gainers session Avast PLC LON rose points trade close Experian PLC LON added points end Samsung Electronics Co Ltd DRC LON points late trade Biggest losers included Next PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Taylor Wimpey PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'AZN Add toRemove Portfolio Investingcom AstraZeneca NASDAQ reported Thursday second quarter missed analysts forecasts revenue topped expectations AstraZeneca announced earnings per share revenue Analysts polled Investingcom anticipated EPS revenue AstraZeneca shares beginning year trading underperforming SP Global start year AstraZeneca shares gained intraday trade report AstraZeneca follows major Healthcare sector earnings month AstraZeneca report follows earnings beat GlaxoSmithKline Wednesday reported EPS revenue compared forecasts EPS revenue ReNeuron beat expectations July second quarter EPS revenue compared forecast EPS revenue Stay uptodate upcoming earnings reports visiting Investingcom earnings calendar',\n",
              " 'Â Reuters FILE PHOTO Pedestrians wearing facial masks reflected electric board showing stock prices outside brokerage business district Tokyo XAUUSD Add toRemove Portfolio Add toRemove Portfolio DJI Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio DX Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio IXIC Add toRemove Portfolio STOXX Add toRemove Portfolio By Stephen Culp NEW YORK Reuters Wall Street edged higher dollar dipped lowest two years Wednesday penultimate trading day remarkable year pandemic recession recovery All three major US stock indexes modestly recently enacted stimulus ongoing rollout vaccines fed optimism economic recovery going beginning said Matthew Keator managing partner Keator Group wealth management firm Lenox Massachusetts My anticipation probably robust latter part Once sense allclear sign would anticipate robust response consumer Keator added For Keator suggests markets waitandsee mode The markets saying done lately people going focusing going happen see restrictions due pandemic said Britain approved coronavirus vaccine developed Oxford University AstraZeneca latest development rapid progression testing approval deployment drugs battle disease The rose points gained points added points European stocks reversed gains end fiveday winning streak closing lower investors locked yearend gains The panEuropean index lost MSCI gauge stocks across globe gained Emerging market stocks rose MSCI broadest index AsiaPacific shares outside Japan closed higher lost US Treasury yields slightly lower thin trading investors bet Republicans unlikely approve passage proposed stimulus checks Benchmark notes last rose price yield late Tuesday The bond last rose price yield late Tuesday The dollar fell lowest since April basket world currencies investors bet fiscal support positioned yearend light trading volume The fell euro The Japanese yen strengthened versus greenback per dollar Sterling last trading day Crude oil prices inched higher back weaker dollar dip US inventories gains capped dimming hopes demand rebound futures gained settle per barrel settled per barrel day Gold prices rose countering dip greenback although global vaccine rollouts increased risk appetite limited safehaven metal gains added ounce Â Reuters Add toRemove Portfolio BP Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio GFSl Add toRemove Portfolio DRX Add toRemove Portfolio AGGK Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio FTMC Add toRemove Portfolio EXPN Add toRemove Portfolio Add toRemove Portfolio EBKG Add toRemove Portfolio PL Add toRemove Portfolio Adds futures news items Feb Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers futures ahead cash market open BOOHOO Boohoo bought Dorothy Perkins Wallis Burton brands administrators Arcadia million pounds completing breakup Philip Green fallen empire DRAX Drax said would buy Canadabased Pinnacle Renewable Energy Inc deal implied enterprise value million including debt EXPERIAN Experian said continuing investigate whether personal data millions Brazilian people found illegally offered sale online could connected Brazilian business Serasa BP BP Germany Energie BadenWuerttemberg AG selected together preferred bidder two major leases UK offshore wind leasing round Londonlisted company said ASTRAZENECA There evidence Astrazeneca vaccine prevent death serious illness South Africa imposed temporary halt using vaccine British junior health minister said ROLLS ROYCE RollsRoyce said proposing twoweek operational shutdown civil aerospace unit summer CSE hold talks City takeover panel Telegraph reported Saturday could lead headtohead auction GardaWorld Allied Universal company buyout GOLD Gold prices edged higher softer US jobs data cemented hopes fiscal stimulus pressured dollar OIL Oil prices rose futures nudging past barrel boosted supply cuts among key producers hopes US economic stimulus measures boost demand The UK midcap index closed higher Friday power equipment supplier Aggreko Plc soared following buyout proposal faster vaccine rollouts supported hopes brisk economic revival TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio RR Add toRemove Portfolio GFSl Add toRemove Portfolio AGGK Add toRemove Portfolio Add toRemove Portfolio RIO Add toRemove Portfolio Copper Add toRemove Portfolio LCO Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio ILND Add toRemove Portfolio AZN Add toRemove Portfolio SONG Add toRemove Portfolio Feb Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers RIO TINTO Mongolia government seeking agreement Rio Tinto terminate deal expand Oyu Tolgoi mine Gobi Desert Financial Times said ASTRAZENECA South Africa put hold use AstraZeneca NASDAQ shot vaccination programme data showed gave minimal protection mildtomoderate infection caused country dominant coronavirus variant ROLLS ROYCE RollsRoyce said proposing twoweek operational shutdown civil aerospace unit summer CSE hold talks City takeover panel Telegraph reported Saturday could lead headtohead auction GardaWorld Allied Universal company buyout HIPGNOSIS SONGS FUND Hipgnosis Songs Fund said Friday raised million pounds share sale investment firm seeks cash explosion online music streaming pandemic Britain plans tax retailers tech companies whose profits soared pandemic Sunday Times reported GOLD Gold prices edged higher softer US jobs data cemented hopes fiscal stimulus pressured dollar OIL Oil prices rose futures nudging past barrel boosted supply cuts among key producers hopes US economic stimulus measures boost demand The UK midcap index closed higher Friday power equipment supplier Aggreko Plc soared following buyout proposal faster vaccine rollouts supported hopes brisk economic revival UK CORPORATE DIARY Electrocomponents Plc Trading update Inland Homes Plc FY results For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Â Reuters FILE PHOTO vaccinations Basingstoke AZN Add toRemove Portfolio AZN Add toRemove Portfolio By John Revill GENEVA Reuters Health officials around world gave backing AstraZeneca NASDAQ vaccine study showing little effect mild disease caused variant spreading quickly South Africa rang global alarm The prospect new virus variants could evolve ability elude vaccines one main risks hanging global strategy emerge pandemic rolling vaccines year South Africa new variant accounts vast bulk cases initially announced pause rollout million doses AstraZeneca vaccine But said Monday could still roll stepped manner giving doses monitoring see prevents hospitalisations deaths It vastly early dismissing vaccine said Richard Hatchett CEO Coalition Epidemic Preparedness Innovations foundation coleads global COVAX programme provide vaccine doses poor countries More million doses AstraZeneca vaccine form overwhelming majority doses COVAX aims begin rolling first phase poor countries beginning soon month Obviously world full wild type virus Astrazeneca LON vaccine known work Hatchett said Professor Salim Abdool Karim cochair South Africaâs Ministerial Advisory Committee said early conclude AstraZeneca would prevent serious disease caused variant prevalent If vaccine work well new evolving variants virus could ominous sign vaccines well showing virus potentially thwart efforts scientists fight The overall message World Health Organization others panic Several global health officials noted South African study small tested vaccine using short fourweek interval first second doses despite evidence since emerged works better longer wait It becoming clear longer interval two doses higher efficacy said Kate head immunisations WHO The lead investigator South African trial told Reuters believed vaccine major role play Africa globally million doses South Africa expire April rolled quickly wasted SERIOUS INFECTIONS Western governments spoke favour vaccine many given approval The vaccine main pillar vaccination programme Britain far fastest large country vaccinate members public It dealing mainly another fastspreading variant vaccine shown work well We think vaccines currently using effective I say stopping serious disease death British Prime Minister Boris Johnson told reporters Britain also using Pfizer NYSE vaccine Olivier Veran health minister France hoping vaccine held speed programme lagged behind rich countries said AstraZeneca vaccine provided sufficient protection nearly variants virus But vaccines work effectively hoped new emerging variants world could facing much longer expensive battle virus previously thought The variant dominant South Africa circulating least countries including United States Austria warned nonessential travel Alpine province Tyrol outbreak South African variant Cases also detected north Paris forcing one school close Â Reuters Add toRemove Portfolio XAGUSD Add toRemove Portfolio HSBA Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio AAL Add toRemove Portfolio RR Add toRemove Portfolio LCO Add toRemove Portfolio Silver Add toRemove Portfolio EVRE Add toRemove Portfolio ODX Add toRemove Portfolio By Samuel Indyk Investingcom â The UKâs higher heading towards midday miners financials push index upwards Cyclical sectors firmly green prospects higher growth coming months global vaccine effort continues pick pace Miners lead index higher Anglo American PLC LON EVRAZ plc LON two best performing stocks UK bluechip index Financials also strong continuation move seen end last week Lloyds Banking Group PLC LON benefitted upgrade Goldman Sachs took rating neutral sell NatWest Group PLC LON also higher HSBC Holdings PLC LON underperformed banking counterparts Shares flat company came scrutiny froze accounts Hong Kong activist Ted Hui family RollsRoyce Jet engine manufacturer RollsRoyce Holdings PLC LON props index reports company considering plans temporarily close jet engine plants summer amid heavy losses A decline air travel impacted sales RollsRoyce engines travelled fewer miles since pandemic began AIMlisted Omega Diagnostics Group Plc LON one best performers UK company selected provide additional lateral flow tests UK AstraZeneca PLC LON shares relatively unreactive reports vaccine less effective new South African variant coronavirus South Africa stopped administering vaccine initial data government tried calm situation UK emphasising dominant strains UK South African strains Oil prices remain elevated crude futures trading first time year Precious metals remain focus particularly recent Reddit squeeze A note Bank America said see silver averaging year next year',\n",
              " 'Â Reuters AZN Add toRemove Portfolio STZ Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio By Geoffrey Smith Investingcom US President Joe Bidenâs tax plans may hit fewer companies campaign promises suggested new details Treasury supporting tech stocks Wall Street gets ready open US jobless claims expected resumed downward trend last week Federal Reserve Chairman Jerome Powell speak later AstraZeneca shares rise despite fact concerns vaccineâs safety refuse go away And crude oil still canât get barrel Hereâs need know financial markets Thursday April Biden softens tax plan President Joe Bidenâs plans tax companies turning less ambitious election campaign promises suggested The US Treasury released details plans Wednesday minimum tax proposed last week Janet Yellen would apply companies billion annual income rather million touted last year The proposals breathed life multilateral push agree common framework corporate taxation finance ministers discussed issue Wednesday aiming agreement July The initiative nearly decade old missed many deadlines already comes fruition could avert creation national taxes digital service companies removing one major bone contention US Europe Jobless claims due Powell speech eyed The latest weekâs jobless claims data hit wires AM ET GMT expected resume downward trend unexpected jump last week Analysts expect initial jobless claims would secondlowest since pandemic started The data suggested pandemic means killing jobs across country steady declines broader measures continuing claims sharp rise hiring job vacancies indicated labor market clearly building momentum Elsewhere Federal Reserve Chairman expected speak PM ET International Monetary Fundâs virtual spring meeting unlikely add much minutes last Fed policy meeting released Wednesday Stocks set open higher tech supported tax plans US stock markets set open higher later two days drift softening President Bidenâs tax plans improving sentiment toward Big Tech names somewhat By AM ET effectively flat mere points Stocks likely focus later include brewer Constellation Brands NYSE whose outlook colored expected impact economic reopening food company The two scheduled release quarterly earnings AM ET AstraZeneca stock rises even vaccine fears refuse go away Shares AstraZeneca NASDAQ rose London trading updated statement European medical regulators turned less negatively feared The European Union UK acknowledge possible link vaccine potentially dangerous blot clotting disorders still argue risks taking outweighed benefits The UKâs Medicines Health Regulatory Agency identified deaths blood clots dispensed million shots AstraZeneca PLC LON jab The vaccine advance orders worldwide drug due AZâs policy selling cost price pandemic lasts As evidence fundamentally unsafe would threat vaccination campaigns poorer countries That important given countries India Brazil currently experiencing worst wave cases Oil struggles despite inventory reports Crude oil prices continue struggle barrel amid fears waves India South America slow recovery global demand Bullish headlines inventories fell expected last week also undermined less encouraging developments gasoline trends raising questions strength final demand By AM ET US crude futures barrel futures barrel Â Reuters C Add toRemove Portfolio AZN Add toRemove Portfolio FGEN Add toRemove Portfolio By Samuel Indyk Investingcom â Two major global investment banks provided updated recommendations AstraZeneca LON shares wake recent news regarding vaccine Both Citigroup NYSE UBS maintained shares âBuyâ rating Although vaccine maker offered sell initial vaccine doses cost risk reputational damage regarding vaccine safety This week UK EU regulators acknowledged could link extremely rare potentially fatal blood clots AstraZeneca jab With company headlines policymakers officials various countries defending companyâs vaccine The UK Health Secretary Matt Hancock spoke risk blood clot vaccine longhaul flight urged people continue take The UK Prime Minister Johnson echoed comments despite UK vaccine taskforce recommending aged take different jab It officials politicians defending company also big banks Citigroup AstraZeneca In research note Thursday Citigroup maintained âBuyâ rating stock target price The bank said also going maintain forecast worth revenue Roxadustat This news comes amid admission FibroGen NASDAQ earlier week misstated data anaemia drug two companies working Fibrogen shares fell Wednesday following announcement UBS Swiss banking giant UBS also kept âBuyâ rating shares although price target lower At AstraZeneca shares trading higher',\n",
              " 'Â Reuters FILE PHOTO People queue receive dose Pfizer BioNTech vaccine Central Middlesex Hospital London Britain August REUTERSHenry Nicholls AZN Add toRemove Portfolio PFE Add toRemove Portfolio AZN Add toRemove Portfolio By Ludwig Burger Reuters A British public health study found protection either two commonly used vaccines prevalent Delta variant coronavirus weakens within three months It also found get infected receiving two shots either PfizerBioNTech AstraZeneca NASDAQ vaccine may greater risk others previous variants coronavirus Based three million nose throat swabs taken across Britain Oxford University study found days second shot Pfizer NYSE Astrazeneca LON vaccine efficacy preventing infections slipped respectively That respectively seen two weeks second dose The decline efficacy pronounced among aged years older age Both vaccines two doses still really well Delta When start high got long way go said Sarah Walker Oxford professor medical statistics chief investigator survey Walker involved work AstraZeneca vaccine initially developed immunology experts Oxford The researchers would project much protection would drop time suggested efficacy two vaccines studied would converge within months second shot VIRAL LOAD Highlighting increased risk contagion Delta variant study also showed get infected despite fully vaccinated tend viral load similar unvaccinated infection clear deterioration Alpha variant still dominant Britain The Oxford findings line analysis US Centers Disease Control Prevention CDC come US government outlines plans make vaccine booster shots widely available next month amid rise Delta variant infections It cited data indicating diminishing protection vaccines time Israel began administering third Pfizer doses last month confront surge local infections driven Delta Several European countries also expected begin offering boosters elderly people weak immune systems Pfizer said vaccine efficacy drops time Last month AstraZeneca said still looking long vaccine protection lasts whether booster dose would needed keep immunity The fact see viral load hints indeed herd immunity might become challenging said coauthor Koen Pouwels also Oxford University Herd immunity large enough portion population immune pathogen either vaccination prior infection stopping infection numbers growing Vaccines probably best preventing severe disease slightly less preventing transmission said Pouwels The authors cautioned viral concentration throat rough proxy severity symptoms new data duration infections The survey yet peerreviewed publication scientific journal underscores concerns scientists Delta variant first identified India infect fully vaccinated people greater rate previous lineages vaccinated could easily transmit To contrast periods Delta became prevalent Oxford researchers analysed million swabs taken randomly picked adults Dec May test results participants May Aug The study conducted partnership Britain Office National Statistics ONS Department Health Social Care DHSC',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio XAGUSD Add toRemove Portfolio BP Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Silver Add toRemove Portfolio OCDO Add toRemove Portfolio TSLA Add toRemove Portfolio BTCUSD Add toRemove Portfolio By Samuel Indyk Investingcom â The trades red heading towards North American crossover little way fresh catalysts drive near term market direction The said European bourses major bourses trading marginally lower The current situation dominated vaccine rollout ongoing hopes US fiscal stimulus current picture effective current vaccines new strains In UK picture improving albeit slowly vaccine rollout promising far Nevertheless fears OxfordAstraZeneca PLC LON jab less effective South African variant The director Oxford Vaccine Group Andrew Pollard spoke BBC earlier tried reassure people vaccine still effective âœI donât think thereâs reason alarm todayâ Pollard said In individual stocks news Ocado Group PLC LON props bluechip index premarket The technologygrocery delivery company provided strong retail revenue growth announced total capex expected around build automated warehouses Oil companies strong BP PLC LON Royal Dutch Shell PLC Class A LON higher energy prices remain elevated hold firm although trades highest levels ahead report market US The USD weaker providing support looking test upside The GBP earlier hit highest level USD since April although weaker EUR today Markets still pushing back expectations rate cut Bank England following central bankâs announcement last week prices continued strong start week precious metal almost also trading gains although modest yellow metal around remains asset focus Tesla Inc NASDAQ cryptocurrency Monday The largest cryptocurrency market cap touched high since pared back around markets await next catalyst move higher',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom TUIGn Add toRemove Portfolio AZN Add toRemove Portfolio III Add toRemove Portfolio PSN Add toRemove Portfolio ICP Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Wednesday losses sectors propelled shares lower At close London declined The biggest gainers session International Consolidated Airlines Group SA LON rose points trade close Tui AG LON added points end AstraZeneca PLC LON points late trade Biggest losers included Persimmon PLC LON lost points trade late trade Group PLC LON declined points end Intermediate Capital Group PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery July fell hit barrel August Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters FILE PHOTO Trucks doses Sinovac CoronaVac coronavirus disease vaccine destined health ministry National Immunization Program Butantan Institute Sao Paulo Brazil March REUTERSCarla CarnielFile PhotoFile Photo AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio By Pedro Fonseca Eduardo SimÃµes RIO DE JANEIROSAO PAULO Reuters One question rippled queue outside makeshift inoculation center Rio de Janeiro beachside neighborhood Copacabana recent morning Which vaccine using Despite world secondhighest death toll infections running high people across Brazil refusing receive shot vaccine used satisfaction Local media dubbed vaccine sommeliers There official figures total number people cherrypicking vaccines dozens towns Brazil sought crack practice taking names refuse inoculated shot offer moving back queue Public health experts Brazil say practice misinformation poorly understood information fuels threatening undermine country vaccination campaign It also say selfish The person putting risk ends putting entire system danger said Alexandre Naime Barbosa infectious diseases professor SÃo Paulo State University It shows lack empathy enormous selfishness The trend comes many countries already vaccinated populations lifting restrictions The Brazilian Society Immunizations said incidents involve people refusing vaccines China Sinovac lesser extent Astrazeneca LON Instead seek shots Pfizer NYSE Johnson Johnson NYSE WhatsApp groups popped people swapping tips vaccination centers offering soughtafter shots Some worried Sinovac CoronaVac work well others fear Europe US might recognize travel restrictions lifted fully vaccinated Brazilian health experts rushing dispel concerns particularly CoronaVac fighting wave criticism including President Jair Bolsonaro said Chinese vaccine use earlier month It work Latestage trials Brazil found CoronaVac efficacy preventing symptomatic infection compared Astrazeneca Pfizer But realworld context public health experts argue CoronaVac shown effective reducing hospitalisation death When look really matters reducing number hospitalizations deaths vaccines Brazil high efficacy Barbosa said In Serrana town Sao Paulo state almost entire adult population vaccinated CoronaVac part study deaths reduced Hospitalizations fell symptomatic infections Public health experts also stressed risk developing blood clots result taking Astrazeneca vaccine incredibly rare No vaccine scientists stress ever entirely removes chance death Choosing vaccine ignorant gesture lacks commitment public health said Dimas Covas president Butantan Institute producing CoronaVac Brazil',\n",
              " 'Â Reuters DX Add toRemove Portfolio AVST Add toRemove Portfolio CRN Add toRemove Portfolio SPI Add toRemove Portfolio STVG Add toRemove Portfolio BOOH Add toRemove Portfolio AZN Add toRemove Portfolio CZR Add toRemove Portfolio POLYP Add toRemove Portfolio LOOK Add toRemove Portfolio JD Add toRemove Portfolio INPP Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio GBPUSD Add toRemove Portfolio SDY Add toRemove Portfolio UTG Add toRemove Portfolio CCC Add toRemove Portfolio CRDA Add toRemove Portfolio MRON Add toRemove Portfolio CRH Add toRemove Portfolio MRW Add toRemove Portfolio AZN Add toRemove Portfolio CSGN Add toRemove Portfolio GNS Add toRemove Portfolio EZJ Add toRemove Portfolio Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading lower The midcap trading lower In FX markets trading trading The flat Todayâs calendar highlights include US weekly inventory data Stocks Holdings LON Confirms agreement Caesars Entertainment NASDAQ acquire William Hillâs nonUS business billion Morrisons LON Two year group likeforlike sales exfuelexVAT Total revenue including fuel billion Maintains guidance profit tax Continues recommend CDRâs takeover offer pence per share Shareholder meeting take place around week commencing October EasyJet LON Recently received unsolicited preliminary takeover approach unanimously rejected The potential bidder since confirmed longer considering offer Company Separately company undertaken fully underwritten rights issue raise gross proceeds approximately billion JD Sports LON â Reportedly considering investment online fashion website Missguided could involve outright takeover JD Sports proposal said involve acquisition controlling interest Missguided Sky News AstraZeneca LON NASDAQ Says PhIII asthma trials met primary endpoints significantly reduced risk severe exacerbations compared albuterol patients moderate severe asthma MANDALA trial used rescue medicine response symptoms Genus LON FY revenue million Adjusted operating profit exJVs million Recent volatility Chinese porcine market expected continue months creating shortterm headwind Computacenter LON revenue increased billion Will endeavour beat last year second half performance match Unite Group LON Agreed million sustainabilitylinked unsecured revolving credit facility HSBC NatWest Royal Bank Canada Spire Healthcare LON revenue increased vs EBITDA million line NHS waiting list continues rise supporting growth selfpay Nearterm margins impacted measures maintain Covidsecure environment International Public Partnership LON Portfolio continued perform line expectations Increases dividend pence per share Lookers LON revenue billion Record underlying profit tax million Intends resume dividend payments soon possible next review position releasing full year results Trading July August remained strong exceeding expectations Current expectations underlying profit tax remain unchanged Cairn Homes LON revenue million Operating profit doubles million Recommencing annual ordinary dividend programme declared interim dividend cent per ordinary share operating profit expected c million increasing c million STV Group LON Advertising recovery continues Total Advertising Revenue expected months end September Board proposes interim dividend Speedy Hire LON Continued benefit positive momentum experienced start current financial year trading line Board expectations Boohoo LON â Upgraded outperform neutral Credit Suisse SIX Croda LON Avast LON Polymetal LON CRH LON Melrose Industries LON go exdividend today',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom PRU Add toRemove Portfolio AZN Add toRemove Portfolio CNA Add toRemove Portfolio STAN Add toRemove Portfolio SDR Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London lost hit new low The biggest gainers session International Consolidated Airlines Group SA LON rose points trade close AstraZeneca PLC LON added points end Centrica PLC LON points late trade Biggest losers included Prudential PLC LON lost points trade late trade Standard Chartered PLC LON declined points end Schroders PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November fell hit barrel November Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters DX Add toRemove Portfolio MOONM Add toRemove Portfolio PRSMB Add toRemove Portfolio UKWG Add toRemove Portfolio AZN Add toRemove Portfolio CBRO Add toRemove Portfolio BAG Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio GBPUSD Add toRemove Portfolio FLTRF Add toRemove Portfolio SMIN Add toRemove Portfolio PNN Add toRemove Portfolio GOG Add toRemove Portfolio BHPB Add toRemove Portfolio AZN Add toRemove Portfolio FERG Add toRemove Portfolio EZJ Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading lower In FX markets trading trading The Todayâs calendar highlights include US Stocks Smiths Group LON Entered binding agreement ICU Medical sell Smiths Medical unit headline enterprise value billion plus additional billion contingent future share price performance Smiths Group also said entered FY good order book momentum expects underlying revenue growth return aggregate around preCOVID levels operational efficiency benefits good cash generation Proposed final dividend pence per share fullyear dividend increased AstraZeneca LON NASDAQ Saphnelo anifrolumab approved Japan treatment adult patients systemic lupus erythematosus SLE serious autoimmune disease Moonpig Group LON Raising guidance group revenue expected approximately million million Mediumterm growth margin targets remain unchanged EasyJet LON â Receives acceptances shareholders new shares sold part billion rights issue Ferguson LON FY revenue billion Records final dividend cents per share bringing total dividend cents increase Expect year good growth overall anticipate tapering second half tougher prior year comparatives Blue Prism LON Agreed taken Vista per share cash valuing company billion GoAhead LON â UK government take control Southeastern rail franchise company admitted making errors Finance director Elodie Brian resigned immediate effect BHP Group LON Proxy adviser Glass Lewis advises shareholders vote companyâs Climate Transition Action Plan citing concerns scope alignment latest climate science Close Brothers LON Adjusted operating profit increased million Board proposing final dividend pence per share resulting fullyear dividend pence Encouraged improvement economic outlook although trajectory remains uncertain Pennon Group LON Overall EBITDA remains line management expectations increased costs offset increased revenues Greencoat LON Agreed acquire Andershaw wind farm Statkraft total consideration million AGBarr LON revenue million Announces recommencement dividends comprising interim dividend pence per share plus oneoff special dividend pence per share Remain track deliver strong fullyear profit performance slightly ahead preCOVID level Flutter Entertainment LON Upgraded Buy Hold HSBC Sectors traded yesterday first time since October',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom NXT Add toRemove Portfolio AZN Add toRemove Portfolio ADML Add toRemove Portfolio SN Add toRemove Portfolio TW Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Wednesday gains sectors propelled shares higher At close London gained The biggest gainers session AstraZeneca PLC LON rose points trade close Next PLC LON added points end International Consolidated Airlines Group SA LON points late trade Biggest losers included Taylor Wimpey PLC LON lost points trade late trade Admiral Group PLC LON declined points end Smith Nephew PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November rose hit barrel December Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Â Reuters ULVR Add toRemove Portfolio NETW Add toRemove Portfolio PRSMB Add toRemove Portfolio SSPG Add toRemove Portfolio ICAG Add toRemove Portfolio ALXN Add toRemove Portfolio Add toRemove Portfolio DX Add toRemove Portfolio BT Add toRemove Portfolio SSE Add toRemove Portfolio GBPUSD Add toRemove Portfolio AAL Add toRemove Portfolio ABDN Add toRemove Portfolio MRW Add toRemove Portfolio AZN Add toRemove Portfolio DBKGn Add toRemove Portfolio LLOY Add toRemove Portfolio NXT Add toRemove Portfolio GS Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include UK Eurozone US weekly data Stocks Next LON brand full price sales versus Profit tax million Full price sales last eight weeks versus materially exceeding company expectations Increasing full price sales guidance rest year Expects profit tax million million ahead previous guidance Unilever LON Has reportedly shortlisted least four bidders tea unit could fetch billion Bidders said include CVC Capital Partners Carlyle Advent International consortium comprising Cinven Abu Dhabi Investment Authroity Sky News Morrisons LON An auction procedure Morrisons take place October determine winning bidder neither CDR offer Fortress offer final Each Morrisons Fortress CDR agreed terms auction procedure AstraZeneca LON Alexion exercised option acquire remaining equity Caelum Biosciences Alexion NASDAQ pay Caelum agreed option exercise price approximately million potential additional payments million upon achievement regulatory commercial milestones Abrdn LON Has sold million shares HDFC Asset Management Company average price INR result receiving approximately INR million million net taxes expenses SSE LON SSE Renewables signs agreement Japanâs Pacifico Energy create joint ownership company pursue offshore wind energy development projects Japan SSE Renewable buy interest offshore wind development platform Pacifico million million deferred Separately company said expects report adjusted earnings per share range halfyear SSE expects recommend fullyear dividend pence plus RPI inflation BT LON The company facing legal bill million almost million customers potentially receiving claims overcharged landline telephone services SSP Group LON revenue expected circa levels Group expected deliver positive EBITDA broadly breakeven second half year Base case scenario return preCovid levels likeforlike revenue EBITDA margins remains unchanged Current planning assumption slightly slower recovery sales FY Network International Holdings LON Completed acquisition DPO Group Continues expect doubledigit ROCE acquisition within three years completion financial guidance remains unchanged Anglo American LON Upgraded Outperform Sector Perform RBC Blue Prism LON Upgraded Buy Hold HSBC Lloyds LON Upgraded Neutral Sell Goldman Sachs NYSE IAG LON Upgraded Buy Hold Deutsche Bank DE',\n",
              " 'Â Reuters FILE PHOTO A healthcare worker prepares Pfizer coronavirus disease vaccination Los Angeles California US January REUTERSLucy Nicholson AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio OSLO Reuters Pfizer NYSE cut July deliveries vaccine Norway doses delaying Nordic country vaccine rollout company Norwegian Institute Public Health FHI told Reuters Thursday The news first reported Norwegian daily VG citing Pfizer Norwegian arm Geir Bukholm Director Infection Prevention Control Norwegian Institute Public Health Pfizer major provider vaccines Norway dropped Astrazeneca LON jab offering JJ NYSE Jenssen vaccine certain conditions provide doses July earlier estimated million doses Pfizer Norway confirmed Reuters As consequence Norway vaccination programme delayed one two weeks compared earlier estimate FHI said Prime Minister Erna Solberg said May government aimed offer first dose aged July',\n",
              " 'Â Reuters FILE PHOTO A company logo seen AstraZeneca site Macclesfield Britain May REUTERSPhil Noble AZN Add toRemove Portfolio Add toRemove Portfolio SINGAPORE Reuters AstraZeneca NASDAQ said Friday supply Singapore antibody cocktail Evusheld end year Evusheld act another layer protection alongside vaccines people high risk infection according AstraZeneca statement The company specify many courses treatment would supplied Southeast Asian citystate The US Food Drug Administration Wednesday authorised use Evusheld prevent infections individuals weak immune systems history severe side effects coronavirus vaccines',\n",
              " 'Â Reuters CPG Add toRemove Portfolio LGRS Add toRemove Portfolio MDCM Add toRemove Portfolio AZN Add toRemove Portfolio MRCM Add toRemove Portfolio JUP Add toRemove Portfolio Add toRemove Portfolio Copper Add toRemove Portfolio DX Add toRemove Portfolio LAND Add toRemove Portfolio GBPUSD Add toRemove Portfolio NG Add toRemove Portfolio ANTO Add toRemove Portfolio TLW Add toRemove Portfolio PSON Add toRemove Portfolio RIO Add toRemove Portfolio HRGV Add toRemove Portfolio AZN Add toRemove Portfolio HOCM Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The flat Todayâs calendar highlights include Eurozone US Stocks Rio Tinto LON Cuts iron ore shipments forecast tighter labour market Now expects Pilbara iron ore shipments Also cuts refined production guidance Pilbara iron ore output previously Hargreaves Lansdown LON Assets administration billion September since June Net new business billion period Added net new clients Normalisation revenues post pandemic line company expectations AstraZeneca LON NASDAQ Imfinzi plus tremelimumab significantly improved overall survival HIMALAYA Phase III trial unresectable liver cancer Pearson LON Group underlying revenue period September Strong performance Assessment Qualifications helps offset declining enrolments Higher Education Pearson says remains track deliver adjusted operating profit line market expectations Hochschild Mining LON Exercised option start earning interest Snip gold project located Golden Triangle Tahltan Territory British Columbia Canada held Skeena Resources Jupiter Fund Management LON Assets management increased billion three months September billion Positive market movements partially offset net outflows Land Securities LON As October collection day net rent due September paid compared June quarter date Compass Group LON Announced commitment reach Net Zero greenhouse gas emissions across global operations value chain Mercantile Investment Trust LON In six months July Company produced total return net assets Expect revenue financial year ending January significantly higher Declared second quarterly interim dividend pence per share Mediclinic International LON group revenue ahead prepandemic levels across three divisions Material recovery Group EBITDA margin around Loungers LON Over weeks October Group delivered like like sales growth using period May October comparator National Grid LON IFA interconnector come back service October ahead previously planned October Tullow Oil LON Upgraded Buy Hold Berenberg Antofagasta LON Upgraded Sector Perform Underperform RBC',\n",
              " 'Â Reuters Add toRemove Portfolio AZN Add toRemove Portfolio DX Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio SGXIO Add toRemove Portfolio By Geoffrey Smith Investingcom Global markets tumble US stocks set extend losses Federal Reserve latest minutes suggested start reducing bond purchases year Jobless claims due provide evidence substantial progress toward Fed employment goals The world two biggest auto groups see chiprelated disruptions continuing new study supports scientific case vaccine booster shots And China country biggest investor avoided collapse accepting stateled bailout Here need know financial markets Thursday August Global markets fall Fed minutes point early tapering Global stock markets tumbled taking industrial commodities prospect early tapering asset purchases Federal Reserve triggered sharp repricing risk worldwide The tracks greenback basket six developed market currencies rose highest since November prices fell lowest May The biggest carnage reserved fell Singapore China cut steel output targets effort reduce carbon emissions Other base metals also tumbled US stock markets set extend Wednesdayâs losses open later By AM ET GMT points Jobless claims show progress The market nerves add extra spice release US numbers AM ET Initial claims expected fallen new postpandemic low last week The numbers uptotheminute data labour market Fedâs chief cause concern recent months â least banner employment report July leaped nearly million The Fedâs minutes released late Wednesday suggested majority policymakers thought enough progress made restoring employment start reducing rate bond purchases early year Study boosts booster shot WHO continues rail A major UK study showed effectiveness vaccines stopping disease fades quickly thought strengthening scientific case booster shots planned governments US UK The study led Oxford University found efficacy PfizerBioNTech vaccine fell half within four months second shot administered The AstraZeneca PLC LON NASDAQ vaccineâs protection degraded slightly slower rate The World Health Organization remains adamantly opposed plans booster shorts saying itâs important get vaccines parts world initial vaccination rates still low Auto giants face chip disruption The impact latest wave pandemic evident report said Toyota forced cut production planned levels September Toyota extensive operations Thailand spread virus exploded last two months forcing many factories suspend production According report worldâs biggest automotive group also struggling chip shortages negative surprise given company â long seen best supply chain manager sector â largely escaped problems chip availability first half In Europe meanwhile Volkswagen DE said expected chip availability remain volatile next months Toyota stock fell local trading VWâs preferred stock fell The flip side chip shortage also evident Nvidiaâs earnings released late Wednesday The company said expects raise prices gaming chips particular thanks rapid growth online gaming Chinese state bails distressed debt investor Huarong The excessive debts Chinese companies slowly surely finding way onto stateâs balance sheet Huarong countryâs largest investor distressed debt announced Thursday accept bailout handful largely stateowned institutions including CITIC China Life The news coincided delayed publication record loss The capital injection removes threat damaging highprofile default local bond market remains plagued fears number highlyleveraged companies â especially real estate sector â could go Huarongâs former chairman Lai Xiaomin executed financial crimes January',\n",
              " 'WEIR Add toRemove Portfolio GLO Add toRemove Portfolio OTB Add toRemove Portfolio PLUSP Add toRemove Portfolio IPO Add toRemove Portfolio FSJ Add toRemove Portfolio Add toRemove Portfolio DX Add toRemove Portfolio RYA Add toRemove Portfolio POG Add toRemove Portfolio GBPUSD Add toRemove Portfolio TLW Add toRemove Portfolio TSCO Add toRemove Portfolio AZN Add toRemove Portfolio BNPP Add toRemove Portfolio PRU Add toRemove Portfolio EZJ Add toRemove Portfolio HSBA Add toRemove Portfolio EURGBP Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include US speech Bank Englandâs Stocks HSBC LON reported profit tax billion billion Increase driven release expected credit losses credit impairment charges higher share profit associates Net interest margin broadly stable compared Expect net release ECL potential small net release ECL dependent offsetting levels stage charges Expect NIM begin increase coming quarters lending growth earlier anticipated policy rate rises Intend initiate share buyback billion Tesco LON The supermarketâs online store hit attempted hack weekend leaving shoppers unable amend orders book new deliveries The company said reason believe issue impacted customer data AstraZeneca LON Imfinzi plus chemotherapy significantly improved overall survival advanced biliary tract cancer Phase III trial interim analysis LON revenue million EBITDA million Board remains confident outlook company Expects FY revenue EBITDA ahead current compiled analysts consensus forecasts Tullow Oil LON Phuthuma Nhleko appointed independent nonexecutive Director Chairmandesignate Ryanair LON Is sued On The Beach LON blocking booking flights airline ContourGlobal LON Operational performance remained strong although slightly average availability factor first months Adjusted EBITDA million To pay dividend pence per share Petropavlovsk LON total gold production fell koz Own mined gold production increased gold sales totalled koz Affirms full year production guidance koz Prudential LON Mandated banks arrange fixed income investor calls benchmark USDdenominated transaction IP Group LON Following completion funding round portfolio company top valuable holdings company recorded net realised realised fair value gain approximately million James Fisher Sons LON Improvement Fendercare shiptoship transfer business remains rate previously expected A recent deterioration condition financially distressed customer increased bad debt risk circa million Now anticipates Underlying Operating Profit full year separately disclosed items range million Management performing detailed review Group cost base balance sheet continuing advance pace divestment noncore businesses assets aimed generating significant proceeds next year EasyJet LON Upgraded hold sell Stifel Weir Group LON Upgraded outperform neutral BNP Paribas PA',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom TUIGn Add toRemove Portfolio AZN Add toRemove Portfolio CPG Add toRemove Portfolio LAND Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio BMEB Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London fell The biggest gainers session Samsung Electronics Co Ltd DRC LON rose points trade close BM European Value Retail SA LON added points end AstraZeneca PLC LON points late trade Biggest losers included Tui AG LON lost points trade late trade Compass Group PLC LON declined points end Land Securities Group PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February fell hit barrel March Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters UK shares higher close trade Investingcom United Kingdom HSBA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio AAL Add toRemove Portfolio PSN Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Thursday gains sectors propelled shares higher At close London rose hit new high The biggest gainers session Flutter Entertainment PLC LON rose points trade close Anglo American PLC LON added points end EasyJet PLC LON points late trade Biggest losers included HSBC Holdings PLC LON lost points trade late trade Persimmon PLC LON declined points end AstraZeneca PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery April rose hit barrel May Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters AZN Add toRemove Portfolio IXIC Add toRemove Portfolio By Dhirendra Tripathi Investingcom Stocks reversed tech slide Disneyâs disappointing earnings weighed Thursday Though investors still digesting news inflation running pace seen years positive sentiment enough lift tech sector The rose nearly boosted chip stocks Nvidia NASDAQ Shares ofWalt Disney Company NYSE lead declines among Dow components reported smallest rise subscriptions video streaming service since start And second day trading shares Rivian Automotive Inc NASDAQ surged another Market participants also watching developments around nomination Federal Reserve Chair President Joe Biden still weighing whether keep Jerome Powell second term nominate Fed Governor Lael Brainard post The bond markets closed US Thursday Veterans Day Here three things could affect markets tomorrow AstraZeneca earnings AstraZeneca PLC ADR NASDAQ expected report thirdquarter profit per share cents revenue billion Job openings The number US likely dropped million September million August Its alltime high Julyâs Consumer sentiment The preliminary reading US consumer sentiment November reflected University Michigan Index seen improving Octoberâs Reuters contributed report',\n",
              " 'Â Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Britain August REUTERSNeil HallFile Photo Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio FTSE Add toRemove Portfolio By Bansari Mayur Kamdar Devik Jain Reuters London slipped Tuesday weighed weaker shares AstraZeneca NASDAQ heavyweight consumer staples stocks although upbeat earnings updates Vodafone LON spirits maker Diageo LON limited overall declines The bluechip index closed lower drugmakers AstraZeneca GlaxoSmithKline respectively Large dollarearning companies including British American Tobacco LON Reckitt Benckiser Unilever LON fell among biggest drags index Vodafone jumped top FTSE mobile operator increased free cash flow outlook reported solid growth earnings first half The domestically focussed midcap ended lower shrugging data showed UK economy withstood end government furlough scheme last month cementing expectations interest rate hike December We still seem caught two strong counterforces strong earnings season providing bullish case long list downside risks notably inflation interest rates continue weigh sentiment said Craig Erlam senior market analyst UK EMEA OANDA What see report relation October payrolls encouraging makes December BoE meeting much live one Financial markets currently priced near chance Bank England BoeE raise rates December Bogged inflationary pressures supply chain problems FTSE gained year underperforming European US peers The focus consumer prices data Wednesday Among stocks Diageo added Johnnie Walker whisky maker forecast double digit sales growth first half Restaurant Group Plc LON climbed Wagamama owner raised annual profit outlook Land Securities Group gained UK largest commercial property firm swung halfyear profit Â Reuters FILE PHOTO A woman reacts receives AstraZenecaOxford coronavirus disease vaccine donated Kenya UK government Nairobi Kenya August REUTERSBaz Ratner AZN Add toRemove Portfolio Reuters Two billion doses AstraZenecaOxford University vaccine supplied worldwide AngloSwedish drugmaker partner said Tuesday year since first approval The shot biggest contributor COVAX vaccine sharing scheme backed World Health Organization made countries supply countries Londonlisted AstraZeneca NASDAQ Oxford University said joint statement AstraZeneca June last year signed India Serum Institute world biggest manufacturer vaccines volume help double vaccine manufacturing capacity two billion doses The shot sold brand names Vaxzevria Covishield faced challenges around efficacy data supplies links rare blood clots AstraZeneca last week said world learns live coronavirus causes would begin earn modest profit shot made commitment sell cost pandemic The company chief executive officer Pascal Soriot however reassured lowincome countries would continue receive vaccines nonprofit basis',\n",
              " 'Â Reuters FILE PHOTO Vials labelled Astra Zeneca Coronavirus Vaccine syringe seen front displayed AstraZeneca logo illustration photo taken March REUTERSDado Ruvic AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters AstraZeneca NASDAQ Thursday cemented lead bringing preventative shot market saying antibody cocktail offered protection six months providing another possible weapon fight pandemic The therapy called Evusheld previously shown confer protection symptomatic illness three months earlier readout latestage PROVENT trial August The data give hope additional protection people respond well vaccines cancer patients The AngloSwedish company also said separate study patients mildtomoderate showed higher dose cut risk symptoms worsening given within three days first symptoms The antibody treatment enhanced remain intact body months given one go two sequential shots arm The latest results longerterm followups potentially position AstraZeneca like rival Pfizer NYSE future supplier vaccines treatments AstraZeneca said therapy real advantage preventative shot The full results submitted publication peerreviewed medical journal Pfizer presented promising efficacy data oral treatment candidate easily distributed injections also leading vaccine supplier partner BioNTech These new data add growing body evidence supporting potential We progressing regulatory filings around world look forward providing important new option quickly possible AstraZeneca Executive Vice President Mene Pangalos said statement referring coronavirus causes The group last month sought approval medicine US European authorities Monoclonal antibodies Regeneron Lilly GSKVir approved US regulators treating unhospitalised patients Earlier month Regeneron said single dose antibody cocktail reduced risk contracting latestage trial LONGTERM This important addition therapeutic armamentarium COVID published study confirms data released Thursday said Penny Ward visiting professor pharmaceutical medicine King College London While injection may seen potential alternative vaccines antibody drugs cost significantly may limit use particularly highrisk groups Antibody cocktails typically cost per dose shots average sold per dose Astra Executive Vice President vaccines immune therapies Iskra Reic said call media unlike vaccine drug would priced commercially negotiates supply contracts governments around globe Chief executive Pascal Soriot said treatment complicated produce vaccine would enough production capacity around world meet demand Monoclonal antibody drugs deliver labmade versions body natural antibodies fight infection vaccines spur body make antibodies build immunity AstraZeneca said shot primarily meant help immunocompromised atrisk individuals point wider group could benefit military personnel tours duty cruise ship passengers It would administered addition vaccines company said It added global population considered inadequately respond vaccine For AstraZeneca PROVENT trial close participants without infection randomly split two groups one volunteer receiving ineffective placebo without knowing every two receiving Evusheld Participants risk suffering severe infected immunocompromised meaning cancer care receiving drugs due autoimmune disease organ transplant The trial volunteers vaccinated even though highrisk groups prioritised global vaccination campaigns Anyone opting get vaccinated trial excluded analysis Trial volunteers followed months provide evidence longerlasting protection',\n",
              " 'Â Reuters FILE PHOTO Vials labelled Astra Zeneca Coronavirus Vaccine syringe seen front displayed AstraZeneca logo illustration photo taken March REUTERSDado RuvicFile Photo AZN Add toRemove Portfolio By Alistair Smout CAMBRIDGE England Reuters Britain Prince Charles formally opened new billion pound billion AstraZeneca NASDAQ research development RD facility Cambridge eastern England Tuesday company aims fuel growth drug pipeline AstraZeneca supplied two billion doses vaccine developed Oxford University also looking bring preventative antibody cocktail market Prince Charles son Queen Elizabeth heir throne saw exhibit pandemic demonstration augmented reality headsets help lab work hearing company netzero targets The last two years difficult generation Prince Charles said speech But quite literally turbocharge sustainable action desperately needed create greener healthier future â people Nature one planet Chief Executive Pascal Soriot said centre would power next stage company growth The plans AstraZeneca new headquarters large RD campus Cambridge unveiled costs timeframe exceeded initial estimate million pounds aimed completion date AstraZeneca large portfolio treatments diseases cancer heart disease diabetes said centre would support research specialised medicines nextgeneration therapeutics including geneediting cell therapies We advances could come clinic next three four years lead really effective new drugs various aspects treating cancer Dr Susan Galbraith AstraZeneca Executive Vice President Oncology Research Development told Reuters interview I optimistic fact make big difference disease coming decade pounds',\n",
              " 'Â Reuters FILE PHOTO Test tubes seen front displayed AstraZeneca logo illustration taken May REUTERSDado RuvicIllustration AZN Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters AstraZeneca said Friday examining impact new coronavirus variant spreading rapidly South Africa vaccine antibody cocktail adding hopeful combination drug would retain efficacy The World Health Organization WHO Friday designated new variant detected South Africa large number mutations concern AstraZeneca NASDAQ distributed billion doses vaccine worldwide although rollout shot paused South Africa February shown offer minimal protection mild moderate illness caused Beta variant dominant country time As new emerging variants looking understand impact vaccine AstraZeneca said statement adding conducting research Botswana Eswatini collect data That enable us collect real world data Vaxzevria new virus variant The AngloSwedish pharmaceutical firm emphasised vaccine shown effective variants concern AstraZeneca said developed vaccine platform respond quickly new variants Oxford University vaccine created It previously said working variant vaccine better target Beta variant The company also developed antibody cocktail used prevent treat Although scientists expressed concern spike protein mutations might hinder effectiveness monoclonal antibody drugs combination drug made AstraZeneca might retain efficacy company said We also testing longacting antibody combination new variant hopeful retain efficacy since comprises two potent antibodies different complementary activities virus said',\n",
              " 'Â Reuters AZN Add toRemove Portfolio HMSO Add toRemove Portfolio FVIG Add toRemove Portfolio AJBA Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include UK Eurozone German Canadian US Fed Chair Powell Speaks Coronavirus The World Health Organization designated Variant Concern named Omicron WHO said primary evidence suggests Omicron carries greater risk infection UK announced temporary measures including mandatory face covering shops public transport All international arrivals must take PCR test selfisolate receive negative result The UK recorded three cases new variant Stocks BT LON Indiaâs Reliance Industries reportedly considering bid BT Reliance may also propose partner BTâs fibre optic arm Openreach fund expansion plans Economic Times AstraZeneca LON Said conducting research Botswana Eswatini obtain real world data vaccine performs Omicron variant AJ Bell LON To launch new commissionfree mobile app called Dodl AJ Bell aimed competing low cost investment platforms straightforward accessible retail traders The app commission free annual charge Hammerson LON Confirms discussions terms possible disposal Silverburn flagship destination near Glasgow The site currently held joint venture CPPIB The Company confirms pricing discussion million AGBarr LON Positive momentum reported September continued sales grown ahead expectations As result continued strong volume performance despite ongoing near term operating cost pressures anticipate revenue profit tax full year ahead current market expectations Assuming significant changes current market conditions expect revenue order million profit tax around million Marshall Motor Holdings LON Constellation Automotive Holdings made offer Marshall Motor Holdings pence per share cash approximately million Constellation received undertaking accept offer shareholder Marshall Cambridge Molten Ventures LON Gross Portfolio fair value growth sixmonth period September NAV per share increased pence pence Anticipate fair value growth region full year March subject wider market conditions IP Group LON Following completion funding round portfolio company top twenty valuable holdings recorded net unrealised fair value gain approximately million per share McColl LON Terms agreed Morrisons extend number Morrisons Daily conversions stores Separately agreement reached defer financial covenant test due November December thereafter expected roll monthly basis Amigo Holdings LON Board continues pursue new Scheme address complaints liability provide solution customers valid complaint A revised offer incorporates two Scheme options submitted Independent Customer Committee November The Board view Scheme contingent continuing business provide creditors value certain outcome Neither proposed Schemes expected satisfy liability owed redress creditors valid claims full contribution new Scheme significantly increased Without approved Scheme Amigo expects file administration insolvency process',\n",
              " 'EZJ Add toRemove Portfolio AZN Add toRemove Portfolio JDW Add toRemove Portfolio GLEN Add toRemove Portfolio GLNCY Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading lower In FX markets trading trading The Todayâs calendar highlights include German Unemployment Eurozone CPI Canadian GDP US House Price Index Chicago PMI Fed Chair Powell testifies Stocks EasyJet LON FY headline loss tax billion ahead consensus estimates Summer Current revenue booked ahead level Too soon say impact Omicron may European travel shortterm restrictions may result Capacity expected Expect fly circa capacity expect summer capacity near levels Glencore LON Activist hedge fund Bluebell Capital Partners asked Glencore separate thermal coal business become barrier investment AstraZeneca LON Companyâs supplemental New Drug Application Lynparza accepted granted Priority Review US FDA adjuvant treatment patients BRCAmutated highrisk early breast cancer Shaftesbury LON Sustained recovery footfall weekends currently back levels weekdays circa Leasing transactions rental value million completed year Momentum continued million lettings renewals two months since September Net property income million Whollyowned portfolio valuation billion full year likeforlike decrease WPP LON Acquired technology company Cloud Commerce Group financial terms disclosed Future PLC LON FY revenue million FY adjusted operating profit million The proposed dividend year per share yearonyear Upgrading outlook full year expect adjusted results FY materially current expectations Holdings LON All mandatory antitrust gaming regulatory clearances received takeover William Hill International Completion expected occur subject satisfaction remaining conditions completion New equity issued via capital raise expected occur prior completion acquisition Micro Focus LON To set plan exit flat better yearonyear revenue trajectory Also provide update progress made transformation date Diversified Energy Company LON Engaged Bridger Photonics leading provider methane leak detection technology perform multiyear aerial scans Company production distribution assets starting Appalachian region Countryside Properties LON FY completions Adjusted revenue billion Adjusted operating profit million Countryside forward sold including million private sales September private net reservation rate nine weeks November Expect deliver adjusted operating profit range million year September including million contribution legacy housebuilding operations DiscoverIE Group PLC LON revenue million Underlying operating profit million Interim dividend increased pence per share On track deliver full year underlying earnings continuing operations ahead Board previous expectations despite ongoing supply chain foreign exchange headwinds Hochschild Mining LON To acquire Amarillo Gold Corporation price per share cash J D Wetherspoon PLC LON Chairman Tim Martin criticised shareholder Fidelity voting two companyâs nonexecutive directors Greencore LON FY group revenue billion Adjusted Operating Profit million Continued positive revenue momentum across business start Expects generate outturn line current market expectations Tritax EuroBox LON Acquired million asset Piacenza Northern Italy part major logistics hub Marstonâs LON Likeforlike sales since restrictions lifted July Current trading encouraging total LFL sales versus despite reduction VAT relief John Menzies LON Expects trading full year least line market expectations stronger expected trading recent months Currently forecast flight volumes around volumes Topps Tiles LON FY group revenue million Total dividend pence per share Twoyear Retail likeforlike sales growth first eight weeks new financial year Continued trading headwinds reduced consumer confidence global supply chain challenges cost inflation',\n",
              " 'AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Reuters Samsung LON Biologics Co Ltd said Monday would continue partnership AstraZeneca NASDAQ Plc manufacturing biopharmaceuticals Samsung said production drug substance drug product valued million initial million companies expanded deal year May The company said would start manufacture cancer immunotherapy product next year along AstraZeneca longacting antibody LAAB combination Samsung Biologics CEO John Rim said We delighted continue expanding strategic collaboration AstraZeneca valuable partner witnessed firsthand strong commitment saving lives patients',\n",
              " 'Â Reuters FILE PHOTO A health worker shows woman vial containing vaccine administering Penda health center Nairobi Kenya December REUTERSBaz Ratner AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters Pfizer NYSE BioNtech set displace AstraZeneca NASDAQ main suppliers vaccines global COVAX programme start shift shows increasing importance shot poorer states The expected change comes headaches receiving countries lack sufficient cold storage capacity handle Pfizer vaccine amid risks shortage syringes needed administer shot AstraZeneca currently distributed vaccine COVAX according data Gavi vaccine alliance comanages programme World Health Organization WHO The programme far delivered million shots nearly countries million AstraZeneca million Pfizer But first quarter next year Pfizer set take according Gavi WHO figures doses assigned COVAX programme future supplies By end March another million Pfizer doses distributed COVAX WHO document shows A spokesperson Gavi confirmed Pfizer far ahead terms allocated jabs million doses delivered readied delivery million AstraZeneca Pfizer first provider vaccines European Union United States Japan It bilateral agreements billion doses making far largest supplier vaccines according data UNICEF UN agency But AstraZeneca seen crucial supplier less developed countries shot cheaper easier deliver COVAX bet heavily AstraZeneca beginning pandemic supply problems export restrictions top producer India gradually reduced reliance AngloSwedish shot As programme faced problems securing doses directly vaccine makers amid global scramble shots donations rich nations became important turning Pfizer main supplier COVAX The United States donating mostly Pfizer shots programme COLD CHAIN AND SYRINGES The change forced Gavi rush invest cold chain capacity receiving countries enough refrigerators cold transport equipment handle Pfizer shot requires lower storage temperatures AstraZeneca vaccine The organization warned insufficient cold chain capacity countries according internal report submitted Gavi board beginning December seen Reuters The problem compounded risk shortages special syringes needed administer Pfizer vaccine Gavi warned document The Pfizer jab hardest deliver given ultracold chain special syringe requirements Gavi says internal document It also hardest plan donated vaccines often come earmarking little notice staggered manner small volumes short shelf lives document says Wealthy countries donating vaccines relatively short shelf life major problem COVAX WHO official said last week many doses wasted An EU official told news briefing last week EU donations Pfizer vaccines COVAX slowed lack syringes A second official familiar issue told Reuters Gavi postpone delivery Pfizer doses Europe lack syringes Pfizer declined comment syringes said produce buy directly As doses made available poorer nations UNICEF WHO long warning insufficient supply autodisable syringes crucial inoculations poorer nations Autodisable syringes lock automatically prevent reuse otherwise common poorer nations could spread diseases To make things complicated autodisable syringes needed Pfizer vaccine different standard syringes UNICEF said Â Reuters FILE PHOTO Adar Poonawalla Chief Executive Officer CEO Serum Institute India poses picture Serum Institute India Pune India November Picture taken November REUTERSFrancis MascarenhasFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio Reuters Vaccine maker Serum Institute India SII pledged million pounds million University Oxford setting research campus would also house institute behind AstraZenecaOxford shot The investment made Indian company Serum Life Sciences unit Oxford University said Wednesday The research building would named Serum billionaire owners Poonawalla family The pledge builds collaboration Oxford University AstraZeneca NASDAQ SII world largest maker vaccines producer version British duo shot low middleincome countries SII also agreed Jenner Institute behind OxfordAstraZeneca vaccine produce develop Jenner malaria shot large scale The shot currently latestage trials SII founded Western Indian city Pune Cyrus Poonawalla son horse breeder India fifthrichest person according Forbes In Cyrus also conferred honorary degree Oxford University It currently run son Adar Poonawalla whose wife Natasha Poonawalla heads Serum Life Sciences With penchant luxury cars racehorses pair often seen rubbing shoulders Hollywood Bollywood stars The Poonawallas September invested million pounds Oxford Biomedica help fund development plant manufactures shots pounds',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel Wisniewski AZN Add toRemove Portfolio REGN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Mrinalika Roy Pushkala Aripaka Reuters AstraZeneca NASDAQ Regeneron Thursday reported contrasting data effectiveness antibody therapies Omicron variant coronavirus underscoring major challenges ahead drugmakers USbased Regeneron said REGENCOV therapy also called Ronapreve less effective Omicron though still active Delta variant confirming indications lab tests computer modelling late last month AngloSwedish rival AstraZeneca however said lab study found antibody cocktail Evusheld retained neutralising activity Omicron first data treatment The new variant detected countries since first identified three weeks ago fuelling concerns large number mutations help spread faster evade protection provided vaccines therapeutics Earlier week German researchers found therapies developed Eli Lilly NYSE Regeneron lose effectiveness exposed laboratory tests Omicron But lab studies week showed GSKVir antibody treatment retains neutralizing activity tested coronavirus variants including Omicron The study Evusheld done independent investigators US Food Drug Administration using socalled pseudoviruses feature major coronavirus mutations across suspicious variants emerged far ROAD AHEAD The researchers found potency Evusheld within ranges seen previously infected showing promise wide use therapy first preventative shot vaccines coronavirus AstraZeneca said analyses Evusheld Omicron conducted company third parties data expected soon Regeneron said REGENCOV still active Delta currently prevalent variant United States The European Union public health body however warned Wednesday high risk Omicron would become dominant Europe early next year REGENCOV currently authorized use United States treat people mildtomoderate prevention infection exposed infected individuals others high risk exposure Evusheld granted authorisation prevent infections individuals weak immune systems history severe sideeffects coronavirus vaccines Both treatments belong class medicines called monoclonal antibodies mimic natural antibodies fighting infections Unlike vaccines rely body create immune response therefore help individuals weak compromised immune systems Â Reuters FILE PHOTO A woman undergoes health screening receiving dose vaccine coronavirus disease mass vaccination program asylum seekers refugees sports hall Jakarta Indonesia October REU AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Francesco Guarascio Panu Wongchaum BRUSSELSBANGKOK Reuters Tens millions migrants may denied vaccines global programme major manufacturers worried legal risks harmful side effects according officials internal documents Gavi charity operating programme reviewed Reuters Nearly two years pandemic already killed million people people lowincome countries received dose Vaccine deliveries worldwide delayed production problems hoarding rich countries export restrictions red tape Many programmes also hampered hesitancy among public The legal concerns additional hurdle public health officials tackling coronavirus â even officials say unvaccinated people offer ideal environment mutate new variants threaten hardwon immunity around world Many vaccine manufacturers required countries indemnify adverse events suffered individuals result vaccines United Nations says Where governments control possible The concerns affect people displaced Myanmar Afghanistan Ethiopian crises beyond reach national governments vaccination schemes For refugees migrants asylumseekers well people afflicted natural disasters events put reach government help global programme known COVAX created Humanitarian Buffer â lastresort reserve shots administered humanitarian groups Gavi vaccine alliance publicprivate partnership set promote vaccination around world But buffer mechanism offer compensation Gavi operates COVAX World Health Organization WHO says applying doses mainly NGOs ca bear legal risks deliveries stockpile made vaccinemakers accept liability The companies willing circumstances provide minority programme vaccines according people familiar matter documents written Gavi staff board meeting starting end November More twothirds COVAX doses come Pfizer Inc NYSE partner BioNTech SE AstraZeneca NASDAQ PLC Moderna NASDAQ Inc Gavi says Moderna declined comment AstraZeneca Pfizer said talks Gavi declined comment All three said committed making doses available poorer nations relatively low prices Pfizer said collaborating directly governments Jordan Lebanon donate doses refugees Mainly legal concerns less million doses far sent buffer Gavi says About million people risk excluded national programmes according United Nations data cited documents Unless firms accept legal liability access vaccines populations remain challenge Gavi documents say adding new crises generate additional demand cover displaced populations The vaccine makers reluctance take legal risks major hurdle attempts provide vaccines buffer spokesperson Gavi told Reuters Gavi comment details documents said applications vaccines confidential doses delivered In September Gavi CEO Seth Berkley tweeted appeal drugmakers waive requirements legal indemnity Three Chinese drugmakers agreed shoulder legal risks shots delivered buffer SinoVac Biotech Ltd Sinopharm Group Co Ltd Clover Biopharmaceuticals Co Ltd according Gavi document The drugmakers respond requests comment Johnson Johnson NYSE United States confirmed would waive requirement indemnity deliveries buffer We proud part effort protect world vulnerable people said Paul Stoffels Vice Chairman Executive Committee Chief Scientific Officer He elaborate However less onethird COVAX supplies come four firms COVAX data shows Clover shot yet approved use The global industry association International Federation Pharmaceutical Manufacturers Associations IFPMA said company refused consider taking legal risk However case shots delivered buffer said firms felt could without full knowledge vaccines would used It would hard continuously monitor vaccines safety refugee camps delivery logistically challenging suitable types said European Federation Pharmaceutical Industries Associations EFPIA represents large pharmaceutical companies Europe People may blame vaccines problems emerge afterwards even unrelated said This could lead increased number litigation cases safety efficacy vaccine would publicly questioned said statement Reuters That might lead increased vaccine hesitancy slower recovery pandemic said So far scant information COVID vaccine litigation claims made outofcourt compensation programmes one measure risk A programme United States far paid anything public data show neither one set WHO lower income countries WHO said In Europe handful compensation awards granted undisclosed amounts money official data Denmark Germany Norway Switzerland show Globally reported COVID infections among refugees migrants asylumseekers â testing always systematic infections generate mild symptoms especially younger people But cramped conditions weak healthcare expose high infection risk This combined low levels vaccination mobile population could favour emergence new variants vector infection said Mireille Lembwadio Global Vaccination Coordinator International Organization Migration IOM UNrelated body advises governments migrants Leaving unvaccinated could help spread virus variants across world said WAITING FOR DOSES Francois Nosten French professor helps coordinate healthcare people Myanmar living border Thailand one waiting vaccines In June put request Humanitarian Buffer doses â sheltering camps along border unregistered migrants border town Mae Sot nearby villages Nosten whose main work researching malaria expecting doses fraction billion administered worldwide month He told come Sinopharm hopes help inoculate key atrisk groups Thailand Tak province Gavi said delivery arrangements still finalised About doses given people camps International Rescue Committee IRC humanitarian group working Nosten At point whatever vaccine secure grateful said Thailand Director Darren Hertz He added IRC believed likelihood member refugee population would attempt take legal action case sideeffects extremely low Hertz said IRC received handful ad hoc vaccine donations Thai government currently tackling significant outbreaks five nine camps border cases confirmed including least deaths A Thai foreign ministry spokesperson confirmed government working IRC providing vaccinations shelters along border Nosten charity Border Health Foundation BHF one eight organisations worldwide applied distribute shots Humanitarian Buffer one three approved Gavi said Ann Burton Chief Public Health UN refugee agency UNHCR said liability issue one reason agencies slow apply The programme also delayed general shortage vaccines administrative hurdles Organisations applying supplies buffer may choose vaccines receive Working displaced people Nosten said would convenient give Johnson Johnson vaccine offers protection single dose instead two doses needed Sinopharm But Sinopharm version better nothing said More national governments promised offer vaccines possible displaced people soil according IOM However UN group says migrants refugees often effectively excluded schemes administrative cultural hurdles In cases governments charge agreed vaccinate migrants COVAX Humanitarian Buffer option At least countries yet include unauthorised migrants vaccination programmes according IOM â UNHCR declined name countries Gavi set buffer March planning reserve vaccine doses become available COVAX would amount roughly million doses far The shots delivered buffer far million Sinopharm doses â landed Iran November high numbers displaced Afghans arrived UNICEF Iran said That enough inoculate people likely needed UNICEF said NEED FOR SPEED The vaccine makers legal concern rooted unprecedented speed effort develop COVID shots EFPIA said In normal circumstances drugmakers buy insurance cover liability vaccines potential adverse effects But COVID forced develop drugs quickly side effects instance rare bloodclotting condition took AstraZeneca vaccine emerging shots go people arms Many governments international agencies set compensation schemes reimburse victims avoid lengthy litigation An emergency law invoked US government provides legal immunity drug companies side effects vaccines used country The exception instances wilful misconduct For drug companies accepting potential liability runs counter standard practice Vaccine manufacturers try minimize legal risks almost every setting said John T Monahan Professor Georgetown University The gold standard full immunity lawsuits If accept carveouts may become difficult reach goal Edited Jospehone Mason Sara Ledwith',\n",
              " 'Â Reuters FILE PHOTO A doctor shows vials AstraZeneca vaccine general practice facility spread coronavirus disease continues Vienna Austria May REUTERSLeonhard Foeger AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca Plc said Tuesday working Oxford University produce vaccine Omicron coronavirus variant joining vaccinemakers looking develop variantspecific vaccine Together Oxford University taken preliminary steps producing Omicron variant vaccine case needed informed emerging data spokesperson company said statement Oxford immediately respond request comment outside business hours The Financial Times first reported news citing Sandy Douglas research group leader Oxford Adenovirusbased vaccines made OxfordAstraZeneca could principle used respond new variant rapidly may previously realised Douglas told FT A labstudy last week found AstraZeneca NASDAQ antibody cocktail Evusheld retained neutralising activity Omicron variant Vaccine makers PfizerBioNTech Moderna NASDAQ also previously said working Omicron specific vaccines Moderna said hopes start clinical trials early next year Â Reuters AZN Add toRemove Portfolio RIO Add toRemove Portfolio RR Add toRemove Portfolio RIO Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading lower In FX markets trading trading The Todayâs calendar highlights include Eurozone UK US Coronavirus Stock futures lower early trade Omicron variant forced European countries announce new restrictions UK Deputy Prime Minister Dominic Raab said UK hospitalisations deaths Omicron Raab added make guarantees pandemic restrictions Stocks Rio Tinto LON Dominic Barton succeed Simon Thompson company new Chair AstraZeneca LON Saphnelo recommended approval EU CHMP treatment patients systemic lupus erythematosus Separately Tezspire tezepelumab approved US severe asthma GlaxoSmithKline LON Sir Dave Lewis appointed NonExecutive Chair Designate new Consumer Healthcare company result proposed demerger GSK His appointment take effect January RollsRoyce LON Reached agreement Qatar Investment Authority invest GBP million RollsRoyce SMR Limited RollsRoyce SMR building new technology solution deliver affordable low carbon nuclear power Standard Chartered LON â Bank England fined Standard Chartered million failing open cooperative Bodycote LON Appointed Daniel Dayan NonExecutive Chair effect January J D Wetherspoon LON Appointed two employee directors full plc director status two associate employee directors The employee directors Debbie Whittingham regional manager West Midlands Hudson Simmons area manager Sheffield Frasers LON CEO Mike Ashley reportedly considering move take Frasers private Telegraph Marks Spencer LON Reportedly hired MWM Consulting help benchmark three internal contenders vying become next CEO Sources added formal search process yet get underway current CEO Rowe could stay another couple years Sky News Â Reuters AZN Add toRemove Portfolio SDRt Add toRemove Portfolio SDR Add toRemove Portfolio FOXT Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The Todayâs calendar highlights include UK Canadian US Data UK November billion expectations billion Public sector net borrowing April November billion around billion period last year However figure almost three times large period Stocks AstraZeneca LON Ultomiris regulatory submission accepted FDA Priority Review US adults generalised myasthenia gravis Schroders LON Reached agreement acquire shareholding renewable infrastructure manager Greencoat Capital Holdings Limited initial consideration million GlaxoSmithKline PLC LON ViiV Healthcare majority owned GSK announced US FDA approval Apretude cabotegravir extendedrelease injectable suspension first longacting injectable option HIV prevention BHP Group LON Confirmed regulatory competition approvals unification received including approval National Treasury South Africa If approved shareholders conditions satisfied waived including UK court sanction scheme arrangement admission Limited shares standard segment FCA official list trading LSE listing JSE unification expected complete January Playtech LON Due recent COVID development possibility revised guidance issued new restrictions imposed Playtech decided implement certain additional arrangements allow Scheme Shareholders participate vote virtually Court Meeting Playtech Shareholders watch submit questions General Meeting virtual platform Johnson Matthey LON To commence first tranche million share buyback programme today Hiscox LON To appoint Paul Cooper Group Chief Financial Officer subject regulatory approval HarbourVest LON Credit facility increased million million immediate effect Foxtons LON To appoint Chris Hough Chief Financial Officer Executive Director Chris succeed Richard Harris tendered resignation order take position Chief Financial Officer The Rank Group LON',\n",
              " 'Â Reuters GBPUSD Add toRemove Portfolio EURGBP Add toRemove Portfolio BATS Add toRemove Portfolio AZN Add toRemove Portfolio BALF Add toRemove Portfolio BHPB Add toRemove Portfolio HLMA Add toRemove Portfolio FLTRF Add toRemove Portfolio DX Add toRemove Portfolio Add toRemove Portfolio INPP Add toRemove Portfolio EVRE Add toRemove Portfolio IHPI Add toRemove Portfolio FNTL Add toRemove Portfolio ROO Add toRemove Portfolio LIFE Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The flat Todayâs calendar highlights include US Stocks Flutter Entertainment LON Announces acquisition Italian gaming operator Sisal CVC Capital Partners consideration billion billion The transaction likely complete expected accretive adjusted earnings first months postcompletion BHP Group LON BHP Noront terminated support agreement In accordance terms support agreement Noront made CAD million termination payment BHP Balfour Beatty LON Reached resolution US Department Justice DoJ resolves DoJ criminal civil investigations specific performance incentive fees improperly claimed subsidiary Balfour Beatty Communities related maintenance work certain United States military housing installations Balfour Beatty Communities pay total resolution amount million million current exchange rate comprising approximately million penalties million restitution The company also pleaded guilty one count fraud AstraZeneca PLC LON â The company said vaccine effective Omicron following third dose according new laboratory study results International Public Partnerships LON Agreed acquire small portfolio UK PPP investments comprising initially interests Townlands Community Hospital Henley Eltham Community Hospital minority interests Building Schools Future projects STaG The interests acquired Amber Infrastructure million Deliveroo LON Love Hemp AQUIS launched trial basis Deliveroo London Fintel LON Premier Milton Carmignac joined growing number firms committed multiyear agreements managed distribution service launched earlier year Ex Dividends British American Tobacco LON EVRAZ LON Halma LON IntegraFin LON trade exdividend today Â Reuters FILE PHOTO Vials labelled Astra Zeneca Coronavirus Vaccine syringe seen front displayed AstraZeneca logo illustration photo taken March REUTERSDado Ruvic AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Reuters A threedose course AstraZeneca NASDAQ vaccine effective rapidlyspreading Omicron coronavirus variant pharmaceutical company said Thursday citing data Oxford University lab study Findings study yet published peerreviewed medical journal match rivals PfizerBioNTech Moderna NASDAQ also found third dose shots works Omicron The study AstraZeneca vaccine Vaxzevria showed threedose course vaccine neutralising levels Omicron broadly similar virus Delta variant two doses The Londonlisted company said researchers Oxford University carried study independent worked vaccine AstraZeneca As better understand Omicron believe find Tcell response provides durable protection severe disease hospitalisations Mene Pangalos head AstraZeneca biopharmaceuticals RD said referring critical component immune system respond fight infection Antibody levels Omicron booster shot higher antibodies people infected recovered naturally AngloSwedish drugmaker added Although early data positive company AstraZeneca said Tuesday working partner Oxford University produce vaccine tailored Omicron joining similar efforts vaccinemakers The Oxford study analysed blood samples infected vaccinated two doses booster previously infected variants concern It included samples people given three doses Vaxzevria Scientists governments scrambling bolster defences Omicron shots therapies variant threatens become dominant globally prompted renewed curbs ahead holidays contain infections Britain earlier month backed use boosters found third dose significantly restored protection mild disease caused Omicron part reversing otherwise steep drop vaccine effectiveness',\n",
              " 'Â Reuters AZN Add toRemove Portfolio AAL Add toRemove Portfolio FRES Add toRemove Portfolio NGLOY Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The flat Todayâs calendar highlights include Eurozone US Coronavirus Daily COVID cases England hit another record high festive period surge cases far led similarly large increase hospital admissions The government far refrained introducing new restrictions England hospitality large events Stocks AstraZeneca LON Closed global development commercialisation deal Ionis Pharmaceuticals eplontersen The upfront payment AstraZeneca Ionis million AstraZeneca make additional conditional payments million following regulatory approvals It also pay billion salesrelated milestones plus royalties range low doubledigit midtwenties percentage depending region Anglo American LON Held preliminary discussions Vale possibility jointly develop Valeâs Serpentina iron ore resource contiguous Anglo American integrated MinasRio iron ore operation Brazil Fresnillo LON Provides update Juanicipio project The team delivered project plant commissioning schedule However Federal de Electricidad stateowned electrical company notified Fresnillo approval complete tiein national power grid yet granted mill commissioning timeline therefore extended approximately six months Diversified Energy Company LON Closed sale predominantly undeveloped Haynesville acreage Texas total cash consideration approximately million',\n",
              " 'Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor New York Stock Exchange NYSE New York US April REUTERSBrendan McDermid AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca Plc agreed develop antibodybased therapy Swiss biotechnology firm Neurimmune rare underdiagnosed condition lead heart failure deal valued million drugmaker said Tuesday AstraZeneca NASDAQ rare diseases unit Alexion NASDAQ Neurimmune firm behind discovery Biogen NASDAQ Alzheimer drug aducanumab work evaluating monoclonal antibody treatment transthyretin amyloid cardiomyopathy The potentially fatal condition characterised deposits proteins called amyloid fibrils walls heart causes become stiff result organ unable pump circulate blood effectively Under agreement Alexion would pay Neurimmune upfront payment million would eligible payments million upon completion targets plus royalties sales AstraZeneca said statement Neurimmune candidate belongs class therapies called monoclonal antibodies labgenerated compounds mimicking body natural defences targets protein deposits breaks AngloSwedish drugmaker AstraZeneca made billion bet Alexion rare diseases portfolio major success monoclonal antibodies recent times Evusheld treatment',\n",
              " 'AstraZeneca NASDAQ AZN announced Tuesday vaccine Vaxzevria Recombinant given full Marketing Authorisation MA European Union EU Vaxzevria originally granted conditional Marketing Authorisation cMA EU AstraZeneca stated âœAs continues sufficient evidence safety efficacy confirming benefits Vaxzevria European Medicines Agency EMA granted full MAâ Iskra Reic EVP Vaccines Immune Therapies AstraZeneca commented âœThe move conditional full marketing authorisation Vaxzevria important confirmation EMA safety efficacy Vaxzevria demonstrating benefits continue outweigh potential risks Vaxzevria estimated helped save six million lives first year vaccination reflects strength evidence showing Vaxzevriaâs protection severe disease death caused Tesla Shifts China Factory Workers To US Plant Complete European Approval For AstraZeneca Shot Tesla Eyes Cybertruck Commercialization Next Year Top Stories Tuesday Nov Â Reuters AstraZeneca shares get lift heartburn drug litigation closure says Citi AZN Add toRemove Portfolio LFCOF Add toRemove Portfolio Add toRemove Portfolio AstraZeneca PLC NASDAQ get boost probability close US kidney damage lawsuit New Jersey prior first bellwether case March according analysts Citi The UK pharma one several firms embroiled US legal action possible damage caused proton pump inhibitor PPI heartburn drugs Nexium launched Astra US The Citi analysts believe likely outcome judge delaying response Defendant Motion summary judgement grounds preemption encourage plaintiffs settle âœAlternatively lower probability Judge Cecchi may delayed start bellwether cases disagrees conclusions Special Master Reisman grants defendant motion dismiss grounds preemption said Either scenario would materially positive Astra depressed share price US bank analysts added would positive interim data Enhertu yearend positive data March The Citi analysts said core EPS forecasts Astra consensus repeated alongside price target recommendation Shares Astra rose Read Proactive Investors UK Disclaimer',\n",
              " 'Â Reuters A nurse prepares dose AstraZeneca coronavirus disease vaccine Mexicali Mexico January REUTERSVictor Medina AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca NASDAQ said Thursday preliminary data trial conducted shot Vaxzevria showed generated higher antibody response Omicron variant others including Beta Delta Alpha Gamma given third booster dose The increased response seen people previously vaccinated either Vaxzevria mRNA vaccine drugmaker said adding would submit data regulators worldwide given urgent need boosters AstraZeneca developed vaccine researchers University Oxford lab studies last month found threedose course Vaxzevria effective rapidly spreading new variant The data first released company trials boosters vaccine The company said adds growing evidence supports third dose vaccine irrespective primary vaccination schedule These important studies show third dose Vaxzevria two initial doses vaccine mRNA inactivated vaccines strongly boosts immunity Oxford Vaccine Group chief Andrew Pollard said statement A major British trial December found AstraZeneca shot increased antibodies given booster initial vaccination shot Pfizer NYSE based mRNA technology However study concluded mRNA vaccines made Pfizer Moderna NASDAQ gave biggest boost antibodies given booster dose',\n",
              " 'Â Reuters AZN Add toRemove Portfolio GSK Add toRemove Portfolio TW Add toRemove Portfolio GSK Add toRemove Portfolio UL Add toRemove Portfolio ULVR Add toRemove Portfolio TWODY Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The flat trading Todayâs calendar highlights include Stocks Unilever LON GlaxoSmithKline LON Unilever confirms approached GSK Pfizer NYSE potential acquisition GSK Consumer Healthcare unit The latest proposal total acquisition value billion comprising billion cash billion Unilever shares GSK rejected three proposals made basis fundamentally undervalued Consumer Healthcare business future prospects Unilever As result reporting interest GSKâs Consumer Health unit Unilever brought forward planned strategic update Unilever said future strategic direction lies materially expanding presence Health Beauty Hygiene The board concluded major acquisitions accompanied accelerated divestment intrinsically lower growth brands businesses Taylor Wimpey LON total UK home completions increased Net private reservation rate homes per outlet per week Average selling prices private completions increased overall average selling price increasing Will announce level excess cash return respect company full year results March forward sold Confident achieving primary performance target return business operating margin AstraZeneca LON Enhertu granted Priority Review US patients metastatic breast cancer treated prior regimen Ashmore LON Total assets management estimated December fell September billion Assets management declined billion period comprising net outflows billion negative investment performance billion Hikma Pharmaceuticals LON Agreed acquire Canadian assets Teligent million The transaction expected completed end first quarter Oxford BioMedica LON Chief Executive Officer John Dawson signalled Board intention retire Company Accordingly Board initiated formal search successor Qinetiq LON Names Shawn Purvis President CEO QinetiQ US effective February Capital Counties Properties LON As December independent property valuation Covent Garden billion representing likeforlike increase second half year overall movement full year Rent collection relation first quarter invoiced December currently Tritax EuroBox LON Completed acquisition land agreed fund development sqm prime sustainable logistics asset Sweden SEK million Big Yellow Group LON total revenue increased million Occupancy across stores decreased sq ft compared loss sq ft Moveouts higher quarter reflective record first quarter occupancy gain leading tapering stamp duty holiday Endeavour Mining LON Announced discovery million ounces Measured Indicated resources million ounces Inferred resources across flagship Ity HoundÃ SabodalaMassawa mines well LafiguÃ deposit Fetekro property Micro Focus LON Announced successfully priced allocated million million Senior Secured Term Loan B Clinigen LON Agrees taken Triton deal worth pence per share ASOS LON Former Farfetch executive Andrew Robb reportedly among candidates CEO position ASOS LON Sky News Darktrace LON Short seller ShadowFall launched short attack Darktrace doubts company âœwill stand test timeâ',\n",
              " 'Â Reuters AstraZenecaMerck Prostate Cancer Combo Drug Try For scPharma FDA Panel Decisions And More October Key PDUFA Catalysts Biotech Investors Must Know AZN Add toRemove Portfolio IXIC Add toRemove Portfolio KECR Add toRemove Portfolio Add toRemove Portfolio Most FDA decisions scheduled September yielded positive results stray disappointments well Seven new molecular entities NMEs approved month taking total NME approvals year This far less approvals received time last year NMEs considered measure innovation drug research contain active moieties ingredients havenât previously approved Food Drug Administration Among positive verdicts bluebird bio Incâs NASDAQ BLUE million gene therapy Skysona approved treating rare neurodegenerative disorder boys Amylyx Pharmaceuticals Inc NASDAQ AMLX scored win amyotrophic sclerosis treatment Revance Therapeutics Incâs NASDAQ RVNC Botox rival Daxxify approved treating frown lines Spectrum Pharmaceuticals Inc NASDAQ SPPI mixed month Rolvedon approved treating chemotherapyinduced neutropenia lung cancer drug get backing FDA panel Here key PDUFA dates scheduled October Will Theratech Score A Win For A More Convenient Formulation Of Its HIV Drug Company Theratechnologies Inc NASDAQ THTX Type Application supplemental biologic license application Candidate Trogarzo Indication Date Oct In fourth quarter company filed sBLA intravenous push mode administration Trogarzo treating human immunodeficiency virus type Trogarzo first approved FDA March treat adult patients multidrugresistant HIV In quarter ended May drug generated sales million Theratech Alnylam On Course For Snagging Label Expansion For Oxlumo Company Alnylam Inc NASDAQ ALNY Type Application supplemental new drug application Candidate Oxlumo Indication hyperoxaluria Type Date Oct Oxlumo goes generic name lumasiran RNAi therapeutic evaluated reduction plasma oxalate patients advanced hyperoxaluria type â rare disorder mainly affects kidneys due accumulation substance called oxalate normally filtered kidneys excreted urine This therapy first approved lowering urinary oxalate labels pediatric adult patients In second quarter fetched company million sales sequentially See also Alzheimer Progression Slowed Down By Biogen NASDAQ New Drug In LateStage Study Analyst Sees Can Third Time Be Charm For scPharma Company scPharmaceuticals Inc NASDAQ SCPH Type Application NDA Candidate Furoscix Indication worsening heart failure due congestion Date Oct Furoscix proprietary subcutaneouslydelivered furosemide solution evaluated outpatient alternative treatment worsening congestive heart failure This scPharma third try Furoscix following complete response letter âGoâ ânoGoâ Amicusâs Pome Disease Treatment Company Amicus Therapeutics Inc NASDAQ FOLD Type Application BLA Candidate cipaglucosidase alfa Indication Pompe disease Date Oct ATGAA investigational therapy consists cipaglucosidase alfa administered conjunction miglustat yet approved FDA The therapy evaluated inherited lysosomal disorder called Pome disease The disease debilitating characterized severe muscle weakness worsens time It ranges rapidly fatal infantile form significant impacts heart function slowly progressive lateonset form primarily affecting skeletal muscle It estimated Pompe disease affects approximately people worldwide Supernus Hopes For No Hiccups In Parkinson Disease Drug Approval Company Supernus Pharmaceuticals Inc NASDAQ SUPN Type Application NDA Candidate apomorphine infusion device Indication OFF episodes Parkinsonâs disease Date Early October Supernusâs initial application seeking approval shot refusetofile letter November citing insufficiently completed application allow substantiative review Following resubmission FDA accepted application assigned PDUFA date sometime early October Also read Best Biotech Stocks Right Now AstraZeneca NASDAQ Knocks At FDA Altar For Liver Cancer Combo Treatment Company AstraZeneca plc NASDAQ AZN Type Application BLAsBLA Candidate Tremelimumab Imfinzi Indication Unresectable hepatocellular carcinoma Date The FDA accepted AstraZenecaâs BLA tremelimumab priority review supporting indication single priming dose antibody added Imfinzi treating patients unresectable hepatocellular carcinoma A sBLA also submitted Imfinzi indication This novel dose schedule combination called STRIDE regimen Single Tremelimumab Regular Interval Durvalumab HCC according company common type liver cancer people US afflicted advanced unresectable HCC year MerckAstraZeneca Await Approval For Prostate Cancer Como Therapy Company Merck Co Inc NYSE MRK AstraZeneca Type Application sNDA Candidate Lynparza combination Abiraterone Prednisone Prednisolone Indication prostate cancer Date The application accepted granted priority review FDA treatment adult patients metastatic castrationresistant prostate cancer Adcom Calendar FDAâs Cardiovascular Renal Drugs Advisory Committee meet Oct discuss GlaxoSmithKline plcâs NYSE GSK NDA hypoxiainducible factor prolyl hydroxylase inhibitor daprodustat tablets treatment option anemia resulting chronic kidney disease The Oncologic Drugs Advisory Committee scheduled meet Oct discuss BLA submitted YmAbs Therapeutics Inc NASDAQ YMAB solution injectable formulation treating neuroblastoma central nervous systemleptomeningeal metastases On Oct Endocrinologic Metabolic Drugs Advisory Committee deliberate Ispen SAâsOTC IPSEY palovarotene capsules proposed indication heterotopic ossification adults children It condition muscle tissue connective tissue tendons ligaments gradually replaced bones Â Benzingacom Benzinga provide investment advice All rights reserved Read original article Benzinga',\n",
              " 'Â Reuters FILE PHOTO A man shelters umbrella walks past London Stock Exchange London Britain August REUTERSSuzanne Plunkett Add toRemove Portfolio AZN Add toRemove Portfolio GLEN Add toRemove Portfolio FTSE Add toRemove Portfolio GLNCY Add toRemove Portfolio Add toRemove Portfolio By Ambar Warrick Reuters British stocks rose Tuesday global risk sentiment improved reports Moscow withdrawing troops near Ukraine calmed fears potential Russian invasion positive data AstraZeneca NASDAQ strong earnings mining company Glencore LON lifted sentiment The bluechip ended higher midcap stocks added Both indexes slumped nearly Monday United States warned Russia could invade Ukraine moment Defensive sectors including healthcare consumer staples top performers Tuesday AstraZeneca jumped biggest boost FTSE positive results latestage trial drugmaker prostate cancer treatment Glencore BHP Group firms announced large dividend payouts following recent strength commodity prices Glencore shares rose steep losses iron prices weighed BHP Chinese iron ore prices slumped traders feared government crackdown Beijing warned would act spread misinformation prices IRONORE Strong earnings helped local stocks weather geopolitical tensions well jitters tightening monetary policy across globe Corporate earnings remained strong despite multitude inflation headwinds The reporting season continue provide support banks energy materials showing particularly strong increases earnings Elisa Belgacem senior credit strategist Generali MI Investments wrote note The FTSE one major stock indexes trading positive year relatively low exposure technology firms helped sidestep global rout sector Â Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio AAL Add toRemove Portfolio BHPB Add toRemove Portfolio MRON Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio SBNCyq Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities higher close Tuesday gains sectors propelled shares higher At close London rose The biggest gainers session Sberbank Of Russia LON rose points trade close AstraZeneca PLC LON added points end Melrose Industries PLC LON points late trade Biggest losers included Fresnillo PLC LON lost points trade late trade Anglo American PLC LON declined points end BHP Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March fell hit barrel April Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Â Reuters FILE PHOTO A healthcare professional prepares dose AstraZeneca vaccine Narok County Referral Hospital Narok Kenya December REUTERSBaz Ratner AZN Add toRemove Portfolio Add toRemove Portfolio By Francesco Guarascio Jennifer Rigby BRUSSELSLONDON Reuters The relatively short shelf life AstraZeneca NASDAQ Plc vaccine complicating rollout world poorest nations according officials internal World Health Organization documents reviewed Reuters It latest headache plague COVAX vaccinesharing project coled WHO aimed getting shots world neediest people Initially poorer countries COVAX lagged richer countries securing vaccine supplies wealthier nations used financial might acquire first available doses As vaccine production ramped richer states began donating excess doses countries particularly Africa â struggling administer big shipments The need turn vaccines short shelf lives along initial inequality hesitancy barriers contributed much lower vaccination rate Africa around people immunised compared richer nations Many vaccines arriving months sometimes weeks useby date adding scramble get shots arms Some countries destroy expired doses including Nigeria dumped million AstraZeneca vaccines November The problem short shelf life largely concerns AstraZeneca according COVAX data officials An internal WHO document reviewed Reuters detailing vaccine stocks several central west African countries week ending Feb highlighted problem Most listed African nations expired AstraZeneca doses compared handful countries expired doses manufacturers Of total expired doses declared countries week million AstraZeneca Johnson Johnson NYSE Moderna NASDAQ Russia Sputnik document shows Many vaccines expected rejected African nations COVAX said January would accept vaccines less twoandahalf months shelf life Yet Benin received AstraZeneca doses COVAX Jan set expire Feb It also got doses Sputnik Light vaccine Russia expiry date outside COVAX initiative Vaccines manufacturers much longer shelf life according document Since January COVAX shipping vaccines countries demand ensuring countries get right volume right time said Phiona Atuhebwe vaccine expert WHO Africa Asked internal document seen Reuters said WHO fully cognizant pressure short shelf life doses put delivery strategies systems amid weak infrastructure low demand Two half months shelf life minimum duration African countries reckon need administer shots AstraZeneca COVAX secondbiggest supplier Pfizer NYSE said since start global rollout million shots left factories less twoandahalf months expiry Short shelf life generally problem wealthy country expertise infrastructure But without systems place insurmountable A spokesperson AngloSwedish AstraZeneca said vaccines undergo scrupulous quality checks pointed fact company major player supporting vaccination drives poorer nations With donations rich countries included AstraZeneca vaccines distributed COVAX shot AstraZeneca supplied billion vaccine doses globally approximately two thirds gone low lower middleincome countries spokesperson said Almost nine doses released manufacturing sites ready donation shelf life least two half months consistent rest supply chains spokesperson added CLOCK TICKING The volumes delivered vaccines vastly outnumber wasted doses losses substantial thanks part time pressures This led AstraZeneca shots turned even shipped Taking account donated doses represent nearly half billion vaccines distributed COVAX million AstraZeneca shots rejected deferred last year poor nations said Gavi nonprofit coruns COVAX alongside WHO That amounts quarter AstraZeneca donated shots via COVAX Many later reassigned countries Gavi added noting AstraZeneca It say Millions additional AstraZeneca doses shared EU COVAX biggest donor distributed yet according EU internal document reviewed Reuters The main problem vaccine shelf life six months date bottling shortest among COVAX top suppliers several COVAX EU officials told Reuters In addition company quality checks sometimes take months COVAX complex system assign doses countries donors requests deliver selected nations often eat vaccine short life leaving sometimes weeks expire Quality checks conducted vaccine makers time constraints less issue COVAX top suppliers Johnson Johnson vaccines last two years frozen Pfizer last nine months Moderna seven months according storage instructions approved WHO Millions Moderna Pfizer vaccines could also go wasted African countries warned WHO document problem linked usually low vaccine uptake insufficient coldchain equipment distribute shots remote regions EXTENDING SHELF LIFE Gavi said encouraged AstraZeneca apply WHO extension expiration date talks led yet formal application AstraZeneca said process complex due vast global network companies manufacturing vaccine One production partners Serum Institute India granted WHO approval ninemonth shelf life initially authorised six But batches produced AstraZeneca rest world six We currently discussions World Health Organisation complex task requires data collected across global manufacturing network spokesperson AstraZeneca said A WHO spokesperson comment talks On average African countries used twothirds received doses drops Burundi Congo large countries including Madagascar Zambia Somalia Uganda used onethird Gavi said citing figures late January Gavi said total wastage rate around doses delivered midDecember It declined share updated figures said rate expected rise',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio HRGV Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio SBNCyq Add toRemove Portfolio VTBRq Add toRemove Portfolio ROSNq Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Monday losses sectors propelled shares lower At close London lost The biggest gainers session AstraZeneca PLC LON rose points trade close Hargreaves Lansdown PLC LON added points end Fresnillo PLC LON points late trade Biggest losers included Sberbank Of Russia LON lost points trade late trade NK Rosneft PAO DRC LON declined points end Bank VTB PAO DRC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery April rose hit barrel May Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Â Reuters FILE PHOTO A vial labelled AstraZeneca Vaccine seen illustration taken January REUTERSDado RuvicIllustration AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Reuters A large study rare blood clots linked AstraZeneca NASDAQ vaccine found one three cases per million first dose shedding fresh light sideeffects shot Researchers sought analyse link vaccines rare blood clots brain arteries veins sometimes accompanied low platelets reports led many nations last year pause use AstraZeneca shot developed Oxford University A study published PLOS Medicine journal Tuesday looked health records million adults England December March assess risk clots month vaccination either PfizerBioNTech vaccine AstraZenecaOxford shot compared unvaccinated It carried William Whiteley University Edinburgh Britain BHF Data Science Centre It found risk major arterial venous thrombotic events aged either vaccines And risk intracranial venous thrombosis ICVT following AstraZenecaOxford vaccine nearly double equal one three cases per million The risks ICVT hospitalisation thrombocytopenia likely outweighed vaccines effect reducing mortality morbidity study authors said Cases rare blood clotting emerged early last year rollout AstraZenecaOxford vaccine began Europe Johnson Johnson NYSE vaccine based similar platform AstraZenecaOxford shot also associated rare combination blood clotting low platelet counts Some countries restricted suspended use vaccines EU drug regulator confirmed possible links shots conditions International drug regulators said benefits vaccines outweigh risks The study line review EU drug regulator said last month fewer side effects observed second AstraZeneca dose AstraZeneca said statement study confirmed already known extremely rare blood disorders following vaccination The risk developing rare condition remains substantially higher added Last year study led funded AstraZeneca found vaccine carried small additional risk thrombosis thrombocytopenia syndrome first dose none second AstraZenecaOxford shot sold brands Vaxzevria Covishield billion doses supplied globally February remains key weapon pandemic middleincome countries A second peerreviewed British study also released Tuesday found risk cerebral venous sinus thrombosis CVST four weeks receiving AstraZenecaOxford shot roughly twice high vaccination still implied one four million people could sideeffect The study assessed data million people England Scotland Wales spanning nearly seven months December June Â Reuters FILE PHOTO Britain Prince Charles AstraZeneca Chairman Leif Johansson smile visit AstraZeneca global RD facility Cambridge Biomedical Campus Cambridge Britain November Chris JacksonPool via REUTERS AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Reuters AstraZeneca nonexecutive Chairman Leif Johansson retire next year serving years role AngloSwedish drugmaker said Tuesday moves onto next stage growth led newer therapies including cancer The Swedish businessman became chairman around time Frenchman Pascal Soriot took charge chief executive Soriot interview Financial Times last May hinted succession planning begun Johansson The Londonlisted drugmaker said Tuesday Johansson would step following annual general meeting search chair successor proceeding well AstraZeneca NASDAQ last year asked Johansson continue role oversee nowcompleted billion acquisition rare diseases drug maker Alexion NASDAQ biggest deal record also navigated developments around shot He also served chairman telecommunications firm Ericsson BS New governance codes introduced diversify talent said chair firm Britain remain post beyond nine years companies must carefully consider extension beyond limited period AstraZeneca said Tuesday asked Johansson reached nine years tenure continue another year facilitate succession planning The Board believes would best interests shareholders Mr Johansson seek reelection AGM April continue serve Chair one year said statement Following confirmation Johansson retirement plans Soriot tenure could come back investor focus leaves behind old guard top Former finance chief Marc Dunoyer moved new role lead Alexion',\n",
              " 'Â Reuters AstraZeneca Stock Gain After Enhertu Meets Primary Endpoint In Breast Cancer Setting AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca plc NASDAQ said Enhertu prolonged survival slowed progression metastatic breast cancer low levels protein known Data pivotal Phase trial showed Enhertu trastuzumab deruxtecan demonstrated statistically significant clinically meaningful improvement progressionfree survival PFS overall survival OS patients versus physician choice chemotherapy The improvement clinically meaningful compared standard chemotherapy said adding detailed results latestage trial would presented asyetundisclosed medical conference Related AstraZenecaDaiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer Enhertu antibodydrug conjugate ADC jointly developed AstraZeneca Daiichi Sankyo OTC DSNKY The trial met key secondary endpoint PFS patients metastatic breast cancer regardless HR status The safety profile Enhertu consistent previous clinical trials new safety concerns identified Overall interstitial lung disease ILD rates consistent observed lateline breast cancer trials Enhertu lower rate Grade ILD observed Price Action AZN shares premarket session last check Tuesday Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel Wisniewski AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca NASDAQ plc signed agreement Canada doses antibody therapy prevention highrisk patients country government said Wednesday AstraZeneca Evusheld review Health Canada use preventive treatment disease immunocompromised While vaccines provide excellent protection people immunocompromised may need additional protection said Canadian health minister JeanYves Duclos Initial deliveries antibody expected arrive Canada within month authorization government said The company said doses Evusheld delivered year',\n",
              " 'Â Reuters AstraZeneca GSK Therapies Lose Efficacy Against Omicron Subvariants AZN Add toRemove Portfolio Add toRemove Portfolio The FDA authorized increased dose case AstraZeneca Plc NASDAQ preexposure prophylaxis drug Evusheld tixagevimab cilgavimab Based recent information data available Evusheld may less active certain Omicron subvariants The dosing regimen revised available data indicate higher dose Evusheld may likely prevent infection Omicron subvariants originally authorized Evusheld dose FDA said statement The revised EUA doubles initial authorized dose mg tixagevimab mg cilgavimab The FDA recommends patients previously received Evusheld get additional doses ASAP nonclinical data indicate neutralizing activity Evusheld decreases fold Omicron subvariants Meanwhile earlier week FDA updated fact sheet GlaxoSmithKline Plc NYSE GSK Vir Biotechnology Inc NASDAQ VIR sotrovimab Omicron subvariant less susceptible sotrovimab original virus The agency added unknown whether reduced potency impact effectiveness In addition updated document adds vague language sotrovimab authorized treatment geographic regions infection likely caused nonsusceptible variant Related Preprint Suggests VirGSK Antibody Can Evade Omicron SubVariant Price Action AZN shares GSK stock market session last check Friday Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga',\n",
              " 'Â Reuters AstraZeneca says ImjudoImfinzi combination approved advanced liver cancer US AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca PLC LON announced US Food Drug Administration FDA approved company Imjudo tremelimumab drug combination Imfinzi durvalumab treatment adult patients unresectable hepatocellular carcinoma HCC common type liver cancer The approval based results HIMALAYA Phase III trial showed single priming dose antibody Imjudo added antibody Imfinzi reduced risk death compared sorafenib pharmaceuticals company said Liver cancer thirdleading cause cancer death sixth commonly diagnosed cancer worldwide It fastestrising cause cancerrelated deaths US approximately new diagnoses year company said In statement Dave Fredrickson executive vice president oncology business unit AstraZeneca commented With first regulatory approval Imjudo patients unresectable liver cancer US approved dual immunotherapy treatment regimen harnesses potential inhibition unique combination inhibitor enhance immune response cancer Dr Ghassan AbouAlfa attending physician Memorial Sloan Kettering Cancer Center MSK principal investigator HIMALAYA Phase III trial said Patients unresectable liver cancer need welltolerated treatments meaningfully extend overall survival In addition regimen demonstrating favourable threeyear survival rate HIMALAYA trial safety data showed increase severe liver toxicity bleeding risk combination important factors patients liver cancer also advanced liver disease Regulatory applications Imjudo combination Imfinzi currently review Europe Japan several countries treatment patients advanced liver cancer based HIMALAYA results AstraZeneca said Read Proactive Investors UK Disclaimer Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor New York Stock Exchange US April REUTERSBrendan McDermidFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio Reuters Shares LogicBio Therapeutics skyrocketed Monday Britain AstraZeneca NASDAQ said would buy USbased gene therapy developer rare premium million LoigBio shares traded since February bell close AstraZeneca offer price per share LogicBio developing gene editing therapies treat pediatric rare disease like methylmalonic acidemia body break certain proteins fats AstraZeneca said deal would accelerate growth Alexion NASDAQ unit acquired billion last year field genomic medicine',\n",
              " 'By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter',\n",
              " 'The European Commission approved AstraZeneca plc AZN Sanofi SAâs SNY Beyfortus nirsevimab longacting antibody prevent respiratory syncytial virus RSV lower respiratory tract disease newborns infants first RSV season Beyfortus nirsevimab longacting antibody prevent respiratory syncytial virus RSV lower respiratory tract disease newborns infants first RSV season Beyfortus first singledose RSV passive immunization broad infant population including born healthy term preterm specific health conditions In pivotal MELODY efficacy trial Beyfortus met primary endpoint reducing incidence medically attended lower respiratory tract infections LRTI caused RSV vs placebo day single dose Beyfortus also demonstrated comparable safety tolerability profile Swedish Orphan Biovitrum AB BIOVF Synagis palivizumab MEDLEY Phase trial Synagis palivizumab MEDLEY Phase trial Globally approximately million cases acute lower respiratory infections leading three million hospitalizations It estimated inhospital deaths children younger five years Price Action SNY shares AZN shares premarket session last check Friday Â Benzingacom Benzinga provide investment advice All rights reserved The European Medicines Agency EMA granted full Marketing Authorisation AstraZeneca Plc AZN vaccine Vaxzevria Recombinant vaccine Vaxzevria Recombinant Vaxzevria initially granted conditional Marketing Authorisation due urgency pandemic As continues sufficient evidence safety efficacy confirming benefits Vaxzevria EMA granted full approval The approval covers use Vaxzevria primary vaccination series heterologous approved mRNA vaccine homologous vaccine thirddose booster Related AstraZenecaOxford University Partnered Nasal Vaccine Flunks Human Trial AstraZenecaOxford University Partnered Nasal Vaccine Flunks Human Trial Vaxzevria demonstrated effective forms mild symptomatic severe disease including hospitalization death according clinical studies realworld evidence These include expert review data realworld studies showed Vaxzevria available mRNA vaccines provide equally effective protection hospitalization death following three doses There also substantial body evidence supporting boosting Vaxzevria following primary vaccination schedules tested date Price Action AZN shares premarket session last check Tuesday AZN shares premarket session last check Tuesday Photo Paul McManus Pixabay Â Benzingacom Benzinga provide investment advice All rights reserved Astrazeneca Beyfortus receives EU approval AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca NASDAQ stated Beyfortus first singledose RSV passive immunisation broad infant population including born healthy term preterm specific health conditions The group said European Commission first regulatory body grant approval Beyfortus approval based results drug clinical development programme follows recommendation The Committee Medicinal Products Human Use European Medicines Agency September In AZN pivotal MELODY efficacy trial Beyfortus met primary endpoint reducing incidence medically attended lower respiratory tract infections caused RSV versus placebo day single dose Iskra Eric AZN executive vice president vaccines immune therapies said Beyfortus first singledose preventative option respiratory syncytial virus gain approval Europe also first preventative option approved broad infant population Today marketing authorisation Beyfortus marks significant achievement scientific community addresses persistent global unmet need RSV prevention Reporting Iain Gilbert Sharecastcom Read Sharecastcom',\n",
              " 'Â Reuters Jim Cramer Gives His Opinion On AstraZeneca Intuitive Surgical And More ISRG Add toRemove Portfolio AZN Add toRemove Portfolio IXIC Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio IIG Add toRemove Portfolio IX Add toRemove Portfolio On CNBCâs Mad Money Lightning Round Jim Cramer said Energy Corp NYSE UEC speculative stock He added stock big run might get cut half double And typically kinds stocks I recommend Cramer recommended looking Intuitive Surgical Inc NASDAQ daytoday basis You look yeartoyear basis thatâs good machines said The Mad Money host said looked Banco Santander SA NYSE BME multiple times Charitable Trust I canât summon pull trigger Cramer said needs research Atlantica Sustainable Infrastructure plc NASDAQ AY Check premarket coverage Although US Bancorp NYSE USB wellrun bank Cramer prefers Morgan Stanley NYSE NYSE Cramer said market doesnât like Brunswick Corporation NYSE BC doesnât believe come back However commented Iâm trying disagree market I think itâs good company Axon Enterprise Inc NASDAQ AXON wellrun terrific company said When asked AstraZeneca PLC NASDAQ NASDAQ Cramer said I canât chase I think itâs gotten expensive versus good drug companies So Iâm going say take pass Cramer said OneMain Holdings Inc NYSE OMF risky point cycle particularly Fed really give us real slowdown Regions Financial Corporation NYSE NYSE smart well run bank He added Believe wonât stay independent forever stays price Itâs way good Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga',\n",
              " 'AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom AstraZeneca NASDAQ reported Friday first quarter beat analysts forecasts revenue topped expectations AstraZeneca announced earnings per share revenue Analysts polled Investingcom anticipated EPS revenue AstraZeneca shares beginning year trading outperforming start year AstraZeneca shares gained intraday trade report AstraZeneca follows major Healthcare sector earnings month AstraZeneca report follows earnings beat GlaxoSmithKline Wednesday reported EPS revenue compared forecasts EPS revenue Oxford BioMedica missed expectations April first quarter EPS revenue compared forecast EPS revenue Stay uptodate upcoming earnings reports visiting Investingcom earnings calendar AZN Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom AstraZeneca NASDAQ ADR reported Friday first quarter beat analysts forecasts revenue topped expectations AstraZeneca ADR announced earnings per share revenue Analysts polled Investingcom anticipated EPS revenue AstraZeneca ADR shares beginning year trading outperforming start year AstraZeneca ADR follows major Healthcare sector earnings month AstraZeneca ADR report follows earnings beat UnitedHealth April reported EPS revenue compared forecasts EPS revenue JJ beat expectations April first quarter EPS revenue compared forecast EPS revenue Stay uptodate upcoming earnings reports visiting Investingcom earnings calendar Â Reuters Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio CVX Add toRemove Portfolio AZN Add toRemove Portfolio XOM Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio SSEC Add toRemove Portfolio KECR Add toRemove Portfolio BTCUSD Add toRemove Portfolio ETHUSD Add toRemove Portfolio By Laura Sanchez Investingcom Today investors focus important macro data eurozone inflation GDP different European countries We also keep eye corporate earnings season Oil trading higher Cryptocurrencies mixed morning Here five factors investors consider making decisions today CPI GDP data Europe This Friday get inflation data eurozone An increase expected We also follow GDP data Corporate results The corporate earnings season continues Today NYSE NYSE NASDAQ among others present quarterly figures Cryptos hold ground The cryptocurrency sector trading mixed today trading dollars Asia American stock market Positive signs today main Asian indices Hong Kong On Wall Street market closed green yesterday well The closed higher Macroeconomic data Key macroeconomic releases include Spain eurozone In US University released Follow day events economic calendar httpsukinvestingcomeconomiccalendar Â Reuters The Daily Biotech Pulse FDA Approves Bristol Myers Oral Heart Disease Drug European Approval For Merck Keytruda Genocea Restructures Zymeworks Takeover Bid AZN Add toRemove Portfolio IXIC Add toRemove Portfolio Add toRemove Portfolio UZE Add toRemove Portfolio Here roundup top developments biotech space last hours Stocks In Focus Bristol Myers Oral Heart Disease Drug Scores FDA Approval The FDA approved Bristol Myers Squibb Co NYSE BMY Camzyos mavacamten obstructive hypertrophic cardiomyopathy obstructive HCM improve functional capacity symptoms Camzyos first FDAapproved allosteric reversible inhibitor selective cardiac myosin targets underlying pathophysiology obstructive HCM BackToBack European Approval For Merck Keytruda In Various Cancer Indications The European Commission approved Merck Co Inc NYSE MRK Keytruda plus chemo without bevacizumab persistent recurrent metastatic cervical cancer adults whose tumors express Europe also approved Keytruda monotherapy microsatellite instabilityhigh deficient mismatch repair tumors five different types cancer The approval covers patients disease progression following prior treatment platinumcontaining therapy setting candidates curative surgery radiation Zymeworks Confirms Takeover Bid Zymeworks Inc NYSE ZYME confirmed received unsolicited nonbinding proposal All Blue Falcons FZE affiliates purchase company per share The Zymeworks board directors carefully review proposal Shares premarket session Click access Benzinga FDA Calendar Genocea Initiates Restructuring Explores Strategic Alternatives Genocea Biosciences Inc GNCA exploring strategic alternatives engaged professional advisors including investment bank act strategic advisor process The company reduce workforce approximately second quarter reviewing clinical research programs Shares closed lower cents afterhours trading Annovis Bio Inks CRADA Agreement To Develop Pharmacodynamic Biomarkers Buntanetap Annovis Bio Inc NYSE ANVS announced Cooperative Research Development Agreement CRADA National Institute Aging NIA part National Institutes Health Under CRADA NIA Annovis collaborate develop pharmacodynamic biomarkers buntanetap focusing isolating brainderived extracellular vesicles containing potential neuronal function viability biomarkers FDA Removes Clinical Hold On Finch Therapeutics C difficile infection The FDA removed clinical hold Finch Therapeutics Group Inc NASDAQ NASDAQ investigational new drug application orally administered microbiome therapeutic Phase study recurrent C difficile infection The FDA lifted clinical hold following review information Finch provided related screening procedures associated informed consent language Shares trading higher premarket session Aldeyra CFO Transition Aldeyra Therapeutics Inc NASDAQ ALDX CFO Treasurer Joshua Reed tendered resignation pursue career opportunities He continue serve current role May Effective Resignation Date Aldeyra plans appoint current Vice President Controller Bruce Greenberg serve Vice President Finance Interim CFO Treasurer Dosing In Monalizumab Lung Cancer Trial Triggers Payment From AstraZeneca NASDAQ To Innate Pharma Innate Pharma SA NASDAQ IPHA announced AstraZeneca Plc NASDAQ AZN started dosing Phase trial evaluating durvalumab combined monalizumab AstraZeneca oleclumab nonsmall cell lung cancer Insider Trading Vaxxinity Inc NASDAQ VAXX Executive chairman Lou Reese purchased shares Offering Abeona Therapeutics Inc NASDAQ ABEO announced private placement convertible redeemable preferred stock million including million shares Series A convertible redeemable preferred stock shares Series B convertible redeemable preferred stock Each share Series A Series B preferred stock purchase price Each share Series A Series B preferred stock convertible initial conversion price cents per share On The Radar Data Presentation ProQR Therapeutics NV NASDAQ PRQR Several presentations Retinal Cell Gene Therapy Innovation Summit PDUFA Dates The FDA scheduled decide expanded use Supernus Pharmaceuticals Inc NASDAQ SUPN Qelbree viloxazine extendedrelease capsules attentiondeficit hyperactivity disorder ADHD adult patients IPOs Belite Bio Inc NASDAQ BLTE Hillevax Inc NASDAQ HLVX Earnings BristolMyers Squibb Co NYSE NYSE Before Market Open AstraZeneca plc NASDAQ AZN Before Market Open AbbVie Inc NYSE NYSE Before Market Open Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga AZN Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca NASDAQ reported EPS better analyst estimate Revenue quarter came billion versus consensus estimate billion For earnings history earningsrelated data AstraZeneca AZN click By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel Wisniewski AZN Add toRemove Portfolio CHNA Add toRemove Portfolio Add toRemove Portfolio By Natalie Grover Pushkala Aripaka Reuters AstraZeneca vaccine still role play fight pandemic even sales slow company charges places CEO Pascal Soriot said Friday latest drugmaker warn global supply glut The comments come company reported betterthanexpected firstquarter profit sales driven vaccine second bestseller last year raking billion It also confirmed forecast sales shot would fall The vaccine branded Vaxzevria Covishield struggled compete rivals made Pfizer NYSE Moderna NASDAQ using mRNA technology hit setbacks production rare sideeffects relatively limited shelf life Approval United States delayed Soriot said shot seen early pandemic inoculation choice lowincome countries remain relevant easy administer distribute Volume ease though people probably need one booster We longer period scarcity vaccine supply oversupply everywhere around world So needs used course able get better sense reordering said media call Rival Johnson Johnson NYSE month pulled sales forecast vaccine blaming oversupply hesitancy developing countries So far billion shots AstraZeneca NASDAQ vaccine delivered globally In first quarter company recorded billion sales product majority came initial contracts number eclipsed analysts consensus forecast million cited Credit Suisse SIX AstraZeneca shares early afternoon trading underperfoming London bluechip index The company started earning modest profit vaccine initially sold atcost continue selling lowincome countries nonprofit basis Apart vaccine AstraZeneca also treatment Evusheld authorised many regions including United States United Kingdom European Union preventing infections people whose immune system weak respond vaccines The drug generated million firstquarter revenue consensus forecast million cited Credit Suisse Access drug United States limited logistical bottlenecks addressed Soriot said adding Britain one developed countries ordered Evusheld It sad situation quite frankly people immunocompromised really suffering COVID crisis CANCER AstraZeneca unveiled plans open RD centre Cambridge Massachusetts designed serve new headquarters rare disease unit Alexion NASDAQ bought last summer relies cancer drugs third total product sales Even though levels beginning wane access cancer diagnoses treatment still rebounded prepandemic levels Things normalise next months Soriot predicted Meanwhile company pared back expectations China accounted total revenue last year The AngloSwedish drugmaker said expected sales decline midsingledigit percentage largely due impact programme designed bring prices offpatent drugs country The future China believe still strong expect return growth next couple years Soriot said cautioning lockdowns China year could hurt uptake cancer drugs',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel WisniewskiFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio By Natalie Grover LONDON Reuters AstraZeneca NASDAQ Daiichi Sankyo Enhertu extended survival six months patients form advanced breast cancer compared standard chemotherapy according data presented Sunday The data unveiled American Society Clinical Oncology ASCO meeting Chicago could open large new multibilliondollar patient population drug US approval late thirdline treatment breast cancer patients disease The ongoing phase III trial involves patients socalled breast cancer tumours hormonesensitive whose disease spread undergone least one round chemotherapy The interim analysis showed Enhertu prolonged survival additional months patients hormonesensitive tumours Patients group lived median months versus months chemotherapy In small group patients hormoneinsensitive tumours patients Enhertu lived months longer That benefit overall survival apparent even point interim analysis surprising David Fredrickson executive vice president AstraZeneca oncology unit told Reuters That really puts lot confidence benefit seeing absolutely real A host targeted therapies greatly improved prognosis patients advanced breast cancer But half women whose breast cancer spread organs express little referred status limited treatment options Hormonesensitive patients received Enhertu also went average months disease began worsen measure known progression free survival PFS compared months chemotherapy statistically significant Enhertu doubled PFS hormoneinsensitive patients months versus months chemotherapy AstraZeneca discussions regulators globally approval population Jefferies analysts last month forecast billion annual global peak Enhertu sales patients billion across indications The drug administered intravenous infusion without safety concerns It linked type lung scarring called interstitial lung disease ILD Fortyfive Enhertu patients trial varying degrees ILD versus one chemotherapy group Enhertu belongs class therapies called antibody drug conjugates ADC engineered antibodies bind tumour cells release cellkilling chemicals Last month gained approval secondline treatment option study showed reduced risk disease progression death compared Roche Kadcyla standard treatment Enhertu evaluated use earlier stages breast cancer well lung colorectal cancers among others It secured approval gastric cancer As far breast cancer goes I say least next years I pretty sure Enhertu going kind finish revolutionising treatment paradigm Tara Hansen consultant Informa Pharma Custom Intelligence told Reuters Enhertu sales million AstraZeneca secured partial rights Daiichi Sankyo compound three years ago deal worth billion',\n",
              " 'Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor New York Stock Exchange NYSE New York US April REUTERSBrendan McDermid AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Reuters Britain medicines regulator approved AstraZeneca NASDAQ antibodybased treatment preventing infections adults poor immune response marking major step fight pandemic infections surge globally The decision grant approval treatment Evusheld endorsed government independent scientific advisory body Britain Medicines Healthcare products Regulatory Agency MHRA said Thursday Figures showing global rise cases could herald much bigger problem World Health Organization said week warning nations remain vigilant Although Britons age vaccinated two doses immune compromised individuals history severe adverse reactions vaccine may need alternative prevention option While vaccines continue firstline defence know people may respond adequately vaccines MHRA chief June Raine said Vaccines rely intact immune system develop targeted antibodies infectionfighting cells Evusheld contains labmade antibodies designed linger body months contain virus case infection The therapy found cut risk developing symptomatic trials protection lasting least six months single dose MHRA said Evusheld also shown save lives prevent disease progression given within week first symptoms Britain AstraZeneca currently agreement supply Evusheld AstraZeneca statement said hopes see therapy made available Britons quickly possible Evusheld European review authorised United States prevent infections individuals weak immune systems history severe side effects coronavirus vaccines The MHRA said treatment given intramuscular shot administered people infected COVIDcausing virus recent exposure someone virus However regulator cautioned insufficient data evaluate fully Evusheld effectiveness highly contagious Omicron variant adding liaising AstraZeneca AstraZeneca December said lab study found treatment retained neutralising activity Omicron Eli Lilly NYSE Regeneron GSK drugmakers working antibodybased therapies Â Reuters FILE PHOTO A company logo seen AstraZeneca site Macclesfield Britain May REUTERSPhil Noble AZN Add toRemove Portfolio Add toRemove Portfolio By Natalie Grover LONDON Reuters AstraZeneca NASDAQ moved bolster portfolio antibodies Tuesday million licensing deal experimental therapies developed newlylaunched biotech RQ Bio In addition initial sum AngloSwedish drugmaker faces possible royalty payments part exclusive licence develop preclinical COVID antibodies engineered RQ Bio startup said AstraZeneca announced deal size The antibodies include designed target people compromised immune systems AstraZeneca antibody cocktail Evusheld already approved multiple countries The deal gives AstraZeneca rights develop sell six antibodies none tested humans far RQ Bio CEO Hugo Fry said interview Reuters In lab studies antibodies shown work known variants including Omicron said Access fresh crop COVID antibodies bolster AstraZeneca COVID portfolio expecting see rapid decline COVID vaccine sales The AngloSwedish drugmaker vaccine second bestseller last year struggled compete rivals made Pfizer NYSE Moderna NASDAQ hit setbacks production rare sideeffects relatively limited shelf life AstraZeneca Evusheld designed prevent symptomatic COVID infections people unable derive maximum benefit vaccines expected partially offset waning vaccine sales It possible manufacture antibodies proteins latch thwart body assailants foreign viruses bacteria domestic like cancer cells time Their use however limited relatively niche conditions patients certain cancers Fry said More recently particularly COVID crisis unfolded scientific understanding antibodies ability make cheaply consistently increased We tipping point nowwhere use lot broadly said Fry RQ Bio hoping capitalise opportunity scientists anticipate recurrent antiCOVID shots Founded scientists formerly Britain COVID antibody taskforce company launched Tuesday funding AstraZeneca deal It aims make antibodies vulnerable people risk severe disease death range viral infections',\n",
              " 'Â Reuters FILE PHOTO A woman holds small bottle labelled Coronavirus Vaccine sticker medical syringe illustration taken October REUTERSDado Ruvic AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Natalie Grover LONDON Reuters The European health regulator Thursday endorsed use AstraZeneca NASDAQ COVID vaccine Vaxzevria booster The recommendation made committee European Medicines Agency EMA encompasses adults either previously vaccinated Vaxzevria mRNA vaccine ones made Pfizer NYSE BioNTech Moderna NASDAQ The recommendation comes weeks EMA backed use PfizerBioNTech Comirnaty booster adults previously inoculated vaccines Vaccine makers including Pfizer Moderna indicated vaccinations year booster shots first inoculations children still gaining regulatory approvals around world It unclear many boosters needed globally many developed countries already begun roll In countries even second booster campaigns highrisk groups begun Meanwhile vaccine makers also developing variantspecific vaccines Earlier month EMA said hoped vaccines adapted address coronavirus variants Omicron approved September Although Vaxzevria AstraZeneca second best seller last year struggled compete mRNA rivals In late April AstraZeneca CEO Pascal Soriot asserted shot still role fighting pandemic We believe vaccine still potential easy administer distribute said The volume future less people probably need one booster per year everybody take About half EU citizens fully vaccinated boosted received even one vaccine shot said Marco Cavaleri EMA head biological health threats vaccines strategy May',\n",
              " 'By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor New York Stock Exchange NYSE New York US April REUTERSBrendan McDermid AZN Add toRemove Portfolio Add toRemove Portfolio Reuters Drugmaker AstraZeneca NASDAQ said Monday vaccine Vaxzevria approved European Union bloc drugs regulator thirddose booster adults following committee endorsement last week The vaccine used booster following twodose Vaxzevria schedule previously vaccinated mRNA vaccine ones made Pfizer NYSE BioNTech Moderna NASDAQ Ensuring longer duration immune protection essential longterm management globally boosters address waning protection time seen primary vaccine schedules date Mene Pangalos executive vice president biopharmaceuticals RD AstraZeneca said A committee European Medicines Agency endorsed Vaxzevria booster last Thursday weeks regulator backed use PfizerBioNTech Comirnaty booster adults previously inoculated vaccines Several vaccine makers indicated vaccinations year booster shots first inoculations children still gaining regulatory approvals globally Typically final say products use European Union decided European Commission',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel Wisniewski AZN Add toRemove Portfolio Add toRemove Portfolio By Divya Chowdhury Lisa Pauline Mattackal DAVOS Switzerland Reuters Although cancer screening diagnosis hit coronavirus pandemic resulting advances medical technology greater diversity clinical trials could help treatments future AstraZeneca NASDAQ executive said Testing diagnosis rates cancer dropped past two years people skipped routine checkups Dave Fredrickson executive vice president oncology AstraZeneca told Reuters Global Markets Forum Davos What means diagnosing cancer patients late Fredrickson said week cancer outcomes best diagnosed early Efforts minimise patients go healthcare facilities wider adoption telemedicine bringing trials patients rather patients come trials particularly important Fredrickson said Clinical trial diversity one important steps deliver cancer therapies equitable way across globe said Fredrickson said optimistic detection treatment lung breast cancer new drugs treatment plans improved survival rates certain settings Publicprivate partnerships important improving cancer diagnosis survival rates said pointing Egypt strategy tackle prevalent cancers US President Joe Biden revival Cancer Moonshot initiative The programme Obama administration initiative revived Biden February aims improve cancer detection prevention encouraging cancer research This interview conducted Reuters Global Markets Forum Join GMF Refinitiv Messenger',\n",
              " 'By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter',\n",
              " 'Â Reuters The Daily Biotech Pulse Thumbs Down For Acadia Pimavanserin Pfizer Buys Stake In Valneva AstraZeneca Ionis Eplontersen Aces Rare Disease Trial AZN Add toRemove Portfolio PFE Add toRemove Portfolio IXIC Add toRemove Portfolio VLS Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Here roundup top developments biotech space last hours Stocks In Focus FDA AdComm Gives Thumbs Down To Acadia Pimavanserin A panel FDA outside experts voted Acadia Pharmaceuticals Inc ACAD pimavanserin appear effective treating patients psychosis The drug Nuplazid already indicated psychosis Acadia tried failed last year get another FDA approval Alzheimer psychosis Shares premarket session AstraZeneca NASDAQ Ionis Eplontersen Achieves Positive Data In Rare Disease Trial AstraZeneca plc NASDAQ AZN partner Ionis Pharmaceuticals Inc NASDAQ IONS announced positive interim analysis eplontersen hereditary transthyretinmediated amyloid polyneuropathy ATTRvPN In Phase NEUROTTRansform study eplontersen met main goals Eplontersen also showed significantly improved patientreported quality life versus historical placebo group Pharma Giant Pfizer Buys Stake In Valneva Pfizer Inc NYSE NYSE invest million million stake Valneva SE NASDAQ VALN companies updated terms agreement Lyme disease vaccine candidate Under revised deal Valneva fund remaining shared development costs compared Pfizer pay Valneva tiered royalties ranging In addition royalties complemented million milestones payable Valneva based cumulative sales VALN shares premarket session Recursion Pharma Starts LateStage Brain Cancer Trial Of Recursion Pharmaceuticals Inc NASDAQ RXRX initiated Phase trial progressive neurofibromatosis type meningiomas tumors form membrane covers brain spinal cord The trial designed investigate safety efficacy pharmacokinetics The study expected enroll approximately participants Hepion Pharma Liver Cancer Candidate Secures Orphan Drug Tag The FDA granted Orphan Drug Designation Hepion Pharmaceuticals Inc NASDAQ HEPA rencofilstat livertargeting orallyadministered novel cyclophilin inhibitor hepatocellular carcinoma In addition two Phase studies patients NASH remain track initiate patient enrollment Phase study rencofilstat HCC third quarter said Robert Foster Hepion CEO Iktos Zealand Pharma Ink AI Technology Pact For Peptide Drug Design Iktos specialized Artificial Intelligence company new drug design announced research collaboration Zealand Pharma AS NASDAQ ZEAL codevelop generative predictive AI technologies peptide drug design Iktos AI technology based comprehensive datadriven chemical structure generation technology automatically designs virtual novel molecules characteristics successful drug molecule XBiotech Concludes Phase Portion Pancreatic Cancer Study XBiotech Inc NASDAQ XBIT completed Phase portion study Phase evaluate anticancer drug Natrunix combination chemotherapy pancreatic cancer Enrollment Phase portion commencing immediately Key endpoints Phase portion progressionfree survival overall survival timetotreatmentfailure The Phase portion enrolling subjects Midatech Pharma Pediatric Brain Cancer Candidate Gets Orphan Drug Status In Europe The European Medicines Agency granted orphan drug designation Midatech Pharma PLC NASDAQ MTP glioma Midatech developing recurrent glioblastoma adult patients diffuse intrinsic pontine glioma medulloblastoma pediatric patients Edgewise Dystrophy Candidate Lowers Muscle Damage Biomarkers Edgewise Therapeutics Inc NASDAQ EWTX announced interim results ARCH study adults Becker Muscular Dystrophy mg showed significant decrease key biomarkers muscle damage Notably creatine kinase fast skeletal muscle troponin I reduced average respectively All patients subsequently doseescalated mg daily per protocol Clinical ReadoutsPresentations Krystal Biotech Inc NASDAQ KRYS Phase safety immunogenicity results beremagene geperpavec BVEC topical gene therapy dystrophic epidermolysis bullosa Society Investigative Dermatology Annual Meeting Aura Biosciences Inc NASDAQ AURA Final safety efficacy data phase trial choroidal melanoma via intravitreal administration International Society Ocular Oncology On The Radar Earnings Acasti Pharma Inc NASDAQ ACST Before market open Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga',\n",
              " 'Â Reuters Short Volatility Alert AstraZeneca PLC AZN Add toRemove Portfolio Add toRemove Portfolio On Tuesday shares AstraZeneca PLC NASDAQ experienced volatile short activity After activity stock price went The overall sentiment AZN Bullish The signal volatility alert trending Bullish Therefore recommendation Strong Buy The volatility alert produced prior trading date volatility change The current volatility indicator stands Overview The securities lending volatility indicator produced Tidal Markets partnership Benzinga Insights Securities lending primarily serves purpose providing liquidity short sellers When unusual activity occurs securities lending markets acts upstream indicator likely occur downstream regular stock market Understanding Volatility Alert Overall sentiment considered bear broad market activity stock shown indicate negative directional basis considered bull indicating positive directional basis The securities lending volatility indicator provides signal detects unusual short activity Unusual short activity based computer generated algorithmic formula utilizing securities lending trade details volume shares shorted rate paid short shares type collateral posted amongst variables The current volatility respective trading day calculated securities lending volatility value The volatility percentage change percentage difference volatility two recent days The recommendation suggestive strategy inferred strength Signal Trending Current Volatility Volatility Change Recommendations may include Strong Buy Strong Sell Increase Short Exposure Decrease Short Exposure Market Neutral ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE Â Benzingacom Benzinga provide investment advice All rights reserved Read Benzinga Read original article Benzinga',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel WisniewskiFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca said Monday two existing therapies recommended treating patients forms highrisk breast cancers European Union boost company oncology portfolio Lynparza cancer drug developed jointly USbased Merck backed standalone use combination endocrine therapy adults form genetically mutated earlystage breast cancer The drug received similar recommendation United States March key asset AstraZeneca NASDAQ It recommended patients lowtonormal levels protein known target several new therapies Enhertu developed jointly Japan Daiichi Sankyo drug endorsed European Medicines Agency treating aggressive form breast cancer characterised high rate Enhertu seen major growth driver AstraZeneca analysts expecting peaks sales billion The drug also expected cleared patients low levels month recent success trial',\n",
              " 'Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel WisniewskiFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca NASDAQ said Thursday combination cancer drug Imfinzi chemotherapy showed promise latestage trial patients aggressive form lung cancer given surgery Data showed combination effective removing cancer cells tissue samples taken surgery compared chemotherapy patients nonsmall cell lung cancer AngloSwedish drugmaker said The interim result boost company oncology efforts major area focus following disappointing data Imfinzi earlier year another area therapy AstraZeneca added trial would continue planned assess additional main goal eventfree survival interim data would shared health authorities globally Imfinzi belongs immunotherapy class treatments boost body defences fight cancer using antibodies block bind foreign substances body The treatment generated billion sales Engaging immune response Imfinzi surgery exciting new strategy said Susan Galbraith executive vice president oncology RD AstraZeneca Nonsmall cell lung cancer common form lung cancer accounting estimated million new cases disease diagnosed year worldwide according World Health Organization',\n",
              " 'Â Reuters AZN Add toRemove Portfolio GCC Add toRemove Portfolio AML Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading higher In FX markets trading trading The lower trading Todayâs calendar highlights include UK Eurozone Eurozone US Canadian Data UK rose December year earlier according Halifax largest annual increase since July Stocks Royal Dutch Shell LON The remaining billion proceeds Permian divestment distributed form share buybacks pace integrated gas production expected thousand barrels oil equivalent per day Upstream production expected thousand barrels oil equivalent per day Oil products marketing results expected line fourth quarter lower compared third quarter due seasonal trends demand impact due Omicron virus foreign exchange impacts Turkey AstraZeneca LON Entered exclusive global collaboration licence agreement Neurimmune AG investigational human monoclonal antibody currently Phase Ib development treatment transthyretin amyloid cardiomyopathy Under agreement AstraZenecaâs Alexion NASDAQ granted exclusive worldwide licence develop manufacture commercialise Aston Martin Lagonda LON FY wholesales grew Aston Martin Valkyrie Valkyrie AMR Pro vehicles shipped This fewer previously planned accordingly adjusted EBITDA anticipated circa million lower expected An associated reduction depreciation amortisation expected result broadly net neutral impact adjusted operating profit Taylor Wimpey LON Elliott Advisors demanding leadership change Taylor Wimpey told shareholders would back Persimmon LON boss Dave Jenkinson take CEO Times Smiths Group LON Completed sale Smiths Medical ICU Medical Smiths intends return amount representing initial cash proceeds equating billion million shareholders form share buyback programme Smiths initiated programme November purchased million shares date total consideration million Essentra LON Strategic reviews Filters Packaging divisions progressing planned following Board decision become pure play Components business revenue increased YoY like like basis Expects deliver FY operating profit range analysts forecasts Clarkson LON Trading December stronger anticipated underlying profit tax subject audit expected less million CC Group LON Trading September November modestly ahead expectations previously stated guidance In December trading conditions ontrade business significantly impacted renewed government restrictions across UK Ireland The operating profit outcome period affected nature extent duration government restrictions In December CC traded directly ontrade outlets vs delivering volume expectation respectively Lookers LON Expects record underlying profit tax ahead company compiled market consensus million Confident Group remains well positioned capitalise opportunities ahead achieve financial expectations',\n",
              " 'Â Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio ABDN Add toRemove Portfolio BDEV Add toRemove Portfolio AV Add toRemove Portfolio SBRY Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Thursday losses sectors propelled shares lower At close London lost The biggest gainers session Ocado Group PLC LON rose points trade close J Sainsbury PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included Aviva PLC LON lost points trade late trade Barratt Developments PLC LON declined points end Abrdn PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery May fell hit barrel June Brent oil contract fell trade barrel GBPUSD unchanged EURGBP unchanged The US Dollar Index Futures',\n",
              " 'By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter',\n",
              " 'Â Reuters CVX Add toRemove Portfolio LLY Add toRemove Portfolio SBUX Add toRemove Portfolio AZN Add toRemove Portfolio XOM Add toRemove Portfolio CVS Add toRemove Portfolio AMD Add toRemove Portfolio PG Add toRemove Portfolio IXIC Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio By Liz Moyer Investingcom Stocks notched twoday rally investors believe Federal Reserve could slow pace interest rate increases new data showed economy slowed The Fed another points Wednesday stocks rallied anyway especially tech They continued climb Thursday earnings continue pour especially big tech names While news always strong week tech stocks holding On Friday new data inflation form expenditure index come That Fed preferred measure inflation Other data expected show rose June expected rise Earnings continue next week reports AMD NASDAQ Starbucks NASDAQ CVS Health NYSE Eli Lilly NYSE among others Here three things could affect markets tomorrow Oil earnings Big producers reporting tomorrow Chevron Corp NYSE expected report earnings per share billion revenue Exxon Mobil Corp NYSE expected report EPS revenue billion Procter Gamble earnings Procter Gamble Company NYSE expected report earnings per share revenue billion AstraZeneca earnings AstraZeneca NASDAQ expected report EPS cents revenue billion',\n",
              " 'AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom AstraZeneca NASDAQ reported Friday second quarter beat analysts forecasts revenue topped expectations AstraZeneca announced earnings per share revenue Analysts polled Investingcom anticipated EPS revenue AstraZeneca shares beginning year trading outperforming TR UK start year AstraZeneca follows major Healthcare sector earnings month AstraZeneca report follows earnings beat GSK plc Wednesday reported EPS revenue compared forecasts EPS revenue Renalytix AI missed expectations June fourth quarter EPS revenue compared forecast EPS revenue Stay uptodate upcoming earnings reports visiting Investingcom earnings calendar AZN Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom AstraZeneca NASDAQ ADR reported Friday second quarter beat analysts forecasts revenue topped expectations AstraZeneca ADR announced earnings per share revenue Analysts polled Investingcom anticipated EPS revenue AstraZeneca ADR shares beginning year trading outperforming Nasdaq start year AstraZeneca ADR follows major Healthcare sector earnings month AstraZeneca ADR report follows earnings beat UnitedHealth July reported EPS revenue compared forecasts EPS revenue JJ beat expectations July second quarter EPS revenue compared forecast EPS revenue Stay uptodate upcoming earnings reports visiting Investingcom earnings calendar Â Reuters FILE PHOTO Pascal Soriot chief executive pharmaceuticals company AstraZeneca attends interview Reuters Shanghai China November REUTERSBrenda GohFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio FRANKFURT Reuters Longserving AstraZeneca NASDAQ boss Pascal Soriot said Friday expects work new chairmandesignate Londonlisted drugmaker take many years come suggesting ready retire The company said Friday Michel Demare take outgoing Chairman Leif Johansson like Soriot leadership position decade Michel I working together forming excellent team many years come Soriot said analyst call company released quarterly results Â Reuters AstraZeneca follows trend sector upgrade guidance Covid vaccines sales show resilience Add toRemove Portfolio AZN Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca PLC LSENASDAQ followed smaller rival GSK PLC LSEGSK NYSEGSK upgrading guidance full year bumper first half exceeded expectations The key driver outperformance appears sales groupâs Covid vaccine jointly developed University Oxford The drugs giant expected revenues jab decline year reckons flat As result AngloSwedish company reckons top line growth low twenties per cent high teens Core EPS meanwhile grow midtohigh twenties per cent unchanged previous guidance reflects AZâs resolve spend research development first planned Sales six months ended June core per share earnings matching advance While performance vaccines business stood pharma group said oncology franchise also performed strongly âœGiven ongoing performance underlying business contribution medicines updating revenue guidance said chief executive Pascal Soriot âœThis enabled us increase RD investment exciting number pipeline opportunities benefit patients drive longterm sustainable growth companyâ In separate announcement group said former UBS vice chairman current AZ independent director Mark DemarÃ succeed Leif Johansson chairman biggest company Read Proactive Investors UK Disclaimer Â Reuters FILE PHOTO The logo AstraZeneca seen outside North America headquarters Wilmington Delaware US March REUTERSRachel WisniewskiFile Photo GLOBAL BUSINESS WEEK AHEAD AZN Add toRemove Portfolio Add toRemove Portfolio By Natalie Grover Ludwig Burger Reuters AstraZeneca said expected prescriptions COVID therapy drive sales growth year company reported secondquarter profit topped analyst estimates The injection called Evusheld designed protect COVID infection least six months deployed many countries people compromised immune systems see little benefit vaccines The longacting antibody therapy launched December last year generated sales million quarter Realworld evidence shown COVID hospitalisations immunocompromised patients real need Evusheld right finance chief Aradhana Sarin told Reuters The Londonlisted company increased fullyear revenue guidance saying expects rise percentage low twenties rather high teens forecast previously It kept forecast gain adjusted earnings per share midtohigh twenties percentage unchanged partly bigger budget drug research development marketing distribution Evusheld The company also felt impact inflation distribution costs like freight rates CFO Sarin said media briefing Analysts brokerages Jefferies JPMorgan NYSE said investors unlikely impressed earnings outlook shares fell much GMT underperforming STOXX Europe Health Care index slipped Secondquarter adjusted earnings almost doubled cents per share three months ended June revenue billion Analysts average expected profit cents per share revenue around billion Refinitiv data showed On Friday company also said Michel DemarÃ take nonexecutive Chairman Leif Johansson retires next year DemarÃ currently serves chair AstraZeneca NASDAQ remuneration committee Johansson became chairman around time Frenchman Pascal Soriot took charge chief executive The move rules Soriot fended takeover approach Pfizer NYSE chairman candidate As past chairman Syngenta DemarÃ led Swiss crop chemicals maker successful defence unwanted takeover approach US rival Monsanto NYSE resulted agreed acquisition Syngenta ChemChina AstraZeneca said expects increasing sales Evusheld offset decline sales vaccine Vaxzevria developed Oxford University face growing competition The company previously expected Evusheld growth would make decline Vaxzevria sales Sales key market China accounted close fifth sales last year slipped billion lower prices COVID lockdown measures kept patients seeking cancer care Astra bestselling product Tagrisso lung cancer quarterly increase revenues billion sales cardiovascular diabetes treatment Farxiga jumped billion quarter slightly ahead market expectations Â Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio STAN Add toRemove Portfolio BLND Add toRemove Portfolio SVT Add toRemove Portfolio CCL Add toRemove Portfolio OCDO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom â UK equities lower close Wednesday losses sectors propelled shares lower At close London fell The biggest gainers session Standard Chartered PLC LON rose points trade close AstraZeneca PLC LON added points end Severn Trent PLC LON points late trade Biggest losers included Carnival PLC LON lost points trade late trade British Land Company PLC LON declined points end Ocado Group PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP unchanged The US Dollar Index Futures By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter',\n",
              " 'Â Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Britain Aug REUTERSPeter NichollsFile Photo Add toRemove Portfolio AZN Add toRemove Portfolio FTSE Add toRemove Portfolio Add toRemove Portfolio ENRY Add toRemove Portfolio By Sruthi Shankar Reuters UK edged Monday gains drugmaker AstraZeneca NASDAQ consumer stocks relieved pressure mining oil heavyweights data showed China economy unexpectedly slowed last month The bluechip FTSE added hold near highs midcap inched Investors awaiting UK employment report well consumer prices data later week gauge state labour market inflation The data could offer clues whether Bank England opts second consecutive hike September meeting The mood dull Asian European stock markets investors turning defensive sectors healthcare consumer staples amid worries health world secondlargest economy AstraZeneca gained drugmaker said cancer drug Enhertu developed Japan Daiichi Sankyo delayed progression form advanced breast cancer previously treated patients Oil major Shell LON miners Rio Tinto LON Anglo American LON slipped tandem weaker commodity prices release China data OR METL The FTSE outperformed global peers year due large exposure commodity stocks surged back jump oil metal prices A weakening pound also boosted dollar earners index Whether trend continue ultimately hinges outlook global energy stocks relative broad market BCA Research analysts wrote note The FTSE nearly far year MSCI world equities index shed almost Our energy strategists remain bullish oil Their expectation breach average suggests overweight energy sector â extension UK equities â remains appropriate Â Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio By Peter Nurse Investingcom European stock markets largely edged higher Monday starting new week cautious note investors digested weak Chinese economic data By ET GMT Germany traded lower France rose UKâs traded higher Economic data released earlier Monday showed Chinaâs economic growth rate unexpectedly slowing July prompting countryâs central bank surprise move grew July year earlier growth rate increase expected rose year ago missing forecasts growth growth seen June China economy worldâs second largest struggling shake June quarter hit growth strict COVID restrictions On flip side back Europe Denmarkâs economy grew faster expected second quarter expanding first three months year contracted first quarter The raised interest rates halfpoint July expected September even though risk Eurozone recession reached highest level since November energy shortages threaten drive already record inflation higher still In corporate news AstraZeneca LON NASDAQ stock rose drugmaker said cancer drug Enhertu delayed progression form advanced breast cancer previously treated patients boosting prospects regulatory approvals Henkel ETR stock rose German consumergoods company said sales rose first half year earnings fell hurt increasing rawmaterial logistics prices Oil prices fell Monday weighed potential increase supply oil giant Saudi Aramco TADAWUL well concerns slowing growth China world secondlargest economy Saudi Aramco stands ready raise crude oil output maximum capacity million barrels per day requested Saudi Arabian government Chief Executive Amin Nasser said Sunday stateowned energy firm announced one largest quarterly profits history By ET futures traded lower barrel contract fell Additionally fell traded lower',\n",
              " 'AVEPp Add toRemove Portfolio ROG Add toRemove Portfolio RHHVF Add toRemove Portfolio SNY Add toRemove Portfolio AZN Add toRemove Portfolio SASY Add toRemove Portfolio By Scott Kanowsky Investingcom Sanofi SA EPA shares slid Wednesday French drugmaker announced halt trials new treatment patients battling advanced breast cancer In statement company said would stop global clinical development medicine known amcenestrant phase study showed effective enough warrant research All studies amcenestrant including earlystage breast cancer also discontinued Sanofi added âœWhile disappointed outcome research scientific understanding endocrine therapies people breast cancer said John Reed global head research development Sanofi In note analysts Morgan Stanley called decision setback innovation narrative put forward Sanofi saying amcenestrant flagged potentially lucrative piece group drug pipeline The end Sanofi amcenestrant trials expected lead negative impact company estimated discounted cash flow according Morgan Stanley analysts The decision could also knockon effect studies conducted similar breast cancer drugs Sanofi rivals Roche SIX AstraZeneca PLC LON analysts added',\n",
              " 'Â Reuters FILE PHOTO Pascal Soriot chief executive pharmaceuticals company AstraZeneca attends interview Reuters Shanghai China November REUTERSBrenda GohFile Photo AZN Add toRemove Portfolio Add toRemove Portfolio By Aimee Donnellan Natalie Grover LONDON Reuters AstraZeneca NASDAQ may stay vaccine business long run CEO told Reuters Tuesday showing quickly fortunes changed drugmaker produced one first shots since lost rivals Production delays probes regulators following rare cases severe side effects concerns relatively short shelf life compared shots stymied adoption company vaccine Now third year pandemic amid global vaccine supply glut use diminished much developed world countries inoculated large numbers people prefer Pfizer NYSE Moderna NASDAQ mRNA vaccines boosters AstraZeneca COVID vaccine still US approval The Londonlisted company building portfolio antibody therapies including respiratory virus RSV viruses Soriot said Reuters Newsmaker interview Tuesday But future COVID vaccines business said I ca sure He also said sure AstraZeneca would broaden roster vaccines infections either adding company looking Investors speculated future vaccine business given slowing sales COVID shot initial sales contracts fulfilled stiff competition mRNA vaccines relatively little expertise field The company created separate division vaccines antibody therapies late last year Still Soriot said regret company work Oxford University develop COVID vaccine given delivered billions doses saved estimated million lives across globe The inoculation AstraZeneca second bestselling product sales billion AstraZeneca also looking bolton acquisitions including small midsized companies specialising oncology cardiovascular treatments Soriot added We always look external opportunities said KEEP ON DOING THIS JOB The CEO presided quadrupling AstraZeneca share price decade helm I keep job many years said The old seen natural successor outgoing Chairman Leif Johansson But July Soriot quashed speculation planning retire time soon saying expected work company newly announced chairmandesignate Michel Demare many years come Soriot tasked turning around troubled AstraZeneca hit string key patent losses spate clinical trial failures October following stint pharma peer Roche With Frenchman helm fortunes AngloSwedish drugmaker changed dramatically He sharpened focus speciality medicines lucrative field oncology made acquisitions refill company medicine cabinet fended hostile takeover US pharma giant Pfizer invested heavily RD improve company lacklustre drug development success rate However warned Tuesday fewer new medicines would developed going forward due US drug price laws passed last week Asked inflationary pressures Soriot said We going become innovative productive We ca expect selling prices go Sales China account close fifth company total annual revenue dipped recent quarters due lower drug prices COVID lockdown measures kept patients diagnosed seeking cancer care On Tuesday Soriot said sales picking third quarter world secondlargest market pharmaceuticals expected country play significant role global market next decade Graphic AstraZeneca shares CEO Soriot helm httpsfingfxthomsonreuterscomgfxmktzjvqkblqgvxAZPNG',\n",
              " 'Â Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor New York Stock Exchange US April REUTERSBrendan McDermid AZN Add toRemove Portfolio Reuters said Friday drug preventing infant RSV Beyfortus nirsevimab recommended approval European Union European Medicines Agency committee The drugmaker also said Beyfortus approved would become first protective option newborn infant population RSV lower respiratory tract disease Â Reuters People pose syringe needle front displayed AstraZeneca logo illustration taken December REUTERSDado RuvicIllustrationFiles AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Natalie Grover LONDON Reuters Europe medicines regulator backed using AstraZeneca NASDAQ preventative therapy treatment disease also endorsed another medicine preventative option another common virus The regulator recommendations usually followed European Commission takes final decision drug approvals AstraZeneca said Friday European Medicines Agency EMA backed Evusheld treatment adults adolescents COVID need supplemental oxygen increased risk disease worsening Last month Japan became first country approve longacting antibody treatment COVID making Evusheld first therapy authorised prevention treatment viral disease Evusheld previously largely secured global approvals including Europe preventative therapy people compromised immune systems see little benefit COVID vaccines AstraZeneca leaning Evusheld help offset tepid sales COVID vaccine rapidly lost ground mRNA shots fight rapidly evolving virus Evusheld first launched December generated million first half AngloSwedish drugmaker Separately Friday EMA also endorsed AstraZeneca partner Sanofi EPA experimental longacting therapy Beyfortus prevention lower respiratory tract infections caused respiratory syncytial virus RSV RSV causes thousands hospitalisations deaths globally year toddlers elderly complex molecular structure virus safety concerns stymied efforts develop vaccine since virus first discovered But one therapy Synagis also developed AstraZeneca sold Swedish Orphan Biovitrum United States It designed prevent lower respiratory tract infections caused RSV highrisk infants requires five injections cover typical RSV season Meanwhile Beyfortus approved would first singledose preventative RSV therapy broad infant population including born healthy deemed highrisk first RSV season',\n",
              " 'Â Reuters AstraZeneca says Evusheld approved treatment EU AZN Add toRemove Portfolio Add toRemove Portfolio said longacting antibody combination Evusheld tixagevimab cilgavimab formerly approved EU treatment The approval European Commission covers people age years require supplemental oxygen increased risk progressing severe pharmaceuticals group said The European Commissionâs approval based results TACKLE phase III treatment trial showed Evusheld significantly reduced risk severe death The recommended dose Evusheld treatment Europe tixagevimab cilgavimab administered two separate sequential IM injections AstraZeneca NASDAQ noted Many people including immunocompromised older adults underlying health conditions high risk severe disease hospitalisation death become infected Evusheld delivered convenient intramuscular formulation muchneeded new treatment option vulnerable populations commented Dr Michel Goldman professor Institute Interdisciplinary Innovation Healthcare UniversitÃ Libre de Bruxelles former executive director European Innovative Medicines Initiative statement Iskra Reic executive vice president vaccines immune therapies AstraZeneca added remains ongoing health concern millions Europeans around world especially may wellprotected virus vaccination With approval Evusheld longacting antibody combination available prevention treatment Europe allowing us protect even people devastating disease Read Proactive Investors UK Disclaimer',\n",
              " 'By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter',\n",
              " 'Â Reuters AstraZeneca gets third regulatory green light matter weeks asthma drug AZN Add toRemove Portfolio Add toRemove Portfolio AstraZeneca PLC LON said Tezspire treatment approved Japan severe bronchial asthma highdose traditional corticosteroids donât work It third approval matter weeks product potential challenger market leader Dupxient It developed collaboration US giant Amgen NASDAQ In clinical trials drug shown lower researchers called âasthma exacerbationsâ Tezspire first biologic approved Japanese Ministry Health Labour Welfare shown consistently significantly reduce attacks exacerbation trials broad population severe asthma patients irrespective biomarker levelsâ Mene Pangalos head biopharmaceutical research AZ âœTezspire potential improve outcomes many patients severe asthma working make important medicine available Japan quickly possibleâ Analysts believe Tezspire could big seller peak sales projected order Read Proactive Investors UK Disclaimer',\n",
              " 'Â Reuters FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Julie Steenhuysen Carl Vishwadha Chander Reuters AstraZeneca Plc L resumed US trial experimental vaccine approval regulators Johnson Johnson N preparing resume trial Monday Tuesday companies said Friday The news signaled progress novel coronavirus infected million globally including million Americans comes days US presidential election may hinge plans fight pandemic AstraZeneca one leading vaccine developers paused US trial Sept report serious neurological illness believed transverse myelitis participant company UK trial JJ paused large latestage trial last week study participant became ill Both companies contracts provide vaccine United States governments cleared regulators Officials experts expressed concern regulatory approval process overseen Food Drug Administration FDA undermined political pressure around quarter Americans say hesitant take vaccine As trial resumes I hoping message communicated public following procedures highest ethical standard interfering FDA regulatory process said Matthew Hepburn head vaccine development Operation Warp Speed publicprivate partnership speed inoculation efforts Infections rising countries httpsgraphicsreuterscomworldcoronavirustrackerandmapsindexhtml people northern hemisphere spend time indoors winter approaching JJ said Friday safety panel called Data Safety Monitoring Board recommended drugmaker resume trial recruitment finding evidence vaccine caused volunteer fall ill JJ expects resume trial United States Monday Tuesday remains track produce data trial vaccines effectiveness end early JJ chief scientific officer Paul Stoffels said JJ also discussions regulators resume trial outside United States company said So far medical board identified clear cause patients illness JJ reveal details patient sickness patient privacy rules Stoffels said AstraZeneca said unusual trial participants fall ill large scale vaccine trials US Food Drug Administration reviewed safety data trials globally deemed safe continue testing vaccine AstraZeneca trials United Kingdom Brazil South Africa resumed last month even US Food Drug Administration continued investigation case Reuters earlier week reported FDA completed review AstraZeneca US trial set resume early week citing four sources familiar situation AstraZeneca vaccine developed along researchers Oxford University',\n",
              " 'AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings By Benzinga With ongoing layoff fiasco happening Twitter cofounder Jack Dorsey come forward take responsibility saying one blame In recent Twitter AstraZeneca PLC said Wednesday Capivasertib plus Faslodex significantly improved progressionfree survival compared Faslodex combined placebo Phase trial advanced hormone receptorpositive breast cancer The AngloSwedish pharma giant AZN AZN said trial met primary endpoints improving progressionfree survival overall patient population prespecified biomarker subgroup patients whose tumors qualifying alterations',\n",
              " 'AstraZeneca Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain Spinal Cord',\n",
              " 'Â Reuters BATS Add toRemove Portfolio AZN Add toRemove Portfolio FTNMX Add toRemove Portfolio BTI Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Samuel Indyk Investingcom â At trading lower In FX markets trading trading The trading Todayâs calendar highlights include Data UK grew still prepandemic peak seen Analysts expected GDP grow quarter In December declined âœGDP fell back slightly December Omicron wave hit retail hospitality seeing biggest impactsâ ONS Director Economic Statistics Darren Morgan said âœHowever partially offset increases Test Trace service vaccination programmesâ Stocks British American Tobacco LON FY adjusted revenue billion Revenue new categories Adjusted profit operations includes negative transactional FX impact Increased dividend pence per share Announced billion share repurchase programme Outlook constant currency revenue growth Highsingle figure constant currency adjusted EPS growth growth second half weighted AstraZeneca LON AstraZeneca ADRs NASDAQ become member prior market open February replacing Xilinx Tate Lyle LON revenue continuing operations trading line expectations The outlook financial year total operations current Tate Lyle remains unchanged performance continuing operations expected stronger discontinued operations weaker Deliveroo LON Partnered Waitrose rapid âœHopâ delivery service Victrex LON group revenue million group sales volume tonnes Expectations full year unchanged Helios Towers LON Longstop date acquisition Omantelâs passive tower infrastructure portfolio extended July Lancashire Holdings LON gross premiums written increased yearonyear record billion Final dividend declared per common share']"
            ]
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 629
        },
        "id": "HAklFEHTM-6O",
        "outputId": "f1bd73c1-3c42-4727-85e2-12488bab8197"
      },
      "source": [
        "# Create column for filtered articles with stopwords removed\n",
        "\n",
        "article_sentiments['filtered_articles_joined'] = filtered_articles_joined\n",
        "article_sentiments.head()"
      ],
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         Date  Adj Close Next  Label    Open         High     Low   Close  \\\n",
              "0  2020-01-10     7070.484375      1  7690.0  7717.000000  7608.0  7645.0   \n",
              "1  2020-02-10     7105.605957      0  7659.0  7710.000000  7610.0  7710.0   \n",
              "2  2020-03-12     5955.197266      1  6692.0  6778.000000  6314.0  6314.0   \n",
              "3  2020-05-11     8350.098633      1  8549.0  8719.000000  8522.0  8707.0   \n",
              "4  2020-06-10     7803.232422      0  8237.0  8444.219727  8170.0  8404.0   \n",
              "\n",
              "     Adj Close   Volume  Unnamed: 0  ...    neg    neu    pos compound  \\\n",
              "0  7065.863770  1020795         331  ...  0.073  0.900  0.027  -0.9274   \n",
              "1  7125.938965  1136979         324  ...  0.058  0.872  0.070   0.7218   \n",
              "2  5953.311523  4529777         248  ...  0.055  0.900  0.045  -0.3612   \n",
              "3  8209.611328  1908220         283  ...  0.028  0.895  0.077   0.9566   \n",
              "4  7923.920410  2515293         310  ...  0.000  0.965  0.035   0.6486   \n",
              "\n",
              "                                       news_combined  \\\n",
              "0  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "1  2/2 Â© Reuters. FILE PHOTO: Small toy figures ...   \n",
              "2  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "3  Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...   \n",
              "4  Â© Reuters. FILE PHOTO: A sign is pictured out...   \n",
              "\n",
              "                                        news_cleaned  subjectivity  polarity  \\\n",
              "0  Â Reuters    UK100 203 Add toRemove from a Por...      0.381333  0.045438   \n",
              "1  22 Â Reuters FILE PHOTO Small toy figures are ...      0.335507  0.077174   \n",
              "2  Â Reuters    UK100 203 Add toRemove from a Por...      0.539865  0.118784   \n",
              "3  Â Reuters    AVV 016 Add toRemove from a Portf...      0.425210  0.096054   \n",
              "4  Â Reuters FILE PHOTO A sign is pictured outsid...      0.321625  0.080579   \n",
              "\n",
              "   sentiment                           filtered_articles_joined  \n",
              "0          1  Â Reuters Add toRemove Portfolio SHEL Add toRe...  \n",
              "1          0  Â Reuters FILE PHOTO Small toy figures seen fr...  \n",
              "2          1  Â Reuters Add toRemove Portfolio AZN Add toRem...  \n",
              "3          1  Â Reuters AVV Add toRemove Portfolio TRNT Add ...  \n",
              "4          0  Â Reuters FILE PHOTO A sign pictured outside P...  \n",
              "\n",
              "[5 rows x 25 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-caf37cfa-62da-46b3-815f-38c0e2a909b1\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Date</th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>...</th>\n",
              "      <th>neg</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "      <th>sentiment</th>\n",
              "      <th>filtered_articles_joined</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2020-01-10</td>\n",
              "      <td>7070.484375</td>\n",
              "      <td>1</td>\n",
              "      <td>7690.0</td>\n",
              "      <td>7717.000000</td>\n",
              "      <td>7608.0</td>\n",
              "      <td>7645.0</td>\n",
              "      <td>7065.863770</td>\n",
              "      <td>1020795</td>\n",
              "      <td>331</td>\n",
              "      <td>...</td>\n",
              "      <td>0.073</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.027</td>\n",
              "      <td>-0.9274</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.381333</td>\n",
              "      <td>0.045438</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters Add toRemove Portfolio SHEL Add toRe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2020-02-10</td>\n",
              "      <td>7105.605957</td>\n",
              "      <td>0</td>\n",
              "      <td>7659.0</td>\n",
              "      <td>7710.000000</td>\n",
              "      <td>7610.0</td>\n",
              "      <td>7710.0</td>\n",
              "      <td>7125.938965</td>\n",
              "      <td>1136979</td>\n",
              "      <td>324</td>\n",
              "      <td>...</td>\n",
              "      <td>0.058</td>\n",
              "      <td>0.872</td>\n",
              "      <td>0.070</td>\n",
              "      <td>0.7218</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: Small toy figures ...</td>\n",
              "      <td>22 Â Reuters FILE PHOTO Small toy figures are ...</td>\n",
              "      <td>0.335507</td>\n",
              "      <td>0.077174</td>\n",
              "      <td>0</td>\n",
              "      <td>Â Reuters FILE PHOTO Small toy figures seen fr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2020-03-12</td>\n",
              "      <td>5955.197266</td>\n",
              "      <td>1</td>\n",
              "      <td>6692.0</td>\n",
              "      <td>6778.000000</td>\n",
              "      <td>6314.0</td>\n",
              "      <td>6314.0</td>\n",
              "      <td>5953.311523</td>\n",
              "      <td>4529777</td>\n",
              "      <td>248</td>\n",
              "      <td>...</td>\n",
              "      <td>0.055</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.045</td>\n",
              "      <td>-0.3612</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.539865</td>\n",
              "      <td>0.118784</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters Add toRemove Portfolio AZN Add toRem...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2020-05-11</td>\n",
              "      <td>8350.098633</td>\n",
              "      <td>1</td>\n",
              "      <td>8549.0</td>\n",
              "      <td>8719.000000</td>\n",
              "      <td>8522.0</td>\n",
              "      <td>8707.0</td>\n",
              "      <td>8209.611328</td>\n",
              "      <td>1908220</td>\n",
              "      <td>283</td>\n",
              "      <td>...</td>\n",
              "      <td>0.028</td>\n",
              "      <td>0.895</td>\n",
              "      <td>0.077</td>\n",
              "      <td>0.9566</td>\n",
              "      <td>Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...</td>\n",
              "      <td>Â Reuters    AVV 016 Add toRemove from a Portf...</td>\n",
              "      <td>0.425210</td>\n",
              "      <td>0.096054</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters AVV Add toRemove Portfolio TRNT Add ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>2020-06-10</td>\n",
              "      <td>7803.232422</td>\n",
              "      <td>0</td>\n",
              "      <td>8237.0</td>\n",
              "      <td>8444.219727</td>\n",
              "      <td>8170.0</td>\n",
              "      <td>8404.0</td>\n",
              "      <td>7923.920410</td>\n",
              "      <td>2515293</td>\n",
              "      <td>310</td>\n",
              "      <td>...</td>\n",
              "      <td>0.000</td>\n",
              "      <td>0.965</td>\n",
              "      <td>0.035</td>\n",
              "      <td>0.6486</td>\n",
              "      <td>Â© Reuters. FILE PHOTO: A sign is pictured out...</td>\n",
              "      <td>Â Reuters FILE PHOTO A sign is pictured outsid...</td>\n",
              "      <td>0.321625</td>\n",
              "      <td>0.080579</td>\n",
              "      <td>0</td>\n",
              "      <td>Â Reuters FILE PHOTO A sign pictured outside P...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 25 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-caf37cfa-62da-46b3-815f-38c0e2a909b1')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-caf37cfa-62da-46b3-815f-38c0e2a909b1 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-caf37cfa-62da-46b3-815f-38c0e2a909b1');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 12
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "z7opROsG8YJl"
      },
      "source": [
        "# Extract the filtered articles and labels as numpy ndarrays\n",
        "\n",
        "articles = article_sentiments.filtered_articles_joined.values\n",
        "labels = article_sentiments.Label.values"
      ],
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "LsbdxbjIJAG2"
      },
      "source": [
        "## 6. BertTokenizer\n",
        "\n",
        "Machine learning models don't work with raw text so we need to transform the dataset into a format BERT can be trained on. \n",
        "\n",
        "To feed our text into BERT, it must be split into tokens, and then these tokens must be mapped to their index in the tokeniser vocabulary.\n",
        "\n",
        "We will load a pre-trained BertTokenizer to perform the tokenisation using the “bert-base-uncased” version of the tokeniser model which is trained on lower case English text, and tokenised using WordPiece (sub-word segmentation algorithm) and a vocabulary size of 30,000.\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Initialize tokeniser\n",
        "tokenizer = BertTokenizer.from_pretrained('bert-base-uncased', do_lower_case=True) "
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 113,
          "referenced_widgets": [
            "a8e7a1d7066a4b4f987f45eccc9e8614",
            "b2f1cc1759aa4a9da35bdb94042aff13",
            "3aaf7f75bdd243beb591b3165a322611",
            "3ea5569b317d49bdb301cc1cba91e69c",
            "2e838c7166a64a988f15e7f7c426285b",
            "e1c32d724c1945e5b7ad314a9c43cf5e",
            "a0e057a0b0ce4d119ee79c949475808a",
            "f8540b1e39924dcb917d9551ef956215",
            "1dd5dc9d2bbb45eab30f024ae3a66a36",
            "db01d1793f77498dbc93900872090dc8",
            "f9a250341cb34bf2bc4a3b8619e40cb3",
            "221d707cc39440f69c9d81f2c2a1c372",
            "b335cdb18d2e43438546932d7a554761",
            "96569e7d1d1d4c3a9bf2b5eb41d161b2",
            "f98fa073d1d747a9a7e12745f535a60c",
            "43390a4f7cf840b3ada0917ab7345aa6",
            "a991d231640a4e26979bb2573a4ac991",
            "65a62a5dda2d4f5bb3f6cb11811f808f",
            "468e1019166649e783e8f18ec67297b6",
            "4c31e7bda81548f2a2cfac3e6b989c72",
            "cd6f05bc0f384a81bf5d03b4efa70d45",
            "e2e239c656fd4b43b24004b56d7b3535",
            "098a64b1364148d1b650e72ae1a30d55",
            "f9c013b0e6a34817b23c4f367091d48e",
            "253a6cffbc7c46168b43e27fb2db6840",
            "d2f14e36573340b5bee69e99e23e9b80",
            "9516bd39c3e54a4db5fc467b824a178a",
            "11c780bfab9a4be59180baa1ee3fc433",
            "24b53ff5032347c8b10345e7dc642eab",
            "ff0521d4fe0440b09d9232eb0d5914c8",
            "a259597da2604f98a2b865aee74a4e23",
            "dede65bed46b41568704d65c7c7bbbe4",
            "77374a00c0bc4fd583a3f4cb838041d7"
          ]
        },
        "id": "Gs0JfS5gkyFr",
        "outputId": "24f26686-5056-4d7e-9d5e-1c47996cac15"
      },
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading:   0%|          | 0.00/232k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "a8e7a1d7066a4b4f987f45eccc9e8614"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading:   0%|          | 0.00/28.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "221d707cc39440f69c9d81f2c2a1c372"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading:   0%|          | 0.00/570 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "098a64b1364148d1b650e72ae1a30d55"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aA7k8zFzOmFj",
        "outputId": "448acf27-9391-48b9-f947-a2312773b209"
      },
      "source": [
        "# Print the original unfiltered article still with non-alpha characters\n",
        "print(' Original: ', article_sentiments.news_cleaned[0])"
      ],
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            " Original:  Â Reuters    UK100 203 Add toRemove from a Portfolio SHEL 077 Add toRemove from a Portfolio AZN 056 Add toRemove from a Portfolio RR 617 Add toRemove from a Portfolio SN 130 Add toRemove from a Portfolio NG 039 Add toRemove from a Portfolio HBR 142 Add toRemove from a Portfolio DLAR 010 Add toRemove from a Portfolio    Oct 1 Reuters  Britain's FTSE 100   index is seen opening 25 points higher at 5891 on Thursday according to financial bookmakers with futures up 047 ahead of cash market open    Smith  Nephew Medical prosthetics maker Smith  Nephew Plc   expects its decline in underlying revenue in the third quarter of this year down from almost 30 in the previous three months when it was suffering heavily from the impact of coronavirus lockdowns and a halt in elective procedures    RollsRoyce Britain's RollsRoyce   said it planned to from shareholders 1 billion pounds from the bond market and secure further loans to rebuild its balance sheet after COVID19    Premier Oil Creditors of North Seafocused Premier Oil   have extended a waiver for the group's debt covenant test  giving it breathing space to avoid a debt crunch the company said on Thursday    De La Rue Banknote printer De La Rue   on Thursday named Rob Harding after appointing him as the interim CFO earlier this year    National Grid National Grid   on Thursday pledged to by 2030 which will see it reduce emissions relating to the gas and electricity it sells in markets such as the United States and Britain    AstraZeneca The US Food and Drug Administration has of a serious illness in AstraZeneca Plc's   COVID19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists three sources familiar with the details told Reuters    Woodford The collapsed Woodford equity income fund has 288 million pounds in remaining assets its authorised corporate director said on Wednesday    The UK bluechip index   closed 05 lower on Wednesday after a bleak production forecast from Shell   and losses in consumer stocks weighed on the index Â Reuters FILE PHOTO A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken    AZN 056 Add toRemove from a Portfolio PFE 140 Add toRemove from a Portfolio JNJ 045 Add toRemove from a Portfolio MRNA 740 Add toRemove from a Portfolio    By Marisa Taylor and Dan Levine    WASHINGTON Reuters  The US Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's L  COVID19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists three sources familiar with the details told Reuters    AstraZeneca's large latestage US trial has remained on hold since Sept 6 after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis    The widened scope of the FDA probe raises the likelihood of additional delays for what has been one of the most advanced COVID19 vaccine candidates in development The requested data was expected to arrive this week after which the FDA would need time to analyze it two of the sources said    Effective vaccines are seen as essential to help end a pandemic that has killed more than one million people worldwide    The administration of President Donald Trump has pledged 12 billion to support development of the AstraZeneca vaccine and secure 300 million doses for the United States Other leading companies in the US vaccine race include Pfizer Inc N  Moderna Inc O  and Johnson  Johnson N     Regulators in the UK Brazil India and South Africa have allowed AstraZeneca to resume its clinical trials there    The FDA however wants to determine whether similar side effects emerged in trials of other vaccines designed by AstraZeneca's coronavirus vaccine partner researchers at Oxford University the sources said That does not mean the agency believes there were safety issues associated with any of these vaccines they added    It just shows that the FDA is being thorough said one of the sources    Further complicating the situation is that the data requested by FDA is in a different format than what the US regulator requires two of the sources said    The FDA declined to comment on discussions involving an experimental product Oxford did not respond to requests for comment AstraZeneca in a statement said We are continuing to work with the FDA to facilitate review of the information needed to make a decision regarding resumption of the US trial    VIRAL VECTOR    All of the vaccines it wants to review use a modified adenovirus as vectors to safely deliver genetic material from the target illnesses  flu Middle East Respiratory Syndrome and other diseases  into the body to stimulate an immune system response to fight future infection    While other vaccine developers have used human adenoviruses for such vaccines the Oxford researchers chose an adenovirus found in chimpanzees They felt this would reduce the likelihood that an individual's immune system would attack the vector virus due to prior exposure rather than the intended target    Reuters reviewed six research papers that detailed safety data of vaccines using the engineered chimpanzee adenovirus called ChAdOx1 for diseases including tuberculosis prostate cancer and influenza    In one of those trials one serious adverse event cited by researchers was deemed unrelated to the vaccine    The type of review being conducted by the FDA is generally intended to scrutinize raw data for other side effects the sources said    The US government's effort to speed development of a COVID19 vaccine  and promises by Trump that one could be available prior to the Nov 3 presidential election  has led to concerns of political interference in the regulatory process at the expense of safety The FDA has denied this    AstraZeneca's vaccine development could also be slowed by a change to its clinical trial protocols to show that it has met predetermined safety and efficacy standards    Independent safety monitors will conduct their first review of the vaccine's safety and effectiveness after 75 trial subjects become infected with COVID19 up from the original initial review plan after about 40 infections according to a Reuters review of protocol documents issued in July and amended in midSeptember    The safety monitors could decide to stop the trial if the vaccine proves either highly effective and therefore should be considered for public use before the trial concludes or if serious safety problems appear    Safety is likely to have been a major reason for the change said Thomas Lumley chair of biostatistics at the University of Auckland who was not involved with the study    AstraZeneca would not say why it had made the change to its protocol Â Reuters A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken    GILD 111 Add toRemove from a Portfolio AZN 056 Add toRemove from a Portfolio    Reuters  The European health regulator said on Thursday it had started a rolling review of the experimental COVID19 vaccine from AstraZeneca L  and Oxford University in a move aimed at speeding up any future approval process    The European Medicines Agency EMA said its human medicines committee had started evaluating the first batch of data on the vaccine and will continue till sufficient data is available and a formal application is submitted https    The news raises the chances of the vaccine being the first to be approved in the region and comes just weeks after several global trials of the vaccine were halted due to an unexplained illness in a study participant    US trials are still under review with regulators widening their probe Reuters reported on Wednesday    This EMA's review does not mean that a conclusion can be reached yet on the vaccine's safety and effectiveness as much of the evidence is still to be submitted to the committee the watchdog said    Earlystage data in July showed the vaccine elicited immune responses in clinical trials and produced no serious side effects with the strongest response seen in people who received two doses Data on latestage trials are expected soon    The EMA would make final recommendations once the review is completed to the European Commission which has the ultimate say over approvals The commission typically follows EMA endorsements    The EMA began a similar realtime review of Gilead's O  Veklury as a treatment for COVID19 earlier this year and the antiviral treatment was given conditional approval for use just months later in July\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Printing out the original unfiltered article shows the non-alpha characters such as dates and quantities before these were removed by filtering. We will now print out a filtered version for comparison and run the pre-trained BertTokenizer on the filtered version just to see the output which will convert the text to tokens and tokens to unique integers (ids)."
      ],
      "metadata": {
        "id": "AEtB4cChfIzC"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_YZ6iUwprypi",
        "outputId": "95a4d8cb-a0e0-40d7-e3a5-fb6383bd5459"
      },
      "source": [
        "# Apply the tokeniser to one article just to see the output.\n",
        "\n",
        "# Print the filtered article.\n",
        "print('Filtered: ', filtered_articles_joined[0])\n",
        "\n",
        "# Print the article split into tokens.\n",
        "print('Tokenized: ', tokenizer.tokenize(filtered_articles_joined[0]))\n",
        "\n",
        "# Print the article mapped to token ids.\n",
        "print('Token IDs: ', tokenizer.convert_tokens_to_ids(tokenizer.tokenize(filtered_articles_joined[0])))"
      ],
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Filtered:  Â Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio NG Add toRemove Portfolio HBR Add toRemove Portfolio DLAR Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open Smith Nephew Medical prosthetics maker Smith Nephew Plc expects decline underlying revenue third quarter year almost previous three months suffering heavily impact coronavirus lockdowns halt elective procedures RollsRoyce Britain RollsRoyce said planned shareholders billion pounds bond market secure loans rebuild balance sheet Premier Oil Creditors North Seafocused Premier Oil extended waiver group debt covenant test giving breathing space avoid debt crunch company said Thursday De La Rue Banknote printer De La Rue Thursday named Rob Harding appointing interim CFO earlier year National Grid National Grid Thursday pledged see reduce emissions relating gas electricity sells markets United States Britain AstraZeneca The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production forecast Shell losses consumer stocks weighed index Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Marisa Taylor Dan Levine WASHINGTON Reuters The US Food Drug Administration broadened investigation serious illness AstraZeneca Plc L vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters AstraZeneca large latestage US trial remained hold since Sept study participant Britain fell ill believed rare spinal inflammatory disorder called transverse myelitis The widened scope FDA probe raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United States Other leading companies US vaccine race include Pfizer Inc N Moderna Inc O Johnson Johnson N Regulators UK Brazil India South Africa allowed AstraZeneca resume clinical trials The FDA however wants determine whether similar side effects emerged trials vaccines designed AstraZeneca coronavirus vaccine partner researchers Oxford University sources said That mean agency believes safety issues associated vaccines added It shows FDA thorough said one sources Further complicating situation data requested FDA different format US regulator requires two sources said The FDA declined comment discussions involving experimental product Oxford respond requests comment AstraZeneca statement said We continuing work FDA facilitate review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus found chimpanzees They felt would reduce likelihood individual immune system would attack vector virus due prior exposure rather intended target Reuters reviewed six research papers detailed safety data vaccines using engineered chimpanzee adenovirus called diseases including tuberculosis prostate cancer influenza In one trials one serious adverse event cited researchers deemed unrelated vaccine The type review conducted FDA generally intended scrutinize raw data side effects sources said The US government effort speed development vaccine promises Trump one could available prior Nov presidential election led concerns political interference regulatory process expense safety The FDA denied AstraZeneca vaccine development could also slowed change clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered public use trial concludes serious safety problems appear Safety likely major reason change said Thomas Lumley chair biostatistics University Auckland involved study AstraZeneca would say made change protocol Â Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken GILD Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The European health regulator said Thursday started rolling review experimental vaccine AstraZeneca L Oxford University move aimed speeding future approval process The European Medicines Agency EMA said human medicines committee started evaluating first batch data vaccine continue till sufficient data available formal application submitted https The news raises chances vaccine first approved region comes weeks several global trials vaccine halted due unexplained illness study participant US trials still review regulators widening probe Reuters reported Wednesday This EMA review mean conclusion reached yet vaccine safety effectiveness much evidence still submitted committee watchdog said Earlystage data July showed vaccine elicited immune responses clinical trials produced serious side effects strongest response seen people received two doses Data latestage trials expected soon The EMA would make final recommendations review completed European Commission ultimate say approvals The commission typically follows EMA endorsements The EMA began similar realtime review Gilead O Veklury treatment earlier year antiviral treatment given conditional approval use months later July\n",
            "Tokenized:  ['a', 'reuters', 'add', 'tore', '##mo', '##ve', 'portfolio', 'she', '##l', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'rr', 'add', 'tore', '##mo', '##ve', 'portfolio', 's', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'ng', 'add', 'tore', '##mo', '##ve', 'portfolio', 'h', '##br', 'add', 'tore', '##mo', '##ve', 'portfolio', 'dl', '##ar', 'add', 'tore', '##mo', '##ve', 'portfolio', 'oct', 'reuters', 'britain', 'ft', '##se', 'index', 'seen', 'opening', 'points', 'higher', 'thursday', 'according', 'financial', 'book', '##makers', 'futures', 'ahead', 'cash', 'market', 'open', 'smith', 'nephew', 'medical', 'pro', '##st', '##hetic', '##s', 'maker', 'smith', 'nephew', 'plc', 'expects', 'decline', 'underlying', 'revenue', 'third', 'quarter', 'year', 'almost', 'previous', 'three', 'months', 'suffering', 'heavily', 'impact', 'corona', '##virus', 'lock', '##down', '##s', 'halt', 'elect', '##ive', 'procedures', 'rolls', '##roy', '##ce', 'britain', 'rolls', '##roy', '##ce', 'said', 'planned', 'shareholders', 'billion', 'pounds', 'bond', 'market', 'secure', 'loans', 'rebuild', 'balance', 'sheet', 'premier', 'oil', 'creditors', 'north', 'sea', '##fo', '##cus', '##ed', 'premier', 'oil', 'extended', 'wai', '##ver', 'group', 'debt', 'covenant', 'test', 'giving', 'breathing', 'space', 'avoid', 'debt', 'crunch', 'company', 'said', 'thursday', 'de', 'la', 'rue', 'bank', '##note', 'printer', 'de', 'la', 'rue', 'thursday', 'named', 'rob', 'harding', 'appointing', 'interim', 'cf', '##o', 'earlier', 'year', 'national', 'grid', 'national', 'grid', 'thursday', 'pledged', 'see', 'reduce', 'emissions', 'relating', 'gas', 'electricity', 'sells', 'markets', 'united', 'states', 'britain', 'as', '##tra', '##zen', '##eca', 'the', 'us', 'food', 'drug', 'administration', 'serious', 'illness', 'as', '##tra', '##zen', '##eca', 'plc', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'reuters', 'wood', '##ford', 'the', 'collapsed', 'wood', '##ford', 'equity', 'income', 'fund', 'million', 'pounds', 'remaining', 'assets', 'authorised', 'corporate', 'director', 'said', 'wednesday', 'the', 'uk', 'blue', '##chi', '##p', 'index', 'closed', 'lower', 'wednesday', 'bleak', 'production', 'forecast', 'shell', 'losses', 'consumer', 'stocks', 'weighed', 'index', 'a', 'reuters', 'file', 'photo', 'a', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'as', '##tra', '##zen', '##eca', 'logo', 'illustration', 'taken', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'p', '##fe', 'add', 'tore', '##mo', '##ve', 'portfolio', 'j', '##n', '##j', 'add', 'tore', '##mo', '##ve', 'portfolio', 'mrna', 'add', 'tore', '##mo', '##ve', 'portfolio', 'by', 'maris', '##a', 'taylor', 'dan', 'levine', 'washington', 'reuters', 'the', 'us', 'food', 'drug', 'administration', 'broad', '##ened', 'investigation', 'serious', 'illness', 'as', '##tra', '##zen', '##eca', 'plc', 'l', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'reuters', 'as', '##tra', '##zen', '##eca', 'large', 'latest', '##age', 'us', 'trial', 'remained', 'hold', 'since', 'sept', 'study', 'participant', 'britain', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'my', '##eli', '##tis', 'the', 'widened', 'scope', 'fda', 'probe', 'raises', 'likelihood', 'additional', 'delays', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'the', 'requested', 'data', 'expected', 'arrive', 'week', 'fda', 'would', 'need', 'time', 'analyze', 'two', 'sources', 'said', 'effective', 'vaccines', 'seen', 'essential', 'help', 'end', 'pan', '##de', '##mic', 'killed', 'one', 'million', 'people', 'worldwide', 'the', 'administration', 'president', 'donald', 'trump', 'pledged', 'billion', 'support', 'development', 'as', '##tra', '##zen', '##eca', 'vaccine', 'secure', 'million', 'doses', 'united', 'states', 'other', 'leading', 'companies', 'us', 'vaccine', 'race', 'include', 'p', '##fi', '##zer', 'inc', 'n', 'modern', '##a', 'inc', 'o', 'johnson', 'johnson', 'n', 'regulators', 'uk', 'brazil', 'india', 'south', 'africa', 'allowed', 'as', '##tra', '##zen', '##eca', 'resume', 'clinical', 'trials', 'the', 'fda', 'however', 'wants', 'determine', 'whether', 'similar', 'side', 'effects', 'emerged', 'trials', 'vaccines', 'designed', 'as', '##tra', '##zen', '##eca', 'corona', '##virus', 'vaccine', 'partner', 'researchers', 'oxford', 'university', 'sources', 'said', 'that', 'mean', 'agency', 'believes', 'safety', 'issues', 'associated', 'vaccines', 'added', 'it', 'shows', 'fda', 'thorough', 'said', 'one', 'sources', 'further', 'com', '##pl', '##ica', '##ting', 'situation', 'data', 'requested', 'fda', 'different', 'format', 'us', 'regulator', 'requires', 'two', 'sources', 'said', 'the', 'fda', 'declined', 'comment', 'discussions', 'involving', 'experimental', 'product', 'oxford', 'respond', 'requests', 'comment', 'as', '##tra', '##zen', '##eca', 'statement', 'said', 'we', 'continuing', 'work', 'fda', 'facilitate', 'review', 'information', 'needed', 'make', 'decision', 'regarding', 'res', '##ump', '##tion', 'us', 'trial', 'viral', 'vector', 'all', 'vaccines', 'wants', 'review', 'use', 'modified', 'aden', '##ov', '##irus', 'vectors', 'safely', 'deliver', 'genetic', 'material', 'target', 'illnesses', 'flu', 'middle', 'east', 'respiratory', 'syndrome', 'diseases', 'body', 'stimulate', 'immune', 'system', 'response', 'fight', 'future', 'infection', 'while', 'vaccine', 'developers', 'used', 'human', 'aden', '##ov', '##irus', '##es', 'vaccines', 'oxford', 'researchers', 'chose', 'aden', '##ov', '##irus', 'found', 'chi', '##mp', '##an', '##zee', '##s', 'they', 'felt', 'would', 'reduce', 'likelihood', 'individual', 'immune', 'system', 'would', 'attack', 'vector', 'virus', 'due', 'prior', 'exposure', 'rather', 'intended', 'target', 'reuters', 'reviewed', 'six', 'research', 'papers', 'detailed', 'safety', 'data', 'vaccines', 'using', 'engineered', 'chi', '##mp', '##an', '##zee', 'aden', '##ov', '##irus', 'called', 'diseases', 'including', 'tuberculosis', 'prostate', 'cancer', 'influenza', 'in', 'one', 'trials', 'one', 'serious', 'adverse', 'event', 'cited', 'researchers', 'deemed', 'unrelated', 'vaccine', 'the', 'type', 'review', 'conducted', 'fda', 'generally', 'intended', 'sc', '##rut', '##ini', '##ze', 'raw', 'data', 'side', 'effects', 'sources', 'said', 'the', 'us', 'government', 'effort', 'speed', 'development', 'vaccine', 'promises', 'trump', 'one', 'could', 'available', 'prior', 'nov', 'presidential', 'election', 'led', 'concerns', 'political', 'interference', 'regulatory', 'process', 'expense', 'safety', 'the', 'fda', 'denied', 'as', '##tra', '##zen', '##eca', 'vaccine', 'development', 'could', 'also', 'slowed', 'change', 'clinical', 'trial', 'protocols', 'show', 'met', 'pre', '##de', '##ter', '##mined', 'safety', 'efficacy', 'standards', 'independent', 'safety', 'monitors', 'conduct', 'first', 'review', 'vaccine', 'safety', 'effectiveness', 'trial', 'subjects', 'become', 'infected', 'original', 'initial', 'review', 'plan', 'infections', 'according', 'reuters', 'review', 'protocol', 'documents', 'issued', 'july', 'amended', 'mid', '##se', '##pt', '##em', '##ber', 'the', 'safety', 'monitors', 'could', 'decide', 'stop', 'trial', 'vaccine', 'proves', 'either', 'highly', 'effective', 'therefore', 'considered', 'public', 'use', 'trial', 'concludes', 'serious', 'safety', 'problems', 'appear', 'safety', 'likely', 'major', 'reason', 'change', 'said', 'thomas', 'lu', '##ml', '##ey', 'chair', 'bio', '##sta', '##tist', '##ics', 'university', 'auckland', 'involved', 'study', 'as', '##tra', '##zen', '##eca', 'would', 'say', 'made', 'change', 'protocol', 'a', 'reuters', 'a', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'as', '##tra', '##zen', '##eca', 'logo', 'illustration', 'taken', 'gil', '##d', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'reuters', 'the', 'european', 'health', 'regulator', 'said', 'thursday', 'started', 'rolling', 'review', 'experimental', 'vaccine', 'as', '##tra', '##zen', '##eca', 'l', 'oxford', 'university', 'move', 'aimed', 'speeding', 'future', 'approval', 'process', 'the', 'european', 'medicines', 'agency', 'em', '##a', 'said', 'human', 'medicines', 'committee', 'started', 'evaluating', 'first', 'batch', 'data', 'vaccine', 'continue', 'till', 'sufficient', 'data', 'available', 'formal', 'application', 'submitted', 'https', 'the', 'news', 'raises', 'chances', 'vaccine', 'first', 'approved', 'region', 'comes', 'weeks', 'several', 'global', 'trials', 'vaccine', 'halted', 'due', 'une', '##x', '##pl', '##aine', '##d', 'illness', 'study', 'participant', 'us', 'trials', 'still', 'review', 'regulators', 'widening', 'probe', 'reuters', 'reported', 'wednesday', 'this', 'em', '##a', 'review', 'mean', 'conclusion', 'reached', 'yet', 'vaccine', 'safety', 'effectiveness', 'much', 'evidence', 'still', 'submitted', 'committee', 'watch', '##dog', 'said', 'early', '##sta', '##ge', 'data', 'july', 'showed', 'vaccine', 'eli', '##cite', '##d', 'immune', 'responses', 'clinical', 'trials', 'produced', 'serious', 'side', 'effects', 'strongest', 'response', 'seen', 'people', 'received', 'two', 'doses', 'data', 'latest', '##age', 'trials', 'expected', 'soon', 'the', 'em', '##a', 'would', 'make', 'final', 'recommendations', 'review', 'completed', 'european', 'commission', 'ultimate', 'say', 'approval', '##s', 'the', 'commission', 'typically', 'follows', 'em', '##a', 'endorsement', '##s', 'the', 'em', '##a', 'began', 'similar', 'real', '##time', 'review', 'gil', '##ead', 'o', 've', '##k', '##lu', '##ry', 'treatment', 'earlier', 'year', 'anti', '##vira', '##l', 'treatment', 'given', 'conditional', 'approval', 'use', 'months', 'later', 'july']\n",
            "Token IDs:  [1037, 26665, 5587, 9538, 5302, 3726, 11103, 2016, 2140, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 25269, 5587, 9538, 5302, 3726, 11103, 1055, 2078, 5587, 9538, 5302, 3726, 11103, 12835, 5587, 9538, 5302, 3726, 11103, 1044, 19892, 5587, 9538, 5302, 3726, 11103, 21469, 2906, 5587, 9538, 5302, 3726, 11103, 13323, 26665, 3725, 3027, 3366, 5950, 2464, 3098, 2685, 3020, 9432, 2429, 3361, 2338, 12088, 17795, 3805, 5356, 3006, 2330, 3044, 7833, 2966, 4013, 3367, 20086, 2015, 9338, 3044, 7833, 15492, 24273, 6689, 10318, 6599, 2353, 4284, 2095, 2471, 3025, 2093, 2706, 6114, 4600, 4254, 21887, 23350, 5843, 7698, 2015, 9190, 11322, 3512, 8853, 9372, 13238, 3401, 3725, 9372, 13238, 3401, 2056, 3740, 15337, 4551, 7038, 5416, 3006, 5851, 10940, 14591, 5703, 7123, 4239, 3514, 23112, 2167, 2712, 14876, 7874, 2098, 4239, 3514, 3668, 23701, 6299, 2177, 7016, 16077, 3231, 3228, 5505, 2686, 4468, 7016, 24514, 2194, 2056, 9432, 2139, 2474, 13413, 2924, 22074, 15041, 2139, 2474, 13413, 9432, 2315, 6487, 15456, 28050, 9455, 12935, 2080, 3041, 2095, 2120, 8370, 2120, 8370, 9432, 16970, 2156, 5547, 11768, 8800, 3806, 6451, 15187, 6089, 2142, 2163, 3725, 2004, 6494, 10431, 19281, 1996, 2149, 2833, 4319, 3447, 3809, 7355, 2004, 6494, 10431, 19281, 15492, 17404, 2817, 2298, 2951, 3041, 7012, 2714, 28896, 2764, 6529, 2093, 4216, 5220, 4751, 2409, 26665, 3536, 3877, 1996, 7798, 3536, 3877, 10067, 3318, 4636, 2454, 7038, 3588, 7045, 19256, 5971, 2472, 2056, 9317, 1996, 2866, 2630, 5428, 2361, 5950, 2701, 2896, 9317, 21657, 2537, 19939, 5806, 6409, 7325, 15768, 12781, 5950, 1037, 26665, 5371, 6302, 1037, 3231, 7270, 18251, 17404, 2464, 2392, 2004, 6494, 10431, 19281, 8154, 14614, 2579, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 1052, 7959, 5587, 9538, 5302, 3726, 11103, 1046, 2078, 3501, 5587, 9538, 5302, 3726, 11103, 28848, 5587, 9538, 5302, 3726, 11103, 2011, 23787, 2050, 4202, 4907, 17780, 2899, 26665, 1996, 2149, 2833, 4319, 3447, 5041, 6675, 4812, 3809, 7355, 2004, 6494, 10431, 19281, 15492, 1048, 17404, 2817, 2298, 2951, 3041, 7012, 2714, 28896, 2764, 6529, 2093, 4216, 5220, 4751, 2409, 26665, 2004, 6494, 10431, 19281, 2312, 6745, 4270, 2149, 3979, 2815, 2907, 2144, 17419, 2817, 13180, 3725, 3062, 5665, 3373, 4678, 16492, 20187, 8761, 2170, 18323, 2026, 20806, 7315, 1996, 8723, 9531, 17473, 15113, 13275, 16593, 3176, 14350, 2028, 3935, 17404, 5347, 2458, 1996, 7303, 2951, 3517, 7180, 2733, 17473, 2052, 2342, 2051, 17908, 2048, 4216, 2056, 4621, 28896, 2464, 6827, 2393, 2203, 6090, 3207, 7712, 2730, 2028, 2454, 2111, 4969, 1996, 3447, 2343, 6221, 8398, 16970, 4551, 2490, 2458, 2004, 6494, 10431, 19281, 17404, 5851, 2454, 21656, 2142, 2163, 2060, 2877, 3316, 2149, 17404, 2679, 2421, 1052, 8873, 6290, 4297, 1050, 2715, 2050, 4297, 1051, 3779, 3779, 1050, 25644, 2866, 4380, 2634, 2148, 3088, 3039, 2004, 6494, 10431, 19281, 13746, 6612, 7012, 1996, 17473, 2174, 4122, 5646, 3251, 2714, 2217, 3896, 6003, 7012, 28896, 2881, 2004, 6494, 10431, 19281, 21887, 23350, 17404, 4256, 6950, 4345, 2118, 4216, 2056, 2008, 2812, 4034, 7164, 3808, 3314, 3378, 28896, 2794, 2009, 3065, 17473, 16030, 2056, 2028, 4216, 2582, 4012, 24759, 5555, 3436, 3663, 2951, 7303, 17473, 2367, 4289, 2149, 21618, 5942, 2048, 4216, 2056, 1996, 17473, 6430, 7615, 10287, 5994, 6388, 4031, 4345, 6869, 11186, 7615, 2004, 6494, 10431, 19281, 4861, 2056, 2057, 5719, 2147, 17473, 10956, 3319, 2592, 2734, 2191, 3247, 4953, 24501, 24237, 3508, 2149, 3979, 13434, 9207, 2035, 28896, 4122, 3319, 2224, 6310, 16298, 4492, 26013, 19019, 9689, 8116, 7403, 3430, 4539, 24757, 19857, 2690, 2264, 16464, 8715, 7870, 2303, 23216, 11311, 2291, 3433, 2954, 2925, 8985, 2096, 17404, 9797, 2109, 2529, 16298, 4492, 26013, 2229, 28896, 4345, 6950, 4900, 16298, 4492, 26013, 2179, 9610, 8737, 2319, 23940, 2015, 2027, 2371, 2052, 5547, 16593, 3265, 11311, 2291, 2052, 2886, 9207, 7865, 2349, 3188, 7524, 2738, 3832, 4539, 26665, 8182, 2416, 2470, 4981, 6851, 3808, 2951, 28896, 2478, 13685, 9610, 8737, 2319, 23940, 16298, 4492, 26013, 2170, 7870, 2164, 15877, 25086, 4456, 24442, 1999, 2028, 7012, 2028, 3809, 15316, 2724, 6563, 6950, 8357, 15142, 17404, 1996, 2828, 3319, 4146, 17473, 3227, 3832, 8040, 22134, 5498, 4371, 6315, 2951, 2217, 3896, 4216, 2056, 1996, 2149, 2231, 3947, 3177, 2458, 17404, 10659, 8398, 2028, 2071, 2800, 3188, 13292, 4883, 2602, 2419, 5936, 2576, 11099, 10738, 2832, 10961, 3808, 1996, 17473, 6380, 2004, 6494, 10431, 19281, 17404, 2458, 2071, 2036, 9784, 2689, 6612, 3979, 16744, 2265, 2777, 3653, 3207, 3334, 25089, 3808, 21150, 4781, 2981, 3808, 15410, 6204, 2034, 3319, 17404, 3808, 12353, 3979, 5739, 2468, 10372, 2434, 3988, 3319, 2933, 15245, 2429, 26665, 3319, 8778, 5491, 3843, 2251, 13266, 3054, 3366, 13876, 6633, 5677, 1996, 3808, 15410, 2071, 5630, 2644, 3979, 17404, 16481, 2593, 3811, 4621, 3568, 2641, 2270, 2224, 3979, 14730, 3809, 3808, 3471, 3711, 3808, 3497, 2350, 3114, 2689, 2056, 2726, 11320, 19968, 3240, 3242, 16012, 9153, 16774, 6558, 2118, 8666, 2920, 2817, 2004, 6494, 10431, 19281, 2052, 2360, 2081, 2689, 8778, 1037, 26665, 1037, 3231, 7270, 18251, 17404, 2464, 2392, 2004, 6494, 10431, 19281, 8154, 14614, 2579, 13097, 2094, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 26665, 1996, 2647, 2740, 21618, 2056, 9432, 2318, 5291, 3319, 6388, 17404, 2004, 6494, 10431, 19281, 1048, 4345, 2118, 2693, 6461, 21485, 2925, 6226, 2832, 1996, 2647, 20233, 4034, 7861, 2050, 2056, 2529, 20233, 2837, 2318, 23208, 2034, 14108, 2951, 17404, 3613, 6229, 7182, 2951, 2800, 5337, 4646, 7864, 16770, 1996, 2739, 13275, 9592, 17404, 2034, 4844, 2555, 3310, 3134, 2195, 3795, 7012, 17404, 12705, 2349, 16655, 2595, 24759, 18175, 2094, 7355, 2817, 13180, 2149, 7012, 2145, 3319, 25644, 17973, 15113, 26665, 2988, 9317, 2023, 7861, 2050, 3319, 2812, 7091, 2584, 2664, 17404, 3808, 12353, 2172, 3350, 2145, 7864, 2837, 3422, 16168, 2056, 2220, 9153, 3351, 2951, 2251, 3662, 17404, 12005, 17847, 2094, 11311, 10960, 6612, 7012, 2550, 3809, 2217, 3896, 10473, 3433, 2464, 2111, 2363, 2048, 21656, 2951, 6745, 4270, 7012, 3517, 2574, 1996, 7861, 2050, 2052, 2191, 2345, 11433, 3319, 2949, 2647, 3222, 7209, 2360, 6226, 2015, 1996, 3222, 4050, 4076, 7861, 2050, 20380, 2015, 1996, 7861, 2050, 2211, 2714, 2613, 7292, 3319, 13097, 13775, 1051, 2310, 2243, 7630, 2854, 3949, 3041, 2095, 3424, 24093, 2140, 3949, 2445, 18462, 6226, 2224, 2706, 2101, 2251]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see by printing out the filtered version above that the non-alpha characters have been removed but after applying the BertTokenizer to the article the OOV (Out-Of-Vocabulary) words, such as Astrazeneca and Pfizer, are being broken down into sub-words with ## used to represent sub-words.\n",
        "\n",
        "We can resolve this issue by adding new tokens to the pre-trained BertTokenizer and then retraining the model."
      ],
      "metadata": {
        "id": "d2yTmHSIftH_"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "NlCxJxWE3gWU",
        "outputId": "426b91de-4484-4d92-cd83-d9b773e462aa"
      },
      "source": [
        "# https://stackoverflow.com/questions/62082938/how-to-stop-bert-from-breaking-apart-specific-words-into-word-piece\n",
        "\n",
        "# Add OOV words to tokeniser\n",
        "tokenizer.add_tokens(['astrazeneca', 'pfizer'])"
      ],
      "execution_count": 17,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "2"
            ]
          },
          "metadata": {},
          "execution_count": 17
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "tSpvQNzONyHL",
        "outputId": "6f1053b5-8b4f-4e1b-a240-2958e8f56200"
      },
      "source": [
        "# Print the filtered article.\n",
        "print('Filtered: ', filtered_articles_joined[0])\n",
        "\n",
        "# Print the article split into tokens.\n",
        "print('Tokenized: ', tokenizer.tokenize(filtered_articles_joined[0]))\n",
        "\n",
        "# Print the article mapped to token ids.\n",
        "print('Token IDs: ', tokenizer.convert_tokens_to_ids(tokenizer.tokenize(filtered_articles_joined[0])))"
      ],
      "execution_count": 18,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Filtered:  Â Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio NG Add toRemove Portfolio HBR Add toRemove Portfolio DLAR Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open Smith Nephew Medical prosthetics maker Smith Nephew Plc expects decline underlying revenue third quarter year almost previous three months suffering heavily impact coronavirus lockdowns halt elective procedures RollsRoyce Britain RollsRoyce said planned shareholders billion pounds bond market secure loans rebuild balance sheet Premier Oil Creditors North Seafocused Premier Oil extended waiver group debt covenant test giving breathing space avoid debt crunch company said Thursday De La Rue Banknote printer De La Rue Thursday named Rob Harding appointing interim CFO earlier year National Grid National Grid Thursday pledged see reduce emissions relating gas electricity sells markets United States Britain AstraZeneca The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production forecast Shell losses consumer stocks weighed index Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Marisa Taylor Dan Levine WASHINGTON Reuters The US Food Drug Administration broadened investigation serious illness AstraZeneca Plc L vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters AstraZeneca large latestage US trial remained hold since Sept study participant Britain fell ill believed rare spinal inflammatory disorder called transverse myelitis The widened scope FDA probe raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United States Other leading companies US vaccine race include Pfizer Inc N Moderna Inc O Johnson Johnson N Regulators UK Brazil India South Africa allowed AstraZeneca resume clinical trials The FDA however wants determine whether similar side effects emerged trials vaccines designed AstraZeneca coronavirus vaccine partner researchers Oxford University sources said That mean agency believes safety issues associated vaccines added It shows FDA thorough said one sources Further complicating situation data requested FDA different format US regulator requires two sources said The FDA declined comment discussions involving experimental product Oxford respond requests comment AstraZeneca statement said We continuing work FDA facilitate review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus found chimpanzees They felt would reduce likelihood individual immune system would attack vector virus due prior exposure rather intended target Reuters reviewed six research papers detailed safety data vaccines using engineered chimpanzee adenovirus called diseases including tuberculosis prostate cancer influenza In one trials one serious adverse event cited researchers deemed unrelated vaccine The type review conducted FDA generally intended scrutinize raw data side effects sources said The US government effort speed development vaccine promises Trump one could available prior Nov presidential election led concerns political interference regulatory process expense safety The FDA denied AstraZeneca vaccine development could also slowed change clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered public use trial concludes serious safety problems appear Safety likely major reason change said Thomas Lumley chair biostatistics University Auckland involved study AstraZeneca would say made change protocol Â Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken GILD Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The European health regulator said Thursday started rolling review experimental vaccine AstraZeneca L Oxford University move aimed speeding future approval process The European Medicines Agency EMA said human medicines committee started evaluating first batch data vaccine continue till sufficient data available formal application submitted https The news raises chances vaccine first approved region comes weeks several global trials vaccine halted due unexplained illness study participant US trials still review regulators widening probe Reuters reported Wednesday This EMA review mean conclusion reached yet vaccine safety effectiveness much evidence still submitted committee watchdog said Earlystage data July showed vaccine elicited immune responses clinical trials produced serious side effects strongest response seen people received two doses Data latestage trials expected soon The EMA would make final recommendations review completed European Commission ultimate say approvals The commission typically follows EMA endorsements The EMA began similar realtime review Gilead O Veklury treatment earlier year antiviral treatment given conditional approval use months later July\n",
            "Tokenized:  ['a', 'reuters', 'add', 'tore', '##mo', '##ve', 'portfolio', 'she', '##l', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'rr', 'add', 'tore', '##mo', '##ve', 'portfolio', 's', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'ng', 'add', 'tore', '##mo', '##ve', 'portfolio', 'h', '##br', 'add', 'tore', '##mo', '##ve', 'portfolio', 'dl', '##ar', 'add', 'tore', '##mo', '##ve', 'portfolio', 'oct', 'reuters', 'britain', 'ft', '##se', 'index', 'seen', 'opening', 'points', 'higher', 'thursday', 'according', 'financial', 'book', '##makers', 'futures', 'ahead', 'cash', 'market', 'open', 'smith', 'nephew', 'medical', 'pro', '##st', '##hetic', '##s', 'maker', 'smith', 'nephew', 'plc', 'expects', 'decline', 'underlying', 'revenue', 'third', 'quarter', 'year', 'almost', 'previous', 'three', 'months', 'suffering', 'heavily', 'impact', 'corona', '##virus', 'lock', '##down', '##s', 'halt', 'elect', '##ive', 'procedures', 'rolls', '##roy', '##ce', 'britain', 'rolls', '##roy', '##ce', 'said', 'planned', 'shareholders', 'billion', 'pounds', 'bond', 'market', 'secure', 'loans', 'rebuild', 'balance', 'sheet', 'premier', 'oil', 'creditors', 'north', 'sea', '##fo', '##cus', '##ed', 'premier', 'oil', 'extended', 'wai', '##ver', 'group', 'debt', 'covenant', 'test', 'giving', 'breathing', 'space', 'avoid', 'debt', 'crunch', 'company', 'said', 'thursday', 'de', 'la', 'rue', 'bank', '##note', 'printer', 'de', 'la', 'rue', 'thursday', 'named', 'rob', 'harding', 'appointing', 'interim', 'cf', '##o', 'earlier', 'year', 'national', 'grid', 'national', 'grid', 'thursday', 'pledged', 'see', 'reduce', 'emissions', 'relating', 'gas', 'electricity', 'sells', 'markets', 'united', 'states', 'britain', 'astrazeneca', 'the', 'us', 'food', 'drug', 'administration', 'serious', 'illness', 'astrazeneca', 'plc', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'reuters', 'wood', '##ford', 'the', 'collapsed', 'wood', '##ford', 'equity', 'income', 'fund', 'million', 'pounds', 'remaining', 'assets', 'authorised', 'corporate', 'director', 'said', 'wednesday', 'the', 'uk', 'blue', '##chi', '##p', 'index', 'closed', 'lower', 'wednesday', 'bleak', 'production', 'forecast', 'shell', 'losses', 'consumer', 'stocks', 'weighed', 'index', 'a', 'reuters', 'file', 'photo', 'a', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'astrazeneca', 'logo', 'illustration', 'taken', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'p', '##fe', 'add', 'tore', '##mo', '##ve', 'portfolio', 'j', '##n', '##j', 'add', 'tore', '##mo', '##ve', 'portfolio', 'mrna', 'add', 'tore', '##mo', '##ve', 'portfolio', 'by', 'maris', '##a', 'taylor', 'dan', 'levine', 'washington', 'reuters', 'the', 'us', 'food', 'drug', 'administration', 'broad', '##ened', 'investigation', 'serious', 'illness', 'astrazeneca', 'plc', 'l', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'reuters', 'astrazeneca', 'large', 'latest', '##age', 'us', 'trial', 'remained', 'hold', 'since', 'sept', 'study', 'participant', 'britain', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'my', '##eli', '##tis', 'the', 'widened', 'scope', 'fda', 'probe', 'raises', 'likelihood', 'additional', 'delays', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'the', 'requested', 'data', 'expected', 'arrive', 'week', 'fda', 'would', 'need', 'time', 'analyze', 'two', 'sources', 'said', 'effective', 'vaccines', 'seen', 'essential', 'help', 'end', 'pan', '##de', '##mic', 'killed', 'one', 'million', 'people', 'worldwide', 'the', 'administration', 'president', 'donald', 'trump', 'pledged', 'billion', 'support', 'development', 'astrazeneca', 'vaccine', 'secure', 'million', 'doses', 'united', 'states', 'other', 'leading', 'companies', 'us', 'vaccine', 'race', 'include', 'pfizer', 'inc', 'n', 'modern', '##a', 'inc', 'o', 'johnson', 'johnson', 'n', 'regulators', 'uk', 'brazil', 'india', 'south', 'africa', 'allowed', 'astrazeneca', 'resume', 'clinical', 'trials', 'the', 'fda', 'however', 'wants', 'determine', 'whether', 'similar', 'side', 'effects', 'emerged', 'trials', 'vaccines', 'designed', 'astrazeneca', 'corona', '##virus', 'vaccine', 'partner', 'researchers', 'oxford', 'university', 'sources', 'said', 'that', 'mean', 'agency', 'believes', 'safety', 'issues', 'associated', 'vaccines', 'added', 'it', 'shows', 'fda', 'thorough', 'said', 'one', 'sources', 'further', 'com', '##pl', '##ica', '##ting', 'situation', 'data', 'requested', 'fda', 'different', 'format', 'us', 'regulator', 'requires', 'two', 'sources', 'said', 'the', 'fda', 'declined', 'comment', 'discussions', 'involving', 'experimental', 'product', 'oxford', 'respond', 'requests', 'comment', 'astrazeneca', 'statement', 'said', 'we', 'continuing', 'work', 'fda', 'facilitate', 'review', 'information', 'needed', 'make', 'decision', 'regarding', 'res', '##ump', '##tion', 'us', 'trial', 'viral', 'vector', 'all', 'vaccines', 'wants', 'review', 'use', 'modified', 'aden', '##ov', '##irus', 'vectors', 'safely', 'deliver', 'genetic', 'material', 'target', 'illnesses', 'flu', 'middle', 'east', 'respiratory', 'syndrome', 'diseases', 'body', 'stimulate', 'immune', 'system', 'response', 'fight', 'future', 'infection', 'while', 'vaccine', 'developers', 'used', 'human', 'aden', '##ov', '##irus', '##es', 'vaccines', 'oxford', 'researchers', 'chose', 'aden', '##ov', '##irus', 'found', 'chi', '##mp', '##an', '##zee', '##s', 'they', 'felt', 'would', 'reduce', 'likelihood', 'individual', 'immune', 'system', 'would', 'attack', 'vector', 'virus', 'due', 'prior', 'exposure', 'rather', 'intended', 'target', 'reuters', 'reviewed', 'six', 'research', 'papers', 'detailed', 'safety', 'data', 'vaccines', 'using', 'engineered', 'chi', '##mp', '##an', '##zee', 'aden', '##ov', '##irus', 'called', 'diseases', 'including', 'tuberculosis', 'prostate', 'cancer', 'influenza', 'in', 'one', 'trials', 'one', 'serious', 'adverse', 'event', 'cited', 'researchers', 'deemed', 'unrelated', 'vaccine', 'the', 'type', 'review', 'conducted', 'fda', 'generally', 'intended', 'sc', '##rut', '##ini', '##ze', 'raw', 'data', 'side', 'effects', 'sources', 'said', 'the', 'us', 'government', 'effort', 'speed', 'development', 'vaccine', 'promises', 'trump', 'one', 'could', 'available', 'prior', 'nov', 'presidential', 'election', 'led', 'concerns', 'political', 'interference', 'regulatory', 'process', 'expense', 'safety', 'the', 'fda', 'denied', 'astrazeneca', 'vaccine', 'development', 'could', 'also', 'slowed', 'change', 'clinical', 'trial', 'protocols', 'show', 'met', 'pre', '##de', '##ter', '##mined', 'safety', 'efficacy', 'standards', 'independent', 'safety', 'monitors', 'conduct', 'first', 'review', 'vaccine', 'safety', 'effectiveness', 'trial', 'subjects', 'become', 'infected', 'original', 'initial', 'review', 'plan', 'infections', 'according', 'reuters', 'review', 'protocol', 'documents', 'issued', 'july', 'amended', 'mid', '##se', '##pt', '##em', '##ber', 'the', 'safety', 'monitors', 'could', 'decide', 'stop', 'trial', 'vaccine', 'proves', 'either', 'highly', 'effective', 'therefore', 'considered', 'public', 'use', 'trial', 'concludes', 'serious', 'safety', 'problems', 'appear', 'safety', 'likely', 'major', 'reason', 'change', 'said', 'thomas', 'lu', '##ml', '##ey', 'chair', 'bio', '##sta', '##tist', '##ics', 'university', 'auckland', 'involved', 'study', 'astrazeneca', 'would', 'say', 'made', 'change', 'protocol', 'a', 'reuters', 'a', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'astrazeneca', 'logo', 'illustration', 'taken', 'gil', '##d', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'reuters', 'the', 'european', 'health', 'regulator', 'said', 'thursday', 'started', 'rolling', 'review', 'experimental', 'vaccine', 'astrazeneca', 'l', 'oxford', 'university', 'move', 'aimed', 'speeding', 'future', 'approval', 'process', 'the', 'european', 'medicines', 'agency', 'em', '##a', 'said', 'human', 'medicines', 'committee', 'started', 'evaluating', 'first', 'batch', 'data', 'vaccine', 'continue', 'till', 'sufficient', 'data', 'available', 'formal', 'application', 'submitted', 'https', 'the', 'news', 'raises', 'chances', 'vaccine', 'first', 'approved', 'region', 'comes', 'weeks', 'several', 'global', 'trials', 'vaccine', 'halted', 'due', 'une', '##x', '##pl', '##aine', '##d', 'illness', 'study', 'participant', 'us', 'trials', 'still', 'review', 'regulators', 'widening', 'probe', 'reuters', 'reported', 'wednesday', 'this', 'em', '##a', 'review', 'mean', 'conclusion', 'reached', 'yet', 'vaccine', 'safety', 'effectiveness', 'much', 'evidence', 'still', 'submitted', 'committee', 'watch', '##dog', 'said', 'early', '##sta', '##ge', 'data', 'july', 'showed', 'vaccine', 'eli', '##cite', '##d', 'immune', 'responses', 'clinical', 'trials', 'produced', 'serious', 'side', 'effects', 'strongest', 'response', 'seen', 'people', 'received', 'two', 'doses', 'data', 'latest', '##age', 'trials', 'expected', 'soon', 'the', 'em', '##a', 'would', 'make', 'final', 'recommendations', 'review', 'completed', 'european', 'commission', 'ultimate', 'say', 'approval', '##s', 'the', 'commission', 'typically', 'follows', 'em', '##a', 'endorsement', '##s', 'the', 'em', '##a', 'began', 'similar', 'real', '##time', 'review', 'gil', '##ead', 'o', 've', '##k', '##lu', '##ry', 'treatment', 'earlier', 'year', 'anti', '##vira', '##l', 'treatment', 'given', 'conditional', 'approval', 'use', 'months', 'later', 'july']\n",
            "Token IDs:  [1037, 26665, 5587, 9538, 5302, 3726, 11103, 2016, 2140, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 25269, 5587, 9538, 5302, 3726, 11103, 1055, 2078, 5587, 9538, 5302, 3726, 11103, 12835, 5587, 9538, 5302, 3726, 11103, 1044, 19892, 5587, 9538, 5302, 3726, 11103, 21469, 2906, 5587, 9538, 5302, 3726, 11103, 13323, 26665, 3725, 3027, 3366, 5950, 2464, 3098, 2685, 3020, 9432, 2429, 3361, 2338, 12088, 17795, 3805, 5356, 3006, 2330, 3044, 7833, 2966, 4013, 3367, 20086, 2015, 9338, 3044, 7833, 15492, 24273, 6689, 10318, 6599, 2353, 4284, 2095, 2471, 3025, 2093, 2706, 6114, 4600, 4254, 21887, 23350, 5843, 7698, 2015, 9190, 11322, 3512, 8853, 9372, 13238, 3401, 3725, 9372, 13238, 3401, 2056, 3740, 15337, 4551, 7038, 5416, 3006, 5851, 10940, 14591, 5703, 7123, 4239, 3514, 23112, 2167, 2712, 14876, 7874, 2098, 4239, 3514, 3668, 23701, 6299, 2177, 7016, 16077, 3231, 3228, 5505, 2686, 4468, 7016, 24514, 2194, 2056, 9432, 2139, 2474, 13413, 2924, 22074, 15041, 2139, 2474, 13413, 9432, 2315, 6487, 15456, 28050, 9455, 12935, 2080, 3041, 2095, 2120, 8370, 2120, 8370, 9432, 16970, 2156, 5547, 11768, 8800, 3806, 6451, 15187, 6089, 2142, 2163, 3725, 30522, 1996, 2149, 2833, 4319, 3447, 3809, 7355, 30522, 15492, 17404, 2817, 2298, 2951, 3041, 7012, 2714, 28896, 2764, 6529, 2093, 4216, 5220, 4751, 2409, 26665, 3536, 3877, 1996, 7798, 3536, 3877, 10067, 3318, 4636, 2454, 7038, 3588, 7045, 19256, 5971, 2472, 2056, 9317, 1996, 2866, 2630, 5428, 2361, 5950, 2701, 2896, 9317, 21657, 2537, 19939, 5806, 6409, 7325, 15768, 12781, 5950, 1037, 26665, 5371, 6302, 1037, 3231, 7270, 18251, 17404, 2464, 2392, 30522, 8154, 14614, 2579, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 1052, 7959, 5587, 9538, 5302, 3726, 11103, 1046, 2078, 3501, 5587, 9538, 5302, 3726, 11103, 28848, 5587, 9538, 5302, 3726, 11103, 2011, 23787, 2050, 4202, 4907, 17780, 2899, 26665, 1996, 2149, 2833, 4319, 3447, 5041, 6675, 4812, 3809, 7355, 30522, 15492, 1048, 17404, 2817, 2298, 2951, 3041, 7012, 2714, 28896, 2764, 6529, 2093, 4216, 5220, 4751, 2409, 26665, 30522, 2312, 6745, 4270, 2149, 3979, 2815, 2907, 2144, 17419, 2817, 13180, 3725, 3062, 5665, 3373, 4678, 16492, 20187, 8761, 2170, 18323, 2026, 20806, 7315, 1996, 8723, 9531, 17473, 15113, 13275, 16593, 3176, 14350, 2028, 3935, 17404, 5347, 2458, 1996, 7303, 2951, 3517, 7180, 2733, 17473, 2052, 2342, 2051, 17908, 2048, 4216, 2056, 4621, 28896, 2464, 6827, 2393, 2203, 6090, 3207, 7712, 2730, 2028, 2454, 2111, 4969, 1996, 3447, 2343, 6221, 8398, 16970, 4551, 2490, 2458, 30522, 17404, 5851, 2454, 21656, 2142, 2163, 2060, 2877, 3316, 2149, 17404, 2679, 2421, 30523, 4297, 1050, 2715, 2050, 4297, 1051, 3779, 3779, 1050, 25644, 2866, 4380, 2634, 2148, 3088, 3039, 30522, 13746, 6612, 7012, 1996, 17473, 2174, 4122, 5646, 3251, 2714, 2217, 3896, 6003, 7012, 28896, 2881, 30522, 21887, 23350, 17404, 4256, 6950, 4345, 2118, 4216, 2056, 2008, 2812, 4034, 7164, 3808, 3314, 3378, 28896, 2794, 2009, 3065, 17473, 16030, 2056, 2028, 4216, 2582, 4012, 24759, 5555, 3436, 3663, 2951, 7303, 17473, 2367, 4289, 2149, 21618, 5942, 2048, 4216, 2056, 1996, 17473, 6430, 7615, 10287, 5994, 6388, 4031, 4345, 6869, 11186, 7615, 30522, 4861, 2056, 2057, 5719, 2147, 17473, 10956, 3319, 2592, 2734, 2191, 3247, 4953, 24501, 24237, 3508, 2149, 3979, 13434, 9207, 2035, 28896, 4122, 3319, 2224, 6310, 16298, 4492, 26013, 19019, 9689, 8116, 7403, 3430, 4539, 24757, 19857, 2690, 2264, 16464, 8715, 7870, 2303, 23216, 11311, 2291, 3433, 2954, 2925, 8985, 2096, 17404, 9797, 2109, 2529, 16298, 4492, 26013, 2229, 28896, 4345, 6950, 4900, 16298, 4492, 26013, 2179, 9610, 8737, 2319, 23940, 2015, 2027, 2371, 2052, 5547, 16593, 3265, 11311, 2291, 2052, 2886, 9207, 7865, 2349, 3188, 7524, 2738, 3832, 4539, 26665, 8182, 2416, 2470, 4981, 6851, 3808, 2951, 28896, 2478, 13685, 9610, 8737, 2319, 23940, 16298, 4492, 26013, 2170, 7870, 2164, 15877, 25086, 4456, 24442, 1999, 2028, 7012, 2028, 3809, 15316, 2724, 6563, 6950, 8357, 15142, 17404, 1996, 2828, 3319, 4146, 17473, 3227, 3832, 8040, 22134, 5498, 4371, 6315, 2951, 2217, 3896, 4216, 2056, 1996, 2149, 2231, 3947, 3177, 2458, 17404, 10659, 8398, 2028, 2071, 2800, 3188, 13292, 4883, 2602, 2419, 5936, 2576, 11099, 10738, 2832, 10961, 3808, 1996, 17473, 6380, 30522, 17404, 2458, 2071, 2036, 9784, 2689, 6612, 3979, 16744, 2265, 2777, 3653, 3207, 3334, 25089, 3808, 21150, 4781, 2981, 3808, 15410, 6204, 2034, 3319, 17404, 3808, 12353, 3979, 5739, 2468, 10372, 2434, 3988, 3319, 2933, 15245, 2429, 26665, 3319, 8778, 5491, 3843, 2251, 13266, 3054, 3366, 13876, 6633, 5677, 1996, 3808, 15410, 2071, 5630, 2644, 3979, 17404, 16481, 2593, 3811, 4621, 3568, 2641, 2270, 2224, 3979, 14730, 3809, 3808, 3471, 3711, 3808, 3497, 2350, 3114, 2689, 2056, 2726, 11320, 19968, 3240, 3242, 16012, 9153, 16774, 6558, 2118, 8666, 2920, 2817, 30522, 2052, 2360, 2081, 2689, 8778, 1037, 26665, 1037, 3231, 7270, 18251, 17404, 2464, 2392, 30522, 8154, 14614, 2579, 13097, 2094, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 26665, 1996, 2647, 2740, 21618, 2056, 9432, 2318, 5291, 3319, 6388, 17404, 30522, 1048, 4345, 2118, 2693, 6461, 21485, 2925, 6226, 2832, 1996, 2647, 20233, 4034, 7861, 2050, 2056, 2529, 20233, 2837, 2318, 23208, 2034, 14108, 2951, 17404, 3613, 6229, 7182, 2951, 2800, 5337, 4646, 7864, 16770, 1996, 2739, 13275, 9592, 17404, 2034, 4844, 2555, 3310, 3134, 2195, 3795, 7012, 17404, 12705, 2349, 16655, 2595, 24759, 18175, 2094, 7355, 2817, 13180, 2149, 7012, 2145, 3319, 25644, 17973, 15113, 26665, 2988, 9317, 2023, 7861, 2050, 3319, 2812, 7091, 2584, 2664, 17404, 3808, 12353, 2172, 3350, 2145, 7864, 2837, 3422, 16168, 2056, 2220, 9153, 3351, 2951, 2251, 3662, 17404, 12005, 17847, 2094, 11311, 10960, 6612, 7012, 2550, 3809, 2217, 3896, 10473, 3433, 2464, 2111, 2363, 2048, 21656, 2951, 6745, 4270, 7012, 3517, 2574, 1996, 7861, 2050, 2052, 2191, 2345, 11433, 3319, 2949, 2647, 3222, 7209, 2360, 6226, 2015, 1996, 3222, 4050, 4076, 7861, 2050, 20380, 2015, 1996, 7861, 2050, 2211, 2714, 2613, 7292, 3319, 13097, 13775, 1051, 2310, 2243, 7630, 2854, 3949, 3041, 2095, 3424, 24093, 2140, 3949, 2445, 18462, 6226, 2224, 2706, 2101, 2251]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that the sub-words have now been replaced by 'astrazeneca' and 'pfizer' tokens which are mapped to their index in the tokeniser vocabulary."
      ],
      "metadata": {
        "id": "ywDFk6pokRHJ"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "D4zIVatSJqHY"
      },
      "source": [
        "### 6.1 Required formatting\n",
        "\n",
        "BERT requires specifically formatted inputs. We need to:\n",
        "\n",
        "1.   Add **special tokens** to the start and end of each each consecutive span of text by appending **`[SEP]`** at the end to separate each sentence, and prepending **`[CLS]`** to the beginning so BERT knows we’re doing classification.\n",
        "2.   **Pad** and truncate all sentences to a single fixed length of maximum 512 tokens. For sentences that are shorter than this maximum length, padding is done with a special **`[PAD]`** (empty) token at index 0 in the BERT vocabulary to make up the length. \n",
        "3.   Create an **attention mask**, or array of 0s (padding tokens) and 1s (real tokens) to explicitly differentiate the two and tell the “Self-Attention” mechanism in BERT not to incorporate these **`[PAD]`** tokens into its interpretation of the sentence.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fLzxKSlBQUDc",
        "outputId": "ff631d30-45e5-4c40-c7e1-16d12fa74ebe"
      },
      "source": [
        "# Before we are ready to encode our text, though, we need to decide on a maximum sentence length for padding / truncating to.\n",
        "# The below cell will perform one tokenisation pass of the dataset in order to measure the maximum sentence length.\n",
        "\n",
        "max_len = 0\n",
        "\n",
        "# For every article...\n",
        "for article in article_sentiments.filtered_articles_joined:\n",
        "\n",
        "    # Tokenise the text and add `[CLS]` and `[SEP]` tokens.\n",
        "    input_ids = tokenizer.encode(article, add_special_tokens=True)\n",
        "\n",
        "    # Update the maximum sentence length.\n",
        "    max_len = max(max_len, len(input_ids))\n",
        "\n",
        "print('Max article length: ', max_len)"
      ],
      "execution_count": 19,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Max article length:  1944\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Y_XmhHaTWP08"
      },
      "source": [
        "Here the maximum length after a tokenisation pass of the whole dataset is 7792, which is clearly too high if the maximum length the model can handle is 512 tokens.\n",
        "\n",
        "We will store the token length of each article and plot the distribution."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "CYEPZgsATqQp"
      },
      "source": [
        "# Create empty list to append token length\n",
        "token_lens = []\n",
        "\n",
        "for txt in article_sentiments.filtered_articles_joined:\n",
        "  tokens = tokenizer.encode(txt, max_length=7792)\n",
        "  token_lens.append(len(tokens))"
      ],
      "execution_count": 20,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot the distribution of token length of dataset\n",
        "sns.distplot(token_lens)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Token length of articles')\n",
        "plt.xlim([0, 7792]);\n",
        "plt.xlabel('Token count');"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 372
        },
        "id": "c6XzFXGQlfdA",
        "outputId": "b9197515-5fd5-4a06-a40a-ad69d26c4551"
      },
      "execution_count": 21,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 576x360 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 6.2 BERT for long text inputs\n",
        "\n",
        "We will follow the main ideas of this [research paper](https://arxiv.org/abs/1910.10781) to overcome the fixed-length sentence limitation to be able to use BERT for encoding long sequences of text. This requires segmenting\n",
        "the input into smaller chunks of 200 tokens each, with 50 tokens overlapping, and feeding each of them into the\n",
        "base model."
      ],
      "metadata": {
        "id": "2PQBQmv-XjJI"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Q2RqxF_Za7Ut"
      },
      "source": [
        "# Segment text into smaller chunks of 200 tokens each with a shift of 50 tokens\n",
        "\n",
        "# Function to split out text\n",
        "\n",
        "def get_split(text1):\n",
        "  l_total = []\n",
        "  l_partial = []\n",
        "  if len(text1.split())//150 >0:\n",
        "    n = len(text1.split())//150\n",
        "  else: \n",
        "    n = 1\n",
        "  for w in range(n):\n",
        "    if w == 0:\n",
        "      l_partial = text1.split()[:200]\n",
        "      l_total.append(\" \".join(l_partial))\n",
        "    else:\n",
        "      l_partial = text1.split()[w*150:w*150 + 200]\n",
        "      l_total.append(\" \".join(l_partial))\n",
        "  return l_total"
      ],
      "execution_count": 22,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Appyling the above function to the whole dataset will give us a column where every row contains a list of strings with length of around 200 words."
      ],
      "metadata": {
        "id": "BahMKwm-jKab"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 629
        },
        "id": "HN1QEDTlfEi2",
        "outputId": "9b0bb01d-d832-48ce-ad21-2c1563ada69a"
      },
      "source": [
        "# Apply get_split() function to every row in our dataset\n",
        "\n",
        "article_sentiments['filtered_articles_split'] = article_sentiments['filtered_articles_joined'].apply(get_split)\n",
        "article_sentiments.head()"
      ],
      "execution_count": 23,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         Date  Adj Close Next  Label    Open         High     Low   Close  \\\n",
              "0  2020-01-10     7070.484375      1  7690.0  7717.000000  7608.0  7645.0   \n",
              "1  2020-02-10     7105.605957      0  7659.0  7710.000000  7610.0  7710.0   \n",
              "2  2020-03-12     5955.197266      1  6692.0  6778.000000  6314.0  6314.0   \n",
              "3  2020-05-11     8350.098633      1  8549.0  8719.000000  8522.0  8707.0   \n",
              "4  2020-06-10     7803.232422      0  8237.0  8444.219727  8170.0  8404.0   \n",
              "\n",
              "     Adj Close   Volume  Unnamed: 0  ...    neu    pos compound  \\\n",
              "0  7065.863770  1020795         331  ...  0.900  0.027  -0.9274   \n",
              "1  7125.938965  1136979         324  ...  0.872  0.070   0.7218   \n",
              "2  5953.311523  4529777         248  ...  0.900  0.045  -0.3612   \n",
              "3  8209.611328  1908220         283  ...  0.895  0.077   0.9566   \n",
              "4  7923.920410  2515293         310  ...  0.965  0.035   0.6486   \n",
              "\n",
              "                                       news_combined  \\\n",
              "0  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "1  2/2 Â© Reuters. FILE PHOTO: Small toy figures ...   \n",
              "2  Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...   \n",
              "3  Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...   \n",
              "4  Â© Reuters. FILE PHOTO: A sign is pictured out...   \n",
              "\n",
              "                                        news_cleaned  subjectivity  polarity  \\\n",
              "0  Â Reuters    UK100 203 Add toRemove from a Por...      0.381333  0.045438   \n",
              "1  22 Â Reuters FILE PHOTO Small toy figures are ...      0.335507  0.077174   \n",
              "2  Â Reuters    UK100 203 Add toRemove from a Por...      0.539865  0.118784   \n",
              "3  Â Reuters    AVV 016 Add toRemove from a Portf...      0.425210  0.096054   \n",
              "4  Â Reuters FILE PHOTO A sign is pictured outsid...      0.321625  0.080579   \n",
              "\n",
              "   sentiment                           filtered_articles_joined  \\\n",
              "0          1  Â Reuters Add toRemove Portfolio SHEL Add toRe...   \n",
              "1          0  Â Reuters FILE PHOTO Small toy figures seen fr...   \n",
              "2          1  Â Reuters Add toRemove Portfolio AZN Add toRem...   \n",
              "3          1  Â Reuters AVV Add toRemove Portfolio TRNT Add ...   \n",
              "4          0  Â Reuters FILE PHOTO A sign pictured outside P...   \n",
              "\n",
              "                             filtered_articles_split  \n",
              "0  [Â Reuters Add toRemove Portfolio SHEL Add toR...  \n",
              "1  [Â Reuters FILE PHOTO Small toy figures seen f...  \n",
              "2  [Â Reuters Add toRemove Portfolio AZN Add toRe...  \n",
              "3  [Â Reuters AVV Add toRemove Portfolio TRNT Add...  \n",
              "4  [Â Reuters FILE PHOTO A sign pictured outside ...  \n",
              "\n",
              "[5 rows x 26 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-7cd10463-a23b-4c4c-8709-d03428e679b4\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Date</th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>...</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "      <th>sentiment</th>\n",
              "      <th>filtered_articles_joined</th>\n",
              "      <th>filtered_articles_split</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2020-01-10</td>\n",
              "      <td>7070.484375</td>\n",
              "      <td>1</td>\n",
              "      <td>7690.0</td>\n",
              "      <td>7717.000000</td>\n",
              "      <td>7608.0</td>\n",
              "      <td>7645.0</td>\n",
              "      <td>7065.863770</td>\n",
              "      <td>1020795</td>\n",
              "      <td>331</td>\n",
              "      <td>...</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.027</td>\n",
              "      <td>-0.9274</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.381333</td>\n",
              "      <td>0.045438</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters Add toRemove Portfolio SHEL Add toRe...</td>\n",
              "      <td>[Â Reuters Add toRemove Portfolio SHEL Add toR...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2020-02-10</td>\n",
              "      <td>7105.605957</td>\n",
              "      <td>0</td>\n",
              "      <td>7659.0</td>\n",
              "      <td>7710.000000</td>\n",
              "      <td>7610.0</td>\n",
              "      <td>7710.0</td>\n",
              "      <td>7125.938965</td>\n",
              "      <td>1136979</td>\n",
              "      <td>324</td>\n",
              "      <td>...</td>\n",
              "      <td>0.872</td>\n",
              "      <td>0.070</td>\n",
              "      <td>0.7218</td>\n",
              "      <td>2/2 Â© Reuters. FILE PHOTO: Small toy figures ...</td>\n",
              "      <td>22 Â Reuters FILE PHOTO Small toy figures are ...</td>\n",
              "      <td>0.335507</td>\n",
              "      <td>0.077174</td>\n",
              "      <td>0</td>\n",
              "      <td>Â Reuters FILE PHOTO Small toy figures seen fr...</td>\n",
              "      <td>[Â Reuters FILE PHOTO Small toy figures seen f...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2020-03-12</td>\n",
              "      <td>5955.197266</td>\n",
              "      <td>1</td>\n",
              "      <td>6692.0</td>\n",
              "      <td>6778.000000</td>\n",
              "      <td>6314.0</td>\n",
              "      <td>6314.0</td>\n",
              "      <td>5953.311523</td>\n",
              "      <td>4529777</td>\n",
              "      <td>248</td>\n",
              "      <td>...</td>\n",
              "      <td>0.900</td>\n",
              "      <td>0.045</td>\n",
              "      <td>-0.3612</td>\n",
              "      <td>Â© Reuters.\\n \\n UK100 +2.03% Add to/Remove fr...</td>\n",
              "      <td>Â Reuters    UK100 203 Add toRemove from a Por...</td>\n",
              "      <td>0.539865</td>\n",
              "      <td>0.118784</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters Add toRemove Portfolio AZN Add toRem...</td>\n",
              "      <td>[Â Reuters Add toRemove Portfolio AZN Add toRe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2020-05-11</td>\n",
              "      <td>8350.098633</td>\n",
              "      <td>1</td>\n",
              "      <td>8549.0</td>\n",
              "      <td>8719.000000</td>\n",
              "      <td>8522.0</td>\n",
              "      <td>8707.0</td>\n",
              "      <td>8209.611328</td>\n",
              "      <td>1908220</td>\n",
              "      <td>283</td>\n",
              "      <td>...</td>\n",
              "      <td>0.895</td>\n",
              "      <td>0.077</td>\n",
              "      <td>0.9566</td>\n",
              "      <td>Â© Reuters.\\n \\n AVV -0.16% Add to/Remove from...</td>\n",
              "      <td>Â Reuters    AVV 016 Add toRemove from a Portf...</td>\n",
              "      <td>0.425210</td>\n",
              "      <td>0.096054</td>\n",
              "      <td>1</td>\n",
              "      <td>Â Reuters AVV Add toRemove Portfolio TRNT Add ...</td>\n",
              "      <td>[Â Reuters AVV Add toRemove Portfolio TRNT Add...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>2020-06-10</td>\n",
              "      <td>7803.232422</td>\n",
              "      <td>0</td>\n",
              "      <td>8237.0</td>\n",
              "      <td>8444.219727</td>\n",
              "      <td>8170.0</td>\n",
              "      <td>8404.0</td>\n",
              "      <td>7923.920410</td>\n",
              "      <td>2515293</td>\n",
              "      <td>310</td>\n",
              "      <td>...</td>\n",
              "      <td>0.965</td>\n",
              "      <td>0.035</td>\n",
              "      <td>0.6486</td>\n",
              "      <td>Â© Reuters. FILE PHOTO: A sign is pictured out...</td>\n",
              "      <td>Â Reuters FILE PHOTO A sign is pictured outsid...</td>\n",
              "      <td>0.321625</td>\n",
              "      <td>0.080579</td>\n",
              "      <td>0</td>\n",
              "      <td>Â Reuters FILE PHOTO A sign pictured outside P...</td>\n",
              "      <td>[Â Reuters FILE PHOTO A sign pictured outside ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 26 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-7cd10463-a23b-4c4c-8709-d03428e679b4')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-7cd10463-a23b-4c4c-8709-d03428e679b4 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-7cd10463-a23b-4c4c-8709-d03428e679b4');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 23
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 424
        },
        "id": "RcZsag6bfO1a",
        "outputId": "0693071d-7335-4ccd-8545-ec6501e372e2"
      },
      "source": [
        "# Keep the two columns we are interested in for classification purposes\n",
        "\n",
        "keep_columns = ['filtered_articles_split', 'Label']\n",
        "df =  article_sentiments[keep_columns]\n",
        "df"
      ],
      "execution_count": 24,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                               filtered_articles_split  Label\n",
              "0    [Â Reuters Add toRemove Portfolio SHEL Add toR...      1\n",
              "1    [Â Reuters FILE PHOTO Small toy figures seen f...      0\n",
              "2    [Â Reuters Add toRemove Portfolio AZN Add toRe...      1\n",
              "3    [Â Reuters AVV Add toRemove Portfolio TRNT Add...      1\n",
              "4    [Â Reuters FILE PHOTO A sign pictured outside ...      0\n",
              "..                                                 ...    ...\n",
              "141  [Â Reuters AstraZeneca gets third regulatory g...      1\n",
              "142  [Â Reuters FILE PHOTO A test tube labelled vac...      0\n",
              "143  [AstraZeneca Touts Positive Data From Two Expe...      0\n",
              "144  [AstraZeneca Ultomiris Showed Zero Relapses In...      1\n",
              "145  [Â Reuters BATS Add toRemove Portfolio AZN Add...      1\n",
              "\n",
              "[146 rows x 2 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-4d3bb07b-39ce-48d0-8906-3f652fa336a5\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>filtered_articles_split</th>\n",
              "      <th>Label</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>[Â Reuters Add toRemove Portfolio SHEL Add toR...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>[Â Reuters FILE PHOTO Small toy figures seen f...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>[Â Reuters Add toRemove Portfolio AZN Add toRe...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>[Â Reuters AVV Add toRemove Portfolio TRNT Add...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>[Â Reuters FILE PHOTO A sign pictured outside ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141</th>\n",
              "      <td>[Â Reuters AstraZeneca gets third regulatory g...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>142</th>\n",
              "      <td>[Â Reuters FILE PHOTO A test tube labelled vac...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143</th>\n",
              "      <td>[AstraZeneca Touts Positive Data From Two Expe...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144</th>\n",
              "      <td>[AstraZeneca Ultomiris Showed Zero Relapses In...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>145</th>\n",
              "      <td>[Â Reuters BATS Add toRemove Portfolio AZN Add...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>146 rows × 2 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4d3bb07b-39ce-48d0-8906-3f652fa336a5')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-4d3bb07b-39ce-48d0-8906-3f652fa336a5 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-4d3bb07b-39ce-48d0-8906-3f652fa336a5');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 24
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6Xpz4KWmsoNc"
      },
      "source": [
        "### 6.3 Split into training and test data\n",
        "\n",
        "We will split the data into training (90%) and test (10%). "
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "raCYh_9zhVWY"
      },
      "source": [
        "split = int(0.9*len(df)) "
      ],
      "execution_count": 25,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "EId_j8Xdhj_K"
      },
      "source": [
        "training_data = df[0:split]\n",
        "test_data = df[split:]"
      ],
      "execution_count": 26,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "K62-5mjIhmjv",
        "outputId": "3639eb9b-df32-447a-cb2a-a51ef9f4bd4f"
      },
      "source": [
        "print(training_data.shape)\n",
        "print(test_data.shape)"
      ],
      "execution_count": 27,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "(131, 2)\n",
            "(15, 2)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "pc9liY7Fwo7_",
        "outputId": "05105c14-2f28-4e8f-ff14-0c4b9ae4beb4"
      },
      "source": [
        "print(len(training_data))\n",
        "print(len(test_data))"
      ],
      "execution_count": 28,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "131\n",
            "15\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GEwsIr7Kjy-S"
      },
      "source": [
        "### 6.4 Tokenise training dataset\n",
        "\n",
        "Now that we have decided on a maximum sentence length of 200 for padding/truncating to, we can perform the real tokenisation. The transformers library provides a **`tokenizer.encode_plus`** function which simplifies the tokenisation and input formatting by the combining multiple steps of:\n",
        "1.   Splitting the sentence into tokens.\n",
        "2.   Adding the special **`[CLS]`** and **`[SEP]`** tokens.\n",
        "2.   Mapping the tokens to their IDs.\n",
        "2.   Padding or truncating all sentences to the same length.\n",
        "2.   Creating the attention masks which explicitly differentiate real tokens from **`[PAD]`** tokens.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "h2j8Mynpi9tB",
        "outputId": "d44cf4da-8f66-41d8-f4e8-c6490daf5512"
      },
      "source": [
        "# Create article and label lists \n",
        "articles = training_data.filtered_articles_split.values\n",
        "labels = training_data.Label.values\n",
        "\n",
        "# Tokenise all of the articles and map the tokens to their word IDs.\n",
        "input_ids = []\n",
        "attention_masks = []\n",
        "\n",
        "# For every sentence..\n",
        "for article in articles:\n",
        "    # `encode_plus` will:\n",
        "    #   (1) Tokenise the sequence.\n",
        "    #   (2) Prepend the `[CLS]` token to the start.\n",
        "    #   (3) Append the `[SEP]` token to the end.\n",
        "    #   (4) Map tokens to their IDs.\n",
        "    #   (5) Pad or truncate the sentence to `max_length`\n",
        "    #   (6) Create attention masks for [PAD] tokens.\n",
        "    encoded_dict = tokenizer.encode_plus(\n",
        "                        article,                   # Sentence to encode.\n",
        "                        add_special_tokens = True, # Add '[CLS]' and '[SEP]'\n",
        "                        max_length = 200,           # Pad and truncate all sentence.\n",
        "                        return_token_type_ids=False,\n",
        "                        pad_to_max_length = True,\n",
        "                        return_attention_mask = True,   # Construct attention. masks.\n",
        "                        return_tensors = 'pt',     # Return PyTorch tensors.\n",
        "                   )\n",
        "    \n",
        "    # Add the encoded sentence to the list.    \n",
        "    input_ids.append(encoded_dict['input_ids'])\n",
        "    \n",
        "    # And its attention mask (simply differentiates padding from non-padding).\n",
        "    attention_masks.append(encoded_dict['attention_mask'])\n",
        "\n",
        "# Convert the lists into tensors.\n",
        "input_ids = torch.cat(input_ids, dim=0)\n",
        "attention_masks = torch.cat(attention_masks, dim=0)\n",
        "labels = torch.tensor(labels)\n",
        "\n",
        "# Print sentence 0, now as a list of IDs.\n",
        "print('Original: ', articles[0])\n",
        "print('Token IDs:', input_ids[0])"
      ],
      "execution_count": 29,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Original:  ['Â Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio NG Add toRemove Portfolio HBR Add toRemove Portfolio DLAR Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open Smith Nephew Medical prosthetics maker Smith Nephew Plc expects decline underlying revenue third quarter year almost previous three months suffering heavily impact coronavirus lockdowns halt elective procedures RollsRoyce Britain RollsRoyce said planned shareholders billion pounds bond market secure loans rebuild balance sheet Premier Oil Creditors North Seafocused Premier Oil extended waiver group debt covenant test giving breathing space avoid debt crunch company said Thursday De La Rue Banknote printer De La Rue Thursday named Rob Harding appointing interim CFO earlier year National Grid National Grid Thursday pledged see reduce emissions relating gas electricity sells markets United States Britain AstraZeneca The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production', 'The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production forecast Shell losses consumer stocks weighed index Â Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Marisa Taylor Dan Levine WASHINGTON Reuters The US Food Drug Administration broadened investigation serious illness AstraZeneca Plc L vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters AstraZeneca large latestage US trial remained hold since Sept study participant Britain fell ill believed rare spinal inflammatory disorder called transverse myelitis The widened scope FDA probe raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United', 'raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United States Other leading companies US vaccine race include Pfizer Inc N Moderna Inc O Johnson Johnson N Regulators UK Brazil India South Africa allowed AstraZeneca resume clinical trials The FDA however wants determine whether similar side effects emerged trials vaccines designed AstraZeneca coronavirus vaccine partner researchers Oxford University sources said That mean agency believes safety issues associated vaccines added It shows FDA thorough said one sources Further complicating situation data requested FDA different format US regulator requires two sources said The FDA declined comment discussions involving experimental product Oxford respond requests comment AstraZeneca statement said We continuing work FDA facilitate review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus', 'review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus found chimpanzees They felt would reduce likelihood individual immune system would attack vector virus due prior exposure rather intended target Reuters reviewed six research papers detailed safety data vaccines using engineered chimpanzee adenovirus called diseases including tuberculosis prostate cancer influenza In one trials one serious adverse event cited researchers deemed unrelated vaccine The type review conducted FDA generally intended scrutinize raw data side effects sources said The US government effort speed development vaccine promises Trump one could available prior Nov presidential election led concerns political interference regulatory process expense safety The FDA denied AstraZeneca vaccine development could also slowed change clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered', 'clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered public use trial concludes serious safety problems appear Safety likely major reason change said Thomas Lumley chair biostatistics University Auckland involved study AstraZeneca would say made change protocol Â Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken GILD Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The European health regulator said Thursday started rolling review experimental vaccine AstraZeneca L Oxford University move aimed speeding future approval process The European Medicines Agency EMA said human medicines committee started evaluating first batch data vaccine continue till sufficient data available formal application submitted https The news raises chances vaccine first approved region comes weeks several global trials vaccine halted due unexplained illness study participant US trials still review regulators widening probe Reuters reported Wednesday This EMA review mean conclusion reached yet vaccine safety effectiveness much evidence still submitted committee watchdog said Earlystage data July showed vaccine elicited immune responses']\n",
            "Token IDs: tensor([101, 100, 100, 100, 100, 100, 102,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0])\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "_rgEBuD0o6ei"
      },
      "source": [
        "### 6.5 Training and Validation Split\n",
        "\n",
        "We will divide up our training set to use 90% for training the model and 10% for validation of the model performance during training. This should help prevent our model from overfitting.\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "SqPrelByG5oH",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "58ca0c10-8d97-4de1-a4db-4dc4d6196dc4"
      },
      "source": [
        "# Combine the training inputs into a TensorDataset.\n",
        "training_data = TensorDataset(input_ids, attention_masks, labels)\n",
        "\n",
        "# Create a 90-10 train-validation split.\n",
        "\n",
        "# Calculate the number of samples to include in each set.\n",
        "train_size = int(0.9 * len(training_data))\n",
        "valid_size = len(training_data) - train_size\n",
        "\n",
        "# Divide the dataset by randomly selecting samples.\n",
        "train_data, valid_data = random_split(training_data, [train_size, valid_size])\n",
        "\n",
        "print(f'{train_size} training samples') \n",
        "print(f'{valid_size} validation samples')"
      ],
      "execution_count": 30,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "117 training samples\n",
            "14 validation samples\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IMlj3O_8q2am"
      },
      "source": [
        "### 6.6 DataLoader class\n",
        "\n",
        "We will create an iterator for our dataset using the torch DataLoader class. This helps save on memory during training because, unlike a for loop, with an iterator the entire dataset does not need to be loaded into memory.\n",
        "\n",
        "The DataLoader needs to know our batch size for training. For fine-tuning BERT on a specific task, the authors of the [BERT paper](https://arxiv.org/pdf/1810.04805.pdf) recommend a batch size of 16 or 32. Note that increasing the batch size reduces the training time significantly, but gives you lower accuracy."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "DWB_O88TyT7I"
      },
      "source": [
        "# We have selected a batch size of 16 here\n",
        "\n",
        "batch_size = 16"
      ],
      "execution_count": 31,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "vghrKe9lyfBa"
      },
      "source": [
        "# Create the DataLoaders for our training and validation sets.\n",
        "\n",
        "train_data_loader = DataLoader(train_data, batch_size, sampler=RandomSampler(train_data), num_workers=4)\n",
        "valid_data_loader = DataLoader(valid_data, batch_size, sampler=SequentialSampler(valid_data), num_workers=4)"
      ],
      "execution_count": 32,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Pj1ei-Ok4UE3"
      },
      "source": [
        "## 7. Train Our Classification Model\n",
        "\n",
        "We are now ready to fine-tune our BERT model having ensured that our input data is properly formatted.\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 7.1 BertForSequenceClassification\n",
        "\n",
        "We will now load and modify the pre-trained BERT model to give outputs for classification using the BertForSequenceClassification class for fine-tuning. This adds an additional untrained classification layer on top of the model which is then trained on our specific task as we feed input data."
      ],
      "metadata": {
        "id": "t1zgAQmEutse"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Load BertForSequenceClassification, the pretrained BERT model with a single linear classification layer on top. \n",
        "model = BertForSequenceClassification.from_pretrained(\n",
        "    \"bert-base-uncased\", # Use the 12-layer BERT model, with an uncased vocab.\n",
        "    return_dict=False, # https://github.com/wandb/client/issues/1627 and 4. https://huggingface.co/transformers/migration.html\n",
        "    num_labels = 2, # The number of output labels--2 for binary classification.\n",
        "                    # You can increase this for multi-class tasks.   \n",
        "    output_attentions = False, # Whether the model returns attentions weights.\n",
        "    output_hidden_states = False, # Whether the model returns all hidden-states.\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "d1ddd4c416494eeaa30648eb6c94783d",
            "b1a0f6de49aa4d629d972cd4649538c5",
            "843725fc45da4889b8b119fcb0caad50",
            "8e44c4e3abaf40ac832fa7cbbc85a8f2",
            "46481f3be96948b390538d52a1300dff",
            "c5012b62253542dda12e4df98bbdcb2e",
            "1d51d0df5ae1403f802d79226e460e29",
            "ead04d73417e4c828e6456733ed18b65",
            "9d116e218ca14febb31ba38d2863a56e",
            "aa6f3119ecb04cbe8a95de93a55460c8",
            "8f6241d5cdec4e39a29c7c2d7c8f798b"
          ]
        },
        "id": "RKr-ashZbXkP",
        "outputId": "6ccab7ba-5069-43b8-efcb-f96dc24a36d5"
      },
      "execution_count": 33,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading:   0%|          | 0.00/440M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "d1ddd4c416494eeaa30648eb6c94783d"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "RVfk0bqdCMhm"
      },
      "source": [
        "### Use GPU for training\n",
        "\n",
        "In order for torch to use the GPU, we identifed and specified the GPU as the device in the imports at the start of the notebook. \n",
        "\n",
        "Here we tell PyTorch to run the model on the GPU to reduce training time."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Mv5uGPGU0nf7"
      },
      "source": [
        "# move model to GPU\n",
        "model = model.to(device)\n"
      ],
      "execution_count": 34,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "mUhszC6tHzHH"
      },
      "source": [
        "### Model parameters\n",
        "\n",
        "BERT base model contains an encoder with 12 Transformer layers, 12 self-attention heads, and a hidden size of 768.\n",
        "\n",
        "We can browse all of the model’s parameters by name here and see the names and dimensions of the weights for:\n",
        "1.   The embedding layer.\n",
        "2.   The first of the twelve transformers.\n",
        "2.   The output layer.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Get all of the model's parameters as a list of tuples.\n",
        "params = list(model.named_parameters())\n",
        "\n",
        "print(f'The BERT model has {len(params):} different named parameters.\\n')\n",
        "\n",
        "print('==== Embedding Layer ====\\n')\n",
        "\n",
        "for p in params[0:5]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")\n",
        "\n",
        "print('\\n==== First Transformer ====\\n')\n",
        "\n",
        "for p in params[5:21]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")\n",
        "\n",
        "print('\\n==== Output Layer ====\\n')\n",
        "\n",
        "for p in params[-4:]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "e96o7lQs_bUi",
        "outputId": "28ec5339-4e29-4d4b-e8f7-29ef913143d0"
      },
      "execution_count": 35,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "The BERT model has 201 different named parameters.\n",
            "\n",
            "==== Embedding Layer ====\n",
            "\n",
            "bert.embeddings.word_embeddings.weight                  (30522, 768)\n",
            "bert.embeddings.position_embeddings.weight                (512, 768)\n",
            "bert.embeddings.token_type_embeddings.weight                (2, 768)\n",
            "bert.embeddings.LayerNorm.weight                              (768,)\n",
            "bert.embeddings.LayerNorm.bias                                (768,)\n",
            "\n",
            "==== First Transformer ====\n",
            "\n",
            "bert.encoder.layer.0.attention.self.query.weight          (768, 768)\n",
            "bert.encoder.layer.0.attention.self.query.bias                (768,)\n",
            "bert.encoder.layer.0.attention.self.key.weight            (768, 768)\n",
            "bert.encoder.layer.0.attention.self.key.bias                  (768,)\n",
            "bert.encoder.layer.0.attention.self.value.weight          (768, 768)\n",
            "bert.encoder.layer.0.attention.self.value.bias                (768,)\n",
            "bert.encoder.layer.0.attention.output.dense.weight        (768, 768)\n",
            "bert.encoder.layer.0.attention.output.dense.bias              (768,)\n",
            "bert.encoder.layer.0.attention.output.LayerNorm.weight        (768,)\n",
            "bert.encoder.layer.0.attention.output.LayerNorm.bias          (768,)\n",
            "bert.encoder.layer.0.intermediate.dense.weight           (3072, 768)\n",
            "bert.encoder.layer.0.intermediate.dense.bias                 (3072,)\n",
            "bert.encoder.layer.0.output.dense.weight                 (768, 3072)\n",
            "bert.encoder.layer.0.output.dense.bias                        (768,)\n",
            "bert.encoder.layer.0.output.LayerNorm.weight                  (768,)\n",
            "bert.encoder.layer.0.output.LayerNorm.bias                    (768,)\n",
            "\n",
            "==== Output Layer ====\n",
            "\n",
            "bert.pooler.dense.weight                                  (768, 768)\n",
            "bert.pooler.dense.bias                                        (768,)\n",
            "classifier.weight                                           (2, 768)\n",
            "classifier.bias                                                 (2,)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IzeIwD2CIZDR"
      },
      "source": [
        "### 7.2 Optimiser and Learning Rate Scheduler\n",
        "\n",
        "Now that we have loaded our “bert-base-uncased” model with BertForSequenceClassification we need to fine-tune the training hyperparameters from within the stored model. \n",
        "\n",
        "For the purposes of fine-tuning, the authors recommend choosing from the following values (from Appendix A.3 of the [BERT paper](https://arxiv.org/pdf/1810.04805.pdf)):\n",
        "\n",
        "*   **Batch size:** 16, 32\n",
        "*   **Learning rate (Adam):** 5e-5, 3e-5, 2e-5\n",
        "*   **Number of epochs:** 2, 3, 4\n",
        "\n",
        "We will choose:\n",
        "\n",
        "*   **Batch size:** 16 (set when creating our DataLoaders)\n",
        "*   **Learning rate (Adam):** 2e-5\n",
        "*   **Number of epochs:** 3\n",
        "\n",
        "\n",
        "To reproduce the training procedure from the BERT paper, we’ll use the [AdamW](https://huggingface.co/transformers/main_classes/optimizer_schedules.html#adamw) optimiser provided by the Hugging Face library (as opposed to PyTorch). It corrects weight decay (the 'W' stands for 'Weight Decay fix'), so it’s similar to the original paper. We’ll also use a linear scheduler with no warmup steps.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "T14S1sleBh9A"
      },
      "source": [
        "# Parameters:\n",
        "lr =  2e-5             \n",
        "adam_epsilon = 1e-8\n",
        "\n",
        "# Number of training epochs (The BERT authors recommend between 2 and 4)\n",
        "epochs = 3\n",
        "\n",
        "num_warmup_steps = 0 # Default value in run_glue.py (a utility which allows you to pick which GLUE benchmark task you want to run on)\n",
        "num_training_steps = len(train_data_loader) * epochs # Total number of training steps is [number of batches] x [number of epochs]. \n",
        "\n",
        "#In Transformers, optimiser and schedules are split and instantiated like this:\n",
        "optimizer = AdamW(model.parameters(), lr=lr,eps=adam_epsilon,correct_bias=False)  # To reproduce BertAdam specific behaviour set correct_bias=False\n",
        "scheduler = get_linear_schedule_with_warmup(optimizer, num_warmup_steps=num_warmup_steps, num_training_steps=num_training_steps)  # PyTorch scheduler"
      ],
      "execution_count": 36,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "_h3BBe-2JzcA"
      },
      "source": [
        "### 7.3 Training the model\n",
        "\n",
        "For each pass in our training loop we have a training phase and a validation phase. \n",
        "\n",
        "**Training phase:**\n",
        "\n",
        "*   Set the BERT model to train mode as the default mode is evaluation.\n",
        "*   Iterate over the batch and unpack our data into inputs and labels.\n",
        "*   Load data onto the GPU for acceleration.\n",
        "*   PyTorch by default accumulates the gradients calculated in the previous pass. Clear those previously accumulated gradients.\n",
        "*   Forward pass: feeding input data through all the neurons in the network from first to last layer.\n",
        "*   Backward pass (back-propagation): counting changes in weights (de facto *learning*), using gradient descent algorithm (or similar). Computation is made from last layer, backward to the first layer.\n",
        "*   Post backward pass, network will perform a parameter update **`optimizer.step()`** function, based on the current gradient (stored in **`.grad`** attribute of a parameter) and the update rule.\n",
        "*   Call **`scheduler.step()`** function, to update the learning rate.\n",
        "*   Track variables for monitoring progress.\n",
        "\n",
        "\n",
        "**Validation phase:**\n",
        "\n",
        "*   Unpack validation data inputs and labels.\n",
        "*   Load data onto the GPU for acceleration.\n",
        "*   Forward pass (feed input data through the network) to predict the outputs.\n",
        "*   Compute loss on our validation data and track variables for monitoring progress.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "bY35NqfhJX6v"
      },
      "source": [
        "### Define helper functions\n",
        "\n",
        "Before writing our training loop we will define helper functions for calculating accuracy of our predictions vs labels, and formatting elapsed times as **`hh:mm:ss`** "
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "lzEKlni-BowF"
      },
      "source": [
        "# Helper function to calculate the accuracy of our predictions vs labels\n",
        "def flat_accuracy(preds, labels):\n",
        "    '''\n",
        "    Calculate the accuracy of predictions vs labels\n",
        "\n",
        "    :param preds: logits, or values which are the output of a dense (fully-connected) layer of a neural network model prior to applying an activation function like softmax\n",
        "    :param labels: pytorch tensor for labels after conversion from list\n",
        "\n",
        "    :returns: computed probability\n",
        "    '''\n",
        "    pred_flat = np.argmax(preds, axis=1).flatten()\n",
        "    labels_flat = labels.flatten()\n",
        "    return np.sum(pred_flat == labels_flat) / len(labels_flat)"
      ],
      "execution_count": 37,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "g0DFTvjiBuXV"
      },
      "source": [
        "# Helper function for formatting elapsed times as hh:mm:ss\n",
        "def format_time(elapsed):\n",
        "    '''\n",
        "    Take a time in seconds and return a string hh:mm:ss\n",
        "\n",
        "    :param elapsed: time in seconds\n",
        "    \n",
        "    :returns: time as hh:mm:ss\n",
        "    '''\n",
        "    # Round to the nearest second.\n",
        "    elapsed_rounded = int(round((elapsed)))\n",
        "    \n",
        "    # Format as hh:mm:ss\n",
        "    return str(datetime.timedelta(seconds=elapsed_rounded))"
      ],
      "execution_count": 38,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Start the training\n",
        "\n",
        "The [BERT Fine-Tuning Tutorial with Python](https://mccormickml.com/2019/07/22/BERT-fine-tuning/) was particularly useful here."
      ],
      "metadata": {
        "id": "cUhynC7L1l4N"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# This training code is based on the `run_glue.py` script here:\n",
        "# https://github.com/huggingface/transformers/blob/5bfcd0485ece086ebcbed2d008813037968a9e58/examples/run_glue.py#L128\n",
        "\n",
        "# Set the seed value to make this reproducible.\n",
        "seed_val = 42\n",
        "\n",
        "random.seed(seed_val)\n",
        "np.random.seed(seed_val)\n",
        "torch.manual_seed(seed_val)\n",
        "torch.cuda.manual_seed_all(seed_val)\n",
        "\n",
        "# Store a number of quantities such as training and validation loss, \n",
        "# validation accuracy, and timings.\n",
        "training_stats = []\n",
        "\n",
        "# Measure the total training time for the whole run.\n",
        "total_t0 = time.time()\n",
        "\n",
        "# For each epoch...\n",
        "for epoch_i in range(0, epochs):\n",
        "    \n",
        "    # ========================================\n",
        "    #               Training\n",
        "    # ========================================\n",
        "    \n",
        "    # Perform one full pass over the training set.\n",
        "\n",
        "    print(\"\")\n",
        "    print('======== Epoch {:} / {:} ========'.format(epoch_i + 1, epochs))\n",
        "    print('Training...')\n",
        "\n",
        "    # Measure how long the training epoch takes.\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Reset the total loss for this epoch.\n",
        "    total_train_loss = 0\n",
        "\n",
        "    # Put the model into training mode as the default is evaluation mode. \n",
        "    # The call to `train` just changes the *mode*, it doesn't *perform* the training.\n",
        "    # `dropout` and `batchnorm` layers behave differently during training vs. test\n",
        "    # (source: https://stackoverflow.com/questions/51433378/what-does-model-train-do-in-pytorch)\n",
        "    model.train()\n",
        "\n",
        "    # For each batch of training data...\n",
        "    for step, batch in enumerate(train_data_loader):\n",
        "\n",
        "        # Progress update every 7 batches.\n",
        "        if step % 7 == 0 and not step == 0:\n",
        "            # Calculate elapsed time in minutes.\n",
        "            elapsed = format_time(time.time() - t0)\n",
        "            \n",
        "            # Report progress.\n",
        "            print(f'  Batch {step}  of  {len(train_data_loader)}.    Elapsed: {elapsed}.')\n",
        "\n",
        "        # Unpack this training batch from our dataloader. \n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using the \n",
        "        # `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids \n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels \n",
        "        b_input_ids = batch[0].to(device)\n",
        "        b_input_mask = batch[1].to(device)\n",
        "        b_labels = batch[2].to(device)\n",
        "\n",
        "        # Gradients get accumulated by default.\n",
        "        # Always clear any previously calculated gradients before performing a\n",
        "        # backward pass. PyTorch doesn't do this automatically because \n",
        "        # accumulating the gradients is \"convenient while training RNNs\". \n",
        "        # (source: https://stackoverflow.com/questions/48001598/why-do-we-need-to-call-zero-grad-in-pytorch)\n",
        "        model.zero_grad()        \n",
        "\n",
        "        # Perform a forward pass (evaluate the model on this training batch).\n",
        "        # The documentation for this `model` function is here: \n",
        "        # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "        # It returns different numbers of parameters depending on what arguments are given and what flags are set. \n",
        "        # For our usage here, it returns the loss (because we provided labels) and the \"logits\" - the model\n",
        "        # outputs prior to activation.\n",
        "        loss, logits = model(b_input_ids, \n",
        "                             token_type_ids=None, \n",
        "                             attention_mask=b_input_mask, \n",
        "                             labels=b_labels)\n",
        "\n",
        "        # Accumulate the training loss over all of the batches so that we can\n",
        "        # calculate the average loss at the end. `loss` is a Tensor containing a\n",
        "        # single value; the `.item()` function just returns the Python value \n",
        "        # from the tensor.\n",
        "        total_train_loss += loss.item()\n",
        "\n",
        "        # Perform a backward pass to calculate the gradients.\n",
        "        loss.backward()\n",
        "\n",
        "        # Clip the norm of the gradients to 1.0.\n",
        "        # This is to help prevent the \"exploding gradients\" problem.\n",
        "        # Gradient clipping is not in AdamW anymore.\n",
        "        torch.nn.utils.clip_grad_norm_(model.parameters(), 1.0)\n",
        "\n",
        "        # Update parameters and take a step using the computed gradient.\n",
        "        # The optimizer dictates the \"update rule\"--how the parameters are\n",
        "        # modified based on their gradients, the learning rate, etc.\n",
        "        optimizer.step()\n",
        "\n",
        "        # Update the learning rate.\n",
        "        scheduler.step()\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_train_loss = total_train_loss / len(train_data_loader)            \n",
        "    \n",
        "    # Measure how long this epoch took.\n",
        "    training_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(\"\")\n",
        "    print(f\"  Average training loss: {avg_train_loss:.2f}\")\n",
        "    print(f\"  Training epoch took: {training_time}\")\n",
        "        \n",
        "    # ========================================\n",
        "    #               Validation\n",
        "    # ========================================\n",
        "    # After the completion of each training epoch, measure our performance on\n",
        "    # our validation set.\n",
        "\n",
        "    print(\"\")\n",
        "    print(\"Running Validation...\")\n",
        "\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Put the model in evaluation mode--the dropout layers behave differently\n",
        "    # during evaluation.\n",
        "    model.eval()\n",
        "\n",
        "    # Tracking variables \n",
        "    total_eval_accuracy = 0\n",
        "    total_eval_loss = 0\n",
        "    nb_eval_steps = 0\n",
        "\n",
        "    # Evaluate data for one epoch\n",
        "    for batch in valid_data_loader:\n",
        "        \n",
        "        # Unpack this training batch from our dataloader. \n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using \n",
        "        # the `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids \n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels \n",
        "        b_input_ids = batch[0].to(device)\n",
        "        b_input_mask = batch[1].to(device)\n",
        "        b_labels = batch[2].to(device)\n",
        "        \n",
        "        # Tell pytorch not to bother with constructing the compute graph during\n",
        "        # the forward pass, since this is only needed for backprop (training).\n",
        "        with torch.no_grad():        \n",
        "\n",
        "            # Forward pass, calculate logit predictions.\n",
        "            # token_type_ids is the same as the \"segment ids\", which \n",
        "            # differentiates sentence 1 and 2 in 2-sentence tasks.\n",
        "            # The documentation for this `model` function is here: \n",
        "            # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "            # Get the \"logits\" output by the model. The \"logits\" are the output\n",
        "            # values prior to applying an activation function like the softmax.\n",
        "            (loss, logits) = model(b_input_ids, \n",
        "                                   token_type_ids=None, \n",
        "                                   attention_mask=b_input_mask,\n",
        "                                   labels=b_labels)\n",
        "            \n",
        "        # Accumulate the validation loss.\n",
        "        total_eval_loss += loss.item()\n",
        "\n",
        "        # Move logits and labels to CPU\n",
        "        logits = logits.detach().cpu().numpy()\n",
        "        label_ids = b_labels.to('cpu').numpy()\n",
        "\n",
        "        # Calculate the accuracy for this batch of test sentences, and\n",
        "        # accumulate it over all batches.\n",
        "        total_eval_accuracy += flat_accuracy(logits, label_ids)\n",
        "        \n",
        "\n",
        "    # Report the final accuracy for this validation run.\n",
        "    avg_val_accuracy = total_eval_accuracy / len(valid_data_loader)\n",
        "    print(\"  Accuracy: {0:.2f}\".format(avg_val_accuracy))\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_val_loss = total_eval_loss / len(valid_data_loader)\n",
        "    \n",
        "    # Measure how long the validation run took.\n",
        "    validation_time = format_time(time.time() - t0)\n",
        "    \n",
        "    print(f\"  Validation Loss: {avg_val_loss:.2f}\")\n",
        "    print(f\"  Validation took: {validation_time}\")\n",
        "\n",
        "    # Record all statistics from this epoch.\n",
        "    training_stats.append(\n",
        "        {\n",
        "            'epoch': epoch_i + 1,\n",
        "            'Training Loss': avg_train_loss,\n",
        "            'Valid. Loss': avg_val_loss,\n",
        "            'Valid. Accur.': avg_val_accuracy,\n",
        "            'Training Time': training_time,\n",
        "            'Validation Time': validation_time\n",
        "        }\n",
        "    )\n",
        "\n",
        "print(\"\")\n",
        "print(\"Training complete!\")\n",
        "\n",
        "print(f\"Total training took {format_time(time.time()-total_t0)} (h:mm:ss)\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2X2ZxFUXdXF1",
        "outputId": "9d3e49b3-d2bf-48c5-ac16-3df52ab8fc3a"
      },
      "execution_count": 39,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "======== Epoch 1 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  8.    Elapsed: 0:03:34.\n",
            "\n",
            "  Average training loss: 0.71\n",
            "  Training epoch took: 0:03:44\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.57\n",
            "  Validation Loss: 0.69\n",
            "  Validation took: 0:00:09\n",
            "\n",
            "======== Epoch 2 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  8.    Elapsed: 0:03:44.\n",
            "\n",
            "  Average training loss: 0.70\n",
            "  Training epoch took: 0:03:55\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.57\n",
            "  Validation Loss: 0.70\n",
            "  Validation took: 0:00:09\n",
            "\n",
            "======== Epoch 3 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  8.    Elapsed: 0:03:37.\n",
            "\n",
            "  Average training loss: 0.70\n",
            "  Training epoch took: 0:03:47\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.50\n",
            "  Validation Loss: 0.69\n",
            "  Validation took: 0:00:09\n",
            "\n",
            "Training complete!\n",
            "Total training took 0:11:54 (h:mm:ss)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### View the summary of the training process"
      ],
      "metadata": {
        "id": "Gfe9vSfW1wnI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Display floats with two decimal places.\n",
        "pd.set_option('precision', 2)\n",
        "\n",
        "# Create a DataFrame from our training statistics.\n",
        "df_stats = pd.DataFrame(data=training_stats)\n",
        "\n",
        "# Use the 'epoch' as the row index.\n",
        "df_stats = df_stats.set_index('epoch')\n",
        "\n",
        "# Display the table.\n",
        "df_stats"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 175
        },
        "id": "qff4fCPInc1y",
        "outputId": "2edc81ff-5374-4224-b1f5-97d7573872b4"
      },
      "execution_count": 40,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "       Training Loss  Valid. Loss  Valid. Accur. Training Time Validation Time\n",
              "epoch                                                                         \n",
              "1               0.71         0.69           0.57       0:03:44         0:00:09\n",
              "2               0.70         0.70           0.57       0:03:55         0:00:09\n",
              "3               0.70         0.69           0.50       0:03:47         0:00:09"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-297e4c5d-392e-40f4-880a-4d2e86357d7e\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Valid. Loss</th>\n",
              "      <th>Valid. Accur.</th>\n",
              "      <th>Training Time</th>\n",
              "      <th>Validation Time</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>epoch</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0.71</td>\n",
              "      <td>0.69</td>\n",
              "      <td>0.57</td>\n",
              "      <td>0:03:44</td>\n",
              "      <td>0:00:09</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0.70</td>\n",
              "      <td>0.70</td>\n",
              "      <td>0.57</td>\n",
              "      <td>0:03:55</td>\n",
              "      <td>0:00:09</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>0.70</td>\n",
              "      <td>0.69</td>\n",
              "      <td>0.50</td>\n",
              "      <td>0:03:47</td>\n",
              "      <td>0:00:09</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-297e4c5d-392e-40f4-880a-4d2e86357d7e')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-297e4c5d-392e-40f4-880a-4d2e86357d7e button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-297e4c5d-392e-40f4-880a-4d2e86357d7e');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 40
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that both the training and validation loss are going down with each epoch and although the validation accuracy increased between the first and second epochs it did not continue to increase between the second and third.\n",
        "\n",
        "The [BERT Fine-Tuning Tutorial with PyTorch](https://mccormickml.com/2019/07/22/BERT-fine-tuning/) argues that validation loss is a more precise measure than accuracy, because with accuracy we are not interested in the exact output value, only which side of a threshold it falls on. If we are predicting the correct answer, but with less confidence, then validation loss will catch this, while accuracy will not."
      ],
      "metadata": {
        "id": "X_kTe4WblwZi"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Save stats\n",
        "\n",
        "df_stats.to_pickle(\"bert_train_val_stats_v1.pkl\")"
      ],
      "metadata": {
        "id": "CiZ5VCyFnlzO"
      },
      "execution_count": 41,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Plot training and validation loss\n",
        "\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "id": "OjnxSmZO165J"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (12,6)\n",
        "\n",
        "# Plot the learning curve.\n",
        "plt.plot(df_stats['Training Loss'], 'b-o', label=\"Training\")\n",
        "plt.plot(df_stats['Valid. Loss'], 'g-o', label=\"Validation\")\n",
        "\n",
        "# Label the plot.\n",
        "plt.title(\"Training & Validation Loss\")\n",
        "plt.xlabel(\"Epoch\")\n",
        "plt.ylabel(\"Loss\")\n",
        "plt.legend()\n",
        "plt.xticks([1, 2, 3])\n",
        "\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 427
        },
        "id": "MXCdrZsBnpjx",
        "outputId": "b2946855-9603-4f6b-cebd-36b16d7dad4b"
      },
      "execution_count": 42,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 864x432 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We will run the training loop again after changing the progress update to be every 8 instead of every 7 batches."
      ],
      "metadata": {
        "id": "WvYpw9-mp2--"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# This training code is based on the `run_glue.py` script here:\n",
        "# https://github.com/huggingface/transformers/blob/5bfcd0485ece086ebcbed2d008813037968a9e58/examples/run_glue.py#L128\n",
        "\n",
        "# Set the seed value to make this reproducible.\n",
        "seed_val = 42\n",
        "\n",
        "random.seed(seed_val)\n",
        "np.random.seed(seed_val)\n",
        "torch.manual_seed(seed_val)\n",
        "torch.cuda.manual_seed_all(seed_val)\n",
        "\n",
        "# Store a number of quantities such as training and validation loss, \n",
        "# validation accuracy, and timings.\n",
        "training_stats = []\n",
        "\n",
        "# Measure the total training time for the whole run.\n",
        "total_t0 = time.time()\n",
        "\n",
        "# For each epoch...\n",
        "for epoch_i in range(0, epochs):\n",
        "    \n",
        "    # ========================================\n",
        "    #               Training\n",
        "    # ========================================\n",
        "    \n",
        "    # Perform one full pass over the training set.\n",
        "\n",
        "    print(\"\")\n",
        "    print('======== Epoch {:} / {:} ========'.format(epoch_i + 1, epochs))\n",
        "    print('Training...')\n",
        "\n",
        "    # Measure how long the training epoch takes.\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Reset the total loss for this epoch.\n",
        "    total_train_loss = 0\n",
        "\n",
        "    # Put the model into training mode as the default is evaluation mode. \n",
        "    # The call to `train` just changes the *mode*, it doesn't *perform* the training.\n",
        "    # `dropout` and `batchnorm` layers behave differently during training vs. test\n",
        "    # (source: https://stackoverflow.com/questions/51433378/what-does-model-train-do-in-pytorch)\n",
        "    model.train()\n",
        "\n",
        "    # For each batch of training data...\n",
        "    for step, batch in enumerate(train_data_loader):\n",
        "\n",
        "        # Progress update every 8 batches.\n",
        "        if step % 8 == 0 and not step == 0:\n",
        "            # Calculate elapsed time in minutes.\n",
        "            elapsed = format_time(time.time() - t0)\n",
        "            \n",
        "            # Report progress.\n",
        "            print(f'  Batch {step}  of  {len(train_data_loader)}.    Elapsed: {elapsed}.')\n",
        "\n",
        "        # Unpack this training batch from our dataloader. \n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using the \n",
        "        # `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids \n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels \n",
        "        b_input_ids = batch[0].to(device)\n",
        "        b_input_mask = batch[1].to(device)\n",
        "        b_labels = batch[2].to(device)\n",
        "\n",
        "        # Gradients get accumulated by default.\n",
        "        # Always clear any previously calculated gradients before performing a\n",
        "        # backward pass. PyTorch doesn't do this automatically because \n",
        "        # accumulating the gradients is \"convenient while training RNNs\". \n",
        "        # (source: https://stackoverflow.com/questions/48001598/why-do-we-need-to-call-zero-grad-in-pytorch)\n",
        "        model.zero_grad()        \n",
        "\n",
        "        # Perform a forward pass (evaluate the model on this training batch).\n",
        "        # The documentation for this `model` function is here: \n",
        "        # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "        # It returns different numbers of parameters depending on what arguments are given and what flags are set. \n",
        "        # For our usage here, it returns the loss (because we provided labels) and the \"logits\" - the model\n",
        "        # outputs prior to activation.\n",
        "        loss, logits = model(b_input_ids, \n",
        "                             token_type_ids=None, \n",
        "                             attention_mask=b_input_mask, \n",
        "                             labels=b_labels)\n",
        "\n",
        "        # Accumulate the training loss over all of the batches so that we can\n",
        "        # calculate the average loss at the end. `loss` is a Tensor containing a\n",
        "        # single value; the `.item()` function just returns the Python value \n",
        "        # from the tensor.\n",
        "        total_train_loss += loss.item()\n",
        "\n",
        "        # Perform a backward pass to calculate the gradients.\n",
        "        loss.backward()\n",
        "\n",
        "        # Clip the norm of the gradients to 1.0.\n",
        "        # This is to help prevent the \"exploding gradients\" problem.\n",
        "        # Gradient clipping is not in AdamW anymore.\n",
        "        torch.nn.utils.clip_grad_norm_(model.parameters(), 1.0)\n",
        "\n",
        "        # Update parameters and take a step using the computed gradient.\n",
        "        # The optimizer dictates the \"update rule\"--how the parameters are\n",
        "        # modified based on their gradients, the learning rate, etc.\n",
        "        optimizer.step()\n",
        "\n",
        "        # Update the learning rate.\n",
        "        scheduler.step()\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_train_loss = total_train_loss / len(train_data_loader)            \n",
        "    \n",
        "    # Measure how long this epoch took.\n",
        "    training_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(\"\")\n",
        "    print(f\"  Average training loss: {avg_train_loss:.2f}\")\n",
        "    print(f\"  Training epoch took: {training_time}\")\n",
        "        \n",
        "    # ========================================\n",
        "    #               Validation\n",
        "    # ========================================\n",
        "    # After the completion of each training epoch, measure our performance on\n",
        "    # our validation set.\n",
        "\n",
        "    print(\"\")\n",
        "    print(\"Running Validation...\")\n",
        "\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Put the model in evaluation mode--the dropout layers behave differently\n",
        "    # during evaluation.\n",
        "    model.eval()\n",
        "\n",
        "    # Tracking variables \n",
        "    total_eval_accuracy = 0\n",
        "    total_eval_loss = 0\n",
        "    nb_eval_steps = 0\n",
        "\n",
        "    # Evaluate data for one epoch\n",
        "    for batch in valid_data_loader:\n",
        "        \n",
        "        # Unpack this training batch from our dataloader. \n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using \n",
        "        # the `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids \n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels \n",
        "        b_input_ids = batch[0].to(device)\n",
        "        b_input_mask = batch[1].to(device)\n",
        "        b_labels = batch[2].to(device)\n",
        "        \n",
        "        # Tell pytorch not to bother with constructing the compute graph during\n",
        "        # the forward pass, since this is only needed for backprop (training).\n",
        "        with torch.no_grad():        \n",
        "\n",
        "            # Forward pass, calculate logit predictions.\n",
        "            # token_type_ids is the same as the \"segment ids\", which \n",
        "            # differentiates sentence 1 and 2 in 2-sentence tasks.\n",
        "            # The documentation for this `model` function is here: \n",
        "            # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "            # Get the \"logits\" output by the model. The \"logits\" are the output\n",
        "            # values prior to applying an activation function like the softmax.\n",
        "            (loss, logits) = model(b_input_ids, \n",
        "                                   token_type_ids=None, \n",
        "                                   attention_mask=b_input_mask,\n",
        "                                   labels=b_labels)\n",
        "            \n",
        "        # Accumulate the validation loss.\n",
        "        total_eval_loss += loss.item()\n",
        "\n",
        "        # Move logits and labels to CPU\n",
        "        logits = logits.detach().cpu().numpy()\n",
        "        label_ids = b_labels.to('cpu').numpy()\n",
        "\n",
        "        # Calculate the accuracy for this batch of test sentences, and\n",
        "        # accumulate it over all batches.\n",
        "        total_eval_accuracy += flat_accuracy(logits, label_ids)\n",
        "        \n",
        "\n",
        "    # Report the final accuracy for this validation run.\n",
        "    avg_val_accuracy = total_eval_accuracy / len(valid_data_loader)\n",
        "    print(\"  Accuracy: {0:.2f}\".format(avg_val_accuracy))\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_val_loss = total_eval_loss / len(valid_data_loader)\n",
        "    \n",
        "    # Measure how long the validation run took.\n",
        "    validation_time = format_time(time.time() - t0)\n",
        "    \n",
        "    print(f\"  Validation Loss: {avg_val_loss:.2f}\")\n",
        "    print(f\"  Validation took: {validation_time}\")\n",
        "\n",
        "    # Record all statistics from this epoch.\n",
        "    training_stats.append(\n",
        "        {\n",
        "            'epoch': epoch_i + 1,\n",
        "            'Training Loss': avg_train_loss,\n",
        "            'Valid. Loss': avg_val_loss,\n",
        "            'Valid. Accur.': avg_val_accuracy,\n",
        "            'Training Time': training_time,\n",
        "            'Validation Time': validation_time\n",
        "        }\n",
        "    )\n",
        "\n",
        "print(\"\")\n",
        "print(\"Training complete!\")\n",
        "\n",
        "print(f\"Total training took {format_time(time.time()-total_t0)} (h:mm:ss)\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "eFw0esbpsCJO",
        "outputId": "68109002-d807-41b8-a6b1-7d852aeb75a3"
      },
      "execution_count": 43,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "======== Epoch 1 / 3 ========\n",
            "Training...\n",
            "\n",
            "  Average training loss: 0.66\n",
            "  Training epoch took: 0:03:48\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.50\n",
            "  Validation Loss: 0.69\n",
            "  Validation took: 0:00:10\n",
            "\n",
            "======== Epoch 2 / 3 ========\n",
            "Training...\n",
            "\n",
            "  Average training loss: 0.63\n",
            "  Training epoch took: 0:03:49\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.50\n",
            "  Validation Loss: 0.69\n",
            "  Validation took: 0:00:10\n",
            "\n",
            "======== Epoch 3 / 3 ========\n",
            "Training...\n",
            "\n",
            "  Average training loss: 0.65\n",
            "  Training epoch took: 0:03:50\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.50\n",
            "  Validation Loss: 0.69\n",
            "  Validation took: 0:00:10\n",
            "\n",
            "Training complete!\n",
            "Total training took 0:11:56 (h:mm:ss)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Display floats with two decimal places.\n",
        "pd.set_option('precision', 2)\n",
        "\n",
        "# Create a DataFrame from our training statistics.\n",
        "df_stats = pd.DataFrame(data=training_stats)\n",
        "\n",
        "# Use the 'epoch' as the row index.\n",
        "df_stats = df_stats.set_index('epoch')\n",
        "\n",
        "# Display the table.\n",
        "df_stats"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 175
        },
        "id": "9o56T3Ngz0N4",
        "outputId": "ab20f009-0392-4eb6-9111-09695eff0e73"
      },
      "execution_count": 44,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "       Training Loss  Valid. Loss  Valid. Accur. Training Time Validation Time\n",
              "epoch                                                                         \n",
              "1               0.66         0.69            0.5       0:03:48         0:00:10\n",
              "2               0.63         0.69            0.5       0:03:49         0:00:10\n",
              "3               0.65         0.69            0.5       0:03:50         0:00:10"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-04920538-9aaa-478c-ab63-1895454022a5\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Valid. Loss</th>\n",
              "      <th>Valid. Accur.</th>\n",
              "      <th>Training Time</th>\n",
              "      <th>Validation Time</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>epoch</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0.66</td>\n",
              "      <td>0.69</td>\n",
              "      <td>0.5</td>\n",
              "      <td>0:03:48</td>\n",
              "      <td>0:00:10</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0.63</td>\n",
              "      <td>0.69</td>\n",
              "      <td>0.5</td>\n",
              "      <td>0:03:49</td>\n",
              "      <td>0:00:10</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>0.65</td>\n",
              "      <td>0.69</td>\n",
              "      <td>0.5</td>\n",
              "      <td>0:03:50</td>\n",
              "      <td>0:00:10</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-04920538-9aaa-478c-ab63-1895454022a5')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-04920538-9aaa-478c-ab63-1895454022a5 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-04920538-9aaa-478c-ab63-1895454022a5');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 44
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that while training and validation loss do go down albeit not with every epoch, the validation accuracy score markedly decreases then increases again and so is perhaps not such a reliable metric as suggested in the tutorial."
      ],
      "metadata": {
        "id": "U3p6rIG6qddf"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Save stats\n",
        "\n",
        "df_stats.to_pickle(\"bert_train_val_stats_v2.pkl\")"
      ],
      "metadata": {
        "id": "hAYHLwXDz_ae"
      },
      "execution_count": 45,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### View the summary of the training process"
      ],
      "metadata": {
        "id": "Nx5DEH9KrrDt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (12,6)\n",
        "\n",
        "# Plot the learning curve.\n",
        "plt.plot(df_stats['Training Loss'], 'b-o', label=\"Training\")\n",
        "plt.plot(df_stats['Valid. Loss'], 'g-o', label=\"Validation\")\n",
        "\n",
        "# Label the plot.\n",
        "plt.title(\"Training & Validation Loss\")\n",
        "plt.xlabel(\"Epoch\")\n",
        "plt.ylabel(\"Loss\")\n",
        "plt.legend()\n",
        "plt.xticks([1, 2, 3])\n",
        "\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 427
        },
        "id": "czuY7TX70Ln4",
        "outputId": "187a9aad-3838-49e9-a3f7-537cc5b58baa"
      },
      "execution_count": 46,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 864x432 with 1 Axes>"
            ],
            "image/png": "iVBORw0KGgoAAAANSUhEUgAAAvAAAAGaCAYAAABpIXfbAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjIsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+WH4yJAAAgAElEQVR4nOzdeUBU5cI/8O/MMAPIqjADAoK4wCACDoh7iihKamouYYtmi9m9t03T0vfqvbfur7c3MteWm+k1UcxUMEXTW7mVZqKCmAokSMoOguw7c35/EHObBpRRYDj6/fxTPOd5znnOQE9fHp7zHIkgCAKIiIiIiEgUpKbuABERERERtR0DPBERERGRiDDAExERERGJCAM8EREREZGIMMATEREREYkIAzwRERERkYgwwBPRAy8rKwve3t7YsGHDXZ9j2bJl8Pb2bsde3b9a+7y9vb2xbNmyNp1jw4YN8Pb2RlZWVrv3LzY2Ft7e3jhz5ky7n5uIqD2YmboDRER/ZEwQPnLkCNzc3DqwN+JTVVWFf/3rX/j6669RUFCAHj16ICgoCH/+85/Rt2/fNp3jlVdewX/+8x989dVX8PHxabGOIAgYN24cysrKcPLkSVhYWLTnbXSoM2fOID4+Hk8//TRsbW1N3R0DWVlZGDduHJ588kn87W9/M3V3iKiLYYAnoi4nMjJS7+vz58/jyy+/REREBIKCgvSO9ejR456v5+rqiosXL0Imk931Of75z3/irbfeuue+tIcVK1bg4MGDmDJlCoYMGYLCwkIcPXoUSUlJbQ7ws2bNwn/+8x/ExMRgxYoVLdb56aefkJ2djYiIiHYJ7xcvXoRU2jl/GI6Pj8eHH36IRx991CDAT5s2DZMnT4ZcLu+UvhARGYsBnoi6nGnTpul93djYiC+//BKDBg0yOPZHFRUVsLa2Nup6EokE5ubmRvfz97pK2Kuursbhw4cxatQofPDBB7ryl156CXV1dW0+z6hRo9CzZ0/ExcXhjTfegEKhMKgTGxsLoCnst4d7/R60F5lMdk+/zBERdTSugSci0QoNDcXcuXNx5coVPPfccwgKCsLUqVMBNAX5NWvWYPbs2Rg6dCgGDhyIsLAwrFq1CtXV1XrnaWlN9u/Ljh07hpkzZ8LPzw+jRo3Ce++9h4aGBr1ztLQGvrmsvLwcf//73zF8+HD4+flhzpw5SEpKMrifW7duYfny5Rg6dCg0Gg3mzZuHK1euYO7cuQgNDW3TZyKRSCCRSFr8haKlEN4aqVSKRx99FCUlJTh69KjB8YqKCnzzzTfw8vKCv7+/UZ93a1paA6/VavHpp58iNDQUfn5+mDJlCvbv399i+/T0dPzjH//A5MmTodFoEBAQgBkzZmD37t169ZYtW4YPP/wQADBu3Dh4e3vrff9bWwNfXFyMt956C2PGjMHAgQMxZswYvPXWW7h165Zeveb2p0+fxubNmzF+/HgMHDgQEydOxN69e9v0WRgjJSUFf/nLXzB06FD4+flh0qRJ+Oyzz9DY2KhXLzc3F8uXL8fYsWMxcOBADB8+HHPmzNHrk1arxeeff45HHnkEGo0GgYGBmDhxIv7nf/4H9fX17d53Iro7nIEnIlHLycnB008/jfDwcEyYMAFVVVUAgPz8fOzZswcTJkzAlClTYGZmhvj4eGzatAnJycnYvHlzm85/4sQJ7NixA3PmzMHMmTNx5MgR/Pvf/4adnR1efPHFNp3jueeeQ48ePfCXv/wFJSUl2LJlC1544QUcOXJE99eCuro6PPPMM0hOTsaMGTPg5+eH1NRUPPPMM7Czs2vz52FhYYHp06cjJiYGBw4cwJQpU9rc9o9mzJiBTz75BLGxsQgPD9c7dvDgQdTU1GDmzJkA2u/z/qN3330XUVFRCA4Oxvz581FUVIS3334bvXr1MqgbHx+Pc+fOISQkBG5ubrq/RqxYsQLFxcVYuHAhACAiIgIVFRX49ttvsXz5cnTv3h3A7Z+9KC8vx+OPP47r169j5syZGDBgAJKTk/HFF1/gp59+wu7duw3+8rNmzRrU1NQgIiICCoUCX3zxBZYtWwZ3d3eDpWB36+eff8bcuXNhZmaGJ598Eo6Ojjh27BhWrVqFlJQU3V9hGhoa8MwzzyA/Px9PPPEEevfujYqKCqSmpuLcuXN49NFHAQCffPIJ1q9fj7Fjx2LOnDmQyWTIysrC0aNHUVdX12X+0kT0wBOIiLq4mJgYwcvLS4iJidErHzt2rODl5SXs2rXLoE1tba1QV1dnUL5mzRrBy8tLSEpK0pVlZmYKXl5ewvr16w3KAgIChMzMTF25VqsVJk+eLIwcOVLvvG+++abg5eXVYtnf//53vfKvv/5a8PLyEr744gtd2fbt2wUvLy/h448/1qvbXD527FiDe2lJeXm5sGDBAmHgwIHCgAEDhIMHD7apXWvmzZsn+Pj4CPn5+Xrljz32mODr6ysUFRUJgnDvn7cgCIKXl5fw5ptv6r5OT08XvL29hXnz5gkNDQ268kuXLgne3t6Cl5eX3vemsrLS4PqNjY3CU089JQQGBur1b/369QbtmzX/vP3000+6stWrVwteXl7C9u3b9eo2f3/WrFlj0H7atGlCbW2trjwvL0/w9fUVFi1aZHDNP2r+jN56663b1ouIiBB8fHyE5ORkXZlWqxVeeeUVwcvLS/jxxx8FQRCE5ORkwcvLS9i4ceNtzzd9+nTh4YcfvmP/iMi0uISGiETN3t4eM2bMMChXKBS62cKGhgaUlpaiuLgYI0aMAIAWl7C0ZNy4cXq73EgkEgwdOhSFhYWorKxs0znmz5+v9/WwYcMAANevX9eVHTt2DDKZDPPmzdOrO3v2bNjY2LTpOlqtFq+++ipSUlJw6NAhjB49GkuWLEFcXJxevZUrV8LX17dNa+JnzZqFxsZGfPXVV7qy9PR0XLhwAaGhobqHiNvr8/69I0eOQBAEPPPMM3pr0n19fTFy5EiD+t26ddP9e21tLW7duoWSkhKMHDkSFRUVuHbtmtF9aPbtt9+iR48eiIiI0CuPiIhAjx498N133xm0eeKJJ/SWLTk5OcHT0xO//vrrXffj94qKipCYmIjQ0FCo1WpduUQiwZ/+9CddvwHofobOnDmDoqKiVs9pbW2N/Px8nDt3rl36SEQdg0toiEjUevXq1eoDh9HR0di5cyfS0tKg1Wr1jpWWlrb5/H9kb28PACgpKYGVlZXR52heslFSUqIry8rKgkqlMjifQqGAm5sbysrK7nidI0eO4OTJk3j//ffh5uaGdevW4aWXXsIbb7yBhoYG3TKJ1NRU+Pn5tWlN/IQJE2Bra4vY2Fi88MILAICYmBgA0C2fadYen/fvZWZmAgD69OljcKxv3744efKkXlllZSU+/PBDHDp0CLm5uQZt2vIZtiYrKwsDBw6EmZn+/zbNzMzQu3dvXLlyxaBNaz872dnZd92PP/YJAPr162dwrE+fPpBKpbrP0NXVFS+++CI2btyIUaNGwcfHB8OGDUN4eDj8/f117RYvXoy//OUvePLJJ6FSqTBkyBCEhIRg4sSJRj1DQUQdiwGeiETN0tKyxfItW7bg//7v/zBq1CjMmzcPKpUKcrkc+fn5WLZsGQRBaNP5b7cbyb2eo63t26r5ocvg4GAATeH/ww8/xJ/+9CcsX74cDQ0NUKvVSEpKwjvvvNOmc5qbm2PKlCnYsWMHEhISEBAQgP3798PZ2RkPPfSQrl57fd734vXXX8fx48fx2GOPITg4GPb29pDJZDhx4gQ+//xzg18qOlpnbYnZVosWLcKsWbNw/PhxnDt3Dnv27MHmzZvx/PPPY+nSpQAAjUaDb7/9FidPnsSZM2dw5swZHDhwAJ988gl27Nih++WViEyLAZ6I7kv79u2Dq6srPvvsM70g9f3335uwV61zdXXF6dOnUVlZqTcLX19fj6ysrDa9bKj5PrOzs9GzZ08ATSH+448/xosvvoiVK1fC1dUVXl5emD59epv7NmvWLOzYsQOxsbEoLS1FYWEhXnzxRb3PtSM+7+YZ7GvXrsHd3V3vWHp6ut7XZWVlOH78OKZNm4a3335b79iPP/5ocG6JRGJ0XzIyMtDQ0KA3C9/Q0IBff/21xdn2jta8tCstLc3g2LVr16DVag361atXL8ydOxdz585FbW0tnnvuOWzatAnPPvssHBwcAABWVlaYOHEiJk6cCKDpLytvv/029uzZg+eff76D74qI2qJrTQ8QEbUTqVQKiUSiN/Pb0NCAzz77zIS9al1oaCgaGxsRFRWlV75r1y6Ul5e36RxjxowB0LT7ye/Xt5ubm2P16tWwtbVFVlYWJk6caLAU5HZ8fX3h4+ODr7/+GtHR0ZBIJAZ7v3fE5x0aGgqJRIItW7bobYl4+fJlg1De/EvDH2f6CwoKDLaRBP67Xr6tS3vGjx+P4uJig3Pt2rULxcXFGD9+fJvO054cHByg0Whw7Ngx/PLLL7pyQRCwceNGAEBYWBiApl10/rgNpLm5uW55UvPnUFxcbHAdX19fvTpEZHqcgSei+1J4eDg++OADLFiwAGFhYaioqMCBAweMCq6dafbs2di5cyfWrl2LGzdu6LaRPHz4MDw8PAz2nW/JyJEjMWvWLOzZsweTJ0/GtGnT4OzsjMzMTOzbtw9AUxj76KOP0LdvXzz88MNt7t+sWbPwz3/+Ez/88AOGDBliMLPbEZ9337598eSTT2L79u14+umnMWHCBBQVFSE6OhpqtVpv3bm1tTVGjhyJ/fv3w8LCAn5+fsjOzsaXX34JNzc3vecNACAgIAAAsGrVKjzyyCMwNzdH//794eXl1WJfnn/+eRw+fBhvv/02rly5Ah8fHyQnJ2PPnj3w9PTssJnpS5cu4eOPPzYoNzMzwwsvvIC//vWvmDt3Lp588kk88cQTUCqVOHbsGE6ePIkpU6Zg+PDhAJqWV61cuRITJkyAp6cnrKyscOnSJezZswcBAQG6ID9p0iQMGjQI/v7+UKlUKCwsxK5duyCXyzF58uQOuUciMl7X/D8ZEdE9eu655yAIAvbs2YN33nkHSqUSDz/8MGbOnIlJkyaZunsGFAoFtm7disjISBw5cgSHDh2Cv78/Pv/8c/z1r39FTU1Nm87zzjvvYMiQIdi5cyc2b96M+vp6uLq6Ijw8HM8++ywUCgUiIiKwdOlS2NjYYNSoUW067yOPPILIyEjU1tYaPLwKdNzn/de//hWOjo7YtWsXIiMj0bt3b/ztb3/D9evXDR4cff/99/HBBx/g6NGj2Lt3L3r37o1FixbBzMwMy5cv16sbFBSEJUuWYOfOnVi5ciUaGhrw0ksvtRrgbWxs8MUXX2D9+vU4evQoYmNj4eDggDlz5uDll182+u2/bZWUlNTiDj4KhQIvvPAC/Pz8sHPnTqxfvx5ffPEFqqqq0KtXLyxZsgTPPvusrr63tzfCwsIQHx+PuLg4aLVa9OzZEwsXLtSr9+yzz+LEiRPYtm0bysvL4eDggICAACxcuFBvpxsiMi2J0BlPFhER0V1pbGzEsGHD4O/vf9cvQyIiovsL18ATEXURLc2y79y5E2VlZS3ue05ERA8mLqEhIuoiVqxYgbq6Omg0GigUCiQmJuLAgQPw8PDAY489ZuruERFRF8ElNEREXcRXX32F6Oho/Prrr6iqqoKDgwPGjBmDV199FY6OjqbuHhERdREM8EREREREIsI18EREREREIsIAT0REREQkInyI1Ui3blVCq+38VUcODtYoKqro9OsSEd0rjl9EJFamGr+kUgm6d7dq9TgDvJG0WsEkAb752kREYsTxi4jEqiuOX1xCQ0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiJn0Ta11dHdatW4d9+/ahrKwMarUaixYtwvDhw9vUPi4uDlu3bkVaWhoUCgW8vLzwxhtvwN/fX1cnPT0dH3zwAeLj49HY2Ah/f38sXboUAwcO7KjbalfxeQnYn34YJbUlsDe3x9S+4RjiHGjqbhER3RHHLyISq64+fkkEQTDZ+2EXL16Mb775BvPmzYOHhwf27t2LS5cuYdu2bdBoNLdtu2bNGmzatAlTp05FYGAgqqqqkJKSgvHjx2PcuHEAgKysLMyYMQMKhQJPPfUULC0tERsbixs3bmD37t3o16+f0X0uKqrotFfqxuclYEdKDOq19boyuVSOJ9Qzu9QPERHRH3H8IiKx6grjl1QqgYODdavHTRbgL168iNmzZ2P58uWYP38+AKC2thZTpkyBSqVCdHR0q20TEhLwxBNPYMOGDQgLC2u13t///nfExMTg4MGD8PDwAABUV1fj4YcfxoABA/Dxxx8b3e/ODPArTv0vbtWWGJSbSczgaefeKX0gIrobGaU30CA0GJRz/CKirq618au7uT3+38j/6ZQ+3CnAm2wN/OHDhyGXyzF79mxdmbm5OWbNmoXz58+joKCg1bZRUVHw8/NDWFgYtFotKisrW6yXkJCAgQMH6sI7AFhaWiI0NBTff/89Kioq2u+GOkBL4R1Aiz9URERdSWvjFMcvIurqWhunWstlpmCyNfDJycnw9PSElZWVXrm/vz8EQUBycjJUKlWLbU+fPo3Jkydj9erV2LZtG6qqquDq6orXXnsNU6dO1dWrq6tDjx49DNpbWFigvr4eV69eveNSHVPqbm7f4g9Ld3N7vBb4ogl6RETUNq39BZHjFxF1dbcbv7oKk83AFxYWthjQlUolALQ6A19aWoqSkhIcPHgQe/bswZIlS7B69Wo4Oztj6dKl+Pbbb3V1PT09kZKSgqqqKr1zJCQk3PYaXcXUvuGQS+V6ZXKpHFP7hpuoR0REbcPxi4jESgzjl8lm4GtqaiCXyw3Kzc3NATSth29JcxgvKSnBrl27EBAQAAAICwtDWFgYPvroI926+McffxzHjh3D4sWL8corr8DS0hI7duzApUuXdH0w1u3WI7W3ycoxsLW1xBcX96GoqhgO3Xrgcf9peMhjSKf1gYjobnD8IiKxEsP4ZbIA37yM5Y+ag3tzkP+j5nI3NzddeAcAhUKBiRMnIioqCpWVlbCyssKYMWOwcuVKfPDBB3j00UcBAB4eHnjttdfw/vvvGyzfaYvOfIgVANTdfPDWMB8olTYoLCwHAN0/iYi6Mo5fRCRWph6/7vQQq8kCvFKpbHEJS2FhIQC0uv7d3t4eCoUCjo6OBsccHR0hCAIqKip04fypp57CjBkzkJqaCrlcDh8fH+zZswcA9B5uJSIiIiISA5OtgVer1cjIyDDYQSYpKUl3vCVSqRQ+Pj7Iz883OJaXlweZTAY7Ozu98m7dukGj0WDgwIGQyWT48ccfoVQq0bdv33a6GyIiIiKizmGyAB8eHo76+nrs3r1bV1ZXV4fY2FgEBgbCyckJAJCTk4P09HSDtrm5uTh16pSurKKiAocOHYJGo4GFhUWr101ISMC3336LefPmQSo12e0TEREREd0Vky2hCQgIQHh4OFatWoXCwkK4u7tj7969yMnJwbvvvqur9+abbyI+Ph6pqam6sscffxy7d+/Gyy+/jPnz58PW1hYxMTEoLy/H4sWLdfVu3LiB119/HaGhoXB0dMTVq1fx5ZdfYvDgwbqXRxERERERiYnJAjwAREZGYu3atdi3bx9KS0vh7e2NjRs3Iigo6LbtLC0tERUVhcjISGzfvh01NTXw9fXFli1b9Nra2NjA0dER27dvR2lpKVxcXLBgwQIsWLAACoWio2+PiIiIiKjdSQRB6LwtVe4Dnb0LTbPfPwVNRCQmHL+ISKxMNX7daRcaLgInIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRBngiIiIiIhFhgCciIiIiEhEGeCIiIiIiEWGAJyIiIiISEQZ4IiIiIiIRYYAnIiIiIhIRkwb4uro6vP/++xg1ahT8/f3x2GOP4fTp021uHxcXh1mzZmHQoEEYMmQInnrqKVy8eFGvTkFBAVasWIHQ0FAEBARgwoQJWLVqFcrKytr7doiIiIiIOpyZKS++bNkyfPPNN5g3bx48PDywd+9eLFiwANu2bYNGo7lt2zVr1mDTpk2YOnUqIiIiUFVVhZSUFBQWFurqVFVVYc6cOaiqqsKTTz4JZ2dnXLlyBVu2bEFCQgJ27NjR0bdIRERERNSuTBbgL168iIMHD2L58uWYP38+AGD69OmYMmUKVq1ahejo6FbbJiQk4NNPP8WGDRsQFhbWar3jx48jOzsbn376KUJCQnTlFhYW+Pe//43MzEz06tWrvW6JiIiIiKjDmWwJzeHDhyGXyzF79mxdmbm5OWbNmoXz58+joKCg1bZRUVHw8/NDWFgYtFotKisrW6xXUVEBAHBwcNArd3R0BNAU5ImIiIiIxMRkAT45ORmenp6wsrLSK/f394cgCEhOTm617enTp+Hn54fVq1cjKCgIgYGBCA0Nxf79+/XqBQUFQSqV4p133sGFCxeQl5eHo0ePYsuWLZgxYwaUSmWH3BsRERERUUcx2RKawsJCODk5GZQ3h+rWZuBLS0tRUlKCgwcPQiaTYcmSJbC3t0d0dDSWLl0KS0tL3bKavn374u2330ZkZCQiIiJ054iIiMA//vGP9r8pIiIiIqIOZrIAX1NTA7lcblBubm4OAKitrW2xXVVVFQCgpKQEu3btQkBAAAAgLCwMYWFh+Oijj/TWxTs7OyMgIACjR4+Gi4sLzp07h23btsHOzg6vv/660f12cLA2uk17USptTHZtIqJ7wfGLiMSqK45fJgvwFhYWqK+vNyhvDu7NQf6Pmsvd3Nx04R0AFAoFJk6ciKioKFRWVsLKygrnz5/Hiy++iD179sDHxwcAMH78eFhbW+PDDz/Eo48+ij59+hjV76KiCmi1glFt2oNSaYPCwvJOvy4R0b3i+EVEYmWq8Usqldx20thka+CVSmWLy2Sat4FUqVQttrO3t4dCodA9iPp7jo6OEARB9/Dql19+CZVKpQvvzUJDQyEIAi5cuHCvt0FERERE1KlMFuDVajUyMjIMdpBJSkrSHW+JVCqFj48P8vPzDY7l5eVBJpPBzs4OAFBUVITGxkaDeg0NDQDQ4jEiIiIioq7MZAE+PDwc9fX12L17t66srq4OsbGxCAwM1D3gmpOTg/T0dIO2ubm5OHXqlK6soqIChw4dgkaj0W0P2bt3b+Tn5+PcuXN67Q8cOAAABjPzRERERERdnUQQhM5f0P2bV199FUeOHMHTTz8Nd3d37N27F5cuXcLWrVsRFBQEAJg7dy7i4+ORmpqqa1ddXY0ZM2YgPz8f8+fPh62tLWJiYpCRkaHX9tq1a5g5cyakUimeeuop9OzZE2fPnsWBAwfw0EMPYdOmTUb3mWvgiYiMw/GLiMSqq66BN9lDrAAQGRmJtWvXYt++fSgtLYW3tzc2btyoC+CtsbS0RFRUFCIjI7F9+3bU1NTA19cXW7Zs0Wvbp08fxMTE6K5x8+ZNqFQqPP/883j55Zc7+vaIiIiIiNqdSWfgxYgz8ERExuH4RURi1VVn4E22Bp6IiIiIiIzHAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCLCAE9EREREJCIM8EREREREIsIAT0REREQkIgzwREREREQiwgBPRERERCQiDPBERERERCJiZsqL19XVYd26ddi3bx/KysqgVquxaNEiDB8+vE3t4+LisHXrVqSlpUGhUMDLywtvvPEG/P39AQAbNmzAhx9+2Gr7HTt2ICgoqF3uhYiIiIioM5g0wC9btgzffPMN5s2bBw8PD+zduxcLFizAtm3boNFobtt2zZo12LRpE6ZOnYqIiAhUVVUhJSUFhYWFujphYWFwd3dvsW1VVRX8/Pza/Z6IiIiIiDqSyQL8xYsXcfDgQSxfvhzz588HAEyfPh1TpkzBqlWrEB0d3WrbhIQEfPrpp9iwYQPCwsJaradWq6FWq/XKcnNzkZeXh9mzZ0OhULTLvRARERERdRaTrYE/fPgw5HI5Zs+erSszNzfHrFmzcP78eRQUFLTaNioqCn5+fggLC4NWq0VlZWWbr3vgwAEIgoBHHnnknvpPRERERGQKJgvwycnJ8PT0hJWVlV65v78/BEFAcnJyq21Pnz4NPz8/rF69GkFBQQgMDERoaCj2799/x+vGxcWhZ8+eCA4Ovud7ICIiIiLqbCZbQlNYWAgnJyeDcqVSCQCtzsCXlpaipKQEBw8ehEwmw5IlS2Bvb4/o6GgsXboUlpaWrS6ruXr1KlJTU/H8889DIpG0380QEREREXUSkwX4mpoayOVyg3Jzc3MAQG1tbYvtqqqqAAAlJSXYtWsXAgICADQ9sBoWFoaPPvqo1QAfFxcHAPe0fMbBwfqu294rpdLGZNcmIroXHL+ISKy64vhlsgBvYWGB+vp6g/Lm4N4c5P+oudzNzU0X3gFAoVBg4sSJiIqKQmVlpcHSHEEQcLWc5JUAACAASURBVODAAXh5eRk82GqMoqIKaLXCXbe/W0qlDQoLyzv9ukRE94rjFxGJlanGL6lUcttJY5OtgVcqlS0uk2neBlKlUrXYzt7eHgqFAo6OjgbHHB0dIQgCKioqDI6dP38e2dnZfHiViIiIiETNZAFerVYjIyPDYAeZpKQk3fGWSKVS+Pj4ID8/3+BYXl4eZDIZ7OzsDI7FxcVBIpFgypQp7dB7IiIiIiLTMFmADw8PR319PXbv3q0rq6urQ2xsLAIDA3UPuObk5CA9Pd2gbW5uLk6dOqUrq6iowKFDh6DRaGBhYaFXv76+HocPH0ZQUBBcXFw68K6IiIiIiDqWydbABwQEIDw8HKtWrUJhYSHc3d2xd+9e5OTk4N1339XVe/PNNxEfH4/U1FRd2eOPP47du3fj5Zdfxvz582Fra4uYmBiUl5dj8eLFBtc6efIkSkpKuHyGiIiIiETPZAEeACIjI7F27Vrs27cPpaWl8Pb2xsaNGxEUFHTbdpaWloiKikJkZCS2b9+Ompoa+Pr6YsuWLS22jYuLg1wuR3h4eEfdChERERFRp5AIgtD5W6qIGHehISIyDscvIhIr7kJDRERERET3jAGeiIiIiEhEGOCJiIiIiESEAZ6IiIiISEQY4ImIiIiIRIQBnoiIiIhIRBjgiYiIiIhEhAGeiIiIiEhEGOCJiIiIiESEAZ6IiIiISEQY4ImIiIiIRIQBnoiIiIhIRBjgiYiIiIhEhAGeiIiIiEhEGOCJiIiIiESEAZ6IiIiISEQY4ImIiIiIRIQBnoiIiIhIRBjgiYiIiIhExKw9TtLQ0IAjR46gtLQUY8eOhVKpbI/TEhERERHRHxgd4CMjI3HmzBnExMQAAARBwDPPPINz585BEATY29tj165dcHd3b/fOEhERERE96IxeQvPDDz9g8ODBuq+PHj2Ks2fP4rnnnsMHH3wAANi4cWP79ZCIiIiIiHSMnoHPy8uDh4eH7utjx47Bzc0NS5YsAQBcvXoVcXFx7ddDIiIiIiLSMXoGvr6+HmZm/839Z86cwYgRI3Rf9+rVC4WFhe3TOyIiIiIi0mN0gHd2dkZiYiKAptn2zMxMBAcH644XFRWhW7du7ddDIiIiIiLSMXoJzeTJk/Hxxx+juLgYV69ehbW1NcaMGaM7npyczAdYiYiIiIg6iNEz8AsXLsSjjz6KCxcuQCKR4L333oOtrS0AoLy8HEePHsXw4cPbvaNERERERARIBEEQ2utkWq0WlZWVsLCwgFwub6/TdilFRRXQatvtI2szpdIGhYXlnX5dIqJ7xfGLiMTKVOOXVCqBg4N1q8fb5UVOzRoaGmBjY9OepyQiIiIiot8xegnNiRMnsGHDBr2y6OhoBAYGYtCgQXj99ddRX1/fbh0kIiIiIqL/MjrAb968GdeuXdN9nZ6ejv/93/+FSqXCiBEj8PXXXyM6OrpdO0lERERERE2MDvDXrl3DwIEDdV9//fXXMDc3x549e7Bp0yZMmjQJX331Vbt2koiIiIiImhgd4EtLS9G9e3fd1z/++COGDRsGa+umhfZDhgxBVlZW+/WQiIiIiIh0jA7w3bt3R05ODgCgoqICP//8MwYPHqw73tDQgMbGxvbrIRERERER6Ri9C82gQYOwc+dO9OvXD99//z0aGxsxevRo3fHr169DpVK1ayeJiIiIiKiJ0TPwr7zyCrRaLV577TXExsZi+vTp6NevHwBAEAR89913CAwMbPeOEhERERHRXczA9+vXD19//TUSEhJgY2OD4OBg3bGysjI8/fTTGDp0aLt2koiIiIiImrTrm1gfBHwTKxGRcTh+EZFY3XdvYr1x4waOHDmCzMxMAECvXr0wbtw4uLu7t/kcdXV1WLduHfbt24eysjKo1WosWrQIw4cPb1P7uLg4bN26FWlpaVAoFPDy8sIbb7wBf39/vXoZGRlYt24dfvrpJ1RVVcHV1RUzZszAggUL2n7DRERERERdwF0F+LVr1+Kzzz4z2G3m/fffx8KFC/Hqq6+26TzLli3DN998g3nz5sHDwwN79+7FggULsG3bNmg0mtu2XbNmDTZt2oSpU6ciIiICVVVVSElJQWFhoV69y5cvY968eejTpw8WLlwIKysrZGZmIi8vz7ibJiIiIiLqAoxeQrNnzx6sWLECGo0Gzz//PPr37w8AuHr1KjZv3ozExES88847mDFjxm3Pc/HiRcyePRvLly/H/PnzAQC1tbWYMmUKVCrVbd/mmpCQgCeeeAIbNmxAWFhYq/UaGxsxdepUeHp6Yv369ZBKjX5m1wCX0BARGYfjFxGJVVddQmN0ot2xYwcCAgKwbds23ZIZd3d3jBs3DlFRUfD398f27dvveJ7Dhw9DLpdj9uzZujJzc3PMmjUL58+fR0FBQatto6Ki4Ofnh7CwMGi1WlRWVrZY7+TJk0hLS8OiRYsglUpRWVkJrVZr7C0TEREREXUZRgf49PR0TJo0CWZmhqtvzMzMMGnSJKSnp9/xPMnJyfD09ISVlZVeub+/PwRBQHJycqttT58+DT8/P6xevRpBQUEIDAxEaGgo9u/fb1DP2toa+fn5mDhxIgIDAxEYGIgVK1agurq6jXdMRERERNR1GL0GXi6Xo6qqqtXjlZWVkMvldzxPYWEhnJycDMqVSiUAtDoDX1paipKSEhw8eBAymQxLliyBvb09oqOjsXTpUlhaWuqW1Vy/fh2NjY3485//jJkzZ+L1119HYmIitmzZguLiYnz88cdtuWUiIiIioi7D6ADv5+eHL7/8ErNnz4ajo6PesaKiIuzatQsBAQF3PE9NTU2LQd/c3BxA03r4ljT/8lBSUqJ3rbCwMISFheGjjz7SBfiqqipUV1djzpw5WLlyJQBgwoQJkEgk2Lx5M1JSUqBWq9t4501utx6poymVNia7NhHRveD4RURi1RXHL6MD/J///GfMnz8fkyZNwsyZM3VvYU1LS0NsbCwqKyuxatWqO57HwsIC9fX1BuXNwb05yP9Rc7mbm5veLwoKhQITJ05EVFQUKisrYWVlBQsLCwDAlClT9M4xdepUbN68GefPnzc6wPMhViIi43D8IiKx6qoPsRod4IODg7Fhwwb885//xJYtW/SOubi44L333sPgwYPveB6lUtniMpnmbSBVKlWL7ezt7aFQKAxm/wHA0dERgiCgoqICVlZWuuU4Dg4OevWavy4rK7tjP4mIiIiIupK72lcxNDQUR44cwa5du7B69WqsXr0au3fvxnfffYe8vDxMmjTpjudQq9XIyMgw2EEmKSlJd7zFDkul8PHxQX5+vsGxvLw8yGQy2NnZAQB8fX0BwKBu8x7wPXr0uGM/iYiIiIi6krveGF0qlcLf3x+TJk3CpEmT4OfnB6lUilu3biEjI+OO7cPDw1FfX4/du3fryurq6hAbG4vAwEDdA645OTkGu9qEh4cjNzcXp06d0pVVVFTg0KFD0Gg0uqUzoaGhkMvl2LNnj1773bt3QyKRYNiwYXd7+0REREREJnFXb2JtDwEBAQgPD8eqVatQWFgId3d37N27Fzk5OXj33Xd19d58803Ex8cjNTVVV/b4449j9+7dePnllzF//nzY2toiJiYG5eXlWLx4sa6ek5MTXnjhBXz00Ueor6/HsGHDkJiYiP379+OJJ56Ah4dHp94zEREREdG9MlmAB4DIyEisXbsW+/btQ2lpKby9vbFx40YEBQXdtp2lpSWioqIQGRmJ7du3o6amBr6+vtiyZYtB25dffhm2trbYsWMHjh49CpVKhddeew0LFy7syFsjIiIiIuoQEkEQ2nVLlU8++QTr16+/7YuYxIy70BARGYfjFxGJVVfdheau18ATEREREVHna9MSmj9uF3k7CQkJd90ZIiIiIiK6vTYF+Pfee8+ok0okkrvqDBERERER3V6bAnxUVFRH94OIiIiIiNqgTQF+yJAhHd0PasXpy3mIPZGO4rJa9LA1x4wxfTHc19nU3SIiIiIiEzHpNpJ0e6cv52HroRTUNWgBAEVltdh6KAUAGOKJiIiIHlDchaYLiz2RrgvvzeoatIg9kd5KCyIiIiK63zHAd2FFZbVGlRMRERHR/Y8BvgtzsDVvsVwqAfafzMCtcgZ5IiIiogcNA3wXNmNMXyjM9L9FZjIJXBys8NXJDCz9+Ed8GPszLmcUQ9u+L9QlIiIioi6KD7F2Yc0Pqra0C03BrSqcuJCDHy7mIuGXQqi6WyJkkCtG+jnDppvCxD0nIiIioo4iEQRO3RqjqKgCWm3nf2RKpQ0KC8sNyusbtDj/SwGOJ2Tjl6xSmMkkGKxWYazGFf1c7fhSLSIyudbGLyKirs5U45dUKoGDg3WrxzkDL3JyMymGDXDGsAHOyC6swPELOfjxUi5+upwPV6UVQga5YsRAZ1ia81tNREREdD/gDLyRutoMfEtq6xpxJjkfxxKzcT2vHOZyGYYOcMJYjSs8nG06uKdERPo4A09EYsUZeOo05goZRge4YHSACzJyy3A8MRs/Xc7D90k58OxpixCNC4b4OMFcLjN1V4mIiIjISJyBN5IYZuBbUlVTjx8v5eH4hRzk3KxEN3MzjPBzRsggV7g4WrVjT4mI9HEGnojEqqvOwDPAG0msAb6ZIAj4JbMExy/k4FxKARq1AtTu9gjRuCLQSwkzGXcWJaL2xQBPRGLFAH+fEHuA/72yyjqc/DkXxxOzcbO0Brbd5HgowAVjAlzgaG/ZrtciogcXAzwRiRUD/H3ifgrwzbSCgCsZxTiWmI0LaTcBAfDr64CQQa7w7+sAqZRbURLR3WOAJyKx6qoBng+xEqQSCQb2ccDAPg4oLqvB90k5OJGUg/UxF9HD1hxjAlzwUIAL7K3NTd1VIiIiogceZ+CNdD/OwLekoVGLpLSbOJ6Yjcu/3oJMKoGmvyNCNK5Qe3SHlC+IIqI24gw8EYkVZ+BJVMxkUgR5qxDkrUL+rSqcSMzByZ9zcS61EE7dLRGiccVIv56wtpSbuqtEREREDxTOwBvpQZmBb0l9QyPOpRbiWGI20rJKYSaTIlitwthAV/R1sYWEs/JE1IKuMH4REd0NzsCT6MnNZBju64zhvs7IKqjA8QvZ+PFSHk5fzoOb0hpjNS4Y5usMS3P+WBERERF1FM7AG+lBnoFvSU1dA85cycexxGzcyK+AuUKG4QOcEKJxhbuTjam7R0RdQFcdv4iI7oQz8HRfslCYYcwgV4wOcEFGbjmOJ2bj1G9vfO3rYosQjSuC1Soo5DJTd5WIiIjovsAZeCNxBv7OKmvq8ePPeTh+IRu5RVWwsjDDSL+eGDPIBT0drEzdPSLqZGIav4iIAOD05TzEnkhHcVktetiaY8aYvhju69xp1+eLnNoZA3zbCYKA1BslOH4hG+dTC9GoFeDj0R0hGldo+jvCTCY1dReJqBOIcfwiogfX6ct52HooBXUNWl2ZwkyKpx9Wd1qI5xIaMhmJRAK1R3eoPbqjtLIOJy/m4HhiDj756hLsrBR4KKAnRge4wNHO0tRdJSIiIgIAxJ5I1wvvAFDXoEXsifROnYW/HQZ46hR2VgpMHt4bDw/1wKWMYhxPzMbB09dx8PR1+PdxQIjGFX59HCCVcitKIiIi6nyNWi1Sb5SgqKy2xeOtlZsCAzx1KqlUAv++DvDv64Ci0hqcSMrBD0k5WLfnIhxsLTBmkAse8u8JO2tzU3eViIiI7nNarYDUzBKcTSnA+dQClFfVt1rXwbbrZBOugTcS18C3v4ZGLS5cvYljidlIvn4LMqkEgV5KhGhcoXa35wuiiETufh6/iEh8tFoBV7NKEJ9SgPOphSirrINCLsWgfo4IVqtQVduA6G9+4Rp4otsxk0kxWK3CYLUKecVVTVtR/pyLsykFcO7RDSEaV4wY6AxrS7mpu0pEREQipBUEpGWV4mxyAc6lFqC0sg4KMyn8+zliiFoFv74OMP/dltdmMqlJd6G5E87AG4kz8J2jrr4R51ILcCwxG+nZZZCbSTFErUJIoCv69LTlrDyRiDxo4xcRdQ1aQUB69n9De0lFHeRmUvj3dUCwWoWAvo4wV9z+PTV8kRORERRyGUYM7IkRA3viRn45jl/IwenLeTh1KQ/uKmuEaFwxzNcJFgr+CBMREVETrSDgWk6ZLrTfKq+Fmex3ob2fw32RHTgDbyTOwJtOdW0DzlzJx7HEbGQWVMBCIcNwX2eEaFzRS9X6b6lEZFocv4ioIwmCgGu5/w3txWW1MJNJ4NenObQ7wtL87kJ7V52BZ4A3EgO86Qm//XZ9PDEb8SkFqG/Qop+rHUI0LghWqyA3u/2fw4ioc3H8IqL2JggCfs0rx9mUApxNLkBRWQ1kUgkGevbAEB8nBPRzRDeLe59pZ4BvQV1dHdatW4d9+/ahrKwMarUaixYtwvDhw9vUPi4uDlu3bkVaWhoUCgW8vLzwxhtvwN/fHwCQlZWFcePGtdj2s88+w+jRo43uMwN811JRXY8ff87FsQs5yC+ugpWFGUb590TIIFc49ehm6u4RETh+EVH7EAQBN/IrEJ+Sj7PJBbhZ2hTafT17IFitgqa/I7pZtO+GF101wJt0EdCyZcvwzTffYN68efDw8MDevXuxYMECbNu2DRqN5rZt16xZg02bNmHq1KmIiIhAVVUVUlJSUFhYaFB36tSpGDVqlF6ZWq1u13sh07C2lGPCEHeEBfdCyvVbOHYhB9+dy8J/4jMxoHd3hAxyxaD+jjCTSU3dVSIiIjKSIAjILKjQzbQXlFRDJpXAp3d3PDKyNwK9lLBq59AuBiYL8BcvXsTBgwexfPlyzJ8/HwAwffp0TJkyBatWrUJ0dHSrbRMSEvDpp59iw4YNCAsLu+O1fH19MW3atPbqOnVBEokEPr17wKd3D5RW1OL7i7n4/kI2Pv7qEuysFRjt74Ixg1zQw9bC1F0lIiKi2xAEAVmFlTj720x7/q1qSCVNoX3ScA8Eeikf+K2lTRbgDx8+DLlcjtmzZ+vKzM3NMWvWLKxZswYFBQVQqVQtto2KioKfnx/CwsKg1WpRXV0NKyur216vqqoKZmZmUCgU7Xof1PXYWZvjkRG9MXmYBy5eK8LxxGwc+PFXHDj9KwL6OiJE44qBfXpAyq0oiYiIugRBEJB9sxJnkwtwNqUAecVVkEgAH4/uCB/qjkAvJWy6McM1M1mAT05Ohqenp0Hw9vf3hyAISE5ObjXAnz59GpMnT8bq1auxbds2VFVVwdXVFa+99hqmTp1qUH/dunV49913IZFIEBAQgCVLliA4OLhD7ou6DqlUgkH9HDGonyNullbjxIUc/HAxFxfSbsLRzgJjBrngIX8X2FpxQCAiIjKFptCej7MpBcgtagrtavfumBDcC4HeStgytLfIZAG+sLAQTk5OBuVKpRIAUFBQ0GK70tJSlJSU4ODBg5DJZFiyZAns7e0RHR2NpUuXwtLSUresRiqVYtSoUQgLC4NKpcL169exefNmPPPMM/j8888xePDgjrtB6lIc7Swxc0xfTBvlicSrN3EsIQsxJ67hqx8yEOStxFiNK7x62fMFUURERB0st+i/M+3ZNyshAeDtbo/xQW4I9FbBjhNrd2SyXWjGjx+Pfv364V//+pdeeWZmJsaPH4+VK1fiqaeeMmiXm5uLkJAQAMCuXbsQEBAAoGlHm7CwMHTv3h1fffVVq9fNz8/H5MmT0a9fP+zcubP9bohEJzO/HId/+hVHzmaisroevZysET68N0IHuz/wa+uIiIjaU3ZhBU5eyMbJpBz8mlsGiQQY4OmAhwJcMMLfBd35jJpRTDYDb2Fhgfr6eoPy2tpaAE3r4VvSXO7m5qYL7wCgUCgwceJEREVFobKystU18U5OTpg8eTJ27dqF6upqWFpaGtVvbiN5/7CQAtNH9Mak4F44m1KAY4nZ+OyrS9h64AqG+DhhbKArejvbcFae6B5x/CJ6MOXfqtLNtGcWVAAA+rvZ4Ynx/RHkrUJ3m6ZM11Bbj8JCw0zYFXAbyT9QKpUtLpNp3gaytfXv9vb2UCgUcHR0NDjm6OgIQRBQUVFx24dae/bsCa1Wi7KyMqMDPN1/FHIZRvr1xEi/nrieV47jF7Lx0+V8nPw5Fx5ONgjRuGDYAGeYK/iCKCIiotspKKnWrWm/kd8U2vu52uHxcf0R5K3kbnDtxGQBXq1WY9u2bQaz5UlJSbrjLZFKpfDx8UF+fr7Bsby8PMhkMtjZ2d322pmZmW2qRw8eD2cbPB2uxmNj++Gny3k4lpiNrYdTsetYGob7OiNE4wo3Zeu/ERMRET1obpZU42xq0z7tv+Y1zVb3dbHFnNB+GKxWMbR3AJMF+PDwcPz73//G7t27dfvA19XVITY2FoGBgboHXHNyclBdXY2+ffvqtX3vvfdw6tQpjBw5EgBQUVGBQ4cOQaPRwMKi6QeluLgYPXr00Lvu9evXcfDgQQwePFhXj+iPLM3NMDbQDSEaV6Rnl+FYYja+T8rF0YRs9HezQ4jGFYO9VZCb8QVRRET04LlZWo1zKYU4m1KAjNwyAIBnT1s8NrYfBquVcLTjCoeOZLKHWAHg1VdfxZEjR/D000/D3d0de/fuxaVLl7B161YEBQUBAObOnYv4+Hikpqbq2lVXV2PGjBnIz8/H/PnzYWtri5iYGGRkZOi1Xb58OTIzMzFs2DCoVCrcuHEDO3fuRENDA6Kjo+Hr62t0n7kG/sFVXlWHUz/n4fiFbBTcqoa1pRyj/HsiZJALVN27mbp7RF0Wxy+i+0NxWQ3OpTStaU/PaQrtvZ1tEOyjwmBvFZT2919o76pr4E0a4Gtra7F27VrExcWhtLQU3t7eWLx4MUaMGKGr01KAB5rWykdGRuLEiROoqamBr68vFi9erLe/+4EDB7Bz506kpaWhvLwctra2GDJkCF566SX079//rvrMAE9aQUDy9Vs4npiNxF9uQisI8PXsgZBBrhjU3wEyKWfliX6P4xeReN0qr9WF9rTsUgCAh9NvoV2tguo+DO2/xwB/n2CAp9+7VV6LHy7m4MSFHNwqr4W9tQKjA1wwOsCFa/6IfsPxi0hcbpXX4nxqU2i/mtUU2t1V1rrQ7vQA/dWZAf4+wQBPLWnUanExvQjHE3Nw6VpR01t/+zlgrMYVAzx7QMqtKOkBxvGLqOsrrajFudSmNe1XM0sgAHBTWiFY3RTaezq0vrvf/ayrBniTPcRKdD+RSaXQ9FdC01+JwpJqnLiQgx8u5iDx6k0o7S0QMsgVI/178pXQRETUZZRW1iHht5n21BtNod3V0QrTRnlisFoFF8cHM7SLAWfgjcQZeGqrhkYtEn4pxLGEbKRmlsBMJsFgbxVCNK7o72bHF0TRA4PjF1HXUVZVh4TfZtpTbtyCIAA9HbohWK1CsFoFV26VrIcz8EQPGDOZFEN8nDDExwk5NytxPDEbpy7l4acr+XB1tEKIxhXDfZ3RzYL/GRIRUccpr6pDwi+/hfbrJdAKApx6dMOU4b0R7KOCq6MVJ5VEhjPwRuIMPN2L2vpGxF/Jx/EL2cjILYdCLsVQHyeMDXRFb2dbU3ePqENw/CLqfBXV9brQnvzrLWgFAarulhjio0Kw2gluSob2tuAMPBHBXC7DQwEueCjABb/mleF4YjZ+upKPHy7morezDUI0rhjq4wRzhczUXSUiIpGprNEP7Y1aAUp7Czw8zB3BahV6qawZ2u8TnIE3Emfgqb1V1TTg9OU8HE/MRvbNSliam2HEQGeEaFzhygeI6D7A8Yuo41TV1CPx6k2cTSnA5YxiNGoFONpZINhHhSFqJ7g7MbTfi646A88AbyQGeOoogiDgalYpjl/IxrmUAjQ0CvDqZY8QjQuCvFSQm/EFUSROHL+I2ldVTQMupBXibHIBLv0W2h1sm0J7sFqF3s42DO3thAH+PsEAT52hrKoOp37OxYnEHBSUVMOmmxyj/HsiZJDrffmqarq/cfwiunfVtQ1ISmuaaf/5WhEaGgX0sDX/bfcYJ3j2ZGjvCAzw9wkGeOpMWkHAlV+LcTwxBxeu3oQgCPDt0wNjB7nCv58DZFLOylPXx/GL6O7U1DUgKa0IZ1MKcDG9CA2NWnS3McdgbxWG+Kjg6WLLFwV2sK4a4PkQK1EXJpVIMNDTAQM9HXCrvBbfJ+Xg+6QcbIj9Gd1tzDHmtwdiu9uYm7qrRETUDmrrGpGUflMX2usbtLCzViBkkAuCfVTo62rH0E6cgTcWZ+DJ1Bq1WiSlFeF4YjYuZRRDKpFA098RIRpX+PTuzoGduhyOX0S3V1vfiJ/TixCfUoCLaTdR16CFnZUCg71VCPZRoZ8bQ7upcAaeiNqFTCpFoJcSgV5KFNyqwokLOfjhYi7O/1IIVXdLhAxyxUg/Z9h0U5i6q0RE1Iq6+kb8fK1pecyFtJuoq9fCtpscI/17Yohahf5u9pBKGdqpZZyBNxJn4Kkrqm/Q4vwvBTiekI1fskphJpMiWK1EiMYV/Vzt+GATmRTHL6Im9Q2N+PlasS6019Y1wqabHEHeTbvHePdiaO9qOANPRB1GbibFsAHOGDbAGdmFFTh+IQc/XsrF6cv5cFNaIUTjiuG+zrA053/yRESdqb5Bi0sZv820X72JmrpGWFvKMWyAU1Nod7fnhgRkNM7AG4kz8CQWtXWNOJOcj2OJ2bieVw5zuQxDBzhhrMYVHs42pu4ePUA4ftGDpr5Bi8u/FuNscgEupBWiurYRVhZmCPJWIljtBG93e5jJGNrFgDPwRNSpzBUyjA5wwegAF2TkluFYYjZ+upyH75Ny4NnTFmM1rgj2UcFcLjN1V4mIRK+hUYsrv4X2hKs3UV3b8FtoV2GIWgW1R3eG9v/f3p3HR1Xf+x9/ZZJM9n1PWBMgwxKSCQQFRMISQEXxWigqbq2XFiu0ylVb23t/P3t/tbXqBRWptXBthVIXNllEWZSIgpUt7AnITtYJCdn3zPz+iAymCZBAwiThpsCZ9gAAIABJREFU/fzHR858zzmfE8Yz73zn+/0eaTPqgW8l9cBLZ1ZRVcuOQ7lsTcsip6ACTzcXRsSFM8YcRUSQl6PLky5K9y/pqurqraSfudAQ2o/lU1Fdh4ebC4n9gkkyhTGgl0J7Z9dRe+AV4FtJAV66ApvNxrFzRaTuy2Z3hoV6qw1TD3+SzVEk9gvRB460Kd2/pCupt1rJOFPErow89hzNp7yqDg83Z8x9Q0gyhTKgVyCuLrqHdhUK8F2EArx0NSXlNXx1MIfUtCzOF1fh6+nKqPhIRsdHEuzv4ejypAvQ/Us6u3qrlaNni9iVYWHP0XzKKmtxNzpj7tvQ0z6wt0J7V6UA30UowEtXZbXZOHyqkNS0LPYdPw82iIsJItkcxeDoIC1tJtdM9y/pjKxWG0fPXQztFkoranEzOmPuE0ySKZRB0YG4umgOUVfXUQO8JrGKCAAGJyfiooOIiw6isKSKbfuz+WJ/Nm+sOECgrxuj4yMZFR+Jv7ebo0sVEWkXVquNbzOL2JlhYU+GhZKKWtxcnYnvE0SSKYy46ECMmvgvHYB64FtJPfByM6mrt7L/+HlS07I4fPoCzgYnzH2DSTZH0b9ngB4QJS2i+5d0ZFabjeOZxexKt7D7qIXi8hqMrgbiYxp62uNigrRa101MPfAi0um4OBsYEhvKkNhQ8i5U8EVaNl8dzGH30XzCAj1JTohkZFwE3h6uji5VRKTFrDYbJ7IuhfaishpcXQwMjgkiyRRKfEwwbkaFdum41APfSuqBl5tdbV09u4/mszUti+OZxbg4GxjWP5RkcxQxkb7qlZcmdP+SjsBqs3Eyu8Qe2i+UVuPi/L3Q3icId6P6NaUx9cCLSJfg6uLM8IHhDB8YTqaljNR9Wew4lMuOQ7l0D/Um2RzFrQPC8HDT7UVEHMtms3Ey51JoLyypxsW5Yb7PtOQY4vsE614lnZJ64FtJPfAiTVXV1PHNkTy2pmVxNq8MN6MzwweEkWyOokeYj6PLEwfT/UtuJJvNxuncUnalW9iVYaGgpAoXZycG9b7Y0x6Mp7tCu7RMR+2BV4BvJQV4kcuz2Wycyilla1omO9Mt1NZZiYn0JdkcRZIpVKs33KR0/5L2ZrPZOJN3KbSfL67C2eDEwN6BJJlCMfcNxtNdc3Wk9RTguwgFeJGWKa+qZcfBXFL3ZZFTUIGXuwsj4yJINkcRHujp6PLkBtL9S9qDzWbjbF4ZuzIs7MrII7+oIbQP6PVdaO8XjJdCu1wnBfguQgFepHVsNhtHzxaRui+LPUfzqbfa6N8zgGRzFOa+wbg46+mFXZ3uX9JWbDYb5ywXQ7sFy4VKDE5ODOgV8F1oD9GqWNKmFOC7iJYE+MrKcsrKiqivr2uz8xoMBqxWa5sdTxzL2dkFb29/PDy8HF3KDVVcXsNXB7JJTcumoKQKPy8jo+IjuD0+kmA/D0eXJ+1EAV6uh81mI+t8uX14TG5hBQYnJ/r39CepfxjmvsH4eBodXaZ0UQrwXcTVAnxlZTmlpRfw9w/B1dXYZkvqubgYqKtTgO8KbDYbtbU1FBXl4+MTcNOFeGh42uGhUwWkpmWz/8R5AAZHB5FsjiIuOgiDQUtRdiUK8HItGkJ7HrsyLOQUVODkBKYeAST1DyWxXwi+Cu1yAyjAdxFXC/D5+Vn4+QVjNLbt4+YV4LuemppqiovPExIS5ehSHKqguIov9mfz5f5sistrCPJ1Z3RCJKPiI/Hz0gd0V6AALy2VU3Cppz3rfDlOQGyPhp72If1C8NU9QW4wBfgu4moBPjf3DGFhPdr8YTYK8F2PzWYjL+8s4eE9HV1Kh1BXb2Xft+fZmpZF+pkLOBucSOwXQrI5ClMPfz0gqhNTgJcryS2ssPe0Z+Y3hPa+3f1JMoUyNDYEP++27RATaY2OGuC1EGo7UNCQltD7pDEXZwNDTaEMNYWSW1hBaloW2w/msCvDQnigJ8nmKEbGhWtVCZEuIK+wwj4R9ZylDIC+3fx4cHxfhsSGEuCj0C5yJeqBb6WW9MC3R4+qeuC7pvZ6v3QVNbX17D5qYWtaFieySnB1MTCsfyjJ5iiiI3z1R1AnoR54AbBcuBTaz+Y1hPY+UX4NPe0mhXbpmNQDL3IFs2f/BIA33/zLDd1XOjajqzMjBkUwYlAEZ/NKSd2XzdeHc9l+MJceYd4km6O4dUAY7kbdykQ6ovyiSnZnWNiZYeFMbkMIion05f6xfRhqCiXQ193BFYp0Tg791KupqeH1119nzZo1lJSUYDKZePrppxk+fHiL9l+3bh3vvvsux48fx2g00q9fP5577jkGDx7cbPsNGzbw9NNP4+Pjw+7du9vyUrqs224b2qJ2y5evJSIisp2rkZtZjzAfHpkYy7TkGL45ksfWtCyWfHqUDz8/zvBB4YxJiKJb6OV7K0TkxjhfXMnujHx2ZeRxKqchtPeO8OWHY/ow1BSiJWNF2oBDh9DMnTuXTZs28cgjj9CzZ09Wr17NoUOHWLp0KWaz+Yr7zp8/n8WLF3PPPfeQmJhIRUUFGRkZjB8/nnHjxjVpX1VVxR133EFRURHOzs7XHOBvtiE0GzduaPTzhx++R15eDnPmzG20/fbbx+Dhce035draWgBcXVs/vvl69nU0DaG5djabjZPZJaSmZbEzw0JtnZU+UX6MMUcx1BSCq4uzo0uU72gITddXWFJlHx5zMrsEgF7hPiT1DyUpNpRgf4V26Zw66hAahwX4AwcOMG3aNJ5//nkee+wxAKqrq5k8eTKhoaEsW7bssvvu3buXBx98kAULFpCSktKi8y1YsID169czaNAgvvjiCwX4a/T88//Bt98eY8WKdVdsV1VVhbu7vhq9GgX4tlFWWcuOgzls3ZdNXmEFXu4u3DY4guSEKMICPR1d3k1PAb5rulBa/V1oz+NEVkNo7xnWENqHmkIJVWiXLqCjBniHDaH59NNPcXV1Zdq0afZtbm5uTJ06lfnz52OxWAgNDW123yVLlhAXF0dKSgpWq5XKykq8vC7/MJzs7GwWL17M/Pnz2bRpU5tfy81u9uyfUFZWxnPP/ZoFC+Zz9GgGM2Y8wuOP/5Qvv0xl7drVHDt2lJKSYkJCQrnzzrt5+OEf4ezs3OgYcGkc+969u/n5z2fx4osvc+rUST76aCUlJcXExcXz7LO/plu37m2yL8DKlR/y/vvLKCg4T0xMDLNnP82iRW81OqZ0bN4erkwY1oOUpO5knLnA1n3ZbNmdycad5xjQK4DkhCgS+gbj4mxwdKkindqF0mr2HG3oaf82sxiAHqHe/GB0NENNoYQF6A9mkRvBYQE+PT2d3r17NwnegwcPxmazkZ6eftkA//XXX3PXXXcxb948li5dSkVFBVFRUTz11FPcc889Tdr/8Y9/xGw2M3bs2E4Z4L8+nMuqbScpKK4iyNeN+0bHMHxguKPLaqSo6ALPPfc0EyZMYtKkuwgLa6hvw4b1eHh4Mn36DDw9PdizZzeLF/+Z8vJynnzyF1c97rvv/i8GgzMPPvgIpaUlvPfeUn772/9k0aJ322Tf1atXMH/+yyQkJDJ9+gPk5OTw/PPP4OPjQ0hI8+8/6bicnJzo3yuQ/r0CKSqr5ssDOWzbl8WfPjqEn7eR2wdHMjohUhPnRFqhuKya3UfzG0L7uSJsQLcQb/7t9miSTKGE61sukRvOYQE+Pz+fsLCwJttDQkIAsFgsze5XXFxMUVERH3/8Mc7OzjzzzDP4+/uzbNkynn32WTw8PBoNq9m5cyebN29m1apV7XMh7ezrw7m8+0kGNd8NnykoqebdTzIAOlSIP38+n1/96r+YPHlKo+0vvPA73NwuhaV7753KK6/8ntWrlzNz5hMYjVd+ql5dXR3vvPMuLi4Nb1VfXz9ef/1VTp48TnR0n+vat7a2lsWL32LgwDhee+1P9nZ9+vTlxRdfUIDv5Py93bh7RC/uurUnB04WkJqWxfodp1n/9WniY4JJNkcxKDoQg5aiFGmiuLyGvd/1tB892xDao0K8mDKqN0mmUCKCLv+tt4i0P4cF+KqqqmYnHbq5NawDW11d3ex+FRUVABQVFfHhhx8SHx8PQEpKCikpKSxcuNAe4Ovr6/nd737Hfffdh8lkapO6rzQeCcBiMeDi0vhr+q8OZLNtX/Y1ne94VjF19Y3H3NfUWfnrhnS+3N+6Y96eEMltg69vpZiL625//xqdnJxwd3dn8uTJTa7dxeVSz0x5eTm1tTWYzYmsWbOKrKyz9O3br9njOn831OHuu6fg7n4p5CcmJgKQm5tDv37Xt++RIxkUFxczZ859jdrdccedLFgwDycnpybX09YMBgMhIT7teg6BlDBfUob3Jq+wgo3/PM3mb87y2vL9hAV6MvHWnqQM64m/1qBuV3qfd3zFZdXsOJjDV/uyOHTiPFYbdA/z5oEJsYyMj6RHuK+jSxRxiI54/3JYgHd3d7evHvJ9F4P7xSD/ry5u79atmz28AxiNRiZOnMiSJUsoLy/Hy8uLDz74gMzMTN555502q/tqk1itVmuTyab19Taudarwv4b3729v7THr623XPRH24pzn7x/HZrN911vt3OT4J0+eYNGit9i7dxfl5eWNXisuLrG3/9fj1tc3/DckJKzRMT09vb/bt/i6983KygIgIqLbv9RtIDw8Apvt+n9fV2O1WjW57wYyAHckdSclMYq9x/JJTctiyYZ0ln2awZDYEMaYo+jX3V8PiGpjmsTacZVW1LD3WMPwmPQzF7DZIDzQk7uG9yKpfyhRwV72/x/0byg3I01i/RchISHNDpPJz88HuOz4d39/f4xGI8HBwU1eCw4OxmazUVZWhqurK2+88Qb33XcfVVVVZGZmAg09+FarlczMTDw9PQkMDGzDq2reyLgIRsZFXNO+z/5pOwUlTb+NCPJ145czEq+3tDbz/WEyF5WWljJnzk/w9PTm8cdnERXVDaPRyLFjGbz11gKs1quHY4Oh+aUAW7J40vXsK12bi7OBYf3DGNY/jJyCclLTstl+MIed6RYigjxJNkcxclA4nu6db2lSkaspq6y9FNpPX8BqsxEW4MFdw3uSZAqjW4iX/ogV6eAcFuBNJhNLly6195ZftH//fvvrzTEYDPTv35+8vLwmr+Xm5uLs7Iyfnx9VVVVcuHCBpUuXsnTp0iZtx40bx5133sn8+fPb6Irax32jYxqNgQcwuhi4b3SMA6tqmbS0PRQXF/Pii6+QkHDpj42cnGsbTtTWwsMb/qjKzDxHfPyl5w7U1dWRk5NDTMyVx9hL1xAR5MUD4/vyg9HR7MqwsDUti/e2fMvK1BMMGxDGGHMUvSM0dEA6t/KqxqG93moj1N+DO27tQZIplO6h3grtIp2IwwL8pEmTeOedd1i+fLl9HfiamhpWrVpFYmKifYJrdnY2lZWVxMTENNr3j3/8I9u3b2fkyJEAlJWV8cknn2A2m3F3d8fZ2ZmFCxc2Oe+SJUs4cOAAr776arOTaDuaixNVO/oqNM0xGBrGj3+/x7u2tpbVq5c7qqRGTKYB+Pn5sXbtaiZOvNM+iXXz5k8pLS1xcHVyoxldne3flp3JLSV1Xxb/PJzHVwdy6BnuwxhzFLf0D8PNqAdESedQUVVL2rfn2ZVh4fCpQuqtNoL93JkwrDvDTGH0CFNoF+msHBbg4+PjmTRpEq+++ir5+fn06NGD1atXk52dzR/+8Ad7u1/+8pfs3LmTo0eP2rc98MADLF++nDlz5vDYY4/h6+vLypUrKS0tZe7chieEurq6Mn78+Cbn3bJlC0eOHGn2tY5q+MBwRsVHdogHObVGXNxgfHx8efHFF5g6dTpOTk5s3LjhmucDtDVXV1d+/OOfMH/+Kzz11M8YM2YcOTk5fPLJOqKiuumD7SbWM9yHRyeZ+OGYPvzzcC5b07L42ycZfPD5t4wYGMFocyTdQq48oV3EESqq6th3PJ9d6RYOfRfag3zdSUnqTpIplF7hPrq3iXQBDgvwAC+//DKvvfYaa9asobi4mNjYWP7yl78wZMiQK+7n4eHBkiVLePnll/n73/9OVVUVAwcO5K9//etV95Ubx8/Pn5dfns+bb77GokVv4ePjy4QJdzB06DDmzp3t6PIA+MEPpmOz2Xj//WUsXPg6MTF9eemlebz22qsYjVqV5Gbn4ebCmMRuJJujOJFVwta0LL7Yn81nezPp282PMeYohsSG4trOqxWJXElldR37jp//LrQXUFdvI9DXjfFDu5FkCqN3hEK7SFfjZNOMvla52io0ublnCA/v2ebndXExdLoe+M7KarUyeXIKo0eP4Ze//M92PVd7vV+k/ZRW1LD9YC6p+7KwXKjE28OV2wZHkJwQSaieQtksrULT9iqr69h/oiG0HzxZSF29lQAfN5JMoSSZQukd6atnHIi0Aa1CI9IBVVdXN1my9NNPP6akpBizWd/mSFM+nkYm3dKDCcO6k37mAqlpWWzaeY5PvznLwN6BJCdEkdA3CGeDeuWlbVXX1NtD+4GTBdTWWfH3NpJsjmSYKYzoKIV2kZuFArzc1A4c2Mdbby0gOXksvr5+HDuWwccfryU6OoYxYzrPPAm58QxOTgzsFcjAXoFcKK3mywPZfLEvm4WrD+LvbeT2+Ehuj48k0LfpEqsiLVVdW8/BEwXszLBw4Ph5auqs+Hk1vL+STKH06ean0C5yE1KAl5taZGQUwcEhrFjxASUlxfj6+jFp0l3MmjW72ScFizQnwMeNe0b25q7hPTlwooDUtGzWbT/N+h1niO8TxBhzFAN6BypoSYvU1NZz8GQBuzIs7Dt+nppaK75eRm4bHEGSKZS+3fwxGPReErmZaQx8K2kMvLQljYHvuixFlWzbl82XB7IpraglxN+d5IQoRg6OwNfT6OjybiiNgb+62rp6Dp4sbAjt356nurYeH09XhsY2jGnv112hXcQROuoYeAX4VlKAl7akAN/11dZZ2Xssn9S0LI6eK8LF2YmhsaEkm6Po283vplgdRAG+ebV19Rw6dSm0V9XU4+3hytDYkIbQ3sNfcylEHKyjBngNoRERaUeuLgZuGRDGLQPCyD5fTmpaFtsP5fLPI3lEBXuRbI5i+MBwPN11O74Z1NZZOXy6kF3pFvYdz6eyuh4vdxeG9Q8jqX8oJoV2EWkB9cC3knrgpS2pB/7mVF1bz84jeaTuy+JUTilGVwO3Dggj2RxFr3BfR5fX5m72Hvi6eitHvgvte789T2V1HV7uLpj7hTDMFIqpZwAuzgrtIh2ReuBFRAQAN1dnRsVHMio+ktO5JaSmZfHPI3ls259D7wgfkhOiGDYgDDdXZ0eXKteort5K+pkLDaH9WD4V1XV4uLmQ2C+YJFMYA3optIvItVMPfCupB17aknrg5aKKqjq+PpxLaloWWefL8XBzYeSgcEabo4gK9nJ0edflZumBr6u3knH2Umgvr6rDw80Zc9+GMe0DewcqtIt0MuqBFxGRy/J0d2HckG6MTYzi28xiUvdlkboviy17MunX3Z8x5igS+4Xg6qIA2JHUW61knC2yh/ayylrcjc6Y+zb0tA/sHah/MxFpcwrwIiIdiJOTE/26+9Ovuz/3j+vL9oM5fJGWzdtrD+Pj6cptgyNITogixN/D0aXetKxWG0fPXmBXhoXdRxtCu5vRGXOfYJJMoQyKDsTVRcOfRKT9KMCLiHRQvp5G7rilJxOH9eDI6UJS07LZ+M05Pv3nWQZGBzImIYrBfYK0askNYLXa+DaziJ3pFvYctVBSUYubqzPxfYJIMoURFx2IUXMWROQGUYCXG2rDhnX8/ve/ZfnytURERAIwderdmM1D+M1vXmj1vtdr797d/Pzns3jjjT+TmDi0TY4p0tYMTk4M6h3EoN5BXCitZtv+bLbtz2bBqoME+Lgx+rsJsQE+bo4utUux2mwczyxmV7qF3UctFJfXYHQ1EB/T0NMeFxOkicYi4hAK8HJFzz33NHv37mLdus14eDT/lf3cubM5fPgga9duws2tYwaILVs2UlhYwA9/+KCjSxG5LgE+bky5rTeTR/Rk//ECUtOy+OirU6zdfhpz32CSzVH07xWA4SZ4QFR7sNpsnMhqCO27jlooLqvB6GJgcEwQSf3DGBwdhJtRoV1EHEsBXq4oJWUiO3Z8yVdffUFKyqQmr1+4UMiePbuYMOGOaw7v//jHSgztPATgs8828e23x5oE+ISERD77bDuurq7ten6RtuZsMJDYL4TEfiFYLlTwxb5svjyQw55j+YQGeJCcEMVtgyPw9tB7+2qsNhsns0vsPe0XSqtxdTEwODqIpP6hDI4Jwt2oj0sR6Th0R5IrGjUqGQ8PT7Zs2dhsgP/88y3U19czYULT11rKaDReT4nXxWAwdNhvDURaKjTAk2lj+nDvqGj2HLWQmpbFh1uPs2rbSZJMISSbo+gT5YeTeuXtbDYbJ3MuhfbCkmpcnA3ERQcybUwM8THBeLjpI1JEOibdneSK3N3dGTVqNFu3bqGkpARf38ZPidyyZSNBQUF0796TV199iT17dpKXl4e7uzuJiUN58slfXHW8enNj4E+ePMFrr73CoUMH8fPzY8qU+wgODmmy75dfprJ27WqOHTtKSUkxISGh3Hnn3Tz88I9wdm74mnv27J+wb99eAG67rWGce3h4BCtWrLvsGPjPPtvE3//+N86cOY2npxcjR47iiSd+jr+/v73N7Nk/oaysjP/zf/6befNeJj39MD4+vkybdj8zZjzaul+0SBtwdTFw68Bwbh0YTlZ+Galp2ew4nMPXh/PoFuJFsjmK4QPDb9pgarPZOJ1b2jA8JsNCQUkVLs4N8wt+MDqGhD4K7SLSOehO1QnszN3LupOfUlhVRICbP/fETGJYeOINO39KyiQ2bfqE1NTPuOeef7Nvz83N4dChA0ydej/p6Yc5dOgA48dPJCQklJycbD76aCVz5vyUv/99Oe7u7i0+X0HBeX7+81lYrVYeeuhR3N09WLt2dbM95Rs2rMfDw5Pp02fg6enBnj27Wbz4z5SXl/Pkk78A4NFHf0xlZSV5eTnMmTMXAA8Pz8ue/+Jk2YED43jiiZ9jseSxcuUHpKcfZtGiJY3qKCkp5j/+4+eMGTOOceMmsHXrFt56awHR0X0YPnxki69ZpK1FhXgzY0I/pibH8E16Hlv3ZvH3TcdYvvUEtw4MIzkhip7hPo4us93ZbDbO5F0K7eeLq3A2ODGwdyD3juqNuW8wnu4aZiQinYsCfAe3M3cv/8hYSa21FoAL1UX8I2MlwA0L8UlJt+DvH8CWLRsbBfgtWzZis9lISZlITEwfxowZ32i/kSNvZ9asH5Ga+hmTJt3V4vMtW/YuxcVFLF68lNhYEwB33DGZBx74tyZtX3jhd7i5Xfrj4N57p/LKK79n9erlzJz5BEajkaSkW1m1ajnFxUVMnHjnFc9dV1fHW28toE+ffixY8LZ9eE9srIkXXvgN69atZurU++3tLZY8/u///Z19eNHkyVOYOnUyH3+8RgFeOgQ3ozO3x0dye3wkp3JK2JqWxdeHcvliXzbRkb4kJ0SR1D+0S62mYrPZOJtXxq4MC7sy8sgvagjtA3oFcs/I3pj7BeOl0C4inZgC/A3wTc4evs7ZdU37nio+S52trtG2Wmsty9JXsCN7Z6uONTwiiVsihrS6BhcXF8aOHc9HH63k/PnzBAcHA7Blyya6devOgAGDGrWvq6ujvLyMbt264+3tw7FjGa0K8F9/vZ24uHh7eAcICAggJeUOVq9e3qjt98N7RUU5NTW1xMebWbNmFWfOnKZv336tutaMjCNcuFBoD/8XjR2bwsKFr7Njx/ZGAd7b25vx4yfaf3Z1daV//4FkZ2e16rwiN0LvCF96R/hy/9g+7DiUy9a0LN7ZkM77n33LyLgIks2RRAR5ObrMa2Kz2ThnuRjaLVguVGJwcmJArwAmD++FuV+IJvSKSJehAN/B/Wt4v9r29pKSMolVq5bz+eeb+OEPH+T06VMcP36MH/1oJgDV1VUsXfo3NmxYR36+BZvNZt+3rKysVefKy8slLi6+yfYePXo22Xby5AkWLXqLvXt3UV5e3ui18vLWnRcahgU1dy6DwUC3bt3Jy8tptD00NKzJxEAfH19OnDje6nOL3Cie7q6MH9qdcUO6cexcEan7svl8byabd5/D1MOfZHMUif1CcHHu2A+IstlsZOWXs/O70J5XWIHByYn+Pf2589aeJCq0i0gXpQB/A9wSMeSaer4B/nP777lQXdRke4CbP08lzrre0losLi6eiIgoNm/+lB/+8EE2b/4UwD50ZP78V9iwYR3Tpj3AoEFxeHt7A0688MKvG4X5tlRaWsqcOT/B09Obxx+fRVRUN4xGI8eOZfDWWwuwWq3tct7vMxiaH3bQXtcs0pacnJyI7RFAbI8AHhjXl68O5pCalsWf1xzG19OVUfGRjI6PJNi/+WdAOEpW/qWe9pyCCpycwNQjgInDupPYLwRfT8etbCUiciMowHdw98RMajQGHsDV4Mo9Mde+bOO1Gj9+AkuX/pXMzHN89tkmYmP723uqL45znzPnaXv76urqVve+A4SFhZOZea7J9rNnzzT6OS1tD8XFxbz44iskJFyaD5CTk93MUVu2fF54eIT9XN8/ps1mIzPzHL17x7ToOCKdja+XkTtv7cmkW3pw+FQhqWlZbPjnGTZ8fYa4mCCSzVEMjg7CYHDMUpTZ58vZ/V1ozzpfjpMTxHb3Z/zQ7gzpF4Kvl0K7iNw8FOA7uIsTVR25Cs1FEybcwdKlf+XNN+eTmXmuUVhvrid65coPqK+vb/V5hg8fyfLl73P0aIZ9HPyFCxfYvPmTRu0uPvzp+73dtbW1TcbJA3h4eLTojwmTaQABAYF89NEK7rhjsv0BT1u3fkZ+voUZMx5p9fWIdCYGJyfiooOIiw6isKSKbfuz+WJ/Nm+sOECgrxuj4yMZFR+Jv3f7Pz8hp+D+oqb4AAAQvUlEQVRSaM/ML8cJ6Nfdn4cm9GNIvxD8bkANIiIdkQJ8JzAsPJER3YZSV9f+Q0KupHfvaPr06cdXX23DYDAwbtylyZsjRtzGxo0b8PLyplev3hw+fJDdu3fi5+fX6vM8+OCjbNy4gblzn2Tq1Ptxc3Nn7drVhIVFUFb2rb1dXNxgfHx8efHFF5g6dTpOTk5s3LiB5kavxMaa2LTpExYsmIfJNAAPD09uu+32Ju1cXFx44ok5/P73v2XOnJ8yfvwELJY8Vqz4gOjoGO6+u+lKOCJdVaCvO/eOimbyiF7sP36e1LQsVn95irXbT2PuG8wYcxSmngFt+oCovMIK+/CYc5YynIC+3fyYkdKPIbEhN+QPBxGRjk4BXlplwoRJHD9+DLN5iH01GoBf/OIZDAYDmzd/QnV1DXFx8bz22kLmzp3T6nMEBwfzxhtvM3/+yyxd+rdGD3J66aX/Z2/n5+fPyy/P5803X2PRorfw8fFlwoQ7GDp0GHPnzm50zClTfsCxYxls2LCeDz74B+HhEc0GeIA777wbo9HIsmXvsnDh63h5eZGSMolZs+boqa1yU3JxNjAkNpQhsaHkFVbwxb5svjqYw+6j+YQFepKcEMnIuIhrnjBquXAptJ/Na/imrE83Px4Y35ehsaEE+Oj/OxGR73OyabZdqxQUlGG1Xv5Xlpt7hvDwpqulXC8XF4PDe+Cl7bXX+0WkvdXW1bM7I5+t+7I4nlmMi7OBYf1DSTZHERPpi5OTE18fzmXVFycoLKkm0NeN+0bHMHxgOAD5RZXszrCwM8PCmdxSAGKifEkyhTE0NoRA35Y//E1EpL2EhPiQn196w89rMDgRFOR92dcV4FtJAV7akgK8dAXnLGWk7mt4QFRVTT3dQ73pEebNznQLtd+7b7m6GEjsG4ylqJJTOQ0fiNGRviSZQhkaG0qQn0K7iHQsCvBdhAK8tCUFeOlKqmrq+OeRPFL3ZnHWcvlJ470jfOw97R1tiUoRke/rqAFeY+BFRKRNuBtdSE6IYnR8JI//cetl2/3Xo0k3sCoRka6nYz9mT0REOh0nJyeCfJufeHq57SIi0nIK8CIi0ubuGx2D0aXxR4zRxcB9o/UwNBGR66UhNCIi0uYurjZzuVVoRETk2inAtwObzdamDzaRrknzx6WrGz4wnOEDwx02CUxEpKvSEJo25uzsQm1tjaPLkE6gtrYGZ2f9DS0iIiKtowDfxry9/Skqyqemplo9rNIsm81GTU01RUX5eHv7O7ocERER6WTU/dfGPDy8ACguPk99fV2bHddgMGC1ah34rsLZ2QUfnwD7+0VERESkpRwa4Gtqanj99ddZs2YNJSUlmEwmnn76aYYPH96i/detW8e7777L8ePHMRqN9OvXj+eee47BgwcDcO7cOebNm8ehQ4fIz8/Hzc2NPn36MHPmTJKTk9vtujw8vNo8mGkMqYiIiIiAgwP8r371KzZt2sQjjzxCz549Wb16NTNnzmTp0qWYzeYr7jt//nwWL17MPffcw/Tp06moqCAjI4P8/Hx7m7y8PIqKirj77rsJDw+nqqqKzZs389Of/pQXX3yRqVOntvclioiIiIi0KSebgwZqHzhwgGnTpvH888/z2GOPAVBdXc3kyZMJDQ1l2bJll9137969PPjggyxYsICUlJRWnddqtXLfffdRV1fH+vXrW113QUEZVuuN/5WpB15EOivdv0Sks3LU/ctgcCIoyPvyr9/AWhr59NNPcXV1Zdq0afZtbm5uTJ06lT179mCxWC6775IlS4iLiyMlJQWr1Up5eXmLz2swGAgPD6ekpOS66hcRERERcQSHBfj09HR69+6Nl1fjseKDBw/GZrORnp5+2X2//vpr4uLimDdvHkOGDCExMZGxY8eydu3aZttXVlZSWFjI2bNn+dvf/sa2bdtaPM5eRERERKQjcdgY+Pz8fMLCwppsDwkJAbhsD3xxcTFFRUV8/PHHODs788wzz+Dv78+yZct49tln8fDwaDKs5o033uCdd94BGnrgJ0yYwG9+85s2viIRERERkfbnsABfVVWFq6trk+1ubm5Aw3j45lRUVABQVFTEhx9+SHx8PAApKSmkpKSwcOHCJgF++vTpjBo1CovFwsaNG6mvr6em5toetnSl8UjtLSTEx2HnFhG5Hrp/iUhn1RHvXw4bQuPu7k5tbW2T7ReD+8Ug/68ubu/WrZs9vAMYjUYmTpxIRkZGkzHxvXr1YsSIEdx777289dZbVFdXM2vWLD1oSUREREQ6HYcF+JCQkGaHyVxcBjI0NLTZ/fz9/TEajQQHBzd5LTg4GJvNRllZ2RXPPXHiRA4ePMipU6euoXIREREREcdxWIA3mUycOnWqSW/5/v377a83x2Aw0L9/f/Ly8pq8lpubi7OzM35+flc898Ve/qsFfRERERGRjsZhAX7SpEnU1tayfPly+7aamhpWrVpFYmKifYJrdnY2J06caLJvTk4O27dvt28rKyvjk08+wWw24+7uDkBhYWGT89bV1bF69Wrc3NyIiYlpj0sTEREREWk3DpvEGh8fz6RJk3j11VfJz8+nR48erF69muzsbP7whz/Y2/3yl79k586dHD161L7tgQceYPny5cyZM4fHHnsMX19fVq5cSWlpKXPnzrW3e+WVVzhz5gy33norERERnD9/nnXr1nHixAmeffbZJktYioiIiIh0dA57Eis0DGV57bXXWLduHcXFxcTGxjJ37lxGjBhhb/Pwww83CfDQMFb+5Zdf5osvvqCqqoqBAwcyd+5ckpKS7G22bNnCe++9x9GjRykqKsLDw4MBAwbw0EMPtfoJriIiIiIiHYFDA7yIiIiIiLSOw8bAi4iIiIhI6ynAi4iIiIh0IgrwIiIiIiKdiAK8iIiIiEgn4rBlJOXKLBYLS5YsYf/+/Rw6dIiKigqWLFnCLbfc4ujSRESu6MCBA6xevZpvvvmG7Oxs/P39MZvNPPXUU/Ts2dPR5YmIXNbBgwf585//zJEjRygoKMDHxweTycSTTz5JYmKio8uzU4DvoE6dOsWiRYvo2bMnsbGxpKWlObokEZEWWbx4MXv37mXSpEnExsaSn5/PsmXLuPfee1mxYoUeoiciHda5c+eor69n2rRphISEUFpayrp163jooYdYtGgRI0eOdHSJgJaR7LDKysqora0lICCALVu28OSTT6oHXkQ6hb179zJo0CCMRqN92+nTp7n77ru56667eOmllxxYnYhI61RWVjJ+/HgGDRrE22+/7ehyAPXAd1je3t6OLkFE5Jo09zVzr1696Nu3LydOnHBARSIi187Dw4PAwEBKSkocXYqdJrGKiEi7s9lsnD9/noCAAEeXIiJyVWVlZRQWFnLy5EnmzZvHsWPHGD58uKPLslMPvIiItLu1a9eSl5fH008/7ehSRESu6te//jUbN24EwNXVlfvvv59Zs2Y5uKpLFOBFRKRdnThxgv/+7/9myJAhTJkyxdHliIhc1ZNPPsn06dPJzc1lzZo11NTUUFtb22hujyNpCI2IiLSb/Px8fvrTn+Ln58frr7+OwaCPHRHp+GJjYxk5ciQ/+MEP+N///V8OHz7M888/7+iy7HQnFRGRdlFaWsrMmTMpLS1l8eLFhISEOLokEZFWc3V1Zdy4cWzatImqqipHlwMowIuISDuorq5m1qxZnD59mrfffpvo6GhHlyQics2qqqqw2WyUl5c7uhRAAV5ERNpYfX09Tz31FPv27eP1118nISHB0SWJiLRIYWFhk21lZWVs3LiRiIgIgoKCHFBVU5rE2oH96U9/ArCvm7xmzRr27NmDr68vDz30kCNLExG5rJdeeonPP/+cMWPGUFRUxJo1a+yveXl5MX78eAdWJyJyeU899RRubm6YzWZCQkLIyclh1apV5ObmMm/ePEeXZ6cnsXZgsbGxzW6Piori888/v8HViIi0zMMPP8zOnTubfU33LxHpyFasWMGaNWs4fvw4JSUl+Pj4kJCQwI9//GOGDRvm6PLsFOBFRERERDoRjYEXEREREelEFOBFRERERDoRBXgRERERkU5EAV5EREREpBNRgBcRERER6UQU4EVEREREOhEFeBERERGRTkQBXkREOryHH36YsWPHOroMEZEOwcXRBYiIiGN88803PPLII5d93dnZmSNHjtzAikREpCUU4EVEbnKTJ0/m9ttvb7LdYNCXtCIiHZECvIjITW7AgAFMmTLF0WWIiEgLqXtFRESuKDMzk9jYWBYsWMD69eu5++67iYuLIzk5mQULFlBXV9dkn4yMDJ588kluueUW4uLiuPPOO1m0aBH19fVN2ubn5/O73/2OcePGMWjQIIYPH86PfvQjtm/f3qRtXl4ec+fOJSkpifj4eB5//HFOnTrVLtctItJRqQdeROQmV1lZSWFhYZPtRqMRb29v+8+ff/45586dY8aMGQQHB/P555/z5ptvkp2dzR/+8Ad7u4MHD/Lwww/j4uJib7t161ZeffVVMjIy+J//+R9728zMTB544AEKCgqYMmUKgwYNorKykv3797Njxw5Gjhxpb1tRUcFDDz1EfHw8Tz/9NJmZmSxZsoSf/exnrF+/Hmdn53b6DYmIdCwK8CIiN7kFCxawYMGCJtuTk5N5++237T9nZGSwYsUKBg4cCMBDDz3E7NmzWbVqFdOnTychIQGAF198kZqaGt5//31MJpO97VNPPcX69euZOnUqw4cPB+C3v/0tFouFxYsXM2rUqEbnt1qtjX6+cOECjz/+ODNnzrRvCwwM5JVXXmHHjh1N9hcR6aoU4EVEbnLTp09n0qRJTbYHBgY2+nnEiBH28A7g5OTEv//7v7NlyxY2b95MQkICBQUFpKWlkZKSYg/vF9s+8cQTfPrpp2zevJnhw4dTVFTEl19+yahRo5oN3/86idZgMDRZNefWW28F4MyZMwrwInLTUIAXEbnJ9ezZkxEjRly1XUxMTJNtffr0AeDcuXNAw5CY72//vujoaAwGg73t2bNnsdlsDBgwoEV1hoaG4ubm1mibv78/AEVFRS06hohIV6BJrCIi0ilcaYy7zWa7gZWIiDiWAryIiLTIiRMnmmw7fvw4AN27dwegW7dujbZ/38mTJ7Farfa2PXr0wMnJifT09PYqWUSkS1KAFxGRFtmxYweHDx+2/2yz2Vi8eDEA48ePByAoKAiz2czWrVs5duxYo7Z/+ctfAEhJSQEahr/cfvvtbNu2jR07djQ5n3rVRUSapzHwIiI3uSNHjrBmzZpmX7sYzAFMJhOPPvooM2bMICQkhM8++4wdO3YwZcoUzGazvd1vfvMbHn74YWbMmMGDDz5ISEgIW7du5auvvmLy5Mn2FWgA/uu//osjR44wc+ZM7r33XgYOHEh1dTX79+8nKiqKZ599tv0uXESkk1KAFxG5ya1fv57169c3+9qmTZvsY8/Hjh1L7969efvttzl16hRBQUH87Gc/42c/+1mjfeLi4nj//fd54403eO+996ioqKB79+4888wz/PjHP27Utnv37qxcuZKFCxeybds21qxZg6+vLyaTienTp7fPBYuIdHJONn1HKSIiV5CZmcm4ceOYPXs2c+bMcXQ5IiI3PY2BFxERERHpRBTgRUREREQ6EQV4EREREZFORGPgRUREREQ6EfXAi4iIiIh0IgrwIiIiIiKdiAK8iIiIiEgnogAvIiIiItKJKMCLiIiIiHQiCvAiIiIiIp3I/wdlEaOe9BNG5QAAAABJRU5ErkJggg==\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "PIiTkifUKorx"
      },
      "source": [
        "## 8. Performance on Test Set\n",
        "\n",
        "We will load the test dataset and prepare inputs as we did for the training set, then evaluate predictions using [Matthews correlation coefficient](https://scikit-learn.org/stable/modules/generated/sklearn.metrics.matthews_corrcoef.html). \n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 8.1 Data Preparation\n",
        "\n",
        "We will apply all of the same steps that we did for the training data to prepare our test dataset."
      ],
      "metadata": {
        "id": "XWSPFoYVukT_"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Print out test dataset\n",
        "test_data"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 520
        },
        "id": "aeTUJ6FCOqKm",
        "outputId": "39651dbf-6057-4826-d33d-4619baa4fa5d"
      },
      "execution_count": 47,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                               filtered_articles_split  Label\n",
              "131  [Â Reuters UK shares lower close trade Investi...      0\n",
              "132  [By Benzinga With ongoing layoff fiasco happen...      0\n",
              "133  [Â Reuters CVX Add toRemove Portfolio LLY Add ...      0\n",
              "134  [AZN Add toRemove Portfolio Add toRemove Portf...      0\n",
              "135  [Â Reuters FILE PHOTO Signage seen outside ent...      1\n",
              "136  [AVEPp Add toRemove Portfolio ROG Add toRemove...      1\n",
              "137  [Â Reuters FILE PHOTO Pascal Soriot chief exec...      1\n",
              "138  [Â Reuters FILE PHOTO The company logo pharmac...      0\n",
              "139  [Â Reuters AstraZeneca says Evusheld approved ...      1\n",
              "140  [By Benzinga With ongoing layoff fiasco happen...      1\n",
              "141  [Â Reuters AstraZeneca gets third regulatory g...      1\n",
              "142  [Â Reuters FILE PHOTO A test tube labelled vac...      0\n",
              "143  [AstraZeneca Touts Positive Data From Two Expe...      0\n",
              "144  [AstraZeneca Ultomiris Showed Zero Relapses In...      1\n",
              "145  [Â Reuters BATS Add toRemove Portfolio AZN Add...      1"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ea87b904-6ebb-48e5-ad5a-64a664809f3f\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>filtered_articles_split</th>\n",
              "      <th>Label</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>131</th>\n",
              "      <td>[Â Reuters UK shares lower close trade Investi...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>132</th>\n",
              "      <td>[By Benzinga With ongoing layoff fiasco happen...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>133</th>\n",
              "      <td>[Â Reuters CVX Add toRemove Portfolio LLY Add ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>134</th>\n",
              "      <td>[AZN Add toRemove Portfolio Add toRemove Portf...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>135</th>\n",
              "      <td>[Â Reuters FILE PHOTO Signage seen outside ent...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>136</th>\n",
              "      <td>[AVEPp Add toRemove Portfolio ROG Add toRemove...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>137</th>\n",
              "      <td>[Â Reuters FILE PHOTO Pascal Soriot chief exec...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>138</th>\n",
              "      <td>[Â Reuters FILE PHOTO The company logo pharmac...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>139</th>\n",
              "      <td>[Â Reuters AstraZeneca says Evusheld approved ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>140</th>\n",
              "      <td>[By Benzinga With ongoing layoff fiasco happen...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141</th>\n",
              "      <td>[Â Reuters AstraZeneca gets third regulatory g...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>142</th>\n",
              "      <td>[Â Reuters FILE PHOTO A test tube labelled vac...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143</th>\n",
              "      <td>[AstraZeneca Touts Positive Data From Two Expe...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144</th>\n",
              "      <td>[AstraZeneca Ultomiris Showed Zero Relapses In...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>145</th>\n",
              "      <td>[Â Reuters BATS Add toRemove Portfolio AZN Add...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ea87b904-6ebb-48e5-ad5a-64a664809f3f')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-ea87b904-6ebb-48e5-ad5a-64a664809f3f button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-ea87b904-6ebb-48e5-ad5a-64a664809f3f');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 47
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Report the number of sentences.\n",
        "print(f'Number of test articles: {test_data.shape[0]}\\n')\n",
        "\n",
        "# Create sentence and label lists\n",
        "articles = test_data.filtered_articles_split.values\n",
        "labels = test_data.Label.values\n",
        "\n",
        "# Tokenise all of the sentences and map the tokens to their word IDs.\n",
        "input_ids = []\n",
        "attention_masks = []\n",
        "\n",
        "# For every sentence...\n",
        "for article in articles:\n",
        "    # `encode_plus` will:\n",
        "    #   (1) Tokenize the sentence.\n",
        "    #   (2) Prepend the `[CLS]` token to the start.\n",
        "    #   (3) Append the `[SEP]` token to the end.\n",
        "    #   (4) Map tokens to their IDs.\n",
        "    #   (5) Pad or truncate the sentence to `max_length`\n",
        "    #   (6) Create attention masks for [PAD] tokens.\n",
        "    encoded_dict = tokenizer.encode_plus(\n",
        "                        article,                   # Sentence to encode.\n",
        "                        add_special_tokens = True, # Add '[CLS]' and '[SEP]'\n",
        "                        max_length = 200,           # Pad and truncate all sentences.  \n",
        "                        return_token_type_ids=False,\n",
        "                        pad_to_max_length = True,\n",
        "                        return_attention_mask = True,   # Construct attention masks.\n",
        "                        return_tensors = 'pt',     # Return pytorch tensors.\n",
        "                   )\n",
        "    \n",
        "    # Add the encoded sentence to the list.    \n",
        "    input_ids.append(encoded_dict['input_ids'])\n",
        "    \n",
        "    # And its attention mask (simply differentiates padding from non-padding).\n",
        "    attention_masks.append(encoded_dict['attention_mask'])\n",
        "\n",
        "# Convert the lists into tensors.\n",
        "input_ids = torch.cat(input_ids, dim=0)\n",
        "attention_masks = torch.cat(attention_masks, dim=0)\n",
        "labels = torch.tensor(labels)\n",
        "\n",
        "# Set the batch size.  \n",
        "batch_size = 16  \n",
        "\n",
        "# Create the DataLoader.\n",
        "prediction_data = TensorDataset(input_ids, attention_masks, labels)\n",
        "prediction_sampler = SequentialSampler(prediction_data)\n",
        "prediction_data_loader = DataLoader(prediction_data, sampler=prediction_sampler, batch_size=batch_size)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PLlfPYl_oa_w",
        "outputId": "e9773ae8-dd97-49ec-a808-4183531ce27e"
      },
      "execution_count": 48,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Number of test articles: 15\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GH2VQhOpZRan"
      },
      "source": [
        "### 8.2 Evaluate on Test Set\n",
        "\n",
        "We can now apply our fine-tuned model to generate predictions on the test set.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Prediction on test set\n",
        "\n",
        "print(f'Predicting labels for {len(input_ids)} test articles...')\n",
        "\n",
        "# Put model in evaluation mode\n",
        "model.eval()\n",
        "\n",
        "# Tracking variables \n",
        "predictions, true_labels = [], []\n",
        "\n",
        "# Predict \n",
        "for batch in prediction_data_loader:\n",
        "  # Add batch to GPU\n",
        "  batch = tuple(t.to(device) for t in batch)\n",
        "  \n",
        "  # Unpack the inputs from our dataloader\n",
        "  b_input_ids, b_input_mask, b_labels = batch\n",
        "  \n",
        "  # Telling the model not to compute or store gradients, saving memory and \n",
        "  # speeding up prediction\n",
        "  with torch.no_grad():\n",
        "      # Forward pass, calculate logit predictions\n",
        "      outputs = model(b_input_ids, token_type_ids=None, \n",
        "                      attention_mask=b_input_mask)\n",
        "\n",
        "  logits = outputs[0]\n",
        "\n",
        "  # Move logits and labels to CPU\n",
        "  logits = logits.detach().cpu().numpy()\n",
        "  label_ids = b_labels.to('cpu').numpy()\n",
        "  \n",
        "  # Store predictions and true labels\n",
        "  predictions.append(logits)\n",
        "  true_labels.append(label_ids)\n",
        "\n",
        "print('    DONE.')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0qhwghFxNY1X",
        "outputId": "3f62708d-612e-424a-fa26-faa6f4a02153"
      },
      "execution_count": 49,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Predicting labels for 15 test articles...\n",
            "    DONE.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print('Positive samples: %d of %d (%.2f%%)' % (test_data.Label.sum(), len(test_data.Label), (test_data.Label.sum() / len(test_data.Label) * 100.0)))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MhbQ00KedYYl",
        "outputId": "75d07cba-fa71-48ea-aa21-1efdd6237e83"
      },
      "execution_count": 50,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Positive samples: 8 of 15 (53.33%)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 10. References\n",
        "\n",
        "*   [BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding](https://arxiv.org/pdf/1810.04805.pdf)\n",
        "*   [Hierarchical Transformers for Long Document Classification](https://arxiv.org/abs/1910.10781.pdf)\n",
        "*   [How to Fine-Tune BERT for Text Classification?](https://arxiv.org/pdf/1905.05583.pdf)\n",
        "*   [BERT Fine-Tuning Tutorial with PyTorch](https://mccormickml.com/2019/07/22/BERT-fine-tuning/)\n",
        "*   [Sentiment Analysis with BERT and Transformers by Hugging Face using PyTorch and Python](https://curiousily.com/posts/sentiment-analysis-with-bert-and-hugging-face-using-pytorch-and-python/#choosing-sequence-length)\n",
        "*   [Text Classification with BERT using Transformers for long text inputs](https://medium.com/analytics-vidhya/text-classification-with-bert-using-transformers-for-long-text-inputs-f54833994dfd)\n",
        "*   [Using BERT For Classifying Documents with Long Texts](https://medium.com/@armandj.olivares/using-bert-for-classifying-documents-with-long-texts-5c3e7b04573d)\n",
        "*   [Fine-Tuning BERT model using PyTorch](https://medium.com/@prakashakshay/fine-tuning-bert-model-using-pytorch-f34148d58a37)\n",
        "\n"
      ],
      "metadata": {
        "id": "eulpvjYd4JIF"
      }
    }
  ]
}